Home   Package List   Routine Alphabetical List   Global Alphabetical List   FileMan Files List   FileMan Sub-Files List   Package Component Lists   Package-Namespace Mapping  
Info |  Desc |  Directly Accessed By Routines |  Accessed By FileMan Db Calls |  Pointed To By FileMan Files |  Pointer To FileMan Files |  Fields |  ICR |  External References |  Global Variables Directly Accessed |  Naked Globals |  Local Variables  | All
Print Page as PDF
Global: ^ONCO(165.5

Package: Oncology

Global: ^ONCO(165.5


Information

FileMan FileNo FileMan Filename Package
165.5 ONCOLOGY PRIMARY Oncology

Description

Directly Accessed By Routines, Total: 508

Package Total Routines
Oncology 335 ONC2PR20    ONC2PS01    ONC2PS05    ONC2PS13    ONC2PS14    ONC2PS1A    ONC2PS4A    ONC2PSTN
ONCACDU1    ONCACDU2    ONCASCI    ONCBPC4    ONCBPC5    ONCBPC6    ONCBRP2    ONCBRP3
ONCBRP5    ONCBRP9B    ONCCPC0    ONCCPC4    ONCCPC4A    ONCCPC7    ONCCS3    ONCCSV2
ONCEDIT    ONCGPC3    ONCHPC2A    ONCHPC4    ONCIPC2A    ONCIPC3    ONCIPC3B    ONCIPC4
ONCIPC5    ONCIPC8C    ONCLPC1    ONCMPC4    ONCMPC9    ONCNPC6    ONCNTX    ONCO ABSTRACT NOT-COMPLETE
ONCO ABSTRACT RECORD    ONCO ANN/ANAL/STA/SITE/DX AGE    ONCO ANNUAL CLASS/SITE    ONCO UPDATE CONTACT    ONCOAI    ONCOAIF    ONCOAIM    ONCOAIP
ONCOAIQ    ONCOAIS    ONCOANC5    ONCOCC    ONCOCFP    ONCOCOFA    ONCOCON    ONCODLF
ONCODSR    ONCOEDC    ONCOEDC2    ONCOEOD1    ONCOES    ONCOHICD    ONCOIT    ONCOMNI
ONCOPA1A    ONCOPA2    ONCOPA2A    ONCOPA3    ONCOPRT    ONCOSCG    ONCOST    ONCOST1
ONCOSUR    ONCOTN    ONCOTNE    ONCOTNO    ONCOU55B    ONCOUK    ONCOUTC    ONCOW
ONCOW1    ONCOX11    ONCOX3    ONCOX51    ONCOX6    ONCOX61    ONCOX71    ONCOXS1
ONCOY55    ONCOY56    ONCP2P4    ONCP2P4A    ONCP2P8    ONCPCDX    ONCPM    ONCPPC1
ONCPPC5    ONCPPC6    ONCPPC9    ONCPST44    ONCPST48    ONCPTX    ONCSCHM0    ONCSCHMC
ONCSCHMD    ONCSCHMN    ONCSCHMS    ONCSCHMY    ONCSG3    ^ONCO(169.99    ONCPST45    ONCPST50
ONCSCHMA    ONCSCHMX    ONCSG4A    ONCSGA8U    ONCSPC2    ONCSRVRP    ONCSSF25    ONCSSF4
ONCSUBS    ONCTIME    ONCTPC3    ONCTPC4    ONCTPC5    ^ONCO(160    ONC2PR21    ONC2PS04
ONC2PS06    ONC2PS10    ONC2PS12    ONC2PS17    ONC2PS18    ONC2PS21    ONC2PS22    ONCACD0
ONCACD1    ONCATF    ONCATF1    ONCATF2    ONCBPC0    ONCBPC1    ONCBPC2    ONCBPC3
ONCBPC4A    ONCBPC8    ONCBPC8A    ONCBRP0    ONCBRP1    ONCBRP4    ONCBRP5A    ONCBRP7
ONCBRP9    ONCCPC2    ONCCPC9B    ONCCS    ONCCS2    ONCCS4    ONCCSRS    ONCCSRS1
ONCCSSTF    ONCCSV2A    ONCDTX    ONCDTX1    ONCFUNC    ONCGENED    ONCGPC0    ONCGPC1
ONCGPC2    ONCGPC4    ONCHPC0    ONCHPC4A    ONCHPC6    ONCHPC8    ONCHPC8A    ONCIPC0
ONCIPC3A    ONCIPC3C    ONCIPC6    ONCIPC8    ONCLPC0    ONCLPC3    ONCLPC5    ONCLPC6
ONCMPC0    ONCMPC1    ONCMPC2    ONCMPC3    ONCMPC4A    ONCMPC6    ONCMPC9B    ONCMPH
ONCNPC0    ONCNPC2    ONCNPC4    ONCNPC4A    ONCNPC8B    ONCNPI    ONCNTX1    ONCO ABSTINCOM-TERMDIG
ONCO ABSTRACT NOT-COMPLETE 1    ONCO ABSTRACT-I    ONCO ANNUAL HIST/SITE/ICDO    ONCO ANNUAL ICDO/STAGE/TX    ONCO ANNUAL SITE/GP    ONCO RECURRENCE FOLLOWUP    ONCO UTL CORRECT DATA    ONCOAIC
ONCOAIP1    ONCOAIP2    ONCOANC0    ONCOANC1    ONCOANC3    ONCOANC4    ONCOAS    ONCOCFL1
ONCOCFR    ONCOCKI    ONCOCOC    ONCOCOF    ONCOCOM    ONCOCOP    ONCOCOS    ONCOCRC
ONCOCRF    ONCODEL    ONCODGR    ONCODSP    ONCODXD    ONCOFDP    ONCOFTS    ONCOGEN
ONCOOT    ONCOPA1    ONCOPA3A    ONCOPCE    ONCOPFX    ONCOPMA    ONCOPMB    ONCOSA
ONCOSA1    ONCOSC1    ONCOSUR1    ONCOSUR2    ONCOSUR3    ONCOTM    ONCOTNM    ONCOTNM2
ONCOTNS    ONCOU    ONCOU55    ONCOU55A    ONCOW11    ONCOX10    ONCOX2    ONCOX21
ONCOX5    ONCOX7    ONCOX8    ONCOX9    ONCOXA1    ONCOXA2    ONCOXA3    ONCOXA4
ONCOXNC    ONCOXU    ONCOY49    ONCOY50    ONCOY51    ONCOY52    ONCOY53    ONCOY54
ONCOY57    ONCOY58    ONCP2P0    ONCP2P2    ONCP2P6    ONCP2P8B    ONCPCI    ONCPHC
ONCPMB    ONCPMC    ONCPML    ONCPMP    ONCPPC0    ONCPPC7    ONCPPC9B    ONCPRE47
ONCPSD    ONCPST46    ONCRESTG    ONCRFNR    ONCRPC    ONCRR    ONCSCHMB    ONCSCHME
ONCSCHMG    ONCSCHMH    ONCSCHMM    ONCSCHMP    ONCSCHMU    ONCSG5A    ONCSGA8B    ONCSGA8H
^ONCO(165.5    ONCSG1    ONCSG5    ONCSGA8A    ONCSPC0    ONCSPC3    ONCSPC4    ONCSPC4A
ONCSPC5    ONCSPC6    ONCSPC8A    ONCSRVTM    ONCSSF1    ONCSSF2    ONCSSF3    ONCSSF5
ONCSSF6    ONCSTX    ONCSYMP    ONCTEXT    ONCTNMC    ONCTPC0    ONCTPC2    ONCTPC6
ONCTPC8A    ONCTXSM    ONCUTX    ONCUTX1    RADIATION TREATMENT    SUBSEQUENT RECURRENCES    TUMOR STATUS    
Health Summary 1 GMTSONE    

Accessed By FileMan Db Calls, Total: 202

Package Total Routines
Oncology 201 ONC2PS04    ONC2PS13    ONC2PS1A    ONC2PS4A    ONCACD0    ONCACD1    ONCACDU1    ONCACDU2
ONCASCI    ONCATF    ONCATF1    ONCBPC1    ONCBPC2    ONCBPC3    ONCBPC4    ONCBPC5
ONCBPC6    ONCBPC8    ONCBRP1    ONCBRP2    ONCBRP3    ONCBRP4    ONCBRP5    ONCBRP5A
ONCBRP6    ONCBRP7    ONCBRP9    ONCCPC1    ONCCPC2    ONCCPC3    ONCCPC4    ONCCPC5
ONCCPC6    ONCCPC7    ONCCPC9    ONCCS    ONCCS2    ONCCSRS    ONCCSRS1    ONCCSSTF
ONCEDIT    ONCEDIT2    ONCFUNC    ONCGENED    ONCGPC1    ONCGPC2    ONCGPC3    ONCGPC4
ONCGPC5    ONCGPC7    ONCGPC7A    ONCGPC7B    ONCHPC1    ONCHPC2    ONCHPC3    ONCHPC4
ONCHPC4A    ONCHPC5    ONCHPC8    ONCHPC8A    ONCIPC1    ONCIPC2    ONCIPC2A    ONCIPC3
ONCIPC3A    ONCIPC3B    ONCIPC3C    ONCIPC4    ONCIPC5    ONCIPC8    ONCIPC8A    ONCIPC8B
ONCIPC8C    ONCLPC1    ONCLPC2    ONCLPC3    ONCLPC4    ONCLPC5    ONCLPC6    ONCLPC7
ONCLPC9    ONCLPC9A    ONCLPC9B    ONCMPC1    ONCMPC2    ONCMPC3    ONCMPC4    ONCMPC5
ONCMPC7    ONCMPC9    ONCMPH    ONCNPC1    ONCNPC2    ONCNPC3    ONCNPC4    ONCNPC5
ONCNPC6    ONCNPC8    ONCNPI    ONCNTX    ONCNTX1    ONCOAI    ONCOAIC    ONCOAIF
ONCOAIM    ONCOAIP    ONCOAIP1    ONCOAIP2    ONCOAIQ    ONCOAIT    ONCOCC    ONCOCOF
ONCOCOM    ONCOCOML    ONCODSP    ONCODSR    ONCOEDC    ONCOEDC1    ONCOEDC2    ONCOFDP
ONCOGEN    ONCOPA1    ONCOPA4    ONCOPAR    ONCOPMP    ONCOPRT    ONCORF    ONCOSSA
ONCOSUR    ONCOSUR3    ONCOTM    ONCOTNE    ONCOTNO    ONCOTNS    ONCOU55    ONCOUK
ONCOUTC    ONCOXA3    ONCOXNC    ONCOY52    ONCOY54    ONCOY55    ONCP2P1    ONCP2P2
ONCP2P3    ONCP2P4    ONCP2P4A    ONCP2P5    ONCP2P6    ONCP2P8    ONCPCI    ONCPCS
ONCPHC    ONCPM    ONCPMB    ONCPMC    ONCPML    ONCPMP    ONCPPC1    ONCPPC2
ONCPPC3    ONCPPC4    ONCPPC5    ONCPPC6    ONCPPC7    ONCPPC9    ONCPPC9A    ONCPPC9B
ONCPRE44    ONCPSD    ONCPST44    ONCPST48    ONCPTX    ONCRFNR    ONCSAPI1    ONCSG5
ONCSPC1    ONCSPC2    ONCSPC3    ONCSPC4    ONCSPC5    ONCSPC6    ONCSPC8    ONCSPC8A
ONCSRVTM    ONCSTX    ONCSYMP    ONCTIME    ONCTNMC    ONCTPC1    ONCTPC2    ONCTPC3
ONCTPC4    ONCTPC5    ONCTPC6    ONCTPC8    ONCTPC8A    ONCTXSM    ONCUTX    ONCUTX1
ONCWEBCS    
Health Summary 1 GMTSONE    

Pointed To By FileMan Files, Total: 1

Package Total FileMan Files
Oncology 1 COMPUTED PRIMARY(#165.59)[.01]    

Pointer To FileMan Files, Total: 43

Package Total FileMan Files
Oncology 39 ONCOLOGY PATIENT(#160)[.02]    TYPE OF RECURRENCE(#160.12)[71, 71.4, #165.572(.02)]
FACILITY(#160.19)[.03, 5, 6, 7, 50.1, 51.1, 52.1, 53.1, 54.1, 55.1, 57.1, #165.51(2)]    PRIMARY PAYER AT DIAGNOSIS(#160.3)[18]    ICDO TOPOGRAPHY(#164)[20, 803, 805, 1102, 1104, 1403, 1573, #165.52(1)]    ICDO-SITES(#164.08)[.022]    ICD-O-2 MORPHOLOGY(#164.1)[22, 804, 806]
TUMOR MARKERS(#164.15)[25.1, 25.2, 25.3]
KARNOFSKY'S RATING(#164.17)[1311, 1367, 1371]
CHEMOTHERAPEUTIC DRUGS(#164.18)[1423, 1423.1, 1423.2, 1423.3, 1423.4, 1576, 1576.1, 1576.2]    SITE-GROUP FOR ONCOLOGY(#164.2)[.01, 148.1, 148.2, 148.3, 148.4]    OTHER STAGING FOR ONCOLOGY(#164.3)[39]    PRIMARY CANCER STATUS CODE(#164.42)[95, #165.573(.02)]    GRADE(#164.43)[24]    TYPE OF STAGING SYSTEM (PEDIATRIC)(#164.6)[849]    RADIATION TREATMENT VOLUME(#164.7)[125, 129]    RADIATION COMPLETION STATUS(#164.8)[128]    ONCO RADIATION EXTERNAL BEAM(#164.81)[5502, 5512, 5522]
ONCO RADIATION TREATMENT VOLUME(#164.82)[5504, 5514, 5524]
ONCO RADIATION TO DRAINING LN(#164.83)[5505, 5515, 5525]
ONCO RADIATION TREATMENT MODALITY(#164.84)[5506, 5516, 5526]
WHO HISTOLOGICAL CLASSIFICATION(#164.9)[1308]    ONCOLOGY CONTACT(#165)[2, 2.1, 2.2, 2.3, 2.4, 66]    CLASS OF CASE(#165.3)[.04]    ONCOLOGY STAGED BY CODES(#165.7)[19, 89]    CASEFINDING SOURCE(#166)[21]    BLADDER PHYSICIAN SPECIALTY(#166.12)[347, 348]    REGIONAL TREATMENT MODALITY(#166.13)[363, 363.1]    ONCOLOGY SUBSITE(#166.3)[519]    HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES(#167)[153, 153.2, #165.51(.02)]
ONCO BRAIN MOLECULAR MARKERS(#167.1)[3816]    GLEASON PATTERNS(#167.2)[3838, 3839]    ONCO LN STATUS(#167.3)[3884]    ONCO PERIPHERAL BLOOD INVOLVEMENT(#167.4)[3910]    ONCO RESIDUAL TUMOR VOLUME(#167.5)[3921]    ONCO HPV STATUS(#167.7)[3700]    TYPE OF REPORTING SOURCE(#168)[1.2]    TYPE OF MULTIPLE TUMORS(#169)[194]    ICD-O-3 MORPHOLOGY(#169.3)[22.3]    
Kernel 3 INSTITUTION(#4)[2000]    STATE(#5)[16, 7000, 7001, 7023]    NEW PERSON(#200)[64.1, 92, 199, 244]    
DRG Grouper 1 ICD DIAGNOSIS(#80)[1400, 1400.1, 1400.2, 1400.3, 1400.4, 1400.5, 1426, 1426.1, 1426.2, 1426.3, 1426.4, 1571, 1571.1, 1571.2, 1571.3, 1571.4, 1571.5, 1579, 1579.1, 1579.2, 1579.3, 1579.4]    

Fields, Total: 1902

Field # Name Loc Type Details
.01 SITE/GP 0;1 POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2)
************************REQUIRED FIELD************************
SITE-GROUP FOR ONCOLOGY(#164.2)

  • LAST EDITED:  AUG 12, 2005
  • HELP-PROMPT:  Enter the SITE/GP which best categorizes the primary.
  • DESCRIPTION:  
    Enter the SITE/GP for this primary.
  • SCREEN:  S DIC("S")="I '$P(^(0),U,3)"
  • EXPLANATION:  Histologic site groups may not be selected.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^B
    1)= S ^ONCO(165.5,"B",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"B",$E(X,1,30),DA)
  • CROSS-REFERENCE:  165.5^ACF^MUMPS
    1)= S ^ONCO(165.59,DA,0)=X
    2)= K ^ONCO(165.59,DA,0)
    This cross reference creates an entry in File 165.59 which consists on;y of computed fields for this file. It is a side-car/side-kick file which does not store any data, but references other data for reports.
.0101 PRIMARY SITE/GP COMPUTED

  • MUMPS CODE:  S X="" I D0>0 S X=$P(^ONCO(164.2,$P(^ONCO(165.5,D0,0),U),0),U)
  • ALGORITHM:  S X=.01 OF ^ONCO(164.2)
  • DESCRIPTION:  
    A COMPUTED FIELD RECORDING THE PRIMARY SITE/GROUP FOR ONCOLOGY.
.015 SELECTED SITES COMPUTED

  • MUMPS CODE:  S X="" D SICD^ONCOCOS
  • ALGORITHM:  S X="" D SICD^ONCOCOS
  • LAST EDITED:  JAN 11, 2007
  • DESCRIPTION:  
    This COMPUTED field displays selected SITE/GP (165.5,.01) values.
.017 SYSTEMS COMPUTED

  • MUMPS CODE:  S X="" D SYS^ONCOCOS
  • ALGORITHM:  S X="" D SYS^ONCOCOS
  • DESCRIPTION:  
    COMPUTED FIELD RECORDING THE MAJOR BODY SYSTEMS, SUCH AS LYMPHATIC, GASTROINTESTINAL, GENITOURINARY, ETC.
.02 PATIENT NAME 0;2 POINTER TO ONCOLOGY PATIENT FILE (#160)
************************REQUIRED FIELD************************
ONCOLOGY PATIENT(#160)

  • INPUT TRANSFORM:  I $D(X) D PSEX^ONCOCKI
  • LAST EDITED:  JUN 20, 1996
  • DESCRIPTION:  
    Enter Oncology Patient Name.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^C
    1)= S ^ONCO(165.5,"C",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"C",$E(X,1,30),DA)
    Indexes file by PATIENT NAME.
.022 ICDO-SITE 0;22 POINTER TO ICDO-SITES FILE (#164.08)
************************REQUIRED FIELD************************
ICDO-SITES(#164.08)

  • LAST EDITED:  APR 06, 1990
  • DESCRIPTION:  
    Listing of primary sites in accordance with ICDO-2 (1992).
.023 PRIMARY SITE CODE PREFIX COMPUTED

  • MUMPS CODE:  S X=$P($G(^ONCO(165.5,D0,2)),U,1) I X'="" S X="C"_$E(X,3,4)
  • ALGORITHM:  CUSTOM CODED
  • LAST EDITED:  NOV 25, 2005
  • DESCRIPTION:  
    Identifies the three-digit code prefix for the primary site.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
.025 PATIENT ID COMPUTED

  • MUMPS CODE:  S X="" D PID^ONCOCOP
  • ALGORITHM:  S X="" D PID^ONCOCOP
  • DESCRIPTION:  
    COMPUTED FIELD FOR RECORDING THE PATIENT IDENTIFICATION NUMBER.
.03 REPORTING FACILITY 0;3 POINTER TO FACILITY FILE (#160.19)
************************REQUIRED FIELD************************
FACILITY(#160.19)

  • OUTPUT TRANSFORM:  I Y'="" S Y=$P($G(^ONCO(160.19,Y,0)),U,2)
  • LAST EDITED:  OCT 22, 2008
  • DESCRIPTION:  
    REPORTING FACILITY identifies the facility reporting the case.
  • GROUP:  ACOS-REQUIRED
.04 CLASS OF CASE 0;4 POINTER TO CLASS OF CASE FILE (#165.3)
************************REQUIRED FIELD************************
CLASS OF CASE(#165.3)

  • INPUT TRANSFORM:  D COCIT^ONCOSUR1
  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(165.3,Y,0),U,1)_" "_$P(^ONCO(165.3,Y,0),U,2)
  • LAST EDITED:  JUN 21, 2022
  • HELP-PROMPT:  Enter a CLASS OF CASE code.
  • DESCRIPTION:  CLASS OF CASE reflects the facility's role in managing the cancer, whether the cancer is required to be reported by CoC, and whether the case was diagnosed after the program's Reference Date.
    CLASS OF CASE divides cases into two groups.
    Analytic cases (codes 00-22) are those that are required by CoC to be abstracted because of the program's primary responsibility in managing the cancer. Analytic cases are grouped according to the location of diagnosis
    and first course of treatment.
    Nonanalytic cases (codes 30-49 and 99) may be abstracted by the facility to meet central registry requirements or in response to a request by the facility's cancer program. Nonanalytic cases are grouped according to the
    reason a patient who received care at the facility is nonanalytic, or the reason a patient who never received care at the facility may have been abstracted.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^.042
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=$P(Y(1),U,20),X=X S DIU=X K Y S X=DIV S X=$S(X>9:0,1:1) S DIH=$G(^ONCO(165.5,DIV(0),0)),DIV=X S $P(^(0),U,20)=DIV,DIH=165.5,DIG=.042 D ^DICR
    2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=$P(Y(1),U,20),X=X S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),0)),DIV=X S $P(^(0),U,20)=DIV,DIH=165.5,DIG=.042 D ^DICR
    CREATE VALUE)= S X=$S(X>9:0,1:1)
    DELETE VALUE)= @
    FIELD)= CLASS CATEGORY
    CLASS CATEGORY (165.5,.042) will be stuffed with either 1 (ANALYTIC) or 0 (NONANALYTIC) depending on the CLASS OF CASE value.
  • CROSS-REFERENCE:  165.5^AAY^MUMPS
    1)= I X>-1,X<10 S XX=$P(^ONCO(165.5,DA,0),U,7) S:XX'="" ^ONCO(165.5,"AAY",XX,DA)=""
    2)= I X>-1,X<10 S XX=$P(^ONCO(165.5,DA,0),U,7) K:XX'="" ^ONCO(165.5,"AAY",XX,DA) K XX
    Creates an index of analytic (CLASS OF CASE 00-22) cases cross-referenced by ACCESSION YEAR (165.5,.07).
.041 CLASS NO. COMPUTED

  • MUMPS CODE:  N COC S COC=$E($$GET1^DIQ(165.5,D0,.04,"E"),1,2),X=$S(COC="":"None",1:COC)
  • ALGORITHM:  N COC S COC=$E($$GET1^DIQ(165.5,D0,.04,"E"),1,2),X=$S(COC="":"None",1:COC)
  • LAST EDITED:  AUG 18, 2010
  • DESCRIPTION:  
    Computed CLASS OF CASE code. It is derived from CLASS OF CASE (165.5,.04).
.042 CLASS CATEGORY 0;20 SET
************************REQUIRED FIELD************************
  • '0' FOR NONANALYTIC;
  • '1' FOR ANALYTIC;

  • LAST EDITED:  OCT 29, 2002
  • HELP-PROMPT:  DO NOT PROMPT-FIELD IS STUFFED BY #.04 (CLASS OF CASE)
  • DESCRIPTION:  
    Record the category of case, either Analytic or Nonanalytic.
  • NOTES:  TRIGGERED by the CLASS OF CASE field of the ONCOLOGY PRIMARY File
  • CROSS-REFERENCE:  165.5^AG
    1)= S ^ONCO(165.5,"AG",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"AG",$E(X,1,30),DA)
    Indexes file by CLASS CATEGORY.
.043 ANALYTIC PRIMARY REQ FOLLOWUP COMPUTED

  • MUMPS CODE:  D ARFPRI^ONCOCOM
  • ALGORITHM:  D ARFPRI^ONCOCOM
  • LAST EDITED:  OCT 08, 2014
.05 ACCESSION NUMBER 0;5 FREE TEXT
************************REQUIRED FIELD************************

  • INPUT TRANSFORM:  K:X[""""!($A(X)=45) X I $D(X) K:$L(X)>9!($L(X)<9)!'(X?.N)!($E(X,5,9)="00000") X I $D(X) D ACN^ONCOCKI
  • LAST EDITED:  DEC 07, 1999
  • HELP-PROMPT:  Enter the 9-digit ACCESSION NUMBER.
  • DESCRIPTION:  Provides a unique identifier for the patient consisting of the year in which the patient was first seen at the reporting facility and the consecutive order in which the patient was abstracted.
    For further information see FORDS page 33.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^D1^MUMPS
    1)= S XX=$P(^ONCO(165.5,DA,0),U,6) Q:XX="" S ^ONCO(165.5,"D",$E(X,1,4)_"-"_$E(X,5,9)_"/"_XX,DA)=""
    2)= S XX=$P(^ONCO(165.5,DA,0),U,6) Q:XX="" K ^ONCO(165.5,"D",$E(X,1,4)_"-"_$E(X,5,9)_"/"_XX,DA)
    Indexes the file by the display value of ACCESSION NUMBER and SEQUENCE NUMBER.
  • CROSS-REFERENCE:  165.5^AE^MUMPS
    1)= S ^ONCO(165.5,"AE",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
    2)= K ^ONCO(165.5,"AE",X,$P(^ONCO(165.5,DA,0),U,2),DA)
    Indexes the file by ACCESSION NUMBER and PATIENT NAME.
  • CROSS-REFERENCE:  165.5^AF^MUMPS
    1)= S ^ONCO(165.5,"AF",999999999-X,DA)=""
    2)= K ^ONCO(165.5,"AF",999999999-X,DA)
    Indexes the file in inverse order by ACCESSION NUMBER.
  • CROSS-REFERENCE:  165.5^AA
    1)= S ^ONCO(165.5,"AA",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"AA",$E(X,1,30),DA)
    Indexes file by ACCESSION NUMBER.
  • CROSS-REFERENCE:  165.5^AC^MUMPS
    1)= S ^ONCO(165.5,"AC",$P(^ONCO(165.5,DA,0),U,2),X,DA)=""
    2)= K ^ONCO(165.5,"AC",$P(^ONCO(165.5,DA,0),U,2),X,DA)
    Indexes the file by PATIENT NAME and ACCESSION NUMBER.
.06 SEQUENCE NUMBER 0;6 FREE TEXT

  • INPUT TRANSFORM:  K:X[""""!($A(X)=45) X I $D(X) K:$L(X)>2!($L(X)<2) X I $D(X) D SEQ^ONCOCKI
  • LAST EDITED:  AUG 16, 2000
  • HELP-PROMPT:  Enter two numerics, e.g. '00' for one primary only.
  • DESCRIPTION:  Indicates the sequence of malignant and non-malignant neoplasms over the lifetime of the patient.
    Codes 00-59 and 99 indicate neoplasms of in situ or malignant behavior (Behavior equals 2 or 3).
    Codes 60-88 indicate neoplasms of non-malignant behavior (Behavior equals 0 or 1).
    Code 00 only if the patient has a single malignant primary. If the patient develops a subsequent malignant or in situ primary tumor, change the code for the first tumor from 00 to 01, and number subsequent tumors
    sequentially. Code 59 for the fifty-ninth of fifty-nine independent malignant or in situ primaries. Code 99 for an unspecified malignant or in situ sequence number or unknown.
    Code 60 only if the patient has a single non-malignant primary. If the patient develops a subsequent non-malignant primary, change the code for the first tumor from 60 to 61, and assign codes to subsequent non-malignant
    tumors sequentially. Code 87 for the twenty-seventh of twenty-seven independent non- malignant primaries. Code 88 for an unspecified number of neoplasms in this category.
    For further information see FORDS pages 34-35.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^D^MUMPS
    1)= S XX=$P(^ONCO(165.5,DA,0),U,5) Q:XX="" S ^ONCO(165.5,"D",$E(XX,1,4)_"-"_$E(XX,5,9)_"/"_X,DA)=""
    2)= S XX=$P(^ONCO(165.5,DA,0),U,5) Q:XX="" K ^ONCO(165.5,"D",$E(XX,1,4)_"-"_$E(XX,5,9)_"/"_X,DA)
    Indexes the file by the display value of ACCESSION NO. and SEQUENCE NO.
.061 ACC/SEQ NUMBER COMPUTED

  • MUMPS CODE:  X ^DD(165.5,.061,9.3) S X=$E(Y(165.5,.061,5),Y(165.5,.061,6),X) S Y=X,X=Y(165.5,.061,4),X=X_Y_"/"_$P(Y(165.5,.061,1),U,6)
    9.2 = S Y(165.5,.061,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=$P(Y(165.5,.061,1),U,5),Y(165.5,.061,2)=X S X=1,Y(165.5,.061,3)=X S X=4
    9.3 = X ^DD(165.5,.061,9.2) S X=$E(Y(165.5,.061,2),Y(165.5,.061,3),X)_"-",Y(165.5,.061,4)=X S X=$P(Y(165.5,.061,1),U,5),Y(165.5,.061,5)=X S X=5,Y(165.5,.061,6)=X S X=9
  • ALGORITHM:  $E(ACCESSION NUMBER,1,4)_"-"_$E(ACCESSION NUMBER,5,9)_"/"_SEQUENCE NO.
  • LAST EDITED:  DEC 07, 1999
  • DESCRIPTION:  ACC/SEQ NUMBER concatinates the ACCESSION NUMBER and SEQUENCE NUMBER values.
.07 ACCESSION YEAR 0;7 FREE TEXT
************************REQUIRED FIELD************************

  • INPUT TRANSFORM:  K:X[""""!($A(X)=45) X I $D(X) K:$L(X)>4!($L(X)<4)!'(X?4N) X
  • LAST EDITED:  DEC 07, 1999
  • HELP-PROMPT:  Enter the year first seen for this primary.
  • DESCRIPTION:  ACCESSION YEAR (aka YEAR FIRST SEEN FOR THIS PRIMARY) is the year the patient was first seen at the reporting institution for diagnosis and/ or treatment of this primary. It is NOT the year that the registrar accession
    the case. ACCESSION YEAR relates only to one primary tumor. A patient with multiple primaries can have a different ACCESSION YEAR on each abstract.
    This data item is used to produce an accession register. The accession register identifies all primaries first treated or seen at the reporting institution for a given year.
  • CROSS-REFERENCE:  165.5^AY
    1)= S ^ONCO(165.5,"AY",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"AY",$E(X,1,30),DA)
    Indexes file by ACCESSION YEAR.
  • CROSS-REFERENCE:  165.5^AAY1^MUMPS
    1)= S XX=$P($G(^ONCO(165.5,DA,0)),U,20) S:XX ^ONCO(165.5,"AAY",X,DA)="" K XX
    2)= S XX=$P($G(^ONCO(165.5,DA,0)),U,20) K:XX ^ONCO(165.5,"AAY",X,DA) K XX
    Maintains an index by ACCESSION YEAR for primaries with stages.
  • CROSS-REFERENCE:  165.5^ACAY^MUMPS
    1)= S ^ONCO(165.5,"ACAY")=X
    2)= S ^ONCO(165.5,"ACAY")=$E(DT,1)+17_$E(DT,2,3)
    Maintains a default ACCESSION YEAR for the system.
.08 MEDICAL RECORD NUMBER COMPUTED

  • MUMPS CODE:  X ^DD(165.5,.08,9.2) X $P(^DD(160,2,0),U,5,99) S Y(165.5,.08,101)=X S X=Y(165.5,.08,101) S D0=Y(165.5,.08,80)
    9.2 = S Y(165.5,.08,80)=$S($D(D0):D0,1:""),Y(165.5,.08,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.08,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
  • ALGORITHM:  PATIENT NAME:SSN
  • DESCRIPTION:  Records the medical record number usually assigned by the reporting facility's health information management (HIM) department.
    For further information see FORDS page 36.
.09 SOCIAL SECURITY NUMBER COMPUTED

  • MUMPS CODE:  X ^DD(165.5,.09,9.2) X $P(^DD(160,2,0),U,5,99) S Y(165.5,.09,101)=X S X=Y(165.5,.09,101) S D0=Y(165.5,.09,80)
    9.2 = S Y(165.5,.09,80)=$S($D(D0):D0,1:""),Y(165.5,.09,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.09,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
  • ALGORITHM:  PATIENT NAME:SSN
  • LAST EDITED:  FEB 12, 2003
  • DESCRIPTION:  Records the patient's Social Security Number.
    For further information see FORDS page 37.
.091 STATUS COMPUTED

  • MUMPS CODE:  X ^DD(165.5,.091,9.3) S X=$P($P(Y(165.5,.091,102),$C(59)_$P(Y(165.5,.091,101),U,1)_":",2),$C(59),1) S D0=Y(165.5,.091,80)
    9.2 = S Y(165.5,.091,80)=$S($D(D0):D0,1:""),Y(165.5,.091,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.091,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
    9.3 = X ^DD(165.5,.091,9.2) S Y(165.5,.091,102)=$C(59)_$S($D(^DD(160,15,0)):$P(^(0),U,3),1:""),Y(165.5,.091,101)=$S($D(^ONCO(160,D0,1)):^(1),1:"")
  • ALGORITHM:  PATIENT NAME:STATUS
  • LAST EDITED:  FEB 06, 1991
  • DESCRIPTION:  
    STATUS IS EITHER ALIVE OR DEAD.
.093 PLACE OF BIRTH (STATE) COMPUTED

  • MUMPS CODE:  X ^DD(165.5,.093,9.2) S Y(165.5,.093,101)=$S($D(^ONCO(160,D0,0)):^(0),1:"") S X=$S('$D(^ONCO(165.2,+$P(Y(165.5,.093,101),U,5),0)):"",1:$P(^(0),U,1)) S D0=Y(165.5,.093,80)
    9.2 = S Y(165.5,.093,80)=$S($D(D0):D0,1:""),Y(165.5,.093,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.093,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
  • ALGORITHM:  PATIENT NAME:PLACE OF BIRTH
  • DESCRIPTION:  
    THE STATE WHERE THE PATIENT WAS BORN.
.1 SEX COMPUTED

  • MUMPS CODE:  X ^DD(165.5,.1,9.3) S X=$P($P(Y(165.5,.1,102),$C(59)_$P(Y(165.5,.1,101),U,8)_":",2),$C(59),1) S D0=Y(165.5,.1,80)
    9.2 = S Y(165.5,.1,80)=$S($D(D0):D0,1:""),Y(165.5,.1,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.1,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
    9.3 = X ^DD(165.5,.1,9.2) S Y(165.5,.1,102)=$C(59)_$S($D(^DD(160,10,0)):$P(^(0),U,3),1:""),Y(165.5,.1,101)=$S($D(^ONCO(160,D0,0)):^(0),1:"")
  • ALGORITHM:  PATIENT NAME:SEX
  • LAST EDITED:  MAY 26, 1999
  • DESCRIPTION:  Code the patient's SEX.
.115 STATE COMPUTED

  • MUMPS CODE:  X ^DD(165.5,.115,9.2) X $P(^DD(160,.115,0),U,5,99) S Y(165.5,.115,101)=X S X=Y(165.5,.115,101) S D0=Y(165.5,.115,80)
    9.2 = S Y(165.5,.115,80)=$S($D(D0):D0,1:""),Y(165.5,.115,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.115,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
  • ALGORITHM:  PATIENT NAME:STATE
  • DESCRIPTION:  
    THE PATIENT'S STATE OF RESIDENCY AT THE TIME OF DIAGNOSIS.
.1157 ST-COUNTY COMPUTED

  • MUMPS CODE:  D STCT^ONCOCOP
  • ALGORITHM:  D STCT^ONCOCOP
  • LAST EDITED:  MAR 22, 1991
  • DESCRIPTION:  
    STATE AND COUNTY COMPUTED FIELD.
.117 COUNTY COMPUTED

  • MUMPS CODE:  X ^DD(165.5,.117,9.2) X $P(^DD(160,.117,0),U,5,99) S Y(165.5,.117,101)=X S X=Y(165.5,.117,101) S D0=Y(165.5,.117,80)
    9.2 = S Y(165.5,.117,80)=$S($D(D0):D0,1:""),Y(165.5,.117,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.117,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
  • ALGORITHM:  PATIENT NAME:COUNTY
  • DESCRIPTION:  
    THE PATIENT'S RESIDENCE COUNTY AT THE TIME OF DIAGNOSIS.
.12 RACE COMPUTED

  • MUMPS CODE:  X ^DD(165.5,.12,9.2) S Y(165.5,.12,101)=$S($D(^ONCO(160,D0,0)):^(0),1:"") S X=$S('$D(^ONCO(164.46,+$P(Y(165.5,.12,101),U,6),0)):"",1:$P(^(0),U,1)) S D0=Y(165.5,.12,80)
    9.2 = S Y(165.5,.12,80)=$S($D(D0):D0,1:""),Y(165.5,.12,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.12,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1
    9.3 = X ^DD(165.5,.12,9.2) S Y(165.5,.12,102)=$C(59)_$S($D(^DD(160,8,0)):$P(^(0),U,3),1:""),Y(165.5,.12,101)=$S($D(^ONCO(160,D0,0)):^(0),1:"")
  • ALGORITHM:  PATIENT NAME:RACE
  • LAST EDITED:  NOV 12, 1996
  • DESCRIPTION:  
    "Race" is analyzed with the data item Spanish/Hispanic origin. Both items must be recorded.
.13 RACE-SEX COMPUTED

  • MUMPS CODE:  S X="" D RSX^ONCOCOS
  • ALGORITHM:  S X="" D RSX^ONCOCOS
  • DESCRIPTION:  
    COMPUTED FIELD COMBINING BOTH RACE AND SEX, USED IN CROSS TABULATIONS.
.14 SEX-RACE COMPUTED

  • MUMPS CODE:  S X="" D SXR^ONCOCOS
  • ALGORITHM:  S X="" D SXR^ONCOCOS
  • DESCRIPTION:  
    This is the combined race and sex code, used for cross tabulations.
1 DATE OF INPATIENT ADMISSION 0;8 DATE

  • INPUT TRANSFORM:  D FADIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JUN 07, 2000
  • HELP-PROMPT:  *** DATE OF INPATIENT ADMISSION MUST BE BEFORE/EQUAL DATE OF INPATIENT DISCHARGE
  • DESCRIPTION:  Record the date of the inpatient admission to the facility for the most definitive surgery. If the patient does not have surgery, use the inpatient admission date for any other cancer-directed therapy. If the patient
    has no cancer-directed therapy, use the date of inpatient admission for diagnostic evaluation.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1.1 DATE OF INPATIENT DISCHARGE 0;9 DATE

  • INPUT TRANSFORM:  D DSDTIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JUN 07, 2000
  • HELP-PROMPT:  DATE OF INPATIENT DISCHARGE MUST BE AFTER/EQUAL DATE OF INPATIENT ADMISSION
  • DESCRIPTION:  Record the date of the inpatient discharge from the facility for the most definitive sugery. If the patient did not have surgery, use the inpatient discharge date for any other cancer-directed therapy. If the patient
    has no cancer-directed therapy, use the date of inpatient discharge for diagnostic evaluation.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1.2 TYPE OF REPORTING SOURCE 0;10 POINTER TO TYPE OF REPORTING SOURCE FILE (#168) TYPE OF REPORTING SOURCE(#168)

  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(168,Y,0),U,2)
  • LAST EDITED:  MAR 28, 2006
  • DESCRIPTION:  Code the source documents used to abstract the cancer being reported. This item is used by central registries.
2 PRIMARY SURGEON 0;11 POINTER TO ONCOLOGY CONTACT FILE (#165) ONCOLOGY CONTACT(#165)

  • INPUT TRANSFORM:  S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  MAY 08, 2023
  • HELP-PROMPT:  Enter the physician who performed the most definitive surgical procedure. You may not enter a new physician contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.
  • DESCRIPTION:  Records the physician who performed the most definitive surgical procedure.
    For further information see FORDS page 77.
  • SCREEN:  S DIC("S")="I $P(^(0),U,2)=2"
  • EXPLANATION:  Enter a PHYSICIAN CONTACT.
  • GROUP:  ACOS-RECOMMENDED
  • CROSS-REFERENCE:  165.5^ACP^MUMPS
    1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""
    2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))
    Creates a list under the Contact file of contacts, and associated patients orginating from the Primary file pointers to the Contact File.
  • CROSS-REFERENCE:  165.5^APC^MUMPS
    1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""
    2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)
    Creates a list under the contact file of patients, and associated contacts originating from the Primary file pointers to the contact file.
  • CROSS-REFERENCE:  165.5^APS^MUMPS
    1)= S ^ONCO(165.5,"APS",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
    2)= K ^ONCO(165.5,"APS",X,$P(^ONCO(165.5,DA,0),U,2),DA)
    Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.
2.1 FOLLOWING PHYSICIAN 0;12 POINTER TO ONCOLOGY CONTACT FILE (#165) ONCOLOGY CONTACT(#165)

  • INPUT TRANSFORM:  S DIC("S")="I ($P(^(0),U,2)=2)!($P(^(0),U,2)=4)" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  MAY 08, 2023
  • HELP-PROMPT:  Enter the person currently responsible for the patient's medical care. You may not enter a new physician contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.
  • DESCRIPTION:  Records the person currently responsible for the patient's medical care.
    For further information see FORDS page 76.
  • SCREEN:  S DIC("S")="I ($P(^(0),U,2)=2)!($P(^(0),U,2)=4)"
  • EXPLANATION:  Enter a PHYSICIAN or INSTITUTION CONTACT.
  • CROSS-REFERENCE:  165.5^ACP^MUMPS
    1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""
    2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))
    Creates a list under the Contact file of contacts, and associated patients orginating from the Primary file pointers to the Contact File.
  • CROSS-REFERENCE:  165.5^APC^MUMPS
    1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""
    2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)
    Creates a list under the contact file of patients, and associated contacts originating from the Primary file pointers to the contact file.
  • CROSS-REFERENCE:  165.5^AFP^MUMPS
    1)= S ^ONCO(165.5,"AFP",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
    2)= K ^ONCO(165.5,"AFP",X,$P(^ONCO(165.5,DA,0),U,2),DA)
    Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.
2.2 MANAGING PHYSICIAN 0;13 POINTER TO ONCOLOGY CONTACT FILE (#165) ONCOLOGY CONTACT(#165)

  • INPUT TRANSFORM:  S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  MAY 08, 2023
  • HELP-PROMPT:  Enter the physician who is responsible for the overall management of the patient. You may not enter a new physician contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.
  • DESCRIPTION:  
    Identifies the physician who is responsible for the overall management of the patient during diagnosis and/or treatment of this cancer.
  • SCREEN:  S DIC("S")="I $P(^(0),U,2)=2"
  • EXPLANATION:  Enter a PHYSICIAN TYPE ONCOLOGY CONTACT.
  • GROUP:  ACOS-RECOMMENDED
  • CROSS-REFERENCE:  165.5^ACP^MUMPS
    1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""
    2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))
    Creates a list under the Contact file of contacts, and associated patients orginating from the Primary file pointers to the Contact File.
  • CROSS-REFERENCE:  165.5^APC^MUMPS
    1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""
    2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)
    Creates a list under the contact file of patients, and associated contacts originating from the Primary file pointers to the contact file.
  • CROSS-REFERENCE:  165.5^AMP^MUMPS
    1)= S ^ONCO(165.5,"AMP",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
    2)= K ^ONCO(165.5,"AMP",X,$P(^ONCO(165.5,DA,0),U,2),DA)
    Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.
2.3 PHYSICIAN #3 0;14 POINTER TO ONCOLOGY CONTACT FILE (#165) ONCOLOGY CONTACT(#165)

  • INPUT TRANSFORM:  S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  MAY 08, 2023
  • HELP-PROMPT:  Enter another physician involved in the care of the patient. You may not enter a new physician contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.
  • DESCRIPTION:  Records another physician involved in the care of the patient. The Commission on Cancer recommends that this data item identify the physician who performed the most definitive radiation therapy.
    For further information see FORDS page 78.
  • SCREEN:  S DIC("S")="I $P(^(0),U,2)=2"
  • EXPLANATION:  Enter a PHYSICIAN CONTACT.
  • GROUP:  ACOS-RECOMMENDED
  • CROSS-REFERENCE:  165.5^ACP^MUMPS
    1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""
    2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))
    Creates a list under the Contact file of contacts, and associated patients orginating from the Primary file pointers to the Contact File.
  • CROSS-REFERENCE:  165.5^APC^MUMPS
    1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""
    2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)
    Creates a list under the contact file of patients, and associated contacts originating from the Primary file pointers to the contact file.
  • CROSS-REFERENCE:  165.5^AOP3^MUMPS
    1)= S ^ONCO(165.5,"AOP3",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
    2)= K ^ONCO(165.5,"AOP3",X,$P(^ONCO(165.5,DA,0),U,2),DA)
    Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.
2.4 PHYSICIAN #4 0;15 POINTER TO ONCOLOGY CONTACT FILE (#165) ONCOLOGY CONTACT(#165)

  • INPUT TRANSFORM:  S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  MAY 08, 2023
  • HELP-PROMPT:  Enter another physician involved in the care of the patient. You may not enter a new physician contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.
  • DESCRIPTION:  Records another physician involved in the care of the patient. The Commission on Cancer recommends that this data item identify the physician who gives the most definitive systemic therapy.
    For further information see FORDS page 79.
  • SCREEN:  S DIC("S")="I $P(^(0),U,2)=2"
  • EXPLANATION:  Enter a PHYSICIAN CONTACT.
  • GROUP:  ACOS-RECOMMENDED
  • CROSS-REFERENCE:  165.5^ACP^MUMPS
    1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""
    2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))
    Creates a list under the Contact file of contacts, and associated patients orginating from the Primary file pointers to the Contact File.
  • CROSS-REFERENCE:  165.5^APC^MUMPS
    1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""
    2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)
    Creates a list under the contact file of patients, and associated contacts originating from the Primary file pointers to the contact file.
  • CROSS-REFERENCE:  165.5^AOP4^MUMPS
    1)= S ^ONCO(165.5,"AOP4",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
    2)= K ^ONCO(165.5,"AOP4",X,$P(^ONCO(165.5,DA,0),U,2),DA)
    Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.
3 DATE DX 0;16 DATE
************************REQUIRED FIELD************************

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) I $D(X) D DTDXIT^ONCODXD
    MAXIMUM LENGTH: 12
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JUN 21, 2022
  • HELP-PROMPT:  Future dates are not allowed.
  • DESCRIPTION:  Records the date of initial diagnosis by a physician for the tumor being reported.
    For further information see FORDS pages 89-90.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ADX
    1)= S ^ONCO(165.5,"ADX",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"ADX",$E(X,1,30),DA)
    3)= DO NOT DELETE
    Cross-reference by DATE DX
3.1 DIAGNOSIS EPISODE CARE COMPUTED

  • MUMPS CODE:  S X="" D ADM^ONCOCON
  • ALGORITHM:  S X="" D ADM^ONCOCON
  • DESCRIPTION:  
    RECORDS THE CARE THE PATIENT RECEIVED DURING THE CURRENT EPISODE OF TREATMENT AT DIAGNOSIS.
3.5 YEAR DX COMPUTED DATE

  • MUMPS CODE:  S Y(165.5,3.5,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=$P(Y(165.5,3.5,1),U,16),X=X S X=X,X=$E(X,1,3)_"0000" S:'X X=""
  • ALGORITHM:  YEAR(INTERNAL(DATE DX))
  • LAST EDITED:  MAR 10, 1998
  • DESCRIPTION:  
    DATE DX (165.5,3) year
4 AGE AT DX COMPUTED

  • MUMPS CODE:  D AGE^ONCOCOM
  • ALGORITHM:  D AGE^ONCOCOM
  • LAST EDITED:  JUN 21, 1990
  • DESCRIPTION:  Records the age of the patient at his or her last birthday before diagnosis.
    For further information see FORDS page 58.
4.1 DX AGE-GP COMPUTED

  • MUMPS CODE:  D DEC^ONCOCOM
  • ALGORITHM:  D DEC^ONCOCOM
  • LAST EDITED:  JUL 19, 1990
  • DESCRIPTION:  
    DIAGNOSIS AGE GROUP WILL GROUP PATIENTS BY AGE.
5 DX FACILITY 0;17 POINTER TO FACILITY FILE (#160.19) FACILITY(#160.19)

  • OUTPUT TRANSFORM:  S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
  • LAST EDITED:  MAY 31, 1996
  • HELP-PROMPT:  Enter Hospital which diagnosed this Primary.
  • DESCRIPTION:  
    Record the name of the facility where diagnosis was first made.
  • EXECUTABLE HELP:  D HELP^ONCOFLF
6 FACILITY REFERRED FROM 0;18 POINTER TO FACILITY FILE (#160.19) FACILITY(#160.19)

  • OUTPUT TRANSFORM:  S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
  • LAST EDITED:  NOV 06, 2002
  • DESCRIPTION:  Identifies the facility that referred the patient to the reporting facility.
    For further information see FORDS page 85.
  • EXECUTABLE HELP:  D HELP^ONCOFLF
  • GROUP:  ACOS-REQUIRED
7 FACILITY REFERRED TO 0;19 POINTER TO FACILITY FILE (#160.19) FACILITY(#160.19)

  • OUTPUT TRANSFORM:  S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
  • LAST EDITED:  NOV 06, 2002
  • DESCRIPTION:  Identifies the facility to which the patient was referred for further care after discharge from the reporting facility.
    For further information see FORDS page 86.
  • EXECUTABLE HELP:  D HELP^ONCOFLF
  • GROUP:  ACOS-RECOMMENDED
8 PATIENT ADDRESS AT DX 1;1 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>40!($L(X)<1) X I $D(X) D NP^ONCOIT
  • LAST EDITED:  JUN 21, 2001
  • HELP-PROMPT:  Enter 1-40 uppercase alphanumeric characters. No punctuation.
  • DESCRIPTION:  Identifies the patient's address (number and street) at the time of diagnosis.
    For further information see FORDS page 42.
  • GROUP:  ACOS-RECOMMENDED
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
8.1 CITY/TOWN AT DX 1;12 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>20!($L(X)<1) X I $D(X) D NP^ONCOIT
  • LAST EDITED:  JUN 21, 2001
  • HELP-PROMPT:  Enter 1-20 uppercase alphanumeric characters. No punctuation.
  • DESCRIPTION:  Identifies the name of the city or town in which the patient resides at the time the tumor is diagnosed and treated.
    For further information see FORDS page 44.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
    TRIGGERED by the POSTAL CODE AT DX field of the ONCOLOGY PRIMARY File
8.2 PATIENT ADDRESS AT DX - SUPP 1;13 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>40!($L(X)<1) X I $D(X) D NP^ONCOIT
  • LAST EDITED:  NOV 04, 2002
  • HELP-PROMPT:  Enter 1-40 uppercase alphanumeric characters. No punctuation.
  • DESCRIPTION:  Provides the ability to store additional adress information such as the name of a place or facility (ie, a nursing home or name of an apartment complex) at the time of diagnosis.
    For further information see FORDS page 43.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
9 POSTAL CODE AT DX 1;2 FREE TEXT

  • INPUT TRANSFORM:  D PCDX^ONCPCDX
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  AUG 25, 2010
  • HELP-PROMPT:  Enter the 5-digit US postal code or 6-character Canadian postal code.
  • DESCRIPTION:  Identifies the postal code of the patient's address at diagnosis.
    For U.S. residents, record the patient's five-digit postal code at the time of diagnosis and treatment.
    For Canadian residents, record the six-character postal code.
  • GROUP:  SEER
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^10
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,3),X=X S DIU=X K Y S X=DIV S X=ONCCOUNTY K ONCCOUNTY X ^DD(165.5,9,1,1,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,3)=DIV,DIH=165.5,DIG=10 D ^DICR
    2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,3),X=X S DIU=X K Y S X="" X ^DD(165.5,9,1,1,2.4)
    2.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,3)=DIV,DIH=165.5,DIG=10 D ^DICR
    CREATE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)
    CREATE VALUE)= S X=ONCCOUNTY K ONCCOUNTY
    DELETE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)
    DELETE VALUE)= @
    FIELD)= COUNTY AT DX
    COUNTY AT DX (165.5,10) will be stuffed with the COUNTY (5.12,2) value associated with the selected POSTAL CODE. If the POSTAL CODE AT DX value is a Canadian postal code or 88888 or 99999, this trigger cross-reference
    will not be executed.
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^16
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,4),X=X S DIU=X K Y S X=DIV S X=ONCSTATE K ONCSTATE X ^DD(165.5,9,1,2,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,4)=DIV,DIH=165.5,DIG=16 D ^DICR
    2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,4),X=X S DIU=X K Y S X="" X ^DD(165.5,9,1,2,2.4)
    2.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,4)=DIV,DIH=165.5,DIG=16 D ^DICR
    CREATE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)
    CREATE VALUE)= S X=ONCSTATE K ONCSTATE
    DELETE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)
    DELETE VALUE)= @
    FIELD)= STATE AT DX
    STATE AT DX (165.5,16) will be stuffed with the STATE (5.12,3) value associated with the selected POSTAL CODE. If the POSTAL CODE AT DX value is a Canadian postal code or 88888 or 99999, this trigger cross-reference will
    not be executed.
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^8.1
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,12),X=X S DIU=X K Y S X=DIV S X=ONCCITY K ONCCITY X ^DD(165.5,9,1,3,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,12)=DIV,DIH=165.5,DIG=8.1 D ^DICR
    2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,12),X=X S DIU=X K Y S X="" X ^DD(165.5,9,1,3,2.4)
    2.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,12)=DIV,DIH=165.5,DIG=8.1 D ^DICR
    CREATE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)
    CREATE VALUE)= S X=ONCCITY K ONCCITY
    DELETE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)
    DELETE VALUE)= @
    FIELD)= CITY/TOWN AT DX
    CITY/TOWN AT DX (165.5,8.1) will be stuffed with the CITY (5.12,1) value associated with the selected POSTAL CODE. If the POSTAL CODE AT DX value is a Canadian postal code or 88888 or 99999, this trigger cross-reference
    will not be executed.
10 COUNTY AT DX 1;3 FREE TEXT

  • INPUT TRANSFORM:  D CCODE^XIPUTIL(X,.XIPC) K:(XIPC("COUNTY")="")&(X'=99998) X K XIPC
  • OUTPUT TRANSFORM:  I Y'="" K XIPC D CCODE^XIPUTIL(Y,.XIPC) S Y=$S(XIPC("COUNTY")'="":XIPC("COUNTY"),1:Y) K XIPC
  • LAST EDITED:  AUG 26, 2010
  • HELP-PROMPT:  Enter the 5-digit FIPS code (2-digit state code + 3 digit county code). If unknown, enter 99998 (Outside state/county code unknown) or 99999 (County unknown).
  • DESCRIPTION:  Identifies the county of the patient's residence at the time the reportable tumor is diagnosed.
    The COUNTY AT DX value will be triggered by the entry of a valid U. S. POSTAL CODE AT DX value. Canadian POSTAL CODE AT DX values will not trigger a COUNTY AT DX value.
    If unknown, enter 99998 (Outside state/county code unknown) or 99999 (County unknown).
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
    TRIGGERED by the POSTAL CODE AT DX field of the ONCOLOGY PRIMARY File
11 MARITAL STATUS AT DX 1;5 SET
  • '1' FOR Single (never married);
  • '2' FOR Married (including common law);
  • '3' FOR Separated;
  • '4' FOR Divorced;
  • '5' FOR Widowed;
  • '6' FOR Unmarried or Domestic Partner;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 14, 2011
  • HELP-PROMPT:  Enter the patient's marital status at the time of diagnosis.
  • DESCRIPTION:  
    This is the patient's marital status at the time of diagnosis for the reportable tumor. If the patient has multiple tumors, marital status may be different for each tumor.
  • GROUP:  ACOS-RECOMMENDED
12 PALLIATIVE CARE 3.1;26 SET
  • '0' FOR No palliative care;
  • '1' FOR Surgery;
  • '2' FOR Radiation;
  • '3' FOR Systemic tx;
  • '4' FOR Pain management;
  • '5' FOR Surg, rad, and/or systemic tx w/o pain mgt;
  • '6' FOR Surg, rad, and/or systemic tx w pain mgt;
  • '7' FOR Palliative care, type unknown;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  MAY 14, 2025
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies any care provided in an effort to palliate or alleviate symptoms. Palliative care is performed to relieve symptoms and may include surgery, radiation therapy, systemic therapy (chemotherapy, hormone therapy,
    or other systemic drugs), and/or pain management therapy. If hospice is recommended and received, capture the type of care provided to palliate or relieve the patient's symptoms. If hospice was recommended and received
    but it is unknown what type of care patient received, assign code 7.
    For further information see STORE manual.
  • CROSS-REFERENCE:  165.5^AN^MUMPS
    1)= Q
    2)= D PP^ONCDTX
13 PALLIATIVE CARE @FAC 3.1;27 SET
  • '0' FOR No palliative care;
  • '1' FOR Surgery;
  • '2' FOR Radiation;
  • '3' FOR Systemic tx;
  • '4' FOR Pain management;
  • '5' FOR Surg, rad, and/or systemic tx w/o pain mgt;
  • '6' FOR Surg, rad, and/or systemic tx w pain mgt;
  • '7' FOR Palliative care, type unknown;
  • '9' FOR Unk, not stated;

  • LAST EDITED:  MAY 14, 2025
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies care provided at this facility in an effort to palliate or alleviate symptoms. Palliative care is performed to relieve symptoms and may include surgery, radiation therapy, systemic therapy (chemotherapy,
    hormone therapy, or other systemic drugs), and/or other pain management therapy. If hospice is recommended and received, capture the type of care provided to palliate or relieve the patient's symptoms. If hospice was
    recommended and received but it is unknown what type of care patient received, assign code 7.
    For further information see STORE manual.
14 READMISSION W/I 30 DAYS/SURG 3.1;28 SET
  • '0' FOR No surgery/not readmitted;
  • '1' FOR Unplanned readmission;
  • '2' FOR Planned readmission;
  • '3' FOR Planned and unplanned readmission;
  • '9' FOR Unknown if surgery or readmission;

  • LAST EDITED:  JAN 08, 2003
  • DESCRIPTION:  Records a readmission to the same hospital within 30 days of discharge following a hospitalization for surgical resection of the primary site.
    For further information see FORDS page 146.
15 SYSTEMIC/SURGERY SEQUENCE 3.1;39 SET
  • '0' FOR No systemic and/or surgery;
  • '2' FOR Systemic before surgery;
  • '3' FOR Systemic after surgery;
  • '4' FOR Systemic before and after surgery;
  • '5' FOR Intraoperative systemic;
  • '6' FOR Intraoperative/other before or after surgery;
  • '9' FOR Sequence unknown;

  • LAST EDITED:  DEC 27, 2005
  • DESCRIPTION:  
    Records the sequencing of systemic therapy and surgical procedures given as part of the first course of treatment.
16 STATE AT DX 1;4 POINTER TO STATE FILE (#5) STATE(#5)

  • LAST EDITED:  SEP 04, 2009
  • HELP-PROMPT:  Enter the patient's state of residence at the time of diagnosis.
  • DESCRIPTION:  Identifies the patient's state of residence at the time of diagnosis.
    For further information see FORDS page 45.
  • NOTES:  TRIGGERED by the POSTAL CODE AT DX field of the ONCOLOGY PRIMARY File
17 SUSPENSE DATE 1;10 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  APR 03, 1997
  • HELP-PROMPT:  *** SUSPENSE DATE MUST BE AFTER OR EQUAL TO THE DATE DX ***
  • DESCRIPTION:  
    This is the date on which the primary was added to the suspense file.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
18 PRIMARY PAYER AT DX 1;11 POINTER TO PRIMARY PAYER AT DIAGNOSIS FILE (#160.3) PRIMARY PAYER AT DIAGNOSIS(#160.3)

  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(160.3,Y,0),U,2)
  • LAST EDITED:  AUG 18, 2025
  • HELP-PROMPT:  Enter the patient's primary payer/insurance carrier.
  • DESCRIPTION:  
    Identifies the patient's primary payer/insurance carrier at the time of initial diagnosis and/or treatment.
19 STAGED BY (CLINICAL STAGE) 3;32 POINTER TO ONCOLOGY STAGED BY CODES FILE (#165.7) ONCOLOGY STAGED BY CODES(#165.7)

  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(165.7,Y,0),U,1)_" "_$P(^ONCO(165.7,Y,0),U,2)
  • LAST EDITED:  APR 06, 2017
  • HELP-PROMPT:  Record the role of the person who documented the Clinical AJCC staging data items and the Stage Group.
  • DESCRIPTION:  Identifies the person who recorded the clinical AJCC staging elements and the stage group in the patient's medical record.
    For further information refer to FORDS manual.
20 PRIMARY SITE 2;1 POINTER TO ICDO TOPOGRAPHY FILE (#164)
************************REQUIRED FIELD************************
ICDO TOPOGRAPHY(#164)

  • INPUT TRANSFORM:  D TOPIT^ONCOSUR1
  • LAST EDITED:  NOV 06, 2002
  • HELP-PROMPT:  Record the ICD-O topography code for the site of origin.
  • DESCRIPTION:  Identifies the primary site.
    For further information see FORDS page 91.
  • EXECUTABLE HELP:  S ONCOX=164 D HP^ONCOHICD
  • GROUP:  ACOS-REQUIRED
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^BT^MUMPS
    1)= S ^ONCO(165.5,"C"_$E(X,3,4),DA)=""
    2)= K ^ONCO(165.5,"C"_$E(X,3,4),DA)
    Indexes the file by the whole number value of the ICD-O second edition topography code.
  • CROSS-REFERENCE:  165.5^AD^MUMPS
    1)= S $P(^ONCO(165.5,DA,0),U,22)=$E(X,1,4)
    2)= S $P(^ONCO(165.5,DA,0),U,22)=""
    Maintains the ICDO-SITE Field (#.022).
  • CROSS-REFERENCE:  165.5^E
    1)= S ^ONCO(165.5,"E",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"E",$E(X,1,30),DA)
    Indexes file by ICDO-TOPOGRAPHY.
20.1 PRIMARY SITE CODE COMPUTED

  • MUMPS CODE:  S X=$P($G(^ONCO(165.5,D0,2)),U),X=$S(X="":"",1:"C"_$E(X,3,4)_"."_$E(X,5))
  • ALGORITHM:  CUSTOM CODED
  • LAST EDITED:  NOV 06, 2002
  • DESCRIPTION:  
    Identifies the primary site ICD-O topography code.
21 CASEFINDING SOURCE 1;6 POINTER TO CASEFINDING SOURCE FILE (#166)
************************REQUIRED FIELD************************
CASEFINDING SOURCE(#166)

  • INPUT TRANSFORM:  S DIC("S")="D SCRCASRC^ONCSCHMM" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(166,Y,0),U,2)
  • LAST EDITED:  JAN 13, 2025
  • HELP-PROMPT:  Enter the appropriate code from the list.
  • DESCRIPTION:  
    This field codes the earliest source of identifying information.
  • SCREEN:  S DIC("S")="D SCRCASRC^ONCSCHMM"
  • EXPLANATION:  Restrict allowable codes to the 11 codes in VACRS Manual
21.5 INFRA/SUPRA 2;7 SET
************************REQUIRED FIELD************************
  • 'I' FOR INFRATENTORIAL;
  • 'S' FOR SUPRATENTORIAL;

  • LAST EDITED:  JUN 22, 1993
  • HELP-PROMPT:  This field applies to brain tumors only.
  • DESCRIPTION:  For brain tumors, enter 'I' or 'S' according to whether the tumor is infratentorial or supratentorial.
    This field does not apply to tumors other than brain tumors.
21.51 IRIS/CILIARY BODY 2;22 SET
  • 'I' FOR Iris;
  • 'C' FOR Ciliary body;

  • LAST EDITED:  JUN 30, 1993
  • DESCRIPTION:  
    This field is used to determine the appropriate TNM encoding for malignant melanomas of the uvea.
21.52 UPPER/LOWER 24;4 SET
  • 'U' FOR Upper 2/3;
  • 'L' FOR Lower 1/3;

  • LAST EDITED:  JUL 04, 1993
  • DESCRIPTION:  
    This field is used to determine the appropriate N coding for tumors of the vagina. Enter U or L according to whether the regional lymph node metastasis relates to the upper two-thirds or lower one-third of the vagina.
22 HISTOLOGY (ICD-O-2) 2;3 POINTER TO ICD-O-2 MORPHOLOGY FILE (#164.1) ICD-O-2 MORPHOLOGY(#164.1)

  • INPUT TRANSFORM:  S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2980101)!((Y<96002)!(Y>96423))&($P(^ONCO(165.5,DA,0),U,16)<3010101)" D ^DIC K DIC S DIC=DIE,X=+Y D HIST23^ONCOHICD K:Y<0 X
  • LAST EDITED:  JUN 12, 2003
  • HELP-PROMPT:  Enter the code, e.g. 81203 or 8120/3, or name, e.g. TRANSITIONAL CELL CA.
  • DESCRIPTION:  Record the histology using the ICD-O-2 codes.
  • SCREEN:  S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2980101)!((Y<96002)!(Y>96423))&($P(^ONCO(165.5,DA,0),U,16)<3010101)"
  • EXPLANATION:  Codes 9600-9642 are not selectable for 1998 or later cases and this field is not editable at all for 2001 or later cases.
  • EXECUTABLE HELP:  S ONCOX=164.1 D HP^ONCOHICD
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AH
    1)= S ^ONCO(165.5,"AH",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"AH",$E(X,1,30),DA)
    3)= DO NOT DELETE
    Cross Reference Histology, (pointer) used in hard-coded routines as FM will not use this index being a pointer.
22.1 ICDO HISTOLOGY-CODE COMPUTED

  • MUMPS CODE:  S X=$$HIST^ONCFUNC(D0),X=$S(X="":"",1:$E(X,1,4)_"/"_$E(X,5))
  • ALGORITHM:  S X=""
  • LAST EDITED:  MAY 22, 2001
  • DESCRIPTION:  
    Display the Histology Code value, based on the primary's date DX: If Date DX is before 2001 use the HISTOLOGY (ICD-O-2) value, if it is a 2001 or later case use the HISTOLOGY (ICD-O-3) value.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
22.2 PAPILLARY/FOLLICULAR 2;4 SET
  • 'P' FOR PAPILLARY;
  • 'F' FOR FOLLICULAR;

  • LAST EDITED:  JUN 14, 1993
  • DESCRIPTION:  This code assists in the characterization of tumors of the thyroid gland. It is only significant for patients 45 years and over.
    If the tumor is neither papillary nor follicular, leave this field blank.
  • TECHNICAL DESCR:  
    For thyroid primaries only (C73.9), this field is set directly by the TBA cross-reference of the HISTOLOGY Field (#22).
22.3 HISTOLOGY (ICD-O-3) 2.2;3 POINTER TO ICD-O-3 MORPHOLOGY FILE (#169.3) ICD-O-3 MORPHOLOGY(#169.3)

  • INPUT TRANSFORM:  D INIT^ONCCS
  • LAST EDITED:  MAY 31, 2005
  • DESCRIPTION:  Identifies the microscopic anatomy of cells for primaries diagnosed in 2001 or later.
    This field also contains the BEHAVIOR CODE which records the behavior of the tumor being reported. The fifth digit of the morphology code is the behavior code.
    For further information see FORDS pages 93-95.
  • EXECUTABLE HELP:  D ICDO3^ONCOHICD
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AL^MUMPS
    1)= Q
    2)= S $P(^ONCO(165.5,DA,8),U,2)=""
    This cross-reference will delete the TEXT-HISTOLOGY TITLE (165.5,101) value if the HISTOLOGY (ICD-O-3) value is changed.
22.4 BEHAVIOR CODE COMPUTED

  • MUMPS CODE:  S Y(165.5,22.4,1)=$S($D(^ONCO(165.5,D0,2.2)):^(2.2),1:"") S X=$P(Y(165.5,22.4,1),U,3),X=X S X=X,Y(165.5,22.4,2)=$G(X) S X=5,X=$E(Y(165.5,22.4,2),X)
  • ALGORITHM:  $E(INTERNAL(HISTOLOGY (ICD-O-3)),5)
  • LAST EDITED:  SEP 21, 2023
  • DESCRIPTION:  
    This field records the behavior of the tumor being reported. The behavior code corresponds to the fifth digit of the morphology (HISTOLOGY ICD-O-3) so the field is calculated from there.
23 RECONSTRUCTION/RESTORATION 3;33 FREE TEXT

  • INPUT TRANSFORM:  D RRDEFIT^ONCNTX1 K:+X'=X!(X>10)!(X<0)!(X?.E1"."1N.N) X I $D(X) S NTXDD=1 D RRIT^ONCRR Q
  • OUTPUT TRANSFORM:  D RROT^ONCRR
  • LAST EDITED:  SEP 21, 2004
  • DESCRIPTION:  RECONSTRUCTIVE/RESTORATION is a surgical procdure that improves the shape and appearance or function of body structures that are missing, defective, damaged or misshapen by cancer or its treatment.
    RECONSTRUCTION/RESTORATION is limited to procedures started during the first course of treatment.
    For further information see ROADS page 195.
  • EXECUTABLE HELP:  D RRHP^ONCRR
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
24 GRADE/DIFFERENTIATION 2;5 POINTER TO GRADE FILE (#164.43) GRADE(#164.43)

  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(164.43,Y,0),U,1)
  • LAST EDITED:  FEB 23, 2010
  • DESCRIPTION:  Describes the tumor's resemblance to normal tissue. Well differentiated (Grade 1) is the most like normal tissue, and undifferentiated (Grade 4) is the least like normal tissue. Grades 5-8 define particular cell lines for
    lymphomas and leukemias.
    For further information see FORDS 2010 pages 112-113.
24.1 GRADE PATH SYSTEM 2.3;1 SET
  • '2' FOR Two-Grade System;
  • '3' FOR Three-Grade System;
  • '4' FOR Four-Grade System;

  • LAST EDITED:  OCT 01, 2009
  • HELP-PROMPT:  Leave blank if no GRADE PATH SYSTEM is noted on the pathology report.
  • DESCRIPTION:  Indicates whether a two, three or four grade system was used in the pathology report.
    Leave blank if no GRADE PATH SYSTEM is noted on the pathology report.
24.2 GRADE PATH VALUE 2.3;2 SET
  • '1' FOR Recorded as Grade I or 1;
  • '2' FOR Recorded as Grade II or 2;
  • '3' FOR Recorded as Grade III or 3;
  • '4' FOR Recorded as Grade IV or 4;

  • LAST EDITED:  OCT 01, 2009
  • HELP-PROMPT:  Leave blank if no GRADE PATH SYSTEM is noted on the pathology report.
  • DESCRIPTION:  Describes the grade assigned according to the grading system in GRADE PATH SYSTEM.
    Leave blank if no GRADE PATH SYSTEM is noted on the pathology report.
24.3 GRADE CLINICAL 2.3;12 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X I $D(X) D IT^ONCSCHMG
    MAXIMUM LENGTH: 1
  • OUTPUT TRANSFORM:  D OT^ONCSCHMG
  • LAST EDITED:  MAR 13, 2019
  • HELP-PROMPT:  Answer must be 1 character in length. Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S
  • DESCRIPTION:  
    This data item records the grade of a solid primary tumor before any treatment (surgical resection or initiation of any treatment including neoadjuvant).
  • EXECUTABLE HELP:  D HLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
24.4 GRADE PATHOLOGICAL 2.3;13 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X I $D(X) D IT^ONCSCHMG
    MAXIMUM LENGTH: 1
  • OUTPUT TRANSFORM:  D OT^ONCSCHMG
  • LAST EDITED:  MAR 13, 2019
  • HELP-PROMPT:  Answer must be 1 character in length. Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S
  • DESCRIPTION:  
    This data item records the grade of a solid primary tumor that has been resected and for which no neoadjuvant therapy was administered.
  • EXECUTABLE HELP:  D HLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
24.5 GRADE POST THERAPY PATH (YP) 2.3;14 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X I $D(X) D IT^ONCSCHMG
    MAXIMUM LENGTH: 1
  • OUTPUT TRANSFORM:  D OT^ONCSCHMG
  • LAST EDITED:  JAN 14, 2021
  • HELP-PROMPT:  Answer must be 1 character in length. Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S
  • DESCRIPTION:  
    This data item records the grade of a solid primary tumor that has been resected following neoadjuvant therapy.
  • EXECUTABLE HELP:  D HLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
24.6 GRADE POST THERAPY CLIN (YC) 2.3;15 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X I $D(X) D IT^ONCSCHMG
    MAXIMUM LENGTH: 1
  • OUTPUT TRANSFORM:  D OT^ONCSCHMG
  • LAST EDITED:  JAN 14, 2021
  • HELP-PROMPT:  Answer must be 1 character in length. Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S
  • DESCRIPTION:  
    This data item records the grade of a solid primary tumor that has been microscopically sampled following neoadjuvant therapy or primary systemic/radiation therapy.
  • EXECUTABLE HELP:  D HLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
25 TNM FORM ASSIGNED 7;7 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date on which the TNM form was assigned to the Managing Physician.
  • DESCRIPTION:  
    Records the date on which the TNM form was assigned to the Managing Physician.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
25.1 TUMOR MARKER 1 24;2 POINTER TO TUMOR MARKERS FILE (#164.15) TUMOR MARKERS(#164.15)

  • INPUT TRANSFORM:  S DIC("S")="D SCREEN^ONCOTM" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.15,+Y,0)),U,2)
  • LAST EDITED:  FEB 27, 1998
  • DESCRIPTION:  
    Record prognostic indicators.
  • SCREEN:  S DIC("S")="D SCREEN^ONCOTM"
  • EXPLANATION:  4th edition: 0-3, 8, 9. 5th edition: 0-3, 4-6 (Testis only), 8, 9.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
25.2 TUMOR MARKER 2 24;3 POINTER TO TUMOR MARKERS FILE (#164.15) TUMOR MARKERS(#164.15)

  • INPUT TRANSFORM:  S DIC("S")="D SCREEN^ONCOTM" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.15,+Y,0)),U,2)
  • LAST EDITED:  JAN 28, 1998
  • DESCRIPTION:  
    Record prognostic indicators.
  • SCREEN:  S DIC("S")="D SCREEN^ONCOTM"
  • EXPLANATION:  4th edition: 0-3, 8, 9. 5th edition: 0-3, 4-6 (Testis only), 8, 9.
25.3 TUMOR MARKER 3 24;7 POINTER TO TUMOR MARKERS FILE (#164.15) TUMOR MARKERS(#164.15)

  • INPUT TRANSFORM:  S DIC("S")="D SCREEN^ONCOTM" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.15,+Y,0)),U,2)
  • LAST EDITED:  JAN 28, 1998
  • DESCRIPTION:  
    Record LDH prognostic indicators for testicular cancer.
  • SCREEN:  S DIC("S")="D SCREEN^ONCOTM"
  • EXPLANATION:  4th edition: 0-3, 8, 9. 5th edition: 0-3, 4-6 (Testis only), 8, 9.
26 DIAGNOSTIC CONFIRMATION 2;6 SET
  • '1' FOR Positive histology;
  • '2' FOR Positive cytology;
  • '3' FOR Pos hist + pos immunophenotyping + pos genetic;
  • '4' FOR Positive microscopic;
  • '5' FOR Positive lab test;
  • '6' FOR Direct visual;
  • '7' FOR Rad/other imaging;
  • '8' FOR Clinical dx only;
  • '9' FOR Unknown;

  • LAST EDITED:  DEC 02, 2009
  • DESCRIPTION:  Records the best method of diagnostic confirmation of the cancer being reported at any time in the patient's history.
    For further information see FORDS 2010 pages 117-119.
27 HISTO-MORPHOLOGY COMPUTED

  • MUMPS CODE:  D HM^ONCOCOM
  • ALGORITHM:  D HM^ONCOCOM
  • LAST EDITED:  JUL 27, 2005
  • DESCRIPTION:  
    This field displays the HISTOLOGY ICD-O-3 (165.5,22.3) value concatinated with the GRADE/DIFFERENTIATION (165.5,24) value.
28 LATERALITY 2;8 SET
  • '0' FOR Not a paired site;
  • '1' FOR Right;
  • '2' FOR Left;
  • '3' FOR One side involved, right/left not specified;
  • '4' FOR Bilateral involvement, side of origin unknown;
  • '5' FOR Paired site, midline tumor;
  • '9' FOR Paired site, no laterality information;

  • LAST EDITED:  NOV 02, 2009
  • HELP-PROMPT:  Enter the primary site laterality.
  • DESCRIPTION:  Identifies the side of a paired organ or the side of the body on which the reportable tumor originated. This applies to the primary site only.
    For further information see FORDS page 92.
29 TUMOR SIZE 2;9 NUMBER

  • INPUT TRANSFORM:  D STIT^ONCOOT
  • OUTPUT TRANSFORM:  D STOT^ONCOOT
  • LAST EDITED:  MAR 04, 2004
  • HELP-PROMPT:  Code the exact size of the primary in millimeters (mm).
  • DESCRIPTION:  Describes the largest dimension of the diameter of the primary tumor in millimeters (mm).
    Code the exact size of the primary tumor in millimeters (mm).
    EXCEPTION:
    For melanomas of the skin (C44.0-C44.9), vulva (C51.0-C51.9), penis
    (C60.0-C60.9), scrotum (C63.3), and conjunctiva (C69.0):
    - code the depth of invasion in HUNDRETHS of millimeters.
    - code 989 for melanomas which are 9.89 mm or greater in depth.
    Code 998 when the following terms describe tumor involvement in these specific sites:
    Esophagus (C15.0-C15.9): Entire circumference Stomach (C16.0-C16.9): Diffuse, widespread, 3/4 or more,
    linitis plastica Colorectal (C18.0-C20.9): Familial/multiple polyposis Lung (C34.0-C34.9): Diffuse, entire lobe of lung Breast (C50.0-C50.9): Inflammatory carcinoma; diffuse, widespread,
    3/4 or more of breast
    Code 999, unknown, if only one size is given for a mixed in situ and invasive tumor.
    Code 999 if the size of the tumor is unknown or the tumor size is not documented in the patient record.
    Code 999 for histologies or sites where size in not applicable:
    Unknown or ill-defined primary (C76.0-C76.8, C80.9) Hematopoietic, reticuloendothelial, immunoproliferative or
    myeloproliferative disease Multiple myeloma (9732) Letterer-Siwe disease (9754)
    For further information see FORDS pages 100-101.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
29.1 TUMOR SIZE/EXT EVAL (CS) CS;1 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(3,1,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 1 numeric.
  • DESCRIPTION:  
    Records how the codes for the two items TUMOR SIZE (CS) and EXTENSION (CS) were determined, based on the diagnostic methods employed.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(3,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
29.2 TUMOR SIZE (CS) CS1;10 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(1,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics.
  • DESCRIPTION:  FOR MALIGNANT MELANOMA: Record the size of the tumor in TUMOR SIZE (CS), not depth or thickness. Depth or thickness is recorded in SITE-SPECIFIC FACTOR 1 (CS).
    Records the largest dimension or diameter of the primary tumor, and is always recorded in millimeters. To convert centimeters to millimeters, multiply the dimension by 10. If tumor size is given in tenths of millimeters,
    round down if between .1 and .5 mm, and round up if between .6 and .9 mm.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(1,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
29.3 TUMOR SIZE SUMMARY 2.1;20 NUMBER

  • INPUT TRANSFORM:  D TSCPSIT^ONCOOT
  • OUTPUT TRANSFORM:  D TSCPSOT^ONCOOT
  • LAST EDITED:  MAR 23, 2017
  • HELP-PROMPT:  Code the most accurate measurement of the primary tumor in millimeters (mm).
  • DESCRIPTION:  Records the most accurate measurement of a solid primary tumor, usually measured on the surgical resection specimen.
    000 No mass/tumor found 001 1 mm or described as less than 1 mm 002-998 Exact size in millimeters (2mm-998mm) 989 989 mm or larger 990 Microscopic focus or foci only and no size of focus is given
    998 SITE SPECIFIC CODES
    Alternate descriptions of tumor size for specific sites:
    Familial/multipl polyposis:
    Rectosigmoid and rectum (C19.9, C20.9)
    Colon (C18.0, C18.2-C18.9)
    If no size is documented:
    Circumferential:
    Esophagus (C15.0-C15.5, C15.8, C15.9)
    Diffuse; widespread: 3/4s or more; linitis plastica:
    Stomach and Esophagus GE Junction (C16.0-C16.6m, C16.8-C16.9)
    Diffuse, entire lung or NOS:
    Lung and main stem bronchus (C34.0-C34.3, C34.8-C34.9)
    Diffuse:
    Breast (C50.0-C50.6, C50.8-C50.9)
    999 Unknown; size not stated; Not documented in patient record; Size
    of tumor cannot be assessed; Not applicable
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
29.4 TUMOR SIZE CLINICAL 2.1;21 NUMBER

  • INPUT TRANSFORM:  D TSCPSIT^ONCOOT
  • OUTPUT TRANSFORM:  D TSCPSOT^ONCOOT
  • LAST EDITED:  MAR 23, 2017
  • HELP-PROMPT:  Code the size of the solid primary tumor before any treatment in mm.
  • DESCRIPTION:  Records the most accurate measurement of a solid primary tumor, usually measured on the surgical resection specimen.
    000 No mass/tumor found 001 1 mm or described as less than 1 mm 002-998 Exact size in millimeters (2mm-998mm) 989 989 mm or larger 990 Microscopic focus or foci only and no size of focus is given
    998 SITE SPECIFIC CODES
    Alternate descriptions of tumor size for specific sites:
    Familial/multipl polyposis:
    Rectosigmoid and rectum (C19.9, C20.9)
    Colon (C18.0, C18.2-C18.9)
    If no size is documented:
    Circumferential:
    Esophagus (C15.0-C15.5, C15.8, C15.9)
    Diffuse; widespread: 3/4s or more; linitis plastica:
    Stomach and Esophagus GE Junction (C16.0-C16.6m, C16.8-C16.9)
    Diffuse, entire lung or NOS:
    Lung and main stem bronchus (C34.0-C34.3, C34.8-C34.9)
    Diffuse:
    Breast (C50.0-C50.6, C50.8-C50.9)
    999 Unknown; size not stated; Not documented in patient record; Size
    of tumor cannot be assessed; Not applicable
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
29.5 TUMOR SIZE PATHOLOGIC 2.1;22 NUMBER

  • INPUT TRANSFORM:  D TSCPSIT^ONCOOT
  • OUTPUT TRANSFORM:  D TSCPSOT^ONCOOT
  • LAST EDITED:  MAR 23, 2017
  • HELP-PROMPT:  Code the size of the primary tumor that has been resected in mm.
  • DESCRIPTION:  Records the most accurate measurement of a solid primary tumor, usually measured on the surgical resection specimen.
    000 No mass/tumor found 001 1 mm or described as less than 1 mm 002-998 Exact size in millimeters (2mm-998mm) 989 989 mm or larger 990 Microscopic focus or foci only and no size of focus is given
    998 SITE SPECIFIC CODES
    Alternate descriptions of tumor size for specific sites:
    Familial/multipl polyposis:
    Rectosigmoid and rectum (C19.9, C20.9)
    Colon (C18.0, C18.2-C18.9)
    If no size is documented:
    Circumferential:
    Esophagus (C15.0-C15.5, C15.8, C15.9)
    Diffuse; widespread: 3/4s or more; linitis plastica:
    Stomach and Esophagus GE Junction (C16.0-C16.6m, C16.8-C16.9)
    Diffuse, entire lung or NOS:
    Lung and main stem bronchus (C34.0-C34.3, C34.8-C34.9)
    Diffuse:
    Breast (C50.0-C50.6, C50.8-C50.9)
    999 Unknown; size not stated; Not documented in patient record; Size
    of tumor cannot be assessed; Not applicable
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
29.9 EXTENSION LIST USED COMPUTED

  • MUMPS CODE:  S X=$$GETLIST^ONCODEL(D0,"E","OUT")
  • ALGORITHM:  S X=$$GETLIST^ONCODEL(D0,"E","OUT")
  • LAST EDITED:  JUL 14, 1994
  • DESCRIPTION:  
    This is a brief description of the SEER extension code list that was selected by the system for this primary. It is used for audit by print template ONCO PRIMARY EXTENT CODE AUDIT.
30 EXTENSION 2;10 NUMBER

  • INPUT TRANSFORM:  S ONCOX="E",ONCFLD=30 D IN^ONCODEL
  • OUTPUT TRANSFORM:  S ONCOX="E",ONCFLD=30 D OT^ONCODEL
  • LAST EDITED:  AUG 09, 2001
  • DESCRIPTION:  
    Seer Extent of Disease coding schema.
  • EXECUTABLE HELP:  S ONCOX="E",ONCFLD=30 D HP^ONCODEL
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
30.1 PATHOLOGIC EXTENSION 2.2;2 NUMBER

  • INPUT TRANSFORM:  K:(X>99)!(X<0)!(X?.E1"."1N.N) X I $D(X) S ONCOX="E",ONCFLD=30.1 D IN^ONCODEL
  • OUTPUT TRANSFORM:  S ONCOX="E",ONCFLD=30.1 D OT^ONCODEL
  • LAST EDITED:  MAR 25, 1999
  • DESCRIPTION:  Code the farthest documented pathologic extension of tumor from the prostate, either by contiguous extension or distant metastasis.
  • EXECUTABLE HELP:  S ONCOX="E",ONCFLD=30.1 D HP^ONCODEL
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
30.2 EXTENSION (CS) CS;11 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(2,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics.
  • DESCRIPTION:  
    Identifies contiguous growth (extension) of the primary tumor within the organ of origin or its direct extension into neighboring organs.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(2,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
30.5 PERIPHERAL BLOOD INVOLVEMENT 24;5 SET
  • 'B0' FOR Absence of significant involvement, 5% or less atypical;
  • 'B0a' FOR Clone negative;
  • 'B0b' FOR Clone positive;
  • 'B1' FOR Low blood tumor burden, > 5% atypical;
  • 'B1a' FOR Clone negative;
  • 'B1b' FOR Clone positive;
  • 'B2' FOR High blood tumor burden;

  • LAST EDITED:  DEC 06, 2010
  • HELP-PROMPT:  Enter the code designating the peripheral blood involvement.
  • DESCRIPTION:  Identifies the percentage of circulating atypical cells of T-cell lymphoma. This information may be found as part of a blood smear differential. It is only associated with an histology of Mycosis fungoides or Sezary
    syndrome.
30.9 LYMPH NODE LIST USED COMPUTED

  • MUMPS CODE:  S X=$$GETLIST^ONCODEL(D0,"L","OUT")
  • ALGORITHM:  S X=$$GETLIST^ONCODEL(D0,"L","OUT")
  • LAST EDITED:  JUL 14, 1994
  • DESCRIPTION:  
    This is a brief description of the SEER lymph node code list that was selected by the system for this primary. It is used for audit by print template ONCO PRIMARY EXTENT CODE AUDIT.
31 LYMPH NODES 2;11 NUMBER

  • INPUT TRANSFORM:  S ONCOX="L" D IN^ONCODEL
  • OUTPUT TRANSFORM:  S ONCOX="L" D OT^ONCODEL
  • LAST EDITED:  AUG 09, 2001
  • HELP-PROMPT:  Type a Number between 0 and 9, 0 Decimal Digits
  • DESCRIPTION:  
    Record SEER lymph node involvement.
  • EXECUTABLE HELP:  S ONCOX="L" D HP^ONCODEL
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^SS1^MUMPS
    1)= D SNHL^ONCOCRC
    2)= D KNHL^ONCOCRC
    Trigger to set SYSTEMIC SYMPTOMS field #843 for NON-HODGKIN'S LYMPHOMA'S.
31.1 LYMPH NODES (CS) CS;12 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(4,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics.
  • DESCRIPTION:  
    Identifies the regional lymph nodes involved with cancer at the time of diagnosis.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(4,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
32 REGIONAL LYMPH NODES POSITIVE 2;12 NUMBER

  • INPUT TRANSFORM:  K:X'?1.2N X I $D(X) S X=+X K:X>99!X<0 X I $D(X) K:(X>$P(^ONCO(165.5,D0,2),U,13))&($P(^ONCO(165.5,D0,2),U,13)<91)&(X<91) X I $D(X) K:($P(^ONCO(165.5,D0,2),U,13)=99)&(X'=99) X I $D(X) D RNPIT^ONCOIT
  • OUTPUT TRANSFORM:  D RNP^ONCOOT
  • LAST EDITED:  APR 22, 2004
  • HELP-PROMPT:  Regional Lymph Nodes Positive cannot exceed Regional Lymph Nodes Examined
  • DESCRIPTION:  Records the exact number of regional lymph nodes examined by the pathologist and found to contain metastases.
    00 All nodes examined are negative. 01-89 1-89 nodes are positive. (Code exact number of nodes positive)
    90 90 or more nodes are positive.
    95 Positive aspiration of lymph node(s) was performed.
    97 Positive nodes are documented, but the number is unspecified.
    98 No nodes were examined.
    99 It is unknown whether nodes are positive; not applicable;
    not stated in patient record.
    For further information see FORDS page 103.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
32.1 LYMPH NODES EVAL (CS) CS;2 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(5,1,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 1 numeric.
  • DESCRIPTION:  
    Records how the code for the item LYMPH NODES (CS) was determined, based on the diagnostic methods employed.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(5,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
33 REGIONAL LYMPH NODES EXAMINED 2;13 NUMBER

  • INPUT TRANSFORM:  K:X'?1.2N X I $D(X) S X=+X K:X>99!(X<0) X I $D(X) D RNEIT^ONCOIT
  • OUTPUT TRANSFORM:  D RNE^ONCOOT
  • LAST EDITED:  NOV 08, 2002
  • HELP-PROMPT:  Allowable Values: 00-90, 95-99
  • DESCRIPTION:  Records the total number of regional lymph nodes examined by the pathologist.
    00 No nodes were examined. 01-89 1-89 nodes were examined.
    (Code the exact number of regional lymph nodes examined.)
    90 90 or more nodes were examined.
    95 No regional nodes were removed, but aspiration of regional
    nodes was performed.
    96 Regional lymph node removal was documented as a sampling,
    and the number of nodes is unknown/not stated.
    97 Regional lymph node removal was documented as a dissection,
    and the number of nodes is unknown/not stated.
    98 Regional lymph nodes were surgically removed, but the number
    of lymph nodes is unknown/not stated and not documented as a
    sampling or dissection; nodes were examined but the number
    is unknown.
    99 It is unknown whether nodes were examined; not applicable or
    negative; not stated in patient record.
    For further information see FORDS page 102.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
33.1 #NODES EXAMINED COMPUTED

  • MUMPS CODE:  S Y=$P($G(^ONCO(165.5,D0,2)),U,13),X=$S(Y=98:"# Not Specified",Y=99:"Unknown if examined",1:Y)
  • ALGORITHM:  S Y=$P($G(^ONCO(165.5,D0,2)),U,13),X=$S(Y=98:"# Not Specified",Y=99:"Unknown if examined",1:Y)
  • LAST EDITED:  AUG 10, 1993
  • DESCRIPTION:  
    RECORD THE NUMBER OF LYMPH NODES EXAMINED BY PATHOLOGIST.
34 SITE OF DISTANT METASTASIS #1 2;14 SET
  • '0' FOR None;
  • '1' FOR Peritoneum;
  • '2' FOR Lung;
  • '3' FOR Pleura;
  • '4' FOR Liver;
  • '5' FOR Bone;
  • '6' FOR Central nervous system;
  • '7' FOR Skin;
  • '8' FOR Lymph nodes (distant);
  • '9' FOR Other/Gen/Carcinomatosis/Unkn;

  • LAST EDITED:  FEB 14, 2003
  • DESCRIPTION:  Code only the site(s) of distant metastasis identified during initial diagnosis and workup.
    For further information see ROADS pages 131-132.
  • GROUP:  ACOS-REQUIRED
34.1 SITE OF DISTANT METASTASIS #2 2;15 SET
  • '0' FOR None;
  • '1' FOR Peritoneum;
  • '2' FOR Lung;
  • '3' FOR Pleura;
  • '4' FOR Liver;
  • '5' FOR Bone;
  • '6' FOR Central nervous system;
  • '7' FOR Skin;
  • '8' FOR Lymph nodes (distant);
  • '9' FOR Other/Gen/Carcinomatosis/Unkn;

  • LAST EDITED:  FEB 14, 2003
  • DESCRIPTION:  Code the second site of distant metastasis identified during initial diagnosis and workup.
    For further information see ROADS pages 133-134.
  • GROUP:  ACOS-REQUIRED
34.2 SITE OF DISTANT METASTASIS #3 2;16 SET
  • '0' FOR None;
  • '1' FOR Peritoneum;
  • '2' FOR Lung;
  • '3' FOR Pleura;
  • '4' FOR Liver;
  • '5' FOR Bone;
  • '6' FOR Central nervous system;
  • '7' FOR Skin;
  • '8' FOR Lymph nodes (distant);
  • '9' FOR Other/Gen/Carcinomatosis/Unkn;

  • LAST EDITED:  FEB 14, 2003
  • DESCRIPTION:  Code the third site of distant metastasis identified during initial diagnosis and workup.
    For further information see ROADS pages 135-136.
  • GROUP:  ACOS-REQUIRED
34.3 METS AT DX (CS) CS;3 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(8,2,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 2 numerics.
  • DESCRIPTION:  
    Identifies the distant site(s) of metastatic involvement at time of diagnosis.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(8,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
34.31 METS AT DX-BONE CS1;20 SET
  • '0' FOR None;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 2009
  • HELP-PROMPT:  Enter whether bone is an involved metastatic site.
  • DESCRIPTION:  
    Identifies the presence of distant metastatic involvement of bone at time of diagnosis.
34.32 METS AT DX-BRAIN CS1;21 SET
  • '0' FOR None;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 2009
  • HELP-PROMPT:  Enter whether the brain is an involved metastatic site.
  • DESCRIPTION:  
    Identifies the presence of distant metastatic involvement of the brain at time of diagnosis.
34.33 METS AT DX-LIVER CS1;22 SET
  • '0' FOR None;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 2009
  • HELP-PROMPT:  Enter whether the liver is an involved metastatic site.
  • DESCRIPTION:  
    Identifies the presence of distant metastatic involvement of the liver at time of diagnosis.
34.34 METS AT DX-LUNG CS1;23 SET
  • '0' FOR None;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 2009
  • HELP-PROMPT:  Enter whether the lung is an involved metastatic site.
  • DESCRIPTION:  
    Identifies the presence of distant metastatic involvement of the lung at time of diagnosis.
34.35 METS AT DX-DISTANT LN CS1;24 SET
  • '0' FOR None;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 13, 2017
  • HELP-PROMPT:  Enter whether distant lymph nodes are an involved metastatic site.
  • DESCRIPTION:  
    Identifies the presence of distant metastatic involvement of the distant lymph nodes at time of diagnosis.
34.36 METS AT DX-OTHER CS1;25 SET
  • '0' FOR None;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 13, 2017
  • HELP-PROMPT:  Enter whether there is any other involved metastatic site.
  • DESCRIPTION:  
    Identifies the presence of distant metastatic involvement other than bone, brain, liver, lung or distant lymph nodes at time of diagnosis.
34.4 METS EVAL (CS) CS;4 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(9,1,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 1 numeric.
  • DESCRIPTION:  
    Records how the code for the item METS AT DX (CS) was determined based on the diagnostic methods employed.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(9,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
35 SEER SUMMARY STAGE 2000 2;17 SET
  • '0' FOR In situ;
  • '1' FOR Localized;
  • '2' FOR Regional by direct extension;
  • '3' FOR Regional to lymph nodes;
  • '4' FOR Regional by extension & to nodes;
  • '5' FOR Regional, NOS;
  • '7' FOR Distant metastasis/systemic disease;
  • '8' FOR NA/Benign;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 08, 2015
  • HELP-PROMPT:  Enter the code which indicates the extent of disease at time of diagnosis.
  • DESCRIPTION:  Provides a site-specific description of the extent of disease at diagnosis.
    For further information see FORDS page 124.
  • SCREEN:  S DIC("S")="I ('$$LYMPHOMA^ONCFUNC(D0))!((Y'=0)&(Y'=2)&(Y'=3)&(Y'=4)&(Y'=8))"
  • EXPLANATION:  Codes 0, 2, 3, 4 and 8 are not valid for HODGKIN AND NON-HODGKIN LYMPHOMAS.
  • GROUP:  ACOS-REQUIRED
35.1 SEER SUMMARY STAGE ABBREVIATED COMPUTED

  • MUMPS CODE:  S X="" D GSS^ONCOCOS
  • ALGORITHM:  S X="" D GSS^ONCOCOS
  • LAST EDITED:  DEC 19, 2006
  • DESCRIPTION:  
    This item abbreviates the SEER SUMMARY STAGE 2000 (165.5,35) output values for condensed display.
36 AJCC STAGING BASIS 2;18 SET
  • 'C' FOR Clinical-diagnostic;
  • 'P' FOR Pathological (Post-surgical);
  • 'R' FOR Retreatment Staging;
  • 'A' FOR Autopsy;
  • 'S' FOR Surgical Evaluative;

  • LAST EDITED:  JUL 02, 1993
  • DESCRIPTION:  Record the most appropriate code to reflect the basis on which the case was staged.
    Clinical-diagnostic staging is used for those sites that are accessible, i.e. cervix, oral cavity, larynx, and for those organs where evaluation of extent must be made only on the basis of clinical-diagnostic findings.
    Clinical-diagnostic staging is based on the physical examination, diagnostic imaging, clinical pathology, and biopsy of the primary.
    Postsurgical pathological staging is a combination of all findings - clinical-diagnostic, surgical-evaluative, and postsurgical retreatment-pathological.
  • TECHNICAL DESCR:  
    This field is referenced direction by PATHSTAG^ONCOU55.
    SOURCE OF DATA: ACOS 3.53
  • GROUP:  ACOS-REQUIRED
37 TNM CLINICAL COMPUTED

  • MUMPS CODE:  S STGIND="C",X=$$TNMOUT^ONCOTNO(D0)
    9.2 = S Y(165.5,37,2)=$S($D(^ONCO(165.5,D0,2)):^(2),1:"") S X="T",Y(165.5,37,1)=X,Y(165.5,37,3)=X,Y=$P(Y(165.5,37,2),U,25) X:$D(^DD(165.5,37.1,2)) ^(2) S X=Y
    9.3 = X ^DD(165.5,37,9.2) S Y=X,X=Y(165.5,37,1),X=X_Y_" N",Y(165.5,37,4)=X,Y(165.5,37,5)=X,Y=$P(Y(165.5,37,2),U,26) X:$D(^DD(165.5,37.2,2)) ^(2) S X=Y
    9.4 = X ^DD(165.5,37,9.3) S Y=X,X=Y(165.5,37,4),X=X_Y_" M",Y(165.5,37,6)=X,Y(165.5,37,7)=X,Y=$P(Y(165.5,37,2),U,27) X:$D(^DD(165.5,37.3,2)) ^(2) S X=Y
  • ALGORITHM:  S STGIND="C",X=$$TNMOUT^ONCOTNO(D0)
  • LAST EDITED:  DEC 14, 2005
  • HELP-PROMPT:  Use 6-12 characters, e.g. T1N0M0, T2aN1bM0, or T3NXMX
  • DESCRIPTION:  
    This is the combined Clinical T, N, and M codes, formatted for display.
    SOURCE OF DATA: ACOS 3.54
  • GROUP:  ACOS-REQUIRED
37.1 CLINICAL T 2;25 FREE TEXT

  • INPUT TRANSFORM:  I $D(X) K:$L(X)>4!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="T",STGIND="C" D IN^ONCOTNM
    MAXIMUM LENGTH: 4
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  FEB 23, 2017
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  
    Evaluates the primary tumor (T) and reflects the tumor size and/or extension of the tumor known prior to the start of any therapy.
  • EXECUTABLE HELP:  N ONCOX,STGIND S ONCOX="T",STGIND="C" D HP^ONCOTNM
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
37.2 CLINICAL N 2;26 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>8!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="N",STGIND="C" D IN^ONCOTNM
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  FEB 23, 2017
  • HELP-PROMPT:  Answer must be 1-8 characters in length.
  • DESCRIPTION:  
    Identifies the absence or presence of regional lymph node (N) metastasis and describes the extent of regional lymph node metastasis of the tumor known prior to the start of any therapy.
  • EXECUTABLE HELP:  N ONCOX,STGIND S ONCOX="N",STGIND="C" D HP^ONCOTNM
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
37.3 CLINICAL M 2;27 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>8!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="M",STGIND="C" D IN^ONCOTNM
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  FEB 23, 2017
  • HELP-PROMPT:  Answer must be 1-8 characters in length.
  • DESCRIPTION:  
    Identifies the presence or absence of distant metastasis (M) of the tumor known prior to the start of any therapy.
  • EXECUTABLE HELP:  N ONCOX,STGIND S ONCOX="M",STGIND="C" D HP^ONCOTNM
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
37.9 AUTOMATIC STAGING OVERRIDDEN 24;1 SET
  • '1' FOR Yes;
  • '0' FOR No;

  • LAST EDITED:  JUL 20, 1993
  • DESCRIPTION:  
    This field is set to 'Yes' by the abstracting option if the operator overrides automatic staging.
  • TECHNICAL DESCR:  
    This field is referenced directly by input template ONCO ABSTRACT-I.
38 STAGE GROUP CLINICAL 2;20 FREE TEXT

  • INPUT TRANSFORM:  K:X[""""!($A(X)=45) X I $D(X) S ONCOX="S",STGIND="C" D IN^ONCOTNS I $D(X) D INNUM^ONCOTNS
  • OUTPUT TRANSFORM:  S X="" D OT^ONCOTNS
  • LAST EDITED:  DEC 14, 2005
  • DESCRIPTION:  Identifies the anatomic extent of disease based on the T , N, and M elements as recorded by the physician.
    For futher information see FORDS page 115.
  • EXECUTABLE HELP:  S ONCOX="S",STGIND="C" D HP^ONCOTNS
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AS1^MUMPS
    1)= D CSSG^ONCOCRC
    2)= D KSG^ONCOCRC
    Maintains STAGE GROUPING-AJCC Field (#38.5).
38.1 GP-I AJCC SUMMARY STAGE COMPUTED

  • MUMPS CODE:  S X="" D SSG1^ONCOCOS
  • ALGORITHM:  S X="" D SSG1^ONCOCOS
  • LAST EDITED:  OCT 29, 1990
  • DESCRIPTION:  
    RECORD THE AJCC STAGE.
38.2 GP-II AJCC SUMMARY STAGE COMPUTED

  • MUMPS CODE:  S X="" D SSG2^ONCOCOS
  • ALGORITHM:  S X="" D SSG2^ONCOCOS
  • DESCRIPTION:  
    RECORD THE AJCC STAGE.
38.3 GP-III AJCC SUMMARY STAGE COMPUTED

  • MUMPS CODE:  S X="" D SSG3^ONCOCOS
  • ALGORITHM:  S X="" D SSG3^ONCOCOS
  • DESCRIPTION:  
    RECORD THE AJCC STAGE.
38.4 GP-IV AJCC SUMMARY STAGE COMPUTED

  • MUMPS CODE:  S X="" D SSG4^ONCOCOS
  • ALGORITHM:  S X="" D SSG4^ONCOCOS
  • DESCRIPTION:  
    RECORD THE AJCC STAGE.
38.5 STAGE GROUPING-AJCC 2;28 SET
  • '0' FOR 0;
  • 'I' FOR I;
  • 'II' FOR II;
  • 'III' FOR III;
  • 'IV' FOR IV;
  • 'U' FOR Unk/Uns;
  • 'NA' FOR NA;

  • LAST EDITED:  APR 06, 2021
  • DESCRIPTION:  This field is set by either the CLINICAL STAGE GROUP (38) or PATHOLOGIC STAGE GROUP (88) field depending on which takes precedence. For 2018+ cases the AJCC TNM CLIN STAGE GROUP (5004) and AJCC TNM PATH STAGE GROUP (5014)
    fields will be used instead. This field consists of the more general stage group values of 0, I, II, III, IV, Unk/Uns or NA.
  • CROSS-REFERENCE:  165.5^ASG
    1)= S ^ONCO(165.5,"ASG",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"ASG",$E(X,1,30),DA)
    Indexes file by STAGE GROUPING-AJCC.
39 OTHER STAGING SYSTEM 2;21 POINTER TO OTHER STAGING FOR ONCOLOGY FILE (#164.3) OTHER STAGING FOR ONCOLOGY(#164.3)

  • INPUT TRANSFORM:  S DIC("S")="I (($P(^ONCO(165.5,DA,0),U,16)<3070000)!((Y>74)&(Y<78))!((Y>94)&(Y<100))!(Y>108))&((Y'=29)&(Y'=30)&(Y'=31)&(Y'=32)&(Y'=33))" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  FEB 12, 2009
  • HELP-PROMPT:  Enter an additional staging classification.
  • DESCRIPTION:  
    OTHER STAGING SYSTEM allows institutions the opportunity to collect additional staging classifications, for example, CDS, RAI, DS or FAB.
  • SCREEN:  S DIC("S")="I (($P(^ONCO(165.5,DA,0),U,16)<3070000)!((Y>74)&(Y<78))!((Y>94)&(Y<100))!(Y>108))&((Y'=29)&(Y'=30)&(Y'=31)&(Y'=32)&(Y'=33))"
  • EXPLANATION:  For 2007+ cases choose from CDS, RAI, DS or FAB entries.
40 STAGE GROUP BEST COMPUTED

  • MUMPS CODE:  S X="" D OT1^ONCOTNS
  • ALGORITHM:  S X="" D OT1^ONCOTNS
  • LAST EDITED:  DEC 14, 2005
  • DESCRIPTION:  
    This field displays the "best" stage group as determined by the clinical/pathological hierarchy rules.
40.1 TNM BEST COMPUTED

  • MUMPS CODE:  S X="" D OT1^ONCOTNS S X=HIERTNM
  • ALGORITHM:  S X="" D OT1^ONCOTNS S X=HIERTNM
  • LAST EDITED:  DEC 14, 2005
  • DESCRIPTION:  
    This field displays the "best" TNM string as determined by the clinical/pathological hierarchy rules.
40.2 STAGED BY COMPUTED

  • MUMPS CODE:  S X="" D STGBY^ONCOTNS
  • ALGORITHM:  S X="" D STGBY^ONCOTNS
  • LAST EDITED:  APR 23, 2003
  • DESCRIPTION:  Choose from:
    0 Not staged
    1 Managing MD
    2 Pathologist
    3 Pathologist & managing MD
    4 Committee chair, liaison MD, registry advisor
    5 Registrar
    6 Registrar & MD
    7 Another facility
    8 NA
    9 Unknown
41 ASSOCIATED WITH HIV 2;23 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '999' FOR Unknown;

  • LAST EDITED:  JUL 14, 1997
  • DESCRIPTION:  
    Record the presence/absence of HIV.
42 TREATMENT ABBREVIATED COMPUTED

  • MUMPS CODE:  S X="" D TXS^ONCOCOS
  • ALGORITHM:  S X="" D TXS^ONCOCOS
  • LAST EDITED:  JUL 10, 2006
  • DESCRIPTION:  TREATMENT ABBREVIATED lists the type(s) of therapies intended to modify or control the malignancy. All cancer-directed therapies specified in TREATMENT ABBREVIATED are a part of the FIRST COURSE OF TREATMENT.
    The therapies have been abbreviated to a 1-character designation:
    S - SURGERY OF PRIMARY SITE (F)
    R - RADIATION
    P - RADIATION THERAPY TO CNS
    C - CHEMOTHERAPY
    H - HORMONE THERAPY
    B - IMMUMOTHERAPY
    O - OTHER TREATMENT
    E - HEMA TRANS/ENDOCRINE PROC
43 TREATMENT COMPUTED

  • MUMPS CODE:  S X="" D TX^ONCOCOS
  • ALGORITHM:  S X="" D TX^ONCOCOS
  • LAST EDITED:  MAY 02, 1996
  • DESCRIPTION:  
    The treatment given to a patient, either curative or palliative in nature.
44 TNM FORM COMPLETED 7;14 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT K:Y<1 X I $D(X) S %DT="E",%DT(0)=$$GET1^DIQ(165.5,D0,25,"I") S:(%DT(0)="0000000")!(%DT(0)=8888888)!(%DT(0)=9999999) %DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAR 25, 2009
  • HELP-PROMPT:  Enter the date on which the TNM form was completed by the Managing Physician. This date must be greater than or equal to TNM FORM ASSIGNED and may not be a future date.
  • DESCRIPTION:  
    Records the date on which the TNM form was completed by the Managing Physician.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.1 SSF1 CS;5 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(10,3,D0)
    MAXIMUM LENGTH: 30
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(10,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.101 SSF10 CS2;4 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(19,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(19,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.11 SSF11 CS2;5 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(20,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(20,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.12 SSF12 CS2;6 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(21,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(21,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.13 SSF13 CS2;7 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(22,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(22,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.14 SSF14 CS2;8 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(23,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(23,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.15 SSF15 CS2;9 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(24,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(24,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.16 SSF16 CS2;10 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(25,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(25,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.17 SSF17 CS2;11 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(26,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(26,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.18 SSF18 CS2;12 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(27,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(27,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.19 SSF19 CS2;13 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(28,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(28,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.2 SSF2 CS;6 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(11,3,D0)
    MAXIMUM LENGTH: 30
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(11,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.201 SSF20 CS2;14 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(29,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(29,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.21 SSF21 CS2;15 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(30,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(30,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.22 SSF22 CS2;16 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(31,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(31,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.23 SSF23 CS2;17 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(32,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(32,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.24 SSF24 CS2;18 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(33,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(33,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.25 SSF25 CS2;19 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(34,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(34,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
    TRIGGERED by the CS SCHEMA DISCRIMINATOR field of the ONCOLOGY PRIMARY File
44.3 SSF3 CS;7 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(12,3,D0)
    MAXIMUM LENGTH: 30
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(12,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.4 SSF4 CS;8 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(13,3,D0)
    MAXIMUM LENGTH: 30
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(13,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.5 SSF5 CS;9 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(14,3,D0)
    MAXIMUM LENGTH: 30
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(14,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.6 SSF6 CS;10 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(15,3,D0)
    MAXIMUM LENGTH: 30
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(15,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.7 SSF7 CS2;1 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(16,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(16,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.8 SSF8 CS2;2 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(17,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(17,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
44.9 SSF9 CS2;3 FREE TEXT

  • INPUT TRANSFORM:  D INPUT^ONCWEBCS(18,3,D0)
    MAXIMUM LENGTH: 30
  • LAST EDITED:  FEB 27, 2024
  • HELP-PROMPT:  Answer must be 3 numerics, no decimal places.
  • DESCRIPTION:  
    Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.
  • EXECUTABLE HELP:  D HELP^ONCWEBCS(18,D0)
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
45 PERFORMANCE STATUS 2;24 SET
  • '100' FOR NORMAL;
  • '90' FOR MINOR SYMTOMS;
  • '80' FOR ACTIVITY W EFFORT;
  • '70' FOR NO WORK/SELF CARE;
  • '60' FOR OCCASIONAL ASSIST;
  • '50' FOR CONSIDERABLE ASSIST;
  • '40' FOR DISABLED/SPECIAL CARE;
  • '30' FOR SEVERLY DISABLED/HOSP;
  • '20' FOR VERY SICK/HOSP;
  • '10' FOR MORIBUND;
  • '0' FOR DEAD;

  • LAST EDITED:  SEP 23, 1992
  • HELP-PROMPT:  Enter Performance Status
  • DESCRIPTION:  
    This is the performance status of the patient.
46 CAP PROTOCOL REVIEW 7;19 SET
  • '0' FOR Failed;
  • '1' FOR Complied;
  • '9' FOR NA or exempt;

  • LAST EDITED:  JUL 13, 2006
  • DESCRIPTION:  The ACS (American College of Surgeons) requires CAP (College of American Pathologists) Protocol Review of cases with surgical resection only. Biopsy only cases are exempt from review.
    Records whether this case failed, complied with or was exempt from CAP Protocol Review.
    To use code 1 (Complied), ALL elements of the CAP Cancer Protocol Checklist must be documented on the pathology report.
47 CAP TEXT 7;20 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>50!($L(X)<1) X
  • LAST EDITED:  JUL 19, 2006
  • HELP-PROMPT:  Answer must be 1-50 characters in length.
  • DESCRIPTION:  
    Records the reason for CAP (College of American Pathologists) Protocol non-compliance.
48 OTHER PRIMARY SITES COMPUTED

  • MUMPS CODE:  S X="" D SDP^ONCOCOM
  • ALGORITHM:  S X="" D SDP^ONCOCOM
  • LAST EDITED:  JUL 13, 1990
  • DESCRIPTION:  
    SITES OTHER THAN THE COMMON CANCER SITES ARE LISTED.
49 DATE 1ST CRS RX COC COMPUTED

  • MUMPS CODE:  S X="" D DFC^ONCOCOM
  • ALGORITHM:  S X="" D DFC^ONCOCOM
  • LAST EDITED:  NOV 19, 2024
  • DESCRIPTION:  Records the date on which treatment (surgery, radiation, systemic, or other therapy) of the patient began at any facility.
    For further information see FORDS pages 129-130.
49.1 FIRST TREATMENT DT-DATE DX COMPUTED

  • MUMPS CODE:  S X="" D DDX^ONCOCOM
  • ALGORITHM:  S X="" D DDX^ONCOCOM
  • LAST EDITED:  OCT 28, 2014
  • DESCRIPTION:  
    A computed field derives from FIRST COURSE OF TREATMENT DATE minus DATE DX.
  • TECHNICAL DESCR:  
    This is a computed field derives from FIRST COURSE OF TREATMENT DATE minus DATE DX.
49.9 DATE INITIAL RX SEER COMPUTED

  • MUMPS CODE:  S X="" D DRXS^ONCOCOM
  • ALGORITHM:  S X="" D DRXS^ONCOCOM
  • LAST EDITED:  FEB 09, 2022
  • DESCRIPTION:  
    Records the date of initiation of the first course therapy for the tumor being reported, using the SEER definition of first course.
50 MOST DEFINITIVE SURG DATE 3;1 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  NOV 09, 2004
  • HELP-PROMPT:  *** MOST DEFINITIVE SURG DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  Records the date of the most definitive surgical resection of the primary site performed as part of the first course of treatment.
    For further information see FORDS pages 133-134.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ATS^MUMPS
    1)= S ^ONCO(165.5,"ATX",DA,X_"S1")=""
    2)= K ^ONCO(165.5,"ATX",DA,X_"S1")
    Records most definitive surgical resection of the primary on the unified treatment index.
50.1 SURGERY HOSPITAL 3;2 POINTER TO FACILITY FILE (#160.19) FACILITY(#160.19)

  • INPUT TRANSFORM:  S V="" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
  • LAST EDITED:  MAR 02, 1998
  • HELP-PROMPT:  Record the name of the institution providing treatment.
  • DESCRIPTION:  
    Record the name of the institution providing treatment.
  • EXECUTABLE HELP:  D HELP^ONCOFLF
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
50.2 SURGERY OF PRIMARY @FAC (R) 3.1;7 FREE TEXT

  • INPUT TRANSFORM:  S FIELD=50.2,SPSFLG=0 D SPSDFIT^ONCTXSM K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X),SPSFLG=0 S NTXDD=1 D SPSIT^ONCOSUR
  • OUTPUT TRANSFORM:  S FIELD=50.2 D SPSOT^ONCOSUR
  • LAST EDITED:  MAR 27, 2003
  • DESCRIPTION:  Records the surgical procedure(s) performed to the primary site at this facilty.
    For further information see ROADS page 190.
  • EXECUTABLE HELP:  S FIELD=50.2 D SPSHP^ONCOSUR
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AT^MUMPS
    1)= Q
    2)= D SPSATF^ONCDTX1
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
50.3 MOST DEFINITIVE SURG @FAC DATE 3.1;8 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  NOV 09, 2004
  • HELP-PROMPT:  *** MOST DEFINITIVE SURG @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Records the date of the most definitive surgical resection of the primary site performed as part of the first course of treatment at this facility.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
51 DATE RADIATION STARTED 3;4 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAY 29, 2025
  • HELP-PROMPT:  *** DATE RADIATION STARTED MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  Records the date on which radiation therapy began at any facility that is part of the first course of treatment.
    For further information see FORDS pages 148-149.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ATR^MUMPS
    1)= S ^ONCO(165.5,"ATX",DA,X_"R")=""
    2)= K ^ONCO(165.5,"ATX",DA,X_"R")
    Records radiation date on the unified treatment index.
  • CROSS-REFERENCE:  165.5^AÀ^MUMPS
    1)= Q
    2)= D RAD^ONCDTX
    When this field (DATE RADIATION STARTED) is deleted, delete the values in the other associated RADIATION fields.
51.1 RADIATION HOSPITAL 3;5 POINTER TO FACILITY FILE (#160.19) FACILITY(#160.19)

  • INPUT TRANSFORM:  S V="" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
  • LAST EDITED:  SEP 02, 1997
  • HELP-PROMPT:  Enter Facility performing Radiation Therapy
  • DESCRIPTION:  
    Record the name of the institution administering the therapy.
  • EXECUTABLE HELP:  D HELP^ONCOFLF
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
51.2 RADIATION 3;6 SET
  • '0' FOR None;
  • '1' FOR Beam radiation;
  • '2' FOR Radioactive implants;
  • '3' FOR Radioisotopes;
  • '4' FOR Beam + implants or radioisotopes;
  • '5' FOR Radiation, NOS;
  • '7' FOR Refused radiation;
  • '8' FOR Recommended, unknown if given;
  • '9' FOR Unknown if administered;

  • INPUT TRANSFORM:  S V=0 D NT^ONCODSR
  • LAST EDITED:  SEP 12, 1997
  • DESCRIPTION:  Record the type of radiation administered to the primary site or any metastatic site. Include all procedures that are part of the first course of treatment, whether delivered at the reporting institution or at other
    institutions.
  • SCREEN:  S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2960101)!((Y'=7)&(Y'=8))"
  • EXPLANATION:  Codes 7 and 8 should not be used for primaries with a DATE DX > 12/31/95.
  • GROUP:  ACOS-REQUIRED
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AJ^MUMPS
    1)= Q
    2)= D RAD^ONCDTX
    When the value of this field is deleted, the KILL logic will delete the following associated field values:
    DATE RADIATION STARTED (165.5,51) LOCATION OF RADIATION TX (165.5,126) RADIATION TREATMENT VOLUME (165.5,125) REGIONAL TREATMENT MODALITY (165.5,363) REGIONAL DOSE:cGy (165.5,442) BOOST TREATMENT
    MODALITY (165.5,363.1) BOOST DOSE:cGy (165.5,443) NUMBER OF TXS TO THIS VOLUME (165.5,56) RADIATION/SURGERY SEQUENCE (165.5,51.3) DATE RADIATION ENDED (165.5,361) REASON FOR NO RADIATION
    (165.5,75) RX TEXT-RADIATION (165.5,109)
51.3 RADIATION/SURGERY SEQUENCE 3;7 SET
  • '0' FOR No rad and/or surgery;
  • '2' FOR Rad before surgery;
  • '3' FOR Rad after surgery;
  • '4' FOR Rad both before/after surgery;
  • '5' FOR Intraoperative rad;
  • '6' FOR Intraoperative rad w rad before/after surgery;
  • '9' FOR Sequence unknown;

  • INPUT TRANSFORM:  S V=0 D NT^ONCODSR
  • LAST EDITED:  SEP 02, 1997
  • DESCRIPTION:  Records the sequencing of radiation and surgical procedures given as part of the first course of treatment.
    For further information see FORDS pages 164-165.
  • GROUP:  ACOS-RECOMMENDED
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
51.4 RADIATION @FACILITY 3.1;12 SET
  • '0' FOR None;
  • '1' FOR Beam radiation;
  • '2' FOR Radioactive implants;
  • '3' FOR Radioisotopes;
  • '4' FOR Beam + implants or radioisotopes;
  • '5' FOR Radiation, NOS;
  • '7' FOR Refused radiation;
  • '8' FOR Recommended, unknown if given;
  • '9' FOR Unknown if administered;

  • INPUT TRANSFORM:  S V=0 D NT^ONCODSR
  • LAST EDITED:  OCT 01, 1998
  • HELP-PROMPT:  Enter the type of radiation administered to the primary site or any metastatic site at this facility
  • DESCRIPTION:  Records the type of radiation administered to the primary site or any metastatic site AT THIS FACILITY. Includes all procedures that are part of the first course of treatment.
  • SCREEN:  S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2960101)!((Y'=7)&(Y'=8))"
  • EXPLANATION:  Codes 7 and 8 should not be used for primaries with a DATE DX > 12/31/95.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AU^MUMPS
    1)= Q
    2)= D RADATF^ONCDTX1
    NOREINDEX)= 1
    When the value of this field is deleted, the KILL logic will delete the following associated field value:
    RADIATION @FACILITY DATE (165.5,51.5)
51.5 RADIATION @FACILITY DATE 3.1;13 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JAN 21, 1999
  • HELP-PROMPT:  *** RADIATION DATE AT THIS FACILITY MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  Record the date that the first course of radiation therapy performed AT THIS FACILITY was started.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
52 RADIATION THERAPY TO CNS DATE 3;8 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  OCT 24, 2005
  • HELP-PROMPT:  *** RADIATION THERAPY TO CNS DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  FOR LUNG AND LEUKEMIA ONLY: record the date radiation therapy to the brain and CNS was initiated.
    ALL OTHER SITES: not a valid entry.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ATP^MUMPS
    1)= S ^ONCO(165.5,"ATX",DA,X_"P")=""
    2)= K ^ONCO(165.5,"ATX",DA,X_"P")
    Records brain/CNS radiation date on the unified treatment index.
52.1 RADIATION THERAPY TO CNS HOSP 3;9 POINTER TO FACILITY FILE (#160.19) FACILITY(#160.19)

  • INPUT TRANSFORM:  S V="" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
  • LAST EDITED:  SEP 02, 1997
  • HELP-PROMPT:  Enter Facility giving the treatment.
  • DESCRIPTION:  
    Record the name of the institution administering the therapy. This field is used only for LUNGS and LEUKEMIAS.
  • EXECUTABLE HELP:  D HELP^ONCOFLF
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
52.2 RADIATION THERAPY TO CNS 3;10 SET
  • '0' FOR No radiation to CNS;
  • '1' FOR Radiation;
  • '7' FOR Patient refused radiation;
  • '8' FOR Radiation recommended, unk if admin;
  • '9' FOR Unknown/NA;

  • INPUT TRANSFORM:  S V=0 D NT^ONCODSR
  • LAST EDITED:  AUG 11, 2003
  • HELP-PROMPT:  Code '9' unless this is a lung or leukemia case
  • DESCRIPTION:  These data are being kept for historical purposes. Do not code for cases diagnosed as of January 1, 1996. Case diagnosed on or after January 1, 1996 should be coded in the field RADIATION.
    Radiation treatment to the central nervous system (CNS) codes 0-8 are valid only for patients with lung or leukemia primaries. Code 9 (Unknown/NA) for all other cases.
  • GROUP:  SEER
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
53 CHEMOTHERAPY DATE 3;11 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAR 11, 1998
  • HELP-PROMPT:  *** CHEMOTHERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  Record the date first course of CHEMOTHERAPY was started.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ATC^MUMPS
    1)= S ^ONCO(165.5,"ATX",DA,X_"C")=""
    2)= K ^ONCO(165.5,"ATX",DA,X_"C")
    Records chemotheraphy date on the unified treatment index.
53.1 CHEMOTHERAPY HOSPITAL 3;12 POINTER TO FACILITY FILE (#160.19) FACILITY(#160.19)

  • INPUT TRANSFORM:  S V="" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
  • LAST EDITED:  SEP 19, 1997
  • HELP-PROMPT:  Enter the institution where CHEMOTHERPY was administered.
  • DESCRIPTION:  Record the name of the institution where CHEMOTHERAPY was given.
  • EXECUTABLE HELP:  D HELP^ONCOFLF
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
53.2 CHEMOTHERAPY 3;13 SET
  • '00' FOR None;
  • '01' FOR Chemotherapy, NOS;
  • '02' FOR Single-agent;
  • '03' FOR Multiagent;
  • '82' FOR Not administered/contraindicated;
  • '85' FOR Pt died prior to tx;
  • '86' FOR Recommended, not admin, no reason given;
  • '87' FOR Refusal;
  • '88' FOR Recommended, unknown if admin;
  • '99' FOR Unknown;

  • LAST EDITED:  SEP 09, 2003
  • DESCRIPTION:  Records the type of chemotherapy administered as first course of treatment at this and at all other facilities. If chemotherapy was not administered, then this item records the reason it was not administered to the
    patient. Chemotherapy consists of a group of anticancer drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis.
    For further information see FORDS pages 171-172.
  • SCREEN:  S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2960101)!((Y'=7)&(Y'=8))"
  • EXPLANATION:  Codes 7 and 8 should not be used for primaries with a DATE DX > 12/31/95.
  • GROUP:  ACOS-REQUIRED
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AM^MUMPS
    1)= Q
    2)= D CHE^ONCDTX
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
53.3 CHEMOTHERAPY @FAC 3.1;14 SET
  • '00' FOR None;
  • '01' FOR Chemotherapy, NOS;
  • '02' FOR Single-agent;
  • '03' FOR Multiagent;
  • '82' FOR Not administered/contraindicated;
  • '85' FOR Pt died prior to tx;
  • '86' FOR Recommended, not admin, no reason given;
  • '87' FOR Refusal;
  • '88' FOR Recommended, unknown if admin;
  • '99' FOR Unknown;

  • LAST EDITED:  FEB 11, 2016
  • HELP-PROMPT:  Enter the type of chemotherapy administered as first course of treatment at this facility
  • DESCRIPTION:  Records the type of chemotherapy administered as first course of treatment at this facility. If chemotherapy was not administered, then this item records the reason it was not administered to the patient. Chemotherapy
    consists of a group of anticancer drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis.
    For further information see FORDS pages 173-174.
  • CROSS-REFERENCE:  165.5^AV^MUMPS
    1)= Q
    2)= D CHEMATF^ONCDTX1
    NOREINDEX)= 1
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
53.4 CHEMOTHERAPY @FAC DATE 3.1;15 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  FEB 25, 2003
  • HELP-PROMPT:  *** CHEMOTHERAPY @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Record the date chemotherapy was administered as first course of treatment at this facility.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
54 HORMONE THERAPY DATE 3;14 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAR 11, 1998
  • HELP-PROMPT:  *** HORMONE THERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  Record the date HORMONE THERAPY was started.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ATH^MUMPS
    1)= S ^ONCO(165.5,"ATX",DA,X_"H")=""
    2)= K ^ONCO(165.5,"ATX",DA,X_"H")
    Records hormone therapy date on the unified treatment index.
54.1 HORMONE THERAPY HOSPITAL 3;15 POINTER TO FACILITY FILE (#160.19) FACILITY(#160.19)

  • INPUT TRANSFORM:  S V="" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
  • LAST EDITED:  OCT 03, 1997
  • HELP-PROMPT:  Enter Hospital where Hormone Therapy was performed.
  • DESCRIPTION:  
    Record the name of the institution that administered the hormone therapy.
  • EXECUTABLE HELP:  D HELP^ONCOFLF
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
54.2 HORMONE THERAPY 3;16 SET
  • '00' FOR None;
  • '01' FOR Hormone therapy;
  • '82' FOR Not administered/contraindicated;
  • '85' FOR Pt died prior to tx;
  • '86' FOR Recommended, not admin, no reason given;
  • '87' FOR Refusal;
  • '88' FOR Recommended, unknown if admin;
  • '99' FOR Unknown;

  • LAST EDITED:  SEP 09, 2003
  • DESCRIPTION:  Records the type of hormone therapy administered as first course treatment at this and all other facilities. If hormone therapy was not administered, then this item records the reason it was not administered to the
    patient. Hormone therapy consists of a group of drugs that may affect the long-term control of a cancer's growth. It is not usually used as a curative measure.
    For further information see FORDS pages 175-176.
  • SCREEN:  S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2960101)!((Y'=7)&(Y'=8))"
  • EXPLANATION:  Codes 7 and 8 should not be used for primaries with a DATE DX > 12/31/95.
  • GROUP:  ACOS-REQUIRED
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AN^MUMPS
    1)= Q
    2)= D HOR^ONCDTX
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
54.3 HORMONE THERAPY @FAC 3.1;16 SET
  • '00' FOR None;
  • '01' FOR Hormone therapy;
  • '82' FOR Not administered/contraindicated;
  • '85' FOR Pt died prior to tx;
  • '86' FOR Recommended, not admin, no reason given;
  • '87' FOR Refusal;
  • '88' FOR Recommended, unknown if admin;
  • '99' FOR Unknown;

  • LAST EDITED:  JUN 29, 2006
  • HELP-PROMPT:  Enter the type of hormone therapy administered as first course of treatment at this facility
  • DESCRIPTION:  Records the type of hormone therapy administered as first course treatment at this facility. If hormone therapy was not administered, then this item records the reason it was not administered to the patient. Hormone
    therapy consists of a group of drugs that may affect the long-term control of a cancer's growth. It is not usually used as a curative measure.
    For further information see FORDS pages 177-178.
  • CROSS-REFERENCE:  165.5^AW^MUMPS
    1)= Q
    2)= D HORATF^ONCDTX1
    NOREINDEX)= 1
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
54.4 HORMONE THERAPY @FAC DATE 3.1;17 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  FEB 25, 2003
  • HELP-PROMPT:  *** HORMONE THERAPY @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Records the date hormone therapy was administered as first course of treatment at this facility.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
55 IMMUNOTHERAPY DATE 3;17 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAR 11, 1998
  • HELP-PROMPT:  *** IMMUNOTHERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    The date immunotherapy was started.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ATB^MUMPS
    1)= S ^ONCO(165.5,"ATX",DA,X_"B")=""
    2)= K ^ONCO(165.5,"ATX",DA,X_"B")
    Records biological response modifier date on the unified treatment index.
55.1 IMMUNOTHERAPY HOSPITAL 3;18 POINTER TO FACILITY FILE (#160.19) FACILITY(#160.19)

  • INPUT TRANSFORM:  S V="" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
  • LAST EDITED:  SEP 23, 1997
  • HELP-PROMPT:  Record the ACOS number of the institution where immunotherapy was performed.
  • DESCRIPTION:  
    The ACOS number of the institution where immunotherapy was performed.
  • EXECUTABLE HELP:  D HELP^ONCOFLF
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
55.2 IMMUNOTHERAPY 3;19 SET
  • '00' FOR None;
  • '01' FOR Immunotherapy;
  • '82' FOR Not administered/contraindicated;
  • '85' FOR Pt died prior to tx;
  • '86' FOR Recommended, not admin, no reason given;
  • '87' FOR Refusal;
  • '88' FOR Recommended, unknown if admin;
  • '99' FOR Unknown;

  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  SEP 09, 2003
  • DESCRIPTION:  Records the type of immunotherapy administered as first course treatment at this and all other facilities. If immunotherapy was not administered, then this item records the reason it was not administered to the patient.
    Immunotherapy consists of biological or chemical agents that alter the immune system or change the host's response to the tumor cells.
    For further information see FORDS pages 179-180.
  • SCREEN:  S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)>2951231)!((Y'=3)&(Y'=4)&(Y'=5)&(Y'=6))"
  • EXPLANATION:  Codes 3, 4, 5 and 6 should only be used for primaries with a DATE DX > 12/31/95.
  • GROUP:  ACOS-REQUIRED
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AO^MUMPS
    1)= Q
    2)= D IMM^ONCDTX
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
55.3 IMMUNOTHERAPY @FAC 3.1;18 SET
  • '00' FOR None;
  • '01' FOR Immunotherapy;
  • '82' FOR Not administered/contraindicated;
  • '85' FOR Pt died prior to tx;
  • '86' FOR Recommended, not admin, no reason given;
  • '87' FOR Refusal;
  • '88' FOR Recommended, unknown if admin;
  • '99' FOR Unknown;

  • LAST EDITED:  JAN 29, 2003
  • HELP-PROMPT:  Enter the type of immunotherapy administered as first course of treatment at this facility
  • DESCRIPTION:  Records the type of immunotherapy administered as first course treatment at this facility. If immunotherapy was not administered, then this item records the reason it was not administered to the patient. Immunotherapy
    consists of biological or chemical agents that alter the immune system or change the host's response to the tumor cells.
    For further information see FORDS page 181.
  • CROSS-REFERENCE:  165.5^AX^MUMPS
    1)= Q
    2)= D IMMATF^ONCDTX1
    NOREINDEX)= 1
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
55.4 IMMUNOTHERAPY @FAC DATE 3.1;19 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  FEB 25, 2003
  • HELP-PROMPT:  *** IMMUNOTHERAPY @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Records the date immunotherapy was administered as first course of treatment at this facility.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
56 NUMBER OF TXS TO THIS VOLUME 3;20 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X I $D(X) S V=0 D NT^ONCODSR
  • OUTPUT TRANSFORM:  S Y=$S(Y="000":"None",Y=999:"Unknown",1:Y)
  • LAST EDITED:  JUL 14, 2010
  • HELP-PROMPT:  Type a Number between 0 and 999, 0 Decimal Digits
  • DESCRIPTION:  Records the total number of treatment sessions (fractions) administered during the first course of treatment.
    For further information see FORDS page 163.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
57 OTHER TREATMENT START DATE 3;23 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JAN 31, 2003
  • HELP-PROMPT:  *** OTHER TREATMENT START DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  Records the date on which other treatment began at any facility.
    For further information see FORDS pages 184-185.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ATO^MUMPS
    1)= S ^ONCO(165.5,"ATX",DA,X_"O")=""
    2)= K ^ONCO(165.5,"ATX",DA,X_"O")
    Records other cancer-directed therapy date on the unified treatment index.
57.1 OTHER TREATMENT HOSPITAL 3;24 POINTER TO FACILITY FILE (#160.19) FACILITY(#160.19)

  • INPUT TRANSFORM:  S V="" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)
  • LAST EDITED:  SEP 23, 1997
  • HELP-PROMPT:  Enter facility where other treatment was given.
  • DESCRIPTION:  
    Record the name of the institution where other treatment was administered.
  • EXECUTABLE HELP:  D HELP^ONCOFLF
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
57.2 OTHER TREATMENT 3;25 SET
  • '0' FOR None;
  • '1' FOR Other;
  • '2' FOR Other - Experimental;
  • '3' FOR Other - Double Blind;
  • '6' FOR Other - Unproven;
  • '7' FOR Refusal;
  • '8' FOR Recommended, unknown if administered;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 2003
  • DESCRIPTION:  Identifies other treatment that cannot be defined as surgery, radiation, or systemic therapy according to the defined data elements in the FORDS manual.
    For further information see FORDS page 186.
  • GROUP:  ACOS-REQUIRED
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AP^MUMPS
    1)= Q
    2)= D OTH^ONCDTX
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
57.3 OTHER TREATMENT @FAC 3.1;20 SET
  • '0' FOR None;
  • '1' FOR Other;
  • '2' FOR Other - Experimental;
  • '3' FOR Other - Double Blind;
  • '6' FOR Other - Unproven;
  • '7' FOR Refusal;
  • '8' FOR Recommended, unknown if administered;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 2003
  • HELP-PROMPT:  Enter other treatment given at this facility that cannot be defined as surgery, radiation or systemic therapy
  • DESCRIPTION:  Identifies other treatment given at this facility that cannot be defined as surgery, radiation, or systemic therapy according to the defined data elements in the FORDS manual.
    For further information see FORDS page 187.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AZ^MUMPS
    1)= Q
    2)= D OTHATF^ONCDTX1
    NOREINDEX)= 1
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
57.4 OTHER TREATMENT @FACILITY DATE 3.1;21 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JAN 21, 1999
  • HELP-PROMPT:  *** OTHER TREATMENT AT THIS FACILITY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  Record the month, day, and year first course of other treatment performed AT THIS FACILITY was started.
    Collecting dates for each treatment modality allows sequencing of multiple treatments and aids evaluation of time intervals (from diagnosis to treatment and from treatment to recurrence).
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
58 REASON NO SURGERY OF PRIMARY 3;26 SET
  • '0' FOR Surgery performed;
  • '1' FOR Not part of 1st course;
  • '2' FOR Contraindicated;
  • '5' FOR Pt died prior to surgery;
  • '6' FOR Recommended, not performed, no reason given;
  • '7' FOR Refusal;
  • '8' FOR Recommended, unknown if performed;
  • '9' FOR Unknown;

  • INPUT TRANSFORM:  Q
  • LAST EDITED:  JAN 25, 2005
  • DESCRIPTION:  Records the reason that no surgery was performed on the primary site.
    For further information see FORDS page 147.
58.1 SURGICAL DX/STAGING PROC 3;27 FREE TEXT

  • INPUT TRANSFORM:  D NCDSIT^ONCODSR
  • OUTPUT TRANSFORM:  D NCDSOT^ONCODSR
  • LAST EDITED:  NOV 08, 2002
  • DESCRIPTION:  Identifies the surgical procedure(s) performed in an effort to diagnose and/or stage disease.
    For further information see FORDS pages 109-110.
  • EXECUTABLE HELP:  D HP0^ONCODSR
  • GROUP:  SEER
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AQ^MUMPS
    1)= Q
    2)= D NCDS^ONCDTX
58.2 SURGERY OF PRIMARY (R) 3;38 NUMBER

  • INPUT TRANSFORM:  S FIELD=58.2,NTXDD=1 D SPSIT^ONCOSUR
  • OUTPUT TRANSFORM:  S FIELD=58.2 D SPSOT^ONCOSUR
  • LAST EDITED:  MAR 27, 2003
  • DESCRIPTION:  Records the surgical procedure(s) performed to the primary site.
    For further information see ROADS pages 187-189.
  • EXECUTABLE HELP:  S FIELD=58.2 D SPSHP^ONCOSUR
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AI^MUMPS
    1)= Q
    2)= D SURR^ONCDTX
58.3 SURGICAL DX/STAGING PROC DATE 3;31 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAR 29, 2007
  • HELP-PROMPT:  Enter the date the surgical diagnostic and/or staging procedure was performed.
  • DESCRIPTION:  Records the date on which the surgical diagnostic and/or staging procedure was performed.
    For further information see FORDS pages 107-108.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
58.4 SURG DX/STAGING PROC @FAC 3.1;5 FREE TEXT

  • INPUT TRANSFORM:  D NCDSIT^ONCODSR
  • OUTPUT TRANSFORM:  D NCDSOT^ONCODSR
  • LAST EDITED:  JAN 07, 2003
  • DESCRIPTION:  Identifies the surgical procedure(s) performed in an effort to diagnose and/or stage disease at this facility.
    For further information see FORDS page 111.
  • EXECUTABLE HELP:  D HP0^ONCODSR
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AR^MUMPS
    1)= Q
    2)= D NCDSATF^ONCDTX1
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
58.5 SURG DX/STAGING PROC @FAC DATE 3.1;6 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAR 29, 2007
  • HELP-PROMPT:  Enter the date the surgical diagnostic and/or staging procedure was performed at this facility.
  • DESCRIPTION:  
    Records the date on which the surgical diagnostic and/or staging procedure was performed at this facility.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
58.6 RX SUMM--SURG PRIMSITE 03-2022 3.1;29 FREE TEXT

  • INPUT TRANSFORM:  S FIELD=58.6,NTXDD=1 D SPSIT^ONCOSUR
    MAXIMUM LENGTH: 30
  • OUTPUT TRANSFORM:  S FIELD=58.6 D SPSOT^ONCOSUR
  • LAST EDITED:  AUG 26, 2024
  • HELP-PROMPT:  Enter the surgical procedure CODE. Alphabetic entries are prohibited.
  • DESCRIPTION:  Records the surgical procedure(s) performed to the primary site.
    For further information see FORDS page 135.
  • EXECUTABLE HELP:  S FIELD=58.6 D SPSHP^ONCOSUR
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AI^MUMPS
    1)= Q
    2)= D SUR^ONCDTX
    If SURGICAL PROC OF PRIMARY is deleted, the associated surgery fields are also deleted.
58.7 RX HOSP--SURG PRIMSITE 03-2022 3.1;30 FREE TEXT

  • INPUT TRANSFORM:  S SPSFLG=0 D SPSDFIT^ONCTXSM K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X),SPSFLG=0 S FIELD=58.7,NTXDD=1 D SPSIT^ONCOSUR
    MAXIMUM LENGTH: 2
  • OUTPUT TRANSFORM:  S FIELD=58.7 D SPSOT^ONCOSUR
  • LAST EDITED:  AUG 26, 2024
  • DESCRIPTION:  Records the surgical procedure(s) performed to the primary at this facility.
    For further information see FORDS page 136.
  • EXECUTABLE HELP:  S FIELD=58.7 D SPSHP^ONCOSUR
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AT^MUMPS
    1)= Q
    2)= D SPSATF^ONCDTX1
    If SURGICAL PROC OF PRIMARY @FAC is deleted, the associated surgery @FAC fields are also deleted.
58.8 RX HOSP--SURG PRIM SITE 2023 3.2;8 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<4) X I $D(X) D SPSIT23^ONCOSUR3
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 08, 2023
  • HELP-PROMPT:  Answer must be 4 characters in length. Format: First character must be 'A' or 'B' followed by 3 numbers. See Appendix A of STORE Manual 2023 for allowable values for each primary site.
  • DESCRIPTION:  
    Records the surgical procedure(s) performed to the primary site at this facility with a diagnosis year of 2023 and forward.
  • EXECUTABLE HELP:  D SPSHP23^ONCOSUR3
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
58.9 RX SUMM--SURG PRIM SITE 2023 3.2;9 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<4) X I $D(X) D SPSIT23^ONCOSUR3
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 08, 2023
  • HELP-PROMPT:  Answer must be 4 characters in length. Format: First character must be 'A' or 'B' followed by 3 numbers. See Appendix A of STORE Manual 2023 for allowable values for each primary site.
  • DESCRIPTION:  
    Surgery of Primary Site describes a surgical procedure that removes and/or destroys tissue of the primary site that is performed as part of the initial diagnostic and staging work-up or first course of therapy.
  • EXECUTABLE HELP:  D SPSHP23^ONCOSUR3
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
59 SURGICAL MARGINS 3;28 SET
  • '0' FOR No residual tumor;
  • '1' FOR Residual tumor, NOS;
  • '2' FOR Microscopic residual tumor;
  • '3' FOR Macroscopic residual tumor;
  • '7' FOR Margins not evaluable;
  • '8' FOR No primary site surgery;
  • '9' FOR Unknown or NA;

  • LAST EDITED:  FEB 25, 2010
  • HELP-PROMPT:  Record the margin status as it appears in the pathology report.
  • DESCRIPTION:  Records the final status of the surgical margins after resection of the primary tumor.
    For further information see FORDS 2010 page 224.
60 SUBSEQUENT COURSE OF TREATMENT 4;0 DATE Multiple #165.51 165.51

  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  MAY 04, 1993
  • DESCRIPTION:  
    Enter subsequent therapy (therapy provided after completion of the first course of therapy).
61 PID# COMPUTED

  • MUMPS CODE:  S X="" D PID5^ONCOCOM
  • ALGORITHM:  S X="" D PID5^ONCOCOM
  • DESCRIPTION:  
    RECORD THE PATIENT'S IDENTIFICATION NUMBER.
62 QA SELECTED 7;4 SET
  • 'Y' FOR YES;

  • LAST EDITED:  SEP 23, 1992
  • HELP-PROMPT:  Abstract has been selected for QA Review (from QA option)
  • DESCRIPTION:  
    Field is stuffed if randomly selected for QA review.
63 QA REVIEW 7;8 SET
  • 'N' FOR NO;
  • 'Y' FOR YES;

  • LAST EDITED:  SEP 23, 1992
  • HELP-PROMPT:  Enter if QReview was performed on the selected Abstract.
  • DESCRIPTION:  
    Field only used if Abstract was randomly selected for QA Review.
64 QA DATE 7;9 DATE

  • INPUT TRANSFORM:  S %DT="EPX" D ^%DT S X=Y K:Y<1 X I $D(X) S DTDX=$P($G(^ONCO(165.5,D0,0)),"^",16) I DTDX'="" K:X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JUL 31, 2014
  • HELP-PROMPT:  *** QA DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Date of QA Review if done on this Abstract.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
64.1 QA REVIEWER 7;18 POINTER TO NEW PERSON FILE (#200) NEW PERSON(#200)

  • LAST EDITED:  JUL 19, 1999
  • DESCRIPTION:  Select the name of the QA reviewer.
64.2 QA FINDINGS 28;0 WORD-PROCESSING #165.54

  • DESCRIPTION:  Enter the QA FINDINGS of the QA review. Please limit your findings to 3 lines of text.
  • LAST EDITED:  JUL 27, 1999
  • DESCRIPTION:  Enter the QA FINDINGS of the QA review. Please limit your findings to 3 lines of text.
65 PHYSICIAN'S STAGE 7;10 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>30!($L(X)<3) X
  • LAST EDITED:  JUL 17, 2003
  • HELP-PROMPT:  Answer must be 3-30 characters in length.
  • DESCRIPTION:  
    Records information regarding the physician's stage.
66 PHYSICIAN STAGING 7;11 POINTER TO ONCOLOGY CONTACT FILE (#165) ONCOLOGY CONTACT(#165)

  • INPUT TRANSFORM:  S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  MAY 11, 1999
  • HELP-PROMPT:  Enter physician's name who did the staging
  • DESCRIPTION:  This is the name of the physician performing the staging.
  • SCREEN:  S DIC("S")="I $P(^(0),U,2)=2"
  • EXPLANATION:  Contact Type is MD
  • CROSS-REFERENCE:  165.5^ACP^MUMPS
    1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""
    2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))
    Creates a list under the Contact file of contacts, and associated patients orginating from the Primary file pointers to the Contact File.
  • CROSS-REFERENCE:  165.5^APC^MUMPS
    1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""
    2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)
    Creates a list under the contact file of patients, and associated contacts originating from the Primary file pointers to the contact file.
  • CROSS-REFERENCE:  165.5^APST^MUMPS
    1)= S ^ONCO(165.5,"APST",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""
    2)= K ^ONCO(165.5,"APST",X,$P(^ONCO(165.5,DA,0),U,2),DA)
    Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.
67 ACOS # COMPUTED

  • MUMPS CODE:  S X=$$IIN^ONCFUNC
  • ALGORITHM:  S X=$$IIN^ONCFUNC
  • LAST EDITED:  NOV 03, 1999
  • DESCRIPTION:  ACOS # is the equivalent of the INSTITUTION ID NUMBER as recorded in the ONCOLOGY SITE PARAMETERS file.
68 STATE HOSPITAL # COMPUTED

  • MUMPS CODE:  S X=$$SHN^ONCFUNC
  • ALGORITHM:  S X=$$SHN^ONCFUNC
  • LAST EDITED:  NOV 03, 1999
  • DESCRIPTION:  This is the state identification number.
69 MULTIPLE TUMORS 2;31 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  JUL 01, 1993
  • HELP-PROMPT:  If multiple tumors, enter a 1 or the exact number if known.
  • DESCRIPTION:  This field documents the existence and (if known) number of multiple tumors at an anatomic site.
    If there are NOT multiple tumors at this site, leave this field BLANK.
    If there ARE multiple tumors at this site, enter the exact number of tumors here if known, or a 1 if the exact number if not known.
69.1 FAMILY HISTORY 2;32 SET
  • '0' FOR No;
  • '1' FOR Yes;

  • LAST EDITED:  JUL 01, 1993
  • DESCRIPTION:  If there is a known family history for this case, enter a 1.
    Otherwise, enter a 0 or leave blank.
    This field only applies to cancers of the retina.
69.2 DIFFUSE RETINAL INVOLVEMENT 3;30 SET
  • '0' FOR No;
  • '1' FOR Yes;

  • LAST EDITED:  JUL 01, 1993
  • DESCRIPTION:  If there is diffuse retinal involvement without the formation of discrete masses, enter a 1.
    Otherwise, enter a 0 or leave blank.
    This field applies only to cancers of the retina.
69.3 MULTIMODALITY THERAPY (CLIN) 7;16 SET
  • 'Y' FOR Yes;
  • 'N' FOR No;

  • LAST EDITED:  MAY 30, 1997
  • DESCRIPTION:  The first method of therapy is other than cancer-directed surgery. The patient is first treated with radiation therapy, chemotherapy, hormone therapy, immunotherapy, "other" therapy, or any combination of these therapies.
    The stage is based on a pathologic resection of the primary done after at least one of the other therapies has started. The other therapy may or may not be complete. This stage should supplement the clinical AJCC stage,
    not replace it.
69.4 MULTIMODALITY THERAPY 7;17 SET
  • 'Y' FOR Yes;
  • 'N' FOR No;

  • LAST EDITED:  OCT 24, 2002
  • HELP-PROMPT:  Enter Yes to prefix the pTNM category with "y".
  • DESCRIPTION:  MULTIMODALITY THERAPY determines whether the pTNM category will have a "y Prefix" (eg yT1 N0 M0).
    The "y Prefix" indicates those cases in which classification is performed during or following initial multimodality therapy. The ypTNM categorizes the extent of tumor actually present at the time of that examination. The
    "y" category is not an estimate of the extent of tumor prior to multimodality therapy.
70 DATE OF FIRST RECURRENCE 5;1 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOPCE
  • LAST EDITED:  SEP 02, 2015
  • HELP-PROMPT:  *** DATE OF FIRST RECURRENCE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  Records the date of the first recurrence.
    For further information see FORDS pages 195-196.
  • GROUP:  ACOS-REQUIRED
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^999.21
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,27)):^(27),1:"") S X=$P(Y(1),U,26),X=X S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),27)),DIV=X S $P(^(27),U,26)=DIV,DIH=165.5,DIG=999.21 D ^DICR
    2)= Q
    CREATE VALUE)= @
    DELETE VALUE)= NO EFFECT
    FIELD)= RECURRENCE DATE-1ST F
    If DATE OF FIRST RECURRENCE field is entered then delete the RECURRENCE DATE-1ST FLAG field value.
71 TYPE OF FIRST RECURRENCE 5;2 POINTER TO TYPE OF RECURRENCE FILE (#160.12) TYPE OF RECURRENCE(#160.12)

  • INPUT TRANSFORM:  S DIC("S")="I ($P(^(0),U,1)'=11)&($P(^(0),U,1)'=""01"")" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  S:Y'="" Y=$P($G(^ONCO(160.12,Y,0)),U,2)
  • LAST EDITED:  FEB 04, 2003
  • DESCRIPTION:  Identifies the type of first recurrence after a period of documented disease-free intermission or remission.
    For further information see FORDS pages 197-198.
  • SCREEN:  S DIC("S")="I ($P(^(0),U,1)'=11)&($P(^(0),U,1)'=""01"")"
  • EXPLANATION:  ROADS codes 01 and 11 have been discontinued.
71.1 DISTANT SITE 1 5;3 SET
  • '0' FOR None;
  • '1' FOR Peritoneum;
  • '2' FOR Lung;
  • '3' FOR Pleura;
  • '4' FOR Liver;
  • '5' FOR Bone;
  • '6' FOR Central Nervous System;
  • '7' FOR Skin;
  • '8' FOR Lymph Nodes (Distant);
  • '9' FOR Other/Generalized/NOS;

  • LAST EDITED:  JUL 09, 2004
  • DESCRIPTION:  
    Record the first site of distant recurrence.
  • GROUP:  ACOS-REQUIRED
71.2 DISTANT SITE 2 5;4 SET
  • '0' FOR None;
  • '1' FOR Peritoneum;
  • '2' FOR Lung;
  • '3' FOR Pleura;
  • '4' FOR Liver;
  • '5' FOR Bone;
  • '6' FOR Central Nervous System;
  • '7' FOR Skin;
  • '8' FOR Lymph Nodes (Distant);
  • '9' FOR Other/Generalized/NOS;

  • LAST EDITED:  JUL 09, 2004
  • DESCRIPTION:  
    Record the second site of distant recurrence.
  • GROUP:  ACOS-REQUIRED
71.3 DISTANT SITE 3 5;5 SET
  • '0' FOR None;
  • '1' FOR Peritoneum;
  • '2' FOR Lung;
  • '3' FOR Pleura;
  • '4' FOR Liver;
  • '5' FOR Bone;
  • '6' FOR Central Nervous System;
  • '7' FOR Skin;
  • '8' FOR Lymph Nodes (Distant);
  • '9' FOR Other/Generalized/NOS;

  • LAST EDITED:  JUL 09, 2004
  • DESCRIPTION:  
    Record the third site of distant recurrence.
  • GROUP:  ACOS-REQUIRED
71.4 OTHER TYPE OF FIRST RECURRENCE 5;6 POINTER TO TYPE OF RECURRENCE FILE (#160.12) TYPE OF RECURRENCE(#160.12)

  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(160.12,Y,0),"^",2)
  • LAST EDITED:  MAR 17, 2000
  • DESCRIPTION:  Record the OTHER TYPE OF FIRST RECURRENCE. The term "recurrence" means the return or reappearance of the cancer after a disease-free intermission or remission.
    The patient may have more than one site of recurrence (i.e., both regional and distant metastases). Code regional in the data field TYPE OF FIRST RECURRENCE, and distant in this field.
    If the patient has only one site of recurrence or has been disease-free since treatment, code 00.
72 SUBSEQUENT RECURRENCES 23;0 DATE Multiple #165.572 165.572

  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • DESCRIPTION:  
    This multiple records information on subsequent recurrences of the tumor.
73 TUMOR STATUS TS;0 DATE Multiple #165.573 165.573

  • LAST EDITED:  MAR 09, 1993
  • DESCRIPTION:  
    This multiple is populated by the Post/Edit Follow-Up option of the Follow-Up Menu. It contains the date of each follow-up for this patient, and the tumor status at each follow-up.
  • TECHNICAL DESCR:  
    This field is set directly by STSMONE^ONCOFTS. This field is killed directly by KTSMONE^ONCOFTS.
74 SURGICAL APPROACH (R) 3;34 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D SAIT^ONCOSUR
  • OUTPUT TRANSFORM:  D SAOT^ONCOSUR
  • LAST EDITED:  MAY 13, 2003
  • HELP-PROMPT:  Type a Number between 0 and 9, 0 Decimal Digits
  • DESCRIPTION:  SURGICAL APPROACH describes the method used to approach the organ of origin and/or primary tumor. Code the approach for surgery of the primary site only. If no primary site surgical procedure was done (SURGERY OF
    PRIMARY SITE is coded 00), SURGICAL APPROACH must be coded 0. If the field SURGERY OF PRIMARY SITE is 99 (Unknown if surgery performed; death certificate ONLY), code SURGICAL APPROACH 9 (Unknown; not stated; death
    certificate ONLY).
    For further information see ROADS page 186.
  • EXECUTABLE HELP:  D SAHP^ONCOSUR
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
75 REASON FOR NO RADIATION 3;35 SET
  • '0' FOR Radiation administered;
  • '1' FOR Not part of 1st course;
  • '2' FOR Contraindicated;
  • '5' FOR Pt died prior to tx;
  • '6' FOR Recommended, not admin, no reason given;
  • '7' FOR Refusal;
  • '8' FOR Recommended, unknown if admin;
  • '9' FOR Unknown;

  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  JAN 28, 2003
  • DESCRIPTION:  Records the reason that no regional radiation therapy was administered to the primary site.
    For further information see FORDS page 168.
76 REASON FOR NO CHEMOTHERAPY 3;36 SET
  • '0' FOR Chemo administered;
  • '1' FOR Chemo not recommended;
  • '2' FOR Contraindicated, autopsy-only cases;
  • '6' FOR Reason unk;
  • '7' FOR Pt refused chemo;
  • '8' FOR Chemo recommended, unk if administered;
  • '9' FOR Unk if administered, death cert-only cases;

  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  AUG 07, 1997
  • DESCRIPTION:  
    Record the reason the patient did not receive chemotherapy. REASON FOR NO CHEMOTHERAPY is useful in survival analysis. It is a quality assurance monitor of appropriateness of treatment.
77 REASON FOR NO HORMONE THERAPY 3;37 SET
  • '0' FOR HT administered;
  • '1' FOR HT not recommended;
  • '2' FOR Contraindicated, autopsy-only cases;
  • '6' FOR Reason unk;
  • '7' FOR Pt refused HT;
  • '8' FOR HT recommended, unk if administered;
  • '9' FOR Unk if administered, death cert-only cases;

  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  AUG 07, 1997
  • DESCRIPTION:  
    The reason the patient did not receive hormone therapy.
78 CONVERTED 24;6 SET
  • 'Y' FOR YES;
  • 'N' FOR NO;

  • LAST EDITED:  FEB 01, 1996
  • DESCRIPTION:  If this field is "YES" it means that the primary has had the pointers in fields 5,6,7,50.1,51.1,52.1,53.1,54.1,55.1,56.1,57.1 and 60 subfield 2 converted from pointers to the ONCOLOGY CONTACT File (165) to pointers to the
    new ACOS NUMBER file (160.19) already, and should not try to convert.
78.1 CONVERTED STAGED BY FIELDS 25;19 SET
  • 'Y' FOR YES;

  • LAST EDITED:  MAR 09, 2017
  • HELP-PROMPT:  Enter 'Y' if this record had it's STAGED BY (CLINICAL) and STAGED BY (PATHOLOGIC) fields converted to pointers to the Oncology Staged By Codes (#163) file.
  • DESCRIPTION:  This field will flag the record as having the STAGED BY CLINICAL (#19) and STAGED BY PATHOLOGIC (#89) fields converted for NAACCR Vol II V16. This conversion is done as part of Patch ONC*2.2*6 and this field will ensure
    that already converted records do not get converted again.
  • TECHNICAL DESCR:  
    This field should not be modified by user. It is set by the Post- Init routine of Patch ONC*2.2*6.
78.2 CONVERTED TNM FIELDS 25;20 SET
  • 'Y' FOR YES;

  • LAST EDITED:  MAR 09, 2017
  • HELP-PROMPT:  Enter 'Y' if this record had its CLINICAL and PATHOLOGIC TNM fields converted to new NAACCR v16 format.
  • DESCRIPTION:  This field will flag the record as having already converted the 6 TNM fields: CLINICAL T (#37.1), CLINICAL N (#37.2), CLINICAL M (#37.3), PATHOLOGIC T (#85), PATHOLOGIC N (#86), PATHOLOGIC M (#87). This conversion is
    being done in Patch ONC*2.2*6 as part of the update for NAACCR Vol II V16 and will ensure that records that have already been converted will not be converted again.
  • TECHNICAL DESCR:  
    This field should not be modified by user. It is set by the Post- Init routine of Patch ONC*2.2*6.
79 SCREENING DATE 0;24 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0)
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  JUL 08, 1997
  • DESCRIPTION:  
    Record the most recent date on which the patient participated in a screening program related to this primary cancer.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
80 RADIATION TREATMENT 6;0 Multiple #165.52 165.52

  • DESCRIPTION:  
    Record the type of radiation therapy.
81 COMPLETED BY 7;12 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<2) X
  • LAST EDITED:  MAY 22, 1998
  • HELP-PROMPT:  Answer must be 2-3 characters in length.
  • DESCRIPTION:  
    Record the initials of the person who completed the PCE.
82 REVIEWED BY CANCER COMMITTEE 7;13 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<2) X
  • LAST EDITED:  MAY 22, 1998
  • HELP-PROMPT:  Answer must be 2-3 characters in length.
  • DESCRIPTION:  As a method of quality control, it is recommended that a member of the cancer committee review the abstract for accuracy prior to the submission of data to the Commission on Cancer. Record the initials of the chairman or
    member of the cancer committee who reviewed the completed PCE.
83 AFIP/JPC SUBMISSION 0;21 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 02, 2011
  • HELP-PROMPT:  Record if this case was submitted to the AFIP or JPC for a second opinion.
  • DESCRIPTION:  AFIP/JPC SUBMISSION records whether the case was sent to the Armed Forces Institute of Pathology (AFIP) or Joint Pathology Center (JPC) for a second opinion.
    Effective April 1, 2011, all consultation cases must be sent to the Joint Pathology Center (JPC).
84 PCE INDICATOR 7;15 SET
  • 'BLA' FOR Bladder;
  • 'THY' FOR Thyroid;
  • 'STS' FOR Soft Tissue Sarcoma;
  • 'PRO' FOR Prostate (1992);
  • 'COL' FOR Colorectal;
  • 'NHL' FOR Non-Hodgkins Lymphoma;
  • 'BRE' FOR Breast;
  • 'PRO2' FOR Prostate (1998);
  • 'MEL' FOR Melanoma;
  • 'HEP' FOR Hepatocellular;
  • 'CNS' FOR Intracranial/CNS;
  • 'GAS' FOR Gastric;
  • 'LNG' FOR Lung;

  • LAST EDITED:  FEB 23, 2001
  • DESCRIPTION:  This field indicates the existence of a PCE (Patient Care Evaluation) study.
  • CROSS-REFERENCE:  165.5^APCE
    1)= S ^ONCO(165.5,"APCE",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"APCE",$E(X,1,30),DA)
    This is a cross-reference of those primaries who have a PCE study.
85 PATHOLOGIC T 2.1;1 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="T",STGIND="P" D IN^ONCOTNM
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  FEB 23, 2017
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  
    Evaluates the primary tumor (T) and reflects the tumor size and/or extension of the tumor known following the completion of surgical therapy.
  • EXECUTABLE HELP:  N ONCOX,STGIND S ONCOX="T",STGIND="P" D HP^ONCOTNM
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
86 PATHOLOGIC N 2.1;2 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>8!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="N",STGIND="P" D IN^ONCOTNM
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  FEB 23, 2017
  • HELP-PROMPT:  Answer must be 1-8 characters in length.
  • DESCRIPTION:  
    Identifies the absence or presence of regional lymph node (N) metastasis and describes the extent of regional lymph node metastasis of the tumor known following the completion of surgical therapy.
  • EXECUTABLE HELP:  N ONCOX,STGIND S ONCOX="N",STGIND="P" D HP^ONCOTNM
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
87 PATHOLOGIC M 2.1;3 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="M",STGIND="P" D IN^ONCOTNM
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  FEB 23, 2017
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  
    Identifies the presence or absence of distant metastasis (M) of the tumor known following the completion of surgical therapy.
  • EXECUTABLE HELP:  N ONCOX,STGIND S ONCOX="M",STGIND="P" D HP^ONCOTNM
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
88 STAGE GROUP PATHOLOGIC 2.1;4 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>14!($L(X)<1) X I $D(X) S ONCOX="S",STGIND="P" D IN^ONCOTNS I $D(X) D INNUM^ONCOTNS
  • OUTPUT TRANSFORM:  S X="" D OT^ONCOTNS
  • LAST EDITED:  DEC 14, 2005
  • DESCRIPTION:  Identifies the anatomic extent of disease based on the T, N, and M elements as recorded by the physician.
    For futher information see FORDS page 121.
  • EXECUTABLE HELP:  S ONCOX="S",STGIND="P" D HP^ONCOTNS
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AS2^MUMPS
    1)= D PSSG^ONCOCRC
    2)= D KSG^ONCOCRC
    Maintains STAGE GROUPING-AJCC field (#38.5).
89 STAGED BY (PATHOLOGIC STAGE) 2.1;5 POINTER TO ONCOLOGY STAGED BY CODES FILE (#165.7) ONCOLOGY STAGED BY CODES(#165.7)

  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(165.7,Y,0),U,1)_" "_$P(^ONCO(165.7,Y,0),U,2)
  • LAST EDITED:  APR 06, 2017
  • HELP-PROMPT:  Record the role of the person who documented the Pathologic AJCC staging items and the Stage Group.
  • DESCRIPTION:  Identifies the person who recorded the pathologic AJCC staging elements and the stage group in the patient's medical record.
    For further information refer to FORDS manual.
89.1 TNM PATHOLOGIC COMPUTED

  • MUMPS CODE:  S STGIND="P",X=$$TNMOUT^ONCOTNO(D0)
  • ALGORITHM:  S STGIND="P",X=$$TNMOUT^ONCOTNO(D0)
  • LAST EDITED:  DEC 14, 2005
  • DESCRIPTION:  
    This is the combined Pathologic T, N, and M codes, formatted for display.
90 DATE CASE COMPLETED 7;1 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JUL 01, 2021
  • HELP-PROMPT:  *** DATE CASE COMPLETED MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    The date that: (1) the abstractor decided that the case was complete, and (2) the abstract passed all edit checks.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AAD^MUMPS
    1)= S ^ONCO(165.5,"AAD",X,DA)=""
    2)= K ^ONCO(165.5,"AAD",X,DA)
    Used for QA - 10% abstracts completed in particular timeframe
91 ABSTRACT STATUS 7;2 SET
  • '0' FOR Incomplete;
  • '1' FOR Minimal data;
  • '2' FOR Partial;
  • '3' FOR Complete;
  • 'A' FOR Accession only;
  • 'D' FOR Pending delete;

  • INPUT TRANSFORM:  D CHECK^ONCOEDC Q
  • LAST EDITED:  SEP 26, 2023
  • HELP-PROMPT:  Enter a code from the list that corresponds to the status of the abstract.
  • DESCRIPTION:  
    Enter the status of the abstract data entry.
  • EXECUTABLE HELP:  D PRINT^ONCOEDC
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AS
    1)= S ^ONCO(165.5,"AS",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"AS",$E(X,1,30),DA)
    Allow sorting by status of abstract.
92 ABSTRACTED BY 7;3 POINTER TO NEW PERSON FILE (#200)
************************REQUIRED FIELD************************
NEW PERSON(#200)

  • LAST EDITED:  FEB 11, 2003
  • DESCRIPTION:  Records the initials or assigned code of the individual abstracting the case.
    For further information see FORDS page 207.
93 OTHER T 2.1;6 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>30!($L(X)<1) X I $D(X) S ONCOX="T",STGIND="O" D IN^ONCOTNM
  • OUTPUT TRANSFORM:  S ONCOX="T",STGIND="O" D OT^ONCOTNM
  • LAST EDITED:  OCT 10, 1996
  • HELP-PROMPT:  Answer must be appropriate "T" code from the AJCC Staging Manual
  • DESCRIPTION:  
    "Other T" evaluates the primary tumor and identifies tumor size and/or extension.
  • EXECUTABLE HELP:  S ONCOX="T",STGIND="O" D HP^ONCOTNM
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
94 REPORTING DATE 7;5 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  APR 03, 1997
  • HELP-PROMPT:  *** REPORTING DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Records automatically the default date as reporting date.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
95 LAST TUMOR STATUS 7;6 POINTER TO PRIMARY CANCER STATUS CODE FILE (#164.42) PRIMARY CANCER STATUS CODE(#164.42)

  • LAST EDITED:  MAY 05, 1993
  • DESCRIPTION:  
    This field records the code that summarizes the cancer status.
  • TECHNICAL DESCR:  
    This field is populated by a call to LTS^ONCOU. This field is referenced directly by TRS^ONCOCOS.
    SOURCE OF DATA: ACOS 3.118
  • GROUP:  ACOS-REQUIRED
  • CROSS-REFERENCE:  165.5^ACS
    1)= S ^ONCO(165.5,"ACS",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"ACS",$E(X,1,30),DA)
    3)= NO DELTETE
    DEVELOPERS NOTE: Please read the Technical Documentation for this field before making any changes to this or any other cross-references for this field.
95.1 V STATUS/LAST TUMOR STATUS COMPUTED

  • MUMPS CODE:  S X="" D TRS^ONCOCOS
  • ALGORITHM:  S X="" D TRS^ONCOCOS
  • LAST EDITED:  DEC 08, 2010
  • DESCRIPTION:  
    This COMPUTED field concatenates STATUS (160,15) and LAST TUMOR STATUS (165.5,95).
96 PSA DATE PRO2;50 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Record the date on which the PSA test was performed.
  • DESCRIPTION:  
    Records the date on which the Prostate Specific Antigen (PSA) test was performed.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
97 ABSTRACT INCOMPLETE BOOLEAN COMPUTED

  • MUMPS CODE:  S Y(165.5,97,1)=$S($D(^ONCO(165.5,D0,7)):^(7),1:"") S X=$P(Y(165.5,97,1),U,2),X=X S X=X=0
    9.2 = S Y(165.5,97,2)=$C(59)_$S($D(^DD(165.5,91,0)):$P(^(0),U,3),1:""),Y(165.5,97,1)=$S($D(^ONCO(165.5,D0,7)):^(7),1:"")
  • ALGORITHM:  INTERNAL(#91)=0
  • LAST EDITED:  AUG 10, 1990
  • DESCRIPTION:  
    RECORD THE ABSTRACT STATUS AS INCOMPLETE WHEN DATA IS MISSING.
  • TECHNICAL DESCR:  
    Looks at Internal value of field #91 (ABstract status) for those values=0
98 OTHER N 2.1;7 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>30!($L(X)<1) X I $D(X) S ONCOX="N",STGIND="O" D IN^ONCOTNM
  • OUTPUT TRANSFORM:  S ONCOX="N",STGIND="O" D OT^ONCOTNM
  • LAST EDITED:  OCT 10, 1996
  • HELP-PROMPT:  Answer must be appropriate "N" code from the AJCC Staging Manual
  • DESCRIPTION:  
    "Other N" classifies the regional lymph nodes and describes the absence or presence and the extent of node metastases.
  • EXECUTABLE HELP:  S ONCOX="N",STGIND="O" D HP^ONCOTNM
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
99 OTHER M 2.1;8 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>30!($L(X)<1) X I $D(X) S ONCOX="M",STGIND="O" D IN^ONCOTNM
  • OUTPUT TRANSFORM:  S ONCOX="M",STGIND="O" D OT^ONCOTNM
  • LAST EDITED:  JAN 15, 1997
  • HELP-PROMPT:  Answer must be appropriate "M" code from the AJCC Staging Manual
  • DESCRIPTION:  
    "Other M" records the presence or absence of distant metastases. Choose the lower (less advanced) M category when there is any uncertainty.
  • EXECUTABLE HELP:  S ONCOX="M",STGIND="O" D HP^ONCOTNM
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
100 TEXT-PRIMARY SITE TITLE 8;1 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>40!($L(X)<1) X
  • LAST EDITED:  OCT 12, 2000
  • HELP-PROMPT:  ANSWER MUST BE 1-40 CHARACTERS IN LENGTH
  • DESCRIPTION:  Text area for description of primary site in natural language.
101 TEXT-HISTOLOGY TITLE 8;2 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>40!($L(X)<1) X
  • LAST EDITED:  OCT 12, 2000
  • HELP-PROMPT:  Answer must be 1-40 characters in length.
  • DESCRIPTION:  Text area for description of histologic type, behavior, and grade in natural language.
102 DRE +/- 24;10 SET
  • '0' FOR Clinically normal;
  • '1' FOR Clinically abnormal;
  • '9' FOR Not done/not documented;

  • LAST EDITED:  AUG 15, 2007
  • HELP-PROMPT:  Enter the DRE (Digital Rectal Examination) results.
  • DESCRIPTION:  A clinically inapparent tumor is one that is neither palpable nor reliably visible by imaging. An apparent tumor is palpable or visible by imaging.
    DO NOT INFER inapparent or apparent tumor based on the registrar's interpretation of terms in the DRE or imaging reports. A physician assignment of cT1C or cT2 is a clear statement of inapparent or apparent respectively.
103 TEXT-DX PROC-OP 9;0 WORD-PROCESSING #165.5103

  • DESCRIPTION:  
    Free text field.
104 TEXT-DX PROC-PE 10;0 WORD-PROCESSING #165.5104

  • DESCRIPTION:  Text area for information from history and physical examinations.
105 TEXT-DX PROC-X-RAY/SCAN 11;0 WORD-PROCESSING #165.5105

  • DESCRIPTION:  
    Free text field.
106 TEXT-DX PROC-SCOPES 12;0 WORD-PROCESSING #165.5106

  • DESCRIPTION:  
    Free text field.
107 TEXT-DX PROC-PATH 13;0 WORD-PROCESSING #165.5107

  • DESCRIPTION:  
    Free text field.
108 RX TEXT-SURGERY 14;0 WORD-PROCESSING #165.5108

  • LAST EDITED:  OCT 13, 2000
  • DESCRIPTION:  
    Free text field.
109 RX TEXT-RADIATION 15;0 WORD-PROCESSING #165.5109

  • LAST EDITED:  JUN 04, 2003
  • DESCRIPTION:  
    Free text field.
110 RX TEXT-RADIATION OTHER 16;0 WORD-PROCESSING #165.53

  • LAST EDITED:  OCT 13, 2000
  • DESCRIPTION:  
    Free text field.
111 RX TEXT-CHEMO 17;0 WORD-PROCESSING #165.5111

  • LAST EDITED:  OCT 13, 2000
  • DESCRIPTION:  
    Free text field.
112 RX TEXT-HORMONE 18;0 WORD-PROCESSING #165.5112

  • LAST EDITED:  OCT 13, 2000
  • DESCRIPTION:  
    Free text field.
113 TEXT-REMARKS 19;0 WORD-PROCESSING #165.5113

  • LAST EDITED:  MAY 18, 1990
  • DESCRIPTION:  
    Free text field.
114 RX TEXT-BRM 20;0 WORD-PROCESSING #165.5114

  • LAST EDITED:  OCT 13, 2000
  • DESCRIPTION:  
    Free text field.
115 RX TEXT-OTHER 21;0 WORD-PROCESSING #165.5115

  • LAST EDITED:  OCT 13, 2000
  • DESCRIPTION:  
    Free text field.
116 TEXT-DX PROC-LAB TESTS 22;0 WORD-PROCESSING #165.5116

  • LAST EDITED:  OCT 13, 2000
  • DESCRIPTION:  Text area for information from laboratory examinations other than cytology and histopatholgy.
117 OTHER STAGE GROUP 2.1;9 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>14!($L(X)<1) X S ONCOX="S",STGIND="O" D IN^ONCOTNS I $D(X) D INNUM^ONCOTNS
  • OUTPUT TRANSFORM:  S X="" D OT^ONCOTNS
  • LAST EDITED:  NOV 24, 1997
  • HELP-PROMPT:  Answer with the appropriate stage from the AJCC Staging Manual.
  • DESCRIPTION:  Record the apparent extent of disease in accordance with AJCC staging requirements.
    Stage codes:
    0 IB III IVB 0A IC IIIA IVC Occult II IIIB Not applicable 0is IIA IIIC Unknown I IIB IV IA IIC IVA
  • EXECUTABLE HELP:  S ONCOX="S",STGIND="O" D HP^ONCOTNS
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
118 STAGED BY (OTHER STAGE) 2.1;10 SET
  • '0' FOR Not staged;
  • '1' FOR Managing physician;
  • '2' FOR Pathologist;
  • '3' FOR Other physician;
  • '4' FOR Any combination of 1, 2, or 3;
  • '5' FOR Registrar;
  • '6' FOR Any combination of 5 with 1, 2, or 3;
  • '7' FOR Other;
  • '8' FOR Staged, individual not specified;
  • '9' FOR Unk if staged;

  • LAST EDITED:  APR 19, 1999
  • DESCRIPTION:  "Staged By (Other Stage)" identifies the person who documented the other AJCC staging elements and the stage group. The Commission requires analytic cases to be staged by the managing physician. Compliance with
    Commission-approved program requirements can be analyzed using this data.
119 SCREENING RESULT 0;25 SET
  • '0' FOR Within normal limits;
  • '1' FOR Abnormal/not suggestive of cancer;
  • '2' FOR Abnormal/suggestive of cancer;
  • '3' FOR Equivocal/no followup necessary;
  • '4' FOR Equivocal/evaluation recommended;
  • '8' FOR NA;
  • '9' FOR Unknown result, not specified;

  • LAST EDITED:  JUL 16, 1997
  • DESCRIPTION:  
    This item categorizes findings from the most recent screening(s), serves as a triage for patient notification, and acts as a tickler file to aid the institution in meeting patient notification requirements.
120 PRESENTATION AT CANCER CONF 0;26 SET
  • '0' FOR Not presented;
  • '1' FOR Prospective (diagnostic);
  • '2' FOR Prospective (treatment);
  • '3' FOR Prospective (follow-up);
  • '4' FOR Prospective (combinations);
  • '5' FOR Prospective, NOS;
  • '6' FOR Retrospective;
  • '7' FOR Follow-up;
  • '8' FOR Presentation, NOS;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 12, 1996
  • DESCRIPTION:  This item documents case presentation at a cancer conference and the type or format of presentation. The number of cancer conferences, sites presented, and types of presentation can be analyzed and reported for
    administrative use, quality control, and survey preperation.
121 DATE OF CANCER CONF 0;27 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) W:'$D(X) !,"Future dates are not allowed"
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  JAN 30, 2001
  • HELP-PROMPT:  Enter the Date of Cancer Conference
  • DESCRIPTION:  Enter the date on which the case was first presented at a cancer conference. The number of cancer conferences, sites presented, types of presentations, and dates can be analyzed and reported for administration, quality
    control, and Commission on Cancer survey preparation. Update this item if a patient is presented at a subsequent cancer conference.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
122 REFERRAL TO SUPPORT SERVICES 0;28 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 12, 1996
  • DESCRIPTION:  Record if the patient was referred to any of the following services.
    Enterostomal/stomal therapy
    Home care
    Hospice
    Infusion/parenteral therapy
    Nutritionist
    Occupational therapy
    Other
    Patient services (American Cancer Society)
    Patient services (other)
    Patient support group (American Cancer Society)
    Patient support group (hospital operated)
    Patient support group (other organization/agency)
    Physical therapy
    Referral; service unspecified
    Rehabilitation facility
    Respiratory therapy
    Speech therapy
    Visiting nurse assistance
123 INPATIENT/OUTPATIENT STATUS 0;23 SET
  • '1' FOR Inpatient only;
  • '2' FOR Outpatient only;
  • '3' FOR In and outpatient;
  • '8' FOR Other, including physician's office;
  • '9' FOR Unknown;

  • LAST EDITED:  DEC 20, 1996
  • DESCRIPTION:  
    "Inpatient/Outpatient Status" allows the facility to identify points of access used to initially diagnose and/or treat the patient.
124 DATE OF NO TREATMENT 2.1;11 DATE

  • INPUT TRANSFORM:  D NTIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  OCT 28, 1997
  • HELP-PROMPT:  *** DATE OF NO TREATMENT MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  If, for any reason, the patient is not treated, record the date of this decision as the DATE OF NO TREATMENT. The physician may decide not to treat the patient because of comorbid conditions, advanced disease, or because
    the accepted management of the cancer is to observe until the disease progresses or until the patient becomes symptomatic. The patient may also refuse treatment.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ATN^MUMPS
    1)= S ^ONCO(165.5,"ATX",DA,X_"N")=""
    2)= K ^ONCO(165.5,"ATX",DA,X_"N")
    Records NO TREATMENT DECISION DATE on the unified treatment index.
  • CROSS-REFERENCE:  165.5^AK^MUMPS
    1)= Q
    2)= S NTDEL="" D DEL^ONCDTX
125 RADIATION TREATMENT VOLUME 3;21 POINTER TO RADIATION TREATMENT VOLUME FILE (#164.7) RADIATION TREATMENT VOLUME(#164.7)

  • INPUT TRANSFORM:  S V=1 D NT^ONCODSR
  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(164.7,Y,0),"^",2)
  • LAST EDITED:  SEP 02, 1997
  • DESCRIPTION:  Identifies the volume or anatomic target of the most clinically significant regional radiation therapy delivered to the patient during the first course of treatment.
    For further information see FORDS pages 151-154.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
126 LOCATION OF RADIATION TX 3;22 SET
  • '0' FOR No radiation tx;
  • '1' FOR All radiation tx at this fac;
  • '2' FOR Regional tx at this fac, boost elsewhere;
  • '3' FOR Boost at this fac, regional elsewhere;
  • '4' FOR All radiation tx elsewhere;
  • '8' FOR Other;
  • '9' FOR Unknown;

  • INPUT TRANSFORM:  S V=0 D NT^ONCODSR
  • LAST EDITED:  NOV 07, 2024
  • DESCRIPTION:  Identifies the location of the facility where radiation therapy was started during the first course of treatment.
    For further information see the current STORE manual.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
127 INTENT OF RADIATION 3;29 SET
  • '0' FOR No radiation;
  • '1' FOR Curative (primary);
  • '2' FOR Curative (adjuvant);
  • '4' FOR Palliative (pain control);
  • '5' FOR Palliative (other, cosmetic);
  • '6' FOR Prophylactic (no symptoms, preventive);
  • '8' FOR Other, NOS;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 02, 2012
  • DESCRIPTION:  Code the intent of radiation treatment.
    This item is useful in assessing the appropriateness of treatment and correlating outcome with original intent of the treatment. The choice in this data field is subjective.
    The responsible radiation oncologist is the best person to provide this information.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^262
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,12),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,127,1,1,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,12)=DIV,DIH=165.5,DIG=262 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0
    DELETE VALUE)= NO EFFECT
    FIELD)= #262
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^260
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,10),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,127,1,2,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,10)=DIV,DIH=165.5,DIG=260 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0
    DELETE VALUE)= NO EFFECT
    FIELD)= #260
128 RADIATION COMPLETION STATUS 3;39 POINTER TO RADIATION COMPLETION STATUS FILE (#164.8) RADIATION COMPLETION STATUS(#164.8)

  • INPUT TRANSFORM:  S V=1 D NT^ONCODSR
  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(164.8,Y,0),U,2)
  • LAST EDITED:  JUN 03, 1998
  • DESCRIPTION:  RADIATION COMPLETION STATUS is useful in evaluating treatment outcomes and the appropriateness of the initial decision to treat.
    This field indicates whether the patient's radiation therapy was completed as outlined in the initial treatment plan. This information is generally available only in the radiation treatment chart.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
129 RADIATION AUXILIARY VOLUME 3.1;1 POINTER TO RADIATION TREATMENT VOLUME FILE (#164.7) RADIATION TREATMENT VOLUME(#164.7)

  • INPUT TRANSFORM:  S V=1 D NT^ONCODSR
  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(164.7,Y,0),"^",2)
  • LAST EDITED:  SEP 29, 1998
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
130 RADIATION AUXILIARY DATE 3.1;2 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAR 11, 1998
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
131 RADIATION AUXILIARY TEXT 15.1;0 WORD-PROCESSING #165.5131

  • LAST EDITED:  AUG 25, 1997
132 RADIATION LOCAL CONTROL STATUS 3.1;3 SET
  • '0' FOR No radiation;
  • '1' FOR Tumor control status not evaluable;
  • '2' FOR Tumor/symptoms controlled;
  • '3' FOR Tumor/symptoms returned;
  • '4' FOR Tumor/symptoms never controlled;
  • '8' FOR Other, NOS;
  • '9' FOR Unknown;

  • INPUT TRANSFORM:  S V=0 D NT^ONCODSR
  • LAST EDITED:  OCT 03, 1997
  • DESCRIPTION:  RADIATION LOCAL CONTROL STATUS records the radiation treatment results in terms of disease control within the irradiated volume. The data may be used in quality assurance studies to assess the effectiveness of treatment.
    This is a dynamic data item. To be clinically useful, this data must be evaluated at each follow-up.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
133 YEAR PUT ON PROTOCOL 3.1;4 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<4)!'(X?4N) X
  • LAST EDITED:  MAR 18, 1998
  • HELP-PROMPT:  Answer must be a 4-digit year.
  • DESCRIPTION:  Record the year in which the patient was entered into a protocol.
134 CLINICAL RISK FACTORS 2.1;12 SET
  • '0' FOR None;
  • '1' FOR hCG > 100,000 IU/24-hour urine;
  • '2' FOR Detection > 6 mo from term of pregnancy;
  • '3' FOR Both;
  • 'U' FOR Unknown;
  • 'L' FOR Low risk;
  • 'H' FOR High risk;

  • LAST EDITED:  AUG 19, 2010
  • DESCRIPTION:  For Gestational Trophoblastic Tumors FIGO added nonsurgical-pathologic prognostic risk factors to the classic anatomic staging system. These include B-hCG levels of greater than 100,000 and the detection of disease more
    than 6 months from termination of the antecedent pregnancy. These risk factors affect staging.
  • SCREEN:  S DIC("S")="N ONCOED S ONCOED=$$TNMED^ONCOU55(D0) I ((ONCOED<6)&(Y?1N))!((ONCOED>5)&(Y?1A))"
  • EXPLANATION:  For 1st-5th edition staging use codes 0-3. For 6th or greater edition staging use codes U, L and H.
135 PATHOLOGIC RISK FACTORS 2.1;13 SET
  • '0' FOR None;
  • '1' FOR hCG > 100,000 IU/24-hour urine;
  • '2' FOR Detection > 6 mo from term of pregnancy;
  • '3' FOR Both;
  • 'U' FOR Unknown;
  • 'L' FOR Low risk;
  • 'H' FOR High risk;

  • LAST EDITED:  AUG 19, 2010
  • DESCRIPTION:  For Gestational Trophoblastic Tumors FIGO added nonsurgical-pathologic prognostic risk factors to the classic anatomic staging system. These include B-hCG levels of greater than 100,000 and the detection of disease more
    than 6 months from termination of the antecedent pregnancy. These risk factors affect staging.
  • SCREEN:  S DIC("S")="N ONCOED S ONCOED=$$TNMED^ONCOU55(D0) I ((ONCOED<6)&(Y?1N))!((ONCOED>5)&(Y?1A))"
  • EXPLANATION:  For 1st-5th edition staging use codes 0-3. For 6th or greater edition staging use codes U, L and H.
136 SERUM TUMOR MARKERS 24;8 SET
  • 'SX' FOR Not available;
  • 'S0' FOR Normal;
  • 'S1' FOR LDH < 1.5XN, hCG < 5000 mIU/ml, AFP < 1000 ng/ml;
  • 'S2' FOR LDH 1.5-10XN or hCG 5000-50,000 mIu/ml or AFP 1000-10,000 ng/ml;
  • 'S3' FOR LDH > 10XN or hCG > 50,000 mIu/ml or AFP > 10,000 ng/ml;

  • OUTPUT TRANSFORM:  S FILNUM=165.5,FLDNUM=136 D SOC^ONCOOT
  • LAST EDITED:  JAN 29, 1998
  • DESCRIPTION:  Serum Tumor Markers (S)
    SX Marker studies not available or not performed S0 Marker study levels within normal limits* S1 LDH < 1.5 X N AND
    hCG (mIU/ml) < 5000 AND
    AFP (ng/ml) < 1000 S2 LDH 1.5-10 X N OR
    hCG (mIu/ml) 5000-50,000 OR
    AFP (ng/ml) 1000-10,000 S3 LDH > 10 X N OR
    hCG (mIu/ml) > 50,000 OR
    AFP (ng/ml) > 10,000
    N indicates the upper limit of normal for the LDH assay. * Check with your laboratory for normal limits values.
137 DATE OF 1ST POSITIVE BIOPSY 2.2;1 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  FEB 04, 1998
  • DESCRIPTION:  Record the date of the first positive incisional or excisional biopsy. The biopsy may be taken from the primary or a secondary site. This data item refers to a tissue biopsy/positive histology only. The first positive
    biopsy may be at any time during the disease course. It may be non cancer-directed or cancer-directed surgery.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
138 SCOPE OF LN SURGERY (R) 3;40 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S FIELD=138,NTXDD=1 D SCIT^ONCOSUR1
  • OUTPUT TRANSFORM:  S FIELD=138 D SCOT^ONCOSUR1 K FIELD
  • LAST EDITED:  MAR 27, 2003
  • DESCRIPTION:  Record the scope of regional lymph node surgery.
    For further information see ROADS page 192.
  • EXECUTABLE HELP:  S FIELD=138 D SCHP^ONCOSUR1 K FIELD
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ASC^MUMPS
    1)= Q
    2)= D SCOPE^ONCDTX
138.1 SCOPE OF LN SURGERY @FAC (R) 3.1;9 FREE TEXT

  • INPUT TRANSFORM:  S SCPFLG=0 D SCPDFIT^ONCTXSM K:$L(X)>1!($L(X)<1)!'(X?1N) X I $D(X),SCPFLG=0 S FIELD=138.1,NTXDD=1 D SCIT^ONCOSUR1
  • OUTPUT TRANSFORM:  S FIELD=138.1 D SCOT^ONCOSUR1 K FIELD
  • LAST EDITED:  APR 03, 2007
  • DESCRIPTION:  Record the scope of regional lymph node surgery done AT THIS FACILITY.
    For further information see ROADS page 190.
  • EXECUTABLE HELP:  S FIELD=138.1 D SCHP^ONCOSUR1 K FIELD
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ASCF^MUMPS
    1)= Q
    2)= D SCPATF^ONCDTX1
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
138.2 SCOPE OF LN SURGERY DATE 3.1;22 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000",ONC138P2="YES" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAY 31, 2022
  • HELP-PROMPT:  *** SCOPE OF LN SURGERY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Record the date that SCOPE OF LN SURGERY was performed.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ATSC^MUMPS
    1)= S ^ONCO(165.5,"ATX",DA,X_"S2")=""
    2)= K ^ONCO(165.5,"ATX",DA,X_"S2")
    Records the scope of regional lymph node surgery date on the unified treatment index.
138.3 SCOPE OF LN SURGERY @FAC DATE 3.1;23 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000",ONC138P2="YES" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAY 31, 2022
  • HELP-PROMPT:  *** SCOPE OF LN SURGERY @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Record the date that SCOPE OF LN SURGERY @FAC was performed.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
138.4 SCOPE OF LN SURGERY (F) 3.1;31 SET
  • '0' FOR None;
  • '1' FOR Bx/aspiration, NOS;
  • '2' FOR Sentinel Bx;
  • '3' FOR Nodes removed, num unk;
  • '4' FOR 1-3 nodes removed;
  • '5' FOR 4 or more nodes removed;
  • '6' FOR Sentinel + 3, 4 or 5, timing not stated;
  • '7' FOR Sentinel + 3, 4, or 5, diff times;
  • '9' FOR Unknown/NA;

  • LAST EDITED:  MAR 19, 2003
  • DESCRIPTION:  Identifies the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event.
    For further information see FORDS pages 138-139.
  • CROSS-REFERENCE:  165.5^ASC^MUMPS
    1)= Q
    2)= D SCOPE^ONCDTX
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
138.5 SCOPE OF LN SURGERY @FAC (F) 3.1;32 SET
  • '0' FOR None;
  • '1' FOR Bx/aspiration, NOS;
  • '2' FOR Sentinel Bx;
  • '3' FOR Nodes removed, num unk;
  • '4' FOR 1-3 nodes removed;
  • '5' FOR 4 or more nodes removed;
  • '6' FOR Sentinel + 3, 4 or 5, timing not stated;
  • '7' FOR Sentinel + 3, 4, or 5, diff times;
  • '9' FOR Unknown/NA;

  • LAST EDITED:  MAR 19, 2003
  • DESCRIPTION:  Identifies the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event at this facility.
    For further information see FORDS pages 140-141.
  • CROSS-REFERENCE:  165.5^ASCF^MUMPS
    1)= Q
    2)= D SCPATF^ONCDTX1
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
139 SURG PROC/OTHER SITE (R) 3;41 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S FIELD=139,NTXDD=1 D SOIT^ONCOSUR1
  • OUTPUT TRANSFORM:  S FIELD=139 D SOOT^ONCOSUR1 K FIELD
  • LAST EDITED:  APR 01, 2003
  • DESCRIPTION:  Enter the code for surgery of other regional site(s), distant site(s) or distant lymph node(s).
    For further information see ROADS page 194.
  • EXECUTABLE HELP:  S FIELD=139 D SOHP^ONCOSUR1 K FIELD
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ASO^MUMPS
    1)= Q
    2)= D SOSNR^ONCDTX
139.1 SURG PROC/OTHER SITE @FAC (R) 3.1;10 FREE TEXT

  • INPUT TRANSFORM:  S SOSFLG=0 D SOSDFIT^ONCTXSM K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X),SOSFLG=0 S FIELD=139.1,NTXDD=1 D SOIT^ONCOSUR1
  • OUTPUT TRANSFORM:  S FIELD=139.1 D SOOT^ONCOSUR1 K FIELD
  • LAST EDITED:  MAR 27, 2003
  • DESCRIPTION:  Enter the code for surgery of other regional site(s), distant site(s) or distant lymph node(s) performed AT THIS FACILITY.
    For further information see ROADS page 190.
  • EXECUTABLE HELP:  S FIELD=139.1 D SOHP^ONCOSUR1 K FIELD
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ASOF^MUMPS
    1)= Q
    2)= D SOSNATF^ONCDTX1
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
139.2 SURG PROC/OTHER SITE DATE 3.1;24 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  NOV 05, 2004
  • HELP-PROMPT:  *** SURG PROC/OTHER SITE DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Records the date of surgical removal of distant lymph nodes or other tissue(s)/organ(s) beyond the primary site.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ATSO^MUMPS
    1)= S ^ONCO(165.5,"ATX",DA,X_"S3")=""
    2)= K ^ONCO(165.5,"ATX",DA,X_"S3")
    Records the surgery of other sites/nodes date on the unified treatment index.
139.3 SURG PROC/OTHER SITE @FAC DATE 3.1;25 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JAN 07, 2003
  • HELP-PROMPT:  *** SURG PROC/OTHER SITE @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Record the date that SURG PROC/OTHER SITE @FAC was performed.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
139.4 SURG PROC/OTHER SITE (F) 3.1;33 SET
  • '0' FOR None;
  • '1' FOR Nonprimary surg proc performed;
  • '2' FOR Nonprimary surg proc/other regional sites;
  • '3' FOR Nonprimary surg proc/distant lymph node(s);
  • '4' FOR Nonprimary surg proc/distant site;
  • '5' FOR Combination of codes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 19, 2003
  • DESCRIPTION:  Records the surgical removal of distant lymph nodes or other issue(s)/organ(s) beyond the primary site.
    For further information see FORDS page 142.
  • CROSS-REFERENCE:  165.5^ASO^MUMPS
    1)= Q
    2)= D SOSN^ONCDTX
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
139.5 SURG PROC/OTHER SITE @FAC (F) 3.1;34 SET
  • '0' FOR None;
  • '1' FOR Nonprimary surg proc performed;
  • '2' FOR Nonprimary surg proc/other regional sites;
  • '3' FOR Nonprimary surg proc/distant lymph node(s);
  • '4' FOR Nonprimary surg proc/distant site;
  • '5' FOR Combination of codes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 19, 2003
  • DESCRIPTION:  Records the surgical removal of distant lymph nodes or other tissue(s)/organ(s) beyond the primary site at this facility.
    For further information see FORDS page 143.
  • CROSS-REFERENCE:  165.5^ASOF^MUMPS
    1)= Q
    2)= D SOSNATF^ONCDTX1
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
139.6 METS SITE RESECTED 3.1;41 SET
  • '1' FOR Peritoneum;
  • '2' FOR Lung;
  • '3' FOR Pleura;
  • '4' FOR Liver;
  • '5' FOR Bone;
  • '6' FOR Brain;
  • '7' FOR Skin;
  • '8' FOR Distant LNS;
  • '9' FOR Other;

  • LAST EDITED:  AUG 07, 2013
  • HELP-PROMPT:  Enter the appropriate site from the list.
  • DESCRIPTION:  
    This is the Metastatic Site Resected for the First Course of Treatment.
139.7 METS SITE RESECTED DATE 3.2;1 DATE

  • INPUT TRANSFORM:  S %DT="E" D ^%DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JAN 23, 2014
  • HELP-PROMPT:  Enter the date the Metastatic Site was resected.
  • DESCRIPTION:  
    This is the date the Metastatic Site was resected. The date must be after or equal to the DATE DX (#3) field.
140 NUMBER OF LN REMOVED (R) 3;42 NUMBER

  • INPUT TRANSFORM:  K:X'?1.2N X I $D(X) S NTXDD=1 S X=+X K:X>99!(X<0) X I $D(X) D NRIT^ONCOSUR1
  • OUTPUT TRANSFORM:  D NROT^ONCOSUR1
  • LAST EDITED:  MAR 19, 2003
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record the number of regional lymph nodes that were microscopically examined and identified in the pathology report FOR THIS SURGICAL PROCEDURE ONLY. DO NOT add numbers of nodes removed during different surgical events.
    00 for No nodes removed
    01 for 1 node removed
    02 for 2 nodes removed
    ...
    90 for 90 or more nodes removed
    95 for No nodes removed, aspiration performed
    96 for Node removal as a sampling, number unknown
    97 for Node removal as dissection, number unknown
    98 for Nodes surgically removed, number unknown
    99 for Unknown, not stated, death cert ONLY
    For further information see ROADS page 193.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
140.1 NUMBER OF LN REMOVED @FAC (R) 3.1;11 FREE TEXT

  • INPUT TRANSFORM:  D NUMDFIT^ONCTXSM K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S NTXDD=1 S X=+X K:X>99!(X<0) X I $D(X) D NRIT^ONCOSUR1
  • OUTPUT TRANSFORM:  D NROT^ONCOSUR1
  • LAST EDITED:  JAN 07, 2003
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record the number of regional lymph nodes that were microscopically examined and identified at this facility in the pathology report FOR THIS SURGICAL PROCEDURE ONLY. DO NOT add numbers of nodes removed during different
    surgical events.
    00 for No nodes removed
    01 for 1 node removed
    02 for 2 nodes removed
    ...
    90 for 90 or more nodes removed
    95 for No nodes removed, aspiration performed
    96 for Node removal as a sampling, number unknown
    97 for Node removal as dissection, number unknown
    98 for Nodes surgically removed, number unknown
    99 for Unknown, not stated, death cert ONLY
    For further information see ROADS page 190.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
141 BIOPSY PROCEDURE 2.1;14 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D BP^ONCOIT
  • OUTPUT TRANSFORM:  D BP^ONCOOT
  • LAST EDITED:  JUL 10, 2001
  • DESCRIPTION:  Records the biopsy procedure if the primary site is breast or prostate.
  • EXECUTABLE HELP:  D BP^ONCOHELP
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
142 GUIDANCE 2.1;15 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D GUIT^ONCOTNMX
  • OUTPUT TRANSFORM:  D GUOT^ONCOTNMX
  • LAST EDITED:  AUG 27, 1998
  • HELP-PROMPT:  Type a Number between 0 and 9, 0 Decimal Digits
  • DESCRIPTION:  
    Records the guidance if the primary site is breast or prostate.
  • EXECUTABLE HELP:  D GUHP^ONCOTNMX
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
143 PALPABILITY OF PRIMARY 2.1;16 SET
  • '0' FOR Not palpable;
  • '1' FOR Palpable;
  • '9' FOR Not stated/death cert only;

  • LAST EDITED:  FEB 04, 1998
  • DESCRIPTION:  
    Records the palpability of primary if the primary site is breast.
144 FIRST DETECTED BY 2.1;17 SET
  • '0' FOR Not a breast primary;
  • '1' FOR Patient felt lump/nipple discharge;
  • '2' FOR Physician felt lump;
  • '3' FOR Mammography - routine;
  • '4' FOR Occult, incidental finding;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 04, 1998
  • DESCRIPTION:  
    Records how it was first detected if the primary site is breast.
145 APPROACH FOR BIOPSY OF PRIMARY 2.1;18 SET
  • '0' FOR No biopsy;
  • '1' FOR Transrectal;
  • '2' FOR Transperineal;
  • '3' FOR Transurethral;
  • '4' FOR Laparoscopic;
  • '5' FOR Open (laparotomy);
  • '9' FOR Unknown/death cert only;

  • LAST EDITED:  FEB 09, 1998
  • DESCRIPTION:  
    Records the approach for biopsy of primary if the primary site is prostate.
146 BIOPSY OF OTHER THAN PRIMARY 2.1;19 SET
  • '0' FOR None;
  • '1' FOR Seminal vesicle(s), NOS;
  • '2' FOR Unilateral;
  • '3' FOR Bilateral;
  • '4' FOR Other than seminal vesicle;
  • '5' FOR 4 + 1;
  • '6' FOR 4 + 2;
  • '7' FOR 4 + 3;
  • '9' FOR Unknown/death cert only;

  • LAST EDITED:  FEB 09, 1998
  • DESCRIPTION:  
    Records the biopsy of other than primary site if the primary site is prostate.
147 CENSUS TRACT 0;29 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>6!($L(X)<1)!'(X?1.6N) X
  • LAST EDITED:  JUN 27, 2000
  • HELP-PROMPT:  Answer must be 6 characters in length, all numeric.
  • DESCRIPTION:  CENSUS TRACT identifies the patient's usual residence at the time the tumor was diagnosed.
    A CENSUS TRACT is a small statistical subdivision of a county.
    To code CENSUS TRACT, assume the decimal point is between the fourth and fifth positions of the field. Add zeros to fill all six positions.
    Example: CENSUS TRACT 409.6 would be coded 040960, and CENSUS TRACT
    516.21 would be coded 051621.
    000000 Area is not census tracted 999999 Area is census tracted, but census tract is not available
148 OTHER CANCER 0;30 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 24, 2009
  • HELP-PROMPT:  Answer 'Yes' if the patient has other reportable malignancies.
  • DESCRIPTION:  
    Records if the patient has other reportable malignancies.
148.1 CANCER #1 0;31 POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2) SITE-GROUP FOR ONCOLOGY(#164.2)

  • LAST EDITED:  APR 24, 2009
  • HELP-PROMPT:  If not applicable for this patient, choose NOT APPLICABLE.
  • DESCRIPTION:  Records the 1st OTHER CANCER associated with this patient.
    If not applicable for this patient, choose NOT APPLICABLE.
148.2 CANCER #2 0;32 POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2) SITE-GROUP FOR ONCOLOGY(#164.2)

  • LAST EDITED:  JAN 24, 2003
  • HELP-PROMPT:  If not applicable for this patient, choose NOT APPLICABLE.
  • DESCRIPTION:  Records the 2nd OTHER CANCER associated with this patient.
    If not applicable for this patient, choose NOT APPLICABLE.
148.3 CANCER #3 0;33 POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2) SITE-GROUP FOR ONCOLOGY(#164.2)

  • LAST EDITED:  JAN 24, 2003
  • HELP-PROMPT:  If not applicable for this patient, choose NOT APPLICABLE.
  • DESCRIPTION:  Records the 3rd OTHER CANCER associated with this patient.
    If not applicable for this patient, choose NOT APPLICABLE.
148.4 CANCER #4 0;34 POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2) SITE-GROUP FOR ONCOLOGY(#164.2)

  • LAST EDITED:  JAN 24, 2003
  • HELP-PROMPT:  If not applicable for this patient, choose NOT APPLICABLE.
  • DESCRIPTION:  Records the 4th OTHER CANCER associated with this patient.
    If not applicable for this patient, choose NOT APPLICABLE.
149 LYMPH-VASCULAR INVASION (L) 2;19 SET
  • '0' FOR Not present;
  • '1' FOR LVI present-NOT for C73-C74;
  • '2' FOR Lym&sm vessel inv only OR lym only (C73-C74 ONLY);
  • '3' FOR Ven OR Angio (C73-C74 ONLY);
  • '4' FOR Lym&sm & ven/lg vessel inv OR lymph & angioinv (C73-C74 ONLY);
  • '8' FOR N/A;
  • '9' FOR UNK;

  • LAST EDITED:  AUG 01, 2022
  • HELP-PROMPT:  Enter the appropriate code. Allowable values are based on schema ID; refer to STORE manual pp. 152-156 for instructions for 2018+ cases.
  • DESCRIPTION:  Indicates the presence or absence of tumor cells in lymphatic channels (not lymph nodes) or blood vessels within the primary tumor as noted microscopically by the pathologist. LVI includes lymphatic invasion, vascular
    invasion, and lymphovascular invasion.
    Codes: 0 Lymphovascular Invasion stated as Not Present 1 Lymphovascular Invasion Present/Identified (NOT
    used for thyroid and adrenal) 2 Lymphatic and small vessel invasion only (L)
    OR
    Lymphatic invasion only (thyroid and adrenal only) 3 Venous (large vessel) invasion only (V)
    OR
    Angioinvasion (thyroid and adrenal gland only) 4 BOTH lymphatic and small vessel AND venous (large
    vessel) invasion
    OR
    BOTH lymphatic AND angioinvasion (thyroid and
    adrenal only) 8 Not Applicable 9 Unknown/Indeterminate/not mentioned in path report
  • SCREEN:  S DIC("S")="D SCRNLV^ONCSCHMM"
  • EXPLANATION:  For <2018 cases only 0,1,8,9 are selectable; For 2018+ cases codes depend on Schema
150 FOLLOW-UP HISTORY COMPUTED

  • MUMPS CODE:  S X="" D FHP^ONCODLF
  • ALGORITHM:  S X="" D FHP^ONCODLF
  • DESCRIPTION:  
    RECORDS ALL FOLLOW SUCCESSFULLY COMPLETED.
151 VENOUS INVASION (V) 2;29 SET
  • 'X' FOR Venous invasion cannot be assessed;
  • '0' FOR No venous invasion;
  • '1' FOR Microscopic venous invasion;
  • '2' FOR Macroscopic venous invasion;

  • LAST EDITED:  OCT 22, 2002
  • DESCRIPTION:  
    VENOUS INVASION records whether venous invasion was involved.
152 DATE SYSTEMIC THERAPY STARTED COMPUTED

  • MUMPS CODE:  S X="" D DSTS^ONCOCOM
  • ALGORITHM:  S X="" D DSTS^ONCOCOM
  • LAST EDITED:  FEB 10, 2003
  • DESCRIPTION:  Records the date of initiation for systemic therapy that is part of the first course of treatment. Systemic therapy includes the administration of chemotherapy agents, hormonal agents, biological response modifiers, bone
    marrow transplants, stem cell harvests, and surgical and/or radiation endocrine therapy.
    For further information see FORDS pages 169-170.
153 HEMA TRANS/ENDOCRINE PROC 3.1;36 POINTER TO HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES FILE (#167) HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES(#167)

  • OUTPUT TRANSFORM:  I Y'="" S Y=$P($G(^ONCO(167,Y,0)),U,2)
  • LAST EDITED:  MAY 16, 2003
  • DESCRIPTION:  Identifies systemic therapeutic procedures administered as part of the first course of treatment at this and all other facilities. If none of these procedures were administered, then this item records the reason they
    were not performed. These include bone marrow transplants, stem cell harvests, surgical and/or radiation endocrine therapy.
    For further information see FORDS pages 182-183.
  • CROSS-REFERENCE:  165.5^AE^MUMPS
    1)= Q
    2)= D HTEP^ONCDTX
153.1 HEMA TRANS/ENDOCRINE PROC DATE 3.1;35 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAY 15, 2003
  • HELP-PROMPT:  *** HEMA TRANS/ENDOCRINE PROC DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Records the date on which hematologic transplant and endocrine procedures were performed.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ATE^MUMPS
    1)= S ^ONCO(165.5,"ATX",DA,X_"E")=""
    2)= K ^ONCO(165.5,"ATX",DA,X_"E")
    Records the hematologic transplant and endocrine procedures date on the unified treatment index.
153.2 HEMA TRANS/ENDOCRINE PROC @FAC 3.2;2 POINTER TO HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES FILE (#167) HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES(#167)

  • OUTPUT TRANSFORM:  I Y'="" S Y=$P($G(^ONCO(167,Y,0)),U,2)
  • LAST EDITED:  FEB 10, 2016
  • HELP-PROMPT:  Enter a Hematologic Transplant Endocrine Procedure at this facility administered for this primary.
  • DESCRIPTION:  Identifies systemic therapeutic procedures administered as part of the first course of treatment at this and all other facilities. If none of these procedures were administered, then this item records the reason they
    were not performed. These include bone marrow transplants, stem cell harvests, surgical and/or radiation endocrine therapy.
    For further information see FORDS pages 182-183.
  • CROSS-REFERENCE:  165.5^AE^MUMPS
    1)= Q
    2)= D HTEATF^ONCDTX1
    NOREINDEX)= 1
    When the value of this field is deleted, the KILL logic will delete all of the associated field values.
153.3 HEMA TRANS/ENDOCRINE PR@FAC DT 3.2;3 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  FEB 10, 2016
  • HELP-PROMPT:  *** HEMATOLOGIC TRANSPLANT ENDOCRINE PROCEDURE AT THIS FACILITY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Records the date on which hematologic transplant and endocrine procedures were performed.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
154 PAIN ASSESSMENT 3.1;37 SET
  • '0' FOR No pain assessment;
  • '1' FOR No need for palliative care;
  • '2' FOR Need for palliative care, no referral;
  • '3' FOR Need for palliative care, referral;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 31, 2003
  • DESCRIPTION:  Records whether or not a pain assessment was performed to determine the need for palliative care.
    For further information see FORDS page 188.
155 DATE OF FIRST CONTACT 0;35 DATE
************************REQUIRED FIELD************************

  • INPUT TRANSFORM:  D FADIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JUN 21, 2022
  • HELP-PROMPT:  Enter the date of first contact with the reporting facility.
  • DESCRIPTION:  Date of first contact with the reporting facility for diagnosis and/or treatment of this cancer.
    If this is an autopsy-only or death certificate-only case, then use the date of death.
    When it is unknown when the first patient contact occurred use 99/99/9999 or 99999999.
    00/00/0000 is not allowed.
    For further information see FORDS page 87.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AFC
    1)= S ^ONCO(165.5,"AFC",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"AFC",$E(X,1,30),DA)
    This cross-reference was added in patch ONC*2.11*48. It enables the user to select a DATE OF FIRST CONTACT date range for the [TIME Timeliness Report] option.
156 DRE DATE 24;11 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Record the date on which the DRE was performed.
  • DESCRIPTION:  
    Records the date on which the DRE (Digital Rectal Examination) was performed.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
157 ELAPSED DAYS TO COMPLETION COMPUTED

  • MUMPS CODE:  D ET^ONCOCOM
  • ALGORITHM:  D ET^ONCOCOM
  • LAST EDITED:  OCT 04, 2006
  • DESCRIPTION:  
    Computes the time interval in days between DATE OF FIRST CONTACT (165.5,155) and DATE CASE COMPLETED (165.5,90).
157.1 ELAPSED MONTHS TO COMPLETION COMPUTED

  • MUMPS CODE:  D EM^ONCOCOM
  • ALGORITHM:  D EM^ONCOCOM
  • LAST EDITED:  AUG 05, 2008
  • DESCRIPTION:  
    Computes the time interval in months between DATE OF FIRST CONTACT (165.5,155) and DATE CASE COMPLETED (165.5,90).
159 AMBIGUOUS TERMINOLOGY DX 24;12 SET
  • '0' FOR Conclusive term;
  • '1' FOR Ambiguous term only;
  • '2' FOR Ambiguous term followed by conclusive term;
  • '9' FOR Unknown term;

  • LAST EDITED:  JAN 17, 2007
  • DESCRIPTION:  Identifies cases for which an ambiguous term is the most definitive word or phrase used to establish a cancer diagnosis (i.e., to determine whether or not the case is reportable). Do not include cases where a definite
    statement of malignancy is made within two months following the original/initial diagnosis. (This does not include the use of ambiguous terminology from cancer screening followed by a positive cancer confirmation that is
    follow-up to the screening.)
160 DERIVED AJCC-6 T CS1;1 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<2) X
  • OUTPUT TRANSFORM:  D TOT^ONCCSOT
  • LAST EDITED:  NOV 13, 2009
  • HELP-PROMPT:  Answer must be 2 characters in length.
  • DESCRIPTION:  
    This is the AJCC 6th edition "T" component that is derived from CS coded fields, using the CS algorithm, effective with 2004 diagnosis.
160.7 DERIVED AJCC-7 T CS1;13 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<2) X
  • OUTPUT TRANSFORM:  D TOT^ONCCSOT
  • LAST EDITED:  FEB 03, 2010
  • HELP-PROMPT:  Answer must be 2 characters in length.
  • DESCRIPTION:  
    This is the AJCC 7th edition "T" component that is derived from CS coded fields, using the CS algorithm, effective with 2010 diagnosis.
161 DERIVED AJCC-6 T DESCRIPTOR CS1;2 SET
  • 'c' FOR clinical;
  • 'p' FOR pathological;
  • 'a' FOR autopsy only;
  • 'y' FOR y prefix;
  • 'N' FOR Not applicable;
  • '0' FOR Not derived;

  • LAST EDITED:  NOV 13, 2009
  • DESCRIPTION:  
    This is the AJCC 6th edition "T Descriptor" component that is derived from CS coded fields, using the CS algorithm, effective with 2004 diagnosis.
161.7 DERIVED AJCC-7 T DESCRIPTOR CS1;14 SET
  • 'c' FOR clinical;
  • 'p' FOR pathological;
  • 'a' FOR autopsy only;
  • 'y' FOR yp prefix;
  • 'N' FOR Not applicable;
  • '0' FOR Not derived;

  • LAST EDITED:  FEB 03, 2010
  • DESCRIPTION:  
    This is the AJCC 7th edition "T Descriptor" component that is derived from CS coded fields, using the CS algorithm, effective with 2010 diagnosis.
162 DERIVED AJCC-6 N CS1;3 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<2) X
  • OUTPUT TRANSFORM:  D NOT^ONCCSOT
  • LAST EDITED:  NOV 13, 2009
  • HELP-PROMPT:  Answer must be 2 characters in length.
  • DESCRIPTION:  
    This is the AJCC 6th edition "N" component that is derived from CS coded fields, using the CS algorithm, effective with 2004 diagnosis.
162.7 DERIVED AJCC-7 N CS1;15 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<2) X
  • OUTPUT TRANSFORM:  D NOT^ONCCSOT
  • LAST EDITED:  FEB 03, 2010
  • HELP-PROMPT:  Answer must be 2 characters in length.
  • DESCRIPTION:  
    This is the AJCC 7th edition "N" component that is derived from CS coded fields, using the CS algoritm, effective with 2010 diagnosis.
163 DERIVED AJCC-6 N DESCRIPTOR CS1;4 SET
  • 'c' FOR clinical;
  • 'p' FOR pathological;
  • 'a' FOR autopsy only;
  • 'y' FOR y prefix;
  • 'N' FOR Not applicable;
  • '0' FOR Not derived;

  • LAST EDITED:  NOV 13, 2009
  • DESCRIPTION:  
    This is the AJCC 6th edition "N Descriptor" component that is derived from CS coded fields, using the CS algorithm, effective with 2004 diagnosis.
163.7 DERIVED AJCC-7 N DESCRIPTOR CS1;16 SET
  • 'c' FOR clinical;
  • 'p' FOR pathological;
  • 'a' FOR autopsy only;
  • 'y' FOR yp prefix;
  • 'N' FOR Not applicable;
  • '0' FOR Not derived;

  • LAST EDITED:  FEB 03, 2010
  • DESCRIPTION:  
    This is the AJCC 7th edition "N Descriptor" component that is derived from CS coded fields, using the CS algorithm, effective with 2010 diagnosis.
164 DERIVED AJCC-6 M CS1;5 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<2) X
  • OUTPUT TRANSFORM:  D MOT^ONCCSOT
  • LAST EDITED:  NOV 13, 2009
  • HELP-PROMPT:  Answer must be 2 characters in length.
  • DESCRIPTION:  
    This is the AJCC 6th edition "N" component that is derived from CS coded fields, using the CS algorithm, effective with 2004 diagnosis.
164.7 DERIVED AJCC-7 M CS1;17 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<2) X
  • OUTPUT TRANSFORM:  D MOT^ONCCSOT
  • LAST EDITED:  FEB 03, 2010
  • HELP-PROMPT:  Answer must be 2 characters in length.
  • DESCRIPTION:  
    This is the AJCC 7th edition "N" component that is derived from CS coded fields, using the CS algorithm, effective with 2010 diagnosis.
165 DERIVED AJCC-6 M DESCRIPTOR CS1;6 SET
  • 'c' FOR clinical;
  • 'p' FOR pathological;
  • 'a' FOR autopsy only;
  • 'y' FOR y prefix;
  • 'N' FOR Not applicable;
  • '0' FOR Not derived;

  • LAST EDITED:  NOV 13, 2009
  • DESCRIPTION:  
    This is the AJCC 6th edition "M Descriptor" component that is derived from CS coded fields, using the CS algorithm, effective with 2004 diagnosis.
165.7 DERIVED AJCC-7 M DESCRIPTOR CS1;18 SET
  • 'c' FOR clinical;
  • 'p' FOR pathological;
  • 'a' FOR autopsy only;
  • 'y' FOR yp prefix;
  • 'N' FOR Not applicable;
  • '0' FOR Not derived;

  • LAST EDITED:  FEB 03, 2010
  • DESCRIPTION:  
    This is the AJCC 7th edition "M Descriptor" component that is derived from CS coded fields, using the CS algorithm, effective with 2010 diagnosis.
166 DERIVED AJCC-6 STAGE GROUP CS1;7 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<2) X
  • OUTPUT TRANSFORM:  D SGOT^ONCCSOT
  • LAST EDITED:  NOV 13, 2009
  • HELP-PROMPT:  Answer must be 2 characters in length.
  • DESCRIPTION:  
    This is the AJCC 6th edition "Stage Group" component that is derived from the CS detailed site-specific codes, using the CS from the CS algorithm effective with 2004 diagnosis.
166.7 DERIVED AJCC-7 STAGE GROUP CS1;19 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<2) X
  • OUTPUT TRANSFORM:  D SGOT^ONCCSOT
  • LAST EDITED:  FEB 01, 2010
  • HELP-PROMPT:  Answer must be 2 characters in length.
  • DESCRIPTION:  
    This is the AJCC 7th edition "Stage Group" component that is derived from the CS detailed site-specific codes, using the CS from the CS algorithm effective with 2010 diagnosis.
167 DERIVED SS1977 CS1;8 SET
  • '0' FOR In situ;
  • '1' FOR Localized;
  • '2' FOR Regional, direct extension;
  • '3' FOR Regional, lymph nodes only;
  • '4' FOR Regional, extension and nodes;
  • '5' FOR Regional, NOS;
  • '7' FOR Distant;
  • '8' FOR NA;
  • '9' FOR Unknown/Unstaged;

  • LAST EDITED:  MAR 10, 2004
  • DESCRIPTION:  
    This is the derived "SEER Summary Stage 1977" from the CS algorithm (or EOD codes) effective with 2004 diagnosis.
168 DERIVED SS2000 CS1;9 SET
  • '0' FOR In situ;
  • '1' FOR Localized;
  • '2' FOR Regional, direct extension;
  • '3' FOR Regional, lymph nodes only;
  • '4' FOR Regional, extension and nodes;
  • '5' FOR Regional, NOS;
  • '7' FOR Distant;
  • '8' FOR NA;
  • '9' FOR Unknown/Unstaged;

  • LAST EDITED:  MAR 09, 2004
  • DESCRIPTION:  
    This is the derived "SEER Summary Stage 2000" from the CS algorithm (or EOD codes) effective with 2004 diagnosis.
169 CS VERSION DERIVED CS1;11 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>6!($L(X)<6) X
  • LAST EDITED:  MAR 31, 2009
  • HELP-PROMPT:  Enter the 6 character version number of the most recently used CS version.
  • DESCRIPTION:  
    This item indicates the Collaborative Staging (CS) version used most recently to derive the CS output fields.
169.1 CS VERSION INPUT ORIGINAL CS1;12 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>6!($L(X)<6) X
  • LAST EDITED:  NOV 04, 2009
  • HELP-PROMPT:  Enter the 6 character version number of the CS version initially used.
  • DESCRIPTION:  
    This item indicates the number of the version initially used to code Collaborative Staging (CS) fields.
170 DATE FIRST SURGICAL PROCEDURE 3.1;38 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) D DFSPIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  NOV 05, 2004
  • HELP-PROMPT:  *** DATE FIRST SURGICAL PROCEDURE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  Records the earliest date on which any first course surgical procedure was performed.
    For further information see FORDS pages 131-132.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^ATSF^MUMPS
    1)= S ^ONCO(165.5,"ATX",DA,X_"S0")=""
    2)= K ^ONCO(165.5,"ATX",DA,X_"S0")
    Records the earliest date on which any first course surgical procedure was performed on the unified treatment index.
171 DATE OF FIRST SYMPTOMS 2.2;4 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date of first symptoms or abnormal test results.
  • DESCRIPTION:  
    Records the date on which the patient was first seen with symptoms or had abnormal test results which began the workup which led to the diagnosis of cancer. This date would be before or equal to the DATE DX.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
172 DATE START OF WORKUP ORDERED 2.2;5 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date the physician ordered diagnostic tests.
  • DESCRIPTION:  
    Records the date the physician placed consult to specialty clinic OR ordered diagnostic procedures or tests.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
173 DATE WORKUP STARTED 2.2;6 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date the patient started diagnostic tests.
  • DESCRIPTION:  
    Records the date when the patient was seen in the specialty clinic OR had diagnostic procedures or tests performed.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
174 BLOOD IN SPUTUM PER PT 2.2;7 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/Not documented;

  • LAST EDITED:  MAY 23, 2005
  • DESCRIPTION:  
    Record the presence of blood in the patient's sputum as reported by the patient.
174.1 DATE OF BLOOD IN SPUTUM PER PT 2.2;18 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date of blood in the patient's sputum.
  • DESCRIPTION:  
    Records the date of the presence of blood in the patient's sputum (as reported by the patient).
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
175 CHEST X-RAY 2.2;8 SET
  • '0' FOR Not done;
  • '1' FOR Abnormal;
  • '2' FOR Within normal limits;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  APR 04, 2005
  • DESCRIPTION:  
    Record the results of the diagnostic test CHEST X-RAY. If this test was not done, record a '0'.
175.1 DATE OF CHEST X-RAY 2.2;19 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date of the diagnostic test CHEST X-RAY.
  • DESCRIPTION:  
    Records the date of the diagnostic test CHEST X-RAY.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
176 CT SCAN 2.2;9 SET
  • '0' FOR Not done;
  • '1' FOR Abnormal;
  • '2' FOR Within normal limits;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  APR 05, 2005
  • DESCRIPTION:  
    Record the results of the diagnostic test CT SCAN. If this test was not done, record a '0'.
176.1 DATE OF CT SCAN 2.2;20 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date of the diagnostic test CT SCAN.
  • DESCRIPTION:  
    Records the date of the diagnostic test CT SCAN.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
177 BRONCHOSCOPY 2.2;10 SET
  • '0' FOR Not done;
  • '1' FOR Abnormal;
  • '2' FOR Within normal limits;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  APR 05, 2005
  • DESCRIPTION:  
    Record the results of the diagnostic test BRONCHOSCOPY. If this test was not done, record a '0'.
177.1 DATE OF BRONCHOSCOPY 2.2;21 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date of the diagnostic test BRONCHOSCOPY.
  • DESCRIPTION:  
    Records the date of the diagnostic test BRONCHOSCOPY.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
178 MEDIASTINOSCOPY 2.2;11 SET
  • '0' FOR Not done;
  • '1' FOR Abnormal;
  • '2' FOR Within normal limits;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  APR 05, 2005
  • DESCRIPTION:  
    Record the results of the diagnostic test MEDIASTINOSCOPY. If this test was not done, record a '0'.
178.1 DATE OF MEDIASTINOSCOPY 2.2;22 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date of the diagnostic test MEDIASTINOSCOPY.
  • DESCRIPTION:  
    Records the date of the diagnostic test MEDIASTINOSCOPY.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
179 PET SCAN 2.2;12 SET
  • '0' FOR Not done;
  • '1' FOR Abnormal;
  • '2' FOR Within normal limits;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  APR 05, 2005
  • DESCRIPTION:  
    Record the results of the diagnostic test PET SCAN. If this test was not done, record a '0'.
179.1 DATE OF PET SCAN 2.2;23 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date of the diagnostic test PET SCAN.
  • DESCRIPTION:  
    Records the date of the diagnostic test PET SCAN.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
180 CHANGE IN BOWEL HABITS PER PT 2.2;13 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  MAY 23, 2005
  • DESCRIPTION:  
    Record all changes in bowel habits as reported by the patient.
180.1 DATE OF CHANGE IN BOWEL HABITS 2.2;24 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date of a change in bowel habits.
  • DESCRIPTION:  
    Records the date of a change in bowel habits (as reported by the patient).
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
181 FECAL OCCULT BLOOD TEST (FOBT) 2.2;14 SET
  • '0' FOR Not done;
  • '1' FOR Positive (3-card sample);
  • '2' FOR Negative (3-card sample);
  • '3' FOR Positive (6-card sample);
  • '4' FOR Negative (6-card sample);
  • '5' FOR FIT Test;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  MAY 25, 2005
  • DESCRIPTION:  
    Record the results of the diagnostic test FECAL OCCULT BLOOD TEST (FOBT). If this test was not done, record a '0'.
181.1 DATE OF FOBT 2.2;25 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date of the diagnostic test FOBT.
  • DESCRIPTION:  
    Records the date of the diagnostic test FECAL OCCULT BLOOD TEST (FOBT).
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
182 BARIUM ENEMA 2.2;15 SET
  • '0' FOR Not done;
  • '1' FOR Abnormal;
  • '2' FOR Within normal limits;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  APR 05, 2005
  • DESCRIPTION:  
    Record the results of the diagnostic test BARIUM ENEMA. If this test was not done, record a '0'.
182.1 DATE OF BARIUM ENEMA 2.2;27 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the results of the diagnostic test BARIUM ENEMA.
  • DESCRIPTION:  
    Records the results of the diagnostic test BARIUM ENEMA.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
183 SIGMOIDOSCOPY 2.2;16 SET
  • '0' FOR Not done;
  • '1' FOR Abnormal;
  • '2' FOR Within normal limits;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  MAY 23, 2005
  • DESCRIPTION:  
    Record the results of the diagnostic test SIGMOIDOSCOPY. If this test was not done, record a '0'.
183.1 DATE OF SIGMOIDOSCOPY 2.2;28 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date of the diagnostic test SIGMOIDOSCOPY.
  • DESCRIPTION:  
    Records the date of the diagnostic test SIGMOIDOSCOPY.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
184 CT OF ABDOMEN/PELVIS 2.2;17 SET
  • '0' FOR Not done;
  • '1' FOR Abnormal;
  • '2' FOR Within normal limits;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  MAY 23, 2005
  • DESCRIPTION:  
    Record the results of the diagnostic test CT OF ABDOMEN/PELVIS. If this test was not done, record a '0'.
184.1 DATE OF CT OF ABDOMEN/PELVIS 2.2;31 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date of the diagnostic test CT OF ABDOMEN/PELVIS.
  • DESCRIPTION:  
    Records the date of the diagnostic test CT OF ABDOMEN/PELVIS.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
185 COLONOSCOPY 2.2;29 SET
  • '0' FOR Not done;
  • '1' FOR Abnormal;
  • '2' FOR Within normal limits;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  MAY 23, 2005
  • DESCRIPTION:  
    Record the results of the diagnostic test COLONOSCOPY. If this test was not done, record a '0'.
185.1 DATE OF COLONOSCOPY 2.2;30 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date of the diagnostic test COLONOSCOPY.
  • DESCRIPTION:  
    Records the date of the diagnostic test COLONOSCOPY. If this test was not done, record a '0'.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
186 DYSPNEA 2.2;32 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  JUN 03, 2005
  • DESCRIPTION:  
    Record whether the patient experienced dyspnea.
186.1 DATE OF DYSPNEA 2.2;33 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date on which the patient was affected by dyspnea.
  • DESCRIPTION:  
    Records the date on which the patient was affected by dyspnea.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
187 INCREASED COUGH 2.2;34 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  MAY 23, 2005
  • DESCRIPTION:  
    Record whether the patient experienced increased coughing.
187.1 DATE OF INCREASED COUGH 2.2;35 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date on which the patient experienced increased coughing.
  • DESCRIPTION:  
    Records the date on which the patient experienced increased coughing.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
188 FEVER 2.2;36 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  MAY 23, 2005
  • DESCRIPTION:  
    Record whether the patient experienced a fever.
188.1 DATE OF FEVER 2.2;37 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date on which the patient experienced a fever.
  • DESCRIPTION:  
    Records the date on which the patient experienced a fever.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
189 NIGHT SWEATS 2.2;38 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  JUN 03, 2005
  • DESCRIPTION:  
    Record whether the patient experienced night sweats.
189.1 DATE OF NIGHT SWEATS 2.2;39 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  SEP 21, 2006
  • HELP-PROMPT:  Enter the date on which the patient experienced night sweats.
  • DESCRIPTION:  
    Records the date on which the patient experienced night sweats.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
190 WEIGHT LOSS PER PT 2.2;40 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  MAY 23, 2005
  • DESCRIPTION:  
    Record weight loss as reported by the patient.
191 ULCERATIVE COLITIS (UC) 2.2;41 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  MAY 24, 2005
  • DESCRIPTION:  
    Record whether the patient was affected by ulcerative colitis (UC).
192 SPORADIC POLYPS 2.2;42 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  JUN 03, 2005
  • DESCRIPTION:  Sporadic polyps can also develop in people with no family history of colon cancer. They are called "sporadic" to distinguish them from the familial kind. Certain types of sporadic polyps do increase the risk of colon
    cancer. These polyps, known as adenomas, often can be removed during a colonoscopic examination.
    Record the existence of sporadic polyps.
193 DATE OF CONCLUSIVE DX 24;13 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X I $D(X) D DCD^ONCOCOM
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JAN 24, 2007
  • HELP-PROMPT:  Enter the date of a definite state of malignancy.
  • DESCRIPTION:  Documents the date when a conclusive cancer diagnosis (definite statement of malignancy) is made following an initial diagnosis that was based only on ambiguous terminology. The date of the conclusive diagnosis must be
    greater than two months following the initial (ambiguous terminology only) diagnosis.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
194 MULT TUM RPT AS ONE PRIM 24;14 POINTER TO TYPE OF MULTIPLE TUMORS FILE (#169) TYPE OF MULTIPLE TUMORS(#169)

  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(169,Y,0),U,2)
  • LAST EDITED:  JAN 24, 2007
  • DESCRIPTION:  This data item is used to identify cases with multiple tumors that are abstracted ans reported as a single primary.
    Codes Description
    ----- -----------
    00 Single tumor 10 At least two benign tumors in same organ/primary site
    (Intracranial and CNS sites only) 11 At least two borderline tumors in the same organ/primary site
    (Intracranial and CNS sites only) 12 Benign and borderline tumors in the same organ/primary site
    (Intracranial and CNS sites only) 20 At least two in situ tumors in the same organ/primary site 30 One or more in situ and one or more invasive tumors in the same
    organ/primary site 31 One or more in situ/invasive adenocarcinoma in a polyp and one
    or more frank adenocarcinoma in one segment of colon 32 Familial polyposis with one or more in situ/invasive carcinoma 40 At least two invasive tumors in the same organ (Includes one
    or more invasive tumor with histology "NOS" and one or more
    separate invasive tumor with a more specific histology) 80 Multiple tumors present in the same organ/primary site, unknown
    if in situ or invasive 88 Information on multiple tumors not collected/not applicable for
    this site 99 Unknown
195 DATE OF MULTIPLE TUMORS 24;15 FREE TEXT

  • INPUT TRANSFORM:  D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JAN 24, 2007
  • HELP-PROMPT:  Enter the date the patient was diagnosed with multiple tumors reported as a single primary.
  • DESCRIPTION:  This data item is used to identify the month, day and year the patient is diagnosed with multiple tumors reported as a single primary. Use the multiple primary rules for that specific site to determine whether the tumors
    are a single primary or multiple primaries.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
196 MULTIPLICITY COUNTER 24;16 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<2)!'(X?2N)!((X>89)&(X<99)) X
  • LAST EDITED:  MAR 16, 2011
  • HELP-PROMPT:  Answer must be a 2-digit number. Allowable Values: 00-89, 99.
  • DESCRIPTION:  Records the number of tumors (multiplicity) reported as a single primary.
    Codes 00 No primary tumor identified 01 One tumor only 02 Two tumors present; bilateral ovaries involved with cystic carcinoma 03 Three tumors present
    ..
    ..
    88 Information on multiple tumors not collected/not applicable for this
    site 89 Multicentric, multifocal, number unknown 99 Unknown if multiple tumors; not documented
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
197 EDITS CHECKSUM EDITS;1 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>20!($L(X)<1) X
  • LAST EDITED:  MAR 06, 2007
  • HELP-PROMPT:  Answer must be 1-20 characters in length.
  • DESCRIPTION:  
    Provides a checksum value for the NAACCR record associated with this abstract. This checksum will be used to detect changes to the NAACCR record once the ABSTRACT STATUS (165.5,91) has been set to 3 (Complete).
197.1 CHECKSUM VERSION EDITS;2 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>10!($L(X)<1) X
  • LAST EDITED:  JAN 12, 2010
  • HELP-PROMPT:  Answer must be 1-10 characters in length.
  • DESCRIPTION:  
    Identifies the NAACCR version that was used to calculate EDITS CHECKSUM (165.5,197).
198 DATE CASE LAST CHANGED 7;21 DATE

  • INPUT TRANSFORM:  S %DT="ESTX" D ^%DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATECLC^ONCOES
  • LAST EDITED:  MAR 27, 2024
  • HELP-PROMPT:  Record the date in which this case was last changed or updated.
  • DESCRIPTION:  
    Date the case was last changed or updated.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^AAE
    1)= S ^ONCO(165.5,"AAE",$E(X,1,30),DA)=""
    2)= K ^ONCO(165.5,"AAE",$E(X,1,30),DA)
    This cross-reference will be used to facilitate the extraction of the data from specified start/end dates.
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^199
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,7)):^(7),1:"") S X=$P(Y(1),U,22),X=X S DIU=X K Y S X=DIV S X=DUZ S DIH=$G(^ONCO(165.5,DIV(0),7)),DIV=X S $P(^(7),U,22)=DIV,DIH=165.5,DIG=199 D ^DICR
    2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,7)):^(7),1:"") S X=$P(Y(1),U,22),X=X S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),7)),DIV=X S $P(^(7),U,22)=DIV,DIH=165.5,DIG=199 D ^DICR
    CREATE VALUE)= S X=DUZ
    DELETE VALUE)= @
    FIELD)= CASE LAST CHANGED BY
    This trigger cross-reference is used to set the CASE LAST CHANGED BY (#199) field to the DUZ of the user who created/modified the case.
199 CASE LAST CHANGED BY 7;22 POINTER TO NEW PERSON FILE (#200) NEW PERSON(#200)

  • LAST EDITED:  MAR 26, 2007
  • DESCRIPTION:  
    Records the name of the individual who last changed the case.
  • NOTES:  TRIGGERED by the DATE CASE LAST CHANGED field of the ONCOLOGY PRIMARY File
200 DATE LAST CONTACT COMPUTED

  • MUMPS CODE:  S X="" D PDLC^ONCOCRF,DATEOT^ONCOES
  • ALGORITHM:  S X=""" D PDLC^ONCOCRF,DATEOT^ONCOES
  • LAST EDITED:  FEB 26, 1997
  • DESCRIPTION:  
    Date last contact with the patient - computed from file #160.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
201 SURVIVAL DAYS COMPUTED

  • MUMPS CODE:  S X="" D SDA^ONCOCRF S X=$J(X,0,0)
  • ALGORITHM:  S X="" D SDA^ONCOCRF (ALWAYS 0 DECIMAL DIGITS)
  • LAST EDITED:  SEP 11, 1990
  • DESCRIPTION:  
    COMPUTED SURVIVAL DATA IN DAYS.
202 SURVIVAL MONTHS COMPUTED

  • MUMPS CODE:  S X="" D SUR^ONCOCRF S X=$J(X,0,1)
    9.2 = X $P(^DD(165.5,200,0),U,5,99) S Y(165.5,202,1)=X S Y(165.5,202,2)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=Y(165.5,202,1),X1=X,X2=$P(Y(165.5,202,2),U,16),X="" D:X2 ^%DTC:X1 S X=X
  • ALGORITHM:  S X="" D SUR^ONCOCRF (ALWAYS 1 DECIMAL DIGITS)
  • LAST EDITED:  SEP 11, 1990
  • DESCRIPTION:  
    COMPUTED SURVIVAL DATA IN MONTHS.
203 SURVIVAL (YEARS) COMPUTED

  • MUMPS CODE:  S X="" D SYR^ONCOCRF S X=$J(X,0,1)
    9.2 = X $P(^DD(165.5,200,0),U,5,99) S Y(165.5,203,1)=X S Y(165.5,203,2)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=Y(165.5,203,1),X1=X,X2=$P(Y(165.5,203,2),U,16),X="" D:X2 ^%DTC:X1 S X=X
  • ALGORITHM:  S X="" D SYR^ONCOCRF (ALWAYS 1 DECIMAL DIGITS)
  • LAST EDITED:  SEP 11, 1990
  • DESCRIPTION:  
    COMPUTED SURVIVAL DATA IN YEARS.
204 WEEKS of FOLLOW-UP COMPUTED

  • MUMPS CODE:  S X="" D SWK^ONCOCRF S X=$J(X,0,0)
    9.2 = X $P(^DD(165.5,201,0),U,5,99) S Y(165.5,204,1)=X S Y(165.5,204,3)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=Y(165.5,204,1),Y(165.5,204,2)=X S X=$P(Y(165.5,204,3),U,16)
  • ALGORITHM:  S X="" D SWK^ONCOCRF (ALWAYS 0 DECIMAL DIGITS)
  • LAST EDITED:  SEP 11, 1990
  • DESCRIPTION:  
    FOLLOW UP IN WEEKS.
205 OVER-RIDE AGE/SITE/MORPH OVRD;1 SET
  • '1' FOR Reviewed;
  • '2' FOR Reviewed, Dx in utero;
  • '3' FOR Reviewed, Codes 1 and 2 both apply;

  • LAST EDITED:  MAR 25, 2009
  • HELP-PROMPT:  Enter the appropriate code to override this edit.
  • DESCRIPTION:  Used with CoC Metafile and the EDITS software to override the edit Age, Primary Site, Morphology (Coc) and/or the edit Age, Primary Site, Morphology ICD-O-3 (CoC).
    For further information see FORDS page 215.
206 OVER-RIDE SEQNO/DXCONF OVRD;2 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  NOV 30, 2000
  • DESCRIPTION:  This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.
207 OVER-RIDE SITE/LAT/SEQNO OVRD;3 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  NOV 30, 2000
  • DESCRIPTION:  This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.
208 OVER-RIDE SURG/DXCONF OVRD;4 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  NOV 30, 2000
  • DESCRIPTION:  This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.
209 OVER-RIDE SITE/TYPE OVRD;5 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  NOV 30, 2000
  • DESCRIPTION:  This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.
210 OVER-RIDE HISTOLOGY OVRD;6 SET
  • '1' FOR Reviewed - allow flags Morphology-Type & Behavior;
  • '2' FOR Reviewed - allow flags Dx Conf, Behavior Code;
  • '3' FOR Reviewed - conditions 1 & 2 both apply;

  • LAST EDITED:  NOV 30, 2000
  • DESCRIPTION:  This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.
211 OVER-RIDE REPORT SOURCE OVRD;7 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  NOV 30, 2000
  • DESCRIPTION:  This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.
212 OVER-RIDE ILL-DEFINE SITE OVRD;8 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  NOV 30, 2000
  • DESCRIPTION:  This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.
213 OVER-RIDE LEUK,LYMPHOMA OVRD;9 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  NOV 30, 2000
  • DESCRIPTION:  This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.
214 OVER-RIDE SITE/BEHAVIOR OVRD;10 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  NOV 30, 2000
  • DESCRIPTION:  This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.
215 OVER-RIDE SITE/EOD/DX DT OVRD;11 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  NOV 30, 2000
  • DESCRIPTION:  This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.
216 OVER-RIDE SITE/LAT/EOD OVRD;12 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  NOV 30, 2000
  • DESCRIPTION:  This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.
217 OVER-RIDE SITE/LAT/MORPH OVRD;13 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  NOV 30, 2000
  • DESCRIPTION:  This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.
218 OVER-RIDE SS/NODESPOS OVRD;14 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  JUL 27, 2001
  • DESCRIPTION:  
    This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.
219 OVER-RIDE SS/TNM-N OVRD;15 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  JUL 27, 2001
  • DESCRIPTION:  
    This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.
220 OVER-RIDE SS/TNM-M OVRD;16 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  JUL 27, 2001
  • DESCRIPTION:  
    This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.
221 OVER-RIDE SS/DISMET1 OVRD;17 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  JUL 27, 2001
  • DESCRIPTION:  
    This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.
222 OVER-RIDE ACSN/CLASS/SEQ OVRD;18 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  JUL 27, 2001
  • DESCRIPTION:  
    This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.
223 OVER-RIDE HOSPSEQ/DXCONF OVRD;19 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  JUL 27, 2001
  • DESCRIPTION:  
    This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.
224 OVER-RIDE COC-SITE/TYPE OVRD;20 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  JUL 27, 2001
  • DESCRIPTION:  
    This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.
225 OVER-RIDE HOSPSEQ/SITE OVRD;21 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  JUL 27, 2001
  • DESCRIPTION:  
    This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.
226 OVER-RIDE SITE/TNM-STGGRP OVRD;22 SET
  • '1' FOR Reviewed;

  • LAST EDITED:  JUL 27, 2001
  • DESCRIPTION:  
    This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.
227 PERFORMANCE STATUS AT DX 1;7 SET
  • '0' FOR ECOG 0;
  • '1' FOR ECOG 1;
  • '2' FOR ECOG 2;
  • '3' FOR ECOG 3;
  • '4' FOR ECOG 4;
  • '5' FOR ECOG 5;
  • '9' FOR UNKNOWN;
  • '10' FOR KPS 10;
  • '20' FOR KPS 20;
  • '30' FOR KPS 30;
  • '40' FOR KPS 40;
  • '50' FOR KPS 50;
  • '60' FOR KPS 60;
  • '70' FOR KPS 70;
  • '80' FOR KPS 80;
  • '90' FOR KPS 90;
  • '100' FOR KPS 100;

  • LAST EDITED:  MAR 25, 2016
  • HELP-PROMPT:  Enter the score which indicates the patient's general well-being.
  • DESCRIPTION:  Records an attempt to quantify the patient's general well-being.
    ECOG 0 - Fully active, able to carry on all pre-disease
    activities without restriction
    ECOG 1 - Restricted in physically strenuous activity but ambulatory
    and able to carry out work of a light or sedentary nature.
    For example, light housework, office work
    ECOG 2 - Ambulatory and capable of all self care but unable to carry out
    and any work activities. Up and about more than 50% of waking
    hours
    ECOG 3 - Capable of only limited self-care, confined to bed or chair
    50% or more of waking hours
    ECOG 4 - Completely disabled. Cannot carry on any self-care.
    Totally confined to bed or chair)
    UNKNOWN - Unknown/not documented
    KPS 100 - Normal, no complaints; no evidence of disease
    KPS 90 - Able to carry on normal activity; minor signs or symptoms
    of disease
    KPS 80 - Normal activity with effort, some signs or symptoms of disease
    KPS 70 - Cares for self but unable to carry on normal activity or
    to do active work
    KPS 60 - Requires occasional assistance but is able to care
    for most of personal needs
    KPS 50 - Requires considerable assistance and frequent medical care
    KPS 40 - Disabled; requires special care and assistance
    KPS 30 - Severely disabled; hospitalization is indicated
    although death not imminent
    KPS 20 - Very ill; hospitalization and active
    supportive care necessary
    KPS 10 - Moribund
228 TREATMENT GUIDELINE #1 24;17 SET
  • '0' FOR None;
  • '1' FOR NCCN;
  • '2' FOR ASCO;
  • '3' FOR ASH;
  • '4' FOR AUA;
  • '5' FOR PDQ;
  • '6' FOR SSO;
  • '7' FOR Other;
  • '8' FOR NA;
  • '99' FOR Unknown;

  • LAST EDITED:  APR 12, 2010
  • HELP-PROMPT:  Enter the first guideline used to determine the first course of treatment.
  • DESCRIPTION:  Identifies the first guideline used to determine the first course of treatment.
    NCCN (National Comprehensive Cancer Network) ASCO (American Society of Clinical Oncology) ASH (American Society of Hematology) AUA (American Urologic Association) PDQ (Physician Data Query) SSO (The Society of Surgical
    Oncology)
229 TREATMENT GUIDELINE #2 24;18 SET
  • '0' FOR None;
  • '1' FOR NCCN;
  • '2' FOR ASCO;
  • '3' FOR ASH;
  • '4' FOR AUA;
  • '5' FOR PDQ;
  • '6' FOR SSO;
  • '7' FOR Other;
  • '8' FOR NA;
  • '99' FOR Unknown;

  • LAST EDITED:  APR 12, 2010
  • HELP-PROMPT:  Enter the second guideline used to determine the first course of treatment.
  • DESCRIPTION:  Identifies the second guideline used to determine the first course of treatment.
    NCCN (National Comprehensive Cancer Network) ASCO (American Society of Clinical Oncology) ASH (American Society of Hematology) AUA (American Urologic Association) PDQ (Physician Data Query) SSO (The Society of Surgical
    Oncology)
230 TREATMENT GUIDELINE #3 24;19 SET
  • '0' FOR None;
  • '1' FOR NCCN;
  • '2' FOR ASCO;
  • '3' FOR ASH;
  • '4' FOR AUA;
  • '5' FOR PDQ;
  • '6' FOR SSO;
  • '7' FOR Other;
  • '8' FOR NA;
  • '99' FOR Unknown;

  • LAST EDITED:  APR 12, 2010
  • HELP-PROMPT:  Enter the third guideline used to determine the first course of treatment.
  • DESCRIPTION:  Identifies the third guideline used to determine the first course of treatment.
    NCCN (National Comprehensive Cancer Network) ASCO (American Society of Clinical Oncology) ASH (American Society of Hematology) AUA (American Urologic Association) PDQ (Physician Data Query) SSO (The Society of Surgical
    Oncology)
231 TREATMENT GUIDELINE LOCATION 24;20 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>30!($L(X)<1) X
  • LAST EDITED:  JUN 12, 2009
  • HELP-PROMPT:  Answer must be 1-30 characters in length.
  • DESCRIPTION:  
    Identifies where the treatment guidelines used in treatment planning are documented in the medical record.
232 TREATMENT GUIDELINE DOC DATE 24;21 DATE

  • INPUT TRANSFORM:  S %DT="E" D ^%DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JUL 07, 2009
  • HELP-PROMPT:  Enter the date treatment guidelines were documented in the medical record.
  • DESCRIPTION:  
    Records the date when treatment guidelines were documented in the medical record.
233 INPATIENT STATUS 2.3;3 SET
  • '0' FOR Patient was never an inpatient;
  • '1' FOR Patient was inpatient;
  • '9' FOR Unknown if patient was an inpatient;

  • LAST EDITED:  OCT 09, 2009
  • HELP-PROMPT:  Enter the appropriate INPATIENT STATUS code.
  • DESCRIPTION:  
    This data item records whether there was an inpatient admission for the most definitive therapy, or in the absence of therapy, for diagnostic evaluation.
234 RX HOSP--SURG APP 2010 2.3;4 SET
  • '0' FOR No surgery/Dx at autopsy;
  • '1' FOR Robotic assisted;
  • '2' FOR Robotic converted to open;
  • '3' FOR Endoscopic/Laparoscopic;
  • '4' FOR Endoscopic/Laparoscopic converted to open;
  • '5' FOR Open/Approach, NOS;
  • '9' FOR Not stated/Death cert only;

  • LAST EDITED:  JUL 27, 2022
  • HELP-PROMPT:  Enter the appropriate code to describe the surgical method used to approach the primary site.
  • DESCRIPTION:  This item is used to describe the surgical method used to approach the primary site for patients undergoing surgery of the primary site at this facility. If the patient has multiple surgeries to the primary site, this
    item describes the approach used for the most invasive, definitive surgery.
235 TREATMENT STATUS 2.3;5 SET
  • '0' FOR No treatment given;
  • '1' FOR Treatment given;
  • '2' FOR Active surveillance (watchful waiting);
  • '9' FOR Unknown if treatment was given;

  • LAST EDITED:  OCT 14, 2009
  • HELP-PROMPT:  Enter the appropriate TREATMENT STATUS code.
  • DESCRIPTION:  
    This data item summarizes whether the patient received any treatment or the tumor was under active surveillance.
236 DATE CASE INITIATED 2.3;6 DATE

  • INPUT TRANSFORM:  S %DT="EX" D ^%DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAY 05, 2010
  • HELP-PROMPT:  Enter the date the abstract was initiated in the reporting facility's cancer registry database.
  • DESCRIPTION:  
    Date the electronic abstract is initiated in the reporting facility's cancer registry database.
237 FEE BASIS 2.3;7 SET
  • '0' FOR No;
  • '1' FOR Yes;

  • LAST EDITED:  JUN 05, 2024
  • HELP-PROMPT:  Enter "Yes" if the patient was referred to a FEE BASIS/CONTRACT facility.
  • DESCRIPTION:  
    Indicates if the patient was referred to another facility for treatment or to a facility closer to the patient's residence either on a "Fee Basis" or via a CONTRACT with the reporting facility.
237.1 FEE BASIS LOCATION 2.3;11 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>30!($L(X)<3) X
  • LAST EDITED:  MAY 24, 2012
  • HELP-PROMPT:  Answer must be 3-30 characters in length.
  • DESCRIPTION:  In many cases the FACILITY REFERRED TO may not be the same place that the FEE BASIS treatment was performed. Therefore, this field enables facilities to track where the patient was referred to. This field is available
    to be displayed on ad hoc reports.
    Enter the name of the FEE BASIS LOCATION in free text.
238 OUTSIDE SLIDES REVIEWED 2.3;8 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 25, 2009
  • HELP-PROMPT:  Enter whether tissue slides diagnosed elsewhere were reviewed at this facility.
  • DESCRIPTION:  Identifies if tissue slides diagnosed at another facility were reviewed at this facility.
    0 (No) Outside tissue diagnosis done, slides not reviewed
    at this facility. 1 (Yes) Outside tissue diagnosis done, slides requested and
    reviewed at this facility. 8 (NA) Not applicable. No outside tissue diagnosis done. 9 (Unknown) Unknown if outside tissue diagnosis done.
239 MITOTIC RATE 2.3;9 SET
  • 'L' FOR Low <5/50 HPF;
  • 'H' FOR High >5/50 HPF;
  • 'U' FOR Unknown;

  • LAST EDITED:  DEC 21, 2009
  • HELP-PROMPT:  Enter the code for MITOTIC RATE.
  • DESCRIPTION:  
    Identifies the rate or speed of cell division.
240 CS SCHEMA DISCRIMINATOR CS3;1 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<3) X I $D(X) D IN^ONCSUBS
  • LAST EDITED:  NOV 03, 2010
  • HELP-PROMPT:  Answer must be 3 characters in length.
  • DESCRIPTION:  This case requires a CS SCHEMA DISCRIMINATOR to determine the correct tables for CSv2 (Collaborative Staging v2) calculations.
    For example, Melanomas of CILIARY BODY AND IRIS (C69.4) require a CS SCHEMA DISCRIMINATOR to discriminate between tumors arising in either ciliary body or iris, both coded C69.4 but requiring different CS schemas.
    For melanomas of the ciliary body CS SCHEMA DISCRIMINATOR should be coded 010. For melanomas of the Iris CS SCHEMA DISCRIMINATOR should be coded 020.
    CS SCHEMA DISCRIMINATOR values will be stuffed into SSF25 for use in CS calculations.
  • EXECUTABLE HELP:  D HELP^ONCSUBS
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^44.25
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"CS2")):^("CS2"),1:"") S X=$P(Y(1),U,19),X=X S DIU=X K Y S X=DIV S SSF25=X S DIH=$G(^ONCO(165.5,DIV(0),"CS2")),DIV=X S $P(^("CS2"),U,19)=DIV,DIH=165.5,DIG=44.25
    D ^DICR
    2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"CS2")):^("CS2"),1:"") S X=$P(Y(1),U,19),X=X S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),"CS2")),DIV=X S $P(^("CS2"),U,19)=DIV,DIH=165.5,DIG=44.25 D ^DICR
    CREATE VALUE)= S SSF25=X
    DELETE VALUE)= @
    FIELD)= SSF25
    SSF25 (165.5,44.25) will be stuffed with the CS SCHEMA DISCRIMINATOR value.
241 TNM CLIN DESCRIPTOR 24;22 SET
  • '0' FOR None;
  • '1' FOR E (Extranodal);
  • '2' FOR S (Spleen);
  • '3' FOR M (Multiple primary tumors in a single site);
  • '5' FOR E&S (Extranodal and spleen);
  • '9' FOR Unknown, not stated in patient record;

  • LAST EDITED:  FEB 04, 2016
  • HELP-PROMPT:  Enter the appropriate descriptor suffix.
  • DESCRIPTION:  Identifies the AJCC clinical stage (suffix) descriptor as recorded by the physician. AJCC stage descriptors identify special cases that need separate data analysis. The descriptors are adjuncts to and do not change the
    stage group.
    0 - None: There are no prefix or suffix descriptors that would be used
    for this case
    1 E - Extranodal, lymphomas only: A lymphoma case involving an
    extranodal site.
    2 S - Spleen, lymphomas only: A lymphoma case involving the spleen
    3 M - Multiple primary tumors in a single site: This is one primary
    with multiple tumors in the organ of origin at the time
    of diagnosis
    5 E&S - Extranodal and spleen, lymphomas only: A lymphoma case with
    involvement of both an extranodal site and the spleen
    9 - Unknown, not stated in patient record: A prefix or suffix would
    describe this stage, but it is not known which would be correct
242 TNM PATH DESCRIPTOR 24;23 SET
  • '0' FOR None;
  • '1' FOR E (Extranodal);
  • '2' FOR S (Spleen);
  • '3' FOR M (Multiple primary tumors);
  • '4' FOR Y (Initial multimodality therapy);
  • '5' FOR E&S (Extranodal and spleen);
  • '6' FOR M&Y (Multiple and multimodality);
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 04, 2016
  • HELP-PROMPT:  Enter the appropriate descriptor suffix.
  • DESCRIPTION:  Identifies the AJCC clinical stage (suffix) descriptor as recorded by the physician. AJCC stage descriptors identify special cases that need separate data analysis. The descriptors are adjuncts to and do not change the
    stage group.
    0 - None: There are no prefix or suffix descriptors that would be used
    for this case
    1 E - Extranodal, lymphomas only: A lymphoma case involving an
    extranodal site
    2 S - Spleen, lymphomas only: A lymphoma case involving the spleen
    3 M - Multiple primary tumors in a single site: This is one primary
    with multiple tumors in the organ of origin at the time
    of diagnosis
    4 Y - Classification during or after initial multimodality therapy
    5 E&S - Extranodal and spleen, lymphomas only: A lymphoma case
    with involvement of both an extranodal site and the spleen
    6 M&Y - Multiple primary tumors and initial multimodality therapy:
    A case meeting the parameters of both codes 3 and 4
    9 - Unknown, not stated in patient record: A prefix or suffix would
    describe this stage, but it's not known which would be correct
244 INITIATED BY 2.3;10 POINTER TO NEW PERSON FILE (#200) NEW PERSON(#200)

  • LAST EDITED:  MAR 08, 2011
  • HELP-PROMPT:  Enter the name of the person initiating the abstract.
  • DESCRIPTION:  The name of the person initiating the abstract in the reporting facility's cancer registry database.
    This field is stuffed with the user's DUZ when a new entry is added to this file. No user interaction is required and it may not be changed.
245 NEOADJUVANT THERAPY (PRE-2021) 3.1;40 SET
  • '0' FOR Not recommended/NA;
  • '1' FOR Radiation;
  • '2' FOR Chemotherapy;
  • '3' FOR Hormone therapy;
  • '4' FOR Immunotherapy;
  • '5' FOR Combination of neoadjuvant tx;
  • '7' FOR Refusal;
  • '8' FOR Recommended but not done;
  • '9' FOR Unknown if recommended or done;

  • LAST EDITED:  MAR 08, 2021
  • HELP-PROMPT:  Enter if NEOADJUVANT THERAPY was performed.
  • DESCRIPTION:  
    Neoadjuvant therapy is the administration of therapeutic agents before the main treatment. This field documents if neoadjuvant therapy was performed for this patient and, if so, the type of neoadjuvant therapy performed.
245.1 NEOADJUVANT THERAPY EOD;5 SET
  • '0' FOR No neoadjuvant therapy;
  • '1' FOR Neoadjuvant therapy completed;
  • '2' FOR Neoadjuvant therapy started, but not completed/unk if completed;
  • '3' FOR Limited systemic exposure;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 08, 2021
  • HELP-PROMPT:  Enter the code describing the patient's neoadjuvant therapy
  • DESCRIPTION:  This data item records whether the patient had neoadjuvant therapy prior to planned definitive surgical resection of the primary site.
    Rationale This data items provides information related to the quality of care and describes whether a patient had neoadjuvant therapy.
    For the purposes of this data item, neoadjuvant therapy is defined as systemic treatment (chemotherapy, endocrine / hormone therapy, targeted therapy, immunotherapy, or biological therapy) and/or radiation therapy before
    intended or performed surgical resection to improve local therapy and long term outcomes. Codes 0 No neoadjuvant therapy, no treatment before surgery, surgical resection
    not part of first course of treatment plan
    Autopsy only 1 Neoadjuvant therapy completed according to treatment plan and guidelines 2 Neoadjuvant therapy started, but not completed OR unknown if completed 3 Limited systemic exposure when the intent was not
    neoadjuvant; treatment
    did not meet the definition of neoadjuvant therapy 9 Unknown if neoadjuvant therapy performed
    Death Certificate only (DCO)
245.2 NEOADJUVANT THERAPY-CLIN RESP EOD;6 SET
  • '0' FOR Not given;
  • '1' FOR Complete CR;
  • '2' FOR Partial CR;
  • '3' FOR Progressive Disease;
  • '4' FOR Stable disease;
  • '5' FOR No response;
  • '6' FOR Done, interpretation not available;
  • '7' FOR Path Report;
  • '8' FOR Not documented;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 28, 2021
  • HELP-PROMPT:  Enter the neoadjuvant therapy-clinical response for the patient
  • DESCRIPTION:  This data item records the clinical outcomes of neoadjuvant therapy prior to planned surgical resection. Rationale: This data items provides information related to the quality of care and describes the clinical outcomes
    after neoadjuvant therapy. This data item provides prognostically relevant information by quantifying the extent of therapy-induced tumor regression. Therefore, this item can provide a better risk stratification for
    patients who received neoadjuvant therapy. In addition, this data item can contribute to assessments of cancer care quality.
    This data item records the clinical outcomes of neoadjuvant therapy as determined by the managing physician (oncologic surgeon, radiation oncologist or medical oncologist).
    For the purposes of this data item, neoadjuvant therapy is defined as systemic treatment (chemotherapy, endocrine/hormone therapy, targeted therapy, immunotherapy, or biological therapy) and/or radiation therapy given to
    shrink a tumor before surgical resection. Codes: 0 Neoadjuvant therapy not given 1 Complete clinical response (CR)(per managing/treating
    physician statement) 2 Partial clinical response (PR) (per managing/treating
    physician statement) 3 Progressive disease (PD)(per managing/treating
    physician statement) 4 Stable disease (SD)(per managing/treating physician statement) 5 No response (NR) (per managing/treating physician statement
    Not stated as progressive disease (PD) or stable disease (SD) 6 Neoadjuvant therapy done, managing/treating physician
    interpretation not available, treatment response inferred
    from imaging, biomarkers, or yc stage 7 Complete clinical response based on pathology report (per
    pathologist assessment) 8 Neoadjuvant therapy done, response not documented or unknown 9 Unknown if neoadjuvant therapy performed
    Death Certificate only (DCO)
245.3 NEOADJUVANT THERAPY-TX EFFECT EOD;7 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D NEOIT^ONCOEOD1
  • LAST EDITED:  JAN 28, 2021
  • HELP-PROMPT:  Type a number between 0 and 9, 0 decimal digits.
  • DESCRIPTION:  This data item records the pathologist's statement of neoadjuvant treatment effect on the primary tumor from the surgical pathology report. Whenever treatment effect definitions are recommended by or available in CAP
    Cancer Protocols, this data item follows the CAP definitions indicating absent or present effect. When specific CAP definitions are not available, registrars should use treatment effect general use categories. Rationale:
    This data item provides information related to the quality of care and describes the pathological outcomes after neoadjuvant therapy. This data item provides prognostically relevant information by quantifying the extent
    of therapy-induced tumor regression. Therefore, this item can provide a better risk stratification for patients who received neoadjuvant therapy. In addition, this data item can contribute to assessments of cancer care
    quality. Codes: 0 Neoadjuvant therapy not given/no known presurgical therapy 1-4 Site-specific code; type of response 6 Neoadjuvant therapy completed and surgical resection
    performed, response not documented or unknown
    Cannot be determined 7 Neoadjuvant therapy completed and planned surgical
    resection not performed 9 Unknown if neoadjuvant therapy performed
    Unknown if planned surgical procedure performed after
    completion of neoadjuvant therapy
    Death Certificate only (DCO)
  • EXECUTABLE HELP:  D NEOHLP^ONCOEOD1
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
247 CS REVIEW REQUIRED CS3;2 SET
  • '0' FOR Reviewed;
  • '1' FOR Needs review;

  • LAST EDITED:  APR 14, 2011
  • HELP-PROMPT:  Enter 'Reviewed' once this case has been reviewed for accuracy.
  • DESCRIPTION:  When a new version of Collaborative Staging (CS) is implemented some cases require manual review/conversion by the registrar.
    This field identifies cases for which Collaborative Staging review is either required or recommended in accordance with the Collaborative Staging Conversion Specifications.
    When the patch implementing the new CS version is installed the post-install program will flag any cases needing manual review by setting CS REVIEW REQUIRED to 1 (Needs review).
    Once a case has been reviewed by the registrar, the review flag can be cleared by setting CS REVIEW REQUIRED to 0 (Reviewed).
248 NOTE TITLE 25;1 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>30!($L(X)<1) X
  • LAST EDITED:  JUN 17, 2011
  • HELP-PROMPT:  Answer must be 1-30 characters in length.
  • DESCRIPTION:  
    Records the name of the note which documents cancer staging in the medical record.
249 NOTE DATE 25;2 DATE

  • INPUT TRANSFORM:  S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  FEB 15, 2012
  • HELP-PROMPT:  Enter the date of the note used for staging. Future dates are not allowed.
  • DESCRIPTION:  
    Records the date of the note which documents cancer staging in the medical record.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
250 GLEASON SCORE PATH - OBSOLETE 25;3 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1) X
    MAXIMUM LENGTH: 2
  • OUTPUT TRANSFORM:  S Y=$S(Y=99:"99 Unknown, not reported, or NA",1:Y)
  • LAST EDITED:  FEB 27, 2025
  • HELP-PROMPT:  This field is no longer in use.
  • DESCRIPTION:  Record the pathologic Gleason Score. Gleason Score (pathologic) is obtained from a curative prostatectomy specimen.
    For cases where Gleason Score is unknown, not reported or not applicable, code 99.
    This field is no longer in use. This field has been superseded by field #3841 Gleason Score Pathological.
  • TECHNICAL DESCR:  
    This field is no longer in use as of Patch ONC*2.2*21.
251 NSLC STAGE 1-3 PATH LN STAGING PM;1 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA (Stage 0 and 4);
  • '9' FOR Unknown;

  • LAST EDITED:  APR 02, 2012
  • HELP-PROMPT:  Enter whether mediastinal lymph node staging was performed at the reporting facility.
  • DESCRIPTION:  
    Documents if mediastinal lymph node staging was performed at the reporting facility.
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^253
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,3),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,251,1,1,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,3)=DIV,DIH=165.5,DIG=253 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU
    DELETE VALUE)= NO EFFECT
    FIELD)= #253
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^255
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,5),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,251,1,2,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,5)=DIV,DIH=165.5,DIG=255 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU
    DELETE VALUE)= NO EFFECT
    FIELD)= #255
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^256
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,6),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,251,1,3,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,6)=DIV,DIH=165.5,DIG=256 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU
    DELETE VALUE)= NO EFFECT
    FIELD)= #256
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^264
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,14),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,251,1,4,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,14)=DIV,DIH=165.5,DIG=264 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU
    DELETE VALUE)= NO EFFECT
    FIELD)= #264
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^265
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,15),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,251,1,5,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,15)=DIV,DIH=165.5,DIG=265 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU
    DELETE VALUE)= NO EFFECT
    FIELD)= #265
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^266
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,16),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,251,1,6,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,16)=DIV,DIH=165.5,DIG=266 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU
    DELETE VALUE)= NO EFFECT
    FIELD)= #266
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^252
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,2),X=X S DIU=X K Y S X=DIV S:(X'=1) X=DIU S:(X=1) X=8 X ^DD(165.5,251,1,7,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,2)=DIV,DIH=165.5,DIG=252 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X'=1) X=DIU S:(X=1) X=8
    DELETE VALUE)= NO EFFECT
    FIELD)= #252
252 REASON FOR NO LN BIOPSY PM;2 SET
  • '1' FOR Contraindicated;
  • '2' FOR Patient declined;
  • '3' FOR Patient transferred;
  • '4' FOR Patient expired;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 06, 2012
  • HELP-PROMPT:  Enter the reason mediastinal lymph nodes were not biopsied at the reporting facility.
  • DESCRIPTION:  
    Records the reason that mediastinal lymph nodes were not biopsied at the reporting facility.
  • NOTES:  TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
253 DATE OF SURGERY CONSULT PM;3 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  APR 02, 2012
  • HELP-PROMPT:  Enter the surgery consult date.
  • DESCRIPTION:  
    Records the surgery consult date. If NO surgery consult was ordered or not DONE, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
    TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^254
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,4),X=X S DIU=X K Y S X=DIV S:(X'="0000000") X=DIU S:(X="0000000") X=0 X ^DD(165.5,253,1,1,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,4)=DIV,DIH=165.5,DIG=254 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X'="0000000") X=DIU S:(X="0000000") X=0
    DELETE VALUE)= NO EFFECT
    FIELD)= #254
254 INTENT OF SURGERY PM;4 SET
  • '0' FOR No surgery;
  • '1' FOR Curative (primary);
  • '2' FOR Curative (adjuvant);
  • '4' FOR Palliative (pain control);
  • '5' FOR Palliative (other);
  • '6' FOR Prophylactic (no symptoms, preventive);
  • '8' FOR Other, NOS;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 21, 2012
  • HELP-PROMPT:  Enter the intent of the surgery performed.
  • DESCRIPTION:  Code the intent of surgical treatment.
    This item is useful in assessing the appropriateness of treatment and correlating outcome with original intent of the treatment.
  • NOTES:  TRIGGERED by the DATE OF SURGERY CONSULT field of the ONCOLOGY PRIMARY File
255 DATE ONCOLOGY CONSULT ORDERED PM;5 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  APR 02, 2012
  • HELP-PROMPT:  Enter the date the oncology consult was ordered.
  • DESCRIPTION:  
    Records the date the oncology consult was ordered. If NO oncology consult was ordered or not DONE, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
    TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^256
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,6),X=X S DIU=X K Y S X=DIV S:(X'="0000000") X=DIU S:(X="0000000") X="0000000" X ^DD(165.5,255,1,1,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,6)=DIV,DIH=165.5,DIG=256 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X'="0000000") X=DIU S:(X="0000000") X="0000000"
    DELETE VALUE)= NO EFFECT
    FIELD)= #256
256 DATE ONCOLOGY CONSULT DONE PM;6 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAR 06, 2012
  • HELP-PROMPT:  Enter the oncology consult date.
  • DESCRIPTION:  
    Records the date the oncology consult was done. If NO oncology consult was done, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
    TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
    TRIGGERED by the DATE ONCOLOGY CONSULT ORDERED field of the ONCOLOGY PRIMARY File
257 CHEMOTHERAPY RECOMMENDED PM;7 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  APR 02, 2012
  • HELP-PROMPT:  Record if there is documentation that chemotherapy was recommended.
  • DESCRIPTION:  
    Records if there is documentation that chemotherapy was recommended.
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^258
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,8),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,257,1,1,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,8)=DIV,DIH=165.5,DIG=258 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0
    DELETE VALUE)= NO EFFECT
    FIELD)= #258
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^259
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,9),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,257,1,2,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,9)=DIV,DIH=165.5,DIG=259 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0
    DELETE VALUE)= NO EFFECT
    FIELD)= #259
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^261
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,11),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=8 X ^DD(165.5,257,1,3,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,11)=DIV,DIH=165.5,DIG=261 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=8
    DELETE VALUE)= NO EFFECT
    FIELD)= #261
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^382
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"BLA2")):^("BLA2"),1:"") S X=$P(Y(1),U,41),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,257,1,4,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"BLA2")),DIV=X S $P(^("BLA2"),U,41)=DIV,DIH=165.5,DIG=382 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0
    DELETE VALUE)= NO EFFECT
    FIELD)= #382
258 INTENT OF CHEMOTHERAPY PM;8 SET
  • '0' FOR No chemotherapy;
  • '1' FOR Curative (primary);
  • '2' FOR Curative (adjuvant);
  • '4' FOR Palliative (pain control);
  • '5' FOR Palliative (other);
  • '6' FOR Prophylactic (no symptoms, preventive);
  • '8' FOR Other, NOS;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 12, 2012
  • HELP-PROMPT:  Enter the documented intent of chemotherapy.
  • DESCRIPTION:  Code the intent of chemotherapy treatment.
    This item is useful in assessing the appropriateness of treatment and correlating outcome with original intent of the treatment.
  • NOTES:  TRIGGERED by the CHEMOTHERAPY RECOMMENDED field of the ONCOLOGY PRIMARY File
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^259
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X=0 I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,9),X=X S DIU=X K Y S X=DIV S X="0" X ^DD(165.5,258,1,1,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,9)=DIV,DIH=165.5,DIG=259 D ^DICR
    2)= Q
    CREATE CONDITION)= INTERNAL(INTENT OF CHEMOTHERAPY)=0
    CREATE VALUE)= "0"
    DELETE VALUE)= NO EFFECT
    FIELD)= #259
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^382
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X=0 I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,"BLA2")):^("BLA2"),1:"") S X=$P(Y(1),U,41),X=X S DIU=X K Y S X=DIV S X="0" X ^DD(165.5,258,1,2,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"BLA2")),DIV=X S $P(^("BLA2"),U,41)=DIV,DIH=165.5,DIG=382 D ^DICR
    2)= Q
    CREATE CONDITION)= INTERNAL(INTENT OF CHEMOTHERAPY)=0
    CREATE VALUE)= "0"
    DELETE VALUE)= NO EFFECT
    FIELD)= #382
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^272
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X=0 I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,21),X=X S DIU=X K Y S X=DIV S X="0000000" X ^DD(165.5,258,1,3,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,21)=DIV,DIH=165.5,DIG=272 D ^DICR
    2)= Q
    CREATE CONDITION)= INTERNAL(INTENT OF CHEMOTHERAPY)=0
    CREATE VALUE)= "0000000"
    DELETE VALUE)= NO EFFECT
    FIELD)= #272
259 TYPE OF CHEMOTHERAPY PM;9 SET
  • '0' FOR No chemotherapy;
  • '1' FOR Adjuvant;
  • '2' FOR Neoadjuvant;
  • '3' FOR Concomitant or concurrent;
  • '4' FOR Palliative;
  • '9' FOR Unknown;

  • LAST EDITED:  AUG 18, 2011
  • HELP-PROMPT:  Enter the type of chemotherapy administered.
  • DESCRIPTION:  Records the type of chemotherapy administered.
    Adjuvant - refers to additional treatment, usually given after surgery where all detectable disease has been removed, but where there remains a statistical risk of relapse due to occult disease.
    Neoadjuvant - in contrast to adjuvant therapy, is given prior to primary treatment, for example, before surgery to remove the tumor. The most common reason for neoadjuvant therapy is to reduce the size of the tumor so as
    to facilitate more effective surgery.
    Concomitant or concurrent - chemotherapy at the same time as other therapies, such as radiation.
    Palliative - chemotherapy given without expectation of a cure.
  • NOTES:  TRIGGERED by the CHEMOTHERAPY RECOMMENDED field of the ONCOLOGY PRIMARY File
    TRIGGERED by the INTENT OF CHEMOTHERAPY field of the ONCOLOGY PRIMARY File
260 REASON RADIATION STOPPED PM;10 SET
  • '0' FOR Treatment completed, NA;
  • '1' FOR Complications;
  • '2' FOR Disease progression;
  • '3' FOR Recommended but medically contraindicated;
  • '8' FOR Other;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 27, 2011
  • HELP-PROMPT:  Enter the reason radiation therapy was discontinued.
  • DESCRIPTION:  
    Record the reason radiation therapy was discontinued. If therapy ended when treatment was complete, or if the patient never received radiation therapy code 0 (treatment completed, NA).
  • NOTES:  TRIGGERED by the INTENT OF RADIATION field of the ONCOLOGY PRIMARY File
261 DOC FOR NO PLAT-BASED CHEMO PM;11 SET
  • '0' FOR No documentation;
  • '1' FOR Documentation;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  AUG 24, 2011
  • HELP-PROMPT:  Enter if there is documentation why platinum-based chemotherapy was not recommended.
  • DESCRIPTION:  
    Records if there is a documented reason in the Progress Notes stating why platinum-based chemotherapy was not recommended.
  • NOTES:  TRIGGERED by the CHEMOTHERAPY RECOMMENDED field of the ONCOLOGY PRIMARY File
262 MULTIMODALITY RADIATION TYPE PM;12 SET
  • '0' FOR No multimodality radiation therapy;
  • '1' FOR Adjuvant;
  • '2' FOR Neoadjuvant;
  • '3' FOR Concomitant or concurrent;
  • '4' FOR Palliative;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 06, 2013
  • HELP-PROMPT:  Enter the type of multimodality radiation therapy administered.
  • DESCRIPTION:  Records the type of radiation therapy administered.
    Adjuvant - refers to additional treatment, usually given after surgery where all detectable disease has been removed, but where there remains a statistical risk of relapse due to occult disease.
    Neoadjuvant - in contrast to adjuvant therapy, is given prior to primary treatment, for example, before surgery to remove the tumor. The most common reason for neoadjuvant therapy is to reduce the size of the tumor so as
    to facilitate more effective surgery.
    Concomitant or concurrent - radiation therapy at the same time as chemotherapy.
    Palliative - radiation therapy given without expectation of a cure.
  • NOTES:  TRIGGERED by the INTENT OF RADIATION field of the ONCOLOGY PRIMARY File
263 REASON HORMONE THERAPY STOPPED PM;28 SET
  • '0' FOR Treatment completed, NA;
  • '1' FOR Complications;
  • '2' FOR Disease progression;
  • '3' FOR Recommended but medically contraindicated;
  • '8' FOR Other;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 27, 2011
  • HELP-PROMPT:  Enter the reason hormone therapy was discontinued.
  • DESCRIPTION:  
    Record the reason hormone therapy was discontinued. If therapy ended when treatment was complete, or if the patient never received hormone therapy code 0 (treatment completed, NA).
264 DATE HOSPICE CONSULT INITIATED PM;14 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  APR 02, 2012
  • HELP-PROMPT:  Enter the date a hospice consult was initiated.
  • DESCRIPTION:  
    Records the date a hospice consult was initiated. If NO date a hospice consult was initiated or not DONE, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
    TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^265
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,15),X=X S DIU=X K Y S X=DIV S:(X'="0000000") X=DIU S:(X="0000000") X="0000000" X ^DD(165.5,264,1,1,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,15)=DIV,DIH=165.5,DIG=265 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X'="0000000") X=DIU S:(X="0000000") X="0000000"
    DELETE VALUE)= NO EFFECT
    FIELD)= #265
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^266
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,16),X=X S DIU=X K Y S X=DIV S:(X'="0000000") X=DIU S:(X="0000000") X="0000000" X ^DD(165.5,264,1,2,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,16)=DIV,DIH=165.5,DIG=266 D ^DICR
    2)= Q
    CREATE VALUE)= S:(X'="0000000") X=DIU S:(X="0000000") X="0000000"
    DELETE VALUE)= NO EFFECT
    FIELD)= #266
265 DATE HOSPICE CONSULT COMPLETED PM;15 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAR 06, 2012
  • HELP-PROMPT:  Enter the date the hospice consult was completed.
  • DESCRIPTION:  
    Records the date the hospice consult was created. If NO hospice consult created or DONE, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
    TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
    TRIGGERED by the DATE HOSPICE CONSULT INITIATED field of the ONCOLOGY PRIMARY File
266 DATE HOSPICE CARE INITIATED PM;16 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAR 06, 2012
  • HELP-PROMPT:  Enter the date the patient entered hospice care.
  • DESCRIPTION:  
    Records the date the patient entered hospice care. If there is NO date entered in hospice care or not DONE, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
    TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File
    TRIGGERED by the DATE HOSPICE CONSULT INITIATED field of the ONCOLOGY PRIMARY File
267 EGFR MUTATION TESTING PM;17 SET
  • '0' FOR No testing;
  • '1' FOR EGFR mutation positive, NOS;
  • '2' FOR EGFR mutation negative;
  • '8' FOR NA;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  JUN 19, 2012
  • HELP-PROMPT:  Enter if an Epidermal Growth Factor Receptor (EGFR) mutation test was performed and the results.
  • DESCRIPTION:  
    Records if the Pathology Department performed an EGFR (Epidermal Growth Factor Receptor) mutation test and the results.
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^268
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X="0" I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,18),X=X S DIU=X K Y S X=DIV S X="9" X ^DD(165.5,267,1,1,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,18)=DIV,DIH=165.5,DIG=268 D ^DICR
    2)= Q
    CREATE CONDITION)= INTERNAL(EGFR MUTATION TESTING)="0"
    CREATE VALUE)= "9"
    DELETE VALUE)= NO EFFECT
    FIELD)= #268
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^269
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X="0" I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,19),X=X S DIU=X K Y S X=DIV S X="9" X ^DD(165.5,267,1,2,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,19)=DIV,DIH=165.5,DIG=269 D ^DICR
    2)= Q
    CREATE CONDITION)= INTERNAL(EGFR MUTATION TESTING)="0"
    CREATE VALUE)= "9"
    DELETE VALUE)= NO EFFECT
    FIELD)= #269
268 EGFR MUTATION 1 PM;18 SET
  • '1' FOR Wild type;
  • '2' FOR G719 (exon 18);
  • '3' FOR Exon 19 deletion;
  • '4' FOR Exon 20 insertion;
  • '5' FOR T790M (exon 20);
  • '6' FOR L858R (exon 21);
  • '7' FOR L861Q (exon 21);
  • '8' FOR Other;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 07, 2012
  • HELP-PROMPT:  Enter the first EGFR mutation type.
  • DESCRIPTION:  
    Records the first EGFR (Epidermal Growth Factor Receptor) mutation type.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
    TRIGGERED by the EGFR MUTATION TESTING field of the ONCOLOGY PRIMARY File
269 EGFR MUTATION 2 PM;19 SET
  • '1' FOR Wild type;
  • '2' FOR G719 (exon 18);
  • '3' FOR Exon 19 deletion;
  • '4' FOR Exon 20 insertion;
  • '5' FOR T790M (exon 20);
  • '6' FOR L858R (exon 21);
  • '7' FOR L861Q (exon 21);
  • '8' FOR Other;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 07, 2012
  • HELP-PROMPT:  Enter the second EGFR mutation type.
  • DESCRIPTION:  
    Records the second EGFR (Epidermal Growth Factor Receptor) mutation type.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
    TRIGGERED by the EGFR MUTATION TESTING field of the ONCOLOGY PRIMARY File
270 PREOP OBSTRUCTING LESION PM;13 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA (in situ lesion/non-invasive polyp);
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  SEP 26, 2011
  • HELP-PROMPT:  Enter if a preoperative obstructing lesion was found.
  • DESCRIPTION:  
    Records if a preoperative obstructing lesion was found.
271 ONCOLOGY REFERRAL PM;20 SET
  • '1' FOR Referred;
  • '2' FOR Not referred, no reason stated;
  • '3' FOR Not referred, reason documented in notes;
  • '8' FOR NA (in situ lesion/non-invasive polyp);
  • '9' FOR Unknown if referred;

  • LAST EDITED:  SEP 26, 2011
  • HELP-PROMPT:  Enter if the patient was referred to Oncology.
  • DESCRIPTION:  
    Records if the patient was referred to Oncology.
272 DATE CHEMOTHERAPY RECOMMENDED PM;21 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  APR 24, 2012
  • HELP-PROMPT:  Enter the date on which chemotherapy was recommended.
  • DESCRIPTION:  
    Records the date on which chemotherapy was recommended.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
    TRIGGERED by the INTENT OF CHEMOTHERAPY field of the ONCOLOGY PRIMARY File
273 ANTI-EGFR MoAB THERAPY PM;22 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA (Stage < 4);
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  SEP 27, 2011
  • HELP-PROMPT:  Enter if anti-EFGR MoAB therapy was administered.
  • DESCRIPTION:  
    For metastatic colorectal cancer, records if anti-EGFR (Epidermal Growth Factor Receptor) MoAb (monoclonal antibody) therapy was administered. e.g. Cetuximab/Panitumumab
274 PERIRECTAL LN INVOLVEMENT PM;23 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA (no surgery);
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  SEP 26, 2011
  • HELP-PROMPT:  Enter if perirectal lymph node involvement was indicated.
  • DESCRIPTION:  
    Records the detection of perirectal lymph node involvement.
275 RISK OF RECURRENCE PM;24 SET
  • '1' FOR Low;
  • '2' FOR Medium;
  • '3' FOR High;
  • '8' FOR NA;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  SEP 26, 2011
  • HELP-PROMPT:  Enter the risk of recurrence after treatment value.
  • DESCRIPTION:  
    Records the risk of recurrence after treatment as documented on the Progress Notes.
276 ANDROGEN DEPRIVATION THERAPY PM;25 SET
  • '0' FOR ADT not administered;
  • '1' FOR GnRH/LHRH agonist;
  • '2' FOR Antiandrogen;
  • '3' FOR CYP17 inhibitor;
  • '4' FOR Combination;
  • '5' FOR Orchiectomy;
  • '8' FOR NA;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  DEC 17, 2012
  • HELP-PROMPT:  Enter the type of ADT administered.
  • DESCRIPTION:  Records the type of ADT (Androgen Deprivation Therapy) administered.
    1 GnRH/LHRH agonist
    Goserelin Acetate
    Leuprolide Acetate
    2 Antiandrogen
    Bicalutamide
    Flutamide
    Nilutamide
    3 CYP17 inhibitor
    Abiraterone acetate
    Ketoconazole
    4 Combination
    5 Orchiectomy
277 DATE ADT INITIATED PM;26 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  APR 24, 2012
  • HELP-PROMPT:  Enter the date Androgen Deprivation Therapy was initiated.
  • DESCRIPTION:  
    Records the date on which ADT (Androgen Deprivation Therapy) was initiated.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
278 NON-ADT CHEMOTHERAPY PM;27 SET
  • '0' FOR No non-ADT chemotherapy administered;
  • '1' FOR Docetaxel;
  • '2' FOR Cabazitaxel;
  • '3' FOR Sipuleucel-T;
  • '4' FOR Other;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  SEP 27, 2011
  • HELP-PROMPT:  Enter the type of non-ADT chemotherapy administered.
  • DESCRIPTION:  
    Records whether non-ADT (Androgen Deprivation Therapy) chemotherapy was administered and, if so, what chemotherapeutic agent was used.
279 CLINICAL TRIALS DISCUSSION 25;4 SET
  • '0' FOR NA (Not discussed);
  • '1' FOR With patient;
  • '2' FOR With Tumor Board;
  • '3' FOR With both patient and Tumor Board;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 05, 2011
  • HELP-PROMPT:  Enter if clinical trials were discussed with the patient and/or the Tumor Board.
  • DESCRIPTION:  
    Records if clinical trials were discussed with the patient and/or the Tumor Board.
280 CLIN TNM DOCUMENTATION PRE-TX 25;5 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 16, 2012
  • HELP-PROMPT:  Enter whether this case had a clinical stage documented prior to treatment.
  • DESCRIPTION:  
    Records whether this case had a clinical stage documented prior to treatment.
280.1 CL TNM DOCUMENTATION LOCATION 25;7 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>30!($L(X)<3) X
  • LAST EDITED:  FEB 16, 2012
  • HELP-PROMPT:  Answer must be 3-30 characters in length. Enter the location of pre-treatment clinical stage documentation.
  • DESCRIPTION:  
    Records the location of pre-treatment clinical stage documentation.
280.2 CL TNM DOCUMENTATION DATE 25;8 DATE

  • INPUT TRANSFORM:  S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X
  • LAST EDITED:  FEB 21, 2012
  • HELP-PROMPT:  Enter the date of pre-treatment clinical stage documentation.
  • DESCRIPTION:  
    Records the date of pre-treatment clinical stage documentation.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
281 TX GUIDELINES DISCUSSION 25;6 SET
  • '0' FOR NA (Not eligible);
  • '1' FOR Eligible;
  • '2' FOR Eligible but not discussed;
  • '3' FOR Discussed;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 05, 2011
  • HELP-PROMPT:  Enter if this case was eligible for a treatment guidelines discussion.
  • DESCRIPTION:  
    Records if this case was eligible for a treatment guidelines discussion.
282 VACCR EXTRACT INDICATOR EDITS;3 SET
  • 'N' FOR New;
  • 'U' FOR Update;

  • LAST EDITED:  OCT 19, 2011
  • HELP-PROMPT:  Enter N (New) for newly completed cases. Enter U (Update) for changes to completed cases.
  • DESCRIPTION:  
    Records whether this case has been newly 'Completed' or is an update to an already 'Completed' case.
283 CS FIELD NEEDING REVIEW CS3;3 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>70!($L(X)<1) X
  • LAST EDITED:  NOV 09, 2011
  • HELP-PROMPT:  Answer must be 1-70 characters in length.
  • DESCRIPTION:  
    Records the CS (Collaborative Staging) item(s) which need manual review/recoding by a registrar after the CS conversion.
284 UDF1 25;9 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>10!($L(X)<1) X
  • LAST EDITED:  OCT 22, 2015
  • HELP-PROMPT:  Answer must be 1-10 characters in length.
  • DESCRIPTION:  
    This will be a User Defined Field.
284.1 UDF2 25;10 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>10!($L(X)<1) X
  • LAST EDITED:  OCT 22, 2015
  • HELP-PROMPT:  Answer must be 1-10 characters in length.
  • DESCRIPTION:  
    This will be a User Defined Field.
284.2 UDF3 25;11 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>10!($L(X)<1) X
  • LAST EDITED:  OCT 22, 2015
  • HELP-PROMPT:  Answer must be 1-10 characters in length.
  • DESCRIPTION:  
    This will be a User Defined Field.
284.3 UDF4 25;12 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>10!($L(X)<1) X
  • LAST EDITED:  OCT 22, 2015
  • HELP-PROMPT:  Answer must be 1-10 characters in length.
  • DESCRIPTION:  
    This will be a User Defined Field.
284.4 UDF5 25;13 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>10!($L(X)<1) X
  • LAST EDITED:  OCT 22, 2015
  • HELP-PROMPT:  Answer must be 1-10 characters in length.
  • DESCRIPTION:  
    This will be a User Defined Field.
284.5 UDF6 25;14 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>10!($L(X)<1) X
  • LAST EDITED:  OCT 22, 2015
  • HELP-PROMPT:  Answer must be 1-10 characters in length.
  • DESCRIPTION:  
    This will be a User Defined Field.
284.6 UDF7 25;15 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>10!($L(X)<1) X
  • LAST EDITED:  OCT 22, 2015
  • HELP-PROMPT:  Answer must be 1-10 characters in length.
  • DESCRIPTION:  
    This will be a User Defined Field.
284.7 UDF8 25;16 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>10!($L(X)<1) X
  • LAST EDITED:  OCT 22, 2015
  • HELP-PROMPT:  Answer must be 1-10 characters in length.
  • DESCRIPTION:  
    This will be a User Defined Field.
284.8 UDF9 25;17 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>10!($L(X)<1) X
  • LAST EDITED:  OCT 22, 2015
  • HELP-PROMPT:  Answer must be 1-10 characters in length.
  • DESCRIPTION:  
    This will be a User Defined Field.
284.9 UDF10 25;18 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>10!($L(X)<1) X
  • LAST EDITED:  OCT 22, 2015
  • HELP-PROMPT:  Answer must be 1-10 characters in length.
  • DESCRIPTION:  
    This will be a User Defined Field.
285 TEXT-STAGING 22.1;0 WORD-PROCESSING #165.5285

  • DESCRIPTION:  Text area for information related to the new NAACCR 2018 staging guidelines for the primary site.
  • LAST EDITED:  APR 09, 2018
  • HELP-PROMPT:  Enter any text relating to the staging of the primary.
  • DESCRIPTION:  
    This field will store any text relating to the staging of the primary.
286 TEXT-SITE SPECIFIC DATA ITEMS 22.2;0 WORD-PROCESSING #165.5286

  • DESCRIPTION:  Text area for information related to the Site Specific Data Items (SSDI) for the primary site. The SSDI are a new data item introduced in NAACCR 2018.
  • LAST EDITED:  APR 09, 2018
  • HELP-PROMPT:  Enter text relating to the Site Specific Data items for the primary.
  • DESCRIPTION:  
    This field will store any text relating to the site specific data items for the primary.
287 TEXT-COVID-19 22.3;0 WORD-PROCESSING #165.5287

  • DESCRIPTION:  
    This word-processing field records any notes or descriptions relevant or related to COVID-19 for the patient.
  • LAST EDITED:  FEB 02, 2021
  • HELP-PROMPT:  Enter text relating to the COVID-19 NCDB data items
  • DESCRIPTION:  
    This word-processing field will store any text related to the COVID-19 data items.
288 TOBACCO USE SMOKING STATUS 25;21 SET
  • '0' FOR Never smoker;
  • '1' FOR Current smoker (or if quit within 30 days prior to dx);
  • '2' FOR Former smoker (must have quit 31 days or more prior to dx);
  • '3' FOR Smoker, current status unknown;
  • '9' FOR Unknown if ever smoked;

  • LAST EDITED:  SEP 26, 2023
  • HELP-PROMPT:  Enter a code from the list that corresponds to the smoking status for this patient.
  • DESCRIPTION:  Instructions for Coding (see SEER Program Coding and Staging Manual 2023 for complete instructions) Tobacco smoking history can be obtained from sections such as the Nursing Interview Guide, Flow Chart, Vital Stats or
    Nursing Assessment section, or other available sources from the patient's hospital medical record or physician office record.
    - Record the past or current use of tobacco. Tobacco use includes cigarette, cigar, and/or pipe. - Do not record the patient's past or current use of e-cigarette vaping devices. - Assign code 2 when the medical record
    indicates patient has smoked tobacco in the past but does not smoke now - If there is evidence in the medical record that the patient quit recently (within 30 days prior to diagnosis), assign code 1, current smoker. The 30
    days prior information, if available, is intended to differentiate patients who may have quit recently due to symptoms that lead to a cancer diagnosis. - Assign code 9 when the medical record only indicates "No". This
    data item is for the specific use of tobacco products. Electronic cigarettes are not considered tobacco use as they use liquid nicotine and do not contain tobacco. However, these users may have a history of tobacco use
    that should be considered. Smoking, vaping or consuming products other than tobacco, such as liquid nicotine, CBD or marijuana is not included.
289 TEXT-HIV, SCA, DRUG & ETOH 22.4;0 WORD-PROCESSING #165.5289

  • LAST EDITED:  SEP 26, 2023
  • HELP-PROMPT:  Enter information regarding HIV/AIDS, Sickle Cell Anemia, Drug and Alcohol Abuse.
  • DESCRIPTION:  TEXT-HIV, SCA, DRUG & ETOH is a VA ONLY text field for medical conditions covered by 38 U.S.C. Section 7332, which prohibits the sharing of information regarding HIV/AIDS, Sickle Cell Anemia and Drug and Alcohol abuse
    with outside entities. This optional field is to record relevant information associated with these conditions, if applicable.
300 PATIENT REFERRED FOR TREATMENT BLA1;1 SET
  • '1' FOR Another hospital;
  • '2' FOR Staff physician office;
  • '3' FOR Non-staff physician office;
  • '4' FOR Free standing facility;
  • '5' FOR Other;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    If the patient was referred elsewhere for part or all of the first course of therapy, record the type of facility to which the referral was made.
301 LENGTH OF STAY BLA1;2 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S(Y=888:"Never an inpatient",Y=999:"Unknown",Y=1:Y_" day",1:Y_" days")
  • LAST EDITED:  SEP 06, 1996
  • HELP-PROMPT:  Type a Number between 0 and 999, 0 Decimal Digits
  • DESCRIPTION:  Record the length of stay in days for inpatient cases only. If the patient has multiple inpatient stays, record the length of the admission for the most definitive treatment. If the patient was never an inpatient at your
    institution, record 888. If the length of stay cannot be determined, code as 999 (unknown).
302 HISTORY OF CERVIX CA (PT) BLA1;3 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether cervix cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.
303 HISTORY OF COLON CA (PT) BLA1;4 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether colon cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.
304 HISTORY OF BLADDER CA (PT) BLA1;5 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether bladder cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.
305 HISTORY OF HEAD & NECK CA (PT) BLA1;6 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether head and neck cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.
306 HISTORY OF KIDNEY CA (PT) BLA1;7 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether kidney cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.
307 HISTORY OF PROSTATE CA (PT) BLA1;8 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether prostate cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.
308 HISTORY OF OTHER CA (PT) BLA1;9 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether other cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.
309 HISTORY OF BLADDER CA (FAM) BLA1;10 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record any familial history of bladder cancer documented in the medical record. If the record does not mention familial history of bladder cancer, code 9 (unknown).
310 HISTORY OF COLON CA (FAM) BLA1;11 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record any familial history of colon cancer documented in the medical record. If the record does not mention familial history of colon cancer, code 9 (unknown).
311 HISTORY OF LUNG CA (FAM) BLA1;12 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record any familial history of lung cancer documented in the medical record. If the record does not mention familial history of lung cancer, code 9 (unknown).
312 HISTORY OF PROSTATE CA (FAM) BLA1;13 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record any familial history of prostate cancer documented in the medical record. If the record does not mention familial history of prostate cancer, code 9 (unknown).
313 HISTORY OF OTHER CA (FAM) BLA1;14 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record any familial history of other cancer documented in the medical record. If the record does not mention familial history of other cancer, code 9 (unknown).
314 SMOKING HISTORY BLA1;15 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S(Y=0:"Never smoked",$L(Y)=1:"0"_Y,Y=98:"98 Currently does not smoke, but did previously",Y=99:"99 Unknown",1:Y)
  • LAST EDITED:  APR 24, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record the actual number of packs of cigarettes smoked per day. A zero must precede single-digit packs. If one or less packs per day are smoked, code as 01. If the patient was never a smoker, code 00. If the patient
    currently does not smoke, but did previously, code as 98. If the medical record does not mention tobacco use, code as 99 (unknown).
315 DURATION OF SMOKING HISTORY BLA1;16 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S(Y=0:"Never smoked",$L(Y)=1:"0"_Y_" years",Y=98:"Currently does not smoke, but did previously",Y=99:"Unknown",1:Y_" years")
  • LAST EDITED:  SEP 06, 1996
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  
    Record the number of years the patient has smoked. A zero must precede single-digit years. If the patient never smoked, code 00. If the medical record does not mention duration of years, code 99 (unknown).
316 DURATION OF SMOKE FREE HISTORY BLA1;17 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S(Y=0:"Never smoked",Y=88:"Not applicable",Y=99:"Unknown",Y=1:Y_" year",1:Y_" years")
  • LAST EDITED:  SEP 06, 1996
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  If the patient was a previous smoker and no longer smokes, record the number of years since his/her last cigarette. A zero must precede single- digit years. If the patient never smoked, code 00. If the patient never
    stopped smoking code 88 (not applicable). If the duration is unknown, code 99 (unknown).
317 GROSS HEMATURIA BLA1;18 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the patient was presented with a clinical finding of gross hematuria. If not present, code 0 (no).
318 MICROSCOPIC HEMATURIA BLA1;19 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the patient was presented with a clinical finding of microscopic hematuria. If not present, code 0 (no).
319 URINARY FREQUENCY BLA1;20 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the patient was presented with a clinical finding of urinary frequency. If not present, code 0 (no).
320 BLADDER IRRITABILITY BLA1;21 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the patient was presented with a clinical finding of bladder irritability. If not present, code 0 (no).
321 DYSURIA BLA1;22 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the patient was presented with a clinical finding of dysuria. If not present, code 0 (no).
322 OTHER CLINICAL DETECTIONS BLA1;23 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the patient was presented with other clinical findings. If not present, code 0 (no).
323 ONSET OF SYMPTOMS BLA1;24 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) W !,"Future dates are not allowed"
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  OCT 15, 1997
  • DESCRIPTION:  Record the date (mm/dd/ccyy) on which the symptoms were noted to begin. If the patient did not experience any symptoms, or if the documentation of symptoms was not recorded, enter date as 00/00/0000. If symptoms were
    present, but date of onset was unknown, record date as 99/99/9999.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
324 DURATION OF GROSS HEMATURIA BLA1;25 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S(Y=0:"Symptoms not present",Y=1:Y_" month",Y=99:"Unknown",1:Y_" months")
  • LAST EDITED:  SEP 06, 1996
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  
    Record the duration (in months) of the patient's symptoms of gross hematuria prior to the diagnosis of cancer. If symptoms were not present, code 00. If symptoms were present and the duration unknown, code 99.
325 DURATION OF DYSURIA BLA1;26 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S(Y=0:"Symptoms not present",Y=1:Y_" month",Y=99:"Unknown",1:Y_" months")
  • LAST EDITED:  SEP 06, 1996
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  
    Record the duration (in months) of the patient's symptoms of dysuria prior to the diagnosis of cancer. If symptoms were not present, code 00. If symptoms were present and the duration unknown, code 99.
326 BIMANAUL EXAM OF BLADDER BLA1;27 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  SEP 18, 1996
  • DESCRIPTION:  
    Record whether a bimanual examination of the bladder was used to diagnose the bladder cancer. If the procedure was not performed, code 0 (not done).
327 CYSTOSCOPY WITH BIOPSY BLA1;28 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  SEP 18, 1996
  • DESCRIPTION:  
    Record whether a cystoscopy with biopsy was used to diagnose the bladder cancer. If the procedure was not performed, code 0 (not done).
328 CYSTOSCOPY WITHOUT BIOPSY BLA1;29 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  SEP 18, 1996
  • DESCRIPTION:  
    Record whether a cystoscopy without biopsy was used to diagnose the bladder cancer. If the procedure was not performed, code 0 (not done).
329 FLOW CYTOMETRY BLA1;30 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  SEP 18, 1996
  • DESCRIPTION:  
    Record whether a flow cytometry was used to diagnose this cancer. If the procedure was not performed, code 0 (not done).
330 INTRAVENOUS PYELOGRAM (BLA) BLA1;31 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record whether an intravenous pyelogram was used to diagnose the bladder cancer. If the procedure was not performed, code 0 (not done).
331 URINE CYTOLOGY BLA1;32 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  SEP 18, 1996
  • DESCRIPTION:  
    Record whether a urine cytology was used to diagnose the bladder cancer. If the procedure was not performed, code 0 (not done).
332 URINALYSIS BLA1;33 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  SEP 18, 1996
  • DESCRIPTION:  
    Record whether a urinalysis was used to diagnose the bladder cancer. If the procedure was not performed, code 0 (not done).
333 OTHER DIAGNOSTIC PROCEDURES BLA1;34 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  SEP 18, 1996
  • DESCRIPTION:  
    Record whether other diagnostic procedures were used to diagnose the bladder cancer. If no other procedure was performed, code 0 (not done).
334 SPECIALTY MAKING DIAGNOSIS BLA1;35 SET
  • '0' FOR Internal Medicine;
  • '1' FOR Family Practice;
  • '2' FOR General Surgeon;
  • '3' FOR Surgical Oncologist;
  • '4' FOR Urologist;
  • '5' FOR Urologic Oncologist;
  • '6' FOR Medical Oncologist;
  • '7' FOR Radiation Oncologist;
  • '8' FOR Other;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Provide the specialty of the practitioner (other than the pathologist) who diagnosed this case of bladder cancer.
335 ABDOMINAL ULTRASOUND BLA1;36 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether an abdominal ultrasound procedure was performed to stage this case.
336 BONE IMAGING BLA1;37 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether a bone imaging procedure was performed to stage this case.
337 CHEST X-RAY (BLADDER) BLA1;38 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether a chest x-ray was performed to stage this case.
338 CT CHEST/LUNG BLA1;39 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether a CT chest/lung procedure was performed to stage this case.
339 CT ABDOMEN/PELVIS BLA1;40 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether a CT abdomen/pelvis procedure was performed to stage this case.
340 CT OTHER BLA1;41 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether other CT procedures were performed to stage this case.
341 MRI PELVIS/ABDOMEN BLA1;42 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether an MRI pelvis/abdomen procedure was performed to stage this case.
342 MRI OTHER BLA1;43 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether other MRI procedures were performed to stage this case.
343 OTHER STAGING PROCEDURES BLA1;44 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether other staging procedures were performed to stage this case.
344 PRESENCE OF HYDRONEPHROSIS BLA1;45 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the patient was noted at any time to have hydronephrosis. If the medical record does not mention hydronephrosis, code as 9 (unknown).
345 PRESENCE OF MULTIPLE TUMORS BLA1;46 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the presence of multiple primary bladder tumors was detected either clinically or pathologically.
346 PROTOCOL ELIGIBILITY STATUS BLA2;1 SET
  • '0' FOR Not available;
  • '1' FOR On protocol;
  • '2' FOR Ineligible (age,stage,etc.);
  • '3' FOR Ineligible (comorbidity, preexist cond);
  • '4' FOR Entered but withdrawn;
  • '6' FOR Eligible, not entered;
  • '7' FOR Eligible, refused;
  • '8' FOR Not recommended;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 22, 1997
  • DESCRIPTION:  
    Record the eligibility status of the patient to be entered into a protocol. Analysis of protocol eligibility status assists program planning.
347 MANAGING PHYSICIAN (PRIMARY) BLA2;2 POINTER TO BLADDER PHYSICIAN SPECIALTY FILE (#166.12) BLADDER PHYSICIAN SPECIALTY(#166.12)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(166.12,+Y,0)),"^",2)
  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record the specialty of the primary-care physician who managed the patient upon discharge. If it cannot be determined who the primary managing physician is, code 99 (unknown).
348 MANAGING PHYSICIAN (SECONDARY) BLA2;3 POINTER TO BLADDER PHYSICIAN SPECIALTY FILE (#166.12) BLADDER PHYSICIAN SPECIALTY(#166.12)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(166.12,+Y,0)),"^",2)
  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record the specialty of the secondary-care physician who managed the patient upon discharge. If it cannot be determined who the secondary managing physician is, code 99 (unknown).
349 TUMOR RESECTION DURING TURB BLA2;4 SET
  • '1' FOR Visibly complete resection;
  • '2' FOR Visibly incomplete resection;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  For all bladder cases undergoing a transurethral resection of the bladder (code 10) for the first course of treatment, record whether or not a tumor was grossly visible or not after resection. This information should be
    found in the operative report. For primary tumors of the prostatic utricle (C68.0), code 8 (not applicable).
350 TYPE OF URINARY DIVERSION BLA2;5 SET
  • '1' FOR Ileoconduit;
  • '2' FOR Continent cutaneous;
  • '3' FOR Neobladder;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  If cancer-directed surgery codes 20-70 are reported, code the type of urinary diversion performed. This information should be found in the operative report. For primary tumors of the prostatic utricle (C68.0), code 8
    (not applicable).
351 PELVIC LYMPH NODE DISSECT (BL) BLA2;6 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  If cancer-directed surgery code 70 is reported, code whether a pelvic lymph node dissection for radical surgery was performed. This information should be obtained from the operative and pathology reports. If the patient
    had a type of cancer-directed surgery other than a code 70, code 8 (not applicable).
352 BLEEDING REQUIRING TRANSFUSION BLA2;7 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).
353 DEEP VENOUS THROMBOSIS BLA2;8 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).
354 MYOCARDIAL INFARCTION (MI) BLA2;9 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 2000
  • DESCRIPTION:  This field describes a patient's prior medical condition.
355 PELVIC ABSCESS BLA2;10 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).
356 PNEUMONIA REQ ANTIBIOTICS BLA2;11 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).
357 POST-OPERATIVE DEATH BLA2;12 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).
358 PULMONARY EMBOLISM/THROMBOSIS BLA2;13 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).
359 REOPERATION BLA2;14 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).
360 OTHER SURGICAL COMPLICATIONS BLA2;15 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, surgery not performed;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 27, 2000
  • DESCRIPTION:  This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.
361 DATE RADIATION ENDED BLA2;16 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  MAR 31, 2000
  • HELP-PROMPT:  *** DATE RADIATION ENDED MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  The date on which the patient completes or receives the last radiation treatment at any facility.
    For further information see FORDS pages 166-167.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
362 TOTAL RAD (cGy/rad) DOSE BLA2;17 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
  • LAST EDITED:  AUG 29, 1996
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  Record the total external rad dose and brachytherapy dosage given to all sites treated, including boost dosage. If the patient did not receive radiation therapy, code 00000. If it is known that the patient received
    radiation therapy but the amount is unknown, code 99999.
363 REGIONAL TREATMENT MODALITY BLA2;18 POINTER TO REGIONAL TREATMENT MODALITY FILE (#166.13) REGIONAL TREATMENT MODALITY(#166.13)

  • INPUT TRANSFORM:  S DIC("S")="I ((+$P(^(0),U,1)<1)!(+$P(^(0),U,1)>16)),(($P(^ONCO(165.5,DA,0),U,16)<3030101)!((Y'=46)&(Y'=47)))" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(166.13,+Y,0)),U,2)
  • LAST EDITED:  NOV 22, 2004
  • DESCRIPTION:  Records the dominant modality of radiation therapy used to deliver the most clinically significant regional dose to the primary volume of interest during the first course of treatment.
    For further information see FORDS pages 155-157.
  • SCREEN:  S DIC("S")="I ((+$P(^(0),U,1)<1)!(+$P(^(0),U,1)>16)),(($P(^ONCO(165.5,DA,0),U,16)<3030101)!((Y'=46)&(Y'=47)))"
  • EXPLANATION:  Codes 01-16 have been discontinued. Codes 80 and 85 are prohibited for 2003+ cases.
363.1 BOOST TREATMENT MODALITY 24;9 POINTER TO REGIONAL TREATMENT MODALITY FILE (#166.13) REGIONAL TREATMENT MODALITY(#166.13)

  • INPUT TRANSFORM:  S DIC("S")="I (+$P(^(0),U,1)<1)!(+$P(^(0),U,1)>16)" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X I $D(X) S V=1 D NT^ONCODSR
  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(166.13,+Y,0)),U,2)
  • LAST EDITED:  JAN 09, 2003
  • DESCRIPTION:  Records the dominant modality of radiation therapy used to deliver the most clinically significant boost dose to the primary volume of interest during the first course of treatment. This is accomplished with external
    beam fields of reduced size (relative to the regional treatment fields), implants, stereotactic radiosurgery, conformal therapy, or IMRT. External beam boosts may consist of two or more successive phases with
    progressively smaller fields generally coded as a single entry.
    For further information see FORDS pages 159-161.
  • SCREEN:  S DIC("S")="I (+$P(^(0),U,1)<1)!(+$P(^(0),U,1)>16)"
  • EXPLANATION:  ROADS codes 01-16 have been discontinued.
364 URINARY INCONTINENCE BLA2;19 SET
  • '0' FOR None;
  • '1' FOR Yes;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the patient experienced any urinary incontinence as a result of radiation therapy. If the patient did not receive radiation therapy, code 8 (not applicable).
365 HEMATURIA BLA2;20 SET
  • '0' FOR None;
  • '1' FOR Yes;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the patient experienced any hematuria as a result of radiation therapy. If the patient did not receive radiation therapy, code 8 (not applicable).
366 RADIATION BOWEL INJURY BLA2;21 SET
  • '0' FOR None;
  • '1' FOR Yes;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the patient experienced a radiation bowel injury as a result of radiation therapy. If the patient did not receive radiation therapy, enter 8 (not applicable).
367 DATE CHEMOTHERAPY ENDED BLA2;22 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  APR 03, 1997
  • HELP-PROMPT:  *** DATE CHEMOTHERAPY ENDED MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Record the date on which the entire first course of chemotherapy was completed. If chemotherapy was not given, code date as 00/00/0000.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
368 ROUTE CHEMOTHERAPY ADMIN BLA2;23 SET
  • '0' FOR No chemotherapy;
  • '1' FOR Systemic;
  • '2' FOR Intravesicle;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record the route by which the chemotherapy was administered. If the patient did not receive chemotherapy, code 0 (no chemotherapy).
369 ADRIAMYCIN BLA2;24 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the chemotherapeutic agent, Adriamycin, was given. If no chemotherapy was given, code as 0 (no).
370 CARBOPLATINUM BLA2;25 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the chemotherapeutic agent, Carboplatinum, was given. If no chemotherapy was given, code as 0 (no).
371 CISPLATIN BLA2;26 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
372 CYCLOPHOSPHAMIDE BLA2;27 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
373 5-FLUOROURACIL BLA2;28 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the chemotherapeutic agent, 5-fluorouracil, was given. If no chemotherapy was given, code as 0 (no).
374 GALLIUM NITRATE BLA2;29 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the chemotherapeutic agent, Gallium Nitrate, was given. If no chemotherapy was given, code as 0 (no).
375 IFOSFAMIDE BLA2;30 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record whether the chemotherapeutic agent, Ifosfamide, was given. If no chemotherapy was given, code as 0 (no).
376 METHOTREXATE BLA2;31 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
377 TAXOL BLA2;32 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the chemotherapeutic agent, Taxol, was given. If no chemotherapy was given, code as 0 (no).
378 THIOTEPA BLA2;33 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the chemotherapeutic agent, Thiotepa, was given. If no chemotherapy was given, code as 0 (no).
379 VINBLASTINE BLA2;34 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the chemotherapeutic agent, Vinblastine, was given. If no chemotherapy was given, code as 0 (no).
380 OTHER CHEMOTHERAPEUTIC AGENTS BLA2;35 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, no chemotherapy administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
381 INDICATION FOR ADMIN OF AGENTS BLA2;36 SET
  • '0' FOR No agents administered, NA;
  • '1' FOR Metastatic disease;
  • '2' FOR Adjuvant therapy;
  • '3' FOR Neoadjuvant therapy;
  • '8' FOR Other;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record the reason for chemotherapy. If the patient never received chemotherapy, code 0 (no agents administered, na).
382 REASON CHEMOTHERAPY STOPPED BLA2;41 SET
  • '0' FOR Treatment completed, NA;
  • '1' FOR Complications;
  • '2' FOR Disease progression;
  • '3' FOR Recommended but medically contraindicated;
  • '8' FOR Other;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • HELP-PROMPT:  Enter the reason chemotherapy treatment was discontinued.
  • DESCRIPTION:  
    Record the reason chemotherapy was discontinued. If therapy ended when treatment was complete, or if the patient never received chemotherapy, code 0 (treatment completed, NA).
  • NOTES:  TRIGGERED by the CHEMOTHERAPY RECOMMENDED field of the ONCOLOGY PRIMARY File
    TRIGGERED by the INTENT OF CHEMOTHERAPY field of the ONCOLOGY PRIMARY File
383 BCG BLA2;37 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 1999
  • DESCRIPTION:  
    Record whether BCG immunotherapy was administered for the first course of therapy.
384 INTERFERON BLA2;38 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
385 INTERLEUKIN-2 BLA2;39 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 1999
  • DESCRIPTION:  
    Record whether Interleukin-2 immunotherapy was administered for the first course of therapy.
  • SCREEN:  S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"
  • EXPLANATION:  Code 8 should not be used for cases with a DATE DX < 1/1/1999
386 OTHER TYPE OF IMMUNOTHERAPY BLA2;40 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 1999
  • DESCRIPTION:  
    Record whether other immunotherapy was administered for the first course of therapy.
  • SCREEN:  S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"
  • EXPLANATION:  Code 8 should not be used for cases with a DATE DX < 1/1/1999
387 TYPE OF 1ST RECURRENCE/BLADDER BLA2;42 SET
  • '0' FOR No recurrence;
  • '1' FOR Bladder, superficial;
  • '2' FOR Bladder, muscle invasion;
  • '3' FOR Bladder, NOS;
  • '4' FOR Pelvis;
  • '5' FOR Distant;
  • '8' FOR Never disease-free;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  Record the type of the first recurrence. "Pelvic recurrence" is tumor that has invaded any of the following sites: prostate, uterus, vagina, pelvic wall, or abdominal wall. "Distant recurrence" occurs in a site
    considered distant from the organ or origin as presented in most staging schemes.
400 HISTORY OF THYROID CA (FAM) THY1;1 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 10, 1997
  • DESCRIPTION:  
    Record any familial history of thyroid cancer documented in the medical record. If the record does not mention familial history of thyroid cancer, code 9 (unknown).
401 HISTORY OF LYMPHOMA (PT) THY1;2 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the patient has a history of Lymphoma, including Hodgkin's Disease.
402 HISTORY OF CHILDHOOD MALIG THY1;3 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record whether the patient has a history of childhood malignancies, other than lymphoma.
403 PRIOR EXPOSURE TO RADIATION THY1;4 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  This field describes a patient's known prior radiation exposure. Exposure to fluoroscopy, exposure to radioactive isotopes, or actual radiation treatments should be considered prior radiation exposure. Do not consider
    routine chest or dental x-rays as prior radiation exposure.
404 HISTORY OF GOITER (PT) THY1;5 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record history of enlarged thyroid gland for a period of greater than 5 years prior to diagnosis.
405 HISTORY OF GOITER (FAM) THY1;6 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record any familial history of thyroid enlargement (goiter), Graves Disease or thyroiditis.
406 HISTORY OF GRAVES DISEASE (PT) THY1;7 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the patient has a history of Graves Disease, i.e., autoimmune hyperthyroidism with or withour eye symptoms.
407 HISTORY OF THYROIDITIS (PT) THY1;8 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the patient has a history of Hashimoto's thyroiditis or any other type of thyroiditis. Thyroiditis is often associated with hypothyroidism.
408 DYSPHAGIA THY1;9 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the sign/symptom 'DYSPHAGIA' was present at the time of diagnosis.
409 HOARSENESS OR VOICE CHANGE THY1;10 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the sign/symptom 'HOARSENESS OR VOICE CHANGE' was present at the time of diagnosis.
410 NECK NODAL MASS THY1;11 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the sign/symptom 'NECK NODAL MASS' was present at the time of diagnosis.
411 PAIN, BONE THY1;12 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the sign/symptom 'PAIN, BONE' was present at the time of diagnosis.
412 PAIN, NECK THY1;13 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the sign/symptom 'PAIN, NECK' was present at the time of diagnosis.
413 PATHOLOGIC FRACTURE THY1;14 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the sign/symptom 'PATHOLOGIC FRACTURE' was present at the time of diagnosis.
414 STRIDOR/DIFFICULTY BREATHING THY1;15 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the sign/symptom 'STRIDOR OR DIFFICULTY BREATHING' was present at the time of diagnosis.
415 THYROID MASS THY1;16 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the sign/symptom 'THYROID MASS' was present at the time of diagnosis.
416 WEIGHT LOSS THY1;17 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the sign/symptom 'WEIGHT LOSS' was present at the time of diagnosis.
417 OTHER SIGNS/SYMPTOMS THY1;18 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether any OTHER signs/symptoms were present at the time of diagnosis.
418 BONE SCAN (THYROID) THY1;19 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic/Surgical Work-up 'BONE SCAN', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
419 CHEST X-RAY (THYROID) THY1;20 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic/Surgical Work-up 'CHEST X-RAY', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
420 CT SCAN OF NECK (THYROID) THY1;21 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic/Surgical Work-up 'CT SCAN OF NECK', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
421 CT SCAN OF CHEST THY1;22 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic/Surgical Work-up 'CT SCAN OF CHEST', if it was performed to evaluate this cancer. If this test was not done record a '0'.
422 INCISIONAL BIOPSY OF THYROID THY1;23 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic/Surgical Work-up 'INCISIONAL BIOPSY OF THYROID', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
423 LARYNGOSCOPY THY1;24 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic/Surgical Work-up 'LARYNGOSCOPY', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
424 NECK X-RAY (AP & LATERAL) THY1;25 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic/Surgical Work-up 'NECK X-RAY (AP & LATERAL)', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
425 NEEDLE ASPIRATION OF NECK NODE THY1;26 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic/Surgical Work-up 'NEEDLE ASPIRATION OF NECK NODE', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
426 NEEDLE ASPIRATION OF THYROID THY1;27 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic/Surgical Work-up 'NEEDLE ASPIRATION OF THYROID', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
427 MRI OF NECK THY1;28 SET
  • '0' FOR Test not donw;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic/Surgical Work-up 'MRI OF NECK', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
428 THYROID SCAN THY1;29 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic/Surgical Work-up 'THYROID SCAN', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
429 ULTRASOUND OF THYROID THY1;30 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic/Surgical Work-up 'ULTRASOUND OF THYROID', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.
430 OTHER DIAGNOSTIC/SURGICAL TEST THY1;31 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if other test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of any OTHER Diagnostic/Surgical Work-ups done, if any were performed to evaluate this Thyroid cancer. If other test were not done record a '0'.
431 BLOOD VESSEL INVASION THY1;32 SET
  • '0' FOR No invasion;
  • '1' FOR Yes;
  • '8' FOR No surgery, not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  Record the presence of blood vessel invasion. NOTE: This refers to the presence of tumor cells inside blood vessels of a caliber larger than capil- laries, located in the tumor capsule or beyond. The tumor cells should
    be attached to the vessel wall.
432 EXTRA-THYROIDAL EXTENSION THY1;33 SET
  • '0' FOR No extension;
  • '1' FOR Esophagus;
  • '2' FOR Trachea;
  • '3' FOR Larynx;
  • '4' FOR Strap muscles;
  • '5' FOR Soft tissue;
  • '6' FOR Multiple sites;
  • '7' FOR Extension, NOS;
  • '8' FOR Not applicable, no surgery;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record any gross or microscopic extension beyond thyroid capsule. NOTE: Do not code invasion of the tumor capsule around a follicular cancer as an extra-thyroidal extension.
433 MULTIFOCAL THY1;34 SET
  • '0' FOR No;
  • '1' FOR Microscopic;
  • '2' FOR Gross;
  • '3' FOR Multifocal, NOS;
  • '9' FOR Unknown;

  • LAST EDITED:  AUG 29, 1996
  • DESCRIPTION:  
    Record whether the tumor was multifocal. Pathologic confirmation is required.
434 LOCATION OF POSITIVE NODES THY1;35 SET
  • '0' FOR No positive nodes;
  • '1' FOR Perithyroid only;
  • '2' FOR Lateral neck only;
  • '3' FOR Mediastinum only;
  • '4' FOR Multiple regions;
  • '5' FOR Other;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  AUG 29, 1996
  • DESCRIPTION:  
    Record the location of regional nodes if they are positive.
435 DATE MOST DEFINITIVE SURG DIS THY1;36 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  APR 29, 2013
  • HELP-PROMPT:  Enter the date the patient was discharged following primary site surgery.
  • DESCRIPTION:  Source of Standard: NAACCR Item #: 3180 This is the date the patient was discharged following primary site surgery. The date must be after or equal to the DATE DX (#3) field. The date corresponds to the event recorded
    in SURGERY OF PRIMARY (F) (#58.6) and MOST DEFINITIVE SURG DATE (#50) fields.
    For further information see FORDS pages 144-145.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
436 AIRWAY PROBLEM THY1;37 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'AIRWAY PROBLEM REQUIRING TRACHEOSTOMY', which resulted from cancer-directed surgery. If no cancer-directed surgery was performed, code 8 (not applicable).
437 BLEEDING/HEMATOMA THY1;38 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'BLEEDING HEMATOMA', which resulted from cancer-directed surgery. If no cancer-directed surgery was performed, code 8 (not applicable).
438 HYPOCALCEMIA THY1;39 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'HYPOCALCEMIA (NEEDS ORAL CALCIUM', which resulted from cancer-directed surgery. If no cancer- directed surgery was performed, code 8 (not applicable).
439 RECURRENT NERVE INJURY THY1;40 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'RECURRENT NERVE INJURY (OR VOCAL CORD PARESIS)', which resulted from cancer-directed surgery. If no cancer-directed surgery was performed, code 8 (not applicable).
440 WOUND INFECTION THY1;41 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'WOUND INFECTION', which resulted from cancer-directed surgery. If no cancer-directed surgery was performed, code 8 (not applicable).
441 POSTOPERATIVE DEATH THY1;42 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR Not applicable, no surgery;
  • '9' FOR Unknown;

  • LAST EDITED:  AUG 30, 1996
  • DESCRIPTION:  
    Record operative death occurring within 30 days of the cancer-directed surgery. If no cancer-directed surgery was performed, code 8 (not applicable).
442 REGIONAL DOSE: cGy THY1;43 NUMBER

  • INPUT TRANSFORM:  K:X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X I $D(X) S V=0 D NT^ONCODSR I $D(X) S ONCL=5 D RDIT^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="00000":"Radiation tx not administered",Y=88888:"NA, brachytherapy/radioisotopes administered",Y=99999:"Dose unknown/unknown if administered",1:Y)
  • LAST EDITED:  JAN 09, 2003
  • HELP-PROMPT:  Type a Number between 0 and 99999
  • DESCRIPTION:  Records the dominant or most clinically significant total dose of regional radiation therapy delivered to the patient during the first course of treatment. The unit of measure is centiGray (cGy).
    Code 88888 (NA, brachytherapy/radioisotopes administered) if not applicable or when brachytherapy or radioisotopes were administered to the patient.
    For further information see FORDS page 248.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
443 BOOST DOSE: cGy THY1;44 NUMBER

  • INPUT TRANSFORM:  K:X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X I $D(X) S V=0 D NT^ONCODSR I $D(X) S ONCL=5 D RDIT^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="00000":"Boost tx not administered",Y=88888:"NA, brachytherapy/radioisotopes administered",Y=99999:"Dose unknown/unknown if administered",1:Y)
  • LAST EDITED:  FEB 21, 2003
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  Records the additional boost dosage delivered to that part of the treatment volume encompassed by the boost fields or devices. The unit of measure is centiGray (cGy).
    Code 88888 (NA, brachytherapy/radioisotopes administered) if not applicable or when brachytherapy or radioisotopes were administered to the patient.
    For further information see FORDS page 252.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
444 INITIAL DOSE OF RADIOIODINE THY1;45 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
  • LAST EDITED:  SEP 03, 1996
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  
    Record the total Millicuries (mCi) of radioiodine given as part of initial therapy, whether for the purpose of ablation or therapy. If none received, code 00000. If unknown, code 99999.
445 SECOND DOSE OF RADIOIODINE THY1;46 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
  • LAST EDITED:  SEP 03, 1996
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  
    Record the total Millicuries (mCi) of radioiodine given as second dose within the next 6 months after date of diagnosis. If none received, code 00000. If unknown, code 99999.
446 ADJUVANT CHEMOTHERAPY (THY) THY1;47 SET
  • '0' FOR No concomitant treatment;
  • '1' FOR Radiation treatment and concomitant adjuvant chemotherapy;
  • '9' FOR Unknown if therapy concomitant;

  • LAST EDITED:  FEB 21, 1997
  • DESCRIPTION:  Record the Adjuvant Chemotherapy with Concomitant External Beam Radiation. If patient receives chemotherapy at any time during radiation as a radio- sensitizing agent, code 1. If chemotherapy is stopped more than 2 days
    prior to radiation therapy and not given until external beam therapy is completed, code 0. If unknown, code 9.
500 HISTORY OF SOFT TIS SARC (FAM) STS1;1 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record any familial history of soft tissue sarcoma documented in the medical record. If the record does not mention familial history of soft tissue sarcoma, code 9 (unknown).
501 HISTORY OF ANY CANCER (PT) STS1;2 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record the personal history of any cancer documented in the medical record. If the record does not mention personal history of any cancer, code 9 (unknown).
502 ANGIOGRAM OF PRIMARY STS1;3 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 24, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic Workup 'Angiogram for Primary', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
503 BONE MARROW ASPIRATE OR BIOPSY STS1;4 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 06, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic Workup 'Bone marrow aspirate and/or Biopsy', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
504 BONE SCAN (SOFT TIS SARCOMA) STS1;5 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic Workup 'Bone scan', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
505 CHEST X-RAY (STS/NHL) STS1;6 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 18, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Workup 'Chest X-RAY', if it was performed to evaluate this primary. If this test was not done, record a '0'.
506 CT SCAN OF CHEST (STS) STS1;7 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic Workup 'CT scan of chest', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
507 CT SCAN OF PRIMARY STS1;8 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic Workup 'CT scan of primary', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
508 LIVER FUNCTION STUDIES (STS) STS1;9 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 20, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Workup 'Liver Function Studies', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
509 LYMPHANGIOGRAM STS1;10 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic Workup 'Lymphangiogram', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
510 MRI OF PRIMARY STS1;11 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic Workup 'MRI of primary', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
511 MRI OF OTHER STS1;12 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic Workup 'MRI of other', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
512 SKELETAL X-RAY STS1;13 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic Workup 'Skeletal X-RAY', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
513 SONOGRAM STS1;14 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record the results of the Diagnostic Workup 'Sonogram', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
514 CYTOGENETICS STS1;15 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the 'Cytogenetics' test was performed to evaluate this primary. If this test was not done, record a '0'.
515 ELECTRON MICROSCOPY STS1;16 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the Histologic Workup 'Electron microscopy' was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
516 IMMUNOHISTOCHEMISTRY STS1;17 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the 'Immunohistochemistry/Tumor Surface Marker' test was performed to evaluate this primary. If this test was not done, record a '0'.
517 IN SITU HYBRIDIZATION STS1;18 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  SEP 09, 1996
  • DESCRIPTION:  
    Record whether the Histologic Workup 'In situ hybridization' was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.
518 OUTSIDE CONFIRMATION REQUESTED STS1;19 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 10, 1996
  • DESCRIPTION:  
    Record whether an outside confirmation of a biopsy was requested.
519 SUBSITE STS1;20 POINTER TO ONCOLOGY SUBSITE FILE (#166.3) ONCOLOGY SUBSITE(#166.3)

  • LAST EDITED:  SEP 10, 1996
  • DESCRIPTION:  
    Record the appropriate subsite code.
520 TYPE OF ADDITIONAL CODING SYS STS1;21 SET
  • '1' FOR 1 to 3 system;
  • '2' FOR 1 to 2 or high/low system;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 10, 1996
  • DESCRIPTION:  If your institution uses an additional grade coding system, record the additional system that is used. Code '1' if the coding system is a 1 to 3 scale. Code '2' if the coding system is a 1 to 2 or high/low scale. If not
    applicable code '8', and if unknown, code '9'.
521 VALUE OF ADDITIONAL CODING SYS STS1;22 SET
  • '1' FOR 1;
  • '2' FOR 2;
  • '3' FOR 3;
  • '5' FOR Low;
  • '6' FOR High;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 10, 1996
  • DESCRIPTION:  
    Enter the numeric (1,2 or 3) value from the additional coding system. If code is 'low', code '5'; if code is 'high', code 6. If not applicable code '8', and if unknown, code '9'.
522 PATHOLOGIC SIZE OF TUMOR STS1;23 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y)
  • LAST EDITED:  SEP 24, 1996
  • HELP-PROMPT:  Type a Number between 0 and 999, 0 Decimal Digits
  • DESCRIPTION:  Record the largest diameter of the primary tumor in milimeters (1 cm = 10 mm) as specified in the pathology report. If there is more than one tumor in the same primary site (multifocal), record the largest diameter of the
    largest tumor. Do not use size of the entire specimen for tumor size. In cases where the tumor diameter is not specified in the pathology report, size of tumor should be obtained from the operative report, followed by
    x-rays, or physical examinations.
523 DEPTH OF TUMOR STS1;24 SET
  • '1' FOR Superficial (above muscle fascia);
  • '2' FOR Deep (all else);
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 10, 1996
  • DESCRIPTION:  
    Tumor depth is applicable for extremity, trunk and head and neck lesions. Code 8 if not applicable and 9 if unknown.
524 CONSULTATIONS (MED ONCOLOGIST) STS1;25 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 10, 1996
  • DESCRIPTION:  
    Enter whether there was a consultation with a medical oncologist.
525 CONSULTATIONS (RAD ONCOLOGIST) STS1;26 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 10, 1996
  • DESCRIPTION:  
    Enter whether there was a consultation with a radiation oncologist.
526 TREATING SURGEON STS2;1 SET
  • '1' FOR General surgeon;
  • '2' FOR Orthopedic surgeon;
  • '3' FOR Urologist;
  • '4' FOR Gynecologist;
  • '5' FOR ENT (ear, nose and throat);
  • '6' FOR Other;
  • '8' FOR Not applicable, no surgery;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 10, 1996
  • DESCRIPTION:  
    Record the appropriate code for the type of treating surgeon.
527 ASA CLASS STS2;2 SET
  • '1' FOR No systemic disturbance;
  • '2' FOR Mild to moderate systemic disturbance;
  • '3' FOR Severe systemic disturbance;
  • '4' FOR Life-threatening disturbance;
  • '5' FOR Moribund with little chance of survival;
  • '9' FOR Class unknown or not applicable;

  • LAST EDITED:  SEP 20, 1996
  • DESCRIPTION:  
    Record appropriate code from anesthesiologist's report. If no organic, physiologic, biochemical or psychiatric disturbance, code 1. If not recorded or if the patient did not receive surgery, code 9.
528 FINE NEEDLE ASPIRATION STS1;27 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>999999)!(X<0)!(X?.E1"."1N.N)!($L(X)<6) X
  • OUTPUT TRANSFORM:  S Y=$E(Y,1,4)_"/"_$E(Y,5)_"/"_$E(Y,6)
  • LAST EDITED:  SEP 11, 1996
  • HELP-PROMPT:  Type a Number between 000000 and 999999, 0 Decimal Digits. Must be 6 characters long.
  • DESCRIPTION:  Enter the morphology code for this biopsy if it was performed. The first 4 digits should represent the HISTOLOGY, the 5th digit should represent the BEHAVIOR, and the 6th digit should represent the GRADE. For example, if
    this biopsy was performed and the HISTOLOGY was '8693', the BEHAVIOR was '3' and the GRADE was '1', then enter "869331". This will display as "8693/3/1".
    If the biopsy was not done code 8's (ie - 888888), if it is unknown whether the biopsy was done code 9's (ie - 999999). If the biopsy was done but one or more items are unknown, code 7's where unknown. For example,
    if the HISTOLOGY is '8693' and the behavior is '3' , but the GRADE is unknown, then enter "869337".
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
529 CORE NEEDLE BIOPSY STS1;28 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>999999)!(X<0)!(X?.E1"."1N.N)!($L(X)<6) X
  • OUTPUT TRANSFORM:  S Y=$E(Y,1,4)_"/"_$E(Y,5)_"/"_$E(Y,6)
  • LAST EDITED:  SEP 11, 1996
  • HELP-PROMPT:  Type a Number between 0 and 999999, 0 Decimal Digits. Must be 6 characters long.
  • DESCRIPTION:  Enter the morphology code for this biopsy if it was performed. The first 4 digits should represent the HISTOLOGY, the 5th digit should represent the BEHAVIOR, and the 6th digit should represent the GRADE. For example, if
    this biopsy was performed and the HISTOLOGY was '8693', the BEHAVIOR was '3' and the GRADE was '1', then enter "869331". This will display as "8693/3/1".
    If the biopsy was not done code 8's (ie - 888888), if it is unknown whether the biopsy was done code 9's (ie - 999999). If the biopsy was done but one or more items are unknown, code 7's where unknown. For example,
    if the HISTOLOGY is '8693' and the behavior is '3' , but the GRADE is unknown, then enter "869337".
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
530 INCISIONAL BIOPSY (STS PCE) STS1;29 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>999999)!(X<0)!(X?.E1"."1N.N)!($L(X)<6) X
  • OUTPUT TRANSFORM:  S Y=$E(Y,1,4)_"/"_$E(Y,5)_"/"_$E(Y,6)
  • LAST EDITED:  SEP 11, 1996
  • HELP-PROMPT:  Type a Number between 0 and 999999, 0 Decimal Digits. Must be 6 characters long.
  • DESCRIPTION:  Enter the morphology code for this biopsy if it was performed. The first 4 digits should represent the HISTOLOGY, the 5th digit should represent the BEHAVIOR, and the 6th digit should represent the GRADE. For example, if
    this biopsy was performed and the HISTOLOGY was '8693', the BEHAVIOR was '3' and the GRADE was '1', then enter "869331". This will display as "8693/3/1".
    If the biopsy was not done code 8's (ie - 888888), if it is unknown whether the biopsy was done code 9's (ie - 999999). If the biopsy was done but one or more items are unknown, code 7's where unknown. For example,
    if the HISTOLOGY is '8693' and the behavior is '3' , but the GRADE is unknown, then enter "869337".
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
531 EXCISIONAL BIOPSY STS1;30 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>999999)!(X<0)!(X?.E1"."1N.N)!($L(X)<6) X
  • OUTPUT TRANSFORM:  S Y=$E(Y,1,4)_"/"_$E(Y,5)_"/"_$E(Y,6)
  • LAST EDITED:  SEP 11, 1996
  • HELP-PROMPT:  Type a Number between 0 and 999999, 0 Decimal Digits. Must be 6 characters long.
  • DESCRIPTION:  Enter the morphology code for this biopsy if it was performed. The first 4 digits should represent the HISTOLOGY, the 5th digit should represent the BEHAVIOR, and the 6th digit should represent the GRADE. For example, if
    this biopsy was performed and the HISTOLOGY was '8693', the BEHAVIOR was '3' and the GRADE was '1', then enter "869331". This will display as "8693/3/1".
    If the biopsy was not done code 8's (ie - 888888), if it is unknown whether the biopsy was done code 9's (ie - 999999). If the biopsy was done but one or more items are unknown, code 7's where unknown. For example,
    if the HISTOLOGY is '8693' and the behavior is '3' , but the GRADE is unknown, then enter "869337".
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
532 EXTERNAL BEAM RADIATION STS2;3 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 12, 1996
  • DESCRIPTION:  
    Record whether any external beam radiation therapy was performed.
533 EXTERNAL BEAM RAD FRACTIONS STS2;4 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y)
  • LAST EDITED:  SEP 13, 1996
  • HELP-PROMPT:  Type a Number between 0 and 999, 0 Decimal Digits
  • DESCRIPTION:  
    Record the number of fractions for external beam radiation.
534 EXTERNAL BEAM RADIATION ENERGY STS2;5 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0"_Y,1:Y)
  • LAST EDITED:  SEP 12, 1996
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  
    Record the units (MV) of radiation energy if external beam radiation was performed .
535 INTRAOPERATIVE RADIATION STS2;6 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 12, 1996
  • DESCRIPTION:  
    Record whether intraoperative radiation was performed.
536 INTRAOPERATIVE RADIATION DOSE STS2;7 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
  • LAST EDITED:  SEP 12, 1996
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  Record the total intraoperative radiation dose given. If the patient did not receive this type of radiation therapy, code 0's. If it is known that the patient received this type of radiation therapy but the dose is not
    known, code 9's.
537 INTRAOPERATIVE RADIATION ENER STS2;8 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0"_Y,1:Y)
  • LAST EDITED:  SEP 12, 1996
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  
    Record the units (MV) of intraoperative radiation energy if this was performed.
538 BRACHYTHERAPY STS2;9 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record whether brachytherapy was performed.
539 BRACHYTHERAPY DAYS STS2;10 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y)
  • LAST EDITED:  SEP 13, 1996
  • HELP-PROMPT:  Type a Number between 0 and 999, 0 Decimal Digits
  • DESCRIPTION:  
    Record the number of days brachytherapy was given.
540 BRACHYTHERAPY RADIATION DOSE STS2;11 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
  • LAST EDITED:  SEP 13, 1996
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  Record the total brachytherapy radiation dose given. If the patient did not receive this type of radiation therapy, code 0's. If it is known that the patient received this type of radiation therapy, but the dose is
    unknown, code 9's.
541 DATE BRACHYTHERAPY STARTED STS2;12 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DBTS^ONCODSR
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  APR 04, 1997
  • HELP-PROMPT:  *** DATE BRACHYTHERAPY STARTED MUST BE AFTER OR EQUAL TO THE DATE DX, AND BEFORE OR EQUAL TO THE DATE BRACHYTHERAPY ENDED ***
  • DESCRIPTION:  
    Record the date on which brachytherapy was started. If brachytherapy was not given, code the date as 00/00/00. If it is unknown code as 99/99/99.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
542 DATE BRACHYTHERAPY ENDED STS2;13 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DBTE^ONCODSR
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  APR 07, 1997
  • HELP-PROMPT:  *** DATE BRACHYTHERAPY ENDED MUST BE AFTER OR EQUAL TO THE DATE BRACHYTHERAPY STARTED ***
  • DESCRIPTION:  
    Record the date on which brachytherapy ended. If brachytherapy was not given, code the date as 00/00/00. If it is unknown code as 99/99/99.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
543 CYTOXAN STS2;14 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record whether the chemotherapeutic agent, Cytoxan, was given. If no chemotherapy was given, code as 0.
544 DTIC STS2;15 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record whether the chemotherapeutic agent, DTIC, was administered. If no chemotherapy was given, code as 0.
545 DOXORUBICIN (STS) STS2;16 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 31, 1997
  • DESCRIPTION:  
    Record whether the chemotherapeutic agent, Doxorubicin, was administered. If no chemotherapy was given, code as 0.
546 ETOPOSIDE STS2;17 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record whether the chemotherapeutic agent, Etoposide, was administered. If no chemotherapy was given, code as 0.
547 CISPLATIN METHOD OF DELIVERY STS2;18 SET
  • '1' FOR Bolus;
  • '2' FOR Infusion;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if unknown code 9.
548 CYTOXAN METHOD OF DELIVERY STS2;19 SET
  • '1' FOR Bolus;
  • '2' FOR Infusion;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if unknown code 9.
549 DTIC METHOD OF DELIVERY STS2;20 SET
  • '1' FOR Bolus;
  • '2' FOR Infusion;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if unknown code 9.
550 DOXORUBICIN METHOD OF DELIVERY STS2;21 SET
  • '1' FOR Bolus;
  • '2' FOR Infusion;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if unknown code 9.
551 ETOPOSIDE METHOD OF DELIVERY STS2;22 SET
  • '1' FOR Bolus;
  • '2' FOR Infusion;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if unknown code 9.
552 IFOSFAMIDE METHOD OF DELIVERY STS2;23 SET
  • '1' FOR Bolus;
  • '2' FOR Infusion;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if unknown code 9.
553 CISPLATIN LOCATION STS2;24 SET
  • '1' FOR Intra-arterial;
  • '2' FOR Intravenous;
  • '3' FOR Oral;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable, code 8, and if unknown code 9.
554 CYTOXAN LOCATION STS2;25 SET
  • '1' FOR Intra-arterial;
  • '2' FOR Intravenous;
  • '3' FOR Oral;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable, code 8, and if unknown code 9.
555 DTIC LOCATION STS2;26 SET
  • '1' FOR Intra-arterial;
  • '2' FOR Intravenous;
  • '3' FOR Oral;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable, code 8, and if unknown code 9.
556 DOXORUBICIN LOCATION STS2;27 SET
  • '1' FOR Intra-arterial;
  • '2' FOR Intravenous;
  • '3' FOR Oral;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable, code 8, and if unknown code 9.
557 ETOPOSIDE LOCATION STS2;28 SET
  • '1' FOR Intra-arterial;
  • '2' FOR Intravenous;
  • '3' FOR Oral;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable, code 8, and if unknown code 9.
558 IFOSFAMIDE LOCATION STS2;29 SET
  • '1' FOR Intra-arterial;
  • '2' FOR Intravenous;
  • '3' FOR Oral;
  • '8' FOR Not applicable;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 13, 1996
  • DESCRIPTION:  
    Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable, code 8, and if unknown code 9.
559 COLONY STIMULATING FACTORS STS2;30 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 1999
  • DESCRIPTION:  
    Record whether colony stimulating factors were used.
  • SCREEN:  S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"
  • EXPLANATION:  Code 8 should not be used for cases with a DATE DX < 1/1/1999
560 PROTOCOL PARTICIPATION STS2;31 SET
  • '00' FOR Not on/NA;
  • '01' FOR NSABP;
  • '02' FOR GOG;
  • '03' FOR RTOG;
  • '04' FOR SWOG;
  • '05' FOR ECOG;
  • '06' FOR POG;
  • '07' FOR CCG;
  • '08' FOR CALGB;
  • '09' FOR NCI;
  • '10' FOR ACS;
  • '11' FOR National protocol, NOS;
  • '12' FOR Local protocol, NOS;
  • '99' FOR Unknown;

  • LAST EDITED:  JAN 11, 1999
  • DESCRIPTION:  Record whether the patient was enrolled in and treated on a protocol. A physician may treat a patient following the guidelines of an established protocol; however, the patient is not enrolled into the protocol. For these
    patients, use code 00 (Not on/NA).
  • SCREEN:  S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=12)"
  • EXPLANATION:  Code 12 should not be used for cases with a DATE DX < 1/1/1999
561 OTHER PROTOCOL STS2;32 SET
  • '0' FOR Not on protocol/not applicable;
  • '1' FOR In house protocol;
  • '2' FOR Non-cooperative, multi-institutional protocol;
  • '3' FOR On protocol, type unknown;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 16, 1996
  • DESCRIPTION:  
    Record whether therapy was given under another protocol.
562 REFERRED TO REHAB SERVICES STS2;33 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 16, 1996
  • DESCRIPTION:  
    Record whether the patient was referred to rehabilitation services.
563 PHYSICAL THERAPY/REHABILTATION STS2;34 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 16, 1996
  • DESCRIPTION:  
    Record whether the patient was referred to physical therapy or rehabilitation service.
564 TRANSFERRED TO REHABILITATION STS2;35 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  SEP 16, 1996
  • DESCRIPTION:  
    Record whether the patient was transferred to a rehabilitation facility after being released from the hospital.
565 NUMBER OF HOSPITALIZATIONS STS2;36 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0"_Y,1:Y)
  • LAST EDITED:  SEP 16, 1996
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  
    Record the number of hospitalizations for this patient, counting only overnight stays during the first six months after diagnosis. Do not count stays for 23 hour observation. If unknown, code 9's.
566 TOTAL LENGTH OF STAYS STS2;37 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y)
  • LAST EDITED:  SEP 16, 1996
  • HELP-PROMPT:  Type a Number between 0 and 999, 0 Decimal Digits
  • DESCRIPTION:  
    Add all days for each overnight hospitalization together to get a cumulative total for all stays during the first six months after diagnosis. Do not count stays for 23 hour observation. If unknown, code 9's.
567 DATE EXT BEAM RAD STARTED STS2;38 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  APR 03, 1997
  • HELP-PROMPT:  *** DATE EXT BEAM RADIATION STARTED MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Record the date external beam radiation therapy was started. Code 0's if not given. Code 9's if unknown.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
600 CLINICAL DX WITH BONE LESION PRO1;1 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the Method of Diagnosis: CLINICAL DIAGNOSIS WITH BONE LESION was used to diagnose this case of prostate cancer.
601 CLINICAL DX BY RECTAL EXAM PRO1;2 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the Method of Diagnosis: CLINICAL DIAGNOSIS BY RECTAL EXAM was used to diagnose this case of prostate cancer.
602 CYTOLOGY PRO1;3 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the Method of Diagnosis: CYTOLOGY was used to diagnose this case of prostate cancer.
603 INCIDENTAL FINDING IN TURP PRO1;4 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the Method of Diagnosis: INCIDENTAL FINDING IN TRANSURETHRAL RESECTION OF PROSTATE (TURP) FOR BENIGN DISEASE was used to diagnose this case of prostate cancer.
604 NEEDLE ASPIRATION BIOPSY PRO1;5 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the Method of Diagnosis: NEEDLE ASPIRATION BIOPSY was used to diagnose this case of prostate cancer.
605 NEEDLE BIOPSY, NOS PRO1;6 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the Method of Diagnosis: NEEDLE BIOPSY, NOS was used to diagnose this case of prostate cancer.
606 PERINEAL BIOPSY PRO1;7 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the Method of Diagnosis: PERINEAL BIOPSY was used to diagnose this case of prostate cancer.
607 TRANSRECTAL BIOPSY PRO1;8 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the Method of Diagnosis: TRANSRECTAL BIOPSY was used to diagnose this case of prostate cancer.
608 TRUS PRO1;9 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the Method of Diagnosis: TRANSRECTAL ULTRASONOGRAPHICALLY GUIDED BIOPSY (TRUS) was used to diagnose this case of prostate cancer.
609 TRANSURETHRAL RESECTION PRO1;10 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the Method of Diagnosis: TRANSURETHRAL RESECTION OF PROSTATE, NOS was used to diagnose this case of prostate cancer.
610 OTHER METHOD OF DX (PROSTATE) PRO1;11 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the Method of Diagnosis: OTHER was used to diagnose this case of prostate cancer.
611 BONE MARROW ASPIRATION PRO1;12 SET
  • '1' FOR Normal;
  • '2' FOR Abnormal/elevated;
  • '8' FOR Test not done/unknown if done;
  • '9' FOR Test done, results unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record the results of the BONE MARROW ASPIRATION diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).
612 BONE SCAN (PROSTATE) PRO1;13 SET
  • '1' FOR Normal;
  • '2' FOR Abnormal/elevated;
  • '8' FOR Test not done/unknown if done;
  • '9' FOR Test done, results unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record the results of the BONE SCAN diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).
613 BONE X-RAY PRO1;14 SET
  • '1' FOR Normal;
  • '2' FOR Abnormal/elevated;
  • '8' FOR Test not done/unknown if done;
  • '9' FOR Test done, results unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record the results of the BONE X-RAY diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).
614 CHEST X-RAY (PROSTATE) PRO1;15 SET
  • '1' FOR Normal;
  • '2' FOR Abnormal/elevated;
  • '8' FOR Test not done/unknown if done;
  • '9' FOR Test done, results unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record the results of the CHEST X-RAY diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).
615 CT SCAN OF PRIMARY SITE PRO1;16 SET
  • '1' FOR Normal;
  • '2' FOR Abnormal/elevated;
  • '8' FOR Test not done/unknown if done;
  • '9' FOR Test done, results unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  Record the results of the CT SCAN OF PRIMARY SITE diagnostic test performed to evaluate the prostate tumor. If a scan of the abdomen was performed by computed tomography (CT), record the results under CT SCAN OF PRIMARY
    SITE. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).
616 INTRAVENOUS PYELOGRAM (PRO) PRO1;17 SET
  • '1' FOR Normal;
  • '2' FOR Abnormal/elevated;
  • '8' FOR Test not done/unknown if done;
  • '9' FOR Test done, results unknown;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the INTRAVENOUS PYELOGRAM (IVP) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).
617 LIVER SCAN PRO1;18 SET
  • '1' FOR Normal;
  • '2' FOR Abnormal/elevated;
  • '8' FOR Test not done/unknown if done;
  • '9' FOR Test done, results unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record the results of the LIVER SCAN diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).
618 MRI (PRO) PRO1;19 SET
  • '1' FOR Normal;
  • '2' FOR Abnormal/elevated;
  • '8' FOR Test not done/unknown if done;
  • '9' FOR Test done, results unknown;

  • LAST EDITED:  FEB 14, 1997
  • DESCRIPTION:  
    Record the results of the MAGNETIC RESONANCE IMAGING (MRI) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).
619 PELVIC LYMPH NODE DISSECT (PR) PRO1;20 SET
  • '1' FOR Normal;
  • '2' FOR Abnormal/elevated;
  • '8' FOR Test not done/unknown if done;
  • '9' FOR Test done, results unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record the results of the PELVIC LYMPH NODE DISSECTION diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).
620 PROSTATIC ACID PHOSPHATASE PRO1;21 SET
  • '1' FOR Normal;
  • '2' FOR Abnormal/elevated;
  • '8' FOR Test not done/unknown if done;
  • '9' FOR Test done, results unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record the results of the PROSTATIC ACID PHOSPHATASE (PAP) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).
621 PROSTATE SPECIFIC ANTIGEN PRO1;22 SET
  • '1' FOR Normal;
  • '2' FOR Abnormal/elevated;
  • '8' FOR Test not done/unknown if done;
  • '9' FOR Test done, results unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record the results of the PROSTATE SPECIFIC ANTIGEN (PSA) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).
622 OTHER DIAGNOSTIC INFORMATION PRO1;23 SET
  • '1' FOR Normal;
  • '2' FOR Abnormal/elelvated;
  • '8' FOR Test not done/unknown if done;
  • '9' FOR Test done, results unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record the results of OTHER diagnostic tests performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).
623 GLEASON SCORE CLIN - OBSOLETE PRO1;24 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1) X
    MAXIMUM LENGTH: 2
  • OUTPUT TRANSFORM:  S Y=$S(Y=99:"99 Unknown, not reported, or NA",1:Y)
  • LAST EDITED:  FEB 27, 2025
  • HELP-PROMPT:  This field is no longer in use.
  • DESCRIPTION:  Record the clinical Gleason Score. Gleason Score (clinical) is obtained from a needle biopsy or TURP specimen.
    For cases where Gleason Score is unknown, not reported or not applicable, code 99.
    This field is no longer in use. This field has been superseded by field #3840 Gleason Score Clinical.
  • TECHNICAL DESCR:  
    This field is no longer in use as of Patch ONC*2.2*21.
623.1 PREDOMINANT PATTERN (02-40) PRO2;43 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X=6)!(X=7)!(X=8)!($L(X)>1)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 11, 1998
  • HELP-PROMPT:  Type a Number between 0 and 5, 0 Decimal Digits
  • DESCRIPTION:  Record the predominant (primary) pattern of tumor for Biopsy, Local Resection, or Simple Prostatectomy, surgical codes 02-40. Gleason's grading system assigns histologic grade ranging from 1-5 to predominant pattern of
    tumor. Record the predominant pattern as stated in the pathology report. If the grade is not provided and only a Gleason score is available, enter a '0'.
623.2 LESSER PATTERN (02-40) PRO2;44 NUMBER

  • INPUT TRANSFORM:  D LP25^ONCOIT
  • LAST EDITED:  MAY 12, 1998
  • HELP-PROMPT:  Type a Number between 0 and 5, 0 Decimal Digits
  • DESCRIPTION:  Record the lesser (secondary) pattern of tumor for Biopsy, Local Resection, or Simple Prostatectomy, surgical codes 02-40. Gleason's grading system assigns histologic grade ranging from 1-5 to lesser pattern of tumor.
    Record the lesser pattern as stated in the pathology report. If the grade is not provided and only a Gleason score is available, enter a '0'.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
623.3 GLEASON'S SCORE (50-70) PRO2;45 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!'(X?1.2N&(((+X>1)&(X<11))!(X=99))) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0"_Y,Y=99:"99 Unknown, not reported, or NA",1:Y)
  • LAST EDITED:  MAY 12, 1998
  • HELP-PROMPT:  Answer 02-10 or 99 (Score unknown, not reported or NA)
  • DESCRIPTION:  Record the Gleason's score for Radical Prostatectomy, surgical codes 50-70. Gleason's grading system assigns histologic grade ranging from 1-5 to predominant (primary) and lesser (secondary) patterns of tumor. The grade
    numbers of the two patterns are added to obtain the Gleason score, which ranges from 02 to 10. Record the Gleason's score by adding the predominant and lesser patterns as stated in the pathology report. For example, if
    predominant pattern is 3 and lesser pattern is 4, then Gleason's score is 3 + 4 = 7. For cases where Gleason's score is unknown, not reported or not applicable, code 99.
623.4 PREDOMINANT PATTERN (50-70) PRO2;46 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X=6)!(X=7)!(X=8)!($L(X)>1)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 11, 1998
  • HELP-PROMPT:  Type a Number between 0 and 5, 0 Decimal Digits
  • DESCRIPTION:  Record the predominant (primary) pattern of tumor for Radical Prostatectomy, surgical codes 50-70. Gleason's grading system assigns histologic grade ranging from 1-5 to predominant pattern of tumor. Record the
    predominant pattern as stated in the pathology report. If the grade is not provided and only a Gleason score is available, enter a '0'.
623.5 LESSER PATTERN (50-70) PRO2;47 NUMBER

  • INPUT TRANSFORM:  D LP26^ONCOIT
  • LAST EDITED:  MAY 13, 1998
  • HELP-PROMPT:  Type a Number between 0 and 5, 0 Decimal Digits
  • DESCRIPTION:  Record the lesser (secondary) pattern of tumor for Radical Prostatectomy, surgical codes 50-70. Gleason's grading system assigns histologic grade ranging from 1-5 to lesser pattern of tumor. Record the lesser pattern as
    stated in the pathology report. If the grade is not provided and only a Gleason score is available, enter a '0'.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
624 RESEARCH PROTOCOL PRO1;25 SET
  • '1' FOR In-house;
  • '2' FOR Cooperative group;
  • '3' FOR Not in a protocol;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the patient was entered into a protocol.
625 RAD THERAPY PLANNED/GIVEN PRO1;26 SET
  • '1' FOR Yes;
  • '2' FOR No, not recommended;
  • '3' FOR Patient refused radiation therapy;
  • '4' FOR Radiation was planned, but not given;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the patient received radiation therapy.
626 INTERSTITIAL RAD PLANNED/GIVEN PRO1;27 SET
  • '1' FOR Yes;
  • '2' FOR No, not recommended;
  • '3' FOR Patient refused radiation therapy;
  • '4' FOR Radiation was planned, but not given;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 25, 1996
  • DESCRIPTION:  
    Record whether the patient received interstitial radiation.
627 IODINE 125 PRO1;28 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 13, 2000
  • DESCRIPTION:  Record whether the isotope IODINE 125 was administered interstitially.
628 GOLD 198 PRO1;29 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 13, 2000
  • DESCRIPTION:  Record whether the isotope GOLD 198 was administered interstitially.
629 PALLADIUM 103 PRO1;30 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 13, 2000
  • DESCRIPTION:  Record whether the isotope PALLADIUM 103 was administered interstitially.
630 IRIDIUM 192 PRO1;31 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 13, 2000
  • DESCRIPTION:  Record whether the isotope IRIDIUM 192 was administered interstitially.
631 OTHER INTERSTITIAL, NOS PRO1;32 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 13, 2000
  • DESCRIPTION:  Record whether OTHER INTERSTITIAL, NOS isotopes were administered.
632 EXTERNAL RAD PLANNED/GIVEN PRO1;33 SET
  • '1' FOR Yes;
  • '2' FOR No, not recommended;
  • '3' FOR Patient refused external radiation;
  • '4' FOR Radiation was planned, but not given;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 29, 1996
  • DESCRIPTION:  
    Record whether the patient received external radiation.
633 PROSTATE REGION ONLY PRO1;34 SET
  • '0' FOR No, region/site not targeted;
  • '1' FOR Yes;
  • '8' FOR NA, external radiation not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 13, 2000
  • DESCRIPTION:  Record whether the PROSTATE REGION ONLY was irradiated.
634 PROSTATE AND PELVIC NODES PRO1;35 SET
  • '0' FOR No, region/site not targeted;
  • '1' FOR Yes;
  • '8' FOR NA, external radiation not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 13, 2000
  • DESCRIPTION:  Record whether PROSTATE AND PELVIC NODES were irradiated.
635 PROSTATE & PELVIC PARA-AORTIC PRO1;36 SET
  • '0' FOR No, region/site not targeted;
  • '1' FOR Yes;
  • '8' FOR NA, external radiation not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 13, 2000
  • DESCRIPTION:  Record whether PROSTATE AND PELVIC PARA-AORTIC NODES were irradiated.
636 DISTANT METASTATIC SITES PRO1;37 SET
  • '0' FOR No, region/site not targeted;
  • '1' FOR Yes;
  • '8' FOR NA, external radiation not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 13, 2000
  • DESCRIPTION:  Record whether DISTANT METASTATIC SITES were irradiated.
637 OTHER EXTERNAL SITES, NOS PRO1;38 SET
  • '0' FOR No, region/site not targeted;
  • '1' FOR Yes;
  • '8' FOR NA, external radiation not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 13, 2000
  • DESCRIPTION:  Record whether OTHER EXTERNAL SITES, NOS were irradiated.
638 TOTAL RAD DOSE (PROSTATE) PRO1;39 SET
  • '1' FOR Less than 1999 rad;
  • '2' FOR 2000-3000 rad;
  • '3' FOR 3001-4000 rad;
  • '4' FOR 4001-5000 rad;
  • '5' FOR 5001-6000 rad;
  • '6' FOR 6001-7000 rad;
  • '7' FOR More than 7001 rad;
  • '8' FOR Not given;
  • '9' FOR Rad does unknown;

  • LAST EDITED:  OCT 29, 1996
  • DESCRIPTION:  Record the TOTAL (external) RAD DOSE given to the PROSTATE; this includes boost dosage. Do not include interstitial rad dose. If it is known that the patient received radiation therapy, but the amount given is unknown,
    code 9 (rad dose unknown).
639 TOTAL RAD DOSE (PELVIC NODES) PRO1;40 SET
  • '1' FOR Less than 1999 rad;
  • '2' FOR 2000-3000 rad;
  • '3' FOR 3001-4000 rad;
  • '4' FOR 4001-5000 rad;
  • '5' FOR More than 5001 rad;
  • '8' FOR Not given;
  • '9' FOR Rad dose unknown;

  • LAST EDITED:  OCT 29, 1996
  • DESCRIPTION:  Record the TOTAL (external) RAD DOSE given to the PELVIC NODES; this includes boost dosage. Do not include interstitial rad dose. If it is known that the patient received radiation therapy, but the amount given is
    unknown, code 9 (rad dose unknown).
640 TOTAL RAD DOSE (PARA-AORTIC) PRO1;41 SET
  • '1' FOR Less than 1999 rad;
  • '2' FOR 2000-3000 rad;
  • '3' FOR 3001-4000 rad;
  • '5' FOR More than 5001 rad;
  • '8' FOR Not given;
  • '9' FOR Rad dose unknown;

  • LAST EDITED:  OCT 29, 1996
  • DESCRIPTION:  Record the TOTAL (external) RAD DOSE given to the PARA-AORTIC NODES; this includes boost dosage. Do not include interstitial rad dose. If it is known that the patient received radiation therapy, but the amount given is
    unknown, code 9 (rad dose unknown).
641 RESEARCH PROTOCOL (RADIATION) PRO1;42 SET
  • '1' FOR In-house;
  • '2' FOR Cooperative group;
  • '3' FOR Not in a protocol;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 29, 1996
  • DESCRIPTION:  
    Record the patient was entered into a protocol.
642 HORMONE THERAPY PLANNED/GIVEN PRO1;43 SET
  • '1' FOR Yes;
  • '2' FOR No, not recommended;
  • '3' FOR Patient refused hormonal therapy;
  • '4' FOR Hormonal therapy was planned, but not given;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 29, 1996
  • DESCRIPTION:  
    Record whether the patient received hormonal therapy.
643 ESTROGENS PRO1;44 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;
  • '2' FOR No;

  • LAST EDITED:  MAY 22, 1998
  • DESCRIPTION:  Record all types of hormonal drugs given.
  • SCREEN:  S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"
  • EXPLANATION:  Record all types of hormonal drugs given.
644 ANTIANDROGENS PRO1;45 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;
  • '2' FOR No;

  • LAST EDITED:  MAY 22, 1998
  • DESCRIPTION:  Record all types of hormonal drugs given.
  • SCREEN:  S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"
  • EXPLANATION:  Record all types of hormonal drugs given.
645 PROGESTATIONAL AGENTS PRO1;46 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;
  • '2' FOR No;

  • LAST EDITED:  MAY 22, 1998
  • DESCRIPTION:  Record all types of hormonal drugs given.
  • SCREEN:  S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"
  • EXPLANATION:  Record all types of hormonal drugs given.
646 LUTEINIZING HORMONES PRO1;47 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;
  • '2' FOR No;

  • LAST EDITED:  MAY 22, 1998
  • DESCRIPTION:  Record all types of hormonal drugs given.
  • SCREEN:  S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"
  • EXPLANATION:  Record all types of hormonal drugs given.
647 ORCHIECTOMY PRO1;48 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 29, 1996
  • DESCRIPTION:  
    Record whether an ORCHIECTOMY was administered. Code 2 (No) if an ORCHIECTOMY was not given.
648 OTHER EXOGENOUS HORMONE AGENTS PRO1;49 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;
  • '2' FOR No;

  • LAST EDITED:  MAY 22, 1998
  • DESCRIPTION:  Record all types of hormonal drugs given.
  • SCREEN:  S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"
  • EXPLANATION:  Record all types of hormonal drugs given.
649 BACKACHE (1ST RECURRENCE) PRO1;50 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 30, 1996
  • DESCRIPTION:  
    Record whether a BACKACHE was used to diagnose the first recurrence.
650 BONE SCAN (1ST RECURRENCE) PRO1;51 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 30, 1996
  • DESCRIPTION:  
    Record if a BONE SCAN was used to diagnose the first recurrence.
651 LETHARGY PRO1;52 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 30, 1996
  • DESCRIPTION:  
    Record if LETHARGY was used to diagnose the first recurrence.
652 RECTAL EXAM (1ST RECURRENCE) PRO1;53 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 30, 1996
  • DESCRIPTION:  
    Record whether a RECTAL EXAMINATION FOLLOWED BY NEEDLE BIOPSY was used to diagnose the first recurrence.
653 TUMOR MARKER (1ST RECURRENCE) PRO1;54 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 30, 1996
  • DESCRIPTION:  
    Record whether TUMOR MARKER ELEVATION was used to diagnose the first recurrence.
654 WEIGHT LOSS (1ST RECURRENCE) PRO1;55 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 30, 1996
  • DESCRIPTION:  
    Record whether WEIGHT LOSS was used to diagnose the first recurrence.
655 OTHER METHODS (1ST RECURRENCE) PRO1;56 SET
  • '1' FOR Yes;
  • '2' FOR No;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 30, 1996
  • DESCRIPTION:  
    Record whether OTHER methods were used to diagnose the first recurrence.
656 REASON FOR 2ND COURSE PRO1;57 SET
  • '1' FOR Recurrence;
  • '2' FOR Progression of disease;
  • '8' FOR No therapy;
  • '9' FOR Unknown;

  • LAST EDITED:  OCT 31, 1996
  • DESCRIPTION:  
    Record whether the patient received treatment for recurrence or progression of disease.
657 FAM HIST OF PROSTATE CA (PR98) PRO2;1 SET
  • '0' FOR No;
  • '1' FOR Yes, 1st degree relative;
  • '2' FOR Yes, relative other than 1st degree;
  • '3' FOR Yes, degree of relative unknown;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 13, 1998
  • DESCRIPTION:  Record any familial history of prostate cancer documented in the medical record. First degree relatives include the patient's father, brother, or son. A grandfather, uncle, or cousin would not be considered a first
    degree relative.
658 HEMATURIA (PR98) PRO2;2 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 13, 1998
  • DESCRIPTION:  Record all symptoms specific to prostate cancer that were reported by the patient and included in the medical chart.
659 LOWER BACK PAIN (PR98) PRO2;3 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 13, 1998
  • DESCRIPTION:  Record all symptoms specific to prostate cancer that were reported by the patient and included in the medical chart.
660 TROUBLE URINATING (PR98) PRO2;4 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 13, 1998
  • DESCRIPTION:  Record all symptoms specific to prostate cancer that were reported by the patient and included in the medical chart.
661 CLIN DX W/ BONE LESION (PR98) PRO2;5 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 1998
  • DESCRIPTION:  Record whether the Initial Method of Diagnosis: CLINICAL DIAGNOSIS WITH BONE LESION was performed to diagnose this case of prostate cancer.
662 CLIN DX BY RECTAL EXAM (PR98) PRO2;6 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 1998
  • DESCRIPTION:  Record whether the Initial Method of Diagnosis: CLINICAL DIAGNOSIS BY RECTAL EXAM was performed to diagnose this case of prostate cancer.
663 CYTOLOGY (PR98) PRO2;7 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 1998
  • DESCRIPTION:  Record whether the Initial Method of Diagnosis: CYTOLOGY was performed to diagnose this case of prostate cancer.
664 DIGITAL TRANSRECTAL BIO (PR98) PRO2;8 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 1998
  • DESCRIPTION:  Record whether the Initial Method of Diagnosis: DIGITAL TRANSRECTAL BIOPSY was performed to diagnose this case of prostate cancer.
665 INCIDENTAL FIND IN TURP (PR98) PRO2;9 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 1998
  • DESCRIPTION:  Record whether the Method of Diagnosis: INCIDENTAL FINDING IN TRANSURETHRAL RESECTION OF PROSTATE (TURP) FOR BENIGN DISEASE was performed to diagnose this case of prostate cancer.
666 NEEDLE BIOPSY, NOS (PR98) PRO2;10 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 1998
  • DESCRIPTION:  Record whether the Initial Method of Diagnosis: NEEDLE BIOPSY, NOS was performed to diagnose this case of prostate cancer.
667 PERINEAL BIOPSY (PR98) PRO2;11 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 1998
  • DESCRIPTION:  Record whether the Initial Method of Diagnosis: PERINEAL BIOPSY was performed to diagnose this case of prostate cancer.
668 PSA METHOD OF DIAGNOSIS (PR98) PRO2;12 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 1998
  • DESCRIPTION:  Record whether the Initial Method of Diagnosis: PROSTATIC SPECIFIC ANTIGEN (PSA) was performed to diagnose this case of prostate cancer.
669 TRANSRECTAL BIOPSY (PR98) PRO2;13 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 1998
  • DESCRIPTION:  Record whether the Initial Method of Diagnosis: TRANSRECTAL ULTRASONOGRAPHICALLY GUIDED BIOPSY (TRUS) was performed to diagnose this case of prostate cancer.
670 TRANSURETHRAL RESECTION (PR98) PRO2;14 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 30, 1998
  • DESCRIPTION:  Record whether the Initial Method of Diagnosis: TRANSURETHRAL RESECTION OF PROSTATE, NOS was performed to diagnose this case of prostate cancer.
671 BONE MARROW ASPIRATION (PR98) PRO2;15 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record the results of the BONE MARROW ASPIRATION diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is
    unknown if the test was done code 9 (Unknown if test done).
672 BONE SCAN (PR98) PRO2;16 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record the results of the BONE SCAN diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is unknown if the test
    was done code 9 (Unknown if test done).
673 BONE X-RAY (PR98) PRO2;17 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record the results of the BONE X-RAY diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is unknown if the
    test was done code 9 (Unknown if test done).
674 CHEST X-RAY (PR98) PRO2;18 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record the results of the CHEST X-RAY diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is unknown if the
    test was done code 9 (Unknown if test done).
675 CT SCAN OF ABDOMEN (PR98) PRO2;19 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record the results of the CT SCAN OF ABDOMEN diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is unknown if
    the test was done code 9 (Unknown if test done).
676 CT SCAN OF PELVIS (PR98) PRO2;20 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record the results of the CT SCAN OF PELVIS diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is unknown if
    the test was done code 9 (Unknown if test done).
677 INTRAVENOUS PYELOGRAM (PR98) PRO2;21 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record the results of the INTRAVENOUS PYELOGRAM (IVP) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is
    unknown if the test was done code 9 (Unknown if test done).
678 MRI (PR98) PRO2;22 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record the results of the MAGNETIC RESONANCE IMAGING (MRI) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it
    is unknown if the test was done code 9 (Unknown if test done).
679 PELVIC LYMPH ND DISSECT (PR98) PRO2;23 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record the results of the PELVIC LYMPH NODE DISSECTION diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is
    unknown if the test was done code 9 (Unknown if test done).
680 POLYMERASE CHAIN REACT (PR98) PRO2;24 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record the results of the POLYMERASE CHAIN REACTION ASSAY (PCR) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown).
    If it is unknown if the test was done code 9 (Unknown if test done).
681 PROSTATIC ACID PHOSPH (PR98) PRO2;25 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record the results of the PROSTATIC ACID PHOSPHATASE (PAP) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it
    is unknown if the test was done code 9 (Unknown if test done).
682 PSA DIAGNOSTIC EVAL (PR98) PRO2;26 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record the results of the PROSTATE SPECIFIC ANTIGEN (PSA) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it
    is unknown if the test was done code 9 (Unknown if test done).
683 ULTRASOUND OF ABDOMEN (PR98) PRO2;27 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record the results of the ULTRASOUND OF ABDOMEN diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is unknown
    if the test was done code 9 (Unknown if test done).
684 PSA PRO2;28 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1) X I $D(X) D PSA^ONCOIT
  • OUTPUT TRANSFORM:  D PSA^ONCOOT
  • LAST EDITED:  OCT 29, 2002
  • HELP-PROMPT:  Answer must be between 000.0 and 999.9, up to 1 decimal digit
  • DESCRIPTION:  Records the results of the highest pre-treatment Prostate Specific Antigen (PSA) test given within the last 12 months.
    If the first course of treatment was Watchful Waiting, the date the decision was made is considered the first course of treatment. Round the test result to the nearest single decimal point.
    Record 999.6 if PSA value was 999.6 or higher. Record 999.7 if no PSA test was performed. Record 999.8 if the test was done and results are unknown/not reported. Record 999.9 if it is unknown if the test was performed.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
685 WATCHFUL WAITING (PR98) PRO2;29 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 08, 1998
  • DESCRIPTION:  Record whether or not the patient chose to forego surgery, radiation therapy, chemotherapy, and hormone therapy in favor of no immediate medical intervention.
686 LENGTH OF STAY (PR98) PRO2;30 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0"_Y,1:Y) S Y=$S(Y=88:Y_" NA",Y=99:Y_" Unknown",Y="01":Y_" day",1:Y_" days")
  • LAST EDITED:  MAY 13, 1998
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record the number of days the patient remained in the hospital following cancer-directed surgery. Include the day on which the patient was admitted to the hospital for treatment, and the day before the patient was
    discharged from the hospital. For example, if patient was admitted 1/12/98 and discharged 1/18/98, the length of stay is 6 days. If not applicable code, 88. If unknown, code 99.
687 LAPAROSCOPIC (PR98) PRO2;31 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 13, 1998
  • DESCRIPTION:  Record whether the LAPAROSCOPIC Type of Regional Lymph Node surgery was performed. If not applicable, code 8. If unknown, code 9.
688 OPEN (PR98) PRO2;32 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 13, 1998
  • DESCRIPTION:  Record whether the OPEN Type of Regional Lymph Node surgery was performed. If not applicable, code 8. If unknown, code 9.
689 PERMANENT RECTAL INJURY (PR98) PRO2;33 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, no surgery;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 15, 1998
  • DESCRIPTION:  Record whether permanent rectal injury was a surgical complication which was reported within 30 days of first course of treatment cancer- directed surgery. If not applicable, code 8. If unknown, code 9.
690 THROMBOEMBOLISM (PR98) PRO2;34 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, no surgery;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 15, 1998
  • DESCRIPTION:  Record whether thromboembolism was a surgical complication which was reported within 30 days of first course of treatment cancer- directed surgery. If not applicable, code 8. If unknown, code 9.
691 URETHRAL STRICTURE (PR98) PRO2;35 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, no surgery;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 15, 1998
  • DESCRIPTION:  Record whether urethral stricture was a surgical complication which was reported within 30 days of first course of treatment cancer- directed surgery. If not applicable, code 8. If unknown, code 9.
692 RADIATION FACILITY PRO2;36 SET
  • '1' FOR Reporting hospital;
  • '2' FOR Other hospital;
  • '3' FOR Freestanding facility;
  • '4' FOR NOS;
  • '8' FOR NA, radiation not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 22, 1998
  • DESCRIPTION:  Record whether radiation was administered at reporting hospital or administered elsewhere. Record 8 if no radiation administered. Record 9 if the radiation facility is unknown.
693 ROUTE OF INTERSTITIAL RAD PRO2;37 SET
  • '1' FOR Perineal;
  • '2' FOR Open;
  • '8' FOR NA, not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 22, 1998
  • DESCRIPTION:  Record the route by which interstitial radiation/brachytherapy was administered. Record 8 if not applicable. Record 9 if unknown.
694 TYPE OF RADIATION ADMIN PRO2;38 SET
  • '1' FOR Conformal therapy;
  • '2' FOR Standard;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 22, 1998
  • DESCRIPTION:  Record the method by which external beam radiation was administered. Conformal therapy is a three dimensional radiation technique that minimizes exposure to normal tissue. Record 8 if not applicable. Record 9 if
    unknown.
695 GASTROINTESTINAL COMPLICATIONS PRO2;39 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 22, 1998
  • DESCRIPTION:  Record whether or not acute gastrointestinal complications were reported within 90 days of the start of radiation therapy. Record 8 if not applicable. Record 9 if unknown.
696 GASTROURINARY COMPLICATIONS PRO2;40 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 22, 1998
  • DESCRIPTION:  Record whether or not acute gastrourinary complications were reported within 90 days of the start of radiation therapy. Record 8 if not applicable. Record 9 if unknown.
697 ANORECTAL COMPLICATIONS PRO2;41 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 22, 1998
  • DESCRIPTION:  Record whether or not anorectal complications were reported within 90 days of the start of radiation therapy. Record 8 if not applicable. Record 9 if unknown.
698 CHRONIC COMPLICATIONS PRO2;42 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 22, 1998
  • DESCRIPTION:  Record whether or not chronic complications requiring surgery or prolonged hospitalization were reported within 90 days of the start of radiation therapy. Record 8 if not applicable. Record 9 if unknown.
699 URETHRAL/BLADDER COMPLICATIONS PRO2;48 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 22, 1998
  • DESCRIPTION:  Record whether or not urethral or bladder complications were reported within 90 days of the start of radiation therapy. Record 8 if not applicable. Record 9 if unknown.
699.1 DATE OF ORCHIECTOMY PRO2;49 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  MAY 22, 1998
  • HELP-PROMPT:  *** DATE OF ORCHIECTOMY MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  Record the date of the orchiectomy. If no orchiectomy was performed, code 00/00/0000. If an orchiectomy was performed, but the month, day or year is unknown, code the unknown item with 9's.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
700 HISTORY OF COLORECTAL CA (FAM) COL1;1 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 10, 1997
  • DESCRIPTION:  
    Record any familial history of colorectal cancer documented in the medical record.
701 HISTORY OF COLORECTAL CA (PT) COL1;2 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 10, 1997
  • DESCRIPTION:  
    Record and personal history of a previous colorectal cancer documented in the medical record prior to 1997.
702 MULTIPLE COLORECTAL PRIMARIES COL1;3 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 10, 1997
  • DESCRIPTION:  Record if a second colorectal primary was diagnosed in addition to this reported cancer. If a patient has more than one colorectal primary and more than one record will be submitted, answer 'yes' on all records submitted
    for the patient.
    Note: If a second primary is accessioned late in the year, please remember to change the data item on any earlier records.
703 HISTORY OF BREAST CA (PT) COL1;4 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 10, 1997
  • DESCRIPTION:  
    Record whether the patient has a history of breast cancer.
704 HISTORY OF LUNG CA (PT) COL1;5 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 10, 1997
  • DESCRIPTION:  
    Record whether the patient has a history of lung cancer.
705 HISTORY OF OVARIAN CA (PT) COL1;6 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 10, 1997
  • DESCRIPTION:  
    Record whether the patient has a history of ovarian cancer.
706 HISTORY OF OVARIAN CARCINOMA COL1;7 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 10, 1997
  • DESCRIPTION:  Record whether the patient has a history of ovarian carcinoma, peritoneal site. Note: Ovarian carcinoma, peritoneal site does not refer to metastatic disease. It is a primary ovarian cancer arising in the peritoneum, not
    in the ovary.
707 HISTORY OF STOMACH CA (PT) COL1;8 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 10, 1997
  • DESCRIPTION:  
    Record whether the patient has a history of stomach cancer.
708 HISTORY OF THYROID CA (PT) COL1;9 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 10, 1997
  • DESCRIPTION:  
    Record whether the patient has a history of thyroid cancer.
709 HISTORY OF UTERUS CA (PT) COL1;10 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 10, 1997
  • DESCRIPTION:  
    Record whether the patient has a history of uterus cancer.
710 PREVIOUS TAH/BSO COL1;11 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 10, 1997
  • DESCRIPTION:  
    TAH/BSO (Total abdominal hysterectomy/bilateral salpingo-oophorectomy) Record the appropriate code.
711 FAMILIAL ADENOMATOUS POLYPS COL1;12 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  MAY 24, 2005
  • DESCRIPTION:  
    Record whether the patient was affected by FAP (Familial adenomatous polyposis).
712 HNPCC COL1;13 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  MAY 24, 2005
  • DESCRIPTION:  
    Record whether the patient is affected by hereditary nonpolyposis colon cancer (HNPCC) syndrome.
713 INFLAMMATORY BOWEL DISEASE COL1;14 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  MAY 24, 2005
  • DESCRIPTION:  
    Record whether the patient was affected by inflammatory bowel disease (IBD).
714 PRIOR POLYPS COL1;15 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 11, 1997
  • DESCRIPTION:  
    Record the appropriate code for prior polyps.
715 POLYPS COL1;16 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0"_Y,Y=88:"NA, no adenomas",Y=90:"Unknown number",Y=99:"Unknown if adenomas",1:Y)
  • LAST EDITED:  FEB 11, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  
    Record number of adenomas. If no adenomas, record 88. If number of adenomas unknown, record 90. If unknown if adenomas, record 99.
716 DURATION OF ANEMIA COL1;17 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")
  • LAST EDITED:  FEB 12, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record all anemia symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example, if the
    patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).
717 DURATION OF BOWEL OBSTRUCTION COL1;18 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")
  • LAST EDITED:  FEB 12, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record all bowel obstruction symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For
    example, if the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).
718 DURATION OF BOWEL HABIT CHANGE COL1;19 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")
  • LAST EDITED:  FEB 12, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record all change in bowel habit symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For
    example, if the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).
719 DURATION OF EMERGENCY PRES-OBS COL1;20 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")
  • LAST EDITED:  FEB 12, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record all emergency presentation-obstruction symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a
    range. For example, if the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).
720 DURATION OF JAUNDICE COL1;21 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")
  • LAST EDITED:  FEB 12, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record all jaundice symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example, if the
    patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).
721 DURATION OF MALAISE COL1;22 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")
  • LAST EDITED:  FEB 12, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record all malaise symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example, if the
    patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).
722 DURATION OF BLOOD IN STOOL COL1;23 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")
  • LAST EDITED:  FEB 12, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record all occult blood in stool symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For
    example, if the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).
723 DURATION OF PAIN (ABDOMINAL) COL1;24 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")
  • LAST EDITED:  FEB 12, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record all abdominal pain symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example,
    if the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).
724 DURATION OF PAIN (PELVIC) COL1;25 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")
  • LAST EDITED:  FEB 12, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record all pelvic pain symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example, if
    the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).
725 DURATION OF RECTAL BLEEDING COL1;26 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")
  • LAST EDITED:  FEB 12, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record all rectal bleeding symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example,
    if the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).
726 DURATION OF OTHER COL1;27 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")
  • LAST EDITED:  FEB 12, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record all other symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example, if the
    patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).
727 ENDOSCOPIC METHOD COL1;28 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record whether 'endoscopic' initial method of diagnosis was performed. If unknown, code a '9'.
728 RADIOGRAPHIC METHOD COL1;29 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record whether 'radiographic' initial method of diagnosis was performed. If unknown, code a '9'.
729 SCREENING DIGITAL RECTAL EXAM COL1;30 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record whether 'screening digital rectal exam' initial method of diagnosis was performed. If unknown, code a '9'.
730 SCREENING PHYSICAL EXAM METHOD COL1;31 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record whether 'screening physical exam' initial method of diagnosis was performed. If unknown, code a '9'.
731 OTHER INITIAL METHOD COL1;32 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record whether other initial method of diagnosis was performed. If unknown, code a '9'.
732 REASON LEADING TO EVENTUAL DX COL1;33 SET
  • '0' FOR General screening (endoscopy, hemocult);
  • '1' FOR Symptoms;
  • '2' FOR Familial history;
  • '3' FOR Genetic test;
  • '4' FOR Other;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the appropriate code for the precipitating reason or procedure which eventually lead to diagnosing this patient with this cancer. If unknown, code a '9'.
733 BARIUM ENEMA, DOUBLE CONTRAST COL1;34 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'BARIUM ENEMA, DOUBLE CONTRAST', if it was performed to evaluate this cancer. If this test was not done record a '0'.
734 BARIUM ENEMA, SINGLE CONTRAST COL1;35 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'BARIUM ENEMA, SINGLE CONTRAST', if it was performed to evaluate this cancer. If this test was not done record a '0'.
735 BARIUM ENEMA, NOS COL1;36 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'BARIUM ENEMA, NOS', if it was performed to evaluate this cancer. If this test was not done record a '0'.
736 BIOPSY OF PRIMARY SITE COL1;37 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'BIOPSY OF PRIMARY SITE', if it was performed to evaluate this cancer. If this test was not done record a '0'.
737 BIOPSY OF METASTATIC SITE COL1;38 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'BIOPSY OF METASTATIC SITE', if it was performed to evaluate this cancer. If this test was not done record a '0'.
738 CT SCAN OF LIVER COL1;39 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'CT SCAN OF LIVER', if it was performed to evaluate this cancer. If this test was not done record a '0'.
739 CT SCAN OF PRIMARY SITE (COL) COL1;40 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'CT SCAN OF PRIMARY SITE', if it was performed to evaluate this cancer. If this test was not done record a '0'.
740 CARCINOEMBRYONIC ANTIGEN (CEA) COL1;41 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'CARCINOEMBRYONIC ANTIGEN (CEA)', if it was performed to evaluate this cancer. If this test was not done record a '0'.
741 CHEST ROENTGENOGRAM COL1;42 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'CHEST ROENTGENOGRAM', if it was performed to evaluate this cancer. If this test was not done record a '0'.
742 COLONOSCOPY COL1;43 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'COLONOSCOPY', if it was performed to evaluate this cancer. If this test was not done record a '0'.
743 DIGITAL RECTAL EXAM COL1;44 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'DIGITAL RECTAL EXAM', if it was performed to evaluate this cancer. If this test was not done record a '0'.
744 FLEXIBLE SIGMOIDOSCOPY COL1;45 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 13, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'FLEXIBLE SIGMOIDOSCOPY', if it was performed to evaluate this cancer. If this test was not done record a '0'.
745 INTRAVENOUS PYELOGRAM (COL) COL1;46 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 14, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'INTRAVENOUS PYELOGRAM (IVP)', if it was performed to evaluate this cancer. If this test was not done record a '0'.
746 SERUM-LIVER FUNCTION TEST COL1;47 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 14, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'SERUM-LIVER FUNCTION TEST', if it was performed to evaluate this cancer. If this test was not done record a '0'.
747 MRI (COL) COL1;48 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 14, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'MAGNETIC RESONANCE IMAGING (MRI)', if it was performed to evaluate this cancer. If this test was not done record a '0'.
748 PROCTOSCOPY (RIGID) COL1;49 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 14, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'PROCTOSCOPY (RIGID)', if it was performed to evaluate this cancer. If this test was not done record a '0'.
749 STOOL GUAIAC (OCCULT BLOOD) COL1;50 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 14, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'STOOL GUAIAC (OCCULT BLOOD)', if it was performed to evaluate this cancer. If this test was not done record a '0'.
750 ULTRASOUND, LIVER, ABDOMEN COL1;51 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 14, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'ULTRASOUND, LIVER, ABDOMEN', if it was performed to evaluate this cancer. If this test was not done record a '0'.
751 ULTRASOUND, ENDORECTAL COL1;52 SET
  • '0' FOR Test not done;
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Procedure attempted and incomplete;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  FEB 14, 1997
  • DESCRIPTION:  
    Record the results of the Diagnostic Test 'ULTRASOUND, ENDORECTAL', if it was performed to evaluate this cancer. If this test was not done record a '0'.
752 TUMOR LEVEL-ENDOSCOPIC EXAM COL2;1 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  D TLEEOT^ONCOES
  • LAST EDITED:  FEB 14, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record the level of tumor from anal verge by endoscopic exam in centimeters if less than 61 centimeters. If greater than 60 centi- meters, record the appropriate code for tumor site in colon. If examination performed but
    tumor not visualized, record a '70'. If examination was performed, but results unknown, record '80'. If unknown whether examination was performed, record '99'. If this exam- ination was not performed code '00'.
753 LEVEL OF RECTAL TUMOR COL2;2 SET
  • '0' FOR Not measured;
  • '1' FOR Low (0-5 cm);
  • '2' FOR Medium (6-10 cm);
  • '3' FOR High (11-15 cm);
  • '7' FOR Measured but results unknown;
  • '8' FOR NA, not a rectal tumor;
  • '9' FOR Unknown if measured;

  • LAST EDITED:  FEB 19, 1997
  • DESCRIPTION:  
    Record the appropriate code for the level of rectal tumor. If level not measured, record '0'. If level measured, but results unknown, record '7'. If not applicable, record '8'. Record '9' if unknown if measured.
754 PROXIMAL MARGIN OF RESECTION COL2;3 SET
  • '0' FOR Negative;
  • '1' FOR Microscopically positive;
  • '2' FOR Grossly positive;
  • '8' FOR NA;
  • '9' FOR Unknown, not described;

  • LAST EDITED:  MAR 19, 1997
  • DESCRIPTION:  
    Record the appropriate code for the Proximal margin of resection.
755 DISTAL MARGIN OF RESECTION COL2;4 SET
  • '0' FOR Negative;
  • '1' FOR Microscopically positive;
  • '2' FOR Grossly positive;
  • '8' FOR NA;
  • '9' FOR Unknown, not described;

  • LAST EDITED:  MAR 19, 1997
  • DESCRIPTION:  
    Record the appropriate code for the Distal margin of resection.
756 RADIAL MARGIN OF RESECTION COL2;5 SET
  • '0' FOR Negative;
  • '1' FOR Microscopically positive;
  • '2' FOR Grossly positive;
  • '8' FOR NA;
  • '9' FOR Unknown, not described;

  • LAST EDITED:  MAR 19, 1997
  • DESCRIPTION:  
    Record the appropriate code for the Radial margin of resection.
757 DIST TO CLOSEST MUCOSAL MARGIN COL2;6 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y=88:"Not applicable",Y=99:"Unknown",1:Y_" mm")
  • LAST EDITED:  FEB 18, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record the distance in millimeters (mm) to the closest mucosal margin (or to dentate for abdominal perineal resection). This may also be described as the lateral or circumferential margin. Record the distance in
    millimeters. Record 88 if not applicable. If unknown, record 99.
758 DIST TO CLOSEST RADIAL MARGIN COL2;7 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y=88:"Not applicable",Y=99:"Unknown",1:Y_" mm")
  • LAST EDITED:  FEB 18, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  
    Record the distance in millimeters (mm) to the closest radial margin (or to the base of excision, if polyp). Record the distance in millimeters. Record 88 if not applicable. If unknown, record 99.
759 BLOOD VESSEL OR LYMPHATIC INV COL2;8 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 18, 1997
  • DESCRIPTION:  
    Record the appropriate code for blood vessel or lymphatic invasion.
760 EXTRAMURAL VENOUS INVASION COL2;9 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 18, 1997
  • DESCRIPTION:  
    Record the appropriate code for extramural venous invasion.
761 PROMINENT LYMPHOID INFILTRATE COL2;10 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 18, 1997
  • DESCRIPTION:  
    Record the appropriate code for prominent lymphoid infiltrate (Crohn's lymphoid follicle).
762 PHYS PROVIDING DEF TREATMENT COL2;11 SET
  • '1' FOR Colorectal board certified surgeon;
  • '2' FOR Gastroenterologist;
  • '3' FOR General surgeon;
  • '4' FOR Radiation therapist;
  • '5' FOR Other;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 19, 1997
  • DESCRIPTION:  
    Record the appropriate code representing the physician that provided the definitive treatment.
763 ADDITIONAL SURGICAL PROCEDURES COL2;12 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X I $D(X) D ASPIT^ONCOES
  • OUTPUT TRANSFORM:  D ASPOT^ONCOES
  • LAST EDITED:  FEB 20, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Enter any modified or additional surgical procedures for primary rectosigmoid or rectal cancer. Record the appropriate code if any of the specified procedures were performed. Please note that these codes do not represent
    the procedures as defined for the required surgery codes. For this field, these codes identify only the specified procedures. Record 88 for not applicable, not performed. Record 99 for unknown if performed.
  • EXECUTABLE HELP:  D ASPHP^ONCOES
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
764 LAPAROSCOPY USED DURING CDS COL2;13 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 19, 1997
  • DESCRIPTION:  
    Record whether a laparoscopic procedure was used during cancer- directed surgery. Record an '8' if not applicable.
765 METHOD OF ANASTOMOSIS COL2;14 SET
  • '0' FOR Not done;
  • '1' FOR Staple;
  • '2' FOR Created by hand;
  • '8' FOR Method not recorded;
  • '9' FOR Unknown if done;

  • LAST EDITED:  FEB 20, 1997
  • DESCRIPTION:  
    Record the appropriate code for the method of anastomosis.
766 CM FROM ANASTOMOSIS TO DENTATE COL2;15 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."2N.N) X
  • LAST EDITED:  FEB 20, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 1 Decimal Digit
  • DESCRIPTION:  
    Record the distance in centimeters of anastomosis from dentate.
767 COLOSTOMY COL2;16 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 20, 1997
  • DESCRIPTION:  
    Record whether a colonscopy was performed.
768 OOPHORECTOMY COL2;17 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 20, 1997
  • DESCRIPTION:  
    Record whether an oophorectomy was performed. If an oophorectomy was performed, record the pathological status in the pathological status field.
769 PATHOLOGICAL STATUS COL2;18 SET
  • '0' FOR Not involved;
  • '1' FOR Involved;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 19, 1997
  • DESCRIPTION:  
    Record the appropriate code. If an oophorectomy was performed, then record the pathological status in this field. If not performed, code an '8' (NA).
770 ABDOMINAL INFECTION COL2;19 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'BLEEDING/HEMATOMA', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
771 ABSCESS COL2;20 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'ABSCESS', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
772 ADMISSION FOR NEUTROPENIA COL2;21 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'ADMISSION FOR NEUTROPENIA', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
773 ANASTOMOTIC DEHISCENCE COL2;22 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'ANASTOMOTIC DEHISCENCE', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
774 DEHYDRATION COL2;23 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'DEHYDRATION', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
775 DIARRHEA COL2;24 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'DIARRHEA', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
776 EARLY BOWEL OBSTRUCTION COL2;25 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'EARLY BOWEL OBSTRUCTION', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
777 PERINEAL INFECTION COL2;26 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'PERINEAL INFECTION', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
778 PNEUMONIA (COL) COL2;27 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'PNEUMONIA', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
779 PROCTITIS COL2;28 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'PROCTITIS', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
780 PULMONARY EMBOLISM (COL) COL2;29 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'PULMONARY EMBOLISM', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
781 RADIATION ENTERITIS COL2;30 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'RADIATION ENTERITIS', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
782 STOMA COMPLICATION COL2;31 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'STOMA COMPLICATION', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
783 URINARY TRACT INFECTION COL2;32 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 04, 1997
  • DESCRIPTION:  
    Record whether the patient had the surgical complication 'URINARY TRACT INFECTION', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).
784 ENDOCAVITARY RADIATION (ECRT) COL2;33 SET
  • '0' FOR None;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 21, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether endocavitary radiation (ECRT) was given. ECRT refers to contact radiation delivered through the bowel lumen, usually proctoscopically, especially for rectal cancer.
785 INTRA-OPERATIVE RAD THERAPY COL2;34 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 21, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether intra-operative radiation therapy (IORT) was given. IORT is beam radiation and/or radioactive implants and/or radioisotopes at time of surgery.
786 PRIMARY TUMOR RAD DOSE (cGy) COL2;35 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  D PTRDOT^ONCOES
  • LAST EDITED:  FEB 21, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  Record the primary tumor total rad dose (cGy) given, including boost. If the patient did not receive radiation therapy, code 00000. If it is known that the patient received radiation therapy but the dose is unknown, code
    88888. If it is unknown if patient received radiation, code 99999.
787 NUMBER OF RADIATION TREATMENTS COL2;36 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"None",Y=88:"Given but number unknown",Y=99:"Unknown if radiation given",1:Y)
  • LAST EDITED:  FEB 21, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  
    Record the number of radiation treatments. If none, record 00. If given, but number unknown, record 88. If unknown if radiation given, record 99.
788 ADJUVANT CHEMOTHERAPY (COL) COL2;37 SET
  • '0' FOR No concomitant treatment;
  • '1' FOR Radiation and concomitant bolus chemo;
  • '2' FOR Radiation and concomitant infusion chemo;
  • '9' FOR Unknown if therapy concomitant;

  • LAST EDITED:  MAR 27, 1997
  • DESCRIPTION:  Record the Adjuvant Chemotherapy with Concomitant External Beam Radiation. If patient receives chemotherapy at any time during radiation as a radio- sensitizing agent, code 1. If chemotherapy is stopped more than 2 days
    prior to radiation therapy and not given until external beam therapy is completed, code 0. If unknown, code 9.
789 5 FU (FLUOROURACIL) COL2;38 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 21, 1997
  • DESCRIPTION:  
    Record whether the adjuvant therapy 5 FU (Fluorouracil) was given. If it is unknown if it was given, record a 9.
790 LEUCOVORIN COL2;39 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 21, 1997
  • DESCRIPTION:  
    Record whether the adjuvant therapy Leucovorin was given. If it is unknown if it was given, record a 9.
791 LEVAMISOLE COL2;40 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 1999
  • DESCRIPTION:  
    Record whether the adjuvant therapy Levamisole was given. If it is unknown if it was given, record a 9.
  • SCREEN:  S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"
  • EXPLANATION:  Code 8 should not be used for cases with a DATE DX < 1/1/1999
792 CPT 11 COL2;41 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 21, 1997
  • DESCRIPTION:  
    Record whether the adjuvant therapy CPT 11 was given. If it is unknown if it was given, record a 9.
793 OTHER ADJUVANT THERAPY COL2;42 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 21, 1997
  • DESCRIPTION:  
    Record whether any other adjuvant therapy was given. If it is unknown if any was given, record a 9.
794 DURATION OF ADJUVANT THERAPY COL2;43 SET
  • '0' FOR No adjuvant therapy;
  • '1' FOR 1 to 6 months;
  • '2' FOR 7 to 12 months;
  • '8' FOR Therapy given but duration unknown;
  • '9' FOR Unknown if therapy given;

  • LAST EDITED:  FEB 21, 1997
  • DESCRIPTION:  
    Record the appropriate code for the duration of adjuvant therapy.
795 COMPLETED DURATION OF THERAPY COL2;44 SET
  • '0' FOR No (0-1 cycle);
  • '1' FOR Yes (2 or more cycles);
  • '7' FOR No therapy planned, not applicable;
  • '8' FOR Unknown if therapy completed;
  • '9' FOR Unknown if therapy given;

  • LAST EDITED:  FEB 21, 1997
  • DESCRIPTION:  Record the appropriate code. If one or less than one cycle completed, record 0. If two or more cycles completed, record 1. If there was no adjuvant therapy planned, record 7. If therapy was given, but unknown if
    completed, record 8. If unknown if therapy given, record 9.
796 NUTRITIONAL CONSULTATION COL2;45 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 21, 1997
  • DESCRIPTION:  
    Record whether the other referral, nutritional consultation was made. If unknown, record 9.
797 OCCUPATIONAL THERAPY COL2;46 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 21, 1997
  • DESCRIPTION:  
    Record whether the other referral, occupational therapy was made. If unknown, record 9.
798 OSTOMY CONSULTATION COL2;47 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 21, 1997
  • DESCRIPTION:  
    Record whether the other referral, ostomy consultation was made. If unknown, record 9.
799 PSYCHOSOCIAL COL2;48 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 21, 1997
  • DESCRIPTION:  
    Record whether the other referral, psychosocial was made. If unknown, record 9.
800 HISTORY OF LEUKEMIA (FAM) NHL1;1 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 25, 1997
  • DESCRIPTION:  
    Record any familial history of leukemia documented in the medical record. If the record does not mention familial history of cancer, code 9 (unknown).
801 HISTORY OF NON-HODGKIN'S LYMPH NHL1;2 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 25, 1997
  • DESCRIPTION:  
    Record any familial history of Non-Hodgkin's lymphoma documented in the medical record. If the record does not mention familial history of cancer, code 9 (unknown).
802 HISTORY OF HODGKIN'S LYMPHOMA NHL1;3 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 25, 1997
  • DESCRIPTION:  
    Record any familial history of Hodgkin's lymphoma documented in the medical record. If the record does not mention familial history of cancer, code 9 (unknown).
803 1ST PRIMARY SITE NHL1;4 POINTER TO ICDO TOPOGRAPHY FILE (#164) ICDO TOPOGRAPHY(#164)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)
    9.1 = D CHFPS^ONCOMNI
  • LAST EDITED:  OCT 07, 1997
  • DESCRIPTION:  
    Record the ICD-O-2 code for the first site of any personal history of cancer documented in the medical record. If not applicable record 8's. If record does not mention personal history of any cancer, record 9's.
    WRITE AUTHORITY: ^
804 1ST PRIMARY HISTOLOGY NHL1;5 POINTER TO ICD-O-2 MORPHOLOGY FILE (#164.1) ICD-O-2 MORPHOLOGY(#164.1)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.1,+Y,0)),U,2)_" "_$P($G(^ONCO(164.1,+Y,0)),U,1)
    9.1 = D CHFPH^ONCOMNI
  • LAST EDITED:  OCT 07, 1997
  • DESCRIPTION:  Record the 5-digit histology (including behavior) code for the first histology of any personal history of cancer documented in the medical record. If not applicable record 8's. If record does not mention personal history
    of any cancer, record 9's.
    WRITE AUTHORITY: ^
805 2ND PRIMARY SITE NHL1;6 POINTER TO ICDO TOPOGRAPHY FILE (#164) ICDO TOPOGRAPHY(#164)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)
    9.1 = D CHSPS^ONCOMNI
  • LAST EDITED:  OCT 07, 1997
  • DESCRIPTION:  
    Record the ICD-O-2 code for the second site of any personal history of cancer documented in the medical record. If not applicable record 8's. If record does not mention personal history of any cancer, record 9's.
    WRITE AUTHORITY: ^
806 2ND PRIMARY HISTOLOGY NHL1;7 POINTER TO ICD-O-2 MORPHOLOGY FILE (#164.1) ICD-O-2 MORPHOLOGY(#164.1)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.1,+Y,0)),U,2)_" "_$P($G(^ONCO(164.1,+Y,0)),U,1)
    9.1 = D CHSPH^ONCOMNI
  • LAST EDITED:  OCT 07, 1997
  • DESCRIPTION:  Record the 5-digit histology (including behavior) code for the second histology of any personal history of cancer documented in the medical record. If not applicable record 8's. If record does not mention personal
    history of any cancer, record 9's.
    WRITE AUTHORITY: ^
807 ORGAN TRANSPLANT NHL1;8 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 27, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether an organ transplant was a pre-existing condition. If unknown, code 9.
808 HIV POSITIVE NHL1;9 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 27, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether being HIV positive was a pre-existing condition. If unknown, code 9.
809 CROHN'S DISEASE NHL1;10 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown/not documented;

  • LAST EDITED:  MAY 24, 2005
  • DESCRIPTION:  
    Record whether Crohn's disease was a pre-existing condition.
810 HASHIMOTO'S THYROIDITIS NHL1;11 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 06, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether Hashimoto's thyroiditis was a pre-existing condition. If unknown, code 9.
811 SYSTEMIC LUPUS ERYTHEMATOSUS NHL1;12 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 06, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether systemic lupus erythematosus was a pre-existing condition. If unknown, code 9.
812 RHEUMATOID ARTHRITIS NHL1;13 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 06, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether rheumatoid arthritis, including Sjogren's syndrome was a pre-existing condition. If unknown, code 9.
813 PNEUMOCYSTIS CARINII NHL1;14 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 06, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether pneumocystis carinii was a pre-existing condition. If unknown, code 9.
814 CMV INFECTION NHL1;15 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 06, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether CMV infection was a pre-existing condition. If unknown, code 9.
815 TUBERCULOSIS NHL1;16 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 06, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether tuberculosis was a pre-existing condition. If unknown, code 9.
816 MYCOBACTERIUM AVIUM NHL1;17 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 06, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether mycobacterium avium was a pre-existing condition. If unknown, code 9.
817 OTHER PARASITIC INFECTIONS NHL1;18 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 06, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether there were any other parasitic infections that were pre-existing conditions. If unknown, code 9.
818 OTHER CONGENITAL DISEASES NHL1;19 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 06, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether there were any other congenital diseases that were pre-existing conditions. If unknown, code 9.
819 OPPORTUNISTIC DISEASE NHL1;20 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 06, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether opportunistic disease was a pre-existing condition, ONLY IF IT WAS WITHIN THE LAST 2 YEARS. If unknown, code 9.
820 PREVIOUS CHEMOTHERAPY NHL1;21 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 11, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether the patient received any previous chemotherapy. If unknown, code 9.
821 PREVIOUS RADIATION THERAPY NHL1;22 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 11, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether the patient received any previous radiation therapy. If unknown, code 9.
822 AIDS RISK CATEGORY NHL1;23 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S Y=X D ARCHP^ONCOMNI W " ",Y K Y
  • OUTPUT TRANSFORM:  D ARCHP^ONCOMNI
  • LAST EDITED:  APR 23, 1997
  • DESCRIPTION:  Record the appropriate code. The risk categories listed (1-8) only apply to those patients who are HIV positive. Record 0 if the patient is not HIV positive. Record 7 if the patient has more than one risk category
    (2-6). Record 8 if the patient's risk category is other or unknown. Record 9 if it is unknown if the patient is HIV positive.
  • EXECUTABLE HELP:  D ARCHHLP^ONCOMNI
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
823 CT SCAN OF BRAIN NHL1;24 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 19, 1997
  • DESCRIPTION:  
    Record the results of the CT SCAN OF BRAIN if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.
824 CT SCAN OF ABDOMEN/PELVIS NHL1;25 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 19, 1997
  • DESCRIPTION:  
    Record the results of the CT SCAN OF ABDOMEN/PELVIS if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.
825 MRI OF BRAIN NHL1;26 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 19, 1997
  • DESCRIPTION:  
    Record the results of the MRI OF BRAIN if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.
826 MRI OF CHEST NHL1;27 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 19, 1997
  • DESCRIPTION:  
    Record the results of the MRI OF CHEST if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.
827 MRI OF ABDOMEN/PELVIS NHL1;28 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 19, 1997
  • DESCRIPTION:  
    Record the results of the MRI OF ABDOMEN/PELVIS if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.
828 GALLIUM SCAN NHL1;29 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 19, 1997
  • DESCRIPTION:  
    Record the results of the GALLIUM SCAN if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.
829 PET SCAN NHL1;30 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 19, 1997
  • DESCRIPTION:  
    Record the results of the PET SCAN if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.
830 LUMBAR PUNCTURE NHL1;31 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 19, 1997
  • DESCRIPTION:  
    Record the results of the LUMBAR PUNCTURE if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.
831 HEMOGLOBIN/HEMATOCRIT NHL1;32 SET
  • '0' FOR Test not done;
  • '1' FOR Normal;
  • '2' FOR Higher than normal;
  • '3' FOR Lower than normal;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 20, 1997
  • DESCRIPTION:  
    Record the appropriate code for the results of the hemoglobin/hematocrit laboratory test, if it was performed. If the test was not performed, record a '0'.
832 WHITE COUNT NHL1;33 SET
  • '0' FOR Test not done;
  • '1' FOR Normal;
  • '2' FOR Higher than normal;
  • '3' FOR Lower than normal;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 20, 1997
  • DESCRIPTION:  
    Record the appropriate code for the results of the white count laboratory test, if it was performed. If the test was not performed, record a '0'.
833 PLATELET COUNT NHL1;34 SET
  • '0' FOR Test not done;
  • '1' FOR Normal;
  • '2' FOR Higher than normal;
  • '3' FOR Lower than normal;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 20, 1997
  • DESCRIPTION:  
    Record the appropriate code for the results of the platelet count laboratory test, if it was performed. If the test was not performed, record a '0'.
834 LACTIC DEHYDROGENASE (LDH) NHL1;35 SET
  • '0' FOR Test not done;
  • '1' FOR Normal;
  • '2' FOR Higher than normal;
  • '3' FOR Lower than normal;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 20, 1997
  • DESCRIPTION:  
    Record the appropriate code for the results of the lactic dehydrogenase (LDH) laboratory test, if it was performed. If the test was not performed, record a '0'.
835 LIVER FUNCTION STUDIES (NHL) NHL1;36 SET
  • '0' FOR Test not done;
  • '1' FOR Normal;
  • '2' FOR Higher than normal;
  • '3' FOR Lower than normal;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 20, 1997
  • DESCRIPTION:  
    Record the appropriate code for the results of the liver function studies laboratory test, if it was performed. If the test was not performed, record a '0'.
836 TOTAL PROTEIN/ALBUMIN NHL1;37 SET
  • '0' FOR Test not done;
  • '1' FOR Normal;
  • '2' FOR Higher than normal;
  • '3' FOR Lower than normal;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 20, 1997
  • DESCRIPTION:  
    Record the appropriate code for the results of the total protein/albumin laboratory test, if it was performed. If the test was not performed, record a '0'.
837 GENE REARRANGEMENTS NHL1;38 SET
  • '0' FOR Not done;
  • '1' FOR Done;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 20, 1997
  • DESCRIPTION:  
    Record whether the 'Gene rearrangements' test was performed to evaluate this primary. If this test was not done, record a '0'.
838 REVIEW OF PATHOLOGY/OTHER INST NHL1;39 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown if done;

  • LAST EDITED:  MAY 28, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether there was a review of pathology at another institution by another pathologist.
839 LYMPH NODE BIOPSY NHL1;40 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 20, 1997
  • DESCRIPTION:  
    Record the appropriate code for lymph node biopsy, if it was performed. If this biopsy was not performed record a '0'.
840 BONE MARROW BIOPSY NHL1;41 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 20, 1997
  • DESCRIPTION:  
    Record the appropriate code for bone marrow biopsy, if it was performed. If this biopsy was not performed record a '0'.
841 CSF CYTOLOGY NHL1;42 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 20, 1997
  • DESCRIPTION:  
    Record the appropriate code for CSF cytology biopsy, if it was performed. If this biopsy was not performed record a '0'.
842 OTHER SITE BIOPSY NHL1;43 SET
  • '0' FOR Test not done;
  • '1' FOR Positive for cancer;
  • '2' FOR Negative for cancer;
  • '3' FOR Equivocal, suggestive of cancer;
  • '7' FOR Test attempted but not completed;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  MAR 20, 1997
  • DESCRIPTION:  
    Record the appropriate code for other site biopsy, if it was performed. If this biopsy was not performed record a '0'.
843 SYSTEMIC SYMPTOMS NHL1;44 SET
  • '1' FOR A (no symptoms);
  • '2' FOR B (defined systemic symptoms);
  • '9' FOR Unknown whether A or B;

  • LAST EDITED:  MAR 20, 1997
  • DESCRIPTION:  Record whether the patient was category A (without defined systemic symptoms) or B (with defined systemic symptoms). These symptoms include unexplained weight loss of at least 10% within 6 months prior to diagnosis,
    unexplained fever above 38 C, and drenching night sweats. Neither pruritus alone or short febrile illness associated with infection qualify within these systemic symptoms.
844 CD4 COUNT NHL1;45 SET
  • '0' FOR Test not done;
  • '1' FOR < 1,000 copies/ml;
  • '2' FOR 1,000 to 9,999 copies/ml;
  • '3' FOR > or = to 10,000 copies/ml;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  APR 15, 1997
  • DESCRIPTION:  
    Record the appropriate code for CD4 count, a diagnostic test specifically related to HIV disease. If the test was not performed, record a '0'.
845 HIV VIRAL LOADS NHL1;46 SET
  • '0' FOR Test not done;
  • '1' FOR < 10,000 copies/ml;
  • '2' FOR > or = to 10,000 copies/ml;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  APR 15, 1997
  • DESCRIPTION:  
    Record the appropriate code for HIV viral loads, a diagnostic test specifically related to HIV disease. If the test was not performed, record a '0'.
846 SPECIFIC HISTOLOGIC INFO NHL2;1 SET
  • '1' FOR Mantle cell lymphoma;
  • '2' FOR MALT lymphoma;
  • '3' FOR Peripheral T-cell lymphoma;
  • '4' FOR Anaplastic, large cell (Ki-1) lymphoma;
  • '8' FOR NA, no additional histologies noted;
  • '9' FOR Unknown if any histologies noted;

  • LAST EDITED:  APR 15, 1997
  • DESCRIPTION:  This field is used to record any additional specific histologic data. For this field record the appropriate code (1-4) if any of the specified histologies were noted. (Please note that 1-Mantle cell lymphoma is not the
    same histology as mantle zone lymphoma which is listed in the ICD-0-2 code book as 9673). Record '8' for not applicable, if none of these listed were noted. Record '9' if unknown if any of these histologies were noted.
847 CELL TYPE OF LYMPHOMA NHL2;2 SET
  • '1' FOR T cell;
  • '2' FOR B cell;
  • '3' FOR Null cell;
  • '4' FOR N X cell (natural killer cell);
  • '9' FOR Cell type unknown;

  • LAST EDITED:  MAR 21, 1997
  • DESCRIPTION:  
    Record the appropriate code for the cell type of the lymphoma. If the cell type is unknown, record a '9'.
848 PATIENT STATUS AT DIAGNOSIS NHL2;3 SET
  • '0' FOR Bedridden < or = to 50%;
  • '1' FOR Bedridden > 50%;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 15, 1997
  • DESCRIPTION:  
    Record the appropriate code for the patient's status at diagnosis. If completely ambulatory, record a '0'. If unknown, record a '9'.
849 TYPE OF STAGING SYSTEM (PED) NHL2;4 POINTER TO TYPE OF STAGING SYSTEM (PEDIATRIC) FILE (#164.6) TYPE OF STAGING SYSTEM (PEDIATRIC)(#164.6)

  • OUTPUT TRANSFORM:  S Y=$S(Y'="":$P($G(^ONCO(164.6,Y,0)),"^",2),1:"")
  • LAST EDITED:  APR 29, 1997
  • DESCRIPTION:  
    If recording a pediatric case, enter the type of staging system used to stage this patient. If not applicable, code '88'. If unknown, code '99'.
850 PEDIATRIC STAGE NHL2;5 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1) X I $D(X) S STGIND="X" D IN^ONCOTNS
  • OUTPUT TRANSFORM:  S X="" D OT^ONCOTNS
  • LAST EDITED:  MAY 01, 1997
  • HELP-PROMPT:  Answer with the appropriate stage from the AJCC Staging Manual.
  • DESCRIPTION:  
    Enter the pediatric stage as specified in the pediatric staging system selected. If not applicable, code '88'. If the pediatric stage is unknown, code '99'.
  • EXECUTABLE HELP:  S STGIND="X" D HP^ONCOTNS
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
851 STAGED BY (PEDIATRIC STAGE) NHL2;6 SET
  • '0' FOR Not staged;
  • '1' FOR Managing physician;
  • '2' FOR Pathologist;
  • '3' FOR Other physician;
  • '4' FOR Any combination of 1,2 or 3;
  • '5' FOR Registrar;
  • '6' FOR Any combination of 5 w/ 1,2 or 3;
  • '7' FOR Other;
  • '8' FOR Staged, individual not specified;
  • '9' FOR Unknown if staged;

  • LAST EDITED:  APR 18, 1997
  • DESCRIPTION:  
    Record the appropriate code for the individual who staged this pediatric case. If the patient was not staged, code '0'.
852 EXTRANODAL SITE 1 NHL2;7 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>20!($L(X)<1) X I $D(X) D EXNSIT^ONCOMNI
  • OUTPUT TRANSFORM:  D EXNSOT^ONCOMNI
  • LAST EDITED:  MAR 26, 1997
  • DESCRIPTION:  
    Provide ICD-O-2 site codes for the 1st clinically and/or pathologically involved extranodal site (in addition to the primary site). If no 1st extranodal site, code 8's. If unknown, code 9's.
  • EXECUTABLE HELP:  D XHP^ONCOMNI
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
853 EXTRANODAL SITE 2 NHL2;8 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>20!($L(X)<1) X I $D(X) D EXNSIT^ONCOMNI
  • OUTPUT TRANSFORM:  D EXNSOT^ONCOMNI
  • LAST EDITED:  MAR 26, 1997
  • DESCRIPTION:  
    Provide ICD-O-2 site codes for the 2nd clinically and/or pathologically involved extranodal site (in addition to the primary site). If no 2nd extranodal site, code 8's. If unknown, code 9's.
  • EXECUTABLE HELP:  D XHP^ONCOMNI
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
854 EXTRANODAL SITE 3 NHL2;9 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>20!($L(X)<1) X I $D(X) D EXNSIT^ONCOMNI
  • OUTPUT TRANSFORM:  D EXNSOT^ONCOMNI
  • LAST EDITED:  MAR 26, 1997
  • DESCRIPTION:  
    Provide ICD-O-2 site codes for the 3rd clinically and/or pathologically involved extranodal site (in addition to the primary site). If no 3rd extranodal site, code 8's. If unknown, code 9's.
  • EXECUTABLE HELP:  D XHP^ONCOMNI
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
855 EXTRANODAL SITE W/C-D SURGERY NHL2;10 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>20!($L(X)<1) X I $D(X) D EXNSIT^ONCOMNI
  • OUTPUT TRANSFORM:  D EXNSOT^ONCOMNI
  • LAST EDITED:  MAR 26, 1997
  • DESCRIPTION:  
    Record the ICD-O-2 site code for any extranodal cancer-directed surgery, other than the primary-site surgery. If no additional cancer-directed surgery to an extranodal site, code 8's. If unknown, code 9's.
  • EXECUTABLE HELP:  D XHP^ONCOMNI
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
856 EXTRANODAL SITE SURGICAL PROC NHL2;11 NUMBER

  • INPUT TRANSFORM:  D ESSPIT^ONCODSR
  • OUTPUT TRANSFORM:  D ESSPOT^ONCODSR
  • LAST EDITED:  MAR 28, 1997
  • HELP-PROMPT:  Type a Number between 0 and 90, 0 Decimal Digits
  • DESCRIPTION:  
    Record the appropriate cancer-directed surgical code for the first extranodal site. If there is no additional cancer-directed surgical procedure to an extranodal site, code '00'.
  • EXECUTABLE HELP:  D ESSHP^ONCODSR
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
857 LYMPH NODES ABOVE DIAPHRAGM NHL2;12 SET
  • '1' FOR Irradiated;
  • '2' FOR Not irradiated;
  • '8' FOR NA, unknown if radiation therapy given;
  • '9' FOR Radiation given, unknown if irradiated;

  • LAST EDITED:  APR 18, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether the lymph nodes above the diaphragm were irradiated. Please see the "Lymph Node Location Relative to Diaphragm" handout for additional information.
858 LYMPH NODES BELOW DIAPHRAGM NHL2;13 SET
  • '1' FOR Irradiated;
  • '2' FOR Not irradiated;
  • '8' FOR NA, unknown if radiation therapy given;
  • '9' FOR Radiation therapy administered, unknown if this field irradiated;

  • LAST EDITED:  MAR 31, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether the lymph nodes below the diaphragm were irradiated. Please see the "Lymph Node Location Relative to Diaphragm" handout for additional information.
859 BRAIN NHL2;14 SET
  • '1' FOR Irradiated;
  • '2' FOR Not irradiated;
  • '8' FOR NA, unknown if radiation therapy given;
  • '9' FOR Radiation therapy administered, unknown if this field irradiated;

  • LAST EDITED:  MAR 28, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether the brain was irradiated. If it is unknown if radiation therapy was given, code 8. If radiation therapy was administered but it is unknown if the brain was irradiated, code 9.
860 OTHER EXTRANODAL SITE(S) NHL2;15 SET
  • '1' FOR Irradiated;
  • '2' FOR Not irradiated;
  • '8' FOR NA, unknown if radiation therapy given;
  • '9' FOR Radiation therapy administered, unknown if this field irradiated;

  • LAST EDITED:  MAR 28, 1997
  • DESCRIPTION:  Record the appropriate code for whether other extranodal site(s) were irradiated. If it is unknown if radiation therapy was given, code 8. If radiation therapy was administered but it is unknown if other extranodal sites
    were irradiated, code 9.
861 TOTAL BODY NHL2;16 SET
  • '1' FOR Irradiated;
  • '2' FOR Not irradiated;
  • '8' FOR NA, unknown if radiation therapy given;
  • '9' FOR Radiation therapy administered, unknown if this field irradiated;

  • LAST EDITED:  MAR 31, 1997
  • DESCRIPTION:  Record the appropriate code for whether the total body was irradiated. If it is unknown if radiation therapy was given, code 8. If radiation therapy was administered but it is unknown if the total body was irradiated,
    code 9.
862 RADIATION/CHEMO SEQUENCE NHL2;17 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D RCSIT^ONCOMNI
  • OUTPUT TRANSFORM:  D RCSOT^ONCOMNI
  • LAST EDITED:  MAR 28, 1997
  • HELP-PROMPT:  Type a Number between 0 and 9, 0 Decimal Digits
  • DESCRIPTION:  
    Record the appropriate code for radiation/chemotherapy sequence.
  • EXECUTABLE HELP:  D RCSHP^ONCOMNI
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
863 PROTOCOL NHL2;18 SET
  • '0' FOR Not on protocol;
  • '1' FOR Cancer cooperative group trial;
  • '2' FOR Other investigative, IRB-approved protocol;
  • '9' FOR Unknown if on protocol;

  • LAST EDITED:  MAR 31, 1997
  • DESCRIPTION:  
    Record the appropriate code for systemic and/or intrathecal chemotherapy. If unknown, code 9.
864 SYSTEMIC CHEMOTHERAPY NHL2;19 SET
  • '0' FOR None;
  • '1' FOR Systemic chemotherapy, NOS;
  • '2' FOR Systemic chemotherapy, single agent;
  • '3' FOR Systemic chemotherapy, multiple agents;
  • '9' FOR Unknown if administered;

  • LAST EDITED:  APR 22, 1997
  • DESCRIPTION:  
    Record the appropriate code for the administration of systemic chemotherapy. If unknown if administered, code 9.
865 SYSTEMIC CHEMOTHERAPY DATE NHL2;20 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  APR 03, 1997
  • HELP-PROMPT:  *** SYSTEMIC CHEMOTHERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  
    Record the first date on which systemic chemotherapy was administered.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
866 SYSTEMIC CHEMOTHERAPY CYCLES NHL2;21 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • OUTPUT TRANSFORM:  S:$L(Y)=1 Y="0"_Y S Y=$S(Y="01":Y_" cycle",Y=88:"NA",Y=97:"Given but number unknown",Y=98:"No termination date assigned at onset of chemotherapy",Y=99:"Unknown if chemotherapy given",1:Y_" cycles")
  • LAST EDITED:  APR 22, 1997
  • HELP-PROMPT:  Type a Number between 0 and 99, 0 Decimal Digits
  • DESCRIPTION:  Record the number of planned cycles of systemic chemotherapy. If not applicable (no systemic chemotherapy given), code 88. If given, but number unknown, code 97. If no termination date assigned at onset of systemic
    chemotherapy, code 98. If unknown if systemic chemotherapy was administered, code 99.
867 CHLORAMBUCIL NHL2;22 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown if given;

  • LAST EDITED:  APR 22, 1997
  • DESCRIPTION:  
    Record whether this chemotherapeutic agent was administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
868 CYCLOPHOSPHAMIDE (NHL) NHL2;23 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown if given;

  • LAST EDITED:  APR 22, 1997
  • DESCRIPTION:  
    Record whether this chemotherapeutic agent was administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
869 DOXORUBICIN (NHL) NHL2;24 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown if given;

  • LAST EDITED:  APR 22, 1997
  • DESCRIPTION:  
    Record whether this chemotherapeutic agent was administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
870 FLUDARABINE NHL2;25 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown if given;

  • LAST EDITED:  APR 22, 1997
  • DESCRIPTION:  
    Record whether this chemotherapeutic agent was administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
871 CHOP NHL2;26 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown if given;

  • LAST EDITED:  APR 22, 1997
  • DESCRIPTION:  
    Record whether the combination chemotherapy agents, CHOP were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
872 CVP NHL2;27 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown if given;

  • LAST EDITED:  APR 22, 1997
  • DESCRIPTION:  
    Record whether the combination chemotherapy agents, CVP were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
873 COMLA NHL2;28 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown if given;

  • LAST EDITED:  APR 22, 1997
  • DESCRIPTION:  
    Record whether the combination chemotherapy agents, COMLA were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
874 MACOP-B NHL2;29 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown if given;

  • LAST EDITED:  APR 22, 1997
  • DESCRIPTION:  
    Record whether the combination chemotherapy agents, MACOP-B were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
875 M-BACOD NHL2;30 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown if given;

  • LAST EDITED:  APR 22, 1997
  • DESCRIPTION:  
    Record whether the combination chemotherapy agents, M-BACOD were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
876 PRO-MACE-Cyta BOM NHL2;31 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown if given;

  • LAST EDITED:  APR 22, 1997
  • DESCRIPTION:  
    Record whether the combination chemotherapy agents, PRO-MACE-Cyta BOM were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
877 OTHER SYSTEMIC CHEMO AGENTS NHL2;32 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown if given;

  • LAST EDITED:  APR 22, 1997
  • DESCRIPTION:  
    Record whether any other combination chemotherapy agents were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.
878 HIGH DOSE SYSTEMIC CHEMO NHL2;33 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown if given;

  • LAST EDITED:  APR 01, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether high dose systemic chemotherapy with stem cell rescue was done. If unknown if done, code 9.
879 INTRATHECAL CHEMOTHERAPY NHL2;34 SET
  • '0' FOR None;
  • '1' FOR Administered;
  • '9' FOR Unknown if administered;

  • LAST EDITED:  APR 23, 1997
  • DESCRIPTION:  
    Record the appropriate code for whether intrathecal chemotherapy was administered. If unknown if administered, code 9.
880 PURPOSE OF INTRATHECAL CHEMO NHL2;35 SET
  • '1' FOR Treatment;
  • '2' FOR Prophylaxis;
  • '7' FOR NA, not administered;
  • '8' FOR Administered, purpose unknown;
  • '9' FOR Unknown if administered;

  • LAST EDITED:  APR 23, 1997
  • DESCRIPTION:  Record the appropriate code for the purpose of intrathecal chemotherapy. If not applicable, intrathecal chemetherapy not administered, code 7. If intrathecal chemotherapy administered, but purpose unknown, code 8. If
    unknown whether intrathecal chemotherapy administered, code 9.
881 INTERFERON (NHL) NHL2;36 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 1999
  • DESCRIPTION:  
    Record the appropriate code for whether this type of immunotherapy was performed. If unknown if performed, code 9.
882 INTERLEUKIN-2 (IL-2) (NHL) NHL2;37 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 1999
  • DESCRIPTION:  
    Record the appropriate code for whether this type of immunotherapy was performed. If unknown if performed, code 9.
883 MONOCLONAL ANTIBODIES NHL2;38 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 1999
  • DESCRIPTION:  
    Record the appropriate code for whether this type of immunotherapy was performed. If unknown if performed, code 9.
884 VACCINE THERAPY NHL2;39 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 1999
  • DESCRIPTION:  
    Record the appropriate code for whether this type of immunotherapy was performed. If unknown if performed, code 9.
  • SCREEN:  S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"
  • EXPLANATION:  Code 8 should not be used for cases with a DATE DX < 1/1/1999
900 DAUGHTER (BR98) BRE1;1 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 15, 1998
  • DESCRIPTION:  Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.
901 MATERNAL AUNT (BR98) BRE1;2 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 15, 1998
  • DESCRIPTION:  Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.
902 MATERNAL GRANDMOTHER (BR98) BRE1;3 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 15, 1998
  • DESCRIPTION:  Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.
903 MOTHER (BR98) BRE1;4 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 15, 1998
  • DESCRIPTION:  Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.
904 ONE SISTER (BR98) BRE1;5 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 15, 1998
  • DESCRIPTION:  Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.
905 MORE THAN ONE SISTER (BR98) BRE1;6 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 15, 1998
  • DESCRIPTION:  Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.
906 FATHER (BR98) BRE1;7 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 15, 1998
  • DESCRIPTION:  Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.
907 BROTHER (BR98) BRE1;8 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 15, 1998
  • DESCRIPTION:  Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.
908 FAM HISTORY BREAST CA (BR98) BRE1;9 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 15, 1998
  • DESCRIPTION:  Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.
909 HISTORY OF BREAST CA (BR98) BRE1;10 SET
  • '0' FOR None;
  • '1' FOR Invasive;
  • '2' FOR Ductal carcinoma in situ;
  • '3' FOR Lobular carcinoma in situ;
  • '4' FOR Other histology;
  • '8' FOR History of breast ca, type unknown;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 25, 1998
  • DESCRIPTION:  For females, record any personal history of breast cancer not synchronous (diagnosed 6 months or more prior) with the current breast cancer. For males, leave this field blank.
910 SYNCHRONOUS BREAST CA (BR98) BRE1;11 SET
  • '0' FOR No;
  • '1' FOR Ipsilateral;
  • '2' FOR Contralateral;
  • '3' FOR Both;
  • '8' FOR Yes, but laterality unknown;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 02, 1998
  • DESCRIPTION:  Record any synchronous breast cancer diagnosed up to but not including 6 months prior to current breast cancer.
911 COLON (BR98) BRE1;12 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 04, 1998
  • DESCRIPTION:  Record whether the patient had colon cancer diagnosed either prior to this breast cancer or at the same time that this breast cancer was diagnosed.
912 OVARY (BR98) BRE1;13 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 04, 1998
  • DESCRIPTION:  Record whether the patient had ovarian cancer diagnosed either prior to this breast cancer or at the same time that this breast cancer was diagnosed. If the patient is a male leave this field blank.
913 UTERUS (BR98) BRE1;14 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 04, 1998
  • DESCRIPTION:  Record whether the patient had uterine cancer diagnosed either prior to this breast cancer or at the same time that this breast cancer was diagnosed. If the patient is a male leave this field blank.
914 PROSTATE (BR98) BRE1;15 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 04, 1998
  • DESCRIPTION:  Record whether the patient had prostate cancer diagnosed either prior to this breast cancer or at the same time that this breast cancer was diagnosed. If the patient is a female leave this field blank.
915 OTHER (BR98) BRE1;16 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 04, 1998
  • DESCRIPTION:  Record whether the patient had other cancer diagnosed either prior to this breast cancer or at the same time that this breast cancer was diagnosed.
916 HORMONE REPLACEMENT TPY (BR98) BRE1;17 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 05, 1998
  • DESCRIPTION:  Record whether the patient was/is on hormone replacement therapy (estrogen/progesterone). If the patient is a male leave this field blank.
917 HORMONE REPLACEMENT YRS (BR98) BRE1;18 SET
  • '1' FOR Less than 5 years;
  • '2' FOR 5 to 9 years;
  • '3' FOR 10 years or more;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 08, 1998
  • DESCRIPTION:  Record the appropriate code for the number of years of hormone replacement therapy the patient had. If patient is not on this therapy, code 8, not applicable. If the patient is a male leave this field blank.
918 UNKNOWN MAMMOGRAM (BR98) BRE1;19 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 05, 1998
  • DESCRIPTION:  For FEMALE patients ONLY, record the appropriate code for whether a mammogram was given, but the type was unknown. If the type is known then record a 0. If the patient is male, leave this field blank.
919 UNKNOWN MAMMOGRAM DT (BR98) BRE1;20 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  JUN 05, 1998
  • HELP-PROMPT:  *** UNKNOWN MAMMOGRAM DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  For FEMALE patients ONLY, record the date the mammogram was given if the type of mammogram is unknown. Use the most recent date if this unknown type of mammogram was done more than once. Record 0's if this type of
    mammogram was not given. Record 9's if it is unknown if this type was given. If the patient is male, leave this field blank.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
920 SCREENING MAMMOGRAM (BR98) BRE1;21 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 05, 1998
  • DESCRIPTION:  For FEMALE patients ONLY, record the appropriate code for whether a screening mammogram was given. If the patient is male, leave this field blank.
921 SCREENING MAMMOGRAM DT (BR98) BRE1;22 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  JUN 05, 1998
  • HELP-PROMPT:  *** SCREENING MAMMOGRAM DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  For FEMALE patients ONLY, record the date the screening mammogram was given. Use the most recent date if screening mammogram was done more than once. Record 0's if screening mammogram was not given. Record 9's if it is
    unknown if screening mammogram was given. If the patient is male, leave this field blank.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
922 DIAGNOSTIC MAMMOGRAM (BR98) BRE1;23 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 05, 1998
  • DESCRIPTION:  For FEMALE patients ONLY, record the appropriate code for whether a diagnostic mammogram was given. If the patient is male, leave this field blank.
923 DIAGNOSTIC MAMMOGRAM DT (BR98) BRE1;24 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  JUN 05, 1998
  • HELP-PROMPT:  *** DIAGNOSTIC MAMMOGRAM DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  For FEMALE patients ONLY, record the date the diagnostic mammogram was given. Use the most recent date if diagnostic mammogram was done more than once. Record 0's if diagnostic mammogram was not given. Record 9's if it
    is unknown if diagnostic mammogram was given. If the patient is male, leave this field blank.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
924 MAGNIFICATION MAMMOGRAM (BR98) BRE1;25 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 05, 1998
  • DESCRIPTION:  For FEMALE patients ONLY, record the appropriate code for whether a magnification mammogram was given. A magnification mammogram can be identified by finding the word "magnification" or "compression" in the title or body
    of the report. If the patient is male, leave this field blank.
925 MAGNIFICATION MAMM DT (BR98) BRE1;26 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  JUN 05, 1998
  • HELP-PROMPT:  *** MAGNIFICATION MAMMOGRAM DATE MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  For FEMALE patients ONLY, record the date the magnification mammogram was given. Use the most recent date if magnification mammogram was done more than once. Record 0's if magnification mammogram was not given. Record
    9's if it is unknown if magnification mammogram was given. If the patient is male, leave this field blank.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
926 MAMMOGRAM (BR98) BRE1;27 SET
  • '0' FOR Test not done;
  • '1' FOR Results positive for cancer;
  • '2' FOR Results negative for cancer;
  • '8' FOR Test done, results equivocal/unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JUN 08, 1998
  • DESCRIPTION:  For MALES ONLY, record the results of the mammogram performed to evaluate the extent of breast cancer. If the mammogram was done but the results cannot be determined, code 8. If it is unknown if a mammogram was
    performed, code 9. If no mammogram was done, code 0.
927 ULTRASOUND (BR98) BRE1;28 SET
  • '0' FOR Test not done;
  • '1' FOR Results positive for cancer;
  • '2' FOR Results negative for cancer;
  • '8' FOR Test done, results equivocal/unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JUN 08, 1998
  • DESCRIPTION:  Record the results of the ultrasound if one was performed to evaluate the extent of breast cancer. If the ultrasound was done but the results cannot be determined, code 8. If it is unknown if an ultrasound was
    performed, code 9. If no ultrasound was done, code 0.
928 MOST DEFINITIVE MAMM (BR98) BRE1;29 SET
  • '0' FOR Negative/no abnormality;
  • '1' FOR Localized calcifications;
  • '2' FOR Diffuse calcifications;
  • '3' FOR Mass, no calcifications;
  • '4' FOR Mass plus one quad calcification;
  • '5' FOR Mass plus multiple quad calcifications;
  • '6' FOR NOS;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 08, 1998
  • DESCRIPTION:  For FEMALES ONLY, record the results of the patient's most definitive mammogram in this field. If no mammogram was done record 8, not applicable. For males, leave this field blank.
929 DATE OF PATHOLOGIC DX (BR98) BRE1;30 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  JUN 08, 1998
  • HELP-PROMPT:  *** DATE OF PATHOLOGIC DX MUST BE AFTER OR EQUAL TO DATE DX ***
  • DESCRIPTION:  Record the date that this breast cancer was first pathologically diagnosed.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
930 DCSI ALSO PRESENT (BR98) BRE1;31 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>1!($L(X)<1) X I $D(X) D DCISIT^ONCOOT
  • OUTPUT TRANSFORM:  D DCISOT^ONCOOT
  • LAST EDITED:  JUN 09, 1998
  • HELP-PROMPT:  Answer must be 1 character in length.
  • DESCRIPTION:  If invasive ductal carcinoma is reported (Behavior code = 3), code if ductal carcinoma in situ (DCIS) is also present. If DCIS is not present, code 0. If DCIS is also present as a separate, simultaneous tumor, record 1.
    If DCIS is also present as mixed histology (in situ/invasive) in one tumor, record 2. If DCIS is also present, both as a separate tumor and in a tumor with mixed histology, record 3. If DCIS is also present, but unknown
    whether as a separate tumor or mixed histology, record 4. If reported tumor is not invasive ductal carcinoma, record 8, not applicable. If unknown whether DCIS is also present, record 9.
  • EXECUTABLE HELP:  D DCISHP^ONCOOT
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
931 ARCHITECTURE PATTERN (BR98) BRE1;32 SET
  • '1' FOR Cribriform;
  • '2' FOR Micro papillary;
  • '3' FOR Comedo;
  • '4' FOR Solid;
  • '5' FOR Other;
  • '6' FOR NOS;
  • '7' FOR Mixed (any combination);
  • '8' FOR NA, not DCIS;
  • '9' FOR Pattern unknown;

  • LAST EDITED:  JUN 12, 1998
  • DESCRIPTION:  Record the architecture pattern, if DCIS is present (either as the reported tumor, or as a separate tumor simultaneous with an invasive ductal carcinoma, or as a tumor with mixed histology - in situ/invasive ductal
    carcinoma). This information is found on the pathology report, often under the histology description, or it may be found in the diagnostic report.
932 NUCLEAR GRADE (BR98) BRE1;33 SET
  • '1' FOR Low;
  • '2' FOR Intermediate;
  • '3' FOR High;
  • '4' FOR NOS;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 12, 1998
  • DESCRIPTION:  Record the nuclear grade, if DCIS is present (either as the reported tumor, or as a separate tumor simultaneous with an invasive ductal carcinoma, or as a tumor with mixed histology - in situ/invasive ductal carcinoma).
    This information is found on the pathology report, often under the histology description, or it may be in the diagnostic report. It is identified by the terms low, intermediate and high.
933 SKIN INVOLVEMENT (BR98) BRE1;34 SET
  • '0' FOR No involvement;
  • '1' FOR Involvement;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 12, 1998
  • DESCRIPTION:  For male patients, record the extent of involvement of the skin. For female patients, leave this field blank.
934 CHEST WALL INVOLVEMENT (BR98) BRE1;35 SET
  • '0' FOR No involvement;
  • '1' FOR Involvement;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 12, 1998
  • DESCRIPTION:  For male patients, record the extent of involvement of the chest wall. For female patients, leave this field blank.
935 PECTORAL INVOLVEMENT (BR98) BRE1;36 SET
  • '0' FOR No involvement;
  • '1' FOR Involvement;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 12, 1998
  • DESCRIPTION:  For male patients, record the extent of involvement of the pectoral muscles. For female patients, leave this field blank.
936 DERMAL/LYMPHATIC INV (BR98) BRE1;37 SET
  • '0' FOR No involvement;
  • '1' FOR Involvement;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 12, 1998
  • DESCRIPTION:  For male patients, record the extent of dermal/lymphatic involvement. For female patients, leave this field blank.
937 DNA INDEX/PLOIDY (BR98) BRE1;38 SET
  • '0' FOR Test not done;
  • '1' FOR Diploid;
  • '2' FOR Non-diploid;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JUN 12, 1998
  • DESCRIPTION:  For male patients, record the DNA Index/Ploidy. This is usually determined by flow symmetry. For females, leave this field blank.
940 ANDROGEN RECEPTOR (BR98) BRE1;41 SET
  • '0' FOR Not done;
  • '1' FOR Positive;
  • '2' FOR Negative;
  • '3' FOR Low borderline;
  • '7' FOR NA;
  • '8' FOR Test done, results unknown;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JUN 12, 1998
  • DESCRIPTION:  For male patients, record the results of the androgen receptor protein test. The results of these tests are sometimes shown as percents. For females, leave this field blank.
941 TYPE OF TEST (BR98) BRE1;42 SET
  • '0' FOR Neither ERA nor PRA was done;
  • '1' FOR Immunohistochemical test;
  • '2' FOR Biochemical test;
  • '8' FOR ERA or PSA was done, type of test unknown;
  • '9' FOR Unknown if ERA/PRA was done;

  • LAST EDITED:  JUN 18, 1998
  • DESCRIPTION:  If possible to determine, indicate which type of test was used for the ERA/PRA. Answer for estrogen receptor protein (ERA) first, and if that was not done, then answer for progesterone receptor protein (PRA). If neither
    ERA or PRA tests were done, record 0.
942 SIZE OF DCIS TUMOR (MM) (BR98) BRE1;43 NUMBER

  • INPUT TRANSFORM:  K:X>999!(X<0)!(X?.E1"."1N.N) X I $D(X) D DCSZIT^ONCOOT
  • OUTPUT TRANSFORM:  D DCSZOT^ONCOOT
  • LAST EDITED:  JUN 19, 1998
  • HELP-PROMPT:  Type a Number between 0 and 999, 0 Decimal Digits
  • DESCRIPTION:  Record the size of DCIS tumor. If the tumor being reported is coded as invasive ductal carcinoma and ductal carcinoma in situ is also present either as a separate, simultaneous tumor or in a tumor with mixed histology
    (in situ/invasive), record the largest dimension or diameter of the DCIS tumor in millimeters. Do not guess the size of the tumor. Do not use specimen size. Use size as recorded in the pathology report, if it is present.
    If invasive ductal carcinoma is reported but DCIS is not present, record 000. If invasive ductal carcinoma is not reported, record 888, not applicable. If invasive ductal carcinoma is reported and DCIS is also present
    but its size is not known, record 988. If ductal carcinoma is reported but presence of DCIS is unknown, record 999.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
943 SENTINEL NODE BIOPSY BRE1;44 SET
  • '0' FOR No;
  • '1' FOR Yes, positive;
  • '2' FOR Yes, negative;
  • '3' FOR Yes, results unknown;
  • '4' FOR Attempted, unsuccessful;
  • '8' FOR NA, not done, ocular site;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 29, 1999
  • DESCRIPTION:  Record whether a sentinel node biopsy was performed. The sentinel node is the first lymph node(s) in the axillary lymph node basin receiving the lymphatic drainage of the breast. There may be one or several sentinel
    nodes identified by radionuclide injection, dye injection, or combination of the two. If surgeon could not find a sentinel node, record 4 - attempted, unsuccessful.
  • SCREEN:  S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"
  • EXPLANATION:  Code 8 should not be used for cases with a DATE DX < 1/1/1999.
944 SENTINEL NODES EXAMINED (BR98) BRE1;45 SET
  • '0' FOR None;
  • '1' FOR 1 node examined;
  • '2' FOR 2 nodes examined;
  • '3' FOR 3 nodes examined;
  • '4' FOR 4 nodes examined;
  • '5' FOR 5 nodes examined;
  • '6' FOR 6 nodes examined;
  • '7' FOR 7 or more nodes examined;
  • '8' FOR Examined, number unknown;
  • '9' FOR Unknown if examined;

  • LAST EDITED:  JUN 17, 1998
  • DESCRIPTION:  Enter the number of sentinel nodes examined. Record 0 if no sentinel nodes examined. Record 8 if nodes examined, but the number is unknown and record 9 if it is unknown if sentinel nodes were examined.
945 SENTINEL NODES POSITIVE (BR98) BRE1;46 SET
  • '0' FOR None positive;
  • '1' FOR 1 positive node;
  • '2' FOR 2 positive nodes;
  • '3' FOR 3 positive nodes;
  • '4' FOR 4 positive nodes;
  • '5' FOR 5 positive nodes;
  • '6' FOR 6 or more positive nodes;
  • '7' FOR None examined;
  • '8' FOR Positive, number unknown;
  • '9' FOR Unknown if positive;

  • LAST EDITED:  JUN 17, 1998
  • DESCRIPTION:  Enter the number of sentinel nodes positive. Record 0 if none are positive. Record 7 if none were examined. Record 8 if the positive number is unknown, and record 9 if it is unknown if any were positive.
946 SENTINEL NODES DETECTED (BR98) BRE1;47 SET
  • '1' FOR Vital blue dye;
  • '2' FOR Radionuclide;
  • '3' FOR Combination;
  • '8' FOR NA, not done;
  • '9' FOR Method unknown;

  • LAST EDITED:  JUN 17, 1998
  • DESCRIPTION:  Record the method by which the sentinel node was detected.
947 SPECIMEN RADIOGRAPH (BR98) BRE1;48 SET
  • '0' FOR Not done;
  • '1' FOR Calcification;
  • '2' FOR Mass;
  • '3' FOR Both calcification and mass;
  • '4' FOR Radiograph done, results NOS;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 18, 1998
  • DESCRIPTION:  Record the results of the radiograph. The radiograph is a film of the excised specimen.
948 SUBMITTED TO PATHOLOGY (BR98) BRE1;49 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 18, 1998
  • DESCRIPTION:  Record whether the entire specimen was submitted to pathology.
949 MARGIN DISTANCE (BR98) BRE1;50 SET
  • '0' FOR Margins not free, involved;
  • '1' FOR Less than 1 mm;
  • '2' FOR 1 to 2 mm;
  • '3' FOR 3 to 5 mm;
  • '4' FOR Greater than 5 mm;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 18, 1998
  • DESCRIPTION:  If margins are free, record the distance in millimeters from the tumor to the edge of the specimen (margin).
950 RE-EXCISION (BR98) BRE1;51 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 18, 1998
  • DESCRIPTION:  Record whether a re-excision was performed following examination of the margins. Record 8 if margins were clear, not applicable. (NOTE: A mastectomy after an excisional biopsy does not count as a re-excision).
951 MICROSCOPIC STATUS (BR98) BRE1;52 SET
  • '0' FOR Uninvolved;
  • '1' FOR Involved;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 18, 1998
  • DESCRIPTION:  Record the microscopic status of final margin after re-excision. If re-excision was performed indicate the status. If re-excision was not done, record 8, not applicable.
952 PRE-RADIATION MAMMOGRAM (BR98) BRE1;53 SET
  • '0' FOR Not done;
  • '1' FOR Done, and entire lesion removed;
  • '2' FOR Done, and entire lesion not removed;
  • '8' FOR Done, but status of lesion unknown;
  • '9' FOR Unknown if done;

  • LAST EDITED:  JUN 18, 1998
  • DESCRIPTION:  Record whether there was a pre-radiation therapy mammogram of the patient. If unknown, record 9.
953 SITES IRRADIATED (BR98) BRE1;54 SET
  • '0' FOR No radiation;
  • '1' FOR Breast only;
  • '2' FOR Breast and regional lymphatics;
  • '3' FOR Other;
  • '8' FOR Radiation, sites unknown;
  • '9' FOR Unknown if radiation;

  • LAST EDITED:  JUN 19, 1998
  • DESCRIPTION:  Record the sites which were irradiated. Regional lymphatics includes axilla, chest wall, internal mammary lymph nodes and supraclavicular lymph nodes. Breast refers to 'whole' or 'entire' breast. If radiation was
    given, but site(s) unknown, record 8. If it is unknown if radiation was given, record 9.
954 cGy DOSE TO BREAST (BR98) BRE1;55 NUMBER

  • INPUT TRANSFORM:  K:X>99999!(X<0)!(X?.E1"."1N.N) X I $D(X) D CGYIT^ONCOOT
  • OUTPUT TRANSFORM:  D CGYOT^ONCOOT
  • LAST EDITED:  JUN 19, 1998
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  For female patients ONLY, record the cGy dose (00001-88887) given to the whole breast or chest wall. Do not include boost dose. If the patient did not receive radiation therapy, code 00000. If it is known that the
    patient received radiation therapy, but the dose is unknown, code 88888. If it is unknown if the patient raceived radiation, code 99999. For male patients, leave this field blank.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
955 SPECIFIC HORMONE THPY (BR98) BRE1;56 SET
  • '0' FOR None;
  • '1' FOR Tamoxifen;
  • '2' FOR Orchiectomy;
  • '3' FOR Estrogen;
  • '4' FOR Other;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 19, 1998
  • DESCRIPTION:  For male patients ONLY, record the specific hormone treatment. Estrogen includes Diethylstilbestrol. For females, leave blank.
956 CHEMOTHERAPY REGIME (BR98) BRE1;57 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, no chemotherapy;
  • '9' FOR Unknown;

  • LAST EDITED:  JUN 19, 1998
  • DESCRIPTION:  Record the chemotherapeutic regime containing doxorubicin. Doxorubicin includes Adriamycin, Adriamycin-TM, Adriblastina, FT-106, 14-hydroxy daunomycin and Rubex.
993 REGIONAL TX MODALITY CONV FLAG 27;7 SET
  • 'Y' FOR YES;

  • LAST EDITED:  FEB 06, 2003
  • DESCRIPTION:  
    This field will flag this record as having its REGIONAL TREATMENT MODALITY values converted from ROADS TO FORDS. The purpose of this field is to avoid converting already converted values.
994 TYPE OF FIRST RECUR CONV FLAG 27;6 SET
  • 'Y' FOR YES;

  • LAST EDITED:  JAN 31, 2003
  • DESCRIPTION:  
    This field will flag this record as having its TYPE OF FIRST RECURRENCE values converted from ROADS TO FORDS. The purpose of this field is to avoid converting already converted values.
995 STAGED BY CONV FLAG 27;5 SET
  • 'Y' FOR YES;

  • LAST EDITED:  JAN 06, 2003
  • DESCRIPTION:  
    This field will flag this record as having its STAGED BY (CLINICAL STAGE and STAGED BY (PATHOLOGIC STAGE) values converted from ROADS to FORDS. The purpose of this field is to avoid converting already converted values.
996 SURGICAL MARGINS CONV FLAG 27;2 SET
  • 'Y' FOR YES;

  • LAST EDITED:  JAN 06, 2003
  • DESCRIPTION:  
    This field will flag this record as having its SURGICAL MARGINS value converted from ROADS to FORDS. The purpose of this field is to avoid converting already converted values.
997 STAGE FLAG 27;1 SET
  • 'Y' FOR YES;
  • 'N' FOR NO;

  • LAST EDITED:  OCT 04, 1996
  • DESCRIPTION:  
    Staging conversion flag.
998 SCOPE OF LN SURGERY CONV FLAG 27;3 SET
  • 'Y' FOR YES;

  • LAST EDITED:  JAN 06, 2003
  • DESCRIPTION:  
    This field will flag this record as having its SCOPE OF LYMPH NODE SURGERY and SCOPE OF LN SURG @FACILITY values converted from ROADS to FORDS. The purpose of this field is to avoid converting already
999 SURGICAL PROC/OTHER CONV FLAG 27;4 SET
  • 'Y' FOR YES;

  • LAST EDITED:  JAN 06, 2003
  • DESCRIPTION:  
    This field will flag this record as having its SURGICAL PROC/OTHER SITE and SURGICAL PROC/OTHER SITE @FAC values converted from ROADS to FORDS. The purpose of this field is to avoid converting already converted values.
999.1 DATE OF DIAGNOSIS FLAG 27;8 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 391 This field is a flag that explains why no appropriate value is entered for DATE DX (#3) field.
  • EXECUTABLE HELP:  S ONCITM=391 D DTFLGHLP^ONCOHELP
999.11 RX DATE SURG DISCH FLAG 27;17 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 3181 This field is a flag that explains why no appropriate value is entered for DATE MOST DEFINITIVE SURG DIS (#435) field.
  • EXECUTABLE HELP:  S ONCITM=3181 D DTFLGHLP^ONCOHELP
999.12 RX DATE-RADIATION FLAG 27;18 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1211 This field is a flag that explains why no appropriate value is entered for DATE RADIATION STARTED (#51) field.
  • EXECUTABLE HELP:  S ONCITM=1211 D DTFLGHLP^ONCOHELP
999.13 RX DATE RAD ENDED FLAG 27;19 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 3221 This field is a flag that explains why no appropriate value is entered for DATE RADIATION ENDED (#361) field.
  • EXECUTABLE HELP:  S ONCITM=3221 D DTFLGHLP^ONCOHELP
999.14 RX DATE SYSTEMIC FLAG 27;20 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 3231 This field is a flag that explains why no appropriate value is entered for DATE SYSTEMIC THERAPY STARTED (#152) field.
  • EXECUTABLE HELP:  S ONCITM=3231 D DTFLGHLP^ONCOHELP
999.15 RX DATE-CHEMO FLAG 27;21 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1221 This field is a flag that explains why no appropriate value is entered for CHEMOTHERAPY DATE (#53) field.
  • EXECUTABLE HELP:  S ONCITM=1221 D DTFLGHLP^ONCOHELP
999.16 RX DATE-HORMONE FLAG 27;22 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1231 This field is a flag that explains why no appropriate value is entered for HORMONE THERAPY DATE (#54) field.
  • EXECUTABLE HELP:  S ONCITM=1231 D DTFLGHLP^ONCOHELP
999.17 RX DATE-BRM FLAG 27;23 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1241 This field is a flag that explains why no appropriate value is entered for IMMUNOTHERAPY DATE (#55) field.
  • EXECUTABLE HELP:  S ONCITM=1241 D DTFLGHLP^ONCOHELP
999.18 RX DATE-OTHER FLAG 27;24 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1251 This field is a flag that explains why no appropriate value is entered for OTHER TREATMENT START DATE (#57) field.
  • EXECUTABLE HELP:  S ONCITM=1251 D DTFLGHLP^ONCOHELP
999.19 RX DATE-DX/STG PROC FLAG 27;25 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1281 This field is a flag that explains why no appropriate value is entered for SURGICAL DX/STAGING PROC DATE (#58.3) field.
  • EXECUTABLE HELP:  S ONCITM=1281 D DTFLGHLP^ONCOHELP
999.2 DATE CONCLUSIVE DX FLAG 27;9 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR ITEM #: 448 This field is a flag that explains why no appropriate value is entered for DATE OF CONCLUSIVE DX (#193) field.
  • EXECUTABLE HELP:  S ONCITM=448 D DTFLGHLP^ONCOHELP
999.21 RECURRENCE DATE-1ST FLAG 27;26 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1861 This field is a flag that explains why no appropriate value is entered for DATE OF FIRST RECURRENCE (#70) field.
  • EXECUTABLE HELP:  S ONCITM=1861 D DTFLGHLP^ONCOHELP
  • NOTES:  TRIGGERED by the DATE OF FIRST RECURRENCE field of the ONCOLOGY PRIMARY File
999.22 DATE OF LAST CONTACT FLAG 27;27 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1751 This field is a flag that explains why no appropriate value is entered for the FOLLOW-UP (#400) multiple of the ONCOLOGY PATIENT (#160) file.
  • EXECUTABLE HELP:  S ONCITM=1751 D DTFLGHLP^ONCOHELP
999.23 SUBSQ RX 2ND CRS DATE FLAG 27;28 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1661 This field is a flag that explains why no appropriate value is entered for SUBSEQUENT COURSE OF TREATMENT (#60) multiple field.
  • EXECUTABLE HELP:  S ONCITM=1661 D DTFLGHLP^ONCOHELP
999.24 SUBSQ RX 3RD CRS DATE FLAG 27;29 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1681 This field is a flag that explains why no appropriate 2nd value is entered for SUBSEQUENT COURSE OF TREATMENT (#60) multiple field.
  • EXECUTABLE HELP:  S ONCITM=1681 D DTFLGHLP^ONCOHELP
999.25 SUBSQ RX 4TH CRS DATE FLAG 27;30 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1701 This field is a flag that explains why no appropriate 3rd value is entered for SUBSEQUENT COURSE OF TREATMENT (#60) multiple field.
  • EXECUTABLE HELP:  S ONCITM=1701 D DTFLGHLP^ONCOHELP
999.26 ADDRESS AT DX--STATE 27;31 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<2)!'(X?2U) X
  • LAST EDITED:  AUG 26, 2014
  • HELP-PROMPT:  Answer must be 2 characters in length.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 80 This field is for the patient's State from their Address at time of Diagnosis.
999.27 ADDRESS AT DX--COUNTRY 27;32 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<3)!'(X?3U) X
  • LAST EDITED:  AUG 26, 2014
  • HELP-PROMPT:  Answer must be 3 characters in length.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 102 This field is for the patient's Country from their Address at the time of diagnosis.
999.28 ADDRESS CURRENT--STATE 27;33 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<2)!'(X?2U) X
  • LAST EDITED:  AUG 26, 2014
  • HELP-PROMPT:  Answer must be 2 characters in length.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1820 This field is for the patient's State from their current Address.
999.289 ADDRESS CURRENT--POSTAL CODE 27;35 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>9!($L(X)<5) X
    MAXIMUM LENGTH: 9
  • LAST EDITED:  AUG 13, 2021
  • HELP-PROMPT:  Answer must be 5-9 characters in length.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1830. Address current Postal Code of the patient. This data field is an override field of the patient zip code.
999.29 ADDRESS CURRENT--COUNTRY 27;34 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<3)!'(X?3U) X
  • LAST EDITED:  AUG 26, 2014
  • HELP-PROMPT:  Answer must be 3 characters in length.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1832 This field is for the patient's Country from their current Address.
999.3 DATE OF MULT TUMORS FLAG 27;10 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 439 This field is a flag that explains why no appropriate value is entered for DATE OF MULTIPLE TUMORS (#195) field.
  • EXECUTABLE HELP:  S ONCITM=439 D DTFLGHLP^ONCOHELP
999.4 DATE OF FIRST CONTACT FLAG 27;11 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 581 This field is a flag that explains why no appropriate value is entered for DATE OF FIRST CONTACT (#155) field.
  • EXECUTABLE HELP:  S ONCITM=581 D DTFLGHLP^ONCOHELP
999.5 DATE OF INPT ADM FLAG 27;12 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 591 This field is a flag that explains why no appropriate value is entered for DATE OF INPATIENT ADMISSION (#1) field.
  • EXECUTABLE HELP:  S ONCITM=591 D DTFLGHLP^ONCOHELP
999.6 DATE OF INPT DISCH FLAG 27;13 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 601 This field is a flag that explains why no appropriate value is entered for DATE OF INPATIENT DISCHARGE (#1.1) field.
  • EXECUTABLE HELP:  S ONCITM=601 D DTFLGHLP^ONCOHELP
999.7 DATE 1ST CRS RX FLAG 27;14 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  JUL 18, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1271 This field is a flag that explains why no appropriate value is entered for FIRST COURSE OF TREATMENT DATE (#49) field.
  • EXECUTABLE HELP:  S ONCITM=1271 D DTFLGHLP^ONCOHELP
999.8 RX DATE-SURGERY FLAG 27;15 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 1201 This field is a flag that explains why no appropriate value is entered for DATE FIRST SURGICAL PROCEDURE (#170) field.
  • EXECUTABLE HELP:  S ONCITM=1201 D DTFLGHLP^ONCOHELP
999.9 RX DATE MST DEFN SRG FLAG 27;16 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  MAY 29, 2013
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    Source of Standard: NAACCR Item #: 3171 This field is a flag that explains why no appropriate value is entered for MOST DEFINITIVE SURG DATE (#50) field.
  • EXECUTABLE HELP:  S ONCITM=3171 D DTFLGHLP^ONCOHELP
1000 ORAL CONTRACEPTIVES HEP1;1 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 06, 2000
  • DESCRIPTION:  This field describes whether the patient was receiving prescribed hormonal therapy at the time of diagnosis. This information can typically be found in either the patient's clinic chart or the managing physician's notes.
1001 ESTROGEN REPLACEMENT HEP1;2 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 06, 2000
  • DESCRIPTION:  
    This field describes whether the patient was receiving prescribed hormonal therapy at the time of diagnosis. This information can typically be found in either the patient's clinic chart or the managing physician's notes.
1002 TAMOXIFEN HEP1;3 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 06, 2000
  • DESCRIPTION:  This field describes whether the patient was receiving prescribed hormonal therapy at the time of diagnosis. This information can typically be found in either the patient's clinic chart or the managing physician's notes.
1003 OTHER HORMONES HEP1;4 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 06, 2000
  • DESCRIPTION:  This field describes whether the patient was receiving prescribed hormonal therapy at the time of diagnosis. This information can typically be found in either the patient's clinic chart or the managing physician's notes.
1004 ASCITES HEP1;5 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 06, 2000
  • DESCRIPTION:  This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.
1005 CIRRHOSIS HEP1;6 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 06, 2000
  • DESCRIPTION:  This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.
1006 CHILD'S CLASS A HEP1;7 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 06, 2000
  • DESCRIPTION:  This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.
1007 CHILD'S CLASS B HEP1;8 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 06, 2000
  • DESCRIPTION:  This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.
1008 CHILD'S CLASS C HEP1;9 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 06, 2000
  • DESCRIPTION:  This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.
1009 HEPATITIS B HEP1;10 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 06, 2000
  • DESCRIPTION:  This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.
1010 HEPATITIS C HEP1;11 SET
  • '0' FOR Patient screened, negative results;
  • '1' FOR Patient screened, positive results for Hep C;
  • '8' FOR Patient refused;
  • '9' FOR Unknown if patient screened;

  • LAST EDITED:  APR 16, 2003
  • DESCRIPTION:  This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.
1011 HEMOCHROMATOSIS HEP1;12 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 06, 2000
  • DESCRIPTION:  This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.
1012 ALCOHOL CONSUMPTION HEP1;13 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Never consumed alcohol" W:X="999" " Number of drinks unknown"
  • OUTPUT TRANSFORM:  S Y=$S(Y="000":"Never consumed alcohol",Y=999:"Number of drinks unknown",1:Y)
  • LAST EDITED:  JUN 30, 2000
  • HELP-PROMPT:  Enter 000-Never consumed alcohol; 001-998; 999-Number of drinks unknown
  • DESCRIPTION:  This field describes the number of drinks (beer, wine, other alcohol) consumed by the patient per week. If the patient has never consumed alcohol, code 000. If the number of drinks per week is unknown, code 999. This
    information can typically be found in either the patient's clinic chart or the managing physician's notes.
1013 AFP (IU/ml) HEP1;14 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
  • LAST EDITED:  JAN 06, 2000
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  This field describes the absolute value of each tumor marker test administered to the patient prior to the start of the first course of treatment. Tumor markers considered in this study include: AFP (IU/ml); CEA (mg/ml);
    and CA19.9 (U/ml). This information can typically be found in either the patient's hospital chart or laboratory records. Record tumor markers as whole numbers, round decimals to the nearest integer; for example 12.5
    would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular tumor marker test was not administered code 00000. If a test was administered but the results is unknown, code 99999.
1014 CEA (mg/ml) HEP1;15 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
  • LAST EDITED:  JAN 06, 2000
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  This field describes the absolute value of each tumor marker test administered to the patient prior to the start of the first course of treatment. Tumor markers considered in this study include: AFP (IU/ml); CEA (mg/ml);
    and CA19.9 (U/ml). This information can typically be found in either the patient's hospital chart or laboratory records. Record tumor markers as whole numbers, round decimals to the nearest integer; for example 12.5
    would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular tumor marker test was not administered code 00000. If a test was administered but the results is unknown, code 99999.
1015 CA19.9 (U/ml) HEP1;16 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
  • LAST EDITED:  JAN 06, 2000
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  This field describes the absolute value of each tumor marker test administered to the patient prior to the start of the first course of treatment. Tumor markers considered in this study include: AFP (IU/ml); CEA (mg/ml);
    and CA19.9 (U/ml). This information can typically be found in either the patient's hospital chart or laboratory records. Record tumor markers as whole numbers, round decimals to the nearest integer; for example 12.5
    would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular tumor marker test was not administered code 00000. If a test was administered but the results is unknown, code 99999.
1016 PROTIME (sec) HEP1;17 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  This field describes the absolute value of each liver function test administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the patient's
    hospital chart or laboratory records. Record test results as whole numbers, round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular test was
    not administered, code 00000. If a test was administered but the result unknown, code 99999.
1017 BILIRUBIN (mg/ml) HEP1;18 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  This field describes the absolute value of each liver function test administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the patient's
    hospital chart or laboratory records. Record test results as whole numbers, round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular test was
    not administered, code 00000. If a test was administered but the result unknown, code 99999.
1018 ALBUMIN (g/dl) HEP1;19 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  This field describes the absolute value of each liver function test administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the patient's
    hospital chart or laboratory records. Record test results as whole numbers, round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular test was
    not administered, code 00000. If a test was administered but the result unknown, code 99999.
1019 LDH (U/I) HEP1;20 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?1.5N) X
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Type a Number between 0 and 99999, 0 Decimal Digits
  • DESCRIPTION:  This field describes the absolute value of each liver function test administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the patient's
    hospital chart or laboratory records. Record test results as whole numbers, round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular test was
    not administered, code 00000. If a test was administered but the result unknown, code 99999.
1020 CT ARTERIAL PORT-PERFORMED HEP1;21 SET
  • '0' FOR Not performed;
  • '1' FOR Performed;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1021 CT ARTERIAL PORT-CIRRHOSIS HEP1;22 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1022 CT ARTERIAL PORT-VASCULAR INV HEP1;23 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1023 CT ARTERIAL PORT-BILOBAR DIS HEP1;24 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1024 CT ARTERIAL PORT-LYMPH NODES HEP1;25 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1025 CT ARTERIAL PORT-SIZE OF TUMOR HEP1;26 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not performed" W:X="999" " Performed, size unknown"
  • OUTPUT TRANSFORM:  S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Enter 000-Not performed; 001-998; 999 Performed, size unknown
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
    The size of the dominant tumor describes the dimension or diameter of the largest identified tumor in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For example, if the dominant
    or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1026 CT ARTERIAL PORT-NUM 0F TUMORS HEP1;27 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99" " Performed, number unknown"
  • OUTPUT TRANSFORM:  S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Enter 00-Not performed; 01-98; 99-Performed, number unknown
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1027 SPIRAL CT-PERFORMED HEP1;28 SET
  • '0' FOR Not performed;
  • '1' FOR Performed;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1028 SPIRAL CT-CIRRHOSIS HEP1;29 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1029 SPIRAL CT-VASCULAR INV HEP1;30 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1030 SPIRAL CT-BILOBAR DIS HEP1;31 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1031 SPIRAL CT-LYMPH NODES HEP1;32 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1032 SPIRAL CT-SIZE OF TUMOR HEP1;33 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not performed" W:X="999" " Performed, size unknown"
  • OUTPUT TRANSFORM:  S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Enter 000-Not performed; 001-998; 999 Performed, size unknown
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
    The size of the dominant tumor describes the dimension or diameter of the largest identified tumor in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For example, if the dominant
    or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1033 SPIRAL CT-NUM OF TUMORS HEP1;34 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99" " Performed, number unknown"
  • OUTPUT TRANSFORM:  S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Enter 00-Not performed; 01-98; 99-Performed, number unknown
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1034 INCREMENTAL CT-PERFORMED HEP1;35 SET
  • '0' FOR Not performed;
  • '1' FOR Performed;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1035 INCREMENTAL CT-CIRRHOSIS HEP1;36 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1036 INCREMENTAL CT-VASCULAR INV HEP1;37 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1037 INCREMENTAL CT-BILOBAR DIS HEP1;38 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1038 INCREMENTAL CT-LYMPH NODES HEP1;39 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1039 INCREMENTAL CT-SIZE OF TUMOR HEP1;40 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not performed" W:X="999" " Performed, size unknown"
  • OUTPUT TRANSFORM:  S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Enter 000-Not performed; 001-998; 999 Performed, size unknown
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
    The size of the dominant tumor describes the dimension or diameter of the largest identified tumor in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For example, if the dominant
    or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1040 INCREMENTAL CT-NUM 0F TUMORS HEP1;41 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99" " Performed, number unknown"
  • OUTPUT TRANSFORM:  S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Enter 00-Not performed; 01-98; 99-Performed, number unknown
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1041 ULTRASOUND-PERFORMED HEP1;42 SET
  • '0' FOR Not performed;
  • '1' FOR Performed;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1042 ULTRASOUND-CIRRHOSIS HEP1;43 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1043 ULTRASOUND-VASCULAR INV HEP1;44 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1044 ULTRASOUND-BILOBAR DIS HEP1;45 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1045 ULTRASOUND-LYMPH NODES HEP1;46 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1046 ULTRASOUND-SIZE OF TUMOR HEP1;47 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not performed" W:X="999" " Performed, size unknown"
  • OUTPUT TRANSFORM:  S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Enter 000-Not performed; 001-998; 999 Performed, size unknown
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
    The size of the dominant tumor describes the dimension or diameter of the largest identified tumor in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For example, if the dominant
    or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1047 ULTRASOUND-NUM 0F TUMORS HEP1;48 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99" " Performed, number unknown"
  • OUTPUT TRANSFORM:  S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Enter 00-Not performed; 01-98; 99-Performed, number unknown
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1048 MRI-PERFORMED HEP1;49 SET
  • '0' FOR Not performed;
  • '1' FOR Performed;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1049 MRI-CIRRHOSIS HEP1;50 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1050 MRI-VASCULAR INV HEP1;51 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1051 MRI-BILOBAR DIS HEP1;52 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1052 MRI-LYMPH NODES HEP1;53 SET
  • '0' FOR NO;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 07, 2000
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
1053 MRI-SIZE OF TUMOR HEP1;54 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not performed" W:X="999" " Performed, size unknown"
  • OUTPUT TRANSFORM:  S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Enter 000-Not performed; 001-998; 999 Performed, size unknown
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
    The size of the dominant tumor describes the dimension or diameter of the largest identified tumor in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For example, if the dominant
    or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1054 MRI-NUM 0F TUMORS HEP1;55 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99" " Performed, number unknown"
  • OUTPUT TRANSFORM:  S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)
  • LAST EDITED:  JAN 07, 2000
  • HELP-PROMPT:  Enter 00-Not performed; 01-98; 99-Performed, number unknown
  • DESCRIPTION:  This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether
    the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This
    information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1055 DEFINITIVE DIAGNOSIS HEP1;56 SET
  • '1' FOR Percutaneous biopsy;
  • '2' FOR At definitive cancer-directed surgery;
  • '3' FOR Incidental at liver transplantation;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 10, 2000
  • DESCRIPTION:  This field describes whether the DEFINITIVE DIAGNOSIS was achieved by percutaneous biopsy; at the time of the definitive cancer-directed surgical procedure; or at the time of pathologic examination of an explanted liver
    specimen. This information can typically by found in either the patient's hospital or clinical chart, or operative note.
1056 RADIO-FREQUENCY DESTRUCTION HEP1;57 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 10, 2000
  • DESCRIPTION:  This field describes cancer-directed surgery of the primary site which does not appear as part of the Commission on Cancer's required surgical codes. If SURGERY OF PRIMARY SITE (question 36) was coded 17 then record
    whether the patient received RADIO-FREQUENCY DESTRUCTION of the tumor.
1057 ABLATION & RESECTION HEP1;58 SET
  • '00' FOR Ablation & resection not administered;
  • '11' FOR Photodynamic therapy;
  • '12' FOR Electrocautery, fulguration;
  • '13' FOR Cryosurgery;
  • '14' FOR Laser;
  • '15' FOR Alcohol;
  • '16' FOR Heat;
  • '17' FOR Radio-frequency;
  • '18' FOR Other;
  • '88' FOR NA;
  • '99' FOR Ablation administered, type unknown;

  • LAST EDITED:  JAN 10, 2000
  • DESCRIPTION:  This field describes the combination of ablative surgery and resection administered to the primary site. If the patient received both ablation and resection, record the ablative surgical therapy administered. If the
    patient did not receive a combination of surgical ablation and resection, code 00. If no cancer-directed surgery was administered, code 88.
1058 DISTANCE TO CLOSEST MARGIN HEP1;59 SET
  • '0' FOR Margins involved;
  • '1' FOR Negative margins, < 1cm;
  • '2' FOR Negative margins, 1cm - 2cm;
  • '3' FOR Negative margins, > 2cm;
  • '8' FOR NA;
  • '9' FOR Unknown, not described;

  • LAST EDITED:  JAN 10, 2000
  • DESCRIPTION:  This field describes the distance from the resected tumor to the closest margin. Code distance of margin ONLY if the tumor was surgically resected, this includes tumors which were ablated and resected. If no
    cancer-directed surgery was administered, or if the tumor was surgically ablated only, code 8.
1059 ABLATION HEP1;60 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 10, 2000
  • DESCRIPTION:  This field describes the surgical treatment of either microscopic or macroscopic residual tumor remaining AFTER the most definitive surgery of the primary site. Record whether this remaining tumor was ablated and/or
    resected. Ablation includes: photodynamic therapy; electrocautery; fulguration; cryosurgery; laser; alcohol; heat; radio-frequency; ultra- sound; acetic acid.
1060 RESECTION HEP1;61 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 10, 2000
  • DESCRIPTION:  This field describes the surgical treatment of either microscopic or macroscopic residual tumor remaining AFTER the most definitive surgery of the primary site. Record whether this remaining tumor was ablated and/or
    resected. Resection includes: wedge resection, NOS; segmental resection; lobectomy, NOS (simple and extended); total hepatectomy with transplant; hepatectomy, NOS.
1061 CISPLATIN HEP1;62 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR Recommended, not known if administered;
  • '9' FOR Unknown if recommended or administered;

  • LAST EDITED:  JAN 11, 2000
  • DESCRIPTION:  This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.
1062 FUDR HEP1;63 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR Recommended, not known if administered;
  • '9' FOR Unknown if recommended or administered;

  • LAST EDITED:  JAN 11, 2000
  • DESCRIPTION:  This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.
1063 5-FU HEP1;64 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR Recommended, not known if administered;
  • '9' FOR Unknown if recommended or administered;

  • LAST EDITED:  JAN 11, 2000
  • DESCRIPTION:  This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.
1064 FU & LEUCOVORIN HEP1;65 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR Recommended, not known if administered;
  • '9' FOR Unknown if recommended or administered;

  • LAST EDITED:  JAN 11, 2000
  • DESCRIPTION:  This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.
1065 IRINOTECAN (CPT-11) HEP1;66 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR Recommended, not known if administered;
  • '9' FOR Unknown if recommended or administered;

  • LAST EDITED:  JAN 11, 2000
  • DESCRIPTION:  This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.
1066 MITOMYCIN C HEP1;67 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR Recommended, now known if administered;
  • '9' FOR Unknown if recommended or administered;

  • LAST EDITED:  JAN 11, 2000
  • DESCRIPTION:  This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.
1067 OXALIPLATIN HEP1;68 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR Recommended, not known if administered;
  • '9' FOR Unknown if recommended or administered;

  • LAST EDITED:  JAN 11, 2000
  • DESCRIPTION:  This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.
1068 GEMCITABINE HEP1;69 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR Recommended, not known if administered;
  • '9' FOR Unknown if recommended or administered;

  • LAST EDITED:  JAN 11, 2000
  • DESCRIPTION:  This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.
1069 ROUTE CHEMO ADMIN HEP1;70 SET
  • '01' FOR Intrathecal;
  • '02' FOR Intra-arterial, bolus;
  • '03' FOR Intravenous inf;
  • '04' FOR Hepatic inf;
  • '05' FOR Intra-arterial chemoembolization;
  • '06' FOR Intratumoral inj of alcohol;
  • '07' FOR Portal inf;
  • '08' FOR Orally;
  • '09' FOR Intramuscular;
  • '88' FOR NA;
  • '99' FOR Chemo admin, route unk;

  • LAST EDITED:  JAN 11, 2000
  • DESCRIPTION:  This field describes the route/method by which chemotherapy was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.
1070 CHEMOTHERAPY/SURGERY SEQUENCE HEP1;71 SET
  • '0' FOR No chemotherapy and/or no surgery;
  • '1' FOR Chemotherapy before surgery;
  • '2' FOR Chemotherapy after surgery;
  • '3' FOR Chemotherapy before and after surgery;
  • '9' FOR Chemotherapy and surgery, sequence unknown;

  • LAST EDITED:  JAN 11, 2000
  • DESCRIPTION:  This field describes the sequence in which chemotherapy and primary tumor cancer-directed surgery were administered.
1071 ARTERIAL EMBOLIZATION HEP1;72 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 11, 2000
  • DESCRIPTION:  This field describes whether the patient had their tumor embolized without chemotherapy. This procedure involves the embolizing or clotting of a portion of the hepatic artery to disrupt the blood flow to the tumor.
    Information about this treatment modality can be found in the Vascular/Interventional Radiology procedure notes.
1072 DEATH W/I 30 DAYS START TX HEP1;73 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 11, 2000
  • DESCRIPTION:  This field describes whether the patient died from any cause within 30 days of the start of cancer-directed therapy.
1100 HISTORY OF MELANOMA (PT) MEL1;1 SET
  • '0' FOR None;
  • '1' FOR Yes, synchronous or <2 months;
  • '2' FOR Yes, 2 months to <4 years;
  • '3' FOR Yes, 4 years to <7 years;
  • '4' FOR Yes, 7 years to <15 years;
  • '5' FOR Yes, 15 years or more;
  • '6' FOR Yes, time period unknown;
  • '9' FOR Unk if history of melanoma exists;

  • LAST EDITED:  JAN 06, 1999
  • DESCRIPTION:  Record if patient had or currently has any personal history of other melanoma and, if so, how far back it occurred in relation to the present melanoma.
1101 HISTORY OF OTHER CANCER (PT) MEL1;2 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 08, 1999
  • DESCRIPTION:  Record if the patient had any history of other types of cancer.
1102 FIRST SITE CODE MEL1;3 POINTER TO ICDO TOPOGRAPHY FILE (#164) ICDO TOPOGRAPHY(#164)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)
  • LAST EDITED:  JAN 07, 1999
  • DESCRIPTION:  Record the primary site of the most recent other cancer with which the patient has been diagnosed, if any. If no previous cancer was diagnosed, code 000. If a previous cancer was diagnosed, but the site is unknown, code
    888. If it is unknown whether a history of other cancers exists for the patient, code 999.
1103 FIRST SITE DIAGNOSIS DATE MEL1;4 DATE

  • INPUT TRANSFORM:  D CHDTIT^ONCOPCE
  • OUTPUT TRANSFORM:  D CHDTOT^ONCOPCE
  • LAST EDITED:  JAN 08, 1999
  • DESCRIPTION:  Record the date on which the most recent other cancer was diagnosed. If no previous cancer was diagnosed, code the date with 0's. If a previous cancer was diagnosed, but the date is unknown, code the date with 8's. If
    it is unknown whether a history of other cancers exists for the patient, code the date with 9's.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1104 SECOND SITE CODE MEL1;5 POINTER TO ICDO TOPOGRAPHY FILE (#164) ICDO TOPOGRAPHY(#164)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)
  • LAST EDITED:  JAN 07, 1999
  • DESCRIPTION:  Record the primary site of the second most recent other cancer with which the patient has been diagnosed, if any. If no previous cancer was diagnosed, code 000. If a previous cancer was diagnosed, but the site is
    unknown, code 888. If it is unknown whether a history of other cancers exists for the patient, code 999.
1105 SECOND SITE DIAGNOSIS DATE MEL1;6 DATE

  • INPUT TRANSFORM:  D CHDTIT^ONCOPCE
  • OUTPUT TRANSFORM:  D CHDTOT^ONCOPCE
  • LAST EDITED:  JAN 08, 1999
  • DESCRIPTION:  Record the date on which the second most recent other cancer was diagnosed. If no previous cancer was diagnosed, code the date 00/00/00. If a previous cancer was diagnosed, but the date is unknown, code the date
    88/88/88. If it is unknown whether a history of other cancers exists for the patient, code the date 99/99/99.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1106 PREGNANCY AT INITIAL DIAGNOSIS MEL1;7 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, male;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 08, 1999
  • DESCRIPTION:  Record whether the patient was pregnant at the time of initial diagnosis.
1107 EXOGENOUS HORMONES MEL1;8 SET
  • '0' FOR None;
  • '1' FOR Yes, HRT (hormone replacement therapy);
  • '2' FOR Yes, OC (oral contraceptives);
  • '3' FOR Yes, both HRT and OC;
  • '4' FOR Yes, type unknown;
  • '8' FOR NA, male;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 12, 1999
  • DESCRIPTION:  Record whether the patient was receiving prescribed exogenous therapy at the time of initial diagnosis and the number of years of therapy. For this question, exogenous hormones are estrogen
1108 DISEASE PRESENTATION LOCATION MEL1;9 SET
  • '1' FOR Solitary cutaneous/subcutaneous;
  • '2' FOR Multiple cutaneous/subcutaneous;
  • '3' FOR Nodal;
  • '4' FOR Visceral;
  • '5' FOR Other;
  • '8' FOR NA, primary site known;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 08, 1999
  • DESCRIPTION:  Record the location of the disease presentation. If the primary site is known, code as 8, not applicable.
1109 TYPE OF BIOPSY MEL1;10 SET
  • '0' FOR No biopsy performed;
  • '1' FOR Excisional;
  • '2' FOR Punch;
  • '3' FOR Incisional;
  • '4' FOR Shave;
  • '5' FOR Saucerization;
  • '6' FOR Fine needle aspiration;
  • '8' FOR NA, non-cutaneous melanoma;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 11, 1999
  • DESCRIPTION:  Record the appropriate code for cutaneous melanomas only. Code 8, not applicable, for non-cutaneous sites.
1110 EXTRANODAL EXTENSION MEL1;11 SET
  • '0' FOR None;
  • '1' FOR Microscopic, 2mm or less;
  • '2' FOR Gross, greater than 2mm;
  • '3' FOR Present, size unknown;
  • '8' FOR NA, no nodes examined;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 08, 1999
  • DESCRIPTION:  Record whether extranodal extension was determined on gross (greater than 2mm) observation or microscopic (2mm or less) observation.
1111 MICROSATELLITOSIS MEL1;12 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, non-cutaneous melanoma;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 08, 1999
  • DESCRIPTION:  Record the presence of microsatellitosis. They are visualized with the aid of a microscope and defined as discrete nests of melanoma cells >0.05mm, noncontiguous and clearly separated from the main body of the tumor by
    normal reticular dermal collagen or subcutaneous fat.
1112 NUMBER OF SATELLITE NODULES MEL1;13 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1) X I $D(X) D NSNIT^ONCOMNI
  • OUTPUT TRANSFORM:  D NSNOT^ONCOMNI
  • LAST EDITED:  JAN 08, 1999
  • HELP-PROMPT:  Answer must be 1-2 numbers, no decimal point.
  • DESCRIPTION:  Record the number of satellite nodules within 2 cm of the primary tumor. If there were no satellite nodules, microsatellitosis not present, record 00. If there were multiple nodules but an exact number is not stated,
    record 97. Record 98 if not applicable, non- cutaneous melanoma. Record 99 if it is unknown whether there were satellite nodules.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1113 LOCATION OF IN-TRANSIT NODULES MEL1;14 SET
  • '0' FOR None;
  • '1' FOR Regional;
  • '2' FOR Distant;
  • '3' FOR Other;
  • '4' FOR Present, location unknown;
  • '8' FOR NA, non-cutaneous melanoma;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 08, 1999
  • DESCRIPTION:  Record the location of in-transit nodules that were farthest from the primary lesion but not beyond the site of primary lymph node drainage.
1114 BRESLOW'S THICKNESS MEL1;15 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1) X I $D(X) D BTIT^ONCOMNI
  • OUTPUT TRANSFORM:  D BTOT^ONCOMNI
  • LAST EDITED:  JAN 08, 1999
  • HELP-PROMPT:  Answer must be 1-3 numbers, no decimal point.
  • DESCRIPTION:  Record the thickness of the primary lesion in millimeters using Breslow's method to measure the depth of the invasion. Record from the pathology report. Record 997 if cutaneous melanoma, Breslow's thickness unknown.
    Record 998, not applicable if non-cutaneous melanoma. Record 999 if cutaneous melanoma, but the primary site is unknown.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1115 CLARK'S LEVEL OF INVASION MEL1;16 SET
  • '1' FOR I;
  • '2' FOR II;
  • '3' FOR III;
  • '4' FOR IV;
  • '5' FOR V;
  • '8' FOR NA, primary site unknown;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 08, 1999
  • DESCRIPTION:  There are 5 levels of invasion. Convert level from Roman to Arabic numerals. Code 8, not applicable, if primary site unknown or non- cutaneous melanoma. Code 9 if Clark's level is unknown.
    1. Level I: All tumor cells confined to the epidermis with no invasion
    through the basement membrane (in situ melanoma).
    2. Level II: Tumor cells penetrating through the basement membrane into
    the papillary dermis but not extending to the reticular dermis.
    3. Level III: Tumor cells filling the papillary dermis and abutting against
    the reticular dermis but not invading it.
    4. Level IV: Extension of tumor cells between the bundles of collagen
    characteristic of the reticular dermis.
    5. Level V: Invasion into the subcutaneous tissue.
1116 ANGIOLYMPHATIC INVASION MEL1;17 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, site unknown or ocular;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 29, 1999
  • DESCRIPTION:  Record if this histologic feature was noted in the pathology report. Angiolymphatic invasion can be pathologically evaluated using either the whole tissue specimen or tissue taken from a core biopsy. Code 8, not
    applicable, in situations in which either there was no specimen, a specimen was not adequately large enough to determine these factors, or the primary site was unknown.
1117 PERINEURAL INVASION MEL1;18 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, site unknown or ocular;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 29, 1999
  • DESCRIPTION:  Record if this histologic feature was noted in the pathology report. Perineural invasion can be pathologically evaluated using either the whole tissue specimen or tissue taken from a core biopsy. Code 8, not applicable,
    in situations in which either there was no specimen, a specimen was not adequately large enough to determine these factors, or the primary site was unknown.
1118 ULCERATION MEL1;19 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, site unknown or ocular;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 29, 1999
  • DESCRIPTION:  Record whether the primary site was ulcerated. Ulceration is defined as a microscopic interruption of the surface epithelium involved by tumor. This does not alter the staging procedure but is typically associated with
    a worse prognosis. Code 8, not applicable, if a primary site is mucosal, occular or unknown.
1119 CLINICALLY AMELANOTIC MEL1;20 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, site unknown or ocular;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 29, 1999
  • DESCRIPTION:  Record whether the primary site was lacking in melanin. Frequently, terms such as brownish, black, blue or tan are used to describe a primary site with melanin. Primary sites lacking melanin may be described as
    non-pigmented or not dark. Primary sites which are reported to appear red or have redness should be considered amelanotic. Code 8, not applicable, if primary site is mucosal, ocular or unknown.
1120 MARGIN DISTANCE (MEL) MEL1;21 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1) X I $D(X) D MDIT^ONCOMNI
  • OUTPUT TRANSFORM:  D MDOT^ONCOMNI
  • LAST EDITED:  JAN 12, 1999
  • HELP-PROMPT:  Answer must be 1-3 numbers, no decimal point.
  • DESCRIPTION:  If margins are free according to the operative report, record the shortest distance in millimeters from the tumor to the edge of specimen (margin).
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1121 SURGICAL CLOSURE MEL1;22 SET
  • '1' FOR Primary or suture closure;
  • '2' FOR Split-thickness skin graft;
  • '3' FOR Flap;
  • '4' FOR Full-thickness skin graft;
  • '5' FOR Other, NOS;
  • '8' FOR NA, surgery not performed;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 12, 1999
  • DESCRIPTION:  Record the type of surgical closure. Code 8, not applicable if surgery was not performed for this site.
1122 PRE-OP LYMPHOSCINTIGRAPHY MEL1;23 SET
  • '0' FOR No;
  • '1' FOR Yes, unidirectional flow;
  • '2' FOR Yes, multidirectional flow;
  • '3' FOR Yes, flow unknown;
  • '8' FOR NA, ocular site;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 12, 1999
  • DESCRIPTION:  Record whether lymphoscintigraphy was performed, and if done, what was the flow. Unidirectional flow indicates that only one lynph node basin drained the site. Multidirectional flow indicates that more than one lymph
    node basin drained the site.
1123 SENTINEL NODES DETECTED BY MEL1;24 SET
  • '0' FOR Not done;
  • '1' FOR Vital blue die;
  • '2' FOR Radiolabeled colloid;
  • '3' FOR Combination of 1 and 2;
  • '4' FOR Done, method unknown;
  • '8' FOR NA, not done, ocular site;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 29, 1999
  • DESCRIPTION:  Record the method of detecion of the sentinel node.
1124 SENTINEL NODES EXAMINED (MEL) MEL1;25 SET
  • '0' FOR No nodes;
  • '1' FOR 1 node;
  • '2' FOR 2 nodes;
  • '3' FOR 3 nodes;
  • '4' FOR 4 nodes;
  • '5' FOR 5 nodes;
  • '6' FOR 6 or more nodes;
  • '7' FOR Nodes examined, number unknown;
  • '8' FOR NA, not done, ocular site;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 29, 1999
  • DESCRIPTION:  Enter the exact number of sentinel nodes examined.
1125 SENTINEL NODES POSITIVE (MEL) MEL1;26 SET
  • '0' FOR No nodes;
  • '1' FOR 1 node;
  • '2' FOR 2 nodes;
  • '3' FOR 3 nodes;
  • '4' FOR 4 nodes;
  • '5' FOR 5 nodes;
  • '6' FOR 6 or more nodes;
  • '7' FOR Nodes positive, number unknown;
  • '8' FOR NA, not done, no exam, ocular site;
  • '9' FOR Unknown;

  • INPUT TRANSFORM:  D SNPIT^ONCOMNI
  • LAST EDITED:  FEB 26, 1999
  • DESCRIPTION:  Enter the exact number of sentinel nodes positive.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1126 METHOD OF PATHOLOGIC EXAM MEL1;27 SET
  • '0' FOR Not examined;
  • '1' FOR Routine staining;
  • '2' FOR Immunochemistry;
  • '3' FOR Serial sectioning;
  • '4' FOR PCR;
  • '5' FOR Other;
  • '6' FOR Any comb of 1,2,3,4;
  • '7' FOR Examined, method unknown;
  • '8' FOR NA, not done, ocular site;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 05, 1999
  • DESCRIPTION:  Record the method of pathological examination of the sentinel node.
1127 LYMPH NODE DISSECTION MEL1;28 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, not done, no + nodes, ocular site;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 05, 1999
  • DESCRIPTION:  If sentinel node(s) positive, record if a complete node dissection was performed. A complete node dissection is the dissection of all nodes found in a particular basin.
1128 NUMBER OF BASINS DISSECTED MEL1;29 SET
  • '0' FOR No basins;
  • '1' FOR 1 basin;
  • '2' FOR 2 basins;
  • '3' FOR 3 basins;
  • '4' FOR 4 basins;
  • '5' FOR 5 basins;
  • '6' FOR 6 or more basins;
  • '7' FOR Basins dissected, number unknown;
  • '8' FOR NA, not done, no + nodes, ocular site;
  • 'Unknown' FOR Unknown;

  • LAST EDITED:  FEB 05, 1999
  • DESCRIPTION:  If sentinel node(s) positive, record the number of basins dissected.
1129 NUMBER OF BASINS POSITIVE MEL1;30 SET
  • '0' FOR No basins;
  • '1' FOR 1 basin;
  • '2' FOR 2 basins;
  • '3' FOR 3 basins;
  • '4' FOR 4 basins;
  • '5' FOR 5 basins;
  • '6' FOR 6 or more basins;
  • '7' FOR Basins positive, number unknown;
  • '8' FOR NA, not done, no basins dissected, ocular;
  • '9' FOR Unknown;

  • INPUT TRANSFORM:  D NBPIT^ONCOMNI
  • LAST EDITED:  MAR 08, 1999
  • DESCRIPTION:  If sentinel node(s) positive, record the number of basins positive. A positive basin is one in which at least one lymph node, other than the sentinel node, is determined to be positive.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1130 INTRAVENOUS THERAPY MEL1;31 SET
  • '1' FOR Yes, systemic;
  • '2' FOR Yes, regional;
  • '3' FOR Yes, combination of 1 and 2;
  • '7' FOR Yes, type unknown;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown if chemotherapy administered;

  • LAST EDITED:  MAR 01, 1999
  • DESCRIPTION:  Record how the intravenous therapy was given.
1131 GENE THERAPY MEL1;32 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 1999
  • DESCRIPTION:  Record whether the patient received this adjuvant immunotherapy.
1132 SIZE OF TUMOR (MELANOMA) MEL1;33 NUMBER

  • INPUT TRANSFORM:  D STMIT^ONCOOT
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y) D STMOT^ONCOOT
  • LAST EDITED:  APR 28, 1999
  • HELP-PROMPT:  Record the largest dimension or diameter, not depth, of the primary tumor.
  • DESCRIPTION:  SIZE OF TUMOR (MELANOMA) is the largest dimension, or the diameter of the primary tumor, and is always recorded in millimeters. Record the largest diameter of the primary tumor for cutaneous melanomas. Record the tumor
    size for clinically diagnosed ocular melanoma. Record 998 for mucosal melanomas. Record 999 when the primary site is unknown or tumor size is not recorded or not available.
    IMPORTANT NOTE: Do NOT confuse this item with SIZE OF TUMOR in ROADS. For malignant melanoma SIZE OF TUMOR in ROADS records "depth of invasion" and is equivalent to PCE item #30 (BRESLOW'S THICKNESS). SIZE OF TUMOR
    (MELANOMA) records the largest dimension or diameter of the primary tumor.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1200 HANDEDNESS CNS1;1 SET
  • '1' FOR Left handed;
  • '2' FOR Right handed;
  • '3' FOR Ambidextrous;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 2000
  • DESCRIPTION:  This field describes whether the patient is left handed, right handed or ambidextrous.
1201 HYPERTENSION CNS1;2 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 2000
  • DESCRIPTION:  This field describes a patient's prior medical condition.
1202 MULTIPLE SCLEROSIS (MS) CNS1;3 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 2000
  • DESCRIPTION:  This field describes a patient's prior medical condition.
1203 DIABETES CNS1;4 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 2000
  • DESCRIPTION:  This field describes a patient's prior medical condition.
1204 CEREBROVASCULAR DISEASE CNS1;5 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 2000
  • DESCRIPTION:  This field describes a patient's prior medical condition.
1205 BRAIN CNS1;6 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 2000
  • DESCRIPTION:  This field describes a patient's prior history of any cancers.
1206 BREAST CNS1;7 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 2000
  • DESCRIPTION:  This field describes a patient's prior history of any cancers.
1207 PROSTATE CNS1;8 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 2000
  • DESCRIPTION:  This field describes a patient's prior history of any cancers.
1208 MALIGNANT MELANOMA CNS1;9 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 2000
  • DESCRIPTION:  This field describes a patient's prior history of any cancers.
1209 OTHER SKIN CANCER CNS1;10 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 2000
  • DESCRIPTION:  This field describes a patient's prior history of any cancers.
1210 LEUKEMIA CNS1;11 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 2000
  • DESCRIPTION:  This field describes a patient's prior history of any cancers.
1211 COLON OR OTHER GI CANCERS CNS1;12 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 14, 2000
  • DESCRIPTION:  This field describes a patient's prior history of any cancers.
1212 OTHER PERSONAL HISTORY OF CA CNS1;13 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a patient's prior history of any cancers.
1213 NEUROFIBROMATOSIS CNS1;14 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes a patient's predispostion to brain/CNS tumors.
1214 VON HIPPEL-LINDAU DISEASE CNS1;15 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes a patient's predispostion to brain/CNS tumors.
1215 TUBEROUS SCLEROSIS CNS1;16 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes a patient's predispostion to brain/CNS tumors.
1216 TURCOT SYNDROME CNS1;17 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes a patient's predispostion to brain/CNS tumors.
1217 LI-FRAUMENI SYNDROME CNS1;18 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes a patient's predispostion to brain/CNS tumors.
1218 KOWDEN DISEASE CNS1;19 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes a patient's predispostion to brain/CNS tumors.
1219 NEVOID BASAL CELL CARCINOMA CNS1;20 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes a patient's predispostion to brain/CNS tumors.
1220 HEADACHE CNS1;21 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1221 NAUSEA/VOMITING CNS1;22 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1222 CHANGE IN SENSE OF SMELL/TASTE CNS1;23 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1223 ALTERED ALERTNESS CNS1;24 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1224 FATIGUE CNS1;25 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1225 SPEECH DISTURBANCE CNS1;26 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1226 PERSONALITY CHANGES CNS1;27 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1227 DEPRESSION CNS1;28 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1228 MEMORY LOSS CNS1;29 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1229 LACK OF CONCENTRATION CNS1;30 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1230 DOUBLE VISION CNS1;31 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1231 OTHER VISUAL DISTURBANCE CNS1;32 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1232 DECREASED HEARING CNS1;33 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1233 VERTIGO CNS1;34 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1234 TINNITUS CNS1;35 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1235 NUMBNESS/TINGLING CNS1;36 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1236 WEAKNESS OR PARALYSIS CNS1;37 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1237 DIFFICULTY IN COORD/BALANCE CNS1;38 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1238 GENERALIZED SEIZURE CNS1;39 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1239 FOCAL SEIZURE CNS1;40 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1240 BLADDER INCONTINENCE CNS1;41 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1241 BOWEL INCONTINENCE CNS1;42 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1242 PAIN (OTHER THAN HEADACHE) CNS1;43 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1243 WEIGHT CHANGE CNS1;44 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1244 OTHER SYMPTOMS CNS1;45 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown, not stated;

  • LAST EDITED:  JAN 18, 2000
  • DESCRIPTION:  This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.
1245 ALERTNESS CNS1;46 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 19, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1246 SPEECH CNS1;47 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 19, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1247 PERSONALITY CNS1;48 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 19, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1248 MEMORY OR JUDGEMENT CNS1;49 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 19, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1249 VISUAL ACUITY CNS1;50 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 19, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1250 VISUAL FIELDS CNS1;51 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 19, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1251 EYE MOVEMENTS (EOM) CNS1;52 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 19, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1252 FACIAL SENSATION CNS1;53 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 24, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1253 FACIAL MOVEMENT CNS1;54 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 24, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1254 HEARING CNS1;55 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 24, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1255 GAG REFLEX CNS1;56 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 24, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1256 STERNOCLEIDOMASTOID/SHLD STR CNS1;57 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 25, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1257 ARTICULATION OR ENUNCIATION CNS1;58 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 25, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1258 PAPILLEDEMA CNS1;59 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 25, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1259 TONGUE FASCICULATIONS/ATROPHY CNS1;60 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 25, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1260 DECREASE IN SENSATION/ANY SITE CNS1;61 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 25, 2000
  • DESCRIPTION:  
    Record all findings from the neurological examination that evaluated the status of the tumor.
1261 CORTICAL SENSORY DEFICIT CNS1;62 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1262 WEAKNESS/ATROPHY/FASCICULATION CNS1;63 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1263 ATAXIA OF GAIT CNS1;64 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1264 TRUNCAL ATAXIA CNS1;65 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1265 DYSMETRIA CNS1;66 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1266 RAPID ALTERNATING MOVEMENTS CNS1;67 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1267 FINGER TO FINGER NOSE TESTING CNS1;68 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1268 HEEL TO KNEE TO SHIN TESTING CNS1;69 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1269 DEEP TENDON REFLEXES/UPPER EXT CNS1;70 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1270 DEEP TENDON REFLEXES/LOWER EXT CNS1;71 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1271 BABINSKI SIGN CNS1;72 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1272 HOFFMAN REFLEX CNS1;73 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1273 OTHER ABNORMAL REFLEXES CNS1;74 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, examination not done;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  Record all findings from the neurological examination that evaluated the status of the tumor.
1274 ANGIOGRAPHY CNS1;75 SET
  • '0' FOR Results -, no evidence of brain tumor;
  • '1' FOR Results +, some indication of disease;
  • '2' FOR Results unknown, equivocal/inconclusive;
  • '8' FOR NA, test not done;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JUN 07, 2000
  • DESCRIPTION:  This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.
1275 COMPUTED TOMOGRAPHY (CT) SCAN CNS1;76 SET
  • '0' FOR Results -, no evidence of brain tumor;
  • '1' FOR Results +, some indication of disease;
  • '2' FOR Results unknown, equivocal/inconclusive;
  • '8' FOR NA, test not done;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.
1276 CT SCAN OF SPINE CNS1;77 SET
  • '0' FOR Results -, no evidence of brain tumor;
  • '1' FOR Results +, some indication of disease;
  • '2' FOR Results unknown, equivocal/inconclusive;
  • '8' FOR NA, test not done;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.
1277 ELECTROENCEPHALOGRAPHY (EEG) CNS1;78 SET
  • '0' FOR Results -, no evidence of brain tumor;
  • '1' FOR Results +, some indication of disease;
  • '2' FOR Results unknown, equivocal/inconclusive;
  • '8' FOR NA, test not done;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.
1278 ISOTOPE BRAIN SCAN CNS1;79 SET
  • '0' FOR Results -, no evidence of brain tumor;
  • '1' FOR Results +, some indication of disease;
  • '2' FOR Results unknown, equivocal/inconclusive;
  • '8' FOR NA, test not done;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.
1279 POSITRON EMISSION TOMOGRAPHY CNS1;80 SET
  • '0' FOR Results -, no evidence of brain tumor;
  • '1' FOR Results +, some indication of disease;
  • '2' FOR Results unknown, equivocal/inconclusive;
  • '8' FOR NA, test not done;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.
1280 SPECT SCAN CNS1;81 SET
  • '0' FOR Results -, no evidence of brain tumor;
  • '1' FOR Results +, some indication of disease;
  • '2' FOR Results unknown, equivocal/inconclusive;
  • '8' FOR NA, test not done;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.
1281 MRI OF BRAIN CNS1;82 SET
  • '0' FOR Results -, no evidence of brain tumor;
  • '1' FOR Results +, some indication of disease;
  • '2' FOR Results unknown, equivocal/inconclusive;
  • '8' FOR NA, test not done;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.
1282 MRI OF SPINE CNS1;83 SET
  • '0' FOR Results -, no evidence of brain tumor;
  • '1' FOR Results +, some indication of disease;
  • '2' FOR Results unknown, equivocal/inconclusive;
  • '8' FOR NA, test not done;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.
1283 FUNCTIONAL MRI CNS1;84 SET
  • '0' FOR Results -, no evidence of brain tumor;
  • '1' FOR Results +, some indication of disease;
  • '2' FOR Results unknown, equivocal/inconclusive;
  • '8' FOR NA, test not done;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.
1284 MYELOGRAPHY CNS1;85 SET
  • '0' FOR Results -, no evidence of brain tumor;
  • '1' FOR Results +, some indication of disease;
  • '2' FOR Results unknown, equivocal/inconclusive;
  • '8' FOR NA, test not done;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.
1285 MAGNETIC RES SPECTROSCOPY CNS1;86 SET
  • '0' FOR Results -, no evidence of brain tumor;
  • '1' FOR Results +, some indication of disease;
  • '2' FOR Results unknown, equivocal/inconclusive;
  • '8' FOR NA, test not done;
  • '9' FOR Unknown if test done;

  • LAST EDITED:  JAN 26, 2000
  • DESCRIPTION:  
    This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.
1286 FRONTAL LOBE CNS2;1 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1287 TEMPORAL LOBE CNS2;2 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1288 PARIETAL LOBE CNS2;3 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1289 OCCIPITAL LOBE CNS2;4 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1290 OPTIC NERVES CNS2;5 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1291 PITUITARY GLAND CNS2;6 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1292 PINEAL GLAND CNS2;7 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1293 CEREBELLUM CNS2;8 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1294 BRAIN STEM CNS2;9 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1295 SKULL BASE CNS2;10 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1296 OTHER SKULL CNS2;11 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1297 SPINAL CORD CNS2;12 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1298 CEREBRAL SPINAL FLUID (CSF) CNS2;13 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1299 CRANIAL MENINGES CNS2;14 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1300 SPINAL MENINGES CNS2;15 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1301 OTHER TUMOR LOC/INVOLVEMENT CNS2;16 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.
1302 LEFT CNS2;17 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes which side of the brain the tumor is located. Some tumors typically involve midline structures, such as pineal and pituitary gland tumors, and extend to the left or right. For these tumors code
    midline yes and indicate the side of the brain into which the tumor extends. Bilateral tumors should be coded as left and right.
1303 RIGHT CNS2;18 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes which side of the brain the tumor is located. Some tumors typically involve midline structures, such as pineal and pituitary gland tumors, and extend to the left or right. For these tumors code
    midline yes and indicate the side of the brain into which the tumor extends. Bilateral tumors should be coded as left and right.
1304 MIDLINE CNS2;19 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes which side of the brain the tumor is located. Some tumors typically involve midline structures, such as pineal and pituitary gland tumors, and extend to the left or right. For these tumors code
    midline yes and indicate the side of the brain into which the tumor extends. Bilateral tumors should be coded as left and right.
1305 NUMBER OF TUMORS CNS2;20 SET
  • '1' FOR One tumor only;
  • '2' FOR Multiple tumors;
  • '9' FOR Unknown;

  • LAST EDITED:  JAN 27, 2000
  • DESCRIPTION:  This field describes whether the tumor is singular or multiple.
1306 DATE OF FIRST SYMPTOMS CNS2;21 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) W:'$D(X) !,"Future dates are not allowed"
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  FEB 01, 2000
  • DESCRIPTION:  This field describes the date of the first onset of symptoms. This information can typically be found in the patient's history & physical. If the date can not be determined or is unknown, code 99999999.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1307 DATE OF PATHOLOGIC DIAGNOSIS CNS2;22 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) W:'$D(X) !,"Future dates are not allowed"
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  FEB 01, 2000
  • DESCRIPTION:  This field describes the month, day, and year that this cancer was first pathologically diagnosed. If no pathologic diagnosis was determined, code 00000000; if the date of pathologic diagnosis is unknown or cannot be
    determined, code 99999999.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1308 WHO HISTOLOGICAL CL CNS2;23 POINTER TO WHO HISTOLOGICAL CLASSIFICATION FILE (#164.9) WHO HISTOLOGICAL CLASSIFICATION(#164.9)

  • LAST EDITED:  MAR 06, 2000
  • DESCRIPTION:  This field describes the WHO histological classfication of the tumor. Report the appropriate WHO code that corresponds to the written description of the tumor appearing on the pathology report.
1309 MOLECULAR MARKERS CNS2;24 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, no pathologic diagnosis;
  • '9' FOR Unknown if molecular markers used;

  • LAST EDITED:  MAR 06, 2000
  • DESCRIPTION:  This field describes whether molecular markers were used in the pathologic evaluation of the tumor. The most commonly used markers are GFAP, DNA analysis, and KI-67 (MIB antibody). If a pathologic diagnosis was not
    made, code 8.
1310 TUMOR SIZE (SOURCE) CNS2;25 SET
  • '0' FOR Size not recorded;
  • '1' FOR CT scan w or w/o contrast;
  • '2' FOR MRI w/o contrast;
  • '3' FOR MRI w contrast;
  • '4' FOR PET scan;
  • '5' FOR SPECT scan;
  • '6' FOR Operative report;
  • '7' FOR Other;
  • '9' FOR Size recorded, source unknown;

  • LAST EDITED:  MAR 06, 2000
  • DESCRIPTION:  This field describes the source of the data from which the reported size of tumor was documented. DO NOT use the pathology report to determine tumor size.
1311 KARNOFSKY'S RATING PRIOR TO TX CNS2;26 POINTER TO KARNOFSKY'S RATING FILE (#164.17) KARNOFSKY'S RATING(#164.17)

  • INPUT TRANSFORM:  S DIC("S")="I $P(^(0),U,1)'=888" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  JUL 19, 2000
  • DESCRIPTION:  This field describes the physical status of the patient prior to the beginning of intial treatment using Karnofsky's Rating. This is prior to any definitive therapy. If the rating is not recorded, assign a rating based
    upon the best available information.
  • SCREEN:  S DIC("S")="I $P(^(0),U,1)'=888"
  • EXPLANATION:  Enter the appropriate Karnofsky's Rating.
1312 PROTOCOL PARTICIPATION (CNS) CNS2;27 SET
  • '00' FOR Not on;
  • '01' FOR RTOG;
  • '02' FOR SWOG;
  • '03' FOR ECOG;
  • '04' FOR POG;
  • '05' FOR CCG;
  • '06' FOR NCI;
  • '07' FOR NABTT;
  • '08' FOR NABTC;
  • '09' FOR National protcol, NOS;
  • '10' FOR Other institutional protocols;

  • LAST EDITED:  MAR 10, 2000
  • DESCRIPTION:  This field describes whether the patient was enrolled in and treated on a protocol. A physician may treat a patient following the guidelines of an established protocol but not enroll the patient. For these cases, code
    00.
1313 PROTOCOL PHASE CNS2;28 SET
  • '0' FOR Not on;
  • '1' FOR Phase I;
  • '2' FOR Phase I/II;
  • '3' FOR Phase II;
  • '4' FOR Phase III;
  • '9' FOR On protocol, phase unknown;

  • LAST EDITED:  MAR 10, 2000
  • DESCRIPTION:  This field describes the phase of the protocol in which the patient is enrolled. If the patient is not enrolled into a protocol, code 0.
1314 NONE, NO NON-CA DIR SURGERY CNS2;29 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 17, 2000
  • DESCRIPTION:  This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
1315 VENTRICULOSTOMY/EXT VENT DRAIN CNS2;30 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 17, 2000
  • DESCRIPTION:  This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
1316 CSF SHUNT/VENTRICULOPERITONEAL CNS2;31 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 20, 2000
  • DESCRIPTION:  This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
1317 CSF SHUNT/3RD VENTRICULOSTOMY CNS2;32 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 20, 2000
  • DESCRIPTION:  This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
1318 CSF SHUNT/OTHER CNS2;33 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 20, 2000
  • DESCRIPTION:  This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
1319 STEREOTACTIC BIOPSY CNS2;34 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 20, 2000
  • DESCRIPTION:  This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
1320 OPEN BRAIN BIOPSY CNS2;35 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 20, 2000
  • DESCRIPTION:  This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
1321 OPEN BX OF SPINCAL CORD TUMOR CNS2;36 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 20, 2000
  • DESCRIPTION:  This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
1322 LAMINECTOMY W/O RESECT/DURA CNS2;37 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 20, 2000
  • DESCRIPTION:  This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
1323 LAMINECTOMY W/O RESECT W DURA CNS2;38 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 20, 2000
  • DESCRIPTION:  This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
1324 SURGERY, NOS CNS2;39 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 20, 2000
  • DESCRIPTION:  This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
1325 UNKNOWN IF SURGERY DONE CNS2;40 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 20, 2000
  • DESCRIPTION:  This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.
1326 SURGICAL APPROACH (CNS) CNS2;41 SET
  • '0' FOR None, no ca-directed surgery;
  • '1' FOR Craniotomy/craniectomy, w/o stereotactic/image guidance;
  • '2' FOR Craniotomy/craniectomy, w sterotactic/image guidance;
  • '3' FOR Endoscopy;
  • '4' FOR Laminectomy;
  • '5' FOR Other;
  • '9' FOR Surgical approach unknown;

  • LAST EDITED:  MAR 23, 2000
  • DESCRIPTION:  This field describes the method used to approach the organ of origin and/or primary tumor. Code the approach for cancer-directed surgery of the primary site only. Stereotactic image guidance, with regard to SURGICAL
    APPROACH, is not the same as stereotactic radiosurgery, a method of radiation therapy. Stereotactic radiosurgery is addressed in question 57. BCNU wafer implants are surgically placed following resection of tumor.
    Report whether a wafer implantation occurred in questions 63 & 64.
1327 EXTENT OF SURGICAL RESECTION CNS2;42 SET
  • '0' FOR None, no surgery performed;
  • '1' FOR Subtotal resection;
  • '2' FOR Total or gross resection;
  • '3' FOR Lobectomy;
  • '4' FOR Surgery, NOS;
  • '9' FOR Unknown if surgery performed;

  • LAST EDITED:  MAR 23, 2000
  • DESCRIPTION:  This field describes only surgeries of the primary site. Record the most definitive surgery performed to the primary site. Biospy procedures are addressed in question 42. Codes 0, 1, 2, 4 and 9 may apply to brain and
    spinal cord tumors. Code 3 applies to brain tumors only.
1328 SIZE OF RESIDUAL TUMOR CNS2;43 NUMBER

  • INPUT TRANSFORM:  D SRPTIT^ONCOOT
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y) D SRPTOT^ONCOOT
  • LAST EDITED:  MAR 24, 2000
  • HELP-PROMPT:  Record the size of the remaining primary tumor AFTER the most definitive therapy.
  • DESCRIPTION:  This field describes the size of remaining primary tumor AFTER the most definitive therapy. Record the largest dimension or diameter of the residual primary tumor in millimeters (1 cm = 10 mm). If the residual tumor has
    multiple measurements, code the largest size. For example, a residual tumor measuring 3 x 4.4 x 2.5 cm is coded as 044. Use information from postoperative or follow-up imaging studies (MRI, CT, PET, SPECT) to determine
    tumor size. Do not guess at the size of tumor.
    000-No residual tumor
    995-Size not specified, tumor judged smaller
    996-Size not specified, tumor judged unchanged
    997-Size not specified, tumor judged larger
    998-NA, surgical treatment not administered
    999-Unknown, tumor not evaluated
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1329 SIZE OF RES TUMOR (SOURCE) CNS2;44 SET
  • '0' FOR Size not recorded;
  • '1' FOR CT scan w or w/o contrast;
  • '2' FOR MRI w/o contrast;
  • '3' FOR MRI w contrast;
  • '4' FOR PET scan;
  • '5' FOR SPECT scan;
  • '6' FOR Operative report;
  • '7' FOR Other;
  • '9' FOR Size recorded, source unknown;

  • LAST EDITED:  MAR 24, 2000
  • DESCRIPTION:  This field describes the source of the data from which the reported size of the residual tumor was documented.
1330 ANESTHETIC PROBLEM CNS2;45 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, surgery not performed;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 27, 2000
  • DESCRIPTION:  This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.
1331 HEMORRHAGE AT OPERATIVE SITE CNS2;46 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, surgery not performed;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 27, 2000
  • DESCRIPTION:  This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.
1332 SEIZURE CNS2;47 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, surgery not performed;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 27, 2000
  • DESCRIPTION:  This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.
1333 INFECTION(S) CNS2;48 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, surgery not performed;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 27, 2000
  • DESCRIPTION:  This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.
1334 DVT (DEEP VENOUS THROMBOSIS) CNS2;49 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, surgery not performed;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 27, 2000
  • DESCRIPTION:  This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.
1335 PERSISTENT NEUROL WORSENING CNS2;50 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, surgery not performed;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 27, 2000
  • DESCRIPTION:  This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.
1336 TOTAL RADIATION DOSE (cGy) CNS2;51 SET
  • '0' FOR No radiation administered;
  • '1' FOR Less than 3000 cGy;
  • '2' FOR 3000-3999 cGy;
  • '3' FOR 4000-4999 cGy;
  • '4' FOR 5000-5999 cGy;
  • '5' FOR 6000-6999 cGy;
  • '6' FOR 7000-7999 cGy;
  • '7' FOR 8000-8999 cGy;
  • '8' FOR 10000 or more cGy;
  • '9' FOR Dose unknown;

  • LAST EDITED:  MAR 31, 2000
  • DESCRIPTION:  This field describes the total dose delivered to the primary volume of interest, include any boost doses.
1337 TYPE OF EXT BEAM RADIATION CNS2;52 SET
  • '0' FOR No radiation therapy;
  • '1' FOR Cobalt;
  • '2' FOR >=2 and <4 MV X-rays;
  • '3' FOR >=4 and <6 MV X-rays;
  • '4' FOR >=6 and <10 MV X-rays;
  • '5' FOR >=10 MV X-rays;
  • '6' FOR Protons;
  • '7' FOR Neutrons;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 31, 2000
  • DESCRIPTION:  This field describes the type of external beam radiation therapy delivered to the primary volume of interest.
1338 INTERSTITIAL RAD/BRACHYTHERAPY CNS2;53 SET
  • '0' FOR None, brachytherapy not given;
  • '1' FOR Iodine-125;
  • '2' FOR Iridium-192;
  • '3' FOR Other;
  • '9' FOR Unknown;

  • LAST EDITED:  MAR 31, 2000
  • DESCRIPTION:  This field describes any radioactive implant used to treat the patient.
1339 STEREOTACTIC RADIOSURGERY CNS2;54 SET
  • '0' FOR None, not administered;
  • '1' FOR Gamma knife;
  • '2' FOR Linear accelerator (linac);
  • '3' FOR Other;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes the type of delivery of the external radiation dose. Stereotactic radiosurgery is a method by which the focus and target of the radiation beam is precisely directed, and is different from external
    beam radiation which is a less controlled means of radiation therapy delivery.
1340 SKIN REACTIONS CNS2;55 SET
  • '0' FOR No, not present;
  • '1' FOR Present, no tx delay, not req medication;
  • '2' FOR Present, no tx delay, req medication;
  • '3' FOR Present, tx delay or cessation;
  • '8' FOR NA, radiation tx not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes a complication that resulted during or subsequent to radiation therapy.
1341 ANOREXIA CNS2;56 SET
  • '0' FOR No, not present;
  • '1' FOR Present, no tx delay, not req medication;
  • '2' FOR Present, no tx delay, req medication;
  • '3' FOR Present, tx delay or cessation;
  • '8' FOR NA, radiation tx not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 18, 2000
  • DESCRIPTION:  This field describes a complication that resulted during or subsequent to radiation therapy.
1342 NAUSEA OR VOMITING CNS2;57 SET
  • '0' FOR No, not present;
  • '1' FOR Present, no tx delay, not req medication;
  • '2' FOR Present, no tx delay, req medication;
  • '3' FOR Present, tx delay or cessation;
  • '8' FOR NA, radiation tx not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 18, 2000
  • DESCRIPTION:  This field describes a complication that resulted during or subsequent to radiation therapy.
1343 FATIGUE CNS2;58 SET
  • '0' FOR No, not present;
  • '1' FOR Present, no tx delay, not req medication;
  • '2' FOR Present, no tx delay, req medication;
  • '3' FOR Present, tx delay or cessation;
  • '8' FOR NA, radiation tx not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 18, 2000
  • DESCRIPTION:  This field describes a complication that resulted during or subsequent to radiation therapy.
1344 NEUROLOGIC WORSENING CNS2;59 SET
  • '0' FOR No, not present;
  • '1' FOR Present, no tx delay, not req medication;
  • '2' FOR Present, no tx delay, req medication;
  • '3' FOR Present, tx delay or cessation;
  • '8' FOR NA, radiation tx not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 18, 2000
  • DESCRIPTION:  This field describes a complication that resulted during or subsequent to radiation therapy.
1345 RADIATION THERAPY CNS2;60 SET
  • '0' FOR None;
  • '1' FOR Ext beam;
  • '2' FOR RA implants (brachytherapy);
  • '3' FOR Radioisotopes;
  • '4' FOR Stereotactic radiosurgery;
  • '5' FOR Ext beam/RA implants or radioisotopes;
  • '6' FOR Ext beam/stereotactic radiosurgery;
  • '7' FOR Radiation, NOS;
  • '9' FOR Unk, death cert cases only;

  • LAST EDITED:  APR 18, 2000
  • DESCRIPTION:  This field describes the type of radiation administered to the primary site. Include all procedures that are part of the first course of treatment, whether delivered at the reporting institution or at other institutions.
1346 PROCARBAZINE CNS2;61 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
1347 CCNU CNS2;62 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
1348 VINCRISTINE CNS2;63 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
1349 HYDROXYUREA CNS2;64 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
1350 BCNU CNS2;65 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
1351 BCNU WAFER IMPLANT CNS2;66 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
1352 VP-16 CNS2;67 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
1353 CARBOPLATIN CNS2;68 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
1354 TEMOZOLOMIDE CNS2;69 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
1355 CPT-11 CNS2;70 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
1356 TAMOXIFEN CNS2;71 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
1357 CYTARABINE (ARA-C) CNS2;72 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one type of chemotherapeutic agent administered to the patient.
1358 CHEMOTHERAPEUTIC ROUTE CNS2;73 SET
  • '1' FOR Intrathecal;
  • '2' FOR Intra-arterial;
  • '3' FOR Intravenous;
  • '4' FOR Orally;
  • '5' FOR Intramuscular;
  • '6' FOR BCNU wafer implant;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes the route or method used to administer the chemotherapy.
1359 HEARING LOSS CNS2;74 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one of the complications which resulted from the administration of chemotherapy.
1360 INFECTION CNS2;75 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one of the complications which resulted from the administration of chemotherapy.
1361 NAUSEA AND VOMITING CNS2;76 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one of the complications which resulted from the administration of chemotherapy.
1362 BLOOD COUNT DROP/BLEEDING CNS2;77 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one of the complications which resulted from the administration of chemotherapy.
1363 PERIPHERAL NEUROPATHY CNS2;78 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one of the complications which resulted from the administration of chemotherapy.
1364 RENAL FAILURE CNS2;79 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one of the complications which resulted from the administration of chemotherapy.
1365 PULMONARY TOXICITY CNS2;80 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one of the complications which resulted from the administration of chemotherapy.
1366 OTHER CHEMO COMPLICATIONS CNS2;81 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 20, 2000
  • DESCRIPTION:  This field describes one of the complications which resulted from the administration of chemotherapy.
1367 KARNOFSKY'S RATING @ DIS/TRANS CNS2;82 POINTER TO KARNOFSKY'S RATING FILE (#164.17) KARNOFSKY'S RATING(#164.17)

  • INPUT TRANSFORM:  S DIC("S")="I $P(^(0),U,1)'=888" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  JUL 19, 2000
  • DESCRIPTION:  This field describes the physical status of the patient at the time of discharge or transfer from the treating facility following definitive therapy. In some cases, the patient may be discharged from the treating
    facility and transferred to another care facility; use codes 030 and 020 to describe these cases. If rating is not recorded, assign a rating based upon the best available information.
  • SCREEN:  S DIC("S")="I $P(^(0),U,1)'=888"
  • EXPLANATION:  Enter the appropriate Karnofsky's Rating.
1368 DATE OF PROGRESSION CNS2;83 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) W:'$D(X) !,"Future dates are not allowed"
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  APR 21, 2000
  • DESCRIPTION:  This field describes the date the medical practitioner determines that the tumor has progressed and that the first course of therapy has failed, necessitating consideration of a subsequent course of treatment. Patients
    with tumor progression were never disease free following the first course of treatment. Record the month, day and year of the determined progression, based on the best available information. If the patient was disease
    free following the first course of treatment, code 00000000; if no progression was noted or first course of therapy was not administered, code 88888888; if the date of tumor progression is unknown, code 99999999.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1369 TYPE OF PROGRESSION CNS2;84 SET
  • '0' FOR None, disease-free;
  • '1' FOR Local;
  • '2' FOR Regional, same hemisphere;
  • '3' FOR Regional, opposite hemisphere;
  • '4' FOR Distant, spine/spinal cord;
  • '5' FOR Distant, abdomen;
  • '6' FOR Distant, other;
  • '8' FOR NA, no progression, or no 1st course;
  • '9' FOR Unknown if progressed;

  • LAST EDITED:  APR 24, 2000
  • DESCRIPTION:  This field describes the progression of the cancer after the completion of the first course of therapy.
1370 RECURRENCE/PROGRESSION DOC CNS2;85 SET
  • '0' FOR No recurrence/progression;
  • '1' FOR Neurological or Karnofsky's deterioration;
  • '2' FOR CT scan;
  • '3' FOR MRI scan;
  • '4' FOR Comb of 1 + 2, or 1 + 3;
  • '5' FOR Other;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 24, 2000
1371 KARNOFSKY'S RATING RECURRENCE CNS2;86 POINTER TO KARNOFSKY'S RATING FILE (#164.17) KARNOFSKY'S RATING(#164.17)

  • LAST EDITED:  APR 24, 2000
  • DESCRIPTION:  This field describes the patient's physical status at the time that either recurrence or progression was noted.
1372 TYPE OF 1ST RECURRENCE/CNS CNS2;87 SET
  • '0' FOR None, disease free;
  • '1' FOR Local;
  • '2' FOR Regional, same hemisphere;
  • '3' FOR Regional, opposite hemisphere;
  • '4' FOR Distant, spine/spincal cord;
  • '5' FOR Distant, abdomen;
  • '6' FOR Distant, other;
  • '8' FOR NA, never disease free;
  • '9' FOR Unknown if recurred;

  • LAST EDITED:  APR 24, 2000
  • DESCRIPTION:  This field describes the return or reappearance of the cancer after a disease free intermission or remission. Record the type of the first recurrence. If the patient has been disease-free since treatment, code 0.
1373 PROTOCOL PARTICIPATION (SUBTX) CNS2;88 SET
  • '00' FOR Not on;
  • '01' FOR RTOG;
  • '02' FOR SWOG;
  • '03' FOR ECOG;
  • '04' FOR POG;
  • '05' FOR CCG;
  • '06' FOR NCI;
  • '07' FOR NABTT;
  • '08' FOR NABTC;
  • '09' FOR National protcol, NOS;
  • '10' FOR Other institutional protocols;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes whether the patient was enrolled in and treated on a protocol as part of their treatment for progression or recurrence of disease. A physician may treat a patient following the guidelines of an
    established protocol but not enroll the patient. For these cases, code 00.
1374 TYPE OF SUBSEQUENT SURGICAL TX CNS2;89 SET
  • '0' FOR None, no subsequent surgery;
  • '1' FOR Subtotal resection;
  • '2' FOR Total or gross resection;
  • '3' FOR Lobectomy;
  • '4' FOR Surgery, NOS;
  • '9' FOR Unknown if subsequent surgery performed;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes subsequent surgical treatment administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1375 TYPE OF SUBSEQUENT RADIATION CNS2;90 SET
  • '0' FOR None;
  • '1' FOR Beam radiation;
  • '2' FOR RA implants;
  • '3' FOR Radioisotopes;
  • '4' FOR Stereotactic radiosurgery;
  • '5' FOR Beam rad/RA implants or radioisotopes;
  • '6' FOR Beam rad/stereotactic radiosurgery;
  • '7' FOR Radiation, NOS;
  • '9' FOR Unknown if administered;

  • LAST EDITED:  NOV 24, 2004
  • DESCRIPTION:  This field describes subsequent radiation treatment administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1376 PROCARBAZINE (SUB TX) CNS3;1 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1377 CCNU (SUB TX) CNS3;2 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1378 VINCRISTINE (SUB TX) CNS3;3 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1379 HYDROXYUREA (SUB TX) CNS3;4 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1380 METHOTREXATE (SUB TX) CNS3;5 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1381 CISPLATIN (SUB TX) CNS3;6 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1382 BCNU (SUB TX) CNS3;7 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1383 BCNU WAFER IMPLANT (SUB TX) CNS3;8 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1384 VP-16 (SUB TX) CNS3;9 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1385 CARBOPLATIN (SUB TX) CNS3;10 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1386 TEMOZOLOMIDE (SUB TX) CNS3;11 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1387 CYCLOPHOSPHAMIDE (SUB TX) CNS3;12 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1388 CPT-11 (SUB TX) CNS3;13 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1389 TAMOXIFEN (SUB TX) CNS3;14 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1390 INTERFERON (SUB TX) CNS3;15 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1391 CYTARABINE (ARA-C) (SUB TX) CNS3;16 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1392 OTHER CHEMOTHERAPY (SUB TX) CNS3;17 SET
  • '0' FOR No;
  • '1' FOR Yes;
  • '8' FOR NA, chemotherapy not administered;
  • '9' FOR Unknown;

  • LAST EDITED:  APR 27, 2000
  • DESCRIPTION:  This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1393 OTHER SUBSEQUENT TREATMENT CNS3;18 SET
  • '0' FOR No other tx;
  • '1' FOR Ca-directed tx, NOS;
  • '2' FOR Monoclonal antibodies;
  • '3' FOR Other experimental ca-dir tx;
  • '4' FOR Double-blind clin trial;
  • '6' FOR Unproven tx;
  • '7' FOR Patient refused tx;
  • '8' FOR Other tx rec, unk if admin;
  • '9' FOR Unk if administered;

  • LAST EDITED:  APR 28, 2000
  • DESCRIPTION:  This field describes other types of subsequent treatment administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.
1394 TUMOR SIZE CNS3;19 NUMBER

  • INPUT TRANSFORM:  D TSIT^ONCOOT
  • OUTPUT TRANSFORM:  S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y) D TSOT^ONCOOT
  • LAST EDITED:  JAN 10, 2001
  • HELP-PROMPT:  Record the tumor size from the most significant imaging test.
  • DESCRIPTION:  This field describes the largest dimension or diameter of the primary tumor in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For example, a tumor measuring 3 x 4.4 x 2.5 cm
    is coded as 044. If there are multiple tumors, code the size of the largest tumor. For example, if the first tumor measures 2 x .5 cm and the second measures 1 x .5 cm, code 020. See ROADS for instructions on converting
    centimeters to millimeters. Use information from preoperative imaging (MRI, CT, PET, SPECT) to determine TUMOR SIZE. DO NOT use the pathology report to determine TUMOR SIZE. DO NOT guess at the TUMOR SIZE. Code 999 if
    TUMOR SIZE cannot be determined.
    Codes: 001 thru 997 - tumor size (mm)
    999 - Unknown, cannot be determined, not recorded
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1400 LNG CO-MORBID CONDITION 1 LUN1;1 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing
    conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.
    Allowable Codes: 000.00
    001.00 thru 994.90 (valid ICD-CM codes)
    If no co-morbid conditions were documented, answer "No" to the CO-MORBID CONDITIONS (YES/NO) prompt.
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
  • EXPLANATION:  If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1400.1 LNG CO-MORBID CONDITION 2 LUN1;2 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing
    conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.
    Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)
    If there was only one co-morbid condition, leave this field blank.
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
  • EXPLANATION:  If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.
1400.2 LNG CO-MORBID CONDITION 3 LUN1;3 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing
    conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.
    Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)
    If there was only one co-morbid condition, leave this field blank.
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
  • EXPLANATION:  If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.
1400.3 LNG CO-MORBID CONDITION 4 LUN1;4 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing
    conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.
    Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)
    If there was only one co-morbid condition, leave this field blank.
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
  • EXPLANATION:  If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.
1400.4 LNG CO-MORBID CONDITION 5 LUN1;5 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing
    conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.
    Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)
    If there was only one co-morbid condition, leave this field blank.
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
  • EXPLANATION:  If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.
1400.5 LNG CO-MORBID CONDITION 6 LUN1;6 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing
    conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.
    Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)
    If there was only one co-morbid condition, leave this field blank.
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
  • EXPLANATION:  If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.
1400.6 LNG CO-MORBID CONDITION Y/N LUN1;76 SET
************************REQUIRED FIELD************************
  • '0' FOR No;
  • '1' FOR Yes;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  Are CO-MORBID CONDITIONS associated with this cancer (Yes/No)?
    This item records if there were pre-existing medical conditions present at the time of diagnosis for this cancer.
    Answering "Yes" will prompt you for CO-MORBID CONDITIONS #1-6.
    Answering "No" will code CO-MORBID CONDITION #1 with 000.00 and leave the remaining co-morbid fields blank.
1401 LNG DURATION OF TOBACCO USE LUN1;7 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D DTU^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="00":"Never used tobacco",Y=99:"Not documented",Y="01":Y_" year",1:Y_" years")
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00 and 99
  • DESCRIPTION:  This item describes the number of known years the patient used some form of tobacco, even if the patient is not presently using tobacco. If the patient has never used tobacco, code 00. If the patient's tobacco use
    cannot be determined, or if the duration of use is not known, code 99.
    Allowable Codes: 00 - never used tobacco
    01 thru 98 - one or more years of tobacco use
    99 - duration of tobacco use not documented
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1402 LNG DATE OF FIRST TISSUE DX LUN1;8 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) D:'$D(X) EN^DDIOL("Future dates are not allowed")
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  JUL 19, 2001
  • DESCRIPTION:  This item describes the month, day, and year (MMDDCCYY) that this primary cancer was first diagnosed using a tissue sample to arrive at a positive histologic or cytologic evaluation of the tumor.
    If a positive histologic or cytologic evaluation was made but the date is unknown code 99/99/9999.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1403 LNG PERSONAL HIST OTH MALIG LUN1;9 POINTER TO ICDO TOPOGRAPHY FILE (#164) ICDO TOPOGRAPHY(#164)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)
  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the patient's prior history of other invasive malignancies. If the patient has a history of other malignancies report the ICD-O-3 site code for the most recently diagnosed disease. If the patient has
    no personal history of other cancer, code C88.8. If the patient's personal history of other invasive malignancies is not documented, code C99.9.
    Allowable Codes: C00.0 thru C80.9 - valid ICD-0-3 site (topography) codes
    C88.8 - no personal history of other cancer
    C99.9 - personal history of other cancer not documented
  • EXECUTABLE HELP:  D ITEM3^ONCLPC1
1404 LNG COUGH LUN1;10 SET
  • '1' FOR Present;
  • '2' FOR Not present;
  • '9' FOR Not documented if present;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the presence of a cough specific to lung (NSCLC) cancer that was recorded in the medical chart.
1404.1 LNG SHORTNESS OF BREATH LUN1;11 SET
  • '1' FOR Present;
  • '2' FOR Not present;
  • '9' FOR Not documented if present;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the presence of shortness of breath specific to lung (NSCLC) cancer that was recorded in the medical chart.
1404.2 LNG WEIGHT LOSS LUN1;12 SET
  • '1' FOR Present;
  • '2' FOR Not present;
  • '9' FOR Not documented if present;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the presence of weight loss specific to lung (NSCLC) cancer that was recorded in the medical chart.
1404.3 LNG HEMOPTYSIS LUN1;13 SET
  • '1' FOR Present;
  • '2' FOR Not present;
  • '9' FOR Not documented if present;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the presence of hemoptysis specific to lung (NSCLC) cancer that was recorded in the medical chart.
1404.4 LNG PALPABLE LYMPH NODES LUN1;14 SET
  • '1' FOR Present;
  • '2' FOR Not present;
  • '9' FOR Not documented if present;

  • LAST EDITED:  APR 30, 2002
  • DESCRIPTION:  
    This item describes the presence of palpable lymph nodes specific to lung (NSCLC) cancer that was recorded in the medical chart.
1405 LNG CHEST X-RAY LUN1;15 SET
  • '1' FOR Used;
  • '2' FOR Not used;
  • '9' FOR Not documented if used;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item identifies patients who are screened routinely or due to a high risk history of cardiac and/or pulmonary disease. Record whether a chest x-ray method was used.
1405.1 LNG CT SCAN LUN1;16 SET
  • '1' FOR Used;
  • '2' FOR Not used;
  • '9' FOR Not documented if used;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item identifies patients who are screened routinely or due to a high risk history of cardiac and/or pulmonary disease. Record whether a CT scan method was used.
1405.2 LNG BRONCHOSCOPY LUN1;17 SET
  • '1' FOR Used;
  • '2' FOR Not used;
  • '9' FOR Not documented if used;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item identifies patients who are screened routinely or due to a high risk history of cardiac and/or pulmonary disease. Record whether a bronchoscopy method was used.
1406 LNG HISTORY AND PHYSICAL LUN1;18 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal results;
  • '8' FOR Not performed, not mentioned in record;
  • '9' FOR Done, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the methods and results of the history and physical performed to evaluate and or diagnose the primary tumor before definitive therapy.
1406.1 LNG BRONCHOSCOPY PRE-THERAPY LUN1;19 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal results;
  • '8' FOR Not performed, not mentioned in record;
  • '9' FOR Done, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the methods and results of the bronchoscopy performed to evaluate and or diagnose the primary tumor before definitive therapy.
1406.2 LNG FNAB LUN1;20 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal results;
  • '8' FOR Not performed, not mentioned in record;
  • '9' FOR Done, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the methods and results of the FNAB (fine needle aspiration biopsy) performed to evaluate and or diagnose the primary tumor before definitive therapy.
1406.3 LNG MEDIASTINOSCOPY LUN1;21 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal results;
  • '8' FOR Not performed, not mentioned in record;
  • '9' FOR Done, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the methods and results of the mediastinoscopy performed to evaluate and or diagnose the primary tumor before definitive therapy.
1406.4 LNG THOROCOTOMY/OPEN BIOPSY LUN1;22 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal results;
  • '8' FOR Not performed, not mentioned in record;
  • '9' FOR Done, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the methods and results of the thorocotomy/open biopsy (open technique) performed to evaluate and or diagnose the primary tumor before definitive therapy.
1406.5 LNG VATS LUN1;23 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal results;
  • '8' FOR Not performed, not mentioned in record;
  • '9' FOR Done, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the methods and results of the VATS (visual assisted thorocotomy surgery) performed to evaluate and or diagnose the primary tumor before definitive therapy.
1407 LNG FVC LUN1;24 NUMBER

  • INPUT TRANSFORM:  K:X>9.99!(X<0)!(X?.E1"."3N.N) X I $D(X) S ONCL=1,ONCF=2 D PFT^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="0.00":"Not done",Y=9.98:"Done, results not documented",Y=9.99:"Not documented if performed",1:Y_" liter(s)")
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 0.00 and 9.99, 2 Decimal Digits
  • DESCRIPTION:  This item describes the results of the FVC (forced vital capacity) pulmonary function test (PFT). Record the absolute value of the result in liters (L). Record results to the precision of 2 decimal points and record
    zeros in unused positions; for example 2.54L would be coded as 2.54; 1.2L would be coded as 1.20; 0.5L would be coded as 0.50. If a test was administered but the result is not documented, code 9.98; if it's not documented
    whether the test was administered, code 9.99.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1407.1 LNG FEV LUN1;25 NUMBER

  • INPUT TRANSFORM:  K:X>9.99!(X<0)!(X?.E1"."3N.N) X I $D(X) S ONCL=1,ONCF=2 D PFT^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(+Y=0:"Not done",Y=9.98:"Done, results not documented",Y=9.99:"Not documented if performed",1:Y_" liter(s)")
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 0.00 and 9.99, 2 Decimal Digits
  • DESCRIPTION:  This item describes the results of the FEV (forced expiratory volume) pulmonary function test (PFT). Record the absolute value of the result in liters (L). Record results to the precision of 2 decimal points and record
    zeros in unused positions; for example 2.54L would be coded as 2.54; 1.2L would be coded as 1.20; 0.5L would be coded as 0.50. If a test was administered but the result is not documented, code 9.98; if it's not documented
    whether the test was administered, code 9.99.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1408 LNG LIVER FUNCTION TESTS LUN1;26 SET
  • '1' FOR Abnormal results, for at least one test;
  • '2' FOR Normal results on all tests;
  • '8' FOR Test(s) not performed, not mentioned;
  • '9' FOR Test(s) done, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the results of any test performed to evaluate the patient's liver function. Liver function tests typically include protime, bilirubin, albumin and LDH. If ANY of these tests were performed and were
    documented with abnormal results, code 1. If ALL liver function tests had normal results, code 2.
1409 LNG BONE SCAN LUN1;27 SET
  • '1' FOR Performed;
  • '2' FOR Not performed;
  • '9' FOR Requested, not documented if performed;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records whether or not a bone scan was performed.
1409.1 LNG EMPHYSEMA (BONE SCAN) LUN1;28 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of emphysema as detected in the bone scan.
1409.2 LNG VASCULAR INV (BONE SCAN) LUN1;29 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of vascular invasion as detected in the bone scan.
1409.3 LNG MEDIASTINAL LN (BONE SCAN) LUN1;30 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the bone scan.
1409.4 LNG TUMOR SIZE (BONE SCAN) LUN1;31 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 000 and 999
  • DESCRIPTION:  
    Record the size in millimeters of the dominant (largest) tumor as detected by the bone scan.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1409.5 LNG NUM OF TUMORS (BONE SCAN) LUN1;32 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00 and 99
  • DESCRIPTION:  
    Record the number of tumor nodules found (or identified) by the bone scan.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1409.6 LNG METASTASIS (BONE SCAN) LUN1;33 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of metastasis as detected in the bone scan.
1410 LNG CT SCAN OF CHEST LUN1;34 SET
  • '1' FOR Performed;
  • '2' FOR Not performed;
  • '9' FOR Requested, not documented if performed;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records whether or not a CT scan of the chest was performed.
1410.1 LNG EMPHYSEMA (CHEST CT) LUN1;35 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of emphysema as detected in the CT scan of the chest.
1410.2 LNG VASCULAR INV (CHEST CT) LUN1;36 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of vascular invasion as detected in the CT scan of the chest.
1410.3 LNG MEDIASTINAL LN (CHEST CT) LUN1;37 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the CT scan of the chest.
1410.4 LNG TUMOR SIZE (CHEST CT) LUN1;38 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 000 and 999
  • DESCRIPTION:  
    Record the size in millimeters of the dominant (largest) tumor as detected by the CT scan of the chest.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1410.5 LNG NUM OF TUMORS (CHEST CT) LUN1;39 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00 and 99
  • DESCRIPTION:  
    Record the number of tumor nodules found (or identified) by the CT scan of the chest.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1410.6 LNG METASTASIS (CHEST CT) LUN1;40 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of metastasis as detected in the CT scan of the chest.
1411 LNG CT SCAN OF BRAIN LUN1;41 SET
  • '1' FOR Performed;
  • '2' FOR Not performed;
  • '9' FOR Requested, not documented if performed;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records whether or not a CT scan of the brain was performed.
1411.1 LNG EMPHYSEMA (BRAIN CT) LUN1;42 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of emphysema as detected in the CT scan of the brain.
1411.2 LNG VASCULAR INV (BRAIN CT) LUN1;43 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of vascular invasion as detected in the CT scan of the brain.
1411.3 LNG MEDIASTINAL LN (BRAIN CT) LUN1;44 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the CT scan of the brain.
1411.4 LNG TUMOR SIZE (BRAIN CT) LUN1;45 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 000 and 999
  • DESCRIPTION:  
    Record the size in millimeters of the dominant (largest) tumor as detected by the CT scan of the brain.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1411.5 LNG NUM OF TUMORS (BRAIN CT) LUN1;46 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00 and 99
  • DESCRIPTION:  
    Record the number of tumor nodules found (or identified) by the CT scan of the brain.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1411.6 LNG METASTASIS (BRAIN CT) LUN1;47 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of metastasis as detected in the CT scan of the brain.
1412 LNG MRI SCAN OF CHEST LUN1;48 SET
  • '1' FOR Performed;
  • '2' FOR Not performed;
  • '9' FOR Requested, not documented if performed;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records whether or not a MRI scan of the chest was performed.
1412.1 LNG EMPHYSEMA (CHEST MRI) LUN1;49 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of emphysema as detected in the MRI of the chest.
1412.2 LNG VASCULAR INV (CHEST MRI) LUN1;50 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of vascular invasion as detected in the MRI scan of chest.
1412.3 LNG MEDIASTINAL LN (CHEST MRI) LUN1;51 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the MRI scan of the chest.
1412.4 LNG TUMOR SIZE (CHEST MRI) LUN1;52 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 000 and 999
  • DESCRIPTION:  
    Record the size in millimeters of the dominant (largest) tumor as detected by the MRI scan of the chest.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1412.5 LNG NUM OF TUMORS (CHEST MRI) LUN1;53 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00 and 99
  • DESCRIPTION:  
    Record the number of tumor nodules found (or identified) by the MRI scan of the chest.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1412.6 LNG METASTASIS (CHEST MRI) LUN1;54 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of metastasis as detected in the MRI scan of the chest.
1413 LNG MRI SCAN OF BRAIN LUN1;55 SET
  • '1' FOR Performed;
  • '2' FOR Not performed;
  • '9' FOR Requested, not documented if performed;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records whether or not a MRI scan of the brain was performed.
1413.1 LNG EMPHYSEMA (BRAIN MRI) LUN1;56 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of emphysema as detected in the MRI of the brain.
1413.2 LNG VASCULAR INV (BRAIN MRI) LUN1;57 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of vascular invasion as detected in the MRI scan of the brain.
1413.3 LNG MEDIASTINAL LN (BRAIN MRI) LUN1;58 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the MRI scan of the brain.
1413.4 LNG TUMOR SIZE (BRAIN MRI) LUN1;59 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 000 and 999
  • DESCRIPTION:  
    Record the size in millimeters of the dominant (largest) tumor as detected by the MRI scan of the brain.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1413.5 LNG NUM OF TUMORS (BRAIN MRI) LUN1;60 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00 and 99
  • DESCRIPTION:  
    Record the number of tumor nodules found (or identified) by the MRI scan of the brain.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1413.6 LNG METASTASIS (BRAIN MRI) LUN1;61 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of metastasis as detected in the MRI scan of the brain.
1414 LNG PET SCAN LUN1;62 SET
  • '1' FOR Performed;
  • '2' FOR Not performed;
  • '9' FOR Requested, not documented if performed;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records whether or not a PET (positron emission tomography) scan was performed.
1414.1 LNG EMPHYSEMA (PET SCAN) LUN1;63 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of emphysema as detected in the PET (positron emission tomography) scan.
1414.2 LNG VASCULAR INV (PET SCAN) LUN1;64 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of vascular invasion as detected in the PET (positron emission tomography) scan.
1414.3 LNG MEDIASTINAL LN (PET SCAN) LUN1;65 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the PET (positron emission tomography) scan.
1414.4 LNG TUMOR SIZE (PET SCAN) LUN1;66 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 000 and 999
  • DESCRIPTION:  
    Record the size in millimeters of the dominant (largest) tumor as detected by the PET (positron emission tomography) scan.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1414.5 LNG NUM OF TUMORS (PET SCAN) LUN1;67 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00 and 99
  • DESCRIPTION:  
    Record the number of tumor nodules found (or identified) by the PET (positron emission tomography) scan.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1414.6 LNG METASTASIS (PET SCAN) LUN1;68 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of metastasis as detected in the PET (positron emission tomography) scan.
1415 LNG X-RAY OF CHEST LUN1;69 SET
  • '1' FOR Performed;
  • '2' FOR Not performed;
  • '9' FOR Requested, not documented if performed;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records whether or not a chest x-ray was performed.
1415.1 LNG EMPHYSEMA (CHEST XRAY) LUN1;70 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of emphysema as detected in the X-Ray of the chest.
1415.2 LNG VASCULAR INV (CHEST XRAY) LUN1;71 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of vascular invasion as detected in the X-ray of the chest.
1415.3 LNG MEDIASTINAL (CHEST XRAY) LUN1;72 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the X-ray of the chest.
1415.4 LNG TUMOR SIZE (CHEST XRAY) LUN1;73 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 000 and 999
  • DESCRIPTION:  
    Record the size in millimeters of the dominant (largest) tumor as detected by the X-ray of the chest.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1415.5 LNG NUM OF TUMORS (CHEST XRAY) LUN1;74 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT
  • OUTPUT TRANSFORM:  D RE^ONCOOT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00 and 99
  • DESCRIPTION:  
    Record the number of tumor nodules found (or identified) by the X-ray of the chest.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1415.6 LNG METASTASIS (CHEST XRAY) LUN1;75 SET
  • '1' FOR Present;
  • '2' FOR Absent;
  • '8' FOR NA, test not performed;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item records the presence or absence of metastasis as detected in the X-ray of the chest.
1416 LNG HIGH MEDIASTINAL (PRE-OP) LUN2;1 SET
  • '1' FOR No nodes sampled;
  • '2' FOR Sampled, no evidence of positive nodes;
  • '3' FOR Sampled, evidence of positive nodes;
  • '4' FOR Node sampling not mentioned;
  • '5' FOR Sampled, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes whether the highest mediastinal (level 1) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.
1416.1 LNG UPPER PARATRACH (PRE-OP) LUN2;2 SET
  • '1' FOR No nodes sampled;
  • '2' FOR Sampled, no evidence of positive nodes;
  • '3' FOR Sampled, evidence of positive nodes;
  • '4' FOR Node sampling not mentioned;
  • '5' FOR Sampled, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes whether the upper paratracheal (level 2) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.
1416.2 LNG PREVASC/RETRO (PRE-OP) LUN2;3 SET
  • '1' FOR No nodes sampled;
  • '2' FOR Sampled, no evidence of positive nodes;
  • '3' FOR Sampled, evidence of positive nodes;
  • '4' FOR Node sampling not mentioned;
  • '5' FOR Sampled, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes whether the prevascular and retrotracheal (level 3) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.
1416.3 LNG LOWER PARATRACH (PRE-OP) LUN2;4 SET
  • '1' FOR No nodes sampled;
  • '2' FOR Sampled, no evidence of positive nodes;
  • '3' FOR Sampled, evidence of positive nodes;
  • '4' FOR Node sampling not mentioned;
  • '5' FOR Sampled, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes whether the lower paratracheal (level 4) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.
1416.4 LNG SUBAORTIC (PRE-OP) LUN2;5 SET
  • '1' FOR No nodes sampled;
  • '2' FOR Sampled, no evidence of positive nodes;
  • '3' FOR Sampled, evidence of positive nodes;
  • '4' FOR Node sampling not mentioned;
  • '5' FOR Sampled, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes whether the subaortic (level 5) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.
1416.5 LNG PARAORTIC (PRE-OP) LUN2;6 SET
  • '1' FOR No nodes sampled;
  • '2' FOR Sampled, no evidence of positive nodes;
  • '3' FOR Sampled, evidence of positive nodes;
  • '4' FOR Node sampling not mentioned;
  • '5' FOR Sampled, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes whether the paraortic (level 6) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.
1416.6 LNG SUBCARINAL (PRE-OP) LUN2;7 SET
  • '1' FOR No nodes sampled;
  • '2' FOR Sampled, no evidence of positive nodes;
  • '3' FOR Sampled, evidence of positive nodes;
  • '4' FOR Node sampling not mentioned;
  • '5' FOR Sampled, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes whether the subcarinal (level 7) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.
1416.7 LNG PARAESOPHAGEAL (PRE-OP) LUN2;8 SET
  • '1' FOR No nodes sampled;
  • '2' FOR Sampled, no evidence of positive nodes;
  • '3' FOR Sampled, evidence of positive nodes;
  • '4' FOR Node sampling not mentioned;
  • '5' FOR Sampled, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes whether the paraesophageal (level 8) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.
1416.8 LNG PULMONARY LIG (PRE-OP) LUN2;9 SET
  • '1' FOR No nodes sampled;
  • '2' FOR Sampled, no evidence of positive nodes;
  • '3' FOR Sampled, evidence of positive nodes;
  • '4' FOR Node sampling not mentioned;
  • '5' FOR Sampled, results not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes whether the pulmonary ligament (level 9) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.
1417 LNG FROZEN SECTION LUN2;10 SET
  • '1' FOR Surgery performed, no frozen section taken;
  • '2' FOR Surgery performed, frozen section taken;
  • '8' FOR NA, no surgery;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes whether or not a frozen section was taken according to the pathology report.
1418 LNG VASCULAR INVASION LUN2;11 SET
  • '1' FOR Structure not involved;
  • '2' FOR Yes, structure involved;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes any tumor invasion of the vascular structure.
1418.1 LNG LYMPHATICS INVASION LUN2;12 SET
  • '1' FOR Structure not involved;
  • '2' FOR Yes, structure involved;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes any tumor invasion of the lymphatics structure.
1418.2 LNG PLEURA INVASION LUN2;13 SET
  • '1' FOR Structure not involved;
  • '2' FOR Yes, structure involved;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes any tumor invasion of the pleura structure.
1418.3 LNG CHEST WALL INVASION LUN2;14 SET
  • '1' FOR Structure not involved;
  • '2' FOR Yes, structure involved;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes any tumor invasion of the chest wall.
1418.4 LNG OTHER INVASION LUN2;15 SET
  • '1' FOR Structure not involved;
  • '2' FOR Yes, structure involved;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes any tumor invasion of any other structure.
1419 LNG HIGH MEDIASTINAL (SCOPE) LUN2;16 SET
  • '1' FOR Nodes not sampled;
  • '2' FOR Nodes sampled, but not removed en bloc;
  • '3' FOR Nodes removed en bloc;
  • '9' FOR Lymph node assessment not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the highest mediastinal (level 1) nodes were sampled or taken en bloc.
1419.1 LNG UPPER PARATRACHEAL (SCOPE) LUN2;17 SET
  • '1' FOR Nodes not sampled;
  • '2' FOR Nodes sampled, but not removed en bloc;
  • '3' FOR Nodes removed en bloc;
  • '9' FOR Lymph node assessment not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the upper paratracheal (level 2) nodes were sampled or taken en bloc.
1419.2 LNG PREVASC/RETROTRACH (SCOPE) LUN2;18 SET
  • '1' FOR Nodes not sampled;
  • '2' FOR Nodes sampled, but not removed en bloc;
  • '3' FOR Nodes removed en bloc;
  • '9' FOR Lymph node assessment not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the prevascular & retrotracheal (level 3) nodes were sampled or taken en bloc.
1419.3 LNG LOWER PARATRACHEAL (SCOPE) LUN2;19 SET
  • '1' FOR Nodes not sampled;
  • '2' FOR Nodes sampled, but not removed en bloc;
  • '3' FOR Nodes removed en bloc;
  • '9' FOR Lymph node assessment not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the lower paratracheal (level 4) nodes were sampled or taken en bloc.
1419.4 LNG SUBAORTIC (SCOPE) LUN2;20 SET
  • '1' FOR Nodes not sampled;
  • '2' FOR Nodes sampled, but not removed en bloc;
  • '3' FOR Nodes removed en bloc;
  • '9' FOR Lymph node assessment not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the subaortic (level 5) nodes were sampled or taken en bloc.
1419.5 LNG PARAORTIC (SCOPE) LUN2;21 SET
  • '1' FOR Nodes not sampled;
  • '2' FOR Nodes sampled, but not removed en bloc;
  • '3' FOR Nodes removed en bloc;
  • '9' FOR Lymph node assessment not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the paraortic (level 6) nodes were sampled or taken en bloc.
1419.6 LNG SUBCARINAL (SCOPE) LUN2;22 SET
  • '1' FOR Nodes not sampled;
  • '2' FOR Nodes sampled, but not removed en bloc;
  • '3' FOR Nodes removed en bloc;
  • '9' FOR Lymph node assessment not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the subcarinal (level 7) nodes were sampled or taken en bloc.
1419.7 LNG PARAESOPHAGEAL (SCOPE) LUN2;23 SET
  • '1' FOR Nodes not sampled;
  • '2' FOR Nodes sampled, but not removed en bloc;
  • '3' FOR Nodes removed en bloc;
  • '9' FOR Lymph node assessment not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the paraesophageal (level 8) nodes were sampled or taken en bloc.
1419.8 LNG PULMONARY LIGAMENT (SCOPE) LUN2;24 SET
  • '1' FOR Nodes not sampled;
  • '2' FOR Nodes sampled, but not removed en bloc;
  • '3' FOR Nodes removed en bloc;
  • '9' FOR Lymph node assessment not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the pulmonary ligament (level 9) nodes were sampled or taken en bloc.
1420 LNG PERI-OPERATIVE BLOOD REP LUN2;25 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D TPBR^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="00":"No transfusion",Y=98:"Transfusion, # of units not documented",Y=99:"Not recorded if transfusion done",Y="01":Y_" unit",1:Y_" units")
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00 and 99
  • DESCRIPTION:  
    This item describes the total number of units of blood transfused within 30 days of operation. If the patient was transfused but the number of units is unknown, code 98.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1421 LNG PERI-OPERATIVE DEATH LUN2;26 SET
  • '1' FOR Died within same hospitalization;
  • '2' FOR Died within 30 days of surgery;
  • '3' FOR Both 1 & 2;
  • '4' FOR Discharged/alive 30 days after surgery;
  • '9' FOR Unknown;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes whether or not the patient died peri-operatively.
1422 LNG BOOST DOSE (cGy) LUN2;27 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) S ONCL=5 D BD^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="00000":"Not administered",Y=99999:Not documented",1:Y)
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00000 and 99999
  • DESCRIPTION:  This item describes the boost dose of radiation administered to the central tumor field of the patient. If radiation was administered but boost dose is unknown, code 99999.
    Allowable Codes: 00000 - no radiation boost dose administered
    00001 thru 99998 - boost dose administered (cGy)
    99999- boost dose administered, dose not documented
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1423 CHEMOTHERAPEUTIC AGENT #1 LUN2;28 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18) CHEMOTHERAPEUTIC DRUGS(#164.18)

  • LAST EDITED:  SEP 13, 2007
  • HELP-PROMPT:  Enter the first chemotherapeutic agent administered to the patient.
  • DESCRIPTION:  Records the first chemotherapeutic agent administered to the patient as part of the first course of therapy.
    Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.
1423.1 CHEMOTHERAPEUTIC AGENT #2 LUN2;29 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18) CHEMOTHERAPEUTIC DRUGS(#164.18)

  • LAST EDITED:  SEP 13, 2007
  • HELP-PROMPT:  Enter the second chemotherapeutic agent administered to the patient.
  • DESCRIPTION:  Records the second chemotherapeutic agent administered to the patient as part of the first course of therapy.
    Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.
1423.2 CHEMOTHERAPEUTIC AGENT #3 LUN2;30 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18) CHEMOTHERAPEUTIC DRUGS(#164.18)

  • LAST EDITED:  SEP 13, 2007
  • HELP-PROMPT:  Enter the third chemotherapeutic agent administered to the patient.
  • DESCRIPTION:  Records the third chemotherapeutic agent administered to the patient as part of the first course of therapy.
    Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.
1423.3 CHEMOTHERAPEUTIC AGENT #4 LUN2;44 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18) CHEMOTHERAPEUTIC DRUGS(#164.18)

  • LAST EDITED:  SEP 12, 2007
  • HELP-PROMPT:  Enter the fourth chemotherapeutic agent administered to the patient.
  • DESCRIPTION:  Records the fourth chemotherapeutic agent administered to the patient as part of the first course of therapy.
    Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.
1423.4 CHEMOTHERAPEUTIC AGENT #5 LUN2;45 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18) CHEMOTHERAPEUTIC DRUGS(#164.18)

  • LAST EDITED:  SEP 12, 2007
  • HELP-PROMPT:  Enter the fifth chemotherapeutic agent administered to the patient.
  • DESCRIPTION:  Records the fifth chemotherapeutic agent administered to the patient as part of the first course of therapy.
    Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.
1424 LNG CHEMOTHERAPEUTIC TOXICITY LUN2;31 SET
  • '1' FOR Chemo discontinued due to toxicity;
  • '2' FOR No chemo toxicity;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes whether the administration of chemotherapy was discontinued as a result of toxicity.
1425 LNG CHEMOTHERAPY/SURG SEQUENCE LUN2;32 SET
  • '1' FOR Chemo before surgery;
  • '2' FOR Chemo after surgery;
  • '3' FOR Chemo before and after surgery;
  • '8' FOR Chemo administered, no surgery;
  • '9' FOR Chemo and surgery, sequence unknown;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This data item describes the sequence in which chemotherapy and surgery of the primary site were administered.
1426 LNG COMPLICATION #1 LUN2;33 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This item describes the first medical complication acquired by the patient during or resulting from the first course of therapy. Record valid ICD-CM codes.
    Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
    E930.0 - E949.7 (valid ICD-CM adverse effect codes)
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
  • EXPLANATION:  If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
1426.1 LNG COMPLICATION #2 LUN2;34 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This item describes the second medical complication acquired by the patient during or resulting from the first course of therapy.
    Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
    E930.0 - E949.7 (valid ICD-CM adverse effect codes)
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
  • EXPLANATION:  If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
1426.2 LNG COMPLICATION #3 LUN2;35 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This item describes the third medical complication acquired by the patient during or resulting from the first course of therapy.
    Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
    E930.0 - E949.7 (valid ICD-CM adverse effect codes)
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
  • EXPLANATION:  If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
1426.3 LNG COMPLICATION #4 LUN2;36 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This item describes the fourth medical complication acquired by the patient during or resulting from the first course of therapy.
    Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
    E930.0 - E949.7 (valid ICD-CM adverse effect codes)
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
  • EXPLANATION:  If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
1426.4 LNG COMPLICATION #5 LUN2;37 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This item describes the fifth medical complication acquired by the patient during or resulting from the first course of therapy.
    Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
    E930.0 - E949.7 (valid ICD-CM adverse effect codes)
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
  • EXPLANATION:  If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
1426.5 LNG TREATMENT COMPLICATION Y/N LUN2;40 SET
************************REQUIRED FIELD************************
  • '0' FOR No;
  • '1' FOR Yes;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item records if there were medical complications acquired by the patient during or resulting from first course of therapy for this cancer.
    If no complications are listed, answer "No". COMPLICATION #1 will be automatically coded 000.00 with the remaining complication fields left blank.
1427 LNG CASE ABSTRACTOR INITIALS LUN2;38 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1) X
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Answer must be 1-3 characters in length.
  • DESCRIPTION:  
    This item records the initials of the person responsible for abstracting this case and having reviewed all the special study items for completeness and validity.
1428 LNG DATE CASE WAS ABSTRACTED LUN2;39 DATE

  • INPUT TRANSFORM:  S %DT="EX" D ^%DT S X=Y K:Y<1 X
  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  
    This item describes the month, day and year (in the MMDDCCYY format) that this case was reviewed for completeness and validity by the case abstractor.
1429 LNG PROXIMAL MARGIN LUN2;41 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D DMCM^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="000":"No free margins",Y=998:"NA, no surgery of primary site",Y=999:"Unknown, not documented",1:Y_" mm")
  • LAST EDITED:  MAY 08, 2001
  • HELP-PROMPT:  Type a number between 0 and 999
  • DESCRIPTION:  This item describes the distance of the closest proximal free margin in millimeters of the resected primary tumor specimen. This information can be obtained from the pathology report. If surgery of primary site was
    performed but the extent of the free margin is unknown, code 999.
    Allowable Codes: 000 - no free margins in this segment
    001 thru 997 - distance of closest free margin (mm)
    998 - NA, no surgery of primary site
    999 - unknown, extent of free margin not documented
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1429.1 LNG DISTAL MARGIN LUN2;42 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D DMCM^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="000":"No free margins",Y=998:"NA, no surgery of primary site",Y=999:"Unknown, not documented",1:Y_" mm")
  • LAST EDITED:  MAY 08, 2001
  • HELP-PROMPT:  Type a Number between 0 and 999
  • DESCRIPTION:  This item describes the distance of the closest distal free margin in millimeters of the resected primary tumor specimen. This information can be obtained from the pathology report. If surgery of primary site was
    performed but the extent of the free margin is unknown, code 999.
    Allowable Codes: 000 - no free margins in this segment
    001 thru 997 - distance of closest free margin (mm)
    998 - NA, no surgery of primary site
    999 - unknown, extent of free margin not documented
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1430 LNG HCT VAL BEFORE TRANSFUSION LUN2;43 NUMBER

  • INPUT TRANSFORM:  K:(X>99.9)!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=2,ONCF=1 D HVBT^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(+Y=0:"No transfusion",Y=99.9:"Transfusion, % Hct not documented",1:Y_"% Hct")
  • LAST EDITED:  MAY 08, 2001
  • HELP-PROMPT:  Type a Number between 0.00 and 99.9, 1 Decimal Digit
  • DESCRIPTION:  This item describes the percent (%) of hematocrit before the first transfusion. Record results to the precision of one decimal point, record zeros in unused positions; for example 9.5% would be coded as 09.5. If the
    patient was transfused but hematocrit value is not documented, code 99.9.
    Allowable Codes: 00.0 - no transfusion
    00.1 thru 99.0 - % Hct
    99.9 - transfusion, % Hct not documented
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1500 GAS PRIOR EXPOSURE TO RAD GAS1;1 SET
  • '1' FOR Documented exposure;
  • '2' FOR Documented no exposure;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes a patient's known prior radiation exposure. Exposure to fluoroscopy, exposure to radioactive isotopes, or actual radiation treatments should be considered prior radiation exposure. Occupational
    exposure to radiation should be considered: radioisotope lab worker; radiation therapist; radiology technician; miner. Do not code routine chest or dental x-rays as prior radiation exposure.
1501 GAS ALCOHOL COMSUMPTION GAS1;2 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D AC^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="00":"Never consumed alcohol",Y=97:"97 or more drinks per week",Y=98:"Yes, number of drinks unknown",Y=99:"Not documented",1:Y_" drink(s) per week")
  • LAST EDITED:  APR 30, 2001
  • HELP-PROMPT:  Type a Number between 00 and 99
  • DESCRIPTION:  This item describes the number of drinks (beer, wine, other alcohol) consumed by the patient per week. If the patient has never consumed alcohol, code 00. If the number of drinks per week is not documented, code 99.
    This information can typically be found in either the patient's clinic chart or the managing physician's notes.
    Allowable Codes: 00 - never consumed alcohol
    01 thru 96 - 1 or more drinks up to 96 drinks per week
    97 - 97 or more drinks per week
    98 - alcohol consumption, number of drinks unknown
    99 - alcohol consumption not documented
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1502 GAS MENOPAUSAL STATUS/HOR TX GAS1;3 SET
  • '1' FOR Menopause, no hormome tx;
  • '2' FOR Menopause, hormone tx stopped before dx;
  • '3' FOR Menopause, hormone tx at dx;
  • '8' FOR NA, male patient;
  • '9' FOR Menopause not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether a female patient has experienced menopause and, if so, whether or not she was receiving prescribed hormone replacement therapy. Menopause may occur naturally or as a result of a hysterectomy.
    If the patient is male, code 8. If the woman's menopausal status can not be determined, code 9. This information can typically be found in either the patient's clinic chart or the managing physician's notes.
1503 GAS H2 BLOCKER/PROTON PUMP GAS1;4 SET
  • '1' FOR H2 blocker;
  • '2' FOR Proton pump inhibitor;
  • '3' FOR Both;
  • '8' FOR Neither;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether the patient was either self-medicating or taking prescribed H2 blocker or proton pump inhibitor drugs to suppress gastric acidity and control reflux. Common drug names for H2 blocker include:
    Pepcid (famotidine), Tagamet (cimetidine), Zantac (ranitidine), and Axid (nizatidine). Common names for proton pump inhibitors include: Prilosec (omeprazole), Prevacid (lansoprazole), Protonix (pantaprazol), Aciphex
    (rebeprazol), and Nexium (es-omeprazole).
1504 GAS FAMILY HIST OF GASTRIC CA GAS1;5 SET
  • '1' FOR No 1st or 2nd deg relatives;
  • '2' FOR 1 1st deg relative;
  • '3' FOR 2 1st deg relatives;
  • '4' FOR 3 or more 1st deg relatives;
  • '5' FOR 1 or more 2nd deg relatives;
  • '6' FOR Both 1st and 2nd deg relatives;
  • '9' FOR Familial history, relation not indicated;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether there is any familial history of gastric cancer. Record familial history of gastric cancer in first degree relatives (parent, siblings, and child) or 2nd degree relatives (1st cousins, aunt,
    uncle, grandparent, grandchild).
1505 GAS H-PYLORI INFECTION GAS1;6 SET
  • '1' FOR Past history, present at dx;
  • '2' FOR No past history, present at dx;
  • '3' FOR Past history, not present at dx;
  • '4' FOR Documented never present;
  • '9' FOR Unknown, not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether the patient had at any time the following associated benign gastric condition:
    Helicobacter pylori (H-pylori) infection
1506 GAS DUODENAL ULCER GAS1;7 SET
  • '1' FOR Past history, present at dx;
  • '2' FOR No past history, present at dx;
  • '3' FOR Past history, not present at dx;
  • '4' FOR Documented never present;
  • '9' FOR Unknown, not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether the patient had at any time the following associated benign gastric condition:
    Duodenal ulcer
1507 GAS GASTRIC ULCER GAS1;8 SET
  • '1' FOR Past history, present at dx;
  • '2' FOR No past history, present at dx;
  • '3' FOR Past history, not present at dx;
  • '4' FOR Documented never present;
  • '9' FOR Unknown, not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether the patient had at any time the following associated benign gastric condition:
    Gastric ulcer
1508 GAS HEARTBURN (BENIGN COND) GAS1;9 SET
  • '1' FOR Past history, present at dx;
  • '2' FOR No past history, present at dx;
  • '3' FOR Past history, not present at dx;
  • '4' FOR Documented never present;
  • '9' FOR Unknown, not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether the patient had at any time the following associated benign gastric condition:
    Heartburn
1509 GAS PERNICIOUS ANEMIA GAS1;10 SET
  • '1' FOR Past history, present at dx;
  • '2' FOR No past history, present at dx;
  • '3' FOR Past history, not present at dx;
  • '4' FOR Documented never present;
  • '9' FOR Unknown, not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether the patient had at any time the following associated benign gastric condition:
    Pernicious anemia
1510 GAS POLYPS OF STOMACH GAS1;11 SET
  • '1' FOR Past history, present at dx;
  • '2' FOR No past history, present at dx;
  • '3' FOR Past history, not present at dx;
  • '4' FOR Documented never present;
  • '9' FOR Unknown, not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether the patient had at any time the following associated benign gastric condition:
    Polyps of stomach
1511 GAS POLYPOSIS OF BOWEL GAS1;12 SET
  • '1' FOR Past history, present at dx;
  • '2' FOR No past history, present at dx;
  • '3' FOR Past history, not present at dx;
  • '4' FOR Documented never present;
  • '9' FOR Unknown, not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether the patient had at any time the following associated benign gastric condition:
    Polyposis of small or large bowel
1512 GAS BARRET'S ESOPHAGUS GAS1;13 SET
  • '1' FOR Past history, present at dx;
  • '2' FOR No past history, present at dx;
  • '3' FOR Past history, not present at dx;
  • '4' FOR Documented never present;
  • '9' FOR Unknown, not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether the patient had at any time the following associated benign gastric condition:
    Barret's esophagus
1513 GAS ATROPHIC GASTRITIS GAS1;14 SET
  • '1' FOR Past history, present at dx;
  • '2' FOR No past history, present at dx;
  • '3' FOR Past history, not present at dx;
  • '4' FOR Documented never present;
  • '9' FOR Unknown, not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether the patient had at any time the following associated benign gastric condition:
    Atrophic gastritis
1514 GAS GASTRIC METAPLASIA GAS1;15 SET
  • '1' FOR Past history, present at dx;
  • '2' FOR No past history, present at dx;
  • '3' FOR Past history, not present at dx;
  • '4' FOR Documented never present;
  • '9' FOR Unknown, not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether the patient had at any time the following associated benign gastric condition:
    Gastric metaplasia
1515 GAS ANTIBIOTICS GAS1;16 SET
  • '1' FOR Regimen given;
  • '2' FOR H-pylori present, regimen not given;
  • '8' FOR H-pylori not present;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item records the use of antibiotics for H-pylori infection prior to diagnosis of gastric cancer. Examples of antibiotics include: ampicillin, amoxicillin, clarithromycin, etc.
1516 GAS PROTON PUMP INHIBITORS GAS1;17 SET
  • '1' FOR Regimen given;
  • '2' FOR H-pylori present, regimen not given;
  • '8' FOR H-pylori not present;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item records the use of proton pump inhibitors for H-pylori infection prior to diagnosis of gastric cancer. Examples of proton pump inhibitors include: omeprazole, lansoprazole, rabeprazole, pantoprazol,
    es-omeprazole.
1517 GAS H2 BLOCKERS GAS1;18 SET
  • '1' FOR Regimen given;
  • '2' FOR H-pylori present, regimen not given;
  • '8' FOR H-pylori not present;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item records the use of H2 blockers for H-pylori infection prior to diagnosis of gastric cancer. Examples of H2 blockers include: ranitidine (Zantac), famotidine (Pepcid), nizatidine (Axid), cimetidine (Tagamet).
1518 GAS BISMUTH COMPOUNDS GAS1;19 SET
  • '1' FOR Regimen given;
  • '2' FOR H-pylori present, regimen not given;
  • '8' FOR H-pylori not present;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item records the use of bismuth compounds for H-pylori infection prior to diagnosis of gastric cancer. Examples of bismuth compounds include: Pepo Bismol, prescription bismuth drugs.
1519 GAS PRIOR INTRA-ABDOMINAL SURG GAS1;20 SET
  • '1' FOR Documented;
  • '2' FOR Documented No;
  • '9' FOR Not mentioned;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether the patient had undergone any intra- abdominal surgery including a prior gastric resection, before the diagnosis of this cancer. Do not record retroperitoneal or extraperitoneal procedures as
    intra-abdominal surgeries.
1520 GAS YEAR OF GASTRIC RESECTION GAS1;21 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<4)!'(X?4N) X I $D(X) D GYGR^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="0000":"No prior gastric resection",Y=9999:"Not documented",1:Y)
  • LAST EDITED:  JUL 19, 2001
  • HELP-PROMPT:  Type a Number between 0000 and 9999
  • DESCRIPTION:  This item describes the year that the patient received a gastric resection prior to this diagnosis. If the patient has a documented prior abdominal surgical resection indicate whether that surgery included a gastric
    resection by coding the year the resection occurred. If the patient has received more than one gastric resection, code the earliest (first) year.
    Allowable Codes: 0000 - documented no prior gastric resection
    1901 thru 2001 - year of prior gastric resection
    9999 - not documented whether there was prior gastric
    resection
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1521 GAS PERFORMANCE STATUS AT DX GAS1;22 SET
  • '1' FOR Normal, no symptoms;
  • '2' FOR Symptoms/ambulatory/min limits;
  • '3' FOR Out of bed > 50% of day/mod limits;
  • '4' FOR In bed > 50% of day/severe limits;
  • '5' FOR Bedridden/moribund;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the performance status of the patient at initial diagnosis. The scale used in this study is widely known as the ECOG performance status.
1522 GAS HEARTBURN (SYMPTOMS) GAS1;23 SET
  • '1' FOR Present;
  • '2' FOR Not present;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the presence of heartburn specific to gastric cancer that was recorded in the medical chart.
1523 GAS FEVER/NIGHT SWEATS GAS1;24 SET
  • '1' FOR Present;
  • '2' FOR Not present;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the presence of fever/night sweats specific to gastric cancer that was recorded in the medical chart.
1524 GAS ACUTE HEMATEMESIS GAS1;25 SET
  • '1' FOR Present;
  • '2' FOR Not present;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the presence of acute hematemesis specific to gastric cancer that was recorded in the medical chart.
1525 GAS TRANSFUSIONS FOR BLD LOSS GAS1;26 SET
  • '1' FOR Present;
  • '2' FOR Not present;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the presence of transfusions for blood loss specific to gastric cancer that were recorded in the medical chart.
1526 GAS MELENA GAS1;27 SET
  • '1' FOR Present;
  • '2' FOR Not present;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the presence of melena specific to gastric cancer that was recorded in the medical chart.
1527 GAS PAIN GAS1;28 SET
  • '1' FOR Present;
  • '2' FOR Not present;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the presence of pain specific to gastric cancer that was recorded in the medical chart.
1528 GAS EARLY SATIETY GAS1;29 SET
  • '1' FOR Present;
  • '2' FOR Not present;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the presence of early satiety specific to gastric cancer that was recorded in the medical chart.
1529 GAS CT SCAN OF ABDOMEN GAS1;30 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Not performed;
  • '8' FOR Performed, results not documented;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the results of a CT scan of abdomen performed to evaluate the primary tumor.
1530 GAS CT SCAN OF CHEST GAS1;31 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Not performed;
  • '8' FOR Performed, results not documented;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the results of a CT scan of chest performed to evaluate the primary tumor.
1531 GAS CT PELVIS GAS1;32 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Not performed;
  • '8' FOR Performed, results not documented;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the results of a CT pelvis performed to evaluate the primary tumor.
1532 GAS CHEST X-RAY GAS1;33 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Not performed;
  • '8' FOR Performed, results not documented;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the results of a chest x-ray performed to evaluate the primary tumor.
1533 GAS GALLIUM SCAN GAS1;34 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Not performed;
  • '8' FOR Performed, results not documented;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the results of a gallium scan performed to evaluate the primary tumor.
1534 GAS BIPEDAL LYMPHANGIOGRAM GAS1;35 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Not performed;
  • '8' FOR Performed, results not documented;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the results of a bipedal lymphangiogram (LAB) performed to evaluate the primary tumor.
1535 GAS MRI GAS1;36 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Not performed;
  • '8' FOR Performed, results not documented;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the results of an MRI performed to evaluate the primary tumor.
1536 GAS PET SCAN GAS1;37 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Not performed;
  • '8' FOR Performed, results not documented;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the results of a PET scan performed to evaluate the primary tumor.
1537 GAS LAPAROSCOPY GAS1;38 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Not performed;
  • '8' FOR Performed, results not documented;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the results of a laparoscopy performed to evaluate the primary tumor.
1538 GAS EUS GAS1;39 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Not performed;
  • '8' FOR Performed, results not documented;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the results of an EUS (endoscopic ultrasound) performed to evaluate the primary tumor.
1539 GAS PERITONEAL LAVAGE GAS1;40 SET
  • '1' FOR Abnormal, suggestive of cancer;
  • '2' FOR Abnormal, not suggestive of cancer;
  • '3' FOR Normal;
  • '4' FOR Not performed;
  • '8' FOR Performed, results not documented;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the results of a peritoneal lavage performed to evaluate the primary tumor.
1540 GAS LDH (IU/L) GAS1;41 NUMBER

  • INPUT TRANSFORM:  K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9":"Not documented",1:Y)
  • LAST EDITED:  APR 30, 2001
  • HELP-PROMPT:  Type a Number between 0000.0 and 9999.9, 1 Decimal Digit
  • DESCRIPTION:  This item describes the absolute value of the LDH (IU/L) study administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the patient's hospital
    chart or laboratory records. Record results to the precision of one decimal point; record zeros in unused positions; for example 12.5 would be coded as 0012.5, and 4.4 would be coded as 0004.4. If a particular test was
    not administered, code 0000.0; if a test was administered but the result is unknown, code 8888.8; if it is not documented whether a test is administered, code 9999.9.
    Allowable Codes: 0000.0 - test not administered
    0000.1 thru 8888.7 - absolute value of test
    8888.8 - test administered, results unknown
    9999.9 - not documented if test administered
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1541 GAS CEA (ng/ml) GAS1;42 NUMBER

  • INPUT TRANSFORM:  K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9":"Not documented",1:Y)
  • LAST EDITED:  APR 30, 2001
  • HELP-PROMPT:  Type a Number between 0000.0 and 9999.9, 1 Decimal Digit
  • DESCRIPTION:  This item describes the absolute value of the Carcinoembryonic antigen, CEA (ng/ml) study administered to the patient prior to the start of the first course of treatment. This information can typically be found in either
    the patient's hospital chart or laboratory records. Record results to the precision of one decimal point; record zeros in unused positions; for example 12.5 would be coded as 0012.5, and 4.4 would be coded as 0004.4. If
    a particular test was not administered, code 0000.0; if a test was administered but the result is unknown, code 8888.8; if it is not documented whether a test is administered, code 9999.9.
    Allowable Codes: 0000.0 - test not administered
    0000.1 thru 8888.7 - absolute value of test
    8888.8 - test administered, results unknown
    9999.9 - not documented if test administered
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1542 GAS CA125 (U/ml) GAS1;43 NUMBER

  • INPUT TRANSFORM:  K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9":"Not documented",1:Y)
  • LAST EDITED:  APR 30, 2001
  • HELP-PROMPT:  Type a Number between 0000.0 and 9999.9, 1 Decimal Digit
  • DESCRIPTION:  This item describes the absolute value of the CA125 (U/ml) study administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the patient's hospital
    chart or laboratory records. Record results to the precision of one decimal point; record zeros in unused positions; for example 12.5 would be coded as 0012.5, and 4.4 would be coded as 0004.4. If a particular test was
    not administered, code 0000.0; if a test was administered but the result is unknown, code 8888.8; if it is not documented whether a test is administered, code 9999.9.
    Allowable Codes: 0000.0 - test not administered
    0000.1 thru 8888.7 - absolute value of test
    8888.8 - test administered, results unknown
    9999.9 - not documented if test administered
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1543 GAS BETA2 MICROGLOBULIN GAS1;44 NUMBER

  • INPUT TRANSFORM:  K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9":"Not documented",1:Y)
  • LAST EDITED:  APR 30, 2001
  • HELP-PROMPT:  Type a Number between 0000.0 and 9999.9, 1 Decimal Digit
  • DESCRIPTION:  This item describes the absolute value of the Beta2 microglobulin (ng/ml) study administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the
    patient's hospital chart or laboratory records. Record results to the precision of one decimal point; record zeros in unused positions; for example 12.5 would be coded as 0012.5, and 4.4 would be coded as 0004.4. If a
    particular test was not administered, code 0000.0; if a test was administered but the result is unknown, code 8888.8; if it is not documented whether a test is administered, code 9999.9.
    Allowable Codes: 0000.0 - test not administered
    0000.1 thru 8888.7 - absolute value of test
    8888.8 - test administered, results unknown
    9999.9 - not documented if test administered
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1544 GAS URINARY 5-HIAA (mg/24hr) GAS1;45 NUMBER

  • INPUT TRANSFORM:  K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9":"Not documented",1:Y)
  • LAST EDITED:  APR 30, 2001
  • HELP-PROMPT:  Type a Number between 0000.0 and 9999.9, 1 Decimal Digit
  • DESCRIPTION:  This item describes the absolute value of the Urinary 5-HIAA (mg/24hr) study administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the
    patient's hospital chart or laboratory records. Record results to the precision of one decimal point; record zeros in unused positions; for example 12.5 would be coded as 0012.5, and 4.4 would be coded as 0004.4. If a
    particular test was not administered, code 0000.0; if a test was administered but the result is unknown, code 8888.8; if it is not documented whether a test is administered, code 9999.9.
    Allowable Codes: 0000.0 - test not administered
    0000.1 thru 8888.7 - absolute value of test
    8888.8 - test administered, results unknown
    9999.9 - not documented if test administered
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1545 GAS CLINICAL/VISUAL EXAM GAS1;46 SET
  • '1' FOR Results positive for cancer;
  • '2' FOR Results negative for caner;
  • '8' FOR Not performed;
  • '9' FOR Not documented, exam type not mentioned;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the most definitive results of a gastroscopic clinical/visual examination.
1545.1 GAS BIOPSY GAS1;47 SET
  • '1' FOR Results positive for cancer;
  • '2' FOR Results negative for cancer;
  • '8' FOR Not performed;
  • '9' FOR Not documented, exam type not mentioned;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the most definitive results of a gastrscopic biopsy.
1546 GAS GASTRO-ESOPHAGEAL JUNCTION GAS1;48 SET
  • '1' FOR Siewart II <= 2cm from squamocolunmar junc;
  • '2' FOR Siewart III > 2cm from squamocolumnar junc;
  • '9' FOR No documented Siewart type or distance;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item distinguishes tumors that clearly arise within the stomach (type III) from those that start at or near the esophageal gastric junction (type II). Siewert type I tumors are excluded from this study as these are
    considered esophageal (C15.0-C15.9). This information may be obtained from the pathology report.
1547 GAS STOMACH GAS1;49 SET
  • '1' FOR Site of initial histologic dx;
  • '2' FOR Not site of initial histologic dx;
  • '9' FOR Site not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the site(s) of the initial histologic diagnosis of this cancer.
1547.1 GAS LIVER GAS1;50 SET
  • '1' FOR Site of initial histologic dx;
  • '2' FOR Not site of initial histologic dx;
  • '9' FOR Site not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the site(s) of the initial histologic diagnosis of this cancer.
1547.2 GAS EXTRA-ABDOMINAL GAS1;51 SET
  • '1' FOR Site of initial histologic dx;
  • '2' FOR Not site of initial histologic dx;
  • '9' FOR Site not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the site(s) of the initial histologic diagnosis of this cancer.
1547.3 GAS LYMPH NODES GAS1;52 SET
  • '1' FOR Site of initial histologic dx;
  • '2' FOR Not site of initial histologic dx;
  • '9' FOR Site not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the site(s) of the initial histologic diagnosis of this cancer.
1547.4 GAS PERITONEUM GAS1;53 SET
  • '1' FOR Site of initial histologic dx;
  • '2' FOR Not site of initial histologic dx;
  • '9' FOR Site not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the site(s) of the initial histologic diagnosis of this cancer.
1548 GAS DATE OF FIRST TISSUE DX GAS1;54 DATE

  • INPUT TRANSFORM:  S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) D:'$D(X) EN^DDIOL("Future dates are not allowed")
  • OUTPUT TRANSFORM:  D DATEOT^ONCOPCE
  • LAST EDITED:  JUL 19, 2001
  • DESCRIPTION:  This item describes the month, day, and year (MMDDCCYY) that this primary cancer was first diagnosed using a tissue sample to arrive at a positive histologic or cytologic evaluation of the tumor.
    If a positive histologic or cytologic evaluation was made but the date is unknown code 99/99/9999.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1549 GAS LAUREN'S CLASSIFICATION GAS1;55 SET
  • '1' FOR Diffuse;
  • '2' FOR Intestinal;
  • '3' FOR Mixed;
  • '4' FOR Other;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes Lauren's classification which divides gastric carcinoma into two main histologic types, diffuse or intestinal. Record the classification if it is stated in the pathology report.
1550 GAS GOSEKI'S CLASSIFICATION GAS1;56 SET
  • '1' FOR Type I tubular diff well/mucin poor;
  • '2' FOR Type II tubular diff well/mucin rich;
  • '3' FOR Type III tubular diff poor/mucin poor;
  • '3' FOR Type IV tubular diff poor/mucin rich;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes Goseki's classification which divides gastric carcinoma into four histologic types, depending upon the degree of tubular differentiation and mucin content. It is thought that this classification
    scheme can aid in predicting a tumor's mode of extension, recurrence and conditions of metastasis. This information may not appear on the pathology report. Request assistance from the attending pathologist to determine
    the appropriate code.
1551 GAS GASTRIN GAS1;57 SET
  • '1' FOR Used in pathologic evaluation;
  • '2' FOR Not used;
  • '8' FOR NA, pathologic dx not made;
  • '9' FOR Not documented if used;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether molecular marker gastrin was used in the pathologic evaluation of the tumor. If a pathologic diagnosis was not made, code 8.
1551.1 GAS 5-HIAA GAS1;58 SET
  • '1' FOR Used in pathologic evaluation;
  • '2' FOR Not used;
  • '8' FOR NA, pathologic dx not made;
  • '9' FOR Not documented if used;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether molecular marker 5-HIAA was used in the pathologic evaluation of the tumor. If a pathologic diagnosis was not made, code 8.
1551.2 GAS CEA GAS1;59 SET
  • '1' FOR Used in pathologic evaluation;
  • '2' FOR Not used;
  • '8' FOR NA, pathologic dx not made;
  • '9' FOR Not documented if used;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether molecular marker CEA was used in the pathologic evaluation of the tumor. If a pathologic diagnosis was not made, code 8.
1551.3 GAS CA125 GAS1;60 SET
  • '1' FOR Used in pathologic evaluation;
  • '2' FOR Not used;
  • '8' FOR NA, pathologic dx not made;
  • '9' FOR Not documented if used;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether molecular marker CA124 was used in the pathologic evaluation of the tumor. If a pathologic diagnosis was not made, code 8.
1551.4 GAS OTHER MOLECULAR MARKER GAS1;61 SET
  • '1' FOR Used in pathologic evaluation;
  • '2' FOR Not used;
  • '8' FOR NA, pathologic dx not made;
  • '9' FOR Not documented if used;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes whether other molecular markers were used in the pathologic evaluation of the tumor. If a pathologic diagnosis was not made, code 8.
1552 GAS MITOTIC RATE GAS1;62 SET
  • '1' FOR < or equal to 2/10 HPF;
  • '2' FOR > 2 and < 5/10 HPF;
  • '3' FOR Equal to or > 5/10 HPF;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 30, 2001
  • DESCRIPTION:  This item describes the number of mitoses per high power field (HPF).
1553 GAS TUMOR NECROSIS GAS1;63 SET
  • '1' FOR Frequent, larger areas;
  • '2' FOR Few small areas (rare/scattered);
  • '3' FOR No tumor cell necrosis;
  • '9' FOR Not documented;

  • LAST EDITED:  MAR 07, 2001
  • DESCRIPTION:  This item describes the presence and degree of tumor necrosis.
1554 GAS FLOW CYTOMETRY/FRESH TISS GAS1;64 SET
  • '1' FOR Used;
  • '2' FOR Not used;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This data item describes if the flow cytometry on fresh tissue phenotype modality was performed on the lymphoma tissue in this case.
1554.1 GAS IMMUNOHISTOCHEM/FROZEN TIS GAS1;65 SET
  • '1' FOR Used;
  • '2' FOR Not used;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This data item describes if the immunohistochemistry on frozen tissue phenotype modality was performed on the lymphoma tissue in this case.
1554.2 GAS IMMUNOHISTOCHEM/PARAFFIN GAS1;66 SET
  • '1' FOR Used;
  • '2' FOR Not used;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This data item describes if the immunohistochemistry on paraffin embedded tissue phenotype modality was performed on the lymphoma tissue in this case.
1554.3 GAS MOLECULAR GENETICS GAS1;67 SET
  • '1' FOR Used;
  • '2' FOR Not used;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This data item describes if the molecular genetics phenotype modality was performed on the lymphoma tissue in this case.
1554.4 GAS POLYMERASE CHAIN REACTION GAS1;68 SET
  • '1' FOR Used;
  • '2' FOR Not used;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This data item describes if the polymerase chain reaction technique phenotype modality was performed on the lymphoma tissue in this case.
1554.5 GAS SOUTHERN BLOT TECHNIQUE GAS1;69 SET
  • '1' FOR Used;
  • '2' FOR Not used;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This data item describes if the Southern blot technique phenotype modality was performed on the lymphoma tissue in this case.
1555 GAS ANN ARBOR STAGING GAS1;70 SET
  • '1' FOR Stage IE (stomach);
  • '2' FOR Stage IIEi (stomach/perigastric ln);
  • '3' FOR Stage IIEii (stomach/periaortic ln);
  • '4' FOR Stage III (spleen tumor);
  • '5' FOR Stage IV (distant/liver/bone marrow);
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  Gastric lymphoma staging is performed differently than adenocarcinoma staging, using a modification of the Ann Arbor System with Stage IE confined to the stomach, Stage IIEi confined to the stomach and perigastric lymph
    nodes, Stage IIEii confined to stomach and periaortic lymph nodes, Stage III involvement of the spleen, tumor on both sides of diaphragm and Stage IV involvement of distant sites (liver, bone marrow).
1556 GAS ADHERENCE OF RESECTED PRIM GAS1;71 SET
  • '1' FOR No tumor adherence;
  • '2' FOR Tumor adherence lysed w/o resection;
  • '3' FOR Tumor adherence, adj organ resected en bloc;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item evaluates adherence of the resected primary specimen to other structures.
1557 GAS MARGIN STAT OF RESECT PRIM GAS1;72 SET
  • '1' FOR Negative proximal and distal;
  • '2' FOR Positive proximal, negative distal;
  • '3' FOR Negative proximal, positive distal;
  • '4' FOR Positive proximal and distal;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item evaluates the margin status of the resected primary specimen.
1558 GAS PROXIMAL MARGIN GAS1;73 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D EFM^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="000":"No free margins",Y=999:"Not documented",1:Y_" mm")
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 0 and 999
  • DESCRIPTION:  This item describes the extent of the proximal free margin around the resected primary tumor specimen. Record the extent of the closest free margin in millimeters. If surgery of primary site was performed but the extent
    of the free margin is not documented, code 999. This information can be obtained from the pathology report.
    Allowable Codes: 000 - no free margins in this segment
    001 thru 997 - extent of free margin (mm)
    999 - extent of free margin not documented
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1558.1 GAS DISTAL MARGIN GAS1;74 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D EFM^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="000":"No free margins",Y=999:"Not documented",1:Y_" mm")
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 0 and 999
  • DESCRIPTION:  This item describes the extent of the distal free margin around the resected primary tumor specimen. Record the extent of the closest free margin in millimeters. If surgery of primary site was performed but the extent
    of the free margin is not documented, code 999. This information can be obtained from the pathology report.
    Allowable Codes: 000 - no free margins in this segment
    001 thru 997 - extent of free margin (mm)
    999 - extent of free margin not documented
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1559 GAS SPLEEN GAS2;1 SET
  • '1' FOR Resected, tumor adherence;
  • '2' FOR Resected, no tumor adherence;
  • '3' FOR Not resected, tumor adherence;
  • '4' FOR Not resected, no tumor adherence;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1559.1 GAS TRANSVERSE COLON GAS2;2 SET
  • '1' FOR Resected, tumor adherence;
  • '2' FOR Resected, no tumor adherence;
  • '3' FOR Not resected, tumor adherence;
  • '4' FOR Not resected, no tumor adherence;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1559.2 GAS LIVER GAS2;3 SET
  • '1' FOR Resected, tumor adherence;
  • '2' FOR Resected, no tumor adherence;
  • '3' FOR Not resected, tumor adherence;
  • '4' FOR Not resected, no tumor adherence;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1559.3 GAS DIAPHRAGM GAS2;4 SET
  • '1' FOR Resected, tumor adherence;
  • '2' FOR Resected, no tumor adherence;
  • '3' FOR Not resected, tumor adherence;
  • '4' FOR Not resected, no tumor adherence;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1559.4 GAS PANCREAS GAS2;5 SET
  • '1' FOR Resected, tumor adherence;
  • '2' FOR Resected, no tumor adherence;
  • '3' FOR Not resected, tumor adherence;
  • '4' FOR Not resected, no tumor adherence;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1559.5 GAS ABDOMINAL WALL GAS2;6 SET
  • '1' FOR Resected, tumor adherence;
  • '2' FOR Resected, no tumor adherence;
  • '3' FOR Not resected, tumor adherence;
  • '4' FOR Not resected, no tumor adherence;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1559.6 GAS ADRENAL GLAND GAS2;7 SET
  • '1' FOR Resected, tumor adherence;
  • '2' FOR Resected, no tumor adherence;
  • '3' FOR Not resected, tumor adherence;
  • '4' FOR Not resected, no tumor adherence;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1559.7 GAS KIDNEY GAS2;8 SET
  • '1' FOR Resected, tumor adherence;
  • '2' FOR Resected, no tumor adherence;
  • '3' FOR Not resected, tumor adherence;
  • '4' FOR Not resected, no tumor adherence;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1559.8 GAS SMALL INTESTINE GAS2;9 SET
  • '1' FOR Resected, tumor adherence;
  • '2' FOR Resected, no tumor adherence;
  • '3' FOR Not resected, tumor adherence;
  • '4' FOR Not resected, no tumor adherence;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1559.9 GAS RETROPERITONEUM GAS2;10 SET
  • '1' FOR Resected, tumor adherence;
  • '2' FOR Resected, no tumor adherence;
  • '3' FOR Not resected, tumor adherence;
  • '4' FOR Not resected, no tumor adherence;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1560 GAS PERIGASTRIC LYMPH NODES GAS2;11 SET
  • '2' FOR Resected;
  • '4' FOR Not resected;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1560.1 GAS COMMON HEPATIC LYMPH NODES GAS2;12 SET
  • '2' FOR Resected;
  • '4' FOR Not resected;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1560.2 GAS CELIAC LYMPH NODES GAS2;13 SET
  • '2' FOR Resected;
  • '4' FOR Not resected;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1560.3 GAS SPLENIC LYMPH NODES GAS2;14 SET
  • '2' FOR Resected;
  • '4' FOR Not resected;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1560.4 GAS OTHER INTRA-ABDOMINAL NDES GAS2;15 SET
  • '2' FOR Resected;
  • '4' FOR Not resected;
  • '9' FOR Extent of resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.
1561 GAS GROSSLY INVOLVED REG LN GAS2;16 SET
  • '1' FOR Resected;
  • '2' FOR Not resected;
  • '9' FOR Resection not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes whether regional nodes were grossly involved at surgical resection. This information should only be recorded from the operative report. Do not report pathologically involved nodes.
1562 GAS HCT VAL BEFORE TRANSFUSION GAS2;17 NUMBER

  • INPUT TRANSFORM:  K:(X>99.9)!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=2,ONCF=1 D HVBT^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(+Y=0:"No transfusion",Y=99.9:"Not documented",1:Y_"% Hct")
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00.0 and 99.9, 1 Decimal Digit
  • DESCRIPTION:  This item describes the percent (%) of hematocrit before the first transfusion. Record results to the precision of one decimal point, record zeros in unused positions; for example 9.5% would be coded as 09.5. If the
    patient was transfused but hematocrit value is not documented, code 99.9.
    Allowable Codes: 00.0 - no transfusion
    00.1 thru 99.0 - % Hct
    99.9 - transfusion, % Hct not documented
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1563 GAS TOTAL OPERATIVE BLOOD REPL GAS2;18 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) D GTOBR^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="00":"No transfusion",Y=98:"Transfusion, # of units not documented",Y=99:"Not recorded if transfusion done",1:Y_" unit(s) tranfused")
  • LAST EDITED:  JUL 19, 2001
  • HELP-PROMPT:  Type a Number between 00 and 99
  • DESCRIPTION:  This item describes the total number of units of blood transfused during the surgery of primary site and within 24 hours postoperatively. If the patient was transfused but the number of units is not documented, code 99.
    Allowable Codes: 00 - no transfusion performed
    01 thru 97 - units transfused
    98 - transfusion, # of units not documented
    99 - not recorded if transfusion done
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1564 GAS INTRA/PERI-OPERATIVE DEATH GAS2;19 SET
  • '1' FOR Pt died intra-operatively;
  • '2' FOR Pt died w/i 30 days while hospitalized ;
  • '3' FOR Pt died > 30 days while hospitalized;
  • '4' FOR Pt died w/i 30 days/discharged;
  • '5' FOR Pt alive and discharged 30 days following;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes whether or not the patient died intra-operatively or peri-operatively.
1565 GAS ANASTOMATIC LEAK GAS2;20 SET
  • '1' FOR Caused re-operation;
  • '2' FOR Did not cause re-operation;
  • '3' FOR Did not occur;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes whether an anastomotic leak required re-operation during the same hospitalization.
1565.1 GAS STUMP LEAK GAS2;21 SET
  • '1' FOR Caused re-operation;
  • '2' FOR Did not cause re-operation;
  • '3' FOR Did not occur;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes whether a stump leak required re-operation during the same hospitalization.
1565.2 GAS BLEEDING GAS2;22 SET
  • '1' FOR Caused re-operation;
  • '2' FOR Did not cause re-operation;
  • '3' FOR Did not occur;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes whether bleeding required re-operation during the same hospitalization.
1565.3 GAS WOUND INFECTION GAS2;23 SET
  • '1' FOR Caused re-operation;
  • '2' FOR Did not cause re-operation;
  • '3' FOR Did not occur;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes whether a wound infection required re-operation during the same hospitalization.
1565.4 GAS SEPSIS GAS2;24 SET
  • '1' FOR Caused re-operation;
  • '2' FOR Did not cause re-operation;
  • '3' FOR Did not occur;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes whether sepsis required re-operation during the same hospitalization.
1565.5 GAS PANCREATITIS GAS2;25 SET
  • '1' FOR Caused re-operation;
  • '2' FOR Did not cause re-operation;
  • '3' FOR Did not occur;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes whether pancreatitis required re-operation during the same hospitalization.
1565.6 GAS DEAD BOWEL GAS2;26 SET
  • '1' FOR Caused re-operation;
  • '2' FOR Did not cause re-operation;
  • '3' FOR Did not occur;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes whether a dead bowel required re-operation during the same hospitalization.
1565.7 GAS OTHER COMPLICATIONS GAS2;27 SET
  • '1' FOR Caused re-operation;
  • '2' FOR Did not cause re-operation;
  • '3' FOR Did not occur;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes whether other complications required re-operation during the same hospitalization.
1566 GAS DATE OF SURGICAL DISCHARGE GAS2;28 DATE

  • INPUT TRANSFORM:  S %DT="EX" D ^%DT S X=Y K:Y<1 X
  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  The date of surgical discharge is used to calculate a patient's length of stay in the hospital and is the month, day, and year that the patient was discharged from the hospital following surgery of primary site. Surgical
    treatment is defined as the surgical event which corresponds to the procedure recorded in the ROADS data item "Date of Surgery and includes surgical procedures of the primary site, scope of regional lymph nodes, or surgery
    to other regional sites, distant sites or distant lymph nodes.
1567 GAS INTRA-OPERATIVE RADIATION GAS2;29 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) S ONCL=5 D IRTD^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="00000":"Not administered",Y=88888:"Administered, dose not documented",Y=99999:"Not documented",1:Y)
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00000 and 99999
  • DESCRIPTION:  This item describes the intra-operative dose of radiation was administered to the patient. The intra-operative dose may not be the dominant or most clinically significant dose delivered (data item #38), record the
    intra-operative dose separately from the dose recorded in data item #38. If intra-operative radiation therapy was not administered, code 00000. If intra-operative radiation was administered but the dose is not documented,
    code 88888.
    Allowable Codes: 00000 - no intraoperative radiation therapy
    00001 thru 99998 - intraoperative dose administered
    88888 - intraoperative radiation administered,
    dose not documented
    99999 - not documented if administered
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1568 GAS CONCURRENT CHEMOTHERAPY GAS2;30 SET
  • '1' FOR Chemo concurrent with radiation;
  • '2' FOR Chemo not concurrent with radiation;
  • '8' FOR No chemo/unknown if chemo administered;
  • '9' FOR Timing of chemo not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes whether radiation therapy and chemotherapy were administered to the patient at the same time during the first course of treatment.
1569 GAS INTRAPERITONEAL CMX GAS2;31 SET
  • '1' FOR Catheter, mitoycin;
  • '2' FOR Catheter, 5-fluorouracil;
  • '3' FOR Catheter, other;
  • '4' FOR Portal vein, mitomycin;
  • '5' FOR Portal vein, 5-fluorouracil;
  • '6' FOR Portal vein, other;
  • '8' FOR Administered, method not documented;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the method of intraperitoneal chemotherapy administration and the chemotherapy agent used.
1570 GAS ADMIN OF INTERFERON GAS2;32 SET
  • '1' FOR Administered;
  • '2' FOR Not administered;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes whether the patient was administered Interferon to treat the primary tumor.
1571 GAS CO-MORBID CONDITION 1 GAS2;33 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing
    conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.
    Allowable Codes: 000.00
    001.00 thru 994.90 (valid ICD-CM codes)
    If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining co-morbid fields blank.
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
  • EXPLANATION:  Enter the ICD-CM code.
1571.1 GAS CO-MORBID CONDITION 2 GAS2;34 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing
    conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.
    Allowable Codes: 000.00
    001.00 thru 994.90 (valid ICD-CM codes)
    If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining co-morbid fields blank.
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
  • EXPLANATION:  Enter the ICD-CM code.
1571.2 GAS CO-MORBID CONDITION 3 GAS2;35 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  
    This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing
    conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.
    Allowable Codes: 000.00
    001.00 thru 994.90 (valid ICD-CM codes)
    If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining co-morbid fields blank.
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
  • EXPLANATION:  Enter the ICD-CM code.
1571.3 GAS CO-MORBID CONDITION 4 GAS2;36 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing
    conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.
    Allowable Codes: 000.00
    001.00 thru 994.90 (valid ICD-CM codes)
    If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining co-morbid fields blank.
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
  • EXPLANATION:  Enter the ICD-CM code.
1571.4 GAS CO-MORBID CONDITION 5 GAS2;37 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing
    conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.
    Allowable Codes: 000.00
    001.00 thru 994.90 (valid ICD-CM codes)
    If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining co-morbid fields blank.
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
  • EXPLANATION:  Enter the ICD-CM code.
1571.5 GAS CO-MORBID CONDITION 6 GAS2;38 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing
    conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.
    Allowable Codes: 000.00
    001.00 thru 994.90 (valid ICD-CM codes)
    If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining co-morbid fields blank.
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"
  • EXPLANATION:  Enter the ICD-CM code.
1572 GAS DURATION OF TOBACCO USE GAS2;39 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D DTU^ONCOIT
  • OUTPUT TRANSFORM:  S Y=$S(Y="00":"Never used tobacco",Y=99:"Not documented",Y="01":Y_" year",1:Y_" years")
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00 and 99
  • DESCRIPTION:  This item describes the number of known years the patient used some form of tobacco, even if the patient is not presently using tobacco. If the patient has never used tobacco, code 00. If the patient's tobacco use
    cannot be determined, or if the duration of use is not known, code 99.
    Allowable Codes: 00 - never used tobacco
    01 thru 98 - one or more years of tobacco use
    99 - duration of tobacco use not documented
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1573 GAS PERSONAL HIST OTH MALIG GAS2;40 POINTER TO ICDO TOPOGRAPHY FILE (#164) ICDO TOPOGRAPHY(#164)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)
  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the patient's prior history of other invasive malignancies. If the patient has a history of other malignancies report the ICD-O-3 site code for the most recently diagnosed disease. If the patient has
    no personal history of other cancer, code C88.8. If the patient's personal history of other invasive malignancies is not documented, code C99.9.
    Allowable Codes: C00.0 thru C80.9 - valid ICD-0-3 site (topography) codes
    C88.8 - no personal history of other cancer
    C99.9 - personal history of other cancer not documented
  • EXECUTABLE HELP:  D ITEM3^ONCLPC1
1574 GAS WEIGHT LOSS GAS2;41 SET
  • '1' FOR Present;
  • '2' FOR Not present;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 01, 2001
  • DESCRIPTION:  This item describes the presence of weight loss specific to gastric cancer that was recorded in the medical chart.
1575 GAS BOOST DOSE (cGy) GAS2;42 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) S ONCL=5 D BD^ONCOIT
  • LAST EDITED:  MAY 01, 2001
  • HELP-PROMPT:  Type a Number between 00000 and 99999
  • DESCRIPTION:  This item describes the boost dose of radiation administered to the central tumor field of the patient. If radiation was administered but boost dose is unknown, code 99999.
    Allowable Codes: 00000 - no radiation boost dose administered
    00001 thru 99998 - boost dose administered (cGy)
    99999- boost dose administered, dose not documented
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1576 GAS CHEMOTHERAPEUTIC AGENT #1 GAS2;43 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18) CHEMOTHERAPEUTIC DRUGS(#164.18)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.18,Y,0)),"^",2)_" "_$P($G(^ONCO(164.18,Y,0)),"^",1)
  • LAST EDITED:  MAY 02, 2001
  • DESCRIPTION:  This item records the first chemotherapeutic agent administered to the patient as part of the first course of therapy. If chemotherapy was administered but the type(s) of agent(s) are unknown, code 999999.
    Allowable Codes: Valid NSC (National Service Center) number for
    chemotherapeutic agents listed in the Self
    Instructional Manual for Tumor Registrars, Book 8,
    Surveillance, Epidemiology and End Results Program,
    National Cancer Institute.
1576.1 GAS CHEMOTHERAPEUTIC AGENT #2 GAS2;44 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18) CHEMOTHERAPEUTIC DRUGS(#164.18)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.18,Y,0)),"^",2)_" "_$P($G(^ONCO(164.18,Y,0)),"^",1)
  • LAST EDITED:  MAY 02, 2001
  • DESCRIPTION:  This item records the second chemotherapeutic agent administered to the patient as part of the first course of therapy. If chemotherapy was administered but the type(s) of agent(s) are unknown, code 999999.
    Allowable Codes: Valid NSC (National Service Center) number for
    chemotherapeutic agents listed in the Self
    Instructional Manual for Tumor Registrars, Book 8,
    Surveillance, Epidemiology and End Results Program,
    National Cancer Institute.
1576.2 GAS CHEMOTHERAPEUTIC AGENT #3 GAS2;45 POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18) CHEMOTHERAPEUTIC DRUGS(#164.18)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.18,Y,0)),"^",2)_" "_$P($G(^ONCO(164.18,Y,0)),"^",1)
  • LAST EDITED:  MAY 02, 2001
  • DESCRIPTION:  This item records the third chemotherapeutic agent administered to the patient as part of the first course of therapy. If chemotherapy was administered but the type(s) of agent(s) are unknown, code 999999.
    Allowable Codes: Valid NSC (National Service Center) number for
    chemotherapeutic agents listed in the Self
    Instructional Manual for Tumor Registrars, Book 8,
    Surveillance, Epidemiology and End Results Program,
    National Cancer Institute.
1577 GAS CHEMOTHERAPEUTIC TOXICITY GAS2;46 SET
  • '1' FOR Chemo discontinued due to toxicity;
  • '2' FOR No chemo toxicity;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 02, 2001
  • DESCRIPTION:  This item describes whether the administration of chemotherapy was discontinued as a result of toxicity.
1578 GAS CHEMOTHERAPY/SURG SEQUENCE GAS2;47 SET
  • '1' FOR Chemo administered, no surgery;
  • '2' FOR Chemo administered before surgery;
  • '3' FOR Chemo administered after surgery;
  • '4' FOR Chemo administered before and after surgery;
  • '9' FOR Chemo and surgery administered, seq unk;

  • LAST EDITED:  MAY 02, 2001
  • DESCRIPTION:  This data item describes the sequence in which chemotherapy and surgery of the primary site were administered.
1579 GAS COMPLICATION #1 GAS2;48 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This item describes the first medical complication acquired by the patient during or resulting from the first course of therapy. Record valid ICD-CM codes.
    Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
    E930.0 - E949.7 (valid ICD-CM adverse effect codes)
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
  • EXPLANATION:  If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
1579.1 GAS COMPLICATION #2 GAS2;49 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This item describes the first medical complication acquired by the patient during or resulting from the first course of therapy. Record valid ICD-CM codes.
    Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
    E930.0 - E949.7 (valid ICD-CM adverse effect codes)
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
  • EXPLANATION:  If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
1579.2 GAS COMPLICATION #3 GAS2;50 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This item describes the first medical complication acquired by the patient during or resulting from the first course of therapy. Record valid ICD-CM codes.
    Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
    E930.0 - E949.7 (valid ICD-CM adverse effect codes)
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
  • EXPLANATION:  If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
1579.3 GAS COMPLICATION #4 GAS2;51 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This item describes the first medical complication acquired by the patient during or resulting from the first course of therapy. Record valid ICD-CM codes.
    Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
    E930.0 - E949.7 (valid ICD-CM adverse effect codes)
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
  • EXPLANATION:  If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
1579.4 GAS COMPLICATION #5 GAS2;52 POINTER TO ICD DIAGNOSIS FILE (#80) ICD DIAGNOSIS(#80)

  • INPUT TRANSFORM:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)
  • LAST EDITED:  JUN 08, 2012
  • DESCRIPTION:  This item describes the first medical complication acquired by the patient during or resulting from the first course of therapy. Record valid ICD-CM codes.
    Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)
    E930.0 - E949.7 (valid ICD-CM adverse effect codes)
  • SCREEN:  S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"
  • EXPLANATION:  If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.
1764 SUMMARY STAGE 2018 EOD;4 SET
  • '0' FOR In situ;
  • '1' FOR Localized only;
  • '2' FOR Regional by direct extension only;
  • '3' FOR Regional lymph nodes only;
  • '4' FOR Regional BOTH direct ext and LN;
  • '7' FOR Distant site(s)/node(s) involved;
  • '8' FOR Benign/Borderline;
  • '9' FOR Unknown;

  • LAST EDITED:  NOV 12, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This item stores the directly assigned Summary Stage 2018. Effective for cases diagnosed 1/1/2018+. Rationale: The SEER program has collected staging information on cases since its inception in 1973. Summary Stage groups
    cases into broad categories of in situ, local, regional, and distant. Summary Stage can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time. Codes: 0 In situ 1 Localized only 2
    Regional by direct extension only 3 Regional lymph nodes only 4 Regional by BOTH direct extension AND lymph node involvement 7 Distant site(s)/node(s) involved 8 Benign/borderline* 9 Unknown if extension or metastasis
    (unstaged, unknown, or unspecified)
    Death certificate only case
  • SCREEN:  S DIC("S")="D SCRNSS^ONCSCHMM"
  • EXPLANATION:  Applicable codes depend on the Schema
  • CROSS-REFERENCE:  ^^TRIGGER^165.5^7012
    1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"NCR18")):^("NCR18"),1:"") S X=$P(Y(1),U,13),X=X S DIU=X K Y S X=DIV S X=9,X=X X ^DD(165.5,1764,1,1,1.4)
    1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"NCR18")),DIV=X S $P(^("NCR18"),U,13)=DIV,DIH=165.5,DIG=7012 D ^DICR
    2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"NCR18")):^("NCR18"),1:"") S X=$P(Y(1),U,13),X=X S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),"NCR18")),DIV=X S $P(^("NCR18"),U,13)=DIV,DIH=165.5,DIG=7012 D ^
    DICR
    CREATE VALUE)= INTERNAL(9)
    DELETE VALUE)= @
    FIELD)= DERIVED SUMM
    This field will set the DERIVED SUMMARY STAGE to be set to '9'.
1772 EOD PRIMARY TUMOR EOD;1 NUMBER

  • INPUT TRANSFORM:  K:X'?1.3N X I $D(X) D PTIT^ONCOEOD1
  • LAST EDITED:  MAR 13, 2019
  • HELP-PROMPT:  Type a number between 0 and 999, 0 decimal digits.
  • DESCRIPTION:  
    EOD Primary Tumor is part of the EOD 2018 data collection system and is used to classify continuous growth (extension) of primary tumor.
  • EXECUTABLE HELP:  D PTHLP^ONCOEOD1
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1774 EOD REGIONAL NODES EOD;2 NUMBER

  • INPUT TRANSFORM:  K:X'?1.3N X I $D(X) D RNIT^ONCOEOD1
  • LAST EDITED:  MAR 13, 2019
  • HELP-PROMPT:  Type a number between 0 and 999, 0 decimal digits.
  • DESCRIPTION:  
    EOD Regional Nodes is part of the EOD 2018 data collection system and is used to classify the regional lymph nodes involved with cancer at the time of diagnosis.
  • EXECUTABLE HELP:  D RNHLP^ONCOEOD1
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
1776 EOD METS EOD;3 NUMBER

  • INPUT TRANSFORM:  K:X'?1.3N X I $D(X) D MTIT^ONCOEOD1
  • LAST EDITED:  MAR 13, 2019
  • HELP-PROMPT:  Type a number between 0 and 99, 0 decimal digits.
  • DESCRIPTION:  
    EOD Mets is part of the EOD 2018 data collection system and is used to classify the distant site(s) of metastatic involvement at time of diagnosis.
  • EXECUTABLE HELP:  D MTHLP^ONCOEOD1
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
2000 DIVISION DIV;1 POINTER TO INSTITUTION FILE (#4)
************************REQUIRED FIELD************************
INSTITUTION(#4)

  • LAST EDITED:  DEC 17, 1999
  • DESCRIPTION:  DIVISION is the division to which this primary belongs.
3000 CLASS OF CASE CONVERSION FLAG CONV;1 SET
  • '1' FOR Converted;

  • LAST EDITED:  SEP 16, 2009
  • HELP-PROMPT:  Enter 1 (Converted) if CLASS OF CASE has been converted to NAACCR v12.
  • DESCRIPTION:  
    Indicates that the CLASS OF CASE value has been converted to NAACCR v12.
3001 STATE AT DX CONVERSION FLAG CONV;2 SET
  • '1' FOR Converted;

  • LAST EDITED:  SEP 16, 2009
  • HELP-PROMPT:  Enter 1 (Converted) if STATE AT DX has been converted to NAACCR v12.
  • DESCRIPTION:  
    Indicates that the STATE AT DX value has been converted to NAACCR v12.
3700 SEER SSF1-HPV STATUS SSD4;33 POINTER TO ONCO HPV STATUS FILE (#167.7) ONCO HPV STATUS(#167.7)

  • LAST EDITED:  NOV 05, 2024
  • HELP-PROMPT:  Enter a code from the list for the HPV Status.
  • DESCRIPTION:  SEER Site-specific Factor 1 is new for 2018. This data item is reserved for human papilloma virus (HPV) status. This data item only applies to:
    Oropharynx (p16+): C019, C024, C051-C052, C090-C091,
    C098-C099, C100, C102-C103, C108-C109, C111
    Oropharynx (p16-) and Hypopharynx: C019, C024, C051-C052,
    C090-C091, C098-C099, C100, C102-C103, C108-C109, C111
    C129, C130-C132, C138-C139
    Lip and Oral Cavity: C000-C009, C020-C023, C028-C029, C030-C031,
    C039, C040-C041, C048-C049, C050, C058-C059, C060-C062, C068-C069 There is evidence that human papilloma virus (HPV) plays a role in the pathogenesis of some cancers. HPV testing may be performed for prognostic
    purposes; testing may also be performed on metastatic sites to aid in determination of the primary site.
    Codes: To be determined for each site where needed. Refer to the most current version of the SEER Program Coding and Staging Manual, for details.
    Blank Field not coded 10 HPV negative by p16 test 11 HPV positive by p16 test 20 HPV negative for viral DNA by ISH test 21 HPV positive for viral DNA by ISH test 30 HPV negative for viral DNA by PCR
    test 31 HPV positive for viral DNA by PCR test 40 HPV negative by ISH E6/E7 RNA test 41 HPV positive by ISH E6/E7 RNA test 50 HPV negative by RT-PCR E6/E7 RNA test 51 HPV positive by RT-PCR E6/E7 RNA
    test 70 HPV status reported in medical records as negative, but test type is unknown 71 HPV status reported in medical records as positive, but test type is unknown 97 Test done, results not in chart 99 Not
    documented in medical record
    HPV test not done, not assessed, or unknown if assessed
3800 SCHEMA ID SSD1;1 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<5) X
    MAXIMUM LENGTH: 5
  • LAST EDITED:  SEP 07, 2018
  • HELP-PROMPT:  Answer must be 5 characters in length.
  • DESCRIPTION:  
    This field contains the SCHEMA ID for the Abstract which is calculated using the Site/GP, Histology and possibly Schema Discriminators.
3800.1 SCHEMA ID DESCRIPTION SSD5;6 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>70!($L(X)<5) X
    MAXIMUM LENGTH: 70
  • LAST EDITED:  DEC 20, 2021
  • HELP-PROMPT:  Answer must be 5-70 characters in length.
  • DESCRIPTION:  
    This field will contain the Schema ID and description which will be useful for the Cancer Cube.
3801 CHROMOSOME 1P: (LOH) SSD1;2 SET
  • '0' FOR LOH not identified/not present;
  • '1' FOR LOH identified/present;
  • '6' FOR Benign or borderline tumor;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR Not applicable;
  • '9' FOR Not documented in patient record;

  • LAST EDITED:  JUN 21, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Chromosome 1p: Loss of Heterozygosity (LOH) refers to the loss of genetic material normally found on the short arm of one of the patient's two copies of chromosome 1. Codeletion of Chromosome 1p and 19q is a diagnostic,
    prognostic and predictive marker for gliomas and is strongly associated with the oligodendroglioma phenotype. Codes: 0 Chromosome 1p deletion/LOH not identified/not present 1 Chromosome 1p deletion/LOH
    identified/present 6 Benign or borderline tumor 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code 8 will result in an edit error.) 9 Not documented in patient record
    Cannot be determined by the pathologist
    Chromosome 1p deletion/LOH not assessed or unknown if assessed
3802 CHROMOSOME 19Q: (LOH) SSD1;3 SET
  • '0' FOR LOH not identified/not present;
  • '1' FOR LOH present;
  • '6' FOR Benign or borderline tumor;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR Not applicable;
  • '9' FOR Not documented in patient record;

  • LAST EDITED:  JUN 21, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Chromosome 19q: Loss of Heterozygosity (LOH) refers to the loss of genetic material normally found on the long arm of one of the patient's two copies of chromosome 19. Codeletion of Chromosome 1p and 19q is a diagnostic,
    prognostic and predictive marker for gliomas and is strongly associated with the oligodendroglioma phenotype. Codes: 0 Chromosome 19q deletion/LOH not identified/not present 1 Chromosome 19q deletion/LOH present 6
    Benign or borderline tumor 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    If this item is required by your standard setter, use of code 8 will
    result in an edit error.) 9 Not documented in patient record
    Cannot be determined by the pathologist
    Chromosome 19q: LOH not assessed or unknown if assessed
3803 ADENOID CYSTIC BASALOID PTTRN SSD1;4 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM
    MAXIMUM LENGTH: 5
  • LAST EDITED:  OCT 09, 2019
  • HELP-PROMPT:  Answer must be 1-5 characters in length.
  • DESCRIPTION:  Adenoid Cystic Basaloid Pattern, the presence of a basaloid pattern on pathological examination is a prognostic factor for adenoid cystic carcinoma of the lacrimal gland. Rationale: Adenoid Cystic Basaloid Pattern is a
    Registry Data Collection Variable in AJCC 8. This data item was previously collected as Lacrimal Gland, SSF#6. Codes: 0.0-100.0 0.0 to 100.0 percent basaloid pattern XXX.5 Basaloid pattern present, percentage not stated
    XXX.8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of code
    XXX.8 will result in an edit error.) XXX.9 Not documented in medical record
    Adenoid Cystic Basaloid Pattern not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3804 ADENOPATHY SSD1;5 SET
  • '0' FOR Adenopathy not identified/not present;
  • '1' FOR Adenopathy present;
  • '5' FOR NA, site not C421;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUN 27, 2022
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Adenopathy is defined as the presence of lymph nodes greater than 1.5 cm on physical examination (PE) and is part of the staging criteria for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). Rationale:
    Adenopathy is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in AJCC 8th edition, Chapter 79 Hodgkin and Non-Hodgkin Lymphomas. It is a new data item for
    cases diagnosed 1/1/2018+. Codes: 0 Adenopathy not identified/not present
    No lymph nodes >1.5 cm 1 Adenopathy present
    Presence of lymph nodes >1.5 cm 5 Not applicable: Primary site is not C421 9 Not documented in medical record
    Adenopathy not assessed or unknown if assessed
  • SCREEN:  S DIC("S")="D SCRNFIV^ONCSCHMM"
  • EXPLANATION:  Codes depend on appropriate primary site
3805 AFP POST-ORCHIECTOMY LAB VAL SSD1;6 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM
    MAXIMUM LENGTH: 7
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-7 characters in length.
  • DESCRIPTION:  AFP (Alpha Fetoprotein) Post-Orchiectomy Lab Value refers to the lowest AFP value measured post-orchiectomy. AFP is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the
    testis. The Post-Orchiectomy lab value is used to monitor response to therapy. Rationale: AFP (Alpha Fetoprotein) Post-Orchiectomy Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as
    Testis CS SSF#12. Codes: 0.0 0.0 nanograms/milliliter (ng/mL) 0.1-99999.9 0.1-99,999.9 ng/mL XXXXX.1 100,000 ng/mL or greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not applicable: Information
    not collected for this case
    (If this information is required by your standard setter,
    use of code XXXXX.8 may result in an edit error.) XXXXX.9 Not documented in medical record
    Noorchiectomy performed
    AFP (Alpha Fetoprotein) Post-Orchiectomy Lab Value
    not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3806 AFP POST-ORCHIECTOMY RANGE SSD1;7 SET
  • '0' FOR Within normal limits;
  • '1' FOR Above normal & <1000ng/mL;
  • '2' FOR 1000-10000ng/mL;
  • '3' FOR >10000ng/mL;
  • '4' FOR AFP stated to be elevated;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 09, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  AFP (Alpha Fetoprotein) Post-Orchiectomy Range identifies the range category of the lowest AFP value measured post-orchiectomy. AFP is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell
    tumors of the testis. The Post-Orchiectomy lab value is used to monitor response to therapy. Rationale: AFP (Alpha Fetoprotein) Post-Orchiectomy Range is a Registry Data Collection Variable in AJCC. AFP (Alpha
    Fetoprotein) Post-Orchiectomy Range is used to assign the S Category Pathological and was previously collected as Testis CS SSF#13. Codes: 0 Within normal limits 1 Above normal and less than 1,000 nanograms/milliliter
    (ng/mL) 2 1,000 -10,000 ng/mL 3 Greater than 10,000 ng/mL 4 Post-Orchiectomy alpha fetoprotein (AFP) stated to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this
    case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error.) 9 Not documented in medical record
    No orchiectomy performed
    AFP (Alpha Fetoprotein) Post-Orchiectomy Range not assessed or
    unknown if assessed
3807 AFP PRE-ORCHIECTOMY LAB VALUE SSD1;8 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM
    MAXIMUM LENGTH: 7
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-7 characters in length.
  • DESCRIPTION:  AFP (Alpha Fetoprotein) Pre-Orchiectomy Lab Value refers to the AFP value measured prior to treatment. AFP is a tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the testis.
    Rationale: AFP (Alpha Fetoprotein) Pre-Orchiectomy Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Testis CS SSF#6 Codes: 0.0 0.0 nanograms/milliliter (ng/mL) 0.1-99999.9
    0.1-99,999.9 ng/mL XXXXX.1 100,000 ng/mL or greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code XXXXX.8 may result in an edit error.) XXXXX.9 Not documented in medical record
    AFP (Alpha Fetoprotein) Pre-Orchiectomy Lab Value
    not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3808 AFP PRE-ORCHIECTOMY RANGE SSD1;9 SET
  • '0' FOR Within normal limits;
  • '1' FOR Above normal & <1000ng/mL;
  • '2' FOR 1000-10000ng/mL;
  • '3' FOR >10000ng/mL;
  • '4' FOR AFP stated to be elevated;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 09, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  AFP (Alpha Fetoprotein) Pre-Orchiectomy Range identifies the range category of the highest AFP value measured prior to treatment. AFP is a serum tumor marker that is often elevated in patients with nonseminomatous germ
    cell tumors of the testis. Rationale: AFP (Alpha Fetoprotein) Pre-Orchiectomy Range is a Registry Data Collection Variable in AJCC. AFP (Alpha Fetoprotein) Pre-Orchiectomy Range is used to assign the S Category Clinical
    and was previously collected as Testis CS SSF#7. Codes: 0 Within normal limits 1 Above normal and less than 1,000 nanograms/milliliter (ng/mL) 2 1,000 -10,000 ng/mL 3 Greater than 10,000 ng/mL 4 Pre-Orchiectomy
    alpha fetoprotein (AFP) stated to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error.) 9 Not documented in medical record
    AFP (Alpha Fetoprotein) Pre-Orchiectomy Range not assessed
    or unknown if assessed
3809 AFP PRETREATMENT INTERPRET SSD1;10 SET
  • '0' FOR Within normal limits;
  • '1' FOR Positive/elevated;
  • '2' FOR Borderline;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUN 28, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  AFP (Alpha Fetoprotein) Pretreatment Interpretation, a nonspecific serum protein that generally is elevated in the setting of hepatocellular carcinoma (HCC), is a prognostic factor for liver cancer. Rationale: AFP (Alpha
    Fetoprotein) Pretreatment Interpretation is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 1. Codes: 0 Negative/normal; within normal limits 1 Positive/elevated
    2 Borderline; undetermined if positive or negative 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of code 8 will
    result in an edit error.) 9 Not documented in medical record
    AFP pretreatment interpretation not assessed or unknown if assessed
3810 AFP PRETREATMENT LAB VALUE SSD1;11 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>6!($L(X)<1)!'(X?0.4AN0.1"."1N) X I $D(X) D DEC4^ONCSCHMM
    MAXIMUM LENGTH: 6
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-6 characters in length.
  • DESCRIPTION:  AFP (Alpha Fetoprotein) Pretreatment Lab Value is a nonspecific serum protein that generally is elevated in the setting of hepatocellular carcinoma (HCC). This data item pertains to the pre-treatment lab value. Rationale:
    AFP (Alpha Fetoprotein) Pretreatment Lab Value is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 3. Codes: 0.0 0.0 nanograms/milliliter (ng/ml); not detected
    0.1-9999.9 0.1-9999.9 ng/ml
    (Exact value to nearest tenth of ng/ml) XXXX.1 10,000.0 ng/ml or greater XXXX.7 Test ordered, results not in chart XXXX.8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code XXXX.8 will result in an edit error.) XXXX.9 Not documented in medical record
    AFP (Alpha Fetoprotein) Pretreatment Lab Value not
    assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3811 ANEMIA SSD1;12 SET
  • '0' FOR Anemia not present, Hgb GT or equal 11.0 g/dL;
  • '1' FOR Anemia present, Hgb<11.0 g/dL;
  • '5' FOR NA, site not C421;
  • '6' FOR Lab value unk, physician states pt is anemic;
  • '7' FOR Test ordered, results not in chart;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  MAY 03, 2023
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Anemia is defined by a deficiency of red blood cells or of hemoglobin in the blood. In staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL), anemia is defined as Hgb less than 11.0 g/dL. Rationale:
    Anemia is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in AJCC 8th edition, Chapter 79 Hodgkin and Non-Hodgkin Lymphomas. It is a new data item for cases
    diagnosed 1/1/2018+. Codes: 0 Anemia not present
    Hgb >=11.0 g/dL
    Physician states RAI stage 0-II 1 Anemia present
    Hgb <11.0 g/dL 5 Not applicable: Primary site is not C421 6 Lab value unknown, physician states patient is anemic
    Physician states RAI stage III 7 Test ordered, results not in chart 9 Not documented in medical record
    Anemia not assessed or unknown if assessed
  • SCREEN:  S DIC("S")="D SCRNFIV^ONCSCHMM"
  • EXPLANATION:  Codes depend on appropriate primary site
3812 B SYMPTOMS SSD1;13 SET
  • '0' FOR No B symptoms (asymptomatic);
  • '1' FOR Any B symptom(s);
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUN 28, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  B symptoms refer to systemic symptoms of fever, night sweats, and weight loss which can be associated with both Hodgkin lymphoma and some non-Hodgkin lymphomas. The presence of B symptoms is a prognostic factor for some
    lymphomas. Rationale: B symptoms is a Registry Data Collection Variable in AJCC. This data item was previously collected for Lymphomas, SSF# 2. Codes: 0 No B symptoms (asymptomatic)
    Classified as "A" by physician when asymptomatic 1 Any B symptom(s)
    Night sweats (drenching)
    Unexplained fever (above 38 degrees C)
    Unexplained weight loss (generally greater than 10% of body
    weight in the six months before admission)
    B symptoms, NOS
    Classified as "B" by physician when symptomatic 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of code 8 will
    result in an edit error.) 9 Not documented in medical record
    B symptoms not assessed or unknown if assessed
3813 BILIRUBIN PRE TOTAL LAB VALUE SSD1;14 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM
    MAXIMUM LENGTH: 5
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-5 characters in length.
  • DESCRIPTION:  Bilirubin Pretreatment Total Lab Value records the bilirubin value prior to treatment. Bilirubin level is an indicator of how effectively the liver excretes bile and is required to calculate the Model for End-Stage Liver
    Disease (MELD) score used to assign priority for liver transplant. Rationale: Bilirubin Pretreatment Total Lab Value is a Registry Data Collection Variable in AJCC. This data item was previously collected as Liver, CS
    SSF# 6. Codes: 0.0 0.0 milligram/deciliter (mg/dL)
    0.0 micromole/liter (umol/L) 0.1-999.9 0.1-999.9 milligram/deciliter (mg/dL)
    0.1-999.9 micromole/liter (umol/L) XXX.1 1000 milligram/deciliter (mg/dL) or greater
    1000 micromole/liter (umol/L) or greater XXX.7 Test ordered, results not in chart XXX.8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code XXX.8 will result in an edit error.) XXX.9 Not documented in medical record
    Bilirubin Pretreatment Total Lab Value not assessed or unknown
    if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3814 BILIRUBIN PRETREATMENT UNIT SSD1;15 SET
  • '1' FOR Milligrams per deciliter (mg/dL);
  • '2' FOR Micromoles/liter (umol/L);
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUN 28, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Bilirubin Pretreatment Unit of Measure identifies the unit of measure for the bilirubin value measured prior to treatment. Bilirubin is commonly measured in units of Milligrams/deciliter (mg/dL) in the United States and
    Micromoles/liter (umol/L) in Canada and Europe. Rationale: Bilirubin Pretreatment is a Registry Data Collection Variable in AJCC. Bilirubin Pretreatment Unit of Measure is needed to identify the unit in which bilirubin
    is measured and was previously collected as Liver, CS SSF# 7. Codes: 1 Milligrams per deciliter (mg/dL) 2 Micromoles/liter (umol/L) 7 Test ordered, results not in chart 8 Not applicable: Information not collected
    for this case
    (If this item is required by your standard setter, use of
    code 8 will result in an edit error.) 9 Not documented in medical record
    Bilirubin unit of measure not assessed or unknown if assessed
3815 BONE INVASION SSD1;16 SET
  • '0' FOR Bone invasion not present/not identified on imaging;
  • '1' FOR Bone invasion present/identified on imaging;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 09, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Bone invasion, the presence or absence of bone invasion based on imaging, is a prognostic factor for soft tissue sarcomas. Rationale: Bone Invasion is a Registry Data Collection Variable in AJCC. This data item was
    previously collected for Soft Tissue, SSF# 3. Codes: 0 Bone invasion not present/not identified on imaging 1 Bone invasion present/identified on imaging 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error.) 9 Not documented in medical record
    Bone invasion not assessed or unknown if assessed
3816 BRAIN MOLECULAR MARKERS SSD1;17 POINTER TO ONCO BRAIN MOLECULAR MARKERS FILE (#167.1) ONCO BRAIN MOLECULAR MARKERS(#167.1)

  • LAST EDITED:  JUL 09, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Multiple brain molecular markers have become standard pathology components necessary for diagnosis. This data item captures clinically important brain cancer subtypes identified by molecular markers that are not
    distinguishable by ICD-O-3 codes. Rationale: Collection of these clinically important brain cancer subtypes has been recommended by CBTRUS. Codes: 01 Diffuse astrocytoma, IDH-mutant (9400/3) 02 Diffuse astrocytoma,
    IDH-wildtype (9400/3) 03 Anaplastic astrocytoma, IDH-mutant (9401/3) 04 Anaplastic astrocytoma, IDH-wildtype (9401/3) 05 Glioblastoma, IDH-wildtype (9440/3) 06 Oligodendroglioma, IDH-mutant and 1 p/19q
    co-deleted (9450/3) 07 Anaplastic oligodendroglioma, IDH-mutant and 1 p/19q
    co-deleted (9451/3) 08 Medulloblastoma, SHH-activated and TP53-wildtype (9471/3) 09 Embryonal tumor with multilayered rosettes, C19MC-
    altered (9478/3) 85 Not applicable: Histology not 9400/3, 9401/3, 9440/3,
    9450/3, 9451/3, 9471/3, 9478/3 86 Benign or borderline tumor 87 Test ordered, results not in chart 88 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code 88 will result in an edit error.) 99 Not documented in patient record
    No microscopic confirmation
    Brain molecular markers not assessed or unknown if assessed
3817 BRESLOW TUMOR THICKNESS SSD1;18 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1) X I $D(X) D BTTIT^ONCSCHMM
    MAXIMUM LENGTH: 4
  • LAST EDITED:  SEP 18, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  Breslow Tumor Thickness, the measurement of the thickness of a Melanoma as defined by Dr. Alexander Breslow, is a prognostic factor for Melanoma of the Skin. Rationale: Breslow Tumor Thickness is a Registry Data
    Collection Variable in AJCC. It was previously collected as Melanoma Skin, CS SSF# 1. Codes:
    0.0 No mass/tumor found
    0.1 Greater than 0.0 and less than or equal to 0.1 0.2-99.9 0.2 - 99.9 millimeters XX.1 100 millimeters or larger A0.1-A9.9 Stated as "at least" some measured value of 0.1 to 9.9 AX.0 Stated as greater than 9.9
    mm XX.8 Not applicable: Information not collected for this schema
    (If this item is required by your standard setter, use of
    code XX.8 will result in an edit error) XX.9 Not documented in medical record
    Microinvasion; microscopic focus or foci only and no depth given
    Cannot be determined by pathologist
    In situ melanoma
    Breslow Tumor Thickness not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3818 CA-125 PRETREATMENT INTER SSD1;19 SET
  • '0' FOR Negative/normal;
  • '1' FOR Positive/elevated;
  • '2' FOR Stated as borderline;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 09, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Carbohydrate Antigen 125 (CA-125) is a tumor marker that is useful for following the response to therapy in patients with ovarian cancer, who may have elevated levels of this marker. Rationale: Preoperative CA-125 is a
    Registry Data Collection Variable listed in AJCC. It was previously collected as Ovary, CS SSF# 1. Codes: 0 Negative/normal; within normal limits 1 Positive/elevated 2 Stated as borderline; undetermined whether
    positive or negative 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code 8 will result in an edit error) 9 Not documented in medical record
    CA-125 not assessed or unknown if assessed
3819 CEA PRETREATMENT INTER SSD1;20 SET
  • '0' FOR CEA negative/normal;
  • '1' FOR CEA positive/elevated;
  • '2' FOR Borderline;
  • '3' FOR Undetermined if positive or negative;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 09, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  CEA (Carcinoembryonic Antigen) Pretreatment Interpretation refers to the interpretation of the CEA value prior to treatment. CEA is a glycoprotein that is produced by adenocarcinomas from all sites as well as many squamous
    cell carcinomas of the lung and other sites. CEA may be measured in blood, plasma or serum. CEA is a prognostic marker for adenocarcinomas of the appendix, colon and rectum and is used to monitor response to treatment
    Rationale: CEA (Carcinoembryonic Antigen) is a Registry Data Collection Variable for AJCC 8. CEA (Carcinoembryonic Antigen) Pretreatment Interpretation was previously collected as Colon and Rectum, CS SSF #1. Codes: 0
    CEA negative/normal; within normal limits 1 CEA positive/elevated 2 Borderline 3 Undetermined if positive or negative (normal values not available)
    AND no MD interpretation 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this data item is required by your standard setter, use of
    code 8 will result in an edit error.) 9 Not documented in medical record
    CEA (Carcinoembryonic Antigen) Pretreatment Interpretation not
    assessed or unknown if assessed
3820 CEA PRETREATMENT LAB VALUE SSD1;21 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>6!($L(X)<1)!'(X?0.4AN0.1"."1N) X I $D(X) D DEC4^ONCSCHMM
    MAXIMUM LENGTH: 6
  • LAST EDITED:  JUL 31, 2019
  • HELP-PROMPT:  Answer must be 1-6 characters in length.
  • DESCRIPTION:  CEA (Carcinoembryonic Antigen) Pretreatment Lab Value records the CEA value prior to treatment. CEA is a nonspecific tumor marker that has prognostic significance for colon and rectum cancer. Rationale: CEA
    (Carcinoembryonic Antigen) Pretreatment Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum, CS SSF# 3. Codes: 0.0 0.0 nanograms/milliliter (ng/m) exactly 0.1-9999.9
    0.1-9999.9 ng/ml
    (Exact value to nearest tenth in ng/ml) XXXX.1 10,000 ng/ml or greater XXXX.7 Test ordered, results not in chart XXXX.8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use
    of code XXXX.8 may result in an edit error.) XXXX.9 Not documented in medical record
    CEA (Carcinoembryonic Antigen) Pretreatment Lab Value not
    assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3821 CHROMOSOME 3 STATUS SSD1;22 SET
  • '0' FOR No loss of chromosome 3;
  • '1' FOR Partial loss of chromosome 3;
  • '2' FOR Complete loss of chromosome 3;
  • '3' FOR Loss of chromosome 3, NOS;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 09, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Chromosome 3 Status refers to the partial or total loss of Chromosome 3, which is a prognostic factor for uveal melanoma. Rationale: Chromosome 3 Status is a Registry Data Collection Variable in AJCC. This data item was
    previously collected as Uveal Melanoma, CS SSF# 5. Codes: 0 No loss of chromosome 3 1 Partial loss of chromosome 3 2 Complete loss of chromosome 3 3 Loss of chromosome 3, NOS 7 Test ordered, results not in chart
    8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use
    of code 8 may result in an edit error.) 9 Not documented in medical record
    Chromosome 3 status not assessed or unknown if assessed
3822 CHROMOSOME 8Q STATUS SSD1;23 SET
  • '0' FOR No gain in chromosome 8q;
  • '1' FOR Gain in chromosome 8q;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 09, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Chromosome 8q Status refers to gain in Chromosome 8q, which is a prognostic factor for uveal melanoma. Rationale: Chromosome 8q Status is a Registry Data Collection Variable in AJCC. This data item was previously
    collected as Uveal Melanoma, CS SSF# 7. Codes: 0 No gain in chromosome 8q 1 Gain in chromosome 8q 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error.) 9 Not documented in medical record
    Chromosome 8q status not assessed or unknown if assessed
3823 CIRCUMFERENTIAL RESECT MARGIN SSD1;24 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  Circumferential or Radial Resection Margin, the distance in millimeters between the leading edge of the tumor and the surgically dissected margin as recorded on the pathology report, is a prognostic indicator for colon and
    rectal cancer. This may also be referred to as the Radial Resection Margin or surgical clearance. Rationale: Circumferential or Radial Resection Margin is a Registry Data Collection Variable in AJCC. It was previously
    collected as Colon and Rectum CS SSF# 6. Codes:
    0.0 Circumferential resection margin (CRM) positive
    Margin IS involved with tumor
    Described as "less than 1 millimeter (mm)" 0.1-99.9 Distance of tumor from margin: 0.1- 99.9 millimeters (mm)
    (Exact size to nearest tenth of millimeter) XX.0 100 mm or greater XX.1 Margins clear, distance from tumor not stated
    Circumferential or radial resection margin negative, NOS
    No residual tumor identified on specimen XX.2 Margins cannot be assessed XX.3 Described as "at least" 1 mm XX.4 Described as "at least" 2 mm XX.5 Described as "at least" 3 mm XX.6 Described as "greater
    than" 3 mm XX.7 No resection of primary site
    Surgical procedure did not remove enough tissue to measure
    the circumferential or radial resection margin
    (Examples include: polypectomy only, endoscopic mucosal
    resection (EMR), excisional biopsy only, transanal disk excision) XX.8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code XX.8 may result in an edit error.) XX.9 Not documented in medical record
    Circumferential or radial resection margin not assessed
    or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3824 CREATININE PRETREAT LAB VALUE SSD1;25 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  Creatinine Pretreatment Lab Value, an indicator of kidney function is required to calculate the Model for End-Stage Liver Disease (MELD) score, which is used to assign priority for liver transplant. Rationale: Creatinine
    Pretreatment Lab Value is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 4. Codes:
    0.0 0.0 milligram/deciliter (mg/dl)
    0.0 micromole/liter (umol/L) 0.1-99.9 0.1-99.9 milligram/deciliter (mg/dl)
    0.1-99.9 micromole/liter (umol/L)
    (Exact value to nearest tenth of mg/dl or umol/L) XX.1 100 mg/dl or greater
    100 umol/L or greater XX.7 Test ordered, results not in chart XX.8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code XX.8 will result in an edit error.) XX.9 Not documented in medical record
    Creatinine Pretreatment Lab Value not assessed or
    unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3825 CREATININE PRETREAT UNIT SSD1;26 SET
  • '1' FOR Milligrams/deciliter;
  • '2' FOR Micromoles/liter;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 10, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Creatinine Pretreatment Unit of Measure identifies the unit of measure for the creatinine value measured in blood or serum prior to treatment. Creatinine is commonly measured in units of Milligrams/deciliter (mg/dL) in
    the United States and Micromoles/liter (umol/L) in Canada and Europe. Rationale: Creatinine Pretreatment is a Registry Data Collection Variable in AJCC. Creatinine Pretreatment Unit of Measure is needed to identify the
    unit in which creatinine is measured and was previously collected as Liver, CS SSF# 5. Codes: 1 Milligrams/deciliter (mg/dL) 2 Micromoles/liter (umol/L) 7 Test ordered, results not in chart 8 Not applicable:
    Information not collected for this case
    (If this item is required by your standard setter, use of
    code 8 will result in an edit error.) 9 Not documented in medical record
    Creatinine unit of measure not assessed or
    unknown if assessed
3826 ER PERCENT POSITIVE SSD1;27 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3AN) X I $D(X) D ERR^ONCSCHMM
    MAXIMUM LENGTH: 3
  • LAST EDITED:  JUN 25, 2020
  • HELP-PROMPT:  Answer must be 1-3 characters in length.
  • DESCRIPTION:  Estrogen Receptor, Percent Positive Range is the percent of cells staining estrogen receptor positive by IHC. Rationale: Estrogen Receptor, Percent Positive Range is a Registry Data Collection Variable in AJCC. It is a
    new data item for cases diagnosed 1/1/2018+. Codes: 000 ER negative, or stated as less than 1% 001-100 1-100 percent R10 Stated as 1-10% R20 Stated as 11-20% R30 Stated as 21-30% R40 Stated as 31-40% R50
    Stated as 41-50% R60 Stated as 51-60% R70 Stated as 61-70% R80 Stated as 71-80% R90 Stated as 81-90% R99 Stated as 91-100% XX8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code XX8 will result in an edit error.) XX9 Not documented in medical record
    Estrogen Receptor, Percent Positive Range not assessed
    or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3827 ER SUMMARY SSD1;28 SET
  • '0' FOR ER negative;
  • '1' FOR ER positive;
  • '7' FOR Test ordered, results not in chart;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  OCT 21, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  ER (Estrogen Receptor) Summary is a summary of results of the estrogen receptor (ER) assay. Rationale: This data item is required for prognostic stage grouping in AJCC 8th ed- ition, Chapter 48, Breast. It was previously
    collected as Breast CS SSF # 1. Codes: 0 ER negative 1 ER positive 7 Test ordered, results not in chart 9 Not documented in medical record
    Cannot be determined (indeterminate)
    ER (Estrogen Receptor) Summary status not assessed
    or unknown if assessed
3828 ER ALLRED SCORE SSD1;29 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D ERTA^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  OCT 22, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  Estrogen Receptor, Total Allred Score is based on the percentage of cells that stain positive by IHC for estrogen receptor (ER) and the intensity of that staining. Rationale: Estrogen Receptor, Total Allred Score is a
    Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 00 Total ER Allred score of 0 01 Total ER Allred score of 1 02 Total ER Allred score of 2 03 Total ER Allred
    score of 3 04 Total ER Allred score of 4 05 Total ER Allred score of 5 06 Total ER Allred score of 6 07 Total ER Allred score of 7 08 Total ER Allred score of 8 X8 Not applicable: Information not collected for
    this case
    (If this item is required by your standard setter, use of
    code X8 will result in an edit error.) X9 Not documented in medical record
    Estrogen Receptor, Total Allred Score not assessed,
    or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3829 ESOPHAGUS EGJ TUMOR EPICENTER SSD1;30 SET
  • '0' FOR U - Upper;
  • '1' FOR M - Middle;
  • '2' FOR L - Lower;
  • '9' FOR X - Esophagus, NOS;

  • LAST EDITED:  JUL 11, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Esophagus and Esophagogastric Junction (EGJ), Squamous Cell (including adenosquamous), Tumor Location refers to the position of the epicenter of the tumor in the esophagus. Rationale: This data item is required for
    prognostic stage grouping for squamous and adenosquamous carcinoma in AJCC 8th edition, Chapter 16. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 U: Upper (Cervical/Proximal esophagus to lower border
    of azygos vein) 1 M: Middle (Lower border of azygos vein to lower border
    of inferior pulmonary vein) 2 L: Lower (Lower border of inferior pulmonary vein to stomach,
    including gastroesophageal junction) 9 X: Esophagus, NOS
    Specific location of epicenter not documented in medical record
    Specific location of epicenter not assessed or unknown if assessed
3830 ENE CLIN (NON-HEAD AND NECK) SSD1;31 SET
  • '0' FOR ENE not present/not identified;
  • '1' FOR ENE present based on exam or imaging;
  • '2' FOR ENE present based on microscopic confirmation;
  • '7' FOR No LN involvement;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  SEP 09, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Extranodal Extension (ENE) Clinical is defined as "the extension of a nodal metastasis through the lymph node capsule into adjacent tissue" during the diagnostic workup. This data item defines clinical ENE for sites other
    than Head and Neck. Rationale: Extranodal Extension Clinical (non-Head and Neck) is a Registry Data Collection Variable for AJCC. This data item was previously collected for Penis, SSF# 17. Codes: 0 Regional lymph
    nodes involved, ENE not present/not identified
    during diagnostic workup 1 Regional lymph nodes involved, ENE present/identified during
    diagnostic workup, based on physical exam and/or imaging 2 Regional lymph nodes involved, ENE present/identified during
    diagnostic workup, based on microscopic confirmation 7 No lymph node involvement during diagnostic workup (cN0) 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error) 9 Not documented in medical record
    Clinical ENE not assessed or unknown if assessed during
    diagnostic workup
    Clinical assessment of lymph nodes not done, or unknown if done
3831 ENE HEAD AND NECK CLINICAL SSD1;32 SET
  • '0' FOR ENE not present/not identified;
  • '1' FOR ENE present based on physical exam;
  • '2' FOR ENE present based on microscopic confirmation;
  • '4' FOR ENE present, UNK;
  • '7' FOR No LN inv;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 20, 2025
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Extranodal extension (ENE) is defined as "the extension of a nodal metastasis through the lymph node capsule into adjacent tissue" and is a prognostic factor for most head and neck tumors. This data item pertains to
    clinical staging extension. Rationale Extranodal Extension Head and Neck Clinical is a Registry Data Collection Variable in AJCC. It was previously collected as Head and Neck SSF# 8 (Common SSF). Codes: 0 Regional
    lymph nodes involved, ENE not present/not identified
    during diagnostic workup 1 Regional lymph nodes involved, ENE present/identified during
    diagnostic workup, based on physical exam and/or imaging 2 Regional lymph nodes involved, ENE present/identified during
    diagnostic workup, based on microscopic confirmation 4 Regional lymph nodes involved, ENE present/identified,
    unknown how identified 7 No lymph node involvement during diagnostic workup (cN0) 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error) 9 Not documented in medical record
    Clinical ENE not assessed or unknown if assessed during
    diagnostic workup
    Clinical assessment of lymph nodes not done, or unknown if done
3832 ENE HEAD AND NECK PATHOLOGICAL SSD1;33 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?0.1AN0.1"."1N) X I $D(X) D DEC1^ONCSCHMM
    MAXIMUM LENGTH: 3
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-3 characters in length.
  • DESCRIPTION:  Extranodal extension (ENE) is defined as "the extension of a nodal metastasis through the lymph node capsule into adjacent tissue" and is a prognostic factor for most head and neck tumors. This data item pertains to
    pathological staging extension. Rationale: Extranodal Extension Head and Neck Pathological is a Registry Data Collection Variable in AJCC. It was previously collected as Head and Neck SSF# 9 (Common SSF). Codes: 0.0
    Lymph nodes positive for cancer but ENE not identified
    or negative 0.1-9.9 ENE 0.1 to 9.9 mm X.1 ENE 10 mm or greater X.2 ENE microscopic, size unknown
    Stated as ENE (mi) X.3 ENE major, size unknown
    Stated as ENE (ma) X.4 ENE present, microscopic or major unknown, size unknown X.7 Surgically resected regional lymph nodes negative for cancer (pN0) X.8 Not applicable: Information not collected for this
    case
    (If this information is required by your standard setter, use of
    code X.8 may result in an edit error) X.9 Not documented in medical record
    No surgical resection of regional lymph nodes
    ENE not assessed pathologically, or unknown if assessed
    Pathological assessment of lymph nodes not done,
    or unknown if done
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3833 ENE PATH (NON-HEAD AND NECK) SSD1;34 SET
  • '0' FOR ENE not present/not identified;
  • '1' FOR ENE present from surgical resection;
  • '7' FOR No LN involvement from surgical resection;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  SEP 09, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Extranodal Extension Pathological is defined as "the extension of a nodal metastasis through the lymph node capsule into adjacent tissue" identified as part of the surgical resection. This data item defines pathological
    ENE for sites other than Head and Neck. Rationale: Extranodal Extension Pathological (non-Head and Neck) is a Registry Data Collection Variable for AJCC. This data item was previously collected for Penis, SSF# 17. Codes:
    0 Regional lymph nodes involved, ENE not present/not identified
    from surgical resection 1 Regional lymph nodes involved, ENE present/identified
    from surgical resection 7 No lymph node involvement from surgical resection (pN0) 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error) 9 Not documented in medical record
    No surgical resection of regional lymph nodes
    Cannot be determined
    Pathological assessment of lymph nodes not done,
    or unknown if done
    Extranodal Extension Pathological not assessed
    or unknown if assessed
3834 EXTRAVASCULAR MATRIX PATTERNS SSD1;35 SET
  • '0' FOR Extravascular matrix pattern not present/not identified;
  • '1' FOR Extravascular matrix pattern present/identified;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 11, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Extravascular Matrix Patterns, the presence of loops and networks in extracellular matrix patterns, is a prognostic factor for uveal melanoma. Rationale: Extravascular Matrix Pattern is a Registry Data Collection Variable
    in AJCC 8. This data item was previously collected as Uveal Melanoma, CS SSF #11 and CS SSF# 12. These two data items were combined and simplified into one data for cases diagnosed 1/1/2018+. Codes: 0 Extravascular
    matrix pattern not present/not identified 1 Extravascular matrix pattern present/identified 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error.) 9 Not documented in medical record
    Extravascular Matrix Pattern not assessed
    or unknown if assessed
3835 FIBROSIS SCORE SSD2;1 SET
  • '0' FOR Ishak fibrosis score 0-4;
  • '1' FOR Ishak fibrosis score 5-6;
  • '7' FOR Clinical statement of advanced/severe fibrosis or cirrhosis;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 12, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Fibrosis Score, the degree of fibrosis of the liver based on pathological examination, is a prognostic factor for liver cancer. Rationale: Fibrosis Score is a Registry Data Collection Variable in AJCC. This data item was
    previously collected for Liver, CS SSF# 2. Codes: 0 Ishak fibrosis score 0-4
    No to moderate fibrosis
    METAVIR score F0-F3
    Batt-Ludwig score 0-3 1 Ishak fibrosis score 5-6
    Advanced/severe fibrosis
    METAVIR score F4
    Batt-Ludwig score 4
    Developing cirrhosis
    Incomplete cirrhosis
    Transition to cirrhosis
    Cirrhosis, probable or definite
    Cirrhosis, NOS 7 Clinical statement of advanced/severe fibrosis or cirrhosis, AND
    Not histologically confirmed or unknown if histologically confirmed 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code 8 will result in an edit error.) 9 Not documented in medical record
    Stated in medical record that patient does not have advanced
    cirrhosis/advanced fibrosis, not histologically confirmed or
    unknown if histologically confirmed
    Fibrosis score stated but cannot be assigned to codes 0 or 1
    Fibrosis score stated but scoring system not recorded
    Fibrosis Score not assessed or unknown if assessed
3836 FIGO STAGE SSD2;2 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1) X I $D(X) D FIGO^ONCSCHMM
    MAXIMUM LENGTH: 5
  • OUTPUT TRANSFORM:  NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!
  • LAST EDITED:  AUG 23, 2021
  • HELP-PROMPT:  Answer must be 1-5 characters in length.
  • DESCRIPTION:  Federation Internationale de Gynecologie et d'Obstetrique (FIGO) is a staging system for female reproductive cancers. Rationale: FIGO stage is a Registry Data Collection Variable in AJCC for the female genital cancers.
    This data item was previously collected for the female genital cancers as: Vulva SSF #10, Vagina SSF #1, Cervix SSF #1, Corpus Carcinoma SSF #1, Corpus Sarcoma SSF #1, Ovary SSF #2, Fallopian Tube SSF #1, Peritoneum Female
    Genital SSF #1, and Placenta SSF #2.
  • EXECUTABLE HELP:  D FIGOHLP^ONCSCHMM
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3837 GESTATIONAL TROPHOBLASTIC SSD2;3 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1AN1N) X
    MAXIMUM LENGTH: 2
  • LAST EDITED:  JUL 12, 2018
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  Gestational Trophoblastic Prognostic Scoring Index, a score based on the FIGO-modified World Health Organization (WHO) Prognostic Scoring Index, is used to stratify women with gestational trophoblastic neoplasia in
    addition to the anatomical stage group. The risk score is appended to the anatomic stage. Rationale: This data item is required for prognostic stage grouping in AJCC 8th edition, Chapter 56 Gestational Trophoblastic
    Neoplasms. It was previously collected as Placenta, CS SSF # 1. Codes: 00-25 Risk factor score
    X9 Not documented in medical record
    Prognostic scoring index not assessed, or unknown if assessed
3838 GLEASON PATTERNS CLINICAL SSD2;4 POINTER TO GLEASON PATTERNS FILE (#167.2) GLEASON PATTERNS(#167.2)

  • INPUT TRANSFORM:  S DIC("S")="I 1 K ONCGPAT" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(167.2,Y,0),U,1)_" "_$P(^ONCO(167.2,Y,0),U,2)
  • LAST EDITED:  JUN 22, 2020
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Prostate cancers are graded using Gleason score or pattern. This data item represents the Gleason primary and secondary patterns from needle core biopsy or TURP. Rationale Gleason Patterns Clinical is a Registry Data
    Collection Variable for Clinical Stage for AJCC. This data item was previously collected as Prostate, CS SSF# 7.
  • SCREEN:  S DIC("S")="I 1 K ONCGPAT"
  • EXPLANATION:  Use Description field for Code X7
  • EXECUTABLE HELP:  K ONCGPAT
3839 GLEASON PATTERNS PATHOLOGICAL SSD2;5 POINTER TO GLEASON PATTERNS FILE (#167.2) GLEASON PATTERNS(#167.2)

  • INPUT TRANSFORM:  S DIC("S")="I 1 S ONCGPAT=1" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(167.2,Y,0),U,1)_" "_$S(Y=32:$P(^ONCO(167.2,Y,0),U,3),1:$P(^ONCO(167.2,Y,0),U,2))
  • LAST EDITED:  JUN 22, 2020
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Prostate cancers are graded using Gleason score or pattern. This data item represents the Gleason primary and secondary patterns from prostatectomy or autopsy. Rationale Gleason Patterns Pathological is a Registry Data
    Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 9.
  • SCREEN:  S DIC("S")="I 1 S ONCGPAT=1"
  • EXPLANATION:  Use Second Description field for Code X7
  • EXECUTABLE HELP:  S ONCGPAT=1
3840 GLEASON SCORE CLINICAL SSD2;6 SET
  • '02' FOR Gleason 2;
  • '03' FOR Gleason 3;
  • '04' FOR Gleason 4;
  • '05' FOR Gleason 5;
  • '06' FOR Gleason 6;
  • '07' FOR Gleason 7;
  • '08' FOR Gleason 8;
  • '09' FOR Gleason 9;
  • '10' FOR Gleason 10;
  • 'X7' FOR No needle core biopsy/TURP performed;
  • 'X8' FOR N/A;
  • 'X9' FOR Not documented;

  • LAST EDITED:  JUL 16, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This data item records the Gleason score based on adding the values for primary and secondary patterns in Needle Core Biopsy or TURP. Rationale: Gleason Score Clinical is a Registry Data Collection Variable for AJCC.
    This data item was previously collected as Prostate, CS SSF# 8. Codes: 02 Gleason score 2 03 Gleason score 3 04 Gleason score 4 05 Gleason score 5 06 Gleason score 6 07 Gleason score 7 08 Gleason score 8 09
    Gleason score 9 10 Gleason score 10 X7 No needle core biopsy/TURP performed X8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code X8 may result in an edit error.) X9 Not documented in medical record
    Gleason Score Clinical not assessed or unknown if assessed
3841 GLEASON SCORE PATHOLOGICAL SSD2;7 SET
  • '02' FOR Gleason 2;
  • '03' FOR Gleason 3;
  • '04' FOR Gleason 4;
  • '05' FOR Gleason 5;
  • '06' FOR Gleason 6;
  • '07' FOR Gleason 7;
  • '08' FOR Gleason 8;
  • '09' FOR Gleason 9;
  • '10' FOR Gleason 10;
  • 'X7' FOR No prostatectomy done;
  • 'X8' FOR N/A;
  • 'X9' FOR Not documented;

  • LAST EDITED:  JUL 16, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This data item records the Gleason score based on adding the values for primary and secondary patterns from prostatectomy or autopsy. Rationale: Gleason Score Pathological is a Registry Data Collection Variable for AJCC.
    This data item was previously collected as Prostate, CS SSF# 10. Codes: 02 Gleason score 2 03 Gleason score 3 04 Gleason score 4 05 Gleason score 5 06 Gleason score 6 07 Gleason score 7 08 Gleason score 8 09
    Gleason score 9 10 Gleason score 10 X7 No prostatectomy done X8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code X8 may result in an edit error.) X9 Not documented in medical record
    Gleason Score Pathological not assessed or unknown if assessed
3842 GLEASON TERTIARY PATTERN SSD2;8 SET
  • '10' FOR Tertiary pattern 1;
  • '20' FOR Tertiary pattern 2;
  • '30' FOR Tertiary pattern 3;
  • '40' FOR Tertiary pattern 4;
  • '50' FOR Tertiary pattern 5;
  • 'X7' FOR No prostatectomy/autopsy performed;
  • 'X8' FOR N/A;
  • 'X9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 16, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Prostate cancers are graded using Gleason score or pattern. This data item represents the tertiary pattern value from prostatectomy or autopsy. Rationale: Tertiary Gleason pattern on prostatectomy is a Registry Data
    Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 11. Codes: 10 Tertiary pattern 1 20 Tertiary pattern 2 30 Tertiary pattern 3 40 Tertiary pattern 4 50 Tertiary pattern 5
    X7 No prostatectomy/autopsy performed X8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code X8 may result in an edit error.) X9 Not documented in medical record
    Gleason Tertiary Pattern not assessed or unknown if assessed
3846 HCG POST-ORCHIECTOMY LAB VALUE SSD2;12 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM
    MAXIMUM LENGTH: 7
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-7 characters in length.
  • DESCRIPTION:  hCG (Human Chorionic Gonadotropin) Post-orchiectomy Lab Value refers to the lowest hCG value measured post-orchiectomy. hCG is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell tumors
    of the testis. The Post- Orchiectomy lab value is used to monitor response to therapy. Rationale: hCG (Human Chorionic Gonadotropin) Post-orchiectomy Lab Value is a Registry Data Collection Variable in AJCC. It was
    previously collected as Testis CS SSF# 14. Codes:
    0.0 0.0 milli-International Units/milliliter (mIU/mL) 0.1-99999.9 0.1-99,999.9 mIU/mL XXXXX.1 100,000 mIU/mL or greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not applicable: Information not
    collected for this case
    (If this information is required by your standard setter,
    use of code XXXXX.8 may result in an edit error.) XXXXX.9 Not documented in medical record
    No orchiectomy performed
    hCG (Human Chorionic Gonadotropin) Post-orchiectomy
    Lab Value not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3847 HCG POST-ORCHIECTOMY RANGE SSD2;13 SET
  • '0' FOR Within normal limits;
  • '1' FOR Above normal and <5000mlU;
  • '2' FOR 5000-50000mlU;
  • '3' FOR >50000mlU;
  • '4' FOR Stated to be elevated;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 17, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Human Chorionic Gonadotropin (hCG) Post-orchiectomy Range identifies the range category of the lowest hCG value measured post-orchiectomy. hCG is a serum tumor marker that is often elevated in patients with
    nonseminomatous germ cell tumors of the testis. The Post-Orchiectomy lab value is used to monitor response to therapy. Rationale: hCG (Human Chorionic Gonadotropin) is a Registry Data Collection Variable in AJCC. hCG
    (Human Chorionic Gonadotropin) Post- orchiectomy Range is used to assign the S Category Pathological and was previously collected as Testis CS SSF# 15. Codes: 0 Within normal limits 1 Above normal and less than 5,000
    milli-International
    Units/milliliter (mIU/mL) 2 5,000-50,000 mIU/mL 3 Greater than 50,000 mIU/mL 4 Post-orchiectomy human chorionic gonadotropin (hCG) stated
    to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error.) 9 Not documented in medical record
    No orchiectomy performed
    hCG (Human Chorionic Gonadotropin) Post-orchiectomy
    Range not assessed or unknown if assessed
3848 HCG PRE-ORCHIECTOMY LAB VALUE SSD2;14 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM
    MAXIMUM LENGTH: 7
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-7 characters in length.
  • DESCRIPTION:  hCG (Human Chorionic Gonadotropin) Pre-orchiectomy Lab Value refers to the hCG value measured prior to treatment. hCG is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the
    testis. Rationale: hCG (Human Chorionic Gonadotropin) Pre-orchiectomy Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Testis CS SSF# 8. Codes:
    0.0 0.0 milli-International Units/milliliter (mIU/mL) 0.1-99999.9 0.1-99,999.9 mIU/mL XXXXX.1 100,000 mIU/mL or greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not applicable: Information not
    collected for this case
    (If this information is required by your standard setter,
    use of code XXXXX.8 may result in an edit error.) XXXXX.9 Not documented in medical record
    hCG (Human Chorionic Gonadotropin) Pre-orchiectomy
    Lab Value not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3849 HCG PRE-ORCHIECTOMY RANGE SSD2;15 SET
  • '0' FOR Within normal limits;
  • '1' FOR Above normal and <5000mlU;
  • '2' FOR 5000-50000mlU;
  • '3' FOR >50000mlU;
  • '4' FOR Stated to be elevated;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 17, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Human Chorionic Gonadotropin (hCG) Pre-orchiectomy Range identifies the range category of the highest hCG value measured prior to treatment. hCG is a serum tumor marker that is often elevated in patients with
    nonseminomatous germ cell tumors of the testis. Rationale: hCG (Human Chorionic Gonadotropin) is a Registry Data Collection Variable in AJCC. hCG (Human Chorionic Gonadotropin) Pre- orchiectomy Range is used to assign the
    S Category Clinical and was previously collected as Testis CS SSF# 9. Codes: 0 Within normal limits 1 Above normal and less than 5,000 milli-International
    Units/milliliter (mIU/mL) 2 5,000 - 50,000 mIU/mL 3 Greater than 50,000 mIU/mL 4 Pre-orchiectomy human chorionic gonadotropin (hCG)
    stated to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error.) 9 Not documented in medical record
    hCG pre-orchiectomy range not assessed or unknown if assessed
3850 HER2 IHC SUMMARY SSD2;16 SET
  • '0' FOR Negative (Score 0);
  • '1' FOR Negative (Score 1+);
  • '2' FOR Equivocal (Score 2+);
  • '3' FOR Positive (Score 3+);
  • '4' FOR Stated as negative, but score not stated;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 17, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  HER2 IHC Summary is the summary score for HER2 testing by IHC. Rationale: HER2 IHC Summary is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 Negative (Score
    0) 1 Negative (Score 1+) 2 Equivocal (Score 2+)
    Stated as equivocal 3 Positive (Score 3+)
    Stated as positive 4 Stated as negative, but score not stated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code 8 will result in an edit error.) 9 Not documented in medical record
    Cannot be determined (indeterminate)
    HER2 IHC Summary not assessed or unknown if assessed
3851 HER2 ISH DUAL PROBE COPY NUM SSD2;17 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  HER2 in situ hybridization (ISH) Dual Probe Copy Number is the HER2 copy number based on a dual probe test. Rationale: HER2 ISH Dual Probe Copy Number is a Registry Data Collection Variable in AJCC. It is a new data item
    for cases diagnosed 1/1/2018+. Codes: 0.0-99.9 Reported HER2 copy number of 0.0-99.9
    XX.1 Reported HER2 copy number of 100 or greater
    XX.7 Test ordered, results not in chart
    XX.8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code XX.8 will result in an edit error.)
    XX.9 Not documented in medical record
    Cannot be determined (indeterminate)
    HER2 ISH Dual Probe Copy Number not assessed or
    unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3852 HER2 ISH DUAL PROBE RATIO SSD2;18 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 26, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  HER2 in situ hybridization (ISH) Dual Probe Ratio is the summary score for HER2 testing using a dual probe. The test will report results for both HER2 and CEP17, the latter used as a control. The HER2/CEP17 ratio is
    reported. Rationale: HER2 ISH Dual Probe Ratio is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0.0-99.9 Ratio of 0.0 to 99.9 XX.2 Less than 2.0 XX.3
    Greater than or equal to 2.0 XX.7 Test ordered, results not in chart XX.8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code XX.8 will result in an edit error.) XX.9 Not documented in medical record
    Results cannot be determined (indeterminate)
    HER2 ISH Dual Probe Ratio not assessed or
    unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3853 HER2 ISH SINGLE PROBE COPY NUM SSD2;19 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 26, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  HER2 in situ hybridization (ISH) Single Probe Copy Number is the HER2 copy number based on a single probe test. Rationale: HER2 ISH Single Probe Copy Number is a Registry Data Collection Variable in AJCC. It is a new data
    item for cases diagnosed 1/1/2018+. Codes: 0.0-99.9 Reported HER2 copy number of 0.0-99.9 XX.1 Reported HER2 copy number of 100 or greater XX.7 Test ordered, results not in chart XX.8 Not applicable: Information
    not collected for this case
    (If this item is required by your standard setter, use of
    code XX.8 will result in an edit error.) XX.9 Not documented in medical record
    Cannot be determined (indeterminate)
    HER2 ISH Single Probe Copy Number not assessed
    or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3854 HER2 ISH SUMMARY SSD2;20 SET
  • '0' FOR Negative [not amplified];
  • '2' FOR Equivocal;
  • '3' FOR Positive [amplified];
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 17, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  HER2 in situ hybridization (ISH) Summary is the summary score for results of testing for ERBB2 gene copy number by any ISH method. An immunohistochemistry (IHC) test identifies the protein expressed by the gene (ERBB2),
    and an ISH test identifies the number of copies of the gene (ERBB2) itself. Rationale: HER2 ISH Summary is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0
    Negative [not amplified] 2 Equivocal 3 Positive [amplified] 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code 8 will result in an edit error.) 9 Not documented in medical record
    Results cannot be determined (indeterminate)
    HER2 ISH Summary not assessed or unknown if assessed
3855 HER2 OVERALL SUMMARY SSD2;21 SET
  • '0' FOR HER2 negative, equivocal;
  • '1' FOR HER2 positive;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR NA;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUN 27, 2022
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  HER2 Overall Summary is a summary of results from HER2 testing. Rationale: This data item is required for prognostic stage grouping in AJCC 8th edition Chapter 48, Breast. It was previously collected as Breast, CS SSF #
    15. Codes: 0 HER2 negative; equivocal 1 HER2 positive 7 Test ordered, results not in chart 8 Not applicable/Not collected 9 Not documented in medical record
    Cannot be determined (indeterminate)
    HER2 Overall Summary status not assessed or unknown if assessed
3856 HERITABLE TRAIT SSD2;22 SET
  • '0' FOR H0-Normal RB1 alleles;
  • '1' FOR H1-RB1 gene mutation;
  • '7' FOR Test ordered, results not in chart;
  • '9' FOR HX-Not documented in medical record;

  • LAST EDITED:  JUL 23, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Heritable trait pertains to evidence that a tumor is associated with a heritable mutation. In retinoblastoma, the heritable trait is a germline mutation in the RB1 gene, which is associated with bilateral disease, family
    history of retinoblastoma, presence of concomitant CNS midline embryonic tumor (commonly in pineal region), or retinoblastoma with an intracranial primitive neuroectodermal tumor (i.e., trilateral retinoblastoma).
    Children with any of these features may be assigned the H1 status without molecular testing. High quality molecular testing for RB1 mutation is required to determine the presence or absence of RB1 mutation for children
    without clinical features of a heritable mutation. Heritable trait is required for prognostic stage grouping in AJCC 8th edition, Chapter 68 Retinoblastoma. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0
    H0: Normal RB1 alleles
    No clinical evidence of mutation 1 H1: RB1 gene mutation OR
    Clinical evidence of mutation 7 Test ordered, results not in chart 9 HX: Not documented in medical record
    Test not done, or unknown if done
    Insufficient evidence of a constitutional RB1 gene mutation
3857 HIGH RISK CYTOGENETICS SSD2;23 SET
  • '0' FOR High-risk cytogenetics not identified/not present;
  • '1' FOR High-risk cytogenetics present;
  • '5' FOR Schema Discriminator 1 coded to 1 or 9;
  • '7' FOR Test ordered, results not in chart;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUN 28, 2022
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  High Risk Cytogenetics is defined as one or more of t(4;14), t(14;16), or del 17p identified from FISH test results and is part of the staging criteria for plasma cell myeloma. Rationale: High Risk Cytogenetics is a
    prognostic factor required in AJCC 8th edition, Chapter 82 Plasma Cell Myeloma and Plasma Cell Disorders, for staging of plasma cell myeloma. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 High-risk
    cytogenetics not identified/not present 1 High-risk cytogenetics present 5 Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9 7 Test ordered, results not in chart 9 Not documented in medical
    record
    High Risk Cytogenetics not assessed or unknown if assessed
  • SCREEN:  S DIC("S")="D SCRN555^ONCSCHMM"
  • EXPLANATION:  Codes depend on appropriate schema discriminator
3858 HIGH RISK HISTOLOGIC FEATURES SSD2;24 SET
  • '0' FOR No high risk features;
  • '1' FOR Desmoplasia;
  • '2' FOR Poor differentiation (grade 3);
  • '3' FOR Sarcomatoid differentiation;
  • '4' FOR Undifferentiated (grade 4);
  • '5' FOR Multiple features;
  • '6' FOR Histologic features NOS;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 23, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  High Risk Histologic Features are defined in AJCC 8 Chapter 15 to include the terms "poor differentiation, desmoplasia, sarcomatoid differentiation, undifferentiated." High risk histologic features are a prognostic factor
    for cutaneous squamous cell carcinomas of the head and neck. Rationale: High Risk Histologic Features is a Registry Data Collection Variable in AJCC. It was previously collected as Skin, CS SSF # 12. Codes: 0 No high
    risk histologic features 1 Desmoplasia 2 Poor differentiation (grade 3) 3 Sarcomatoid differentiation 4 Undifferentiated (grade 4) 5 Multiple high risk histologic features 6 Histologic features, NOS (type of
    high risk histologic
    feature not specified) 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error) 9 Not documented in medical record
    High risk histologic features not assessed or unknown if assessed
3859 HIV STATUS SSD2;25 SET
  • '0' FOR Not associated with HIV/AIDS;
  • '1' FOR Associated with HIV/AIDS;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 23, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  HIV status refers to infection with the Human Immunodeficiency Virus which causes Acquired Immune Deficiency Syndrome (AIDS). AIDS is associated with increased risk of developing some lymphomas. Rationale: HIV status may
    be collected by the surveillance community for neoplasms (e.g., Kaposi Sarcoma, Lymphomas) that are closely related to HIV/AIDS. Prior to 2018, Lymphoma SSF#1 and Kaposi Sarcoma SSF# 1, were used for HIV Status. Codes: 0
    Not associated with Human Immunodeficiency
    Virus (HIV)/Acquired Immune Deficiency Syndrome(AIDS)
    HIV negative 1 Associated with HIV/AIDS
    HIV positive 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code 8 will result in an edit error.) 9 Not documented in medical record
    HIV status not assessed or unknown if assessed
3860 INR PROTHROMBIN TIME SSD2;26 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?0.1AN0.1"."1N) X I $D(X) D DEC1^ONCSCHMM
    MAXIMUM LENGTH: 3
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-3 characters in length.
  • DESCRIPTION:  International Normalized Ratio for Prothrombin Time (INR), an indicator of the liver's ability to make clotting factors, is required to calculate the Model for End-Stage Liver Disease (MELD) score, which is used to assign
    priority for liver transplant. Rationale: International Normalized Ratio for Prothrombin Time (INR) is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 8. Codes: 0.0
    0.0 0.1 0.1 or less 0.2-9.9 0.2 - 9.9 (Exact ratio to nearest tenth) X.1 10 or greater X.7 Test ordered, results not in chart X.8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code X.8 may result in an edit error.) X.9 Not documented in medical record
    INR (International Normalized Ratio for Prothrombin Time)
    not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3861 IPSILATERANL ADRENAL GLAND INV SSD2;27 SET
  • '0' FOR Not present/not identified;
  • '1' FOR Direct involvement (contiguous involvement);
  • '2' FOR Separate nodule (noncontiguous involvement);
  • '3' FOR Combo of 1-2;
  • '4' FOR Involvement, unk if direct or separate;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 23, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Ipsilateral adrenal gland involvement pertains to direct extension of the tumor into the ipsilateral adrenal gland (continuous) or ipsilateral adrenal gland involvement by a separate nodule (noncontiguous). Rationale:
    Ipsilateral adrenal gland involvement for Kidney is a Registry Data Collection Variable in AJCC. It was previously collected as Kidney, CS SSF #3. Codes: 0 Ipsilateral adrenal gland involvement not present/not
    identified 1 Adrenal gland involvement by direct involvement (contiguous
    involvement) 2 Adrenal gland involvement by separate nodule (noncontiguous
    involvement) 3 Combination of code 1-2 4 Ipsilateral adrenal gland involvement, unknown if direct
    involvement or separate nodule 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error.) 9 Not documented in medical record
    Ipsilateral adrenal gland not resected
    Ipsilateral adrenal gland involvement not assessed or
    unknown if assessed
    No surgical resection of primary site is performed
3862 JAK2 SSD2;28 SET
  • '0' FOR Stated as negative;
  • '1' FOR Positive for mutation V617F w or w/o other;
  • '2' FOR Positive for exon 12;
  • '3' FOR Positive for oth spec mutation;
  • '4' FOR Positive for more than 1 other than V617F;
  • '5' FOR Positive NOS;
  • '7' FOR Results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 24, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Janus Kinase 2 (JAK2, JAK 2) is a gene mutation that increases susceptibility to several myeloproliferative neoplasms (MPNs). Testing for the JAK2 mutation is done on whole blood. Nearly all people with polycythemia vera,
    and about half of those with primary myelofibrosis and essential thrombocythemia, have the mutation. JAK2 analysis continues to increase in use for hematopoietic neoplasms. Rationale: JAK2 can be collected by the
    surveillance community for myeloproliferative neoplasms. Prior to 2018, HemeRetic SSF#1 was used for JAK2. Codes: 0 JAK2 result stated as negative 1 JAK2 positive for mutation V617F WITH or WITHOUT other mutations 2
    JAK2 positive for exon 12 mutation 3 JAK2 positive for other specified mutation 4 JAK2 positive for more than one mutation other than V617F 5 JAK2 positive NOS
    Specific mutation(s) not stated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code 8 will result in an edit error.) 9 Not documented in medical record
    JAK2 not assessed or unknown if assessed
3863 KI-67 SSD2;29 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM
    MAXIMUM LENGTH: 5
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-5 characters in length.
  • DESCRIPTION:  Ki-67 (MIB-1) is a marker of cell proliferation. A high value indicates a tumor that is proliferating more rapidly. Rationale: Ki-67 (MIB-1) is a Registry Data Collection Variable in AJCC. It is a new data item for cases
    diagnosed 1/1/2018+. Codes: 0.0-100.0 0.0 to 100.0 percent positive: enter percent positive XXX.4 Ki-67 stated as less than 3% XXX.5 Ki-67 stated as 3%-20% XXX.6 Ki-67 stated as greater than 20% XXX.7 Test done,
    actual percentage not stated XXX.8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code XXX.8 will result in an edit error.) XXX.9 Not documented in medical record
    Ki-67 (MIB-1) not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3864 INVASION BEYOND CAPSULE SSD2;30 SET
  • '0' FOR Invasion beyond capsule not identified;
  • '1' FOR Perinephric (beyond renal capsule) fat or tissue;
  • '2' FOR Renal sinus;
  • '3' FOR Gerota's fascia;
  • '4' FOR Any combo of codes 1-3;
  • '5' FOR Invasion beyond capsule, NOS;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 24, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Invasion beyond capsule pertains to the pathologically confirmed invasion of the tumor beyond the fibrous capsule in which the kidney is enclosed. Rationale: Invasion beyond capsule into specific tissues for Kidney is a
    Registry Data Collection Variable in AJCC. It was previously collected as Kidney, CS SSF #1. Codes: 0 Invasion beyond capsule not identified 1 Perinephric (beyond renal capsule) fat or tissue 2 Renal sinus 3
    Gerota's fascia 4 Any combination of codes 1-3 5 Invasion beyond capsule, NOS 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error.) 9 Not documented in medical record
    Invasion beyond capsule not assessed or unknown if assessed
    No surgical resection of primary site is performed
3865 KIT GENE IMMUNOHISTOCHEMISTRY SSD2;31 SET
  • '0' FOR KIT negative,normal-within normal limits;
  • '1' FOR KIT positive;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 25, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  KIT Gene Immunohistochemistry (IHC) is the expression of the KIT gene in tumor tissue specimens based on immunohistochemical (IHC) stains. A positive test is a diagnostic and predictive marker for GIST tumors. Rationale:
    KIT Gene Immunohistochemistry (IHC) is a Registry Data Collection Variable in AJCC. This data item was previously collected for GIST schemas in CS (different SSF's). Codes: 0 KIT negative/normal; within normal limits 1
    KIT positive 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error.) 9 Not documented in medical record
    Cannot be determined by pathologist
    KIT not assessed or unknown if assessed
3866 KRAS SSD2;32 SET
  • '0' FOR Normal (wild type);
  • '1' FOR Abnormal in codons 12,13 and or 61;
  • '2' FOR Abnormal in codon 146 only;
  • '3' FOR Abnormal but not in codons 12,13,61 or 146;
  • '4' FOR Abnormal NOS, codon not specified;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 25, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  KRAS is an important signaling intermediate in the growth receptor pathway which controls cell proliferation and survival. KRAS is a protein with production controlled by the K-ras gene. When the K-ras gene is activated
    through mutation during colorectal carcinogenesis, production of KRAS continuously stimulates cell proliferation and prevents cell deaths. Activating mutations in KRAS are an adverse prognostic factor for colorectal
    carcinoma and predict a poor response to monoclonal anti-EGFR antibody therapy in advanced colorectal carcinoma. Rationale: KRAS is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and
    Rectum CS SSF# 9. Codes: 0 Normal (wild type)
    Negative for mutations 1 Abnormal (mutated) in codon(s) 12, 13 and/or 61 2 Abnormal (mutated) in codon 146 only 3 Abnormal (mutated), but not in codon(s) 12, 13, 61, or 146 4 Abnormal (mutated), NOS, codon(s)
    not specified 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error.) 9 Not documented in medical record
    KRAS not assessed or unknown if assessed
3867 LDH POST-ORCHIECTOMY RANGE SSD2;33 SET
  • '0' FOR Within normal limits;
  • '1' FOR Less than 1.5xN;
  • '2' FOR 1.5 to 10xN;
  • '3' FOR Greater than 10xN;
  • '4' FOR LDH range stated to be elevated;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 25, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  LDH (Lactate Dehydrogenase) Post-Orchiectomy Range identifies the range category of the lowest LDH value measured post-orchiectomy. LDH is a nonspecific marker for testicular cancer that is elevated in some germ cell
    tumors. The Post-Orchiectomy lab value is used to monitor response to therapy. Rationale: LDH (Lactate Dehydrogenase) is a Registry Data Collection Variable in AJCC. LDH (Lactate Dehydrogenase) Post-Orchiectomy Range is
    used to assign the S Category Pathological and was previously collected as Testis CS SSF# 16. Codes: 0 Within normal limits 1 Less than 1.5 x N
    (Less than 1.5 times the upper limit of normal for LDH) 2 1.5 to 10 x N
    (Between 1.5 and 10 times the upper limit of normal for LDH) 3 Greater than 10 x N
    (Greater than 10 times the upper limit of normal for LDH) 4 Post-Orchiectomy lactate dehydrogenase (LDH) range stated
    to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error.) 9 Not documented in medical record
    No orchiectomy performed
    LDH (Lactate Dehydrogenase) Post-Orchiectomy Range
    not assessed or unknown if assessed
3868 LDH PRE-ORCHIECTOMY RANGE SSD2;34 SET
  • '0' FOR Within normal limits;
  • '1' FOR Less than 1.5xN;
  • '2' FOR 1.5 to 10xN;
  • '3' FOR Greater than 10xN;
  • '4' FOR LDH range stated to be elevated;
  • '7' FOR Test ordered;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 25, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Lactate Dehydrogenase (LDH) Range identifies the range category of the highest LDH value measured prior to treatment. LDH is a nonspecific marker for testicular cancer that is elevated in some germ cell tumors. This data
    item refers to the Pre-Orchiectomy range. Rationale: LDH (Lactate Dehydrogenase) is a Registry Data Collection Variable in AJCC. LDH (Lactate Dehydrogenase) Pre-Orchiectomy Range is used to assign the S Category Clinical
    and was previously collected as Testis CS SSF# 10. Codes: 0 Within normal limits 1 Less than 1.5 x N
    (Less than 1.5 times the upper limit of normal for LDH) 2 1.5 to 10 x N
    (Between 1.5 and 10 times the upper limit of normal for LDH) 3 Greater than 10 x N
    (Greater than 10 times the upper limit of normal for LDH) 4 Pre-Orchiectomy lactate dehydrogenase (LDH) range stated
    to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error.) 9 Not documented in medical record
    LDH (Lactate Dehydrogenase) Pre-Orchiectomy Range
    not assessed or unknown if assessed
3869 LDH LEVEL SSD2;35 SET
  • '0' FOR Normal LDH level;
  • '1' FOR Above normal LDH level - High;
  • '5' FOR Schema Discriminator 1 coded to 1 or 9;
  • '7' FOR Test ordered, results not in chart;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUN 28, 2022
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  LDH (Lactate Dehydrogenase) is an enzyme involved in conversion of sugars to energy and present in most cells in the body. Elevated pretreatment LDH is an adverse prognostic factor for plasma cell myeloma and melanoma of
    the skin. Rationale: LDH (Lactate Dehydrogenase) Level is a prognostic factor required in AJCC 8th edition for Chapter 83 Plasma Cell Myeloma and Plasma Cell Disorders and Chapter 47 Melanoma Skin. For Plasma Cell
    Myeloma, LDH is part of the RISS Stage and is new for cases diagnosed 1/1/2018+. For Melanoma Skin, LDH is used to define the M subcategories and was previously collected as Melanoma Skin, SSF #4. Codes: 0 Normal LDH
    level
    Low, below normal 1 Above normal LDH level; High 5 Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9 7 Test ordered, results not in chart 9 Not documented in medical record
    LDH (Lactate Dehydrogenase) Pretreatment Level not assessed
    or unknown if assessed
  • SCREEN:  S DIC("S")="D SCRN555^ONCSCHMM"
  • EXPLANATION:  Codes depend on appropriate schema discriminator
3870 LDH UPPER LIMITS OF NORMAL SSD2;36 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?0.2AN1N) X I $D(X) D GEN3^ONCSCHMM
    MAXIMUM LENGTH: 3
  • LAST EDITED:  JUL 26, 2019
  • HELP-PROMPT:  Answer must be 1-3 characters in length.
  • DESCRIPTION:  LDH (Lactate Dehydrogenase), an enzyme involved in converting sugars to energy in the body, is elevated in some malignancies. LDH level is a prognostic factor for patients with Stage IV melanoma. This data Item refers to
    the Upper Limit of Normal in the laboratory test used to interpret the Serum LDH result. Rationale: LDH (Lactate Dehydrogenase) Upper Limits of Normal is a Registry Data Collection Variable in AJCC. It was previously
    collected as Melanoma Skin, CS SSF# 6. Codes: 001-999 001 - 999 upper limit of normal
    (Exact upper limit of normal) XX8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code XX8 may result in an edit error.) XX9 Not documented in medical record
    LDH Upper Limit not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3871 LN ASSESS METH FEMORAL-INGUIN SSD3;1 SET
  • '0' FOR Radiography, imaging;
  • '1' FOR Incisional biopsy, fine needle aspiration (FNA);
  • '2' FOR Lymphadenectomy;
  • '7' FOR Regional LN(s) assessed, unknown assessment method;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 26, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This data item describes the method used to assess involvement of femoral-inguinal lymph nodes associated with certain female genital cancers. Rationale: Method of assessment of regional nodal status is listed as a
    Registry Data Collection Variable in the AJCC GYN chapters. This data item was previously collected as Vulva, SSF# 15. Codes: 0 Radiography, imaging
    (Ultrasound (US), computed tomography scan (CT), magnetic
    resonance imaging (MRI), positron emission tomography scan (PET))
    Physical exam only 1 Incisional biopsy; fine needle aspiration (FNA) 2 Lymphadenectomy
    Excisional biopsy or resection with microscopic confirmation 7 Regional lymph node(s) assessed, unknown assessment method 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of code 8
    will result in an edit error.) 9 Not documented in medical record
    Regional lymph nodes not assessed or unknown if assessed
3872 LN ASSESS METHOD PARA-AORTIC SSD3;2 SET
  • '0' FOR Radiography, imaging;
  • '1' FOR Incisional biopsy, fine needle aspiration (FNA);
  • '2' FOR Lymphadenectomy;
  • '7' FOR Regional LN(s) assessed, unknown assessment method;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 26, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This data item describes the method used to assess involvement of para-aortic lymph nodes associated with certain female genital cancers. Rationale: Method of assessment of regional nodal status is listed as a Registry
    Data Collection Variable in the AJCC GYN chapters. This data item was previously collected as Vagina, CS SSF# 5. Codes: 0 Radiography, imaging
    (Ultrasound (US), computed tomography scan (CT), magnetic
    resonance imaging (MRI), positron emission tomography scan (PET))
    Physical exam only 1 Incisional biopsy; fine needle aspiration (FNA) 2 Lymphadenectomy
    Excisional biopsy or resection with microscopic confirmation 7 Regional lymph node(s) assessed, unknown assessment method 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of code 8
    will result in an edit error.) 9 Not documented in medical record
    Regional lymph nodes not assessed or unknown if assessed
3873 LN ASSESSMENT METHOD PELVIC SSD3;3 SET
  • '0' FOR Radiography, imaging;
  • '1' FOR Incisional biopsy, fine needle aspiration (FNA);
  • '2' FOR Lymphadenectomy;
  • '7' FOR Regional LN(s) assessed, unknown assessment method;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 26, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This data item describes the method used to assess involvement of pelvic lymph nodes associated with certain female genital cancers. Rationale: Method of assessment of regional nodal status is listed as a Registry Data
    Collection Variable in the AJCC GYN chapters. This data item was previously collected as Vagina, CS SSF# 3. Codes: 0 Ultrasound (US), computed tomography scan (CT), magnetic
    resonance imaging (MRI), positron emission tomography scan (PET))
    Physical exam only 1 Incisional biopsy; fine needle aspiration (FNA) 2 Lymphadenectomy
    Excisional biopsy or resection with microscopic confirmation 7 Regional lymph node(s) assessed, unknown assessment method 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of code 8 will
    result in an edit error.) 9 Not documented in medical record
    Regional lymph nodes not assessed or unknown if assessed
3874 LN DISTANT ASSESSMENT METHOD SSD3;4 SET
  • '0' FOR Radiography, imaging;
  • '1' FOR Incisional biopsy, fine needle aspiration (FNA);
  • '2' FOR Lymphadenectomy;
  • '7' FOR Distant LN(s) assessed, unknown assessment method;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 26, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This data item describes the method used to assess involvement of Distant (mediastinal, scalene) nodes associated with certain female genital cancers. Rationale: Method of assessment of distant nodal status is listed as a
    Registry Data Collection Variable in the AJCC GYN chapters. This data item was previously collected as Vagina, CS SSF# 7. Codes: 0 Radiography, imaging
    (Ultrasound (US), computed tomography scan (CT), magnetic
    resonance imaging (MRI), positron emission tomography scan (PET))
    Physical exam only 1 Incisional biopsy; fine needle aspiration (FNA) 2 Lymphadenectomy
    Excisional biopsy or resection with microscopic confirmation 7 Distant lymph node(s) assessed, unknown assessment method 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of code 8
    will result in an edit error.) 9 Not documented in medical record
    Distant lymph nodes not assessed or unknown if assessed
3875 LN DISTANT MEDIASTINAL,SCALENE SSD3;5 SET
  • '0' FOR Negative mediastinal and scalene lymph nodes;
  • '1' FOR Positive mediastinal lymph nodes;
  • '2' FOR Positive scalene lymph nodes;
  • '3' FOR Positive mediastinal and scalene lymph nodes;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 26, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This data item describes the status of Distant (mediastinal, scalene) nodes associated with certain female genital cancers. Rationale: Specific distant lymph node involvement is listed as a Registry Data Collection
    Variable in the AJCC. This data was previously collected as Vagina, CS SSF# 6. Codes: 0 Negative mediastinal and scalene lymph nodes 1 Positive mediastinal lymph nodes 2 Positive scalene lymph nodes 3 Positive
    mediastinal and scalene lymph nodes 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of code 8
    will result in an edit error.) 9 Not documented in medical record
    Mediastinal and scalene lymph nodes not assessed or
    unknown if assessed
3876 LN HEAD & NECK LEVELS I-III SSD3;6 SET
  • '0' FOR No inv of Levels I,II or III;
  • '1' FOR Level I;
  • '2' FOR Level II;
  • '3' FOR Level III;
  • '4' FOR Level I & II;
  • '5' FOR Level I & III;
  • '6' FOR Level II & III;
  • '7' FOR Levels I,II and III;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUL 26, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Lymph Nodes for Head and Neck, Levels I-III records the involvement of Levels I-III lymph nodes. Rationale: Level of nodal involvement is a Registry Data Collection Variable in AJCC for several head and neck chapters.
    This data item was previously collected as Head and Neck SSF# 3 (common SSF). Codes: 0 No involvement in Levels I, II, or III lymph nodes 1 Level I lymph node(s) involved 2 Level II lymph node(s) involved 3 Level
    III lymph node(s) involved 4 Levels I and II lymph nodes involved 5 Levels I and III lymph nodes involved 6 Levels II and III lymph nodes involved 7 Levels I, II and III lymph nodes involved 8 Not applicable:
    Information not collected for this case
    (If this item is required by your standard setter, use of code 8
    will result in an edit error) 9 Not documented in medical record
    Positive nodes, but level of positive node(s) unknown
    Lymph node levels I-III not assessed, or unknown if assessed
3877 LN HEAD & NECK LEVELS IV-V SSD3;7 SET
  • '0' FOR No inv of Levels IV or V;
  • '1' FOR Level IV;
  • '2' FOR Level V;
  • '3' FOR Levels IV & V;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 26, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Lymph Nodes for Head and Neck, Levels IV-V records the involvement of Levels IV-V lymph nodes. Rationale: Level of nodal involvement is a Registry Data Collection Variable in AJCC. This data item was previously collected
    as Head and Neck SSF# 4 (common SSF). Codes: 0 No involvement in Levels IV or V lymph nodes 1 Level IV lymph node(s) involved 2 Level V lymph node(s) involved 3 Levels IV and V lymph node(s) involved 8 Not
    applicable: Information not collected for this case
    (If this item is required by your standard setter, use of code 8
    will result in an edit error) 9 Not documented in medical record
    Positive nodes, but level of positive node(s) unknown
    Lymph node levels IV-V not assessed, or unknown if assessed
3878 LN HEAD & NECK LEVELS VI-VII SSD3;8 SET
  • '0' FOR No inv in Levels VI or VII;
  • '1' FOR Level VI;
  • '2' FOR Level VII;
  • '3' FOR Levels VI and VII;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 26, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Lymph Nodes for Head and Neck, Levels VI-VII records the involvement of Levels VI-VII lymph nodes. Rationale: Level of nodal involvement is a Registry Data Collection Variable in AJCC. This data item was previously
    collected as Head and Neck SSF# 5 (common SSF). Codes: 0 No involvement in Levels VI or VII lymph nodes 1 Level VI lymph node(s) involved 2 Level VII lymph node(s) involved 3 Levels VI and VII lymph node(s)
    involved 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code 8 will result in an edit error) 9 Not documented in medical record
    Positive nodes, but level of positive node(s) unknown
    Lymph nodes levels VI-VII not assessed, or unknown if assessed
3879 LN HEAD AND NECK OTHER SSD3;9 SET
  • '0' FOR No inv other head & neck LN regions;
  • '1' FOR Buccinator LN(s);
  • '2' FOR Parapharyngeal LN(s);
  • '3' FOR Periparotid & intraparotid LN(s);
  • '4' FOR Preauricular LN(s);
  • '5' FOR Retropharyngeal LN(s);
  • '6' FOR Suboccipital;
  • '7' FOR Any combo 1-6;
  • '8' FOR N/A;
  • '9' FOR Not;

  • LAST EDITED:  JUL 26, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Lymph Nodes for Head and Neck, Other records the involvement of lymph nodes other than Levels I-III, IV-V, and VI-VII. Rationale: Level of nodal involvement is a Registry Data Collection Variable in AJCC. This data item
    was previously collected as Head and Neck SSF# 6 (common SSF). Codes: 0 No involvement in other head and neck lymph node regions 1 Buccinator (facial) lymph node(s) involved 2 Parapharyngeal lymph node(s) involved 3
    Periparotid and intraparotid lymph node(s) involved 4 Preauricular lymph node(s) involved 5 Retropharyngeal lymph node(s) involved 6 Suboccipital/retroauricular lymph node(s) involved 7 Any combination of codes
    1-6 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of code 8
    will result in an edit error.) 9 Not documented in medical record
    Positive nodes, but level of positive node(s) unknown
    Other Head and Neck lymph nodes not assessed,
    or unknown if assessed
3880 LN ISOLATED TUMOR CELLS (ITC) SSD3;10 SET
  • '0' FOR Regional lymph nodes negative for ITCs;
  • '1' FOR Regional lymph nodes positive;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUL 26, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Lymph Nodes Isolated Tumor Cells (ITC), the presence of isolated tumor cells in regional lymph node(s) that may be detected by hematoxylin and eosin or by immunohistochemical staining, is a potential prognostic factor for
    Merkel Cell Carcinoma. Rationale: Regional lymph nodes positive for ITCs (Tumor cell clusters not greater than 0.2 millimeter (mm)) Codes: 0 Regional lymph nodes negative for ITCs 1 Regional lymph nodes positive for
    ITCs
    (Tumor cell clusters not greater than 0.2 millimeter (mm)) 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error.) 9 Not documented in medical record
    ITCs not assessed or unknown if assessed
3881 LN LATERALITY SSD3;11 SET
  • '0' FOR No regional lymph node involvement;
  • '1' FOR Unilateral;
  • '2' FOR Bilateral;
  • '3' FOR Laterality unknown;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  AUG 07, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This data item describes whether positive regional lymph nodes are unilateral or bilateral. Rationale: Laterality of regional node metastasis is a Registry Data Collection Variable in AJCC. This data item was previously
    collected as Vulva, CS SSF# 11. Codes: 0 No regional lymph node involvement 1 Unilateral - all positive regional nodes with same laterality OR
    only one regional node positive 2 Bilateral - positive bilateral regional lymph nodes 3 Laterality unknown - positive regional lymph nodes with
    unknown laterality 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error.) 9 Not documented in medical record
    Lymph node laterality not assessed or unknown if assessed
3882 LN POSITIVE AXILLARY LVL I-II SSD3;12 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  JUL 26, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  This data item pertains to the number of positive ipsilateral level I and II axillary lymph nodes and intramammary lymph nodes based on pathological information. Rationale: Lymph Nodes Positive Axillary Level I-II can be
    collected by the surveillance community for breast cancers. Prior to 2018, Breast SSF#3 was used for Lymph Nodes Positive Axillary Level I-II. Codes: 00 All ipsilateral axillary nodes examined negative 01-99 1 - 99
    nodes positive
    (Exact number of nodes positive) X1 100 or more nodes positive X5 Positive nodes, number unspecified X6 Positive aspiration or needle core biopsy of lymph node(s) X8 Not applicable: Information not
    collected for this case
    (If this item is required by your standard setter,
    use of code X8 will result in an edit error.) X9 Not documented in medical record
    Level I-II axillary nodes not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3883 LN SIZE SSD3;13 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  Lymph Nodes Size records diameter of the involved regional lymph node(s) with the largest diameter of any involved regional lymph node(s). Pathological measurement takes precedence over a clinical measurement for the same
    node. Rational: Lymph Nodes Size is a Registry Data Collection Variable in AJCC for several chapters. It was previously collected in the Head and Neck chapters as Size of Lymph Nodes, SSF# 1 Codes: 0.0 No involved
    regional nodes 0.1-99.9 0.1-99.9 millimeters (mm)
    (Exact size of lymph node to nearest tenth of a mm) XX.1 100 millimeters (mm) or greater XX.2 Microscopic focus or foci only and no size of focus given XX.3 Described as "less than 1 centimeter (cm)" XX.4
    Described as "at least" 2 cm XX.5 Described as "at least" 3 cm XX.6 Described as "at least" 4 cm XX.7 Described as greater than 5 cm XX.8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code XX.8 will result in an edit error) XX.9 Not documented in medical record
    Regional lymph node(s) involved, size not stated
    Lymph Nodes Size not assessed, or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3884 LN STATUS FEM-ING,PAR-AOR,PLV SSD3;14 POINTER TO ONCO LN STATUS FILE (#167.3) ONCO LN STATUS(#167.3)

  • OUTPUT TRANSFORM:  S:Y'="" Y=$P(^ONCO(167.3,Y,0),U,1)_" "_$P(^ONCO(167.3,Y,0),U,2)
  • LAST EDITED:  NOV 07, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This data item describes the status of femoral-inguinal, para-aortic and pelvic lymph nodes associated with certain female genital cancers. Rationale: Specific regional lymph node involvement is listed as a Registry Data
    Collection Variable in AJCC. This information was previously collected as Vagina, CS SSF# 2 and CS SSF# 4 Codes: 0 Negative femoral-inguinal, para-aortic and pelvic lymph nodes 1 Positive femoral-inguinal lymph nodes 2
    Positive para-aortic lymph nodes 3 Positive pelvic lymph nodes 4 Positive femoral-inguinal and para-aortic lymph nodes 5 Positive femoral-inguinal and pelvic lymph nodes 6 Positive para-aortic and pelvic lymph
    nodes 7 Positive para-aortic, pelvic, and femoral-inguinal lymph nodes 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error.) 9 Not documented in medical record
    Femoral-Inguinal, Para-aortic and Pelvic lymph nodes
    not assessed or unknown if assessed
3885 LYMPHOCYTOSIS SSD3;15 SET
  • '0' FOR Not present, count LT or EQ 5000;
  • '1' FOR Present, count > 5000;
  • '5' FOR NA, not C421;
  • '6' FOR Lab value unk, physician states lymphocytosis present;
  • '7' FOR Test ordered, results not in chart;
  • '9' FOR Not documented;

  • LAST EDITED:  MAY 09, 2023
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Lymphocytosis is defined by an excess of lymphocytes in the blood. In staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), lymphocytosis is defined as an absolute lymphocyte count (ALC) greater
    than 5,000 cells/µL. Rationale: Lymphocytosis is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) in AJCC 8th edition, Chapter 79 Hodgkin and Non-Hodgkin
    Lymphomas. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 Lymphocytosis not present
    Absolute lymphocyte count <= 5,000 cells/ µL 1 Lymphocytosis present
    Absolute lymphocyte count > 5,000 cells/µL 5 Not applicable: Primary site is not C421 6 Lab value unknown, physician states lymphocytosis is present
    Physician states RAI stage 0-IV 7 Test ordered, results not in chart 9 Not documented in medical record
    Lymphocytosis not assessed or unknown if assessed
  • SCREEN:  S DIC("S")="D SCRNFIV^ONCSCHMM"
  • EXPLANATION:  Codes depend on appropriate primary site
3886 MAJOR VEIN INVOLVEMENT SSD3;16 SET
  • '0' FOR Not present or not identified;
  • '1' FOR Renal vein or its segmental branches;
  • '2' FOR Inferior vena cava (IVC);
  • '3' FOR Major vein invasion, NOS;
  • '4' FOR Any combination of codes 1-3;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  AUG 14, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Major vein involvement pertains to the invasion of the kidney tumor into major veins. Rationale: Involvement of major veins for Kidney is a Registry Data Collection Variable in AJCC. It was previously collected as Kidney,
    CS SSF #2. Codes: 0 Major vein involvement not present/not identified 1 Renal vein or its segmental branches 2 Inferior vena cava (IVC) 3 Major vein invasion, NOS 4 Any combination of codes 1-3 8 Not
    applicable: Information not collected for this case
    (If this information is required by your standard setter, use of
    code 8 may result in an edit error.) 9 Not documented in medical record
    Vein involvement not assessed or unknown if assessed
    No surgical resection of primary site is performed
3887 MEASURED BASAL DIAMETER SSD3;17 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  Measured Basal Diameter, the largest basal diameter of a uveal melanoma, is a prognostic indicator for this tumor. Rationale: Measured Basal Diameter is listed as a Registry Data Collection Variable in AJCC. It was
    previously collected as Uveal Melanoma, CS SSF# 2. Codes: 0.0 No mass/tumor found 0.1-99.9 0.1-99.9 millimeters (mm)
    (Exact measurement to nearest tenth of mm) XX.0 100 millimeters (mm) or larger XX.1 Described as "less than 3 mm" XX.2 Described as "at least" 3 mm XX.3 Described as "at least" 6 mm XX.4 Described as
    "at least" 9 mm XX.5 Described as "at least" 12 mm XX.6 Described as "at least" 15 mm XX.8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code XX.8 may result in an edit error.) XX.9 Not documented in medical record
    Cannot be determined by pathologist
    Measured Basal Diameter not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3888 MEASURED THICKNESS SSD3;18 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  Measured Thickness, or height, of a uveal melanoma, is a prognostic indicator for this tumor. Rationale: Measured Thickness is listed as a Registry Data Collection Variable in AJCC. It was previously collected as Uveal
    Melanoma, CS SSF# 3. Codes: 0.0 No mass/tumor found 0.1-99.9 0.1-99.9 millimeters (mm)
    (Exact measurement to nearest tenth of mm) XX.0 100 millimeters (mm) or larger XX.1 Described as "less than 3 mm" XX.2 Described as "at least" 3 mm XX.3 Described as "at least" 6 mm XX.4 Described as
    "at least" 9 mm XX.5 Described as "at least" 12 mm XX.6 Described as "greater than" 15 mm XX.8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code XX.8 may result in an edit error.) XX.9 Not documented in medical record
    Cannot be determined
    Measured Thickness not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3889 METHYLATION OF MGMT SSD3;19 SET
  • '0' FOR Absent or not present, unmethylated MGMT;
  • '1' FOR Present, low level;
  • '2' FOR Present, high level;
  • '3' FOR Present, level unspecified;
  • '6' FOR Benign or borderline tumor;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  AUG 14, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  O6-Methylguanine-Methyltransferase (MGMT) is an enzyme in cells that repairs DNA. Methylation of the MGMT gene reduces production of MGMT enzyme and the ability of tumor cells to repair damage caused by chemotherapy.
    Methylation of MGMT is a prognostic and predictive factor for high grade gliomas. Rationale: Methylation of O6-Methylguanine-Methyltransferase (MGMT) is a Registry Data Collection Variable in AJCC. It was previously
    collected as Brain, CS SSF #4. Codes: 0 MGMT methylation absent/not present, unmethylated MGMT 1 MGMT methylation present, low level
    Hypomethylated
    Partial methylated 2 MGMT methylation present, high level
    Hypermethylated 3 MGMT Methylation present, level unspecified 6 Benign or borderline tumor 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code 8 will result in an edit error.) 9 Not documented in patient record
    Cannot be determined by the pathologist
    MGMT not assessed or unknown if assessed
3890 MICROSATELLITE INSTABILITY SSD3;20 SET
  • '0' FOR Microsatellite instability (MSI) stable, microsatellite stable (MSS), negative NOS;
  • '1' FOR MSI unstable low (MSI-L);
  • '2' FOR MSI unstable high (MSI-H);
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  AUG 14, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Microsatellite Instability (MSI) is a form of genetic instability manifested by changes in the length of repeated single- to six-nucleotide sequences (known as DNA microsatellite sequences). High MSI, found in about 15% of
    colorectal carcinomas, is an adverse prognostic factor for colorectal carcinomas and predicts poor response to 5-FU chemotherapy (although the addition of oxaliplatin in FOLFOX regimens negates the adverse effects [page
    266 AJCC manual]). High MSI is a hallmark of hereditary nonpolyposis colorectal carcinoma, also known as Lynch syndrome. Rationale: Microsatellite Instability (MSI) is a Registry Data Collection Variable in AJCC. It was
    previously collected as Colon and Rectum, CS SSF# 7. Codes: 0 Microsatellite instability (MSI) stable;
    microsatellite stable (MSS); negative NOS
    AND/OR Mismatch repair (MMR) intact, no loss of nuclear expression of MMR proteins 1 MSI unstable low (MSI-L) 2 MSI unstable high (MSI-H)
    AND/OR
    MMR-D (loss of nuclear expression of one or more MMR proteins,
    MMR protein deficient) 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error.) 9 Not documented in medical record
    MSI-indeterminate
    Microsatellite instability not assessed or unknown if assessed
3891 MICROVASCULAR DENSITY SSD3;21 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  JUL 26, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  Microvascular Density (MVD), a quantitative measure of tumor vascularity, is a prognostic factor for uveal melanoma. Rationale: Microvascular Density (MVD), is a Registry Data Collection Variable in AJCC. This data item
    was previously collected as Uveal Melanoma, CS SSF# 13. Codes: 00 No vessels involved 01-99 01-99 vessels per 0.3 square millimeter (mm2) X1 Greater than or equal to 100 vessels per 0.3 square millimeter (mm2) X2
    Lowest quartile for laboratory X3 Second quartile for laboratory X4 Third quartile for laboratory X5 Highest quartile for laboratory X7 Test ordered, results not in chart X8 Not applicable: Information not
    collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error.) X9 Not documented in medical record
    Microvascular Density (MVD) not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3892 MITOTIC COUNT UVEAL MELANOMA SSD3;22 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  Mitotic Count Uveal Melanoma, the number of mitoses per 40 high-power fields (HPF) based on pathological evaluation, is a prognostic factor for uveal melanoma. Rationale: Mitotic Count Uveal Melanoma is listed as a
    Registry Data Collection Variable in AJCC. It was previously collected as Uveal Melanoma, CS SSF# 9. Codes: 0.0 0 mitoses per 40 high-power fields (HPF)
    Mitoses absent, no mitoses present, no mitotic activity 0.1-99.9 0.1-99.9 mitosis per 40 HPF XX.1 100 or more mitoses per 40 HPF XX.2 Stated as low mitotic count or rate with no specific number XX.3 Stated
    as high mitotic count or rate with no specific number XX.4 Mitotic count described with denominator other than 40 HPF XX.7 Test ordered, results not in chart XX.8 Not applicable: Information not collected for this
    case
    (If this information is required by your standard setter,
    use of code XX.8 may result in an edit error.) XX.9 Not documented in medical record
    Mitotic Count Uveal Melanoma not assessed or
    unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3893 MITOTIC RATE MELANOMA SSD3;23 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  JUL 26, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  Mitotic Rate Melanoma, the number of mitoses per square millimeter based on pathological evaluation, is a prognostic factor for melanoma of the skin. Rationale: Mitotic Rate Melanoma is a Registry Data Collection Variable
    in AJCC. It was previously collected as Melanoma Skin, CS SSF# 7. Codes: 00 0 mitoses per square millimeter (mm)
    Mitoses absent
    No mitoses present 01-99 1 - 99 mitoses/square mm
    (Exact measurement in mitoses/square mm) X1 100 mitoses/square mm or more X2 Stated as "less than 1 mitosis/square mm"
    Stated as "nonmitogenic" X3 Stated as "at least 1 mitosis/square mm"
    Stated as "mitogenic" X4 Mitotic rate described with denominator other
    than square millimeter (mm) X7 Test ordered, results not in chart X8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code X8 may result in an edit error.) X9 Not documented in medical record
    Mitotic Rate Melanoma not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3894 MULTIGENE SIGNATURE METHOD SSD3;24 SET
  • '1' FOR Mammaprint;
  • '2' FOR PAM50 (Prosigna);
  • '3' FOR Breast Cancer Index;
  • '4' FOR EndoPredict;
  • '5' FOR Test performed, type of test unknown;
  • '6' FOR Multiple tests, any test in codes 1-4;
  • '7' FOR Test ordered;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  AUG 14, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Multigene signatures or classifiers are assays of a panel of genes from a tumor specimen, intended to provide a quantitative assessment of the likelihood of response to chemotherapy and to evaluate prognosis or the
    likelihood of future metastasis. This data item identifies the multigene signature method used. Oncotype Dx is coded elsewhere. Rationale: Multigene Signature Method is a Registry Data Collection Variable in AJCC. It was
    previously collected as Breast, CS SSF #22. See also Multigene Signature Results. Codes: 1 Mammaprint 2 PAM50 (Prosigna) 3 Breast Cancer Index 4 EndoPredict 5 Test performed, type of test unknown 6 Multiple
    tests, any tests in codes 1-4 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code 8 will result in an edit error.) 9 Not documented in medical record
    Multigene Signature Method not assessed or unknown if assessed
3895 MULTIGENE SIGNATURE RESULTS SSD3;25 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  JUL 26, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  Multigene signatures or classifiers are assays of a panel of genes from a tumor specimen, intended to provide a quantitative assessment of the likelihood of response to chemotherapy and to evaluate prognosis or the
    likelihood of future metastasis. This data item identified the multigene signature result. Oncotype Dx is coded elsewhere. Rationale: Multigene Signature Results is a Registry Data Collection Variable in AJCC. It was
    previously collected as Breast, CS SSF #23. See also Multigene Signature Method. Codes: 00-99 Enter actual recurrence score
    Note: Depending on the test, the range of values
    may be different X1 Score 100 X2 Low risk X3 Moderate [intermediate] risk X4 High risk X7 Test ordered, results not in chart X8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code X8 will result in an edit error.) X9 Not documented in medical record
    Multigene Signature Results not assessed or
    unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3896 NCCN IPI SSD3;26 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  JUL 26, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  The NCCN International Prognostic Index (IPI) (previously only "IPI") is used to define risk groups for specific lymphomas using a 0-5 score range, based on age, stage, number of extranodal sites of involvement, patient's
    performance status and pretreatment LDH level. Rationale: NCCN International Prognostic Index (IPI) is a Registry Data Collection Variable in AJCC. It was previously collected for Lymphomas, SSF# 3. Codes: 00-08 0-8
    points X1 Stated as low risk (0-1 point) X2 Stated as low intermediate risk (2-3 points) X3 Stated as intermediate risk (4-5 points) X4 Stated as high risk (6-8 points) X8 Not applicable: Information not
    collected for this case
    (If this item is required by your standard setter,
    use of code X8 will result in an edit error.) X9 Not documented in medical record
    NCCN International Prognostic Index (IPI) not assessed
    or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3897 NUMBER OF CORES EXAMINED SSD3;27 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  MAY 11, 2020
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  This data item represents the number of cores examined as documented in the pathology report from needle biopsy of the prostate gland. Rationale: Number of Cores Examined is a Registry Data Collection Variable for AJCC.
    This data item was previously collected as Prostate, CS SSF# 13. Codes: 01-99 1 - 99 cores examined
    (Exact number of cores examined) X1 100 or more cores examined X6 Biopsy cores examined, number unknown X7 No needle core biopsy performed X8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code X8 may result in an edit error.) X9 Not documented in medical record
    Number of cores examined not assessed
    or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3898 NUMBER OF CORES POSITIVE SSD3;28 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  MAY 11, 2020
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  This data item represents the number of positive cores documented in the pathology report from needle biopsy of the prostate gland. Rationale: Number of Cores Positive is a Registry Data Collection Variable for AJCC. This
    data item was previously collected as Prostate, CS SSF# 12. Codes: 00 All examined cores negative 01-99 1 - 99 cores positive
    (Exact number of cores positive) X1 100 or more cores positive X6 Biopsy cores positive, number unknown X7 No needle core biopsy performed X8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code X8 may result in an edit error.) X9 Not documented in medical record
    Number of Cores Positive not assessed
    or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3899 NUM OF EXAMINED PARA-AORTIC SSD3;29 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  JUL 26, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  Number of examined para-aortic nodes is the number of nodes examined based on para-aortic nodal dissection. Rationale: Number of Examined Para-aortic Nodes is listed as a Registry Data Collection Variable in AJCC. This
    data item was previously collected as Corpus, CS SSF# 6. Codes: 00 No para-aortic nodes examined 01-99 1 - 99 para-aortic nodes examined
    (Exact number of para-aortic lymph nodes examined) X1 100 or more para-aortic nodes examined X2 Para-aortic nodes examined, number unknown X6 No para-aortic lymph nodes removed, but
    aspiration or core biopsy of para-aortic node(s) only X8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code X8 will result in an edit error.) X9 Not documented in medical record
    Cannot be determined, indeterminate if positive
    para-aortic nodes present
    Para-aortic lymph nodes not assessed
    or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3900 NUM OF EXAMINED PELVIC NODES SSD3;30 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  JUL 26, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  Number of examined pelvic nodes is the number of nodes examined based on pelvic nodal dissection. Rationale: Number of Examined Pelvic Nodes is listed as a Registry Data Collection Variable in AJCC. This data item was
    previously collected as Corpus, CS SSF# 4. Codes: 00 No pelvic lymph nodes examined 01-99 1 - 99 pelvic lymph nodes examined
    (Exact number of pelvic lymph nodes examined) X1 100 or more pelvic nodes examined X2 Pelvic nodes examined, number unknown X6 No pelvic lymph nodes removed, but aspiration or core
    biopsy of pelvic node(s) only X8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code X8 will result in an edit error.) X9 Not documented in medical record
    Cannot be determined, indeterminate if positive pelvic
    nodes present
    Pelvic lymph nodes not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3901 NUM OF POS PARA-AORTIC NODES SSD3;31 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  JUL 26, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  Number of Positive Para-Aortic Nodes is the number of positive nodes based on para-aortic nodal dissection Rationale: Number of Positive Para-aortic Nodes is listed as a Registry Data Collection Variable in AJCC. This data
    item was previously collected as Corpus, CS SSF# 5. Codes: 00 All para-aortic lymph nodes examined negative 01-99 1-99 para-aortic lymph nodes positive
    (Exact number of nodes positive) X1 100 or more para-aortic nodes positive X2 Positive para-aortic nodes identified, number unknown X6 Positive aspiration or core biopsy of para-aortic lymph node(s) X8 Not
    applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code X8 will result in an edit error.) X9 Not documented in medical record
    Cannot be determined, indeterminate if positive
    para-aortic nodes present
    Para-aortic lymph nodes not assessed
    or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3902 NUM OF POSITIVE PELVIC NODES SSD3;32 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  JUL 26, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  Number of Positive Pelvic Nodes is the number of positive nodes based on pelvic nodal dissection. Rationale: Number of Positive Pelvic Nodes is listed as a Registry Data Collection Variable in AJCC. This data item was
    previously collected as Corpus, CS SSF# 3. Codes: 00 All pelvic nodes examined negative 01-99 1 - 99 pelvic nodes positive
    (Exact number of nodes positive) X1 100 or more pelvic nodes positive X2 Positive pelvic nodes identified, number unknown X6 Positive aspiration or core biopsy of pelvic lymph node(s) X8 Not applicable:
    Information not collected for this case
    (If this item is required by your standard setter,
    use of code X8 will result in an edit error.) X9 Not documented in medical record
    Cannot be determined, indeterminate if positive
    pelvic nodes present
    Pelvic lymph nodes not assessed
    or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3903 ONCOTYPE DX RECUR SCORE-DCIS SSD3;33 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?0.2AN1N) X I $D(X) D GEN3^ONCSCHMM
    MAXIMUM LENGTH: 3
  • LAST EDITED:  JUL 26, 2019
  • HELP-PROMPT:  Answer must be 1-3 characters in length.
  • DESCRIPTION:  Oncotype Dx Recurrence Score-DCIS is a numeric score of a genomic test to predict the risk of local recurrence of breast cancer based on the assessment of 12 genes. Rationale: Oncotype Dx Recurrence Score-DCIS is a
    Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0-100 Enter actual recurrence score between 0 and 100 XX6 Not applicable: invasive case XX7 Test ordered,
    results not in chart XX8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code XX8 will result in an edit error.) XX9 Not documented in medical record
    Oncotype Dx Recurrence Score-DCIS not assessed
    or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3904 ONCOTYPE DX REC SCORE-INVASIVE SSD3;34 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?0.2AN1N) X I $D(X) D GEN3^ONCSCHMM
    MAXIMUM LENGTH: 3
  • LAST EDITED:  JUL 26, 2019
  • HELP-PROMPT:  Answer must be 1-3 characters in length.
  • DESCRIPTION:  Oncotype Dx Recurrence Score-Invasive is a numeric score of a genomic test to predict the likelihood of distant recurrence of invasive breast cancer based on the assessment of 21 genes. Rationale: Oncotype Dx Recurrence
    Score-Invasive is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0-100 Enter actual recurrence score between 0 and 100 XX4 Stated as less than 11 XX5 Stated
    as equal to or greater than 11 XX6 Not applicable: in situ case XX7 Test ordered, results not in chart XX9 Not documented in medical record
    Oncotype Dx Recurrence Score-Invasive not assessed
    or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3905 ONCOTYPE DX RISK LEVEL-DCIS SSD4;1 SET
  • '0' FOR Low risk;
  • '1' FOR Intermediate risk;
  • '2' FOR High risk;
  • '6' FOR Not applicable, invasive case;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  AUG 15, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Oncotype Dx Risk Level-DCIS stratifies Oncotype Dx recurrence scores into low, intermediate, and high risk of local recurrence. Rationale: Oncotype Dx Risk Level-DCIS is a Registry Data Collection Variable in AJCC. It is
    a new data item for cases diagnosed 1/1/2018+. Codes: 0 Low risk (recurrence score 0-38) 1 Intermediate risk (recurrence score 39-54) 2 High risk (recurrence score greater than or equal to 55) 6 Not applicable:
    invasive case 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code 8 will result in an edit error.) 9 Not documented in medical record
    Oncotype Dx Risk Level-DCIS not assessed or unknown if assessed
3906 ONCOTYPE DX RISK LEVEL-INVAS SSD4;2 SET
  • '0' FOR Low risk;
  • '1' FOR Intermediate risk;
  • '2' FOR High risk;
  • '6' FOR Not applicable, DCIS case;
  • '7' FOR Test done, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  AUG 15, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Oncotype Dx Risk Level-Invasive stratifies Oncotype Dx recurrence scores into low, intermediate, and high risk of distant recurrence. Rationale: Oncotype Dx Risk Level-Invasive is a Registry Data Collection Variable in
    AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 Low risk (recurrence score 0-17) 1 Intermediate risk (recurrence score 18-30) 2 High risk (recurrence score greater than or equal to 31) 6 Not
    applicable: DCIS case 7 Test done, results not in chart 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code 8 will result in an edit error.) 9 Not documented in medical record
    Oncotype Dx Risk Level-Invasive not assessed or unknown if assessed
3907 ORGANOMEGALY SSD4;3 SET
  • '0' FOR Organomegaly of liver and/or spleen not present;
  • '1' FOR Organomegaly of liver and/or spleen present;
  • '5' FOR NA, site not C421;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUN 27, 2022
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Organomegaly is defined as presence of enlarged liver and/or spleen on physical examination and is part of the staging criteria for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). Rationale:
    Organomegaly is a prognostic factor required for staging of CLL/SLL in AJCC 8th edition, Chapter 79 Hodgkin and Non-Hodgkin Lymphomas. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 Organomegaly of liver
    and/or spleen not present 1 Organomegaly of liver and/or spleen present 5 Not applicable: Primary site is not C421 9 Not documented in medical record
    Organomegaly not assessed or unknown if assessed
  • SCREEN:  S DIC("S")="D SCRNFIV^ONCSCHMM"
  • EXPLANATION:  Codes depend on appropriate site
3908 PERCENT NECROSIS PST NEOADJVNT SSD4;4 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM
    MAXIMUM LENGTH: 5
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-5 characters in length.
  • DESCRIPTION:  Percent Necrosis Post Neoadjuvant is a prognostic factor for bone sarcomas. Rationale Percent Necrosis Post Neoadjuvant is a Registry Data Collection Variable for AJCC. It was previously collected as Bone, CS SSF# 3.
    Codes 0.0 Tumor necrosis not identified/not present 0.1-100.0 0.1-100.0 percent tumor necrosis
    (Percentage of tumor necrosis to nearest tenth of a percent) XXX.2 Tumor necrosis present, percent not stated XXX.8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code XXX.8 will result in an edit error.) XXX.9 Not documented in medical record
    No histologic examined of primary site
    No neoadjuvant therapy
    No surgical resection of primary site is performed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3909 PERINEURAL INVASION 2018 SSD4;5 SET
  • '0' FOR Perineural invasion not identified/not present;
  • '1' FOR Perineural invasion identified/present;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  AUG 15, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Perineural Invasion, within or adjacent to the primary tumor, is a negative prognostic factor for cutaneous squamous cell carcinomas of the head and neck and carcinomas of the colon and rectum, eyelid and lacrimal gland.
    Rationale: Perineural Invasion is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum CS SSF# 8 and Lacrimal Gland CS SSF# 4. Codes: 0 Perineural invasion not identified/not
    present 1 Perineural invasion identified/present 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error.) 9 Not documented in medical record
    Pathology report does not mention perineural invasion
    Cannot be determined by the pathologist
    Perineural invasion not assessed or unknown if assessed
3910 PERIPHERAL BLOOD INVOLV 2018 SSD4;6 POINTER TO ONCO PERIPHERAL BLOOD INVOLVEMENT FILE (#167.4) ONCO PERIPHERAL BLOOD INVOLVEMENT(#167.4)

  • LAST EDITED:  AUG 15, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Peripheral blood involvement, summarized in "B category", refers to the percentage of peripheral blood lymphocytes that are atypical (Sezary) cells and whether they are "Clone negative" or "Clone positive". Rationale:
    Peripheral blood involvement is a prognostic factor required in AJCC 8th edition, Chapter 81 Primary Cutaneous Lymphomas, for staging of Mycosis Fungoides and Sezary Syndrome. It was previously collected as Mycosis
    Fungoides, CS SSF #1. Codes: 0 Absence of significant blood involvement
    5% or less of peripheral blood lymphocytes are atypical (Sezary) cells
    Clone unknown
    Stated as B0 1 Absence of significant blood involvement
    5% or less of peripheral blood lymphocytes are atypical (Sezary) cells
    Clone negative
    Stated as B0a 2 Absence of significant blood involvement:
    5% or less of peripheral blood lymphocytes are atypical (Sezary) cells
    Clone positive
    Stated as B0b 3 Low blood tumor burden
    More than 5% of peripheral blood lymphocytes are
    atypical (Sezary) cells but does not meet the criteria of B2
    Clone unknown
    Stated as B1 4 Low blood tumor burden
    More than 5% of peripheral blood lymphocytes are
    atypical (Sezary) cells but does not meet the criteria of B2
    Clone negative
    Stated as B1a 5 Low blood tumor burden
    More than 5% of peripheral blood lymphocytes are
    atypical (Sezary) cells but does not meet the criteria of B2
    Clone positive
    Stated as B1b 6 High blood tumor burden
    Greater than or equal to 1000 Sezary cells per microliter (uL)
    Clone positive
    Stated as B2 7 Test ordered, results not in chart 9Not documented in medical record
    Peripheral Blood Involvement not assessed or unknown if assessed
3911 PERITONEAL CYTOLOGY SSD4;7 SET
  • '0' FOR Negative for malignancy;
  • '1' FOR Atypical and/or suspicious;
  • '2' FOR Malignant (positive for malignancy);
  • '3' FOR Unsatisfactory/nondiagnostic;
  • '7' FOR Test order, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  AUG 16, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Peritoneal cytology pertains to the results of cytologic examination for malignant cells performed on fluid that is obtained from the peritoneal cavity. Rationale: Peritoneal Cytology is listed as a Registry Data
    Collection Variable in AJCC. This data item was previously collected as Corpus, CS SSF# 2. Codes: 0 Peritoneal cytology/washing negative for malignancy 1 Peritoneal cytology/washing atypical and/or suspicious 2
    Peritoneal cytology/washing malignant (positive for malignancy) 3 Unsatisfactory/nondiagnostic 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code 8 will result in an edit error.) 9 Not documented in medical record
    Peritoneal cytology not assessed or unknown if assessed
3913 PLEURAL EFFUSION SSD4;8 SET
  • '0' FOR Not identified/not present;
  • '1' FOR Present, non-malignant (negative);
  • '2' FOR Present, malignant (positive);
  • '3' FOR Atypical mesothelial cells;
  • '4' FOR Pleural effusion, NOS;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  AUG 16, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Pleural effusion is the accumulation of fluid between the parietal pleura (the pleura covering the chest wall and diaphragm) and the visceral pleura (the pleura covering the lungs). Rationale: Pleural Effusion is
    collected by the surveillance community for pleura cancers. Prior to 2018, Pleura SSF #1 was used for Pleural Effusion. Codes: 0 Pleural effusion not identified/not present 1 Pleural effusion present, non-malignant
    (negative) 2 Pleural effusion present, malignant (positive) 3 Pleural effusion, atypical/atypical mesothelial cells 4 Pleural effusion, NOS 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code 8 will result in an edit error.) 9 Not documented in medical record
    Pleural Effusion not assessed or unknown if assessed
3914 PR PERCENT POSITIVE SSD4;9 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3AN) X I $D(X) D ERR^ONCSCHMM
    MAXIMUM LENGTH: 3
  • LAST EDITED:  JUN 25, 2020
  • HELP-PROMPT:  Answer must be 1-3 characters in length.
  • DESCRIPTION:  Progesterone Receptor, Percent Positive or Range is the percent of cells staining progesterone receptor positive measured by IHC. Rationale: Progesterone Receptor, Percent Positive or Range is a Registry Data Collection
    Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 000 PR negative, or stated as less than 1% 001-100 1-100 percent R10 Stated as 1-10% R20 Stated as 11-20% R30 Stated as 21-30% R40
    Stated as 31-40% R50 Stated as 41-50% R60 Stated as 51-60% R70 Stated as 61-70% R80 Stated as 71-80% R90 Stated as 81-90% R99 Stated as 91-100% XX8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code XX8 will result in an edit error.) XX9 Not documented in medical record
    PR (Progesterone Receptor) Percent Positive or
    Range not assessed or unknown if assessed Notes: -Physician statement of PR (Progesterone Receptor) Percent Positive or
    Range can be used to code this data item. -Code this data item using the same report used to record PR Summary. -If PR negative, or percentage less than 1%, code 000. -The actual PR (1-100%) percent takes priority
    over the range codes. -If PR positive but percentage unknown, code XX9.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3915 PR SUMMARY SSD4;10 SET
  • '0' FOR PR negative;
  • '1' FOR PR positive;
  • '7' FOR Test ordered, results not in chart;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  OCT 21, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  PR (Progesterone Receptor) Summary is a summary of results from the progesterone receptor (PR) assay. Rationale: This data item is required for prognostic stage grouping in AJCC 8th edition, Chapter 48, Breast. It was
    previously collected as Breast CS SSF # 2. Codes: 0 PR negative 1 PR positive 7 Test ordered, results not in chart 9 Not documented in medical record
    Cannot be determined (indeterminate)
    PR (Progesterone Receptor) Summary status not assessed
    or unknown if assessed Note 1: Physician statement of PR (Progesterone Receptor) Summary status can be used to code this data item when no other information is available. Note 2: The result of the PR test
    performed on the primary breast tissue is to be recorded in this data item. Note 3: Results from nodal or metastatic tissue may be used ONLY when there is no evidence of primary tumor. Note 4: In cases where PR is
    reported on more than one breast tumor specimen, record the highest value. If any sample is positive, record as positive.
    Exception: If PR is positive on an in situ specimen and PR is negative on all tested invasive specimens, code PR as negative (code 0). Note 5: If neoadjuvant therapy is given, record the assay from tumor specimens
    prior to neoadjuvant therapy.
    If neoadjuvant therapy is given and there are no PR results from pre-treatment specimens, report the findings from post-treatment specimens. Note 6: If the patient is PR positive and node negative, a multigene test
    such as Oncotype Dx may be performed, in which case another PR test will be performed. Do not record the results of that test in this field.
    Record only the results of the test which made the patient eligible to be given the multigene test.
3916 PR ALLRED SCORE SSD4;11 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D ERTA^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  OCT 22, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  Progesterone Receptor, Total Allred Score is based on the percentage of cells that stain by IHC for progesterone receptor (PR) and the intensity of that staining. Rationale: Progesterone Receptor, Total Allred Score is a
    Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 00 Total PR Allred score of 0 01 Total PR Allred score of 1 02 Total PR Allred score of 2 03 Total PR Allred
    score of 3 04 Total PR Allred score of 4 05 Total PR Allred score of 5 06 Total PR Allred score of 6 07 Total PR Allred score of 7 08 Total PR Allred score of 8 X8 Not applicable: Information not collected for
    this case
    (If this item is required by your standard setter,
    use of code X8 will result in an edit error.) X9 Not documented in medical record
    PR (Progesterone Receptor) Total Allred Score not assessed,
    or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3917 PRIMARY SCLEROSING CHOLANGITIS SSD4;12 SET
  • '0' FOR PSC not identified/not present;
  • '1' FOR PSC present;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  AUG 16, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Primary sclerosing cholangitis denotes a chronic autoimmune inflammation of the bile ducts that leads to scar formation and narrowing of the ducts over time. It is a prognostic factor for intrahepatic bile duct cancer.
    Rationale: Primary Sclerosing Cholangitis is a Registry Data Collection Variable in AJCC. This data item was previously collected for Intrahepatic Bile Duct, SSF# 11. Codes: 0 PSC not identified/not present 1 PSC
    present 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error.) 9 Not documented in medical record
    PSC not assessed or unknown if assessed
3918 PROFOUND IMMUNE SUPPRESSION SSD4;13 SET
  • '0' FOR No immune suppression identified;
  • '1' FOR HIV/AIDS;
  • '2' FOR Solid organ transplant recipient;
  • '3' FOR Chronic lymphocytic leukemia;
  • '4' FOR Non-Hodgkin lymphoma;
  • '5' FOR Multiple;
  • '6' FOR Profound;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  AUG 16, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Profound Immune Suppression, suppressed immune status that may be associated with HIV/AIDs, solid organ transplant, chronic lymphocytic leukemia, non-Hodgkin lymphoma, multiple conditions or other conditions, increases the
    risk of developing Merkel Cell Carcinoma and is an adverse prognostic factor. Rationale: Profound Immune Suppression is a Registry Data Collection Variable in AJCC. It was previously collected as Merkel Cell Penis, SSF
    #22, Merkel Cell Scrotum SSF #22, Merkel Cell Skin, SSF# 22, and Merkel Cell Vulva, SSF# 22. Codes: 0 No immune suppression condition(s) identified/not present 1 Human Immunodeficiency Virus (HIV)/Acquired
    Immunodeficiency Syndrome (AIDS) 2 Solid organ transplant recipient 3 Chronic lymphocytic leukemia 4 Non-Hodgkin lymphoma 5 Multiple immune suppression conditions 6 Profound immune suppression present 8
    Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error.) 9 Not documented in medical record
    Profound immune suppression not assessed
    or unknown if assessed
3919 PROSTATE PATHOLOGICAL EXT SSD4;14 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1) X I $D(X) D PROPE^ONCSCHMM
    MAXIMUM LENGTH: 3
  • LAST EDITED:  JUN 10, 2020
  • HELP-PROMPT:  Answer must be 1-3 characters in length.
  • DESCRIPTION:  Pathological extension is used to assign pT category for prostate cancer based on radical prostatectomy specimens. Rationale: Pathological extension is used in EOD. It was previously collected as Prostate, CS SSF# 3.
    Codes: (See the most current version of EOD (Prostate) (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding structures.)
    000 In situ: noninvasive; intraepithelial 300 Invasion into (but not beyond) prostatic capsule
    Intracapsular involvement only
    No extracapsular extension
    Confined to prostate, NOS
    Localized, NOS 350 Bladder neck, microscopic invasion
    Extraprostatic extension (beyond prostatic capsule), unilateral,
    bilateral, or NOS WITHOUT invasion of the seminal vesicles
    Extension to periprostatic tissue WITHOUT invasion of seminal vesicles 400 Tumor invades seminal vesicle(s) 500 Extraprostatic tumor that is not fixed
    WITHOUT invasion of adjacent structures
    Periprostatic extension, NOS (unknown if seminal vesicle(s) involved)
    Extraprostatic extension, NOS (unknown if seminal vesicle(s) involved)
    Through capsule, NOS 600 Bladder neck, except microscopic bladder neck involvement
    Bladder, NOS
    External sphincter
    Extraprostatic urethra (membranous urethra)
    Fixation, NOS
    Levator muscles
    Rectovesical (Denonvillier's) fascia
    Rectum
    Skeletal muscle
    Ureter(s) 700 Extension to or fixation to pelvic wall or pelvic bone
    "Frozen pelvis", NOS
    Further contiguous extension including
    Other organs
    Penis
    Sigmoid colon
    Soft tissue other than periprostatic 800 No evidence of primary tumor 900 No prostatectomy or autopsy performed 950 Prostatectomy performed, but not first course of treatment
    for example performed after disease progression 999 Unknown; extension not stated
    Unknown if prostatectomy done
    Primary tumor cannot be assessed
    Not documented in patient record
    Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3920 PSA LAB VALUE SSD4;15 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM
    MAXIMUM LENGTH: 5
  • LAST EDITED:  AUG 01, 2019
  • HELP-PROMPT:  Answer must be 1-5 characters in length.
  • DESCRIPTION:  PSA (Prostatic Specific Antigen) is a protein produced by cells of the prostate gland and is elevated in patients with prostate cancer. This data item pertains to PSA lab value. Rationale: This data item is required for
    prognostic stage grouping in AJCC 8th edition, Chapter 58, Prostate. It was previously collected as Prostate, CS SSF# 1. Codes: 0.1 0.1 or less nanograms/milliliter (ng/ml)
    (Exact value to nearest tenth of ng/ml) 0.2-999.9 0.2-999.9 ng/ml
    (Exact value to nearest tenth of ng/ml) XXX.1 1,000 ng/ml or greater XXX.2 Lab value not available, physician states PSA is
    negative/normal XXX.3 Lab value not available, physician states PSA is
    positive/elevated/high XXX.7 Test ordered, results not in chart XXX.9 Not documented in medical record
    PSA lab value not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3921 RESIDUAL TUM VOL PST CYTO SSD4;16 POINTER TO ONCO RESIDUAL TUMOR VOLUME FILE (#167.5) ONCO RESIDUAL TUMOR VOLUME(#167.5)

  • LAST EDITED:  AUG 16, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Gross residual tumor after primary cytoreductive surgery is a prognostic factor for ovarian cancer and residual tumor volume after cytoreductive surgery is a prognostic factor for late stage ovarian cancers. Rationale:
    Residual Tumor Volume Post Cytoreduction is a Registry Data Collection Variable listed in AJCC. It was previously collected as Ovary, CS SSF # 3. Codes: 00 No gross residual tumor nodules 10 Residual tumor nodule(s) 1
    centimeter (cm) or less
    AND neoadjuvant chemotherapy not given or unknown if given 20 Residual tumor nodule(s) 1 cm or less
    AND neoadjuvant chemotherapy given (before surgery) 30 Residual tumor nodule(s) greater than 1 cm
    AND neoadjuvant chemotherapy not given or unknown if given 40 Residual tumor nodule(s) greater than 1 cm
    AND neoadjuvant chemotherapy given (before surgery) 90 Macroscopic residual tumor, size not stated
    AND neoadjuvant chemotherapy not given or unknown if given 91 Macroscopic residual tumor nodule(s), size not stated
    AND neoadjuvant chemotherapy given (before surgery) 92 Procedure described as optimal debulking and size of residual tumor
    nodule(s) not given AND neoadjuvant chemotherapy not given
    or unknown if given 93 Procedure described as optimal debulking and size of residual tumor
    nodue(s) not given AND neoadjuvant chemotherapy given (before
    surgery) 97 No cytoreductive surgery performed 98 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code 98 will result in an edit error.) 99 Not documented in medical record
    Residual tumor status after cytoreductive surgery not
    assessed or unknown if assessed
3922 RESPONSE TO NEOADJUVANT THERA SSD4;17 SET
  • '0' FOR Neoadjuvant therapy not given;
  • '1' FOR Complete response (CR);
  • '2' FOR Partial response (PR);
  • '3' FOR Response to treatment, but not noted if complete or partial;
  • '4' FOR No response (NR);
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  AUG 20, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This data item records the physician's statement of response to neoadjuvant chemotherapy. Rationale: Response to Neoadjuvant Therapy is a Registry Data Collection Variable in AJCC. It was previously collected as Breast,
    CS SSF #21. Codes: 0 Neoadjuvant therapy not given 1 Stated as complete response (CR) 2 Stated as partial response (PR) 3 Stated as response to treatment, but not noted if complete or partial 4 Stated as no
    response (NR) 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code 8 will result in an edit error.) 9 Not documented in medical record
    Response to neoadjuvant therapy not assessed or unknown if assessed
3923 S CATEGORY CLINICAL SSD4;18 SET
  • '0' FOR S0;
  • '1' FOR S1;
  • '2' FOR S2;
  • '3' FOR S3;
  • '9' FOR SX;

  • LAST EDITED:  AUG 20, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  S Category Clinical combines the results of pre-orchiectomy Alpha Fetoprotein (AFP), Human Chorionic Gonadotropin (hCG) and Lactate Dehydrogenase (LDH) into a summary S value. Rationale: S Category Clinical is required
    for prognostic stage grouping in AJCC 8th edition, Chapter 59 Testis. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 S0: Marker study levels within normal levels 1 S1: At least one of these values is
    elevated AND
    LDH less than 1.5 x N* AND
    hCG (mIU/L) less than 5,000 AND
    AFP (ng/mL) less than 1,000 2 S2:
    LDH 1.5 x N* to 10 x N* OR
    hCG (mIU/L) 5,000 to 50,000 OR
    AFP (ng/mL) 1,000 to 10,000 3 S3: Only one elevated test is needed
    LDH greater than 10 x N* OR
    hcG (mIU/mL) greater than 50,000 OR
    AFP (ng/mL) greater than 10,000 9 SX: Not documented in medical record
    S Category Clinical not assessed or unknown if assessed
    *N indicates the upper limit of normal for the LDH assay.
3924 S CATEGORY PATHOLOGICAL SSD4;19 SET
  • '0' FOR S0;
  • '1' FOR S1;
  • '2' FOR S2;
  • '3' FOR S3;
  • '9' FOR SX;

  • LAST EDITED:  AUG 20, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  S Category Pathological combines the results of post-orchiectomy Alpha Fetoprotein (AFP), Human Chorionic Gonadotropin (hCG) and Lactate Dehydrogenase (LDH) into a summary S value. Rationale: S Category Pathological is
    required for prognostic stage grouping in AJCC 8th edition, Chapter 59 Testis. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 S0: Marker study levels within normal levels 1 S1: At least one of these
    values is elevated AND
    LDH less than 1.5 x N* AND
    hCG (mIU/L) less than 5,000 AND
    AFP (ng/mL) less than 1,000 2 S2:
    LDH 1.5 x N* to 10 x N* OR
    hCG (mIU/L) 5,000 to 50,000 OR
    AFP (ng/mL) 1,000 to 10,000 3 S3: Only one elevated test is needed
    LDH greater than 10 x N* OR
    hcG (mIU/mL) greater than 50,000 OR
    AFP (ng/mL) greater than 10,000 9 SX: Not documented in medical record
    S Category Pathological not assessed or unknown if assessed
    *N indicates the upper limit of normal for the LDH assay.
3925 SARCOMATOID FEATURES SSD4;20 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3AN) X I $D(X) D SAR^ONCSCHMM
    MAXIMUM LENGTH: 3
  • LAST EDITED:  JUN 25, 2020
  • HELP-PROMPT:  Answer must be 1-3 characters in length.
  • DESCRIPTION:  Sarcomatoid features: present or absent and percentage refers to the observation of sheets and fascicles of malignant spindle cells in a kidney tumor which can occur across all histologic subtypes. The percentage of
    sarcomatoid component has been shown to correlate with cancer-specific mortality. Rationale: Sarcomatoid features for Kidney is a Registry Data Collection Variable in AJCC. It was previously collected as Kidney, CS SSF
    #4. Codes: 000 Sarcomatoid features not present/not identified 000-100 Sarcomatoid features 1-100% R01 Sarcomatoid features stated as less than 10% R02 Sarcomatoid features stated as range 10%-30% present R03
    Sarcomatoid features stated as a range 31% to 50% present R04 Sarcomatoid features stated as a range 51% to 80% present R05 Sarcomatoid features stated as greater than 80% XX5 Sarcomatoid features present from
    metastatic site only AND
    Sarcomatoid features not present in primary site,
    or unknown if present XX6 Sarcomatoid features present, percentage unknown XX7 Not applicable: Not a renal cell carcinoma morphology XX8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code XX8 may result in an edit error.) XX9 Not documented in medical record
    Sarcomatoid features not assessed or unknown if assessed
    No surgical resection of primary site is performed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3926 SCHEMA DISCRIMINATOR 1 SSD4;21 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S ONCSDND=1 D SDIT^ONCSCHMG
  • LAST EDITED:  SEP 07, 2018
  • HELP-PROMPT:  Type a number between 0 and 9, 0 decimal digits.
  • DESCRIPTION:  Captures additional information needed to generate AJCC ID [995] and Schema ID [3800] for some anatomic sites. Discriminators can be based on sub site, histology or other features which affect prognosis. Rationale: A
    schema discriminator is used to assign AJCC ID [995] when site and histology alone are insufficient to identify the applicable AJCC staging method and to assign Schema ID [3800], which links each case to the appropriate
    SSDIs, Summary Stage and EOD data collection system.
  • EXECUTABLE HELP:  S ONCSDND=1 D SDHLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3927 SCHEMA DISCRIMINATOR 2 SSD4;22 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S ONCSDND=2 D SDIT^ONCSCHMG
  • LAST EDITED:  SEP 07, 2018
  • HELP-PROMPT:  Type a number between 0 and 9, 0 decimal digits.
  • DESCRIPTION:  Captures additional information needed to generate AJCC ID [995] and Schema ID [3800] for some anatomic sites. Discriminators can be based on sub site, histology or other features which affect prognosis. Rationale: A
    schema discriminator is used to assign AJCC ID [995] when site and histology alone are insufficient to identify the applicable AJCC staging method and to assign Schema ID [3800], which links each case to the appropriate
    SSDIs, Summary Stage and EOD data collection system.
  • EXECUTABLE HELP:  S ONCSDND=2 D SDHLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3928 SCHEMA DISCRIMINATOR 3 SSD4;23 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  SEP 07, 2018
  • HELP-PROMPT:  Type a number between 0 and 9, 0 decimal digits.
  • DESCRIPTION:  Captures additional information needed to generate AJCC ID [995] and Schema ID [3800] for some anatomic sites. Discriminators can be based on sub site, histology or other features which affect prognosis. Rationale: A
    schema discriminator is used to assign AJCC ID [995] when site and histology alone are insufficient to identify the applicable AJCC staging method and to assign Schema ID [3800], which links each case to the appropriate
    SSDIs, Summary Stage and EOD data collection system.
3929 SEPARATE TUMOR NODULES SSD4;24 SET
  • '0' FOR Single tumor only;
  • '1' FOR Ipsilateral lung same lobe;
  • '2' FOR Ipsilateral lung different lobe;
  • '3' FOR Ipsilateral lung same AND diff lobes;
  • '4' FOR Ipsilateral lung unk if same or diff;
  • '7' FOR Multiple nodules;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  AUG 21, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  "Separate tumor nodules" refers to what is conceptually a single tumor with intrapulmonary metastasis in the ipsilateral (same) lung. Their presence in the same or different lobes of lung from the primary tumor affects the
    T and M categories. Rationale: This data item was previously collected for Lung, SSF# 1 and at least one standard setter is continuing to collect it. Codes: 0 No separate tumor nodules; single tumor only
    Separate tumor nodules of same histologic
    not identified/not present
    Intrapulmonary metastasis not identified/not present
    Multiple nodules described as multiple foci of adenocarcinoma in situ
    or minimally invasive adenocarcinoma 1 Separate tumor nodules of same histologic type
    in ipsilateral lung, same lobe 2 Separate tumor nodules of same histologic type
    in ipsilateral lung, different lobe 3 Separate tumor nodules of same histologic type
    in ipsilateral lung, same AND different lobes 4 Separate tumor nodules of same histologic type
    in ipsilateral lung, unknown if same or different lobe(s) 7 Multiple nodules or foci of tumor present, not classifiable
    based on notes 3 and 4 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code 8 will result in an edit error.) 9 Not documented in medical record
    Primary tumor is in situ
    Separate Tumor Nodules not assessed or unknown if assessed
3930 SERUM ALBUMIN PRETREAT VALUE SSD4;25 SET
  • '0' FOR Serum albumin <3.5g/dL;
  • '1' FOR Serum albumin greater or equal 3.5g/dL;
  • '5' FOR Schema Discriminator 1 coded to 1 or 9;
  • '7' FOR Test ordered, results not in chart;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUN 28, 2022
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Albumin is the most abundant protein in human blood plasma. Serum albumin pretreatment level is a prognostic factor for plasma cell myeloma. Rationale: Serum albumin pretreatment level is a prognostic factor required in
    AJCC 8th edition, Chapter 82 Plasma Cell Myeloma and Plasma Cell Disorders, for the Revised International Staging System (RISS). It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 Serum albumin <3.5 g/dL 1
    Serum albumin > or =3.5 g/dL 5 Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9 7 Test ordered, results not in chart 9 Not documented in medical record
    Serum Albumin Pretreatment Level not assessed or unknown if assessed
  • SCREEN:  S DIC("S")="D SCRN555^ONCSCHMM"
  • EXPLANATION:  Codes depend on appropriate schema discriminator
3931 SERUM BETA-2 MICROGLOBULIN SSD4;26 SET
  • '0' FOR Less than 3.5mg/L;
  • '1' FOR Greater than or equal 3.5mg/L AND Less than 5.5mg/L;
  • '2' FOR Greater than or equal 5.5mg/L;
  • '5' FOR Schema Discriminator 1 coded to 1 or 9;
  • '7' FOR Test ordered, results not in chart;
  • '9' FOR Not documented;

  • LAST EDITED:  JUN 28, 2022
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Serum Beta-2 Microglobulin is a protein that is found on the surface of many cells and plentiful on the surface of white blood cells. Increased production or destruction of these cells causes Serum ß2 (beta-2)
    Microglobulin level to increase. Elevated Serum ß2 (beta-2) Microglobulin level is a prognostic factor for plasma cell myeloma. Rationale: Serum Beta-2 Microglobulin Pretreatment Level is a prognostic factor required in
    AJCC 8th edition, Chapter 82 Plasma Cell Myeloma and Plasma Cell Disorders, for staging of plasma cell myeloma. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 ß2-microglobulin <3.5 mg/L 1
    ß2-microglobulin > or =3.5 mg/L <5.5 mg/L 2 ß2-microglobulin > or =5.5 mg/L 5 Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9 7 Test ordered, results not in chart 9 Not documented in medical
    record
    Serum Beta-2 Microglobulin Pretreatment Level not assessed or
    unknown if assessed
  • SCREEN:  S DIC("S")="D SCRN555^ONCSCHMM"
  • EXPLANATION:  Codes depend on appropriate schema discriminator
3932 LDH LAB VALUE SSD4;27 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM
    MAXIMUM LENGTH: 7
  • LAST EDITED:  JAN 26, 2021
  • HELP-PROMPT:  Answer must be 1-7 characters in length.
  • DESCRIPTION:  LDH (Lactate Dehydrogenase) Lab Value, measured in serum, is a predictor of treatment response, progression-free survival and overall survival for patients with Stage IV melanoma of the skin. Rationale: LDH (Lactate
    Dehydrogenase) Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Melanoma Skin, CS SSF# 5. Codes:
    0.0 0.0 (U/L) 0.1-99999.9 0.1-99,999.9 U/L XXXXX.1 100,000 U/L or greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code XXXXX.8 will result in an edit error.) XXXXX.9 Not documented in medical record
    LDH (Lactate Dehydrogenase) Pretreatment Lab
    Value not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3933 THROMBOCYTOPENIA SSD4;28 SET
  • '0' FOR Thromb not present, Plt GT or equal 100000;
  • '1' FOR Thromb present, Plt < 100000;
  • '5' FOR NA, not C421;
  • '6' FOR Lab value unk, physician states Thromb present or RAI stage IV;
  • '7' FOR Test ordered, results not in chart;
  • '9' FOR Not documented;

  • LAST EDITED:  SEP 26, 2023
  • HELP-PROMPT:  Enter a code from the list that corresponds to the Thrombocytopenia for this patient's primary.
  • DESCRIPTION:  Thrombocytopenia is defined by a deficiency of platelets in the blood. In staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), thrombocytopenia is defined as Platelets (Plt) less than 100,000/µL.
    Rationale: Thrombocytopenia is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in AJCC 8th edition, Chapter 79 Hodgkin and Non-Hodgkin Lymphomas. It is a new
    data item for cases diagnosed 1/1/2018+. Codes: 0 Thrombocytopenia not present
    Platelets (Plt) >= 100,000/µL
    Physician states RAI stage 0-III 1 Thrombocytopenia present
    Platelets (Plt) < 100,000/µL 5 Not applicable: Primary site is not C421 6 Lab value unknown, physician states thrombocytopenia is present
    Physician states RAI stage IV 7 Test ordered, results not in chart 9 Not documented in medical record
    Thrombocytopenia not assessed or unknown if assessed
  • SCREEN:  S DIC("S")="D SCRNFIV^ONCSCHMM"
  • EXPLANATION:  Codes depend on appropriate primary site
3934 TUMOR DEPOSITS SSD4;29 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  JUL 26, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  A tumor deposit is defined as a discrete nodule of cancer in pericolic/perirectal fat or in adjacent mesentery (mesocolic or rectal fat) within the lymph drainage area of the primary carcinoma, without identifiable lymph
    node tissue or identifiable vascular structure. Rationale: The presence of tumor deposits is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum CS SSF# 4. Codes: 00 No tumor
    deposits 01-99 01-99 Tumor deposits (Exact number of Tumor Deposits) X1 100 or more Tumor Deposits X2 Tumor Deposits identified, number unknown X8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code X8 may result in an edit error.) X9 Not documented in medical record
    Cannot be determined by the pathologist
    Pathology report does not mention tumor deposits
    No surgical resection done
    Tumor Deposits not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3935 TUMOR GROWTH PATTERN SSD4;30 SET
  • '1' FOR Mass-forming;
  • '2' FOR Periductal infiltrating;
  • '3' FOR Mixed mass-forming and periductal infiltrating;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JAN 29, 2025
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Tumor Growth Pattern refers to the growth pattern of intrahepatic cholangiocarcinoma. Rationale: Tumor Growth Pattern is a Registry Data Collection Variable in AJCC. This data item was previously collected for
    Intrahepatic Bile Duct, SSF# 10. Codes: 1 Mass-forming 2 Periductal infiltrating 3 Mixed mass-forming and periductal infiltrating 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error.) 9 Not documented in medical record
    Pathology report does not mention tumor growth pattern
    Cannot be determined by the pathologist
    Tumor growth pattern not assessed or unknown if assessed
3936 ULCERATION 2018 SSD4;31 SET
  • '0' FOR Ulceration not identified/not present;
  • '1' FOR Ulceration present;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  AUG 22, 2018
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Ulceration, the absence of an intact epidermis overlying the primary melanoma based upon histopathological examination, is a prognostic factor for melanoma of the skin. Rationale Ulceration is a Registry Data Collection
    Variable in AJCC. It was previously collected as Melanoma Skin, CS SSF# 2. Codes 0 Ulceration not identified/not present 1 Ulceration present 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code 8 will result in an edit error.) 9 Not documented in medical record
    Cannot be determined by the pathologist
    Pathology report does not mention ulceration
    Ulceration not assessed or unknown if assessed
3937 VISCERAL PARIETAL PLEURAL INV SSD4;32 SET
  • '0' FOR No evidence/PL0;
  • '4' FOR Inv of visceral pleura, NOS/PL1 or PL2;
  • '5' FOR Invades into or through parietal pleura OR chest wall/PL3;
  • '6' FOR Extends to pleura, NOS;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUN 01, 2021
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Visceral and Parietal Pleural Invasion is defined as invasion beyond the elastic layer or to the surface of the visceral pleura. Rationale: Visceral and Parietal Pleural Invasion (previously called "pleural/elastic layer
    invasion (PL)") is a Registry Data Collection Variable for AJCC. This data item was previously collected for Lung, SSF# 2. Codes: 0 No evidence of visceral pleural invasion identified
    Tumor does not completely traverse the elastic layer of the pleura
    Stated as PL0 4 Invasion of visceral pleura present, NOS
    Stated as PL1 or PL2 5 Tumor invades into or through the parietal pleural OR chest wall
    Stated as PL3 6 Tumor extends to pleura, NOS; not stated if visceral or parietal 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code 8 will result in an edit error.) 9 Not documented in medical record
    No surgical resection of primary site is performed
    Visceral Pleural Invasion not assessed or unknown if assessed
    or cannot be determined
3938 ALK REARRANGEMENT SSD5;1 SET
  • '0' FOR Normal/ALK negative;
  • '1' FOR EML4-ALK,KIF5B-ALK,TFG-ALK,KLC1-ALK;
  • '2' FOR Other ALK not listed in code 1;
  • '4' FOR Rearrangement, NOS;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUN 01, 2021
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Testing for ALK rearrangement is performed for patients with advanced non-small cell lung cancer (NSCLC) to identify tumors which are sensitive to small-molecule ALK kinase inhibitors. Rationale: ALK rearrangement is
    recommended by treatment guidelines for patients with advanced lung cancer as a prognostic marker and factor in determining appropriate therapy. It is a new data item for cases diagnosed 01/01/2021+. Codes: 0 Normal
    ALK negative
    Negative for rearrangement, no rearrangement identified,
    no mutations (somatic) identified, not present, not detected 1 Abnormal Rearrangement identified/detected: EML4-ALK,
    KIF5B-ALK, TFG-ALK, and/or KLC1-ALK 2 Rearrangement identified/detected: Other ALK
    Rearrangement not listed in code 1 4 Rearrangement, NOS 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    If this information is required by your standard setter,
    use of code 8 may result in an edit error. 9 Not documented in medical record
    ALK Rearrangement not assessed or unknown if assessed
3939 EGFR MUTATIONAL ANALYSIS SSD5;2 SET
  • '0' FOR Normal, EGFR negative,EGFR wild type;
  • '1' FOR Abnormal-detected in exon(s) 18,19,20,21;
  • '2' FOR Abnormal-detected BUT NOT in exon(s) 18,19,20,21;
  • '4' FOR Detected, NOS;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JUN 01, 2021
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Epidermal growth factor receptor (EGFR) mutational analysis is performed for patients with advanced non-small cell lung cancer (NSCLC) to identify patients with certain activating mutations in the EGFR gene which are
    sensitive to tyrosine kinase inhibitors. Rationale: EGFR mutational analysis is recommended by treatment guidelines for patients with advanced lung cancer as a prognostic marker and factor in determining appropriate
    therapy. It is a new data item for cases diagnosed 01/01/2021+. Codes: 0 Normal
    EGFR negative, EGFR wild type
    Negative for mutations, no alterations,
    no mutations (somatic) identified, not present, not detected 1 Abnormal (mutated)/detected in exon(s) 18, 19, 20, and/or 21 2 Abnormal (mutated)/detected but not in exon(s) 18, 19, 20, and/or 21 4 Abnormal
    (mutated)/detected, NOS, exon(s) not specified 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    If this information is required by your standard setter,
    use of code 8 may result in an edit error. 9 Not documented in medical record
    EGFR not assessed or unknown if assessed
3940 BRAF MUTATIONAL ANALYSIS SSD5;3 SET
  • '0' FOR Normal;
  • '1' FOR Detected, BRAF V600E;
  • '2' FOR Detected, but not BRAF V600E;
  • '3' FOR Detected, KIAA1549 BRAF gene fusion;
  • '4' FOR Abnormal, NOS;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  APR 17, 2025
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  The BRAF oncoprotein is involved in transmitting cell growth and proliferation signals from KRAS and NRAS. The BRAF V600E mutation is associated with poorer prognosis and predicts lack of response to anti-EGFR therapies.
    Rationale: BRAF mutational analysis is recommended in clinical guidelines for patients with advanced colorectal cancer as a prognostic marker and factor in determining appropriate therapy. It is a new data item for cases
    diagnosed 1/1/2021+. Codes: 0 Normal
    BRAF negative, BRAF wild type
    Negative for (somatic) mutations, no alterations,
    no (somatic) mutations identified, not present, not detected 1 Abnormal (mutated)/detected: BRAF V600E (c.1799T>A) mutation 2 Abnormal (mutated)/detected, but not BRAF V600E (c.1799T>A) mutation 3 Abnormal
    (mutated)/detected, KIAA1549: BRAF gene fusion 4 Abnormal (mutated), BRAF, NOS 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    If this information is required by your standard setter,
    use of code 8 may result in an edit error.) 9 Not documented in medical record
    BRAF not assessed or unknown if assessed
3941 NRAS MUTATIONAL ANALYSIS SSD5;4 SET
  • '0' FOR Normal;
  • '1' FOR Detected in codon(s) 12,13, and/or 61;
  • '2' FOR Detected, codon(s) specified but not in codon(s) 12,13, or 61;
  • '4' FOR Abnormal, NOS;
  • '7' FOR Test ordered, results not in chart;
  • '8' FOR N/A;
  • '9' FOR Not documented;

  • LAST EDITED:  JAN 14, 2021
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  NRAS is a signaling intermediate in the growth receptor pathway. Certain NRAS mutations predict poor response to anti-EGFR therapy in patients with metastatic colorectal cancer. Rationale: NRAS mutational analysis is
    recommended in clinical guidelines for patients with metastatic colon cancer who are being considered for anti-EGFR therapy. It is a new data item for cases diagnosed 01/01/2021+. Codes: 0 Normal
    NRAS negative; NRAS wild type
    Negative for (somatic) mutations, no alterations,
    no (somatic) mutations identified, not present, not detected 1 Abnormal (mutated)/detected in codon(s) 12, 13, and/or 61 2 Abnormal (mutated)/detected, codon(s) specified but not
    in codon(s) 12, 13, or 61 4 Abnormal (mutated), NOS, codon(s) not specified 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case
    If this information is required by your standard setter,
    use of code 8 may result in an edit error. 9 Not documented in medical record
    NRAS not assessed or unknown if assessed
3942 CA 19-9 PRETX LAB VALUE SSD5;5 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>6!($L(X)<1)!'(X?0.4AN0.1"."1N) X I $D(X) D DEC4^ONCSCHMM
    MAXIMUM LENGTH: 6
  • LAST EDITED:  JAN 14, 2021
  • HELP-PROMPT:  Answer must be 1-6 characters in length.
  • DESCRIPTION:  Carbohydrate Antigen (CA) 19-9 Pretreatment Lab Value records the CA 19-9 value prior to treatment. CA 19-9 is a tumor marker that has prognostic significance for pancreatic cancer. Rationale: CA 19-9 Pretreatment Lab
    Value is a strong predictor of resectability in the absence of metastatic disease. It is a new data item for cases diagnosed 01/01/2021+. Codes: 0.0 0.0 Units/milliliter (U/ml) exactly 0.1-9999.9 0.1-9999.9 U/ml
    Exact value to nearest tenth in U/ml) XXXX.1 10,000 U/ml or greater XXXX.2 Lab value not available, physician states CA 19-9 is
    negative/normal XXXX.3 Lab value not available, physician states CA 19-9 is
    positive/elevated/high XXXX.7 Test ordered, results not in chart XXXX.8 Not applicable: Information not collected for this case
    If this information is required by your standard setter,
    use of code XXXX.8 may result in an edit error. XXXX.9 Not documented in medical record
    CA (Carbohydrate Antigen) 19-9 Pretreatment Lab Value
    not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3943 NCDB-SARSCOV2-TEST NCR21;1 SET
  • '0' FOR Patient not tested for SARS-CoV2;
  • '1' FOR Patient tested for Active SARS-CoV2;
  • '9' FOR Unknown if patient tested for SARS-CoV2;

  • LAST EDITED:  FEB 02, 2021
  • HELP-PROMPT:  Enter the value corresponding to the correct SARS-CoV2 test
  • DESCRIPTION:  This data item is designed to track whether patient received a SARS-CoV-2 test or not. Collection based on diagnosis years 2020 and 2021.
    Rationale: To evaluate the impact of COVID-19 diagnosis on cancer patients.
    Codes: 0 Patient not tested for SARS-CoV-2: facility records support
    that patient did not undergo pre-admit or in-hospital testing 1 Patient tested for Active SARS-CoV2 9 Unknown if patient tested for SARS-CoV-2/No facility record of
    preadmit hospital testing of SARS-CoV-2 Note: This item may be left blank.
3944 NCDB-SARSCOV2-POSITIVE NCR21;2 SET
  • '0' FOR Patient did not test positive for active SARS-CoV-2;
  • '1' FOR Patient tested positive for active SARS-CoV-2;
  • '9' FOR Unknown if tested or test done, results unknown;

  • LAST EDITED:  FEB 02, 2021
  • HELP-PROMPT:  Enter the value corresponding to the correct SARS-CoV2 test
  • DESCRIPTION:  Data item is designed to track whether patient received a POSITIVE SARS-CoV-2 test or not. Collection based on diagnosis years 2020 and 2021.
    Rationale: To evaluate the impact of COVID-19 diagnosis on cancer patients.
    Codes: 0 Patient did not test positive for active SARS-CoV-2:
    No positive test 1 Patient tested positive for active SARS-CoV-2: test
    positive on at least one test 9 Unknown if tested; test done, results unknown Note: This item may be left blank.
3945 NCDB-SARSCOV2-POSITIVE DATE NCR21;3 DATE

  • INPUT TRANSFORM:  S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  JUL 06, 2021
  • HELP-PROMPT:  Enter the date the patient had a positive COVID-19 test
  • DESCRIPTION:  This field stores the date of the first positive COVID-19 test for the patient. Collection based on diagnosis years 2020 and 2021.
    Rationale: To evaluate the impact of COVID-19 diagnosis on cancer patients.
    This field will store the date the patient had a positive test for SARS-CoV-2, the virus that causes the 2019 novel coronavirus disease (COVID-19) as documented by a medical provider. May be blank if date of the test is
    unknown or the date of a positive (diagnostic or serologic) test is unknown for SARS-CoV-2.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3946 NCDB-COVID19-TX IMPACT NCR21;4 SET
  • '1' FOR Treatment not affected;
  • '2' FOR First course timeline delayed;
  • '3' FOR First course plan altered;
  • '4' FOR Cancelled first course;
  • '5' FOR Patient refused treatment due to COVID-19;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 02, 2021
  • HELP-PROMPT:  Enter the code evaluating treatment impact
  • DESCRIPTION:  This field stores whether or not the first course of treatment (diagnosis, staging, treatment or other cancer management events) was impacted by hospital avail- ability (limited access to facilities or postponement of
    non-essential procedures) due to COVID-19 pandemic. Collection based on diagnosis years 2020 and 2021.
    Rationale: To evaluate the impact of COVID-19 pandemic on cancer patients.
    Codes: 1 Treatment not affected; active surveillance, no change 2 First Course of Treatment timeline delayed 3 First Course of Treatment plan altered 4 Cancelled First Course of Treatment 5 Patient refused treatment
    due to COVID-19 9 Not known if treatment affected Note: This item may be left blank.
3950 MACROSCOPIC EVAL OF MESORECTUM SSD5;7 SET
  • '00' FOR Did not receive TME;
  • '10' FOR Incomplete;
  • '20' FOR Nearly complete;
  • '30' FOR Complete;
  • '40' FOR TME performed, not specified;
  • '99' FOR Unknown;

  • LAST EDITED:  JUN 06, 2022
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Description: This data item records the results of a macroscopic evaluation of the mesorectum from a total mesorectal excision (TME).
    Rationale: Numerous studies have demonstrated the total mesorectal excision (TME) improves local recurrence rates and the corresponding survival by as much as 20%. Macroscopic pathologic assessment of the completeness of
    the mesorectum, scored as complete, partially complete, or incomplete, accurately predicts both local recurrence and distant metastasis.
    Codes: 00 Patient did not receive TME 10 Incomplete 20 Nearly complete 30 Complete 40 TME performed not specified on pathology report as incomplete,
    nearly complete, or complete TME performed, but pathology report
    not available Physician statement that TME performed, no mention
    of incomplete, nearly complete, or complete status 99 Unknown if TME performed Blank Site not rectum (C20.9)
3955 DERIVED RAI STAGE SSD5;8 SET
  • '0' FOR Lymphocytosis;
  • '1' FOR Lymphocytosis & Adenopathy;
  • '2' FOR Lymphocytosis & Organomegaly;
  • '3' FOR Lymphocytosis & Anemia;
  • '4' FOR Lymphocytosis & Thrombocytopenia;
  • '8' FOR N/A;
  • '9' FOR Unk;

  • LAST EDITED:  JUN 06, 2022
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Description: This data item stores the Derived Rai stage value derived from the values coded in the following SSDIs for the Lymphoma-CLL/SLL schema (9823/3):
    Lymphocytosis [3885]
    Adenopathy [3804]
    Organomegaly [3907]
    Anemia [3811]
    Thrombocytopenia [3933] The Rai stage is only applicable for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (9823/3) cases where the primary site is bone marrow (C421). For cases with a primary site
    other than bone marrow (C421), the derived Rai stage will be 8 and all the SSDIs will be coded to 5. Derivation will be run on all cases diagnosed 1/1/2018 and forward.
    Rationale: The Derived Rai stage can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time.
    Codes: 0 Lymphocytosis 1 Lymphocytosis and Adenopathy 2 Lymphocytosis and Organomegaly
    (Adenopathy is any value other than 5) 3 Lymphocytosis and Anemia
    (Adenopathy and Organomegaly are any value other than 5) 4 Lymphocytosis and Thrombocytopenia
    (Adenopathy, Organomegaly and Anemia are any value other than 5) 8 Does not apply, primary site not bone marrow (C421)
    (All 5 SSDIs should be set to 5) 9 Unknown
    (All 5 SSDIs are 9 or blank; at least one is set to 9 OR
    Lymphocytosis is 0,7,9 OR
    Lymphocytosis is blank and one of the other SSDIs
    is a value other than 5 0r 9)
3956 P16 SSD5;9 SET
  • '0' FOR p16 Negative, Nonreactive;
  • '1' FOR p16 Positive - Diffuse, Strong reactivity;
  • '8' FOR N/A;
  • '9' FOR Not tested for p16 - Unknown;

  • LAST EDITED:  JUN 06, 2022
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Description: The p16 biomarker is over-expressed (produced) in response to HPV. It is therefore a surrogate marker for HPV disease.
    Rationale: Patients with HPV have a different survival or outcome so it is important to be able to distinguish this by documenting the p16 results. Testing is performed by immunohistochemistry (IHC) which is inexpensive
    and has near universal availability. It has an easily standardized interpretation. HPV testing is usually performed through DNA testing which is more expensive and less widely available. HPV testing also has technically
    more variability with the interpretation. p16 is a tumor suppressor protein also known as cyclin- dependent kinase inhibitor 2A. The p16 biomarker is over- expressed (produced) in response to HPV. It is therefore a
    surrogate marker for HPV disease.
    Codes: 0 p16 Negative; Nonreactive 1 p16 Positive; Diffuse, Strong reactivity 8 Not applicable: Information not collected for this case
    (If this time is required by your standard setter, use of
    code 8 will result in an edit error). 9 Not tested for p16; Unknown Blank Diagnosis year prior to 2021
    Note 1: This SSDI is effective for diagnosis years 2022+
    For cases diagnosed 2018-2021, leave this SSDI blank Note 2: Code 0 for p16 expression of weak intensity or limited distribution. Note 3: This data item must be based on testing results for p16
    overexpression.
    A statement of a patient being HPV positive or negative
    is not enough to code this data item
    Testing for HPV by DNA, mRNA, antibody, or other
    methods should not be coded in this data item Do not confuse p16 with HPV 16, which is a specific strain of virus
3957 LN STATUS PELVIC SSD5;10 SET
  • '0' FOR Negative pelvic lymph nodes;
  • '1' FOR Positive pelvic lymph nodes;
  • '8' FOR N/A;
  • '9' FOR Not documented on medical record;

  • LAST EDITED:  JUN 06, 2022
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Description: This data item describes the status of pelvic lymph nodes associated with certain female genital cancers.
    Rationale: Specific regional lymph node involvement is listed as a Registry Data Collection Variable in AJCC. This information was previously collected as Cervix SSF #2. Variable in AJCC. This information was previously
    collected as Cervix SSF #2.
    Codes: 0 Negative pelvic lymph nodes 1 Positive pelvic lymph nodes 8 Not applicable: Information not collected for this case (If this
    information is required by your standard setter, use of code 8
    may result in edit error.) 9 Not documented in medical record
    Pelvic lymph node(s) not assessed or unknown if assessed
3958 LN STATUS PARA-AORTIC SSD5;11 SET
  • '0' FOR Negative para-aortic lymph nodes;
  • '1' FOR Positive para-aortic lymph nodes;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUN 06, 2022
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Description: This data item describes the status of para-aortic lymph nodes associated with certain female genital cancers.
    Rationale: Specific regional lymph node involvement is listed as a Registry Data Collection Variable in AJCC. This information was previously collected as Vagina SSF #4.
    See Lymph Node Assessment Methods and Status for Regional and Distant Lymph Nodes in GYN sites for additional information.
    Codes: 0 Negative para-aortic lymph nodes 1 Positive para-aortic lymph nodes 8 Not applicable: Information not collected for this case (If
    this information is required by your standard setter, use
    of code 8 may result in an edit error.) 9 Not documented in medical record
    Para-aortic lymph node(s) not assessed or unknown if assessed
3959 LN STATUS FEMORAL-INGUINAL SSD5;12 SET
  • '0' FOR Negative femoral-inguinal lymph nodes;
  • '1' FOR Positive femoral-inguinal lymph nodes;
  • '8' FOR N/A;
  • '9' FOR Not documented in medical record;

  • LAST EDITED:  JUN 06, 2022
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Description: This data item describes the status of femoral-inguinal lymph nodes associated with certain female genital cancers.
    Rationale: Specific regional lymph node involvement is listed as a Registry Data Collection Variable in AJCC.
    See Lymph Node Assessment Methods and Status for Regional and Distant Lymph Nodes in GYN sites for additional information.
    Codes: 0 Negative femoral-inguinal lymph nodes 1 Positive femoral-inguinal lymph nodes 8 Not applicable: Information not collected for this case
    (If this information is required by your standard setter,
    use of code 8 may result in an edit error.) 9 Not documented in medical record Femoral-Inguinal lymph nodes not assessed or unknown if assessed
3960 HISTOLOGIC SUBTYPE SSD5;13 SET
  • '0' FOR Histology is not 8480;
  • '1' FOR Low-grade appendiceal mucinous neoplasm (LAMN);
  • '2' FOR High-grade appendiceal mucinous neoplasm (HAMN);
  • '3' FOR Mucinous/Mucus/Mucoid/Colloid adenocarcinoma/carcinoma;
  • '4' FOR Other terminology coded to 8480;

  • LAST EDITED:  SEP 26, 2023
  • HELP-PROMPT:  Enter a code from the list that corresponds to the histologic subtype of this patient's primary.
  • DESCRIPTION:  Histology code for appendiceal tumors (8480) is defined as "Mucinous Adenocarcinoma (in situ or invasive)." In the AJCC 8th chapter for Appendix-Carcinoma, there are also low-grade appendiceal mucinous neoplasm (LAMN) and
    high- grade appendiceal mucinous neoplasm (HAMN) diagnoses that are assigned the same histology.
3961 CLINICAL MARGIN WIDTH SSD5;14 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM
    MAXIMUM LENGTH: 4
  • LAST EDITED:  SEP 26, 2023
  • HELP-PROMPT:  Answer must be 1-4 characters in length. Enter the clinical margin width in centimeters as measured by the surgeon.
  • DESCRIPTION:  Clinical Margin Width describes the margins from a wide excision for a melanoma primary. The margin width is measured by the surgeon prior to the procedure. The measurement is taken, in centimeters, from the edge of the
    lesion or the prior excision scar to the peripheral margin of the specimen. 0.1 Documented as 0.1cm or less (1mm or less) 0.2-9.9 0.2 cm - 9.9 cm XX.1 10 centimeters or greater XX.8 Not Applicable.
    Information not collected for
    this schema (If this information is required
    by your standard setter, use of code XX.8 may
    result in an edit error) XX.9 Not documented in medical record
    No Wide Excision performed
    Mohs or similar procedure
    Wide Excision performed, but clinical margin
    width not documented.
    No surgical resection performed (B000)
    Unknown if procedure performed.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
3964 BRAIN PRIMARY TUMOR LOCATION SSD5;17 SET
  • '1' FOR Pons;
  • '2' FOR Subsite other than Pons;
  • '8' FOR Not applicable;
  • '9' FOR Brain stem, NOS;

  • LAST EDITED:  OCT 10, 2024
  • HELP-PROMPT:  Enter the appropriate code from the list.
  • DESCRIPTION:  This data item is to distinguish between the Pons and all other subsites within the Brain Stem (C717). This site specific data item is effective for diagnosis years 2024+. Codes: 1 Pons
    2 Subsite other than Pons Basis peduncle Cerebral peduncle Choroid plexus of fourth ventricle Fourth ventricle, NOS Infratentorial brain, NOS Medulla oblongata Midbrain Olive Pyramid
    8 Not applicable: Information not collected for this case (If this item is required by your standard setter, use of code 8 will result in an edit error.)
    9 Brain stem, NOS Unknown subsite of Brain Stem Primary Site is NOT C717 Diagnosis year is prior to 2024
5000 AJCC ID AJCC8;1 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1)!'(X?0.2"X"0.2N0.1"."0.1N0.4N) X
    MAXIMUM LENGTH: 4
  • LAST EDITED:  NOV 12, 2024
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  This field is the AJCC ID for the case. The values for this field are based on the chapters of the AJCC 8th Edition Staging Manual. The value will be derived primarily by the Site/Histology fields. For cases where
    staging is not available this field will be "XX".
    Starting with AJCC 9th Edition, there are no longer chapters and chapter numbers so this field will be in the 9001-9999 range.
5001 AJCC TNM CLIN T AJCC8;2 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=1 D AJCCIT^ONCSCHMG
    MAXIMUM LENGTH: 15
  • LAST EDITED:  FEB 13, 2019
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the clinical tumor (T) as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S ONCNODE=1 D AJCCHP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5002 AJCC TNM CLIN N AJCC8;3 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=2 D AJCCIT^ONCSCHMG
    MAXIMUM LENGTH: 15
  • LAST EDITED:  AUG 28, 2019
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the clinical nodes (N) as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S ONCNODE=2 D AJCCHP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5003 AJCC TNM CLIN M AJCC8;4 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=3 D AJCCIT^ONCSCHMG
    MAXIMUM LENGTH: 15
  • LAST EDITED:  JAN 30, 2019
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the clinical metastases (M) as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S ONCNODE=3 D AJCCHP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5004 AJCC TNM CLIN STAGE GROUP AJCC8;5 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S STGIND="C",ONCSHLST="NO" D INP^ONCSGA8H
    MAXIMUM LENGTH: 15
  • LAST EDITED:  AUG 20, 2021
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the clinical stage group as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S STGIND="C" D HELP^ONCSGA8H
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^G^MUMPS
    1)= D CSSG^ONCOCRC
    2)= D KSG^ONCOCRC
    Maintains STAGE GROUPING-AJCC Field (#38.5). See fields #38 and #88. This is an update for new AJCC TNM staging fields 8th Edition and beyond.
5011 AJCC TNM PATH T AJCC8;6 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=1,ONCTNMTP="P" D AJCCIT^ONCSCHMG
    MAXIMUM LENGTH: 15
  • LAST EDITED:  FEB 14, 2019
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the pathological tumor (T) as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S ONCNODE=1,ONCTNMTP="P" D AJCCHP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5012 AJCC TNM PATH N AJCC8;7 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=2,ONCTNMTP="P" D AJCCIT^ONCSCHMG
    MAXIMUM LENGTH: 15
  • LAST EDITED:  FEB 14, 2019
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the pathological nodes (T) as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S ONCNODE=2,ONCTNMTP="P" D AJCCHP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5013 AJCC TNM PATH M AJCC8;8 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=3 D AJCCIT^ONCSCHMG
    MAXIMUM LENGTH: 15
  • LAST EDITED:  OCT 30, 2018
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the pathological metastases (T) as defined by the currect AJCC edition.
  • EXECUTABLE HELP:  S ONCNODE=3 D AJCCHP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5014 AJCC TNM PATH STAGE GROUP AJCC8;9 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S STGIND="P",ONCSHLST="NO" D INP^ONCSGA8H
    MAXIMUM LENGTH: 15
  • LAST EDITED:  APR 06, 2021
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the pathological stage group as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S STGIND="P" D HELP^ONCSGA8H
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  165.5^H^MUMPS
    1)= D PSSG^ONCOCRC
    2)= D KSG^ONCOCRC
    Maintains STAGE GROUPING-AJCC Field (#38.5). See fields #38 and #88. This is an update for new AJCC TNM staging fields 8th Edition and beyond.
5021 AJCC TNM POST THER (yp) T AJCC8;10 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=1,ONCTNMTP="Y" D AJCCIT^ONCSCHMG
    MAXIMUM LENGTH: 15
  • LAST EDITED:  AUG 16, 2021
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the post-therapy path (yp) tumor (T) as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S ONCNODE=1,ONCTNMTP="Y" D AJCCHP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5022 AJCC TNM POST THER (yp) N AJCC8;11 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=2,ONCTNMTP="Y" D AJCCIT^ONCSCHMG
    MAXIMUM LENGTH: 15
  • LAST EDITED:  JUN 28, 2021
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the postneoadjuvant therapy Path nodes (N) as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S ONCNODE=2,ONCTNMTP="Y" D AJCCHP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5023 AJCC TNM POST THER (yp) M AJCC8;12 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=3 D AJCCIT^ONCSCHMG
    MAXIMUM LENGTH: 15
  • LAST EDITED:  JUN 28, 2021
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the postneoadjuvant therapy category matestases (M) as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S ONCNODE=3 D AJCCHP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5024 AJCC TNM POST THER (yp) SG AJCC8;13 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S STGIND="PT",ONCSHLST="NO" D INP^ONCSGA8H
    MAXIMUM LENGTH: 15
  • LAST EDITED:  JUN 28, 2021
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the postneoadjuvant therapy Path stage group as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S STGIND="PT" D HELP^ONCSGA8H
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5025 AJCC TNM POST THER (yc) T AJCC8;20 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=1,ONCTNMTP="Y",ONCYC="yc" D AJCCIT^ONCSCHMG
    MAXIMUM LENGTH: 15
  • LAST EDITED:  AUG 16, 2021
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the post-therapy clinical (yc) tumor (T) as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S ONCNODE=1,ONCTNMTP="Y",ONCYC="yc" D AJCCHP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5026 AJCC TNM POST THER (yc) N AJCC8;21 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=2,ONCTNMTP="Y",ONCYC="yc" D AJCCIT^ONCSCHMG
    MAXIMUM LENGTH: 15
  • LAST EDITED:  AUG 16, 2021
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the post-therapy clinical (yc) nodes (N) as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S ONCNODE=2,ONCTNMTP="Y",ONCYC="yc" D AJCCHP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5027 AJCC TNM POST THER (yc) M AJCC8;22 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=3 D AJCCIT^ONCSCHMG
    MAXIMUM LENGTH: 15
  • LAST EDITED:  JUN 28, 2021
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the post-therapy clinical (yc) metastases (M) as defined by the current AJCC edition.
  • EXECUTABLE HELP:  S ONCNODE=3 D AJCCHP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5028 AJCC TNM POST THER (yc) SG AJCC8;23 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X I $D(X) S STGIND="PT",ONCSHLST="NO" D INP^ONCSGA8H
    MAXIMUM LENGTH: 15
  • LAST EDITED:  JUN 28, 2021
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the post therapy clinical (yc) stage group as defined by AJCC.
  • EXECUTABLE HELP:  S STGIND="PT" D HELP^ONCSGA8H
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5031 AJCC TNM CLIN T SUFFIX AJCC8;14 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="T" D SUFFIT^ONCSCHMG
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 28, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  
    This field is the Clinical Suffix that may be added to the Clinical T-Code for AJCC 8th Edition staging.
  • EXECUTABLE HELP:  S ONCSFFX="T" D SUFFHLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5032 AJCC TNM PATH T SUFFIX AJCC8;16 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="T" D SUFFIT^ONCSCHMG
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 28, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  
    This field is the Pathologic Suffix that may be added to the Pathologic T-Code for AJCC 8th Edition staging.
  • EXECUTABLE HELP:  S ONCSFFX="T" D SUFFHLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5033 AJCC TNM POST THER (yp) T SFX AJCC8;18 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="T" D SUFFIT^ONCSCHMG
    MAXIMUM LENGTH: 4
  • LAST EDITED:  JUN 28, 2021
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  
    This field is the detailed site-specific codes for the postneoadjuvant therapy Path T category suffix as defined by AJCC.
  • EXECUTABLE HELP:  S ONCSFFX="T" D SUFFHLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5033.5 AJCC TNM POST THER (yc) T SFX AJCC8;24 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="T" D SUFFIT^ONCSCHMG
    MAXIMUM LENGTH: 4
  • LAST EDITED:  JUN 28, 2021
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the post therapy clinical (yc) tumor T category suffix as defined by AJCC.
  • EXECUTABLE HELP:  S ONCSFFX="T" D SUFFHLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5034 AJCC TNM CLIN N SUFFIX AJCC8;15 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="N" D SUFFIT^ONCSCHMG
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 28, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  
    This field is the Clinical Suffix that may be added to the Clinical N-Code for AJCC 8th Edition staging.
  • EXECUTABLE HELP:  S ONCSFFX="N" D SUFFHLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5035 AJCC TNM PATH N SUFFIX AJCC8;17 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="N" D SUFFIT^ONCSCHMG
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 28, 2019
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  
    This field is the Pathologic Suffix that may be added to the Pathologic N-Code for AJCC 8th Edition staging.
  • EXECUTABLE HELP:  S ONCSFFX="N" D SUFFHLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5036 AJCC TNM POST THER (yp) N SFX AJCC8;19 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="N" D SUFFIT^ONCSCHMG
    MAXIMUM LENGTH: 4
  • LAST EDITED:  JUN 28, 2021
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  
    This field is the detailed site-specific codes for the postneoadjuvant therapy Path N category suffix as defined by AJCC.
  • EXECUTABLE HELP:  S ONCSFFX="N" D SUFFHLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5036.5 AJCC TNM POST THER (yc) N SFX AJCC8;25 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="N" D SUFFIT^ONCSCHMG
    MAXIMUM LENGTH: 4
  • LAST EDITED:  JUN 28, 2021
  • HELP-PROMPT:  Answer must be 1-4 characters in length.
  • DESCRIPTION:  
    Detailed site-specific codes for the post therapy clinical (yc) N category suffix as defined by AJCC.
  • EXECUTABLE HELP:  S ONCSFFX="N" D SUFFHLP^ONCSCHMG
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5501 PHASE 1 DOSE PER FRACTION RAD18;1 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) D RADPH5^ONCSCHMM
    MAXIMUM LENGTH: 5
  • LAST EDITED:  MAR 26, 2020
  • HELP-PROMPT:  Answer must be 1-5 characters in length.
  • DESCRIPTION:  Records the dose per fraction (treatment session) delivered to the patient in the first phase of radiation during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for
    CoC-accredited facilities as of 01/01/2018. Rationale: Radiation therapy is delivered in one or more phases with identified dose per fraction. It is necessary to capture information describing the dose per fraction to
    evaluate patterns of radiation oncology care. Outcomes are strongly related to the dose delivered. Codes: 00000 Radiation therapy was not administered 00001-99997 Record the actual Phase I dose delivered in cGy 99998
    Not applicable, brachytherapy or
    radioisotopes administered to the patient 99999 Regional radiation therapy was administered
    but dose is unknown, it is unknown whether
    radiation therapy was administered.
    Death Certificate only.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5502 PHASE 1 RAD EXT BEAM PLAN TECH RAD18;2 POINTER TO ONCO RADIATION EXTERNAL BEAM FILE (#164.81) ONCO RADIATION EXTERNAL BEAM(#164.81)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.81,+Y,0)),U,2)
  • LAST EDITED:  JUL 11, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies the external beam radiation planning technique used to administer the first phase of radiation treatment during the first course of treatment. This data item is required for CoC-accredited facilities as of
    01/01/2018. Rationale: External beam radiation is the most commonly-used radiation modality in North America. In this data item we specified the planning technique for external beam treatment. Identifying the radiation
    technique is of interest for patterns of care and comparative effectiveness studies.
5503 PHASE 1 NUMBER OF FRACTIONS RAD18;3 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) D RADPH3^ONCSCHMM
    MAXIMUM LENGTH: 3
  • LAST EDITED:  OCT 09, 2019
  • HELP-PROMPT:  Answer must be 1-3 characters in length.
  • DESCRIPTION:  Records the total number of fractions (treatment sessions) delivered to the patient in the first phase of radiation during the first course of treatment. This data item is required for CoC-accredited facilities as of
    01/01/2018. Rationale: Radiation therapy is delivered in one or more phases with each phase spread out over a number of fractions (treatment sessions). It is necessary to capture information describing the number of
    fraction(s) to evaluate patterns of radiation oncology care. Codes: 000 Radiation therapy was not administered to the patient. 001-998 Number of fractions administered to the patient during
    the first phase of radiation therapy. 999 Phase I Radiation therapy was administered, but the
    number of fractions is unknown; It is unknown
    whether radiation therapy was administered.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5504 PHASE 1 RAD TREATMENT VOLUME RAD18;4 POINTER TO ONCO RADIATION TREATMENT VOLUME FILE (#164.82) ONCO RADIATION TREATMENT VOLUME(#164.82)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.82,+Y,0)),U,2)
  • LAST EDITED:  JUL 11, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies the primary treatment volume or primary anatomic target treated during the first phase of radiation therapy during the first course of treatment. This data item is required for CoC-accredited facilities as of
    01/01/2018. Rationale: Radiation treatment is commonly delivered in one or more phases. Typically, in each phase, the primary tumor or tumor bed is treated. This data item should be used to indicate the primary target
    volume, which might include the primary tumor or tumor bed. If the primary tumor was not targeted, record the other regional or distant site that was targeted. Draining lymph nodes may also be targeted during the first
    phase. These will be identified in a separate data item Phase I Radiation to Draining Lymph Nodes [1505].
    This data item provides information describing the anatomical structure targeted by radiation therapy during the first phase of radiation treatment and can be used to determine whether the site of the primary diseases was
    treated with radiation or if other regional or distant sites were targeted. This information is useful in evaluating the patterns of care within a facility and on a regional or national basis. The breakdown and
    reorganization of the sites will allow for concise reporting.
5505 PHASE 1 RAD TO DRAINING LN RAD18;5 POINTER TO ONCO RADIATION TO DRAINING LN FILE (#164.83) ONCO RADIATION TO DRAINING LN(#164.83)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.83,+Y,0)),U,2)
  • LAST EDITED:  JUL 11, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies the draining lymph nodes treated (if any) during the first phase of radiation therapy delivered to the patient during the first course of treatment. This data item is required for CoC-accredited facilities as of
    01/01/2018. Rationale: The first phase of radiation treatment commonly targets both the primary tumor (or tumor bed) and draining lymph nodes as a secondary site. This data item should be used to indicate the draining
    regional lymph nodes, if any, that were irradiated during the first phase of radiation.
5506 PHASE 1 RAD TREATMENT MODALITY RAD18;6 POINTER TO ONCO RADIATION TREATMENT MODALITY FILE (#164.84) ONCO RADIATION TREATMENT MODALITY(#164.84)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.84,+Y,0)),U,2)
  • LAST EDITED:  JUL 11, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies the radiation modality administered during the first phase of radiation treatment delivered during the first course of treatment. This data item is required for CoC-accredited facilities as of 01/01/2018.
    Rationale: Radiation modality reflects whether a treatment was external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of modalities. This data item should be used to indicate the
    radiation modality administered during the first phase of radiation.
5507 PHASE 1 TOTAL DOSE RAD18;7 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>6!($L(X)<1)!'(X?1.6N) X I $D(X) D RADPH6^ONCSCHMM
    MAXIMUM LENGTH: 6
  • LAST EDITED:  OCT 09, 2019
  • HELP-PROMPT:  Answer must be 1-6 characters in length.
  • DESCRIPTION:  Identifies the total radiation dose delivered to the patient in the first phase of radiation treatment during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for
    CoC-accredited facilities as of 01/01/2018. Rationale: To evaluate the patterns of radiation care, it is necessary to capture information describing the prescribed dose of Phase I radiation to the patient during the first
    course of treatment. Outcomes are strongly related to the total dose delivered. Codes: 000000 No therapy administered 000001-999997 Record the actual total dose delivered in cGy 999998 Not applicable, radioisotopes
    administered
    to the patient 999999 Radiation therapy was administered, but the
    dose is unknown; it is unknown whether
    radiation therapy was administered
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5511 PHASE 2 DOSE PER FRACTION RAD18;8 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) D RADPH5^ONCSCHMM
    MAXIMUM LENGTH: 5
  • LAST EDITED:  OCT 09, 2019
  • HELP-PROMPT:  Answer must be 1-5 characters in length.
  • DESCRIPTION:  Records the dose per fraction (treatment session) delivered to the patient in the second phase of radiation during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for
    CoC-accredited facilities as of 01/01/2018. Rationale: Radiation therapy is delivered in one or more phases with identified dose per fraction. It is necessary to capture information describing the dose per fraction to
    evaluate patterns of radiation oncology care. Outcomes are strongly related to the dose delivered. Codes: 00000 Radiation therapy was not administered 00001-99997 Record the actual Phase II dose delivered in cGy 99998
    Not applicable, brachytherapy or
    radioisotopes administered to the patient 99999 Regional radiation therapy was administered
    but dose is unknown, it is unknown whether
    radiation therapy was administered.
    Death Certificate only.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5512 PHASE 2 RAD EXT BEAM PLAN TECH RAD18;9 POINTER TO ONCO RADIATION EXTERNAL BEAM FILE (#164.81) ONCO RADIATION EXTERNAL BEAM(#164.81)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.81,+Y,0)),U,2)
  • LAST EDITED:  JUL 11, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies the external beam radiation planning technique used to administer the second phase of radiation treatment during the first course of treatment. This data item is required for CoC-accredited facilities for cases
    diagnosed as of 01/01/2018. Rationale: External beam radiation is the most commonly-used radiation modality in North America. In this data item we specified the planning technique for external beam treatment. Identifying
    the radiation technique is of interest for patterns of care and comparative effectiveness studies.
5513 PHASE 2 NUMBER OF FRACTIONS RAD18;10 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) D RADPH3^ONCSCHMM
    MAXIMUM LENGTH: 3
  • LAST EDITED:  OCT 09, 2019
  • HELP-PROMPT:  Answer must be 1-3 characters in length.
  • DESCRIPTION:  Records the total number of fractions (treatment sessions) administered to the patient in the second phase of radiation during the first course of treatment. This data item is required for CoC-accredited facilities for
    cases diagnosed as of 01/01/2018. Rationale: Radiation therapy is delivered in one or more phases with each phase spread out over a number of fractions (treatment sessions). It is necessary to capture information
    describing the number of fraction(s) to evaluate patterns of radiation oncology care. Codes: 000 Radiation therapy was not administered to the patient 001-998 Number of fractions administered to the patient during
    the second phase of radiation therapy 999 Phase II Radiation therapy was administered, but the
    number of fractions is unknown; It is unknown whether
    radiation therapy was administered
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5514 PHASE 2 RAD TREATMENT VOLUME RAD18;11 POINTER TO ONCO RADIATION TREATMENT VOLUME FILE (#164.82) ONCO RADIATION TREATMENT VOLUME(#164.82)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.82,+Y,0)),U,2)
  • LAST EDITED:  JUL 11, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies the primary treatment volume or primary anatomic target treated during the second phase of radiation therapy during the first course of treatment. This data item is required for CoC-accredited facilities as of
    cases diagnosed 01/01/2018. Rationale: Radiation treatment is commonly delivered in one or more phases. Typically, in each phase, the primary tumor or tumor bed is treated. This data item should be used to indicate the
    primary target volume, which might include the primary tumor or tumor bed. If the primary tumor was not targeted, record the other regional or distant site that was targeted. Draining lymph nodes may also be targeted
    during the second phase. These will be identified in a separate data item Phase II Radiation to Draining Lymph Nodes [1515].
5515 PHASE 2 RAD TO DRAINING LN RAD18;12 POINTER TO ONCO RADIATION TO DRAINING LN FILE (#164.83) ONCO RADIATION TO DRAINING LN(#164.83)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.83,+Y,0)),U,2)
  • LAST EDITED:  JUL 11, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies the draining lymph nodes treated (if any) during the second phase of radiation therapy delivered to the patient during the first course of treatment. This data item is required for CoC-accredited facilities as
    of cases diagnosed 01/01/2018. Rationale: The second phase of radiation treatment commonly targets both the primary tumor (or tumor bed) and draining lymph nodes as a secondary site. This data item should be used to
    indicate the draining regional lymph nodes, if any, that were irradiated during the second phase of radiation.
5516 PHASE 2 RAD TREATMENT MODALITY RAD18;13 POINTER TO ONCO RADIATION TREATMENT MODALITY FILE (#164.84) ONCO RADIATION TREATMENT MODALITY(#164.84)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.84,+Y,0)),U,2)
  • LAST EDITED:  JUL 11, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies the radiation modality administered during the second phase of radiation treatment delivered during the first course of treatment. This data item is required for CoC-accredited facilities as of 01/01/2018.
    Rationale: Radiation modality reflects whether a treatment was external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of modalities. This data item should be used to indicate the
    radiation modality administered during the second phase of radiation.
5517 PHASE 2 TOTAL DOSE RAD18;14 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>6!($L(X)<1)!'(X?1.6N) X I $D(X) D RADPH6^ONCSCHMM
    MAXIMUM LENGTH: 6
  • LAST EDITED:  OCT 09, 2019
  • HELP-PROMPT:  Answer must be 1-6 characters in length.
  • DESCRIPTION:  Identifies the total radiation dose administered in the second phase of radiation treatment delivered to the patient during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required
    for CoC-accredited facilities for cases diagnosed as of 01/01/2018. Rationale: To evaluate the patterns of radiation care, it is necessary to capture information describing the prescribed dose of Phase II radiation to the
    patient during the first course of treatment. Outcomes are strongly related to the total dose delivered. Codes 000000 No radiation treatment 000001-999997 Record the actual total dose delivered in cGy 999998 Not
    applicable, brachytherapy or radioisotopes
    administered to the patient 999999 Radiation therapy was administered, but the
    dose is unknown; it is unknown whether
    radiation therapy was administered
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5521 PHASE 3 DOSE PER FRACTION RAD18;15 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) D RADPH5^ONCSCHMM
    MAXIMUM LENGTH: 5
  • LAST EDITED:  OCT 09, 2019
  • HELP-PROMPT:  Answer must be 1-5 characters in length.
  • DESCRIPTION:  Records the dose per fraction (treatment session) delivered to the patient in the third phase of radiation during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for
    CoC-accredited facilities as of 01/01/2018. Rationale: Radiation therapy is delivered in one or more phases with identified dose per fraction. It is necessary to capture information describing the dose per fraction to
    evaluate patterns of radiation oncology care. Outcomes are strongly related to the dose delivered. Codes: 00000 Radiation therapy was not administered 00001-99997 Record the actual Phase II dose delivered in cGy 99998
    Not applicable, brachytherapy or
    radioisotopes administered to the patient 99999 Regional radiation therapy was administered
    but dose is unknown, it is unknown whether
    radiation therapy was administered.
    Death Certificate only.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5522 PHASE 3 RAD EXT BEAM PLAN TECH RAD18;16 POINTER TO ONCO RADIATION EXTERNAL BEAM FILE (#164.81) ONCO RADIATION EXTERNAL BEAM(#164.81)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.81,+Y,0)),U,2)
  • LAST EDITED:  JUL 11, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies the external beam radiation planning technique used to administer the third phase of radiation treatment during the first course of treatment. This data item is required for CoC-accredited facilities for cases
    diagnosed as of 01/01/2018. Rationale: External beam radiation is the most commonly-used radiation modality in North America. In this data item we specified the planning technique for external beam treatment. Identifying
    the radiation technique is of interest for patterns of care and comparative effectiveness studies.
5523 PHASE 3 NUMBER OF FRACTIONS RAD18;17 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) D RADPH3^ONCSCHMM
    MAXIMUM LENGTH: 3
  • LAST EDITED:  OCT 09, 2019
  • HELP-PROMPT:  Answer must be 1-3 characters in length.
  • DESCRIPTION:  Records the total number of fractions (treatment sessions) administered to the patient in the third phase of radiation during the first course of treatment. This data item is required for CoC-accredited facilities for
    cases diagnosed as of 01/01/2018. Rationale: Radiation therapy is delivered in one or more phases with each phase spread out over a number of fractions (treatment sessions). It is necessary to capture information
    describing the number of fraction(s) to evaluate patterns of radiation oncology care. Codes: 000 Radiation therapy was not administered to the patient 001-998 Number of fractions administered to the patient during
    the third phase of radiation therapy 999 Phase II Radiation therapy was administered, but the
    number of fractions is unknown; It is unknown whether
    radiation therapy was administered
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
5524 PHASE 3 RAD TREATMENT VOLUME RAD18;18 POINTER TO ONCO RADIATION TREATMENT VOLUME FILE (#164.82) ONCO RADIATION TREATMENT VOLUME(#164.82)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.82,+Y,0)),U,2)
  • LAST EDITED:  JUL 11, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies the primary treatment volume or primary anatomic target treated during the third phase of radiation therapy during the first course of treatment. This data item is required for CoC-accredited facilities as of
    cases diagnosed 01/01/2018. Rationale: Radiation treatment is commonly delivered in one or more phases. Typically, in each phase, the primary tumor or tumor bed is treated. This data item should be used to indicate the
    primary target volume, which might include the primary tumor or tumor bed. If the primary tumor was not targeted, record the other regional or distant site that was targeted. Draining lymph nodes may also be targeted
    during the second phase. These will be identified in a separate data item Phase II Radiation to Draining Lymph Nodes [1515].
5525 PHASE 3 RAD TO DRAINING LN RAD18;19 POINTER TO ONCO RADIATION TO DRAINING LN FILE (#164.83) ONCO RADIATION TO DRAINING LN(#164.83)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.83,+Y,0)),U,2)
  • LAST EDITED:  JUL 11, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies the draining lymph nodes treated (if any) during the third phase of radiation therapy delivered to the patient during the first course of treatment. This data item is required for CoC-accredited facilities as of
    cases diagnosed 01/01/2018. Rationale: The third phase of radiation treatment commonly targets both the primary tumor (or tumor bed) and draining lymph nodes as a secondary site. This data item should be used to indicate
    the draining regional lymph nodes, if any, that were irradiated during the second phase of radiation.
5526 PHASE 3 RAD TREATMENT MODALITY RAD18;20 POINTER TO ONCO RADIATION TREATMENT MODALITY FILE (#164.84) ONCO RADIATION TREATMENT MODALITY(#164.84)

  • OUTPUT TRANSFORM:  S Y=$P($G(^ONCO(164.84,+Y,0)),U,2)
  • LAST EDITED:  JUL 11, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies the radiation modality administered during the third phase of radiation treatment delivered during the first course of treatment. This data item is required for CoC-accredited facilities as of 01/01/2018.
    Rationale: Radiation modality reflects whether a treatment was external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of modalities. This data item should be used to indicate the
    radiation modality administered during the second phase of radiation.
5527 PHASE 3 TOTAL DOSE RAD18;21 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>6!($L(X)<1)!'(X?1.6N) X I $D(X) D RADPH6^ONCSCHMM
    MAXIMUM LENGTH: 6
  • LAST EDITED:  OCT 09, 2019
  • HELP-PROMPT:  Answer must be 1-6 characters in length.
  • DESCRIPTION:  Identifies the total radiation dose administered in the second phase of radiation treatment delivered to the patient during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required
    for CoC-accredited facilities for cases diagnosed as of 01/01/2018. Rationale: To evaluate the patterns of radiation care, it is necessary to capture information describing the prescribed dose of Phase II radiation to the
    patient during the first course of treatment. Outcomes are strongly related to the total dose delivered. Codes 000000 No radiation treatment 000001-999997 Record the actual total dose delivered in cGy 999998 Not
    applicable, brachytherapy or radioisotopes
    administered to the patient 999999 Radiation therapy was administered, but the
    dose is unknown; it is unknown whether
    radiation therapy was administered
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
7000 STATE AT DX GEOCODE 1970/80/90 NCR18;1 POINTER TO STATE FILE (#5) STATE(#5)

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a valid state.
  • DESCRIPTION:  Code for the state of the patient's residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 1970, 1980, or 1990 Decennial Census. Rationale: Populating the
    GeoLocationID 70/80/90 [351] correctly requires FIPS code for state and not the USPS abbreviations. Also, on rare occasions, the boundaries of states do change (North Carolina and South Carolina border, for example).
7001 STATE AT DX GEOCODE 2010 NCR18;2 POINTER TO STATE FILE (#5) STATE(#5)

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a valid state.
  • DESCRIPTION:  Code for the state of the patient's residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 2010 Decennial Census. Rationale: Populating the GeoLocationID 2010
    [353] correctly requires FIPS code for state and not the USPS abbreviations. Also, on rare occasions, the boundaries of states do change (North Carolina and South Carolina border, for example).
7002 BEHAVIOR (73-91) ICD-O-1 NCR18;3 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Type a number between 0 and 9, 0 decimal digits.
  • DESCRIPTION:  Area for retaining behavior portion (1 digit) of the ICD-O-1 or field trial morphology codes entered before a conversion to ICD-O-2. See grouped data item Morph (73-91) ICD-O-1 [1970] in Appendix E. The item name includes
    years 73-91. However, some states may have used the codes for cases before 1973. It is a subfield of the morphology code. Codes: For tumors diagnosed before 1992, contains the ICD-O-1 or field trial 1-digit behavior code
    as originally coded, if available. Blank for tumors coded directly into a later version of ICD-O.
7003 GRADE (73-91) ICD-O-1 NCR18;4 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Type a number between 0 and 9, 0 decimal digits.
  • DESCRIPTION:  Area for retaining the grade portion (1 digit) of the ICD-O-1 or field trial grade code entered before a conversion to ICD-O-2. See grouped data item Morph (73-91) ICD-O-1 [1970] in Appendix E. The item name includes years
    1973-91. However, some states may have used the codes for cases before 1973. Codes: For cases diagnosed before 1992, contains the ICD-O-1 or field trial 1-digit grade code as originally coded, if available.
7004 RUCA 2000 NCR18;5 SET
  • '1' FOR Urban commuting area RUCA 1.0,1.1,2.0,2.1,3.0,4.1,5.1,7.1,8.1,10.1;
  • '2' FOR Not an urban commuting area;
  • '9' FOR Unknown or census tract N/A RUCA 99;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  A measure of how accessible to an urban center a cancer patient's census tract at diagnosis is based on the USDA identification of urban and rural commuting areas. The variable is a binomial-either in an urban commuting
    area or not. The measure indicates proximity to large urban centers and can be an indicator of access to oncology specialists and cancer treatment facilities. Collecting the variable with each decennial census allows for
    retrospective and cross- sectional epidemiologic analysis.
7005 RUCA 2010 NCR18;6 SET
  • '1' FOR Urban commuting area RUCA 1.0,1.1,2.0,2.1,3.0,4.1,5.1,7.1,8.1,10.1;
  • '2' FOR Not an urban commuting area;
  • '9' FOR Unknown or census tract N/A RUCA 99;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  A measure of how accessible to an urban center a cancer patient's census tract at diagnosis is based on the USDA identification of urban and rural commuting areas. The variable is a binomial-either in an urban commuting
    area or not. The measure indicates proximity to large urban centers and can be an indicator of access to oncology specialists and cancer treatment facilities. Collecting the variable with each decennial census allows for
    retrospective and cross- sectional epidemiologic analysis.
7006 URIC 2000 NCR18;7 SET
  • '1' FOR All Urban;
  • '2' FOR Mostly Urban;
  • '3' FOR Mostly Rural;
  • '4' FOR All Rural;
  • '9' FOR Unknown or N/A;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  A measure of how urban a cancer patient's census tract at diagnosis is based on the Census Bureau's identification of urban and rural areas (already collect at county-level). The variable is a 4 code continuum. The
    measure indicates of the rural nature of the place of residence and can be an indicator of access to recreation, access to food stores, exposures to pollutants, crime levels, social cohesion, etc. Collecting the variable
    with each decennial census allows for retrospective and cross-sectional epidemiologic analysis. Codes:
    1 All urban-the percent of the population in an urban area = 100%
    2 Mostly urban-the percent of the population in an urban area < 100% and = 50%
    3 Mostly rural-the percent of the population in an urban area > 0% and < 50%
    4 All rural-the percent of the population in an urban area = 0%
    9 Unknown or not applicable-census tract not available or tract population was zero at the last decadal census
7007 URIC 2010 NCR18;8 SET
  • '1' FOR All Urban;
  • '2' FOR Mostly Urban;
  • '3' FOR Mostly Rural;
  • '4' FOR All Rural;
  • '9' FOR Unknown or N/A;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  A measure of how urban a cancer patient's census tract at diagnosis is based on the Census Bureau's identification of urban and rural areas (already collect at county-level). The variable is a 4 code continuum. The
    measure indicates of the rural nature of the place of residence and can be an indicator of access to recreation, access to food stores, exposures to pollutants, crime levels, social cohesion, etc. Collecting the variable
    with each decennial census allows for retrospective and cross-sectional epidemiologic analysis. Codes:
    1 All urban-the percent of the population in an urban area = 100%
    2 Mostly urban-the percent of the population in an urban area < 100% and = 50%
    3 Mostly rural-the percent of the population in an urban area > 0% and < 50%
    4 All rural-the percent of the population in an urban area = 0%
    9 Unknown or not applicable-census tract not available or tract population was zero at the last decadal census
7008 DERIVED EOD 2018 T NCR18;9 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X
    MAXIMUM LENGTH: 15
  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  This item stores the derived EOD 2018 T value derived from coded fields using the EOD algorithm. Effective for cases diagnosed 1/1/2018+. Rationale: Derived EOD 2018 T can be used to evaluate disease spread at diagnosis,
    treatment patterns and outcomes over time.
    Derived EOD 2018 T is only available at the central registry level. Codes: See the most current version of EOD (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding structures.
7009 DERIVED EOD 2018 N NCR18;10 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X
    MAXIMUM LENGTH: 15
  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  This item stores the derived EOD 2018 N value derived from coded fields using the EOD algorithm. Effective for cases diagnosed 1/1/2018+. Rationale: Derived EOD 2018 N can be used to evaluate disease spread at diagnosis,
    treatment patterns and outcomes over time.
    Derived EOD 2018 N is only available at the central registry level. Codes: See the most current version of EOD (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding structures.
7010 DERIVED EOD 2018 M NCR18;11 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X
    MAXIMUM LENGTH: 15
  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  This item stores the derived EOD 2018 M value derived from coded fields using the EOD algorithm. Effective for cases diagnosed 1/1/2018+. Rationale: Derived EOD 2018 M can be used to evaluate disease spread at diagnosis,
    treatment patterns and outcomes over time.
    Derived EOD 2018 M is only available at the central registry level. Codes: See the most current version of EOD (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding structures.
7011 DERIVED EOD 2018 STAGE GROUP NCR18;12 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X
    MAXIMUM LENGTH: 15
  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  This item stores the derived EOD 2018 SG value derived from coded fields using the EOD algorithm. Effective for cases diagnosed 1/1/2018+. Rationale: Derived EOD 2018 SG can be used to evaluate disease spread at
    diagnosis, treatment patterns and outcomes over time.
    Derived EOD 2018 SG is only available at the central registry level. Codes: See the most current version of EOD (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding structures.
7012 DERIVED SUMMARY STAGE 2018 NCR18;13 SET
  • '0' FOR In situ;
  • '1' FOR Localized;
  • '2' FOR Regional, direct ext only;
  • '3' FOR Regional, reg LN only;
  • '4' FOR Regional, direct ext and reg LN;
  • '7' FOR Distant;
  • '8' FOR Benign, borderline;
  • '9' FOR Unknown;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Derived Summary Stage 2018 is derived using the EOD data collection system (EOD Primary Tumor [772], EOD Regional Nodes [774] and EOD Mets [776]) algorithm. Other data items may be included in the derivation process.
    Effective for cases diagnosed 1/1/2018+. Rationale: The SEER program has collected staging information on cases since its inception in 1973. Summary Stage groups cases into broad categories of in situ, local, regional,
    and distant. Summary Stage can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time.
  • NOTES:  TRIGGERED by the SUMMARY STAGE 2018 field of the ONCOLOGY PRIMARY File
7013 DATE REGIONAL LN DISSECTION NCR18;14 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  OCT 17, 2019
  • HELP-PROMPT:  Enter the date NON-SENTINEL regional node dissection was performed.
  • DESCRIPTION:  Records the date NON-SENTINEL regional node dissection was performed. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. Rationale: It is a known fact that sentinel lymph
    node biopsies have been under-reported. Additionally, the timing and results of sentinel lymph node biopsy procedures are used in quality of care measures. This data item can be used to more accurately assess the date of
    regional node dissection separate from the date of sentinel lymph node biopsy if performed.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
7014 DATE REG LN DISSECTION FLAG NCR18;15 SET
  • '10' FOR No information whatsoever can be inferred from this exceptional value;
  • '11' FOR No proper value is applicable in this context;
  • '12' FOR A proper value is applicable but not known;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This flag explains why there is no appropriate value in the corresponding date data item, Date of Regional Lymph Node Dissection [682]. This data item is required for CoC-accredited facilities as of cases diagnosed
    01/01/2018 and later.
    Coding Instructions: -Leave this item blank if Date of Regional Lymph Node Dissection has a
    full or partial date recorded -Code 10 if it is unknown whether Regional Lymph Nodes were dissected. -Code 11 if no Regional Lymph Nodes were dissected. -Code 12 if the Date of the Regional Lymph Node Dissection
    cannot be
    determined, but regional lymph nodes were dissected.
7015 SENTINEL LYMPH NODES POSITIVE NCR18;16 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  SEP 18, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  Records the exact number of sentinel lymph nodes biopsied by the pathologist and found to contain metastases. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. This data
    item is required for breast and melanoma cases only. Rationale: It is a known fact that sentinel lymph node biopsies have been under- reported. Additionally, the timing and results of sentinel lymph node biopsy procedures
    are used in quality of care measures. This data item can be used to more accurately assess the number of positive sentinel lymph nodes biopsied separate from the number of positive lymph nodes identified during additional
    subsequent regional node dissection procedures, if performed. Codes: 00 All sentinel nodes examined are negative 01-90 Sentinel nodes are positive (code exact number of nodes positive) 95 Positive aspiration of
    sentinel lymph node(s) was performed 97 Positive sentinel nodes are documented, but the number is unspecified; For breast ONLY: SLN and RLND occurred during the same procedure 98 No sentinel nodes were biopsied 99 It is
    unknown whether sentinel nodes are positive; not applicable; not stated in patient record
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
7016 SENTINEL LYMPH NODES EXAMINED NCR18;17 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) D GEN2^ONCSCHMM
    MAXIMUM LENGTH: 2
  • LAST EDITED:  SEP 18, 2019
  • HELP-PROMPT:  Answer must be 1-2 characters in length.
  • DESCRIPTION:  Records the exact number of sentinel lymph nodes biopsied by the pathologist and found to contain metastases. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. This data
    item is required for breast and melanoma cases only. Rationale: It is a known fact that sentinel lymph node biopsies have been under- reported. Additionally, the timing and results of sentinel lymph node biopsy procedures
    are used in quality of care measures. This data item can be used to more accurately assess the number of positive sentinel lymph nodes biopsied separate from the number of positive lymph nodes identified during additional
    subsequent regional node dissection procedures, if performed. Codes: 00 No sentinel nodes were examined 01-90 Sentinel nodes were examined (code the exact number of sentinel lymph nodes examined) 95 No sentinel nodes
    were removed, but aspiration of sentinel node(s) was perf ormed 98 Sentinel lymph nodes were biopsied, but the number is unknown 99 It is unknown whether sentinel nodes were examined; not stated in patient record
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
7017 DATE OF SENTINEL LN BIOPSY NCR18;18 DATE

  • INPUT TRANSFORM:  D DFIT^ONCODSR
  • OUTPUT TRANSFORM:  S X=Y D DATEOT^ONCOES
  • LAST EDITED:  OCT 07, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Records the date of the sentinel lymph node(s) biopsy procedure. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. This data item is required for breast and melanoma
    cases only.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
7018 DATE OF SENTINEL LN BIOPSY FLG NCR18;19 SET
  • '10' FOR No information whatsoever can be inferred from this exceptional value;
  • '11' FOR No proper value is applicable in this context;
  • '12' FOR A proper value is applicable but unknown;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This flag explains why there is no appropriate value in the corresponding date data item, Date of Sentinel Lymph Node Biopsy [832]. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018
    and later. This data item is required for breast and melanoma cases only.
    Coding Instructions: -Leave this item blank if Date of Sentinel Lymph Node Biopsy has a full
    or partial date recorded. -Code 10 if it is unknown whether sentinel lymph nodes were biopsied. -Code 11 if no sentinel lymph node biopsy was performed. -Code 12 if the Date of Sentinel Lymph Node Biopsy cannot be
    determined,
    but a sentinel lymph node biopsy was performed.
7019 NPCR DERIVED AJCC8 CLN STG GRP NCR18;20 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X
    MAXIMUM LENGTH: 15
  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  This item stores the results of NPCR's derived algorithmic calculation of clinical stage group based on AJCC T, N, and M and relevant biomarkers and prognostic factors. The algorithm derives AJCC 8th ed. stage group for
    2018, however, updates to future AJCC editions are anticipated. The derived values for 7th ed. were stored in NPCR Derived Clin Stg Grp [3650]. Rationale: The purpose of the derived stage fields is to segregate data
    values for AJCC stage groups derived from the NPCR algorithm from values directly entered from the medical record or by the registrar. NPCR's primary interest is in the directly-entered values, but derived values will have
    a purpose primarily at the central registry. It is important to not mix data values from the two sources in the same data items. This item was added in 2018 because the required length to hold AJCC stage group values
    increased from 4 columns to 15. Codes (in addition to those published in the AJCC Cancer Staging Manual)
    88 Not applicable
    99 Unknown
    BlankNot staged
7020 NPCR DERIVED AJCC8 PTH STG GRP NCR18;21 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X
    MAXIMUM LENGTH: 15
  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  This item stores the results of NPCR's derived algorithmic calculation of pathologic stage group based on AJCC T, N, and M and relevant biomarkers and prognostic factors. The algorithm derives AJCC 8th ed. stage group for
    2018, however, updates to future AJCC editions are anticipated. The derived values for 7th ed. were stored in NPCR Derived Path Stg Grp [3650]. Rationale: The purpose of the derived stage fields is to segregate data
    values for AJCC stage groups derived from the NPCR algorithm from values directly entered from the medical record or by the registrar. NPCR's primary interest is in the directly-entered values, but derived values will have
    a purpose primarily at the central registry. It is important to not mix data values from the two sources in the same data items. This item was added in 2018 because the required length to hold AJCC stage group values
    increased from 4 columns to 15. Codes (in addition to those published in the AJCC Cancer Staging Manual)
    88 Not applicable
    99 Unknown
    BlankNot staged
7021 NPCR DERIVED AJCC8 PT STG GRP NCR18;22 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>15!($L(X)<1) X
    MAXIMUM LENGTH: 15
  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Answer must be 1-15 characters in length.
  • DESCRIPTION:  This item stores the results of NPCR's derived algorithmic calculation of post-therapy stage group based on AJCC T, N, and M and relevant biomarkers and prognostic factors. The algorithm derives AJCC 8th ed. stage group
    for 2018, however, updates to future AJCC editions are anticipated. The derived values for 7th ed. were stored in NPCR Derived Post-Therapy Stg Grp [3650]. Rationale: The purpose of the derived stage fields is to
    segregate data values for AJCC stage groups derived from the NPCR algorithm from values directly entered from the medical record or by the registrar. NPCR's primary interest is in the directly-entered values, but derived
    values will have a purpose primarily at the central registry. It is important to not mix data values from the two sources in the same data items. This item was added in 2018 because the required length to hold AJCC stage
    group values increased from 4 columns to 15. Codes (in addition to those published in the AJCC Cancer Staging Manual)
    88 Not applicable
    99 Unknown
    BlankNot staged
7022 NPCR SPECIFIC FIELD NCR18;23 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>75!($L(X)<1) X
    MAXIMUM LENGTH: 75
  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Answer must be 1-75 characters in length.
  • DESCRIPTION:  A 75 character field to be used when information for a particular primary site needs to be collected by NPCR. This field allows NPCR to retain data collected through the CER project and is a place holder when additional
    site-specific information is needed.
7023 STATE AT DX GEOCODE 2000 NCR18;24 POINTER TO STATE FILE (#5) STATE(#5)

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a valid state.
  • DESCRIPTION:  Code for the state of the patient's residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 2000 Decennial Census. Rationale: Populating the GeoLocationID 2000
    [353] correctly requires FIPS code for state and not the USPS abbreviations. Also, on rare occasions, the boundaries of states do change (North Carolina and South Carolina border, for example).
7024 NUMBER OF PHASES RAD TX NCR18B;1 SET
  • '00' FOR No Radiation Treatment;
  • '01' FOR 1 phase;
  • '02' FOR 2 phases;
  • '03' FOR 3 phases;
  • '04' FOR 4 or more phases;
  • '99' FOR Unknown number of phases;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Identifies the total number of phases administered to the patient during the first course of treatment. A "phase" consists of one or more consecutive treatments delivered to the same anatomic volume with no change in the
    treatment technique. Although the majority of courses of radiation therapy are completed in one or two phases (historically, the "regional" and "boost" treatments) there are occasions in which three or more phases are
    used, most typically with head and neck malignancies. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later.
7025 RADIATION TREATMENT DISC EARLY NCR18B;2 SET
  • '00' FOR No rad TX;
  • '01' FOR Completed as prescribed;
  • '02' FOR Toxicity;
  • '03' FOR Contraindicated;
  • '04' FOR Patient decision;
  • '05' FOR Family decision;
  • '06' FOR Patient expired;
  • '07' FOR Not documented;
  • '99' FOR Unknown;

  • LAST EDITED:  FEB 10, 2020
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This field is used to identify patients/tumors whose radiation treatment course was discontinued earlier than initially planned. That is the patients/tumors received fewer treatment fractions (sessions) than originally
    intended by the treating physician. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. Codes: 00 No radiation treatment 01 Radiation treatment completed as prescribed
    02 Radiation treatment discontinued early - toxicity 03 Radiation treatment discontinued early - contraindicated due
    to other patient risk factors (comorbid conditions, advanced age,
    progression of tumor prior to planned radiation etc.) 04 Radiation treatment discontinued early - patient decision 05 Radiation discontinued early - family decision 06 Radiation discontinued early - patient
    expired 07 Radiation discontinued early - reason not documented 99 Unknown if radiation treatment discontinued; Unknown whether radiation therapy administered
7026 TOTAL DOSE NCR18B;3 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>6!($L(X)<1)!'(X?1.6N) X I $D(X) D RADPH6^ONCSCHMM
    MAXIMUM LENGTH: 6
  • LAST EDITED:  MAR 30, 2020
  • HELP-PROMPT:  Answer must be 1-6 characters in length.
  • DESCRIPTION:  Identifies the total radiation dose administered to the patient across all phases during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for CoC-accredited facilities as of
    cases diagnosed 01/01/2018 and later. To evaluate the patterns of radiation care, it is necessary to capture information describing the prescribed total dose of radiation during the first course of treatment. Outcomes are
    strongly related to the dose delivered. Codes: 000000 No radiation treatment 000001-999997 Record the actual dose delivered in cGy 999998 Not applicable, radioisotopes administered
    to the patient 999999 Radiation therapy was administered, but the
    dose is unknown; it is unknown whether
    radiation therapy was administered
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
7027 OVER-RIDE TNM STAGE NCR18B;4 SET
  • '1' FOR Reviewed and confirmed as reported;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter 1 or leave blank.
  • DESCRIPTION:  Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate
    that data in a record (or records) have been reviewed and, while unusual, are correct. This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software: Primary Site, TNM Clin Stage Valid A- Ed
    7 (CoC) Primary Site, TNM Clin Stage Valid B- Ed 7 (CoC) Primary Site, TNM Path Stage Valid A- Ed 7 (CoC) Primary Site, TNM Path Stage Valid B- Ed 7 (CoC) These edits check T, N, and M combinations against stage group.
    Adding this over-ride allows the edit to pass when combinations of T, N, and M are entered that are not included in the stage tables used with the edits. Rationale This over-ride will allow registrars to enter combination
    of T, N, and M with a stage group that differs from the combinations documented in the AJCC Staging Manual. Codes:
    1 Reviewed and confirmed as reported
    BlankNot reviewed or reviewed and corrected
7028 OVER-RIDE TNM TIS NCR18B;5 SET
  • '1' FOR Reviewed and confirmed as reported;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter 1 or leave blank.
  • DESCRIPTION:  Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate
    that data in a record (or records) have been reviewed and, while unusual, are correct. This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software: TNM Clin T, N, M, In Situ (CoC) TNM Path
    T, N, M, In Situ (CoC) If the patient has a T value indicating in situ/ noninvasive, this edit verifies that the N, M, and stage group reflect in situ/noninvasive disease. However, there are certain circumstances where
    AJCC does allow a T value indicating in situ/noninvasive and N, M, and/or stage group that indicates invasive disease. An over-ride is required to accommodate these situations. Rationale This over-ride will allow
    registrars to enter combination of T, N, and M with a stage group that differs from the combinations documented in the AJCC Staging Manual. Codes:
    1 Reviewed and confirmed as reported
    BlankNot reviewed or reviewed and corrected
7029 OVER-RIDE TNM 3 NCR18B;6 SET
  • '1' FOR Reviewed and confirmed as reported;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter 1 or leave blank.
  • DESCRIPTION:  Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate
    that data in a record (or records) have been reviewed and, while unusual, are correct. Rationale This over-ride will allow registrars to enter combination of T, N, and M with a stage group that differs from the
    combinations documented in the AJCC Staging Manual. Codes:
    1 Reviewed and confirmed as reported
    BlankNot reviewed or reviewed and corrected
7030 OVER-RIDE NAME/SEX NCR18B;7 SET
  • '1' FOR Reviewed and confirmed as reported;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter 1 or leave blank.
  • DESCRIPTION:  This over-ride is used with the following edit in the NAACCR Metafile of the EDITS software: Sex, Name-First, Date of Birth (NAACCR) Rationale: Some edits check for code combinations that are possible, but quite rare. If
    the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data
    Edits and Software Coordination of Standards. Over-ride flag as used in the EDITS Software Package Edits of the type Sex, Name does not allow extremely rare or nonexistent combinations of first name and sex, such as
    John/female. Codes:
    1 Reviewed and confirmed as reported
    BlankNot reviewed or reviewed and corrected
7031 HISTOLOGY (73-91) ICD-O-1 NCR18B;8 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9999)!(X<0)!(X?.E1"."1N.N) X
  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Type a number between 0 and 9999, 0 decimal digits.
  • DESCRIPTION:  Area for retaining the histology portion (4 digits) of the ICD-O-1 or field trial morphology codes entered before a conversion to ICD-O-2. See grouped data item Morph (73-91) ICD-O-1 [1970], in Appendix E. The item name
    includes years 1973-91. However, some states may have used the codes for cases before 1973. Codes: For cases diagnosed before 1992, contains the ICD-O-1 or field trial 4-digit histology code as originally coded, if
    available. Blank for tumors coded directly into ICD-O-2 or ICD-O-3 (i.e., 1992 and later cases).
7032 RQRS NCDB SUBMISSION FLAG NCR18B;9 SET
  • '1' FOR Data Submission for RQRS;
  • '2' FOR Data Submission for NCDB Annual Call for Data;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This flag identifies the type of data submission from reporting facilities to the CoC National Cancer Database (NCDB). This data item is required for CoC-accredited facilities with submission starting 01/01/2018.
    Rationale: CoC-accredited hospitals make multiple data submissions for various reasons: Rapid Quality Reporting System (current, generally incomplete cases) NCDB Call for Data (older, complete cases) The NCDB is moving to
    submission of data via a single data portal rather than the current separate data portals for RQRS and NCDB. This data item will facilitate identification of the purpose of the data submission at the receiving end. Codes
    1 Data Submission for RQRS
    2 Data Submission for NCDB Annual Call for Data
7033 COC ACCREDITED FLAG NCR18B;10 SET
  • '0' FOR Abstract prepared at a facility WITHOUT CoC;
  • '1' FOR ANALYTIC abstract prepared at facility WITH CoC;
  • '2' FOR NON-ANALYTIC abstract prepared at facility WITH CoC;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  CoC Accredited Flag is assigned at the point and time of data abstraction to label an abstract being prepared for an analytic cancer case at a facility accredited by the Commission on Cancer (CoC). The flag may be assigned
    manually or can be defaulted by the registry's software. Codes
    0 Abstract prepared at a facility WITHOUT CoC
    accreditation of its cancer program
    1 ANALYTIC abstract prepared at facility WITH
    CoC accreditation of its cancer program (Includes Class of Case codes 10-22)
    2 NON-ANALYTIC abstract prepared at facility
    WITH CoC accreditation of its cancer program (Includes Class of Case codes 30-43 and 99, plus code 00 which CoC considers analytic but does not require to be staged)
    BlankNot applicable; DCO
7034 VITAL STATUS RECODE NCR18B;11 SET
  • '0' FOR Dead as of study cutoff date;
  • '1' FOR Alive as of study cutoff date;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This variable is akin to Vital Status [1760], with the exception that any patient that dies after the follow-up cut-off date is recoded to alive as of the cut-off date. This variable is used as part of the algorithm for
    calculating the survival time recode variables (NAACCR items 1782- 1788) and is used for survival, prevalence, and multiple primary - standardized incidence ratio analyses in SEER*Stat. This recode is necessary to conduct
    survival and prevalence analyses outside of SEER*Stat using other statistical software.
7037 RECORD NUMBER RECODE NCR18B;14 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99)!(X<1)!(X?.E1"."1N.N) X
  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Type a number between 1 and 99, 0 decimal digits.
  • DESCRIPTION:  This variable sequentially numbers a person's tumors within each dataset. The ordered values are based on date of diagnosis and then sequence number central. This variable is used as part of the algorithm for calculating
    the survival time recode variables (NAACCR items 1782-1788) and is used for survival, prevalence, and multiple primary - standardized incidence ratio analyses in SEER*Stat. Codes:
    01 Record number 01 for patient in database
    02 Record number 02 for patient in database
    ...
    99 Record number 99 for patient in database
7038 SEER CAUSE SPECIFIC COD NCR18B;15 SET
  • '0' FOR Alive or dead of other cause;
  • '1' FOR Dead (attributable to this cancer dx);
  • '8' FOR Missing/Unknown cause of death;
  • '9' FOR Not applicable/Not first tumor;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  This variable was created for use in cause-specific survival and designates that the person died of their cancer. Adapted from http://seer.cancer.gov/causespecific/: Cause-specific survival is a net survival measure
    representing survival of a specified cause of death in the absence of other causes of death. Estimates are calculated by specifying the cause of death. Individuals who die of causes other than the specified cause are
    considered to be censored. This requires a cause of death variable that accurately captures all causes related to the specific cause. Vital records offices use algorithms to process causes of death from death certificates
    in order to identify a single, disease-specific, underlying cause of death. In some cases, attribution of a single cause of death may be difficult and misattribution may occur. For example a death may be attributed to the
    site of metastasis instead of the primary site.
7039 SEER OTHER COD NCR18B;16 SET
  • '0' FOR Alive or dead due to cancer;
  • '1' FOR Dead (attributable to causes other than this cancer diagnosis);
  • '8' FOR Missing/Unknown cause of death;
  • '9' FOR Not applicable/not first tumor;

  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Enter a code from the list.
  • DESCRIPTION:  Using the same recoding logic as the 'SEER cause-specific death classification' variable, the 'SEER other cause of death classification' variable designates that the person died of causes other than their cancer. Adapted
    from http://seer.cancer.gov/causespecific/: The 'SEER other cause of death classification' variable is used to obtain the other-cause survival probability for a cohort of patients. It is used when deaths attributed to
    causes other than cancer are treated as events and deaths from cancer are treated as censored observation. This variable is used in the SEER*Stat left-truncated life table session. -specific survival and crude probability
    of death using cause of death information.
7040 MEDICARE BENEFICIARY ID NCR18B;17 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>11!($L(X)<1)!'(X?1.11AN) X
    MAXIMUM LENGTH: 11
  • LAST EDITED:  FEB 06, 2019
  • HELP-PROMPT:  Answer must be 1-11 characters in length.
  • DESCRIPTION:  Congress passed the Medicare Access and CHIP Reauthorization ACT to remove Social Security Number (SSN) from Medicare ID card and replace the existing Medicare Health Insurance Claim Numbers with a Medicare Beneficiary
    Identifier (MBI). The MBI will be a randomly generated identifier that will not include a SSN or any personal identifiable information.
10104 RX HOSP--SURG BREAST 3.2;4 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<4) X I $D(X) D RXSBIT^ONCOSUR1
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 29, 2022
  • HELP-PROMPT:  Enter the surgical procedure code performed at this facility for 2022 breast cases, 4 characters in length.
  • DESCRIPTION:  
    This field records the surgical procedure performed of the primary site at this facility. This data item is required for date of diagnosis 2022 breast cases only.
  • EXECUTABLE HELP:  D RXSBHP^ONCOSUR1
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
10105 RX SUMM--SURG BREAST 3.2;5 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<4) X I $D(X) D RXSBIT^ONCOSUR1
    MAXIMUM LENGTH: 4
  • LAST EDITED:  AUG 29, 2022
  • HELP-PROMPT:  Enter the surgical procedure code performed at any facility, 4 characters in length.
  • DESCRIPTION:  
    This field records the surgical procedure performed of the primary site performed at any facility. This data item is required for 2022 breast cases only.
  • EXECUTABLE HELP:  D RXSBHP^ONCOSUR1
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
10106 RX HOSP--RECON BREAST 22-23 3.2;6 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<4) X I $D(X) D RXRECIT^ONCOSUR1
    MAXIMUM LENGTH: 4
  • LAST EDITED:  OCT 23, 2024
  • HELP-PROMPT:  Enter the reconstruction procedure performed at this facility, 4 characters in length.
  • DESCRIPTION:  
    This field records the reconstruction procedure immediately following resection performed at this facility. This data item is required for 2022-23 breast cases only.
  • EXECUTABLE HELP:  D RXRECHP^ONCOSUR1
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
10107 RX SUMM--RECON BREAST 22-23 3.2;7 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<4) X I $D(X) D RXRECIT^ONCOSUR1
    MAXIMUM LENGTH: 4
  • LAST EDITED:  OCT 23, 2024
  • HELP-PROMPT:  Enter the reconstruction procedure performed at any facility, 4 characters in length.
  • DESCRIPTION:  
    This field records the reconstruction procedure immediately following resection performed at any facility. This data item is required for 2022-23 breast cases only.
  • EXECUTABLE HELP:  D RXRECHP^ONCOSUR1
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
10108 RX HOSP--RECON BREAST 3.2;10 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<4) X I $D(X) D RXRECIT^ONCOSUR1
    MAXIMUM LENGTH: 4
  • LAST EDITED:  OCT 23, 2024
  • HELP-PROMPT:  Enter the reconstruction procedure performed at this facility, 4 characters in length.
  • DESCRIPTION:  
    This field records the reconstruction procedure immediately following resection performed at this facility. This data item is required for 2024+ breast cases only.
  • EXECUTABLE HELP:  D RXRECHP^ONCOSUR1
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
10109 RX SUMM--RECON BREAST 3.2;11 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>4!($L(X)<4) X I $D(X) D RXRECIT^ONCOSUR1
    MAXIMUM LENGTH: 4
  • LAST EDITED:  OCT 23, 2024
  • HELP-PROMPT:  Enter the reconstruction procedure performed at any facility, 4 characters in length.
  • DESCRIPTION:  
    This field records the reconstruction procedure immediately following resection performed at any facility. This data item is required for 2024+ breast cases only.
  • EXECUTABLE HELP:  D RXRECHP^ONCOSUR1
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
11132 PEDIATRIC ID SSD5;18 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1) X
    MAXIMUM LENGTH: 5
  • LAST EDITED:  APR 29, 2025
  • HELP-PROMPT:  Answer must be 1-5 characters in length.
  • DESCRIPTION:  The values in this data item link Site-Specific Data Items with the appropriate site/histology grouping and account for the combination of primary site and histologies that are being collected for Pediatric Cancers
    starting in 2024. The values for this data item are derived based on primary site and histology and are initially based on the Toronto Childhood Cancer Stage Guidelines. The derived values link Site-Specific Data Items
    with the appropriate site/histology grouping.
11172 PTLD SSD5;16 NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N)!("01248"'[X) X
  • LAST EDITED:  JUN 11, 2025
  • HELP-PROMPT:  Type a number from the allowable range of 0,1,2,4,8. For definition and coding instructions, see https://staging.seer.cancer.gov/eod_public/list/3.2/
  • DESCRIPTION:  Post Transplant Lymphoproliferative Disorder (PTLD) is a lymphoid proliferation arising in a recipient of a solid organ transplant, allogeneic bone marrow transplantation, or an umbilical cord blood transfusion. The
    patient must have a history of a solid organ transplant or an allogeneic bone marrow transplant. Both polymorphic and monomorphic PTLD are actually caused by post-transplant immunosuppression. Most cases of PTLD occur
    within a year of transplantation; however, they can occur any time after the transplant. Monomorphic PTLD may have histology indistinguishable from that of various malignant hematopoietic neoplasms, particularly lymphomas
    such as Diffuse Large B-cell Lymphoma.
    Code Description 0 PTLD not documented on the pathology report or in
    the medical record 1 Monomorphic PTLD
    PTLD WITH a specified histology (lymphoma, plasmacytoma,
    plasma cell myeloma) 2 Classic Hodgkin lymphoma-PTLD type
    PTLD, Hodgkin like 4 PTLD not specified as monomorphic or Hodgkin lymphoma-PTLD type
    WITH a specified histology (lymphoma, plasmacytoma,
    plasma cell myeloma)
    Includes Burkitt type PTLD 8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter, use of
    code 8 will result in an edit error)
    BLANK Diagnosis year prior to 2025
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
11174 PD-L1 SSD5;15 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM K:"XXX.0^XXX.1^XXX.5^XXX.6"[X X
    MAXIMUM LENGTH: 5
  • LAST EDITED:  APR 10, 2025
  • HELP-PROMPT:  Answer must be 1-5 characters in length. Allowable values are 0.0, 0.1-100.0, XXX.2, XXX.3, XXX.4, XXX.7, XXX.8, XXX.9
  • DESCRIPTION:  The absence or presence of PD-L1 expression determines if the tumor will respond to treatment with a targeted inhibitor inhibitor (immunotherapy). PD-L1 is done for Non-Small Cell lung cancers (NSCLC).
    Codes: 0.0 No PD-L1 expression identified
    Tumor Proportion Score (TPS) = 0% 0.1-100.0 0.1-100.0 PD-L1 expression
    Tumor Proportion Score (TPS) = 0.1%-100.0% XXX.2 PD-L1 expression absent AND
    Tumor Proportion Score (TPS) stated as negative XXX.3 PD-L1 expression present AND
    Tumor Proportion Score (TPS) stated as low XXX.4 PD-L1 expression present AND
    Tumor Proportion Score (TPS) stated as high/positive XXX.7 Test ordered, results not in chart XXX.8 Not applicable: Information not collected for this case
    (If this item is required by your standard setter,
    use of code 8 will result in an edit error) XXX.9 Not documented in medical
    No microscopic confirmation of tumor
    PD-L1 cannot be determined
    PD-L1 not assessed or unknown if assessed
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER

ICR, Total: 1

ICR LINK Subscribing Package(s) Fields Referenced Description
ICR #2888
  • Health Summary
    		•  DATE DX (3).
    Access: Read w/Fileman

    ICDO-TOPOGRAPHY (20).
    Access: Read w/Fileman

    HISTOLOGY (22).
    Access: Read w/Fileman

    GRADE/DIFFERENTIATION (24).
    Access: Read w/Fileman

    SIZE OF TUMOR (29).
    Access: Read w/Fileman

    CLINICAL STAGE GROUP (38).
    Access: Read w/Fileman

    CLINICAL T (37.1).
    Access: Read w/Fileman

    CLINICAL N (37.2).
    Access: Read w/Fileman

    CLINICAL M (37.3).
    Access: Read w/Fileman

    PATHOLOGIC T (85).
    Access: Read w/Fileman

    PATHOLOGIC N (86).
    Access: Read w/Fileman

    PATHOLOGIC M (87).
    Access: Read w/Fileman

    PATHOLOGIC STAGE GROUP (88).
    Access: Read w/Fileman

    SURGERY OF PRIMARY SITE DATE (50).
    Access: Read w/Fileman

    RADIATION DATE (51).
    Access: Read w/Fileman

    RADIATION (51.2).
    Access: Read w/Fileman

    CHEMOTHERAPY DATE (53).
    Access: Read w/Fileman

    CHEMOTHERAPY (53.2).
    Access: Read w/Fileman

    HORMONE THERAPY DATE (54).
    Access: Read w/Fileman

    HORMONE THERAPY (54.2).
    Access: Read w/Fileman

    IMMUNOTHERAPY DATE (55).
    Access: Read w/Fileman

    IMMUNOTHERAPY (BRM) (55.2).
    Access: Read w/Fileman

    RADIATION TREATMENT VOLUME (125).
    Access: Read w/Fileman

    NON CANCER-DIRECTED SURGERY (58.1).
    Access: Read w/Fileman

    INTENT OF RADIATION (127).
    Access: Read w/Fileman

    NON CANCER-DIRECTED SURG DATE (58.3).
    Access: Read w/Fileman

    SURGERY OF PRIMARY SITE (58.2).
    Access: Read w/Fileman

    RADIATION COMPLETION STATUS (128).
    Access: Read w/Fileman

    ABSTRACT STATUS (91).
    Access: Read w/Fileman

    PROTOCOL ELIGIBILITY STATUS (346).
    Access: Read w/Fileman

    PROTOCOL PARTICIPATION (560).
    Access: Read w/Fileman

    REGIONAL DOSE:cGy (442).
    Access: Read w/Fileman

    External References

    Name Field # of Occurrence
    ^%DT 3+1, 25+1, 44+1, 64+1, 79+1, 96+1, 121+1, 139.7+1, 156+1, 171+1
    , 172+1, 173+1, 174.1+1, 175.1+1, 176.1+1, 177.1+1, 178.1+1, 179.1+1, 180.1+1, 181.1+1
    , 182.1+1, 183.1+1, 184.1+1, 185.1+1, 186.1+1, 187.1+1, 188.1+1, 189.1+1, 193+1, 195+1
    , 198+1, 232+1, 236+1, 249+1, 280.2+1, 323+1, 1306+1, 1307+1, 1368+1, 1402+1
    , 1428+1, 1548+1, 1566+1, 3945+1
    ^%DTC 202OF9.2+1, 203OF9.2+1
    EN^DDIOL 1402+1, 1548+1
    ^DIC 2+1, 2.1+1, 2.2+1, 2.3+1, 2.4+1, 21+1, 22+1, 25.1+1, 25.2+1, 25.3+1
    , 39+1, 66+1, 71+1, 363+1, 363.1+1, 1311+1, 1367+1, 1400+1, 1400.1+1, 1400.2+1
    , 1400.3+1, 1400.4+1, 1400.5+1, 1426+1, 1426.1+1, 1426.2+1, 1426.3+1, 1426.4+1, 1571+1, 1571.1+1
    , 1571.2+1, 1571.3+1, 1571.4+1, 1571.5+1, 1579+1, 1579.1+1, 1579.2+1, 1579.3+1, 1579.4+1, 3838+1
    , 3839+1
    ^DICR .04(XREF 1S), .04(XREF 1K), 9(XREF 1n1.4), 9(XREF 1n2.4), 9(XREF 2n1.4), 9(XREF 2n2.4), 9(XREF 3n1.4), 9(XREF 3n2.4), 70(XREF 1S), 127(XREF 1n1.4)
    , 127(XREF 2n1.4), 198(XREF 2S), 198(XREF 2K), 240(XREF 1S), 240(XREF 1K), 251(XREF 1n1.4), 251(XREF 2n1.4), 251(XREF 3n1.4), 251(XREF 4n1.4), 251(XREF 5n1.4)
    , 251(XREF 6n1.4), 251(XREF 7n1.4), 253(XREF 1n1.4), 255(XREF 1n1.4), 257(XREF 1n1.4), 257(XREF 2n1.4), 257(XREF 3n1.4), 257(XREF 4n1.4), 258(XREF 1n1.4), 258(XREF 2n1.4)
    , 258(XREF 3n1.4), 264(XREF 1n1.4), 264(XREF 2n1.4), 267(XREF 1n1.4), 267(XREF 2n1.4), 1764(XREF 1n1.4), 1764(XREF 1K)
    $$GET1^DIQ .041+1, 44+1
    Y^DIQ ID20+1, IDWRITE+1
    $$ICDDX^ICDCODE 1400OT+1, 1400.1OT+1, 1400.2OT+1, 1400.3OT+1, 1400.4OT+1, 1400.5OT+1, 1426OT+1, 1426.1OT+1, 1426.2OT+1, 1426.3OT+1
    , 1426.4OT+1, 1571OT+1, 1571.1OT+1, 1571.2OT+1, 1571.3OT+1, 1571.4OT+1, 1571.5OT+1, 1579OT+1, 1579.1OT+1, 1579.2OT+1
    , 1579.3OT+1, 1579.4OT+1
    INIT^ONCCS 22.3+1
    MOT^ONCCSOT 164OT+1, 164.7OT+1
    NOT^ONCCSOT 162OT+1, 162.7OT+1
    SGOT^ONCCSOT 166OT+1, 166.7OT+1
    TOT^ONCCSOT 160OT+1, 160.7OT+1
    CHE^ONCDTX 53.2(XREF 1K)
    DEL^ONCDTX 124(XREF 2K)
    HOR^ONCDTX 54.2(XREF 1K)
    HTEP^ONCDTX 153(XREF 1K)
    IMM^ONCDTX 55.2(XREF 1K)
    NCDS^ONCDTX 58.1(XREF 1K)
    OTH^ONCDTX 57.2(XREF 1K)
    PP^ONCDTX 12(XREF 1K)
    RAD^ONCDTX 51(XREF 2K), 51.2(XREF 1K)
    SCOPE^ONCDTX 138(XREF 1K), 138.4(XREF 1K)
    SOSN^ONCDTX 139.4(XREF 1K)
    SOSNR^ONCDTX 139(XREF 1K)
    SUR^ONCDTX 58.6(XREF 1K)
    SURR^ONCDTX 58.2(XREF 1K)
    CHEMATF^ONCDTX1 53.3(XREF 1K)
    HORATF^ONCDTX1 54.3(XREF 1K)
    HTEATF^ONCDTX1 153.2(XREF 1K)
    IMMATF^ONCDTX1 55.3(XREF 1K)
    NCDSATF^ONCDTX1 58.4(XREF 1K)
    OTHATF^ONCDTX1 57.3(XREF 1K)
    RADATF^ONCDTX1 51.4(XREF 1K)
    SCPATF^ONCDTX1 138.1(XREF 1K), 138.5(XREF 1K)
    SOSNATF^ONCDTX1 139.1(XREF 1K), 139.5(XREF 1K)
    SPSATF^ONCDTX1 50.2(XREF 1K), 58.7(XREF 1K)
    $$HIST^ONCFUNC 22.1+1
    $$IIN^ONCFUNC 67+1
    $$SHN^ONCFUNC 68+1
    ITEM3^ONCLPC1 1403(HELP ), 1573(HELP )
    RRDEFIT^ONCNTX1 23+1
    ACN^ONCOCKI .05+1
    PSEX^ONCOCKI .02+1
    SEQ^ONCOCKI .06+1
    AGE^ONCOCOM 4+1
    ARFPRI^ONCOCOM .043+1
    DCD^ONCOCOM 193+1
    DDX^ONCOCOM 49.1+1
    DEC^ONCOCOM 4.1+1
    DFC^ONCOCOM 49+1
    DRXS^ONCOCOM 49.9+1
    DSTS^ONCOCOM 152+1
    EM^ONCOCOM 157.1+1
    ET^ONCOCOM 157+1
    HM^ONCOCOM 27+1
    PID5^ONCOCOM 61+1
    SDP^ONCOCOM 48+1
    ADM^ONCOCON 3.1+1
    PID^ONCOCOP .025+1
    STCT^ONCOCOP .1157+1
    GSS^ONCOCOS 35.1+1
    RSX^ONCOCOS .13+1
    SICD^ONCOCOS .015+1
    SSG1^ONCOCOS 38.1+1
    SSG2^ONCOCOS 38.2+1
    SSG3^ONCOCOS 38.3+1
    SSG4^ONCOCOS 38.4+1
    SXR^ONCOCOS .14+1
    SYS^ONCOCOS .017+1
    TRS^ONCOCOS 95.1+1
    TX^ONCOCOS 43+1
    TXS^ONCOCOS 42+1
    CSSG^ONCOCRC 38(XREF 1S), 5004(XREF 1S)
    KNHL^ONCOCRC 31(XREF 1K)
    KSG^ONCOCRC 38(XREF 1K), 88(XREF 1K), 5004(XREF 1K), 5014(XREF 1K)
    PSSG^ONCOCRC 88(XREF 1S), 5014(XREF 1S)
    SNHL^ONCOCRC 31(XREF 1S)
    PDLC^ONCOCRF 200+1
    SDA^ONCOCRF 201+1
    SUR^ONCOCRF 202+1
    SWK^ONCOCRF 204+1
    SYR^ONCOCRF 203+1
    $$GETLIST^ONCODEL 29.9+1, 30.9+1
    HP^ONCODEL 30(HELP ), 30.1(HELP ), 31(HELP )
    IN^ONCODEL 30+1, 30.1+1, 31+1
    OT^ONCODEL 30OT+1, 30.1OT+1, 31OT+1
    FHP^ONCODLF 150+1
    DBTE^ONCODSR 542+1
    DBTS^ONCODSR 541+1
    DFIT^ONCODSR 17+1, 50+1, 50.3+1, 51+1, 51.5+1, 52+1, 53+1, 53.4+1, 54+1, 54.4+1
    , 55+1, 55.4+1, 57+1, 57.4+1, 58.3+1, 58.5+1, 70+1, 90+1, 94+1, 130+1
    , 137+1, 138.2+1, 138.3+1, 139.2+1, 139.3+1, 153.1+1, 153.3+1, 170+1, 253+1, 255+1
    , 256+1, 264+1, 265+1, 266+1, 272+1, 277+1, 361+1, 367+1, 435+1, 567+1
    , 699.1+1, 865+1, 919+1, 921+1, 923+1, 925+1, 929+1, 7013+1, 7017+1
    DFSPIT^ONCODSR 170+1
    DSDTIT^ONCODSR 1.1+1
    ESSHP^ONCODSR 856(HELP )
    ESSPIT^ONCODSR 856+1
    ESSPOT^ONCODSR 856OT+1
    FADIT^ONCODSR 1+1, 155+1
    HP0^ONCODSR 58.1(HELP ), 58.4(HELP )
    NCDSIT^ONCODSR 58.1+1, 58.4+1
    NCDSOT^ONCODSR 58.1OT+1, 58.4OT+1
    NT^ONCODSR 50+1, 50.1+1, 50.3+1, 51+1, 51.1+1, 51.5+1, 52+1, 52.1+1, 53+1, 53.1+1
    , 53.4+1, 54+1, 54.1+1, 54.4+1, 55+1, 55.1+1, 55.4+1, 56+1, 57+1, 57.1+1
    , 57.4+1, 125+1, 128+1, 129+1, 130+1, 138.2+1, 138.3+1, 139.2+1, 139.3+1, 153.1+1
    , 153.3+1, 170+1, 361+1, 363.1+1, 435+1, 442+1, 443+1
    NTIT^ONCODSR 124+1
    ZS9S^ONCODSR 3+1, 25+1, 44+1, 96+1, 156+1, 171+1, 172+1, 173+1, 174.1+1, 175.1+1
    , 176.1+1, 177.1+1, 178.1+1, 179.1+1, 180.1+1, 181.1+1, 182.1+1, 183.1+1, 184.1+1, 185.1+1
    , 186.1+1, 187.1+1, 188.1+1, 189.1+1, 193+1, 195+1
    DTDXIT^ONCODXD 3+1
    PRINT^ONCOEDC 91(HELP )
    MTHLP^ONCOEOD1 1776(HELP )
    MTIT^ONCOEOD1 1776+1
    NEOHLP^ONCOEOD1 245.3(HELP )
    NEOIT^ONCOEOD1 245.3+1
    PTHLP^ONCOEOD1 1772(HELP )
    PTIT^ONCOEOD1 1772+1
    RNHLP^ONCOEOD1 1774(HELP )
    RNIT^ONCOEOD1 1774+1
    ASPHP^ONCOES 763(HELP )
    ASPIT^ONCOES 763+1
    ASPOT^ONCOES 763OT+1
    DATECLC^ONCOES 198OT+1
    DATEOT^ONCOES 1OT+1, 1.1OT+1, 3OT+1, 17OT+1, 25OT+1, 44OT+1, 50OT+1, 50.3OT+1, 51OT+1, 51.5OT+1
    , 52OT+1, 53OT+1, 53.4OT+1, 54OT+1, 54.4OT+1, 55OT+1, 55.4OT+1, 57OT+1, 57.4OT+1, 58.3OT+1
    , 58.5OT+1, 64OT+1, 90OT+1, 94OT+1, 96OT+1, 124OT+1, 130OT+1, 137OT+1, 138.2OT+1, 138.3OT+1
    , 139.2OT+1, 139.3OT+1, 139.7OT+1, 153.1OT+1, 153.3OT+1, 155OT+1, 156OT+1, 170OT+1, 171OT+1, 172OT+1
    , 173OT+1, 174.1OT+1, 175.1OT+1, 176.1OT+1, 177.1OT+1, 178.1OT+1, 179.1OT+1, 180.1OT+1, 181.1OT+1, 182.1OT+1
    , 183.1OT+1, 184.1OT+1, 185.1OT+1, 186.1OT+1, 187.1OT+1, 188.1OT+1, 189.1OT+1, 193OT+1, 195OT+1, 200+1
    , 232OT+1, 236OT+1, 249OT+1, 253OT+1, 255OT+1, 256OT+1, 264OT+1, 265OT+1, 266OT+1, 272OT+1
    , 277OT+1, 361OT+1, 435OT+1, 865OT+1, 3945OT+1, 7013OT+1, 7017OT+1
    PTRDOT^ONCOES 786OT+1
    TLEEOT^ONCOES 752OT+1
    HELP^ONCOFLF 5(HELP ), 6(HELP ), 7(HELP ), 50.1(HELP ), 51.1(HELP ), 52.1(HELP ), 53.1(HELP ), 54.1(HELP ), 55.1(HELP ), 57.1(HELP )
    BP^ONCOHELP 141(HELP )
    DTFLGHLP^ONCOHELP 999.1(HELP ), 999.11(HELP ), 999.12(HELP ), 999.13(HELP ), 999.14(HELP ), 999.15(HELP ), 999.16(HELP ), 999.17(HELP ), 999.18(HELP ), 999.19(HELP )
    , 999.2(HELP ), 999.21(HELP ), 999.22(HELP ), 999.23(HELP ), 999.24(HELP ), 999.25(HELP ), 999.3(HELP ), 999.4(HELP ), 999.5(HELP ), 999.6(HELP )
    , 999.7(HELP ), 999.8(HELP ), 999.9(HELP )
    HIST23^ONCOHICD 22+1
    HP^ONCOHICD 20(HELP ), 22(HELP )
    ICDO3^ONCOHICD 22.3(HELP )
    AC^ONCOIT 1501+1
    BD^ONCOIT 1422+1, 1575+1
    BP^ONCOIT 141+1
    DMCM^ONCOIT 1429+1, 1429.1+1
    DTU^ONCOIT 1401+1, 1572+1
    EFM^ONCOIT 1558+1, 1558.1+1
    GTOBR^ONCOIT 1563+1
    GYGR^ONCOIT 1520+1
    HVBT^ONCOIT 1430+1, 1562+1
    IRTD^ONCOIT 1567+1
    LP25^ONCOIT 623.2+1
    LP26^ONCOIT 623.5+1
    LS^ONCOIT 1540+1, 1541+1, 1542+1, 1543+1, 1544+1
    NP^ONCOIT 8+1, 8.1+1, 8.2+1
    PFT^ONCOIT 1407+1, 1407.1+1
    PSA^ONCOIT 684+1
    RDIT^ONCOIT 442+1, 443+1
    RE^ONCOIT 1409.4+1, 1409.5+1, 1410.4+1, 1410.5+1, 1411.4+1, 1411.5+1, 1412.4+1, 1412.5+1, 1413.4+1, 1413.5+1
    , 1414.4+1, 1414.5+1, 1415.4+1, 1415.5+1
    RNEIT^ONCOIT 33+1
    RNPIT^ONCOIT 32+1
    TPBR^ONCOIT 1420+1
    ARCHHLP^ONCOMNI 822(HELP )
    ARCHP^ONCOMNI 822+1, 822OT+1
    BTIT^ONCOMNI 1114+1
    BTOT^ONCOMNI 1114OT+1
    EXNSIT^ONCOMNI 852+1, 853+1, 854+1, 855+1
    EXNSOT^ONCOMNI 852OT+1, 853OT+1, 854OT+1, 855OT+1
    MDIT^ONCOMNI 1120+1
    MDOT^ONCOMNI 1120OT+1
    NSNIT^ONCOMNI 1112+1
    NSNOT^ONCOMNI 1112OT+1
    RCSHP^ONCOMNI 862(HELP )
    RCSIT^ONCOMNI 862+1
    RCSOT^ONCOMNI 862OT+1
    XHP^ONCOMNI 852(HELP ), 853(HELP ), 854(HELP ), 855(HELP )
    BP^ONCOOT 141OT+1
    CGYIT^ONCOOT 954+1
    CGYOT^ONCOOT 954OT+1
    DCISHP^ONCOOT 930(HELP )
    DCISIT^ONCOOT 930+1
    DCISOT^ONCOOT 930OT+1
    DCSZIT^ONCOOT 942+1
    DCSZOT^ONCOOT 942OT+1
    PSA^ONCOOT 684OT+1
    RE^ONCOOT 1409.4OT+1, 1409.5OT+1, 1410.4OT+1, 1410.5OT+1, 1411.4OT+1, 1411.5OT+1, 1412.4OT+1, 1412.5OT+1, 1413.4OT+1, 1413.5OT+1
    , 1414.4OT+1, 1414.5OT+1, 1415.4OT+1, 1415.5OT+1
    RNE^ONCOOT 33OT+1
    RNP^ONCOOT 32OT+1
    SOC^ONCOOT 136OT+1
    SRPTIT^ONCOOT 1328+1
    SRPTOT^ONCOOT 1328OT+1
    STIT^ONCOOT 29+1
    STMIT^ONCOOT 1132+1
    STMOT^ONCOOT 1132OT+1
    STOT^ONCOOT 29OT+1
    TSCPSIT^ONCOOT 29.3+1, 29.4+1, 29.5+1
    TSCPSOT^ONCOOT 29.3OT+1, 29.4OT+1, 29.5OT+1
    TSIT^ONCOOT 1394+1
    TSOT^ONCOOT 1394OT+1
    CHDTIT^ONCOPCE 1103+1, 1105+1
    CHDTOT^ONCOPCE 1103OT+1, 1105OT+1
    DATEIT^ONCOPCE 70+1, 79+1, 121+1, 323+1, 367+1, 541+1, 542+1, 567+1, 699.1+1, 865+1
    , 919+1, 921+1, 923+1, 925+1, 929+1, 1306+1, 1307+1, 1368+1, 1402+1, 1548+1
    DATEOT^ONCOPCE 70OT+1, 79OT+1, 121OT+1, 323OT+1, 367OT+1, 541OT+1, 542OT+1, 567OT+1, 699.1OT+1, 919OT+1
    , 921OT+1, 923OT+1, 925OT+1, 929OT+1, 1306OT+1, 1307OT+1, 1368OT+1, 1402OT+1, 1548OT+1
    SAHP^ONCOSUR 74(HELP )
    SAIT^ONCOSUR 74+1
    SAOT^ONCOSUR 74OT+1
    SPSHP^ONCOSUR 50.2(HELP ), 58.2(HELP ), 58.6(HELP ), 58.7(HELP )
    SPSIT^ONCOSUR 50.2+1, 58.2+1, 58.6+1, 58.7+1
    SPSOT^ONCOSUR 50.2OT+1, 58.2OT+1, 58.6OT+1, 58.7OT+1
    COCIT^ONCOSUR1 .04+1
    NRIT^ONCOSUR1 140+1, 140.1+1
    NROT^ONCOSUR1 140OT+1, 140.1OT+1
    RXRECHP^ONCOSUR1 10106(HELP ), 10107(HELP ), 10108(HELP ), 10109(HELP )
    RXRECIT^ONCOSUR1 10106+1, 10107+1, 10108+1, 10109+1
    RXSBHP^ONCOSUR1 10104(HELP ), 10105(HELP )
    RXSBIT^ONCOSUR1 10104+1, 10105+1
    SCHP^ONCOSUR1 138(HELP ), 138.1(HELP )
    SCIT^ONCOSUR1 138+1, 138.1+1
    SCOT^ONCOSUR1 138OT+1, 138.1OT+1
    SOHP^ONCOSUR1 139(HELP ), 139.1(HELP )
    SOIT^ONCOSUR1 139+1, 139.1+1
    SOOT^ONCOSUR1 139OT+1, 139.1OT+1
    TOPIT^ONCOSUR1 20+1
    SPSHP23^ONCOSUR3 58.8(HELP ), 58.9(HELP )
    SPSIT23^ONCOSUR3 58.8+1, 58.9+1
    HP^ONCOTNM 37.1(HELP ), 37.2(HELP ), 37.3(HELP ), 85(HELP ), 86(HELP ), 87(HELP ), 93(HELP ), 98(HELP ), 99(HELP )
    IN^ONCOTNM 37.1+1, 37.2+1, 37.3+1, 85+1, 86+1, 87+1, 93+1, 98+1, 99+1
    OT^ONCOTNM 93OT+1, 98OT+1, 99OT+1
    GUHP^ONCOTNMX 142(HELP )
    GUIT^ONCOTNMX 142+1
    GUOT^ONCOTNMX 142OT+1
    $$TNMOUT^ONCOTNO 37+1, 89.1+1
    HP^ONCOTNS 38(HELP ), 88(HELP ), 117(HELP ), 850(HELP )
    IN^ONCOTNS 38+1, 88+1, 117+1, 850+1
    INNUM^ONCOTNS 38+1, 88+1, 117+1
    OT^ONCOTNS 38OT+1, 88OT+1, 117OT+1, 850OT+1
    OT1^ONCOTNS 40+1, 40.1+1
    STGBY^ONCOTNS 40.2+1
    PCDX^ONCPCDX 9+1
    RRHP^ONCRR 23(HELP )
    RRIT^ONCRR 23+1
    RROT^ONCRR 23OT+1
    AJCCHP^ONCSCHMG 5001(HELP ), 5002(HELP ), 5003(HELP ), 5011(HELP ), 5012(HELP ), 5013(HELP ), 5021(HELP ), 5022(HELP ), 5023(HELP ), 5025(HELP )
    , 5026(HELP ), 5027(HELP )
    AJCCIT^ONCSCHMG 5001+1, 5002+1, 5003+1, 5011+1, 5012+1, 5013+1, 5021+1, 5022+1, 5023+1, 5025+1
    , 5026+1, 5027+1
    HLP^ONCSCHMG 24.3(HELP ), 24.4(HELP ), 24.5(HELP ), 24.6(HELP )
    IT^ONCSCHMG 24.3+1, 24.4+1, 24.5+1, 24.6+1
    OT^ONCSCHMG 24.3OT+1, 24.4OT+1, 24.5OT+1, 24.6OT+1
    SDHLP^ONCSCHMG 3926(HELP ), 3927(HELP )
    SDIT^ONCSCHMG 3926+1, 3927+1
    SUFFHLP^ONCSCHMG 5031(HELP ), 5032(HELP ), 5033(HELP ), 5033.5(HELP ), 5034(HELP ), 5035(HELP ), 5036(HELP ), 5036.5(HELP )
    SUFFIT^ONCSCHMG 5031+1, 5032+1, 5033+1, 5033.5+1, 5034+1, 5035+1, 5036+1, 5036.5+1
    BTTIT^ONCSCHMM 3817+1
    DEC1^ONCSCHMM 3832+1, 3860+1
    DEC2^ONCSCHMM 3823+1, 3824+1, 3851+1, 3852+1, 3853+1, 3883+1, 3887+1, 3888+1, 3892+1, 3961+1
    DEC3^ONCSCHMM 3803+1, 3813+1, 3863+1, 3908+1, 3920+1, 11174+1
    DEC4^ONCSCHMM 3810+1, 3820+1, 3942+1
    DEC5^ONCSCHMM 3805+1, 3807+1, 3846+1, 3848+1, 3932+1
    ERR^ONCSCHMM 3826+1, 3914+1
    ERTA^ONCSCHMM 3828+1, 3916+1
    FIGO^ONCSCHMM 3836+1
    FIGOHLP^ONCSCHMM 3836(HELP )
    FIGOOT^ONCSCHMM 3836OT+1
    GEN2^ONCSCHMM 3882+1, 3891+1, 3893+1, 3895+1, 3896+1, 3897+1, 3898+1, 3899+1, 3900+1, 3901+1
    , 3902+1, 3934+1, 7015+1, 7016+1
    GEN3^ONCSCHMM 3870+1, 3903+1, 3904+1
    PROPE^ONCSCHMM 3919+1
    RADPH3^ONCSCHMM 5503+1, 5513+1, 5523+1
    RADPH5^ONCSCHMM 5501+1, 5511+1, 5521+1
    RADPH6^ONCSCHMM 5507+1, 5517+1, 5527+1, 7026+1
    SAR^ONCSCHMM 3925+1
    HELP^ONCSGA8H 5004(HELP ), 5014(HELP ), 5024(HELP ), 5028(HELP )
    INP^ONCSGA8H 5004+1, 5014+1, 5024+1, 5028+1
    SSF1OT^ONCSSF1 44.1OT+1
    SSF2OT^ONCSSF2 44.2OT+1
    SSF3OT^ONCSSF3 44.3OT+1
    SSF4OT^ONCSSF4 44.4OT+1
    SSF5OT^ONCSSF5 44.5OT+1
    SSF6OT^ONCSSF6 44.6OT+1
    HELP^ONCSUBS 240(HELP )
    IN^ONCSUBS 240+1
    NUMDFIT^ONCTXSM 140.1+1
    SCPDFIT^ONCTXSM 138.1+1
    SOSDFIT^ONCTXSM 139.1+1
    SPSDFIT^ONCTXSM 50.2+1, 58.7+1
    HELP^ONCWEBCS 29.1(HELP ), 29.2(HELP ), 30.2(HELP ), 31.1(HELP ), 32.1(HELP ), 34.3(HELP ), 34.4(HELP ), 44.1(HELP ), 44.101(HELP ), 44.11(HELP )
    , 44.12(HELP ), 44.13(HELP ), 44.14(HELP ), 44.15(HELP ), 44.16(HELP ), 44.17(HELP ), 44.18(HELP ), 44.19(HELP ), 44.2(HELP ), 44.201(HELP )
    , 44.21(HELP ), 44.22(HELP ), 44.23(HELP ), 44.24(HELP ), 44.25(HELP ), 44.3(HELP ), 44.4(HELP ), 44.5(HELP ), 44.6(HELP ), 44.7(HELP )
    , 44.8(HELP ), 44.9(HELP )
    INPUT^ONCWEBCS 29.1+1, 29.2+1, 30.2+1, 31.1+1, 32.1+1, 34.3+1, 34.4+1, 44.1+1, 44.101+1, 44.11+1
    , 44.12+1, 44.13+1, 44.14+1, 44.15+1, 44.16+1, 44.17+1, 44.18+1, 44.19+1, 44.2+1, 44.201+1
    , 44.21+1, 44.22+1, 44.23+1, 44.24+1, 44.25+1, 44.3+1, 44.4+1, 44.5+1, 44.6+1, 44.7+1
    , 44.8+1, 44.9+1
    CCODE^XIPUTIL 10+1, 10OT+1

    Global Variables Directly Accessed

    Name Line Occurrences  (* Changed,  ! Killed)
    ^DD(160 IDWRITE+1, .08+1, .09+1, .091OF9.3+1, .1OF9.3+1, .115+1, .117+1, .12OF9.3+1
    ^DD(164 ID20+1
    ^DD(165.5 .061+1, .061OF9.3+1, .08+1, .09+1, .091+1, .091OF9.3+1, .093+1, .1+1, .1OF9.3+1, .115+1
    , .117+1, .12+1, .12OF9.3+1, 9(XREF 1S), 9(XREF 1K), 9(XREF 2S), 9(XREF 2K), 9(XREF 3S), 9(XREF 3K), 37OF9.2+1
    , 37OF9.3+1, 37OF9.4+1, 97OF9.2+1, 127(XREF 1S), 127(XREF 2S), 202OF9.2+1, 203OF9.2+1, 204OF9.2+1, 251(XREF 1S), 251(XREF 2S)
    , 251(XREF 3S), 251(XREF 4S), 251(XREF 5S), 251(XREF 6S), 251(XREF 7S), 253(XREF 1S), 255(XREF 1S), 257(XREF 1S), 257(XREF 2S), 257(XREF 3S)
    , 257(XREF 4S), 258(XREF 1S), 258(XREF 2S), 258(XREF 3S), 264(XREF 1S), 264(XREF 2S), 267(XREF 1S), 267(XREF 2S), 1764(XREF 1S)
    ^DIC(5 - [#5] 9OT+1
    ^ONCO(160 - [#160] IDWRITE+1, .08OF9.2+1, .09OF9.2+1, .091OF9.2+1, .091OF9.3+1, .093+1, .093OF9.2+1, .1OF9.2+1, .1OF9.3+1, .115OF9.2+1
    , .117OF9.2+1, .12+1, .12OF9.2+1, .12OF9.3+1
    ^ONCO(160.12 - [#160.12] 71OT+1, 71.4OT+1
    ^ONCO(160.19 - [#160.19] .03OT+1, 5OT+1, 6OT+1, 7OT+1, 50.1OT+1, 51.1OT+1, 52.1OT+1, 53.1OT+1, 54.1OT+1, 55.1OT+1
    , 57.1OT+1
    ^ONCO(160.3 - [#160.3] 18OT+1
    ^ONCO(160.5 55.2OT+1
    ^ONCO(160.7 75OT+1
    ^ONCO(160.8 76OT+1
    ^ONCO(160.9 77OT+1
    ^ONCO(164 - [#164] ID20+1, 803OT+1, 805OT+1, 1102OT+1, 1104OT+1, 1403OT+1, 1573OT+1
    ^ONCO(164.1 - [#164.1] 804OT+1, 806OT+1
    ^ONCO(164.15 - [#164.15] 25.1OT+1, 25.2OT+1, 25.3OT+1
    ^ONCO(164.18 - [#164.18] 1576OT+1, 1576.1OT+1, 1576.2OT+1
    ^ONCO(164.2 - [#164.2] .0101+1
    ^ONCO(164.43 - [#164.43] 24OT+1
    ^ONCO(164.46 - [#164.46] .12+1
    ^ONCO(164.6 - [#164.6] 849OT+1
    ^ONCO(164.7 - [#164.7] 125OT+1, 129OT+1
    ^ONCO(164.8 - [#164.8] 128OT+1
    ^ONCO(164.81 - [#164.81] 5502OT+1, 5512OT+1, 5522OT+1
    ^ONCO(164.82 - [#164.82] 5504OT+1, 5514OT+1, 5524OT+1
    ^ONCO(164.83 - [#164.83] 5505OT+1, 5515OT+1, 5525OT+1
    ^ONCO(164.84 - [#164.84] 5506OT+1, 5516OT+1, 5526OT+1
    ^ONCO(165 - [#165] 2(XREF 1S), 2(XREF 1K), 2(XREF 2S), 2(XREF 2K), 2.1(XREF 1S), 2.1(XREF 1K), 2.1(XREF 2S), 2.1(XREF 2K), 2.2(XREF 1S), 2.2(XREF 1K)
    , 2.2(XREF 2S), 2.2(XREF 2K), 2.3(XREF 1S), 2.3(XREF 1K), 2.3(XREF 2S), 2.3(XREF 2K), 2.4(XREF 1S), 2.4(XREF 1K), 2.4(XREF 2S), 2.4(XREF 2K)
    , 66(XREF 1S), 66(XREF 1K), 66(XREF 2S), 66(XREF 2K)
    ^ONCO(165.2 - [#165.2] .093+1
    ^ONCO(165.3 - [#165.3] .04OT+1
    ^ONCO(165.5 - [#165.5] .01(XREF 1S), .01(XREF 1K), .0101+1, .02(XREF 1S), .02(XREF 1K), .023+1, .04(XREF 1S), .04(XREF 1K), .04(XREF 3S), .04(XREF 3K)
    , .042(XREF 1S), .042(XREF 1K), .05(XREF 1S), .05(XREF 1K), .05(XREF 2S), .05(XREF 2K), .05(XREF 3S), .05(XREF 3K), .05(XREF 4S), .05(XREF 4K)
    , .05(XREF 5S), .05(XREF 5K), .06(XREF 1S), .06(XREF 1K), .061OF9.2+1, .07(XREF 1S), .07(XREF 1K), .07(XREF 2S), .07(XREF 2K), .07(XREF 3S)
    , .07(XREF 3K), .08OF9.2+1, .09OF9.2+1, .091OF9.2+1, .093OF9.2+1, .1OF9.2+1, .115OF9.2+1, .117OF9.2+1, .12OF9.2+1, 2(XREF 1S)
    , 2(XREF 1K), 2(XREF 2S), 2(XREF 2K), 2(XREF 3S), 2(XREF 3K), 2.1(XREF 1S), 2.1(XREF 1K), 2.1(XREF 2S), 2.1(XREF 2K), 2.1(XREF 3S)
    , 2.1(XREF 3K), 2.2(XREF 1S), 2.2(XREF 1K), 2.2(XREF 2S), 2.2(XREF 2K), 2.2(XREF 3S), 2.2(XREF 3K), 2.3(XREF 1S), 2.3(XREF 1K), 2.3(XREF 2S)
    , 2.3(XREF 2K), 2.3(XREF 3S), 2.3(XREF 3K), 2.4(XREF 1S), 2.4(XREF 1K), 2.4(XREF 2S), 2.4(XREF 2K), 2.4(XREF 3S), 2.4(XREF 3K), 3(XREF 1S)
    , 3(XREF 1K), 3.5+1, 9(XREF 1S), 9(XREF 1n1.4), 9(XREF 1K), 9(XREF 1n2.4), 9(XREF 2S), 9(XREF 2n1.4), 9(XREF 2K), 9(XREF 2n2.4)
    , 9(XREF 3S), 9(XREF 3n1.4), 9(XREF 3K), 9(XREF 3n2.4), 20(XREF 1S), 20(XREF 1K), 20(XREF 2S), 20(XREF 2K), 20(XREF 3S), 20(XREF 3K)
    , 20.1+1, 22(XREF 1S), 22(XREF 1K), 22.3(XREF 1K), 22.4+1, 32+1, 33.1+1, 37OF9.2+1, 38.5(XREF 1S), 38.5(XREF 1K)
    , 50(XREF 1S), 50(XREF 1K), 51(XREF 1S), 51(XREF 1K), 52(XREF 1S), 52(XREF 1K), 53(XREF 1S), 53(XREF 1K), 54(XREF 1S), 54(XREF 1K)
    , 55(XREF 1S), 55(XREF 1K), 57(XREF 1S), 57(XREF 1K), 64+1, 66(XREF 1S), 66(XREF 1K), 66(XREF 2S), 66(XREF 2K), 66(XREF 3S)
    , 66(XREF 3K), 70(XREF 1S), 84(XREF 1S), 84(XREF 1K), 90(XREF 1S), 90(XREF 1K), 91(XREF 1S), 91(XREF 1K), 95(XREF 1S), 95(XREF 1K)
    , 97+1, 97OF9.2+1, 124(XREF 1S), 124(XREF 1K), 127(XREF 1S), 127(XREF 1n1.4), 127(XREF 2S), 127(XREF 2n1.4), 138.2(XREF 1S), 138.2(XREF 1K)
    , 139.2(XREF 1S), 139.2(XREF 1K), 153.1(XREF 1S), 153.1(XREF 1K), 155(XREF 1S), 155(XREF 1K), 170(XREF 1S), 170(XREF 1K), 198(XREF 1S), 198(XREF 1K)
    , 198(XREF 2S), 198(XREF 2K), 202OF9.2+1, 203OF9.2+1, 204OF9.2+1, 240(XREF 1S), 240(XREF 1K), 251(XREF 1S), 251(XREF 1n1.4), 251(XREF 2S)
    , 251(XREF 2n1.4), 251(XREF 3S), 251(XREF 3n1.4), 251(XREF 4S), 251(XREF 4n1.4), 251(XREF 5S), 251(XREF 5n1.4), 251(XREF 6S), 251(XREF 6n1.4), 251(XREF 7S)
    , 251(XREF 7n1.4), 253(XREF 1S), 253(XREF 1n1.4), 255(XREF 1S), 255(XREF 1n1.4), 257(XREF 1S), 257(XREF 1n1.4), 257(XREF 2S), 257(XREF 2n1.4), 257(XREF 3S)
    , 257(XREF 3n1.4), 257(XREF 4S), 257(XREF 4n1.4), 258(XREF 1S), 258(XREF 1n1.4), 258(XREF 2S), 258(XREF 2n1.4), 258(XREF 3S), 258(XREF 3n1.4), 264(XREF 1S)
    , 264(XREF 1n1.4), 264(XREF 2S), 264(XREF 2n1.4), 267(XREF 1S), 267(XREF 1n1.4), 267(XREF 2S), 267(XREF 2n1.4), 1764(XREF 1S), 1764(XREF 1n1.4), 1764(XREF 1K)
    ^ONCO(165.59 - [#165.59] .01(XREF 2S), .01(XREF 2K)
    ^ONCO(165.7 - [#165.7] 19OT+1, 89OT+1
    ^ONCO(166 - [#166] 21OT+1
    ^ONCO(166.12 - [#166.12] 347OT+1, 348OT+1
    ^ONCO(166.13 - [#166.13] 363OT+1, 363.1OT+1
    ^ONCO(167 - [#167] 153OT+1, 153.2OT+1
    ^ONCO(167.2 - [#167.2] 3838OT+1, 3839OT+1
    ^ONCO(167.3 - [#167.3] 3884OT+1
    ^ONCO(168 - [#168] 1.2OT+1
    ^ONCO(169 - [#169] 194OT+1
    ^VIC(5.1 - [#5.1] 9OT+1
    ^VIC(5.11 - [#5.11] 9OT+1

    Naked Globals

    Name Field # of Occurrence
    ^("BLA2" 257(XREF 4S), 257(XREF 4n1.4), 258(XREF 2S), 258(XREF 2n1.4)
    ^("CS2" 240(XREF 1S), 240(XREF 1K)
    ^("NCR18" 1764(XREF 1S), 1764(XREF 1n1.4), 1764(XREF 1K)
    ^("PM" 127(XREF 1S), 127(XREF 1n1.4), 127(XREF 2S), 127(XREF 2n1.4), 251(XREF 1S), 251(XREF 1n1.4), 251(XREF 2S), 251(XREF 2n1.4), 251(XREF 3S), 251(XREF 3n1.4)
    , 251(XREF 4S), 251(XREF 4n1.4), 251(XREF 5S), 251(XREF 5n1.4), 251(XREF 6S), 251(XREF 6n1.4), 251(XREF 7S), 251(XREF 7n1.4), 253(XREF 1S), 253(XREF 1n1.4)
    , 255(XREF 1S), 255(XREF 1n1.4), 257(XREF 1S), 257(XREF 1n1.4), 257(XREF 2S), 257(XREF 2n1.4), 257(XREF 3S), 257(XREF 3n1.4), 258(XREF 1S), 258(XREF 1n1.4)
    , 258(XREF 3S), 258(XREF 3n1.4), 264(XREF 1S), 264(XREF 1n1.4), 264(XREF 2S), 264(XREF 2n1.4), 267(XREF 1S), 267(XREF 1n1.4), 267(XREF 2S), 267(XREF 2n1.4)
    ^(0 ID20+1, IDWRITE+1, .04(XREF 1S), .04(XREF 1K), .061OF9.2+1, .08OF9.2+1, .09OF9.2+1, .091OF9.2+1, .091OF9.3+1, .093+1
    , .093OF9.2+1, .1OF9.2+1, .1OF9.3+1, .115OF9.2+1, .117OF9.2+1, .12+1, .12OF9.2+1, .12OF9.3+1, 3.5+1, 5OT+1
    , 6OT+1, 7OT+1, 9OT+1, 50.1OT+1, 51.1OT+1, 52.1OT+1, 53.1OT+1, 54.1OT+1, 55.1OT+1, 57.1OT+1
    , 97OF9.2+1, 202OF9.2+1, 203OF9.2+1, 204OF9.2+1
    ^(1 .091OF9.3+1, 9(XREF 1S), 9(XREF 1n1.4), 9(XREF 1K), 9(XREF 1n2.4), 9(XREF 2S), 9(XREF 2n1.4), 9(XREF 2K), 9(XREF 2n2.4), 9(XREF 3S)
    , 9(XREF 3n1.4), 9(XREF 3K), 9(XREF 3n2.4)
    ^(2 ID20+1, 37OF9.2+1, 37OF9.3+1, 37OF9.4+1
    ^(2.2 22.4+1
    ^(27 70(XREF 1S)
    ^(7 97+1, 97OF9.2+1, 198(XREF 2S), 198(XREF 2K)

    Local Variables

    Legend:

    >> Not killed explicitly
    * Changed
    ! Killed
    ~ Newed

    Name Field # of Occurrence
    %DT 3+1*, 25+1*!, 44+1*!, 64+1*, 79+1*, 96+1*!, 121+1*, 139.7+1*, 156+1*!, 171+1*!
    , 172+1*!, 173+1*!, 174.1+1*!, 175.1+1*!, 176.1+1*!, 177.1+1*!, 178.1+1*!, 179.1+1*!, 180.1+1*!, 181.1+1*!
    , 182.1+1*!, 183.1+1*!, 184.1+1*!, 185.1+1*!, 186.1+1*!, 187.1+1*!, 188.1+1*!, 189.1+1*!, 193+1*!, 195+1*!
    , 198+1*, 232+1*, 236+1*, 249+1*, 280.2+1*, 323+1*, 1306+1*, 1307+1*, 1368+1*, 1402+1*
    , 1428+1*, 1548+1*, 1566+1*, 3945+1*
    %DT(0 3+1*!, 25+1*, 44+1*, 64+1!, 79+1*!, 96+1*, 121+1*!, 156+1*, 171+1*, 172+1*
    , 173+1*, 174.1+1*, 175.1+1*, 176.1+1*, 177.1+1*, 178.1+1*, 179.1+1*, 180.1+1*, 181.1+1*, 182.1+1*
    , 183.1+1*, 184.1+1*, 185.1+1*, 186.1+1*, 187.1+1*, 188.1+1*, 189.1+1*, 193+1*, 195+1*, 249+1*
    , 280.2+1*, 323+1*!, 1306+1*!, 1307+1*!, 1368+1*!, 1402+1*!, 1548+1*!, 3945+1*
    %I ID20+1*!, IDWRITE+1*!
    >> C ID20+1*, IDWRITE+1*
    COC .041+1~*
    >> D0 .0101+1, .023+1, .04(XREF 1S), .04(XREF 1K), .041+1, .061OF9.2+1, .08+1*, .08OF9.2+1*, .09+1*, .09OF9.2+1*
    , .091+1*, .091OF9.2+1*, .091OF9.3+1, .093+1*, .093OF9.2+1*, .1+1*, .1OF9.2+1*, .1OF9.3+1, .115+1*, .115OF9.2+1*
    , .117+1*, .117OF9.2+1*, .12+1*, .12OF9.2+1*, .12OF9.3+1, 3.5+1, 9(XREF 1S), 9(XREF 1K), 9(XREF 2S), 9(XREF 2K)
    , 9(XREF 3S), 9(XREF 3K), 20.1+1, 22.1+1, 22.4+1, 29.1+1, 29.1(HELP ), 29.2+1, 29.2(HELP ), 29.9+1
    , 30.2+1, 30.2(HELP ), 30.9+1, 31.1+1, 31.1(HELP ), 32+1, 32.1+1, 32.1(HELP ), 33.1+1, 34.3+1
    , 34.3(HELP ), 34.4+1, 34.4(HELP ), 37+1, 37OF9.2+1, 44+1, 44.1+1, 44.1(HELP ), 44.101+1, 44.101(HELP )
    , 44.11+1, 44.11(HELP ), 44.12+1, 44.12(HELP ), 44.13+1, 44.13(HELP ), 44.14+1, 44.14(HELP ), 44.15+1, 44.15(HELP )
    , 44.16+1, 44.16(HELP ), 44.17+1, 44.17(HELP ), 44.18+1, 44.18(HELP ), 44.19+1, 44.19(HELP ), 44.2+1, 44.2(HELP )
    , 44.201+1, 44.201(HELP ), 44.21+1, 44.21(HELP ), 44.22+1, 44.22(HELP ), 44.23+1, 44.23(HELP ), 44.24+1, 44.24(HELP )
    , 44.25+1, 44.25(HELP ), 44.3+1, 44.3(HELP ), 44.4+1, 44.4(HELP ), 44.5+1, 44.5(HELP ), 44.6+1, 44.6(HELP )
    , 44.7+1, 44.7(HELP ), 44.8+1, 44.8(HELP ), 44.9+1, 44.9(HELP ), 64+1, 70(XREF 1S), 89.1+1, 97+1
    , 97OF9.2+1, 127(XREF 1S), 127(XREF 2S), 198(XREF 2S), 198(XREF 2K), 202OF9.2+1, 203OF9.2+1, 204OF9.2+1, 240(XREF 1S), 240(XREF 1K)
    , 251(XREF 1S), 251(XREF 2S), 251(XREF 3S), 251(XREF 4S), 251(XREF 5S), 251(XREF 6S), 251(XREF 7S), 253(XREF 1S), 255(XREF 1S), 257(XREF 1S)
    , 257(XREF 2S), 257(XREF 3S), 257(XREF 4S), 258(XREF 1S), 258(XREF 2S), 258(XREF 3S), 264(XREF 1S), 264(XREF 2S), 267(XREF 1S), 267(XREF 2S)
    , 1764(XREF 1S), 1764(XREF 1K)
    >> DA .01(XREF 1S), .01(XREF 1K), .01(XREF 2S), .01(XREF 2K), .02(XREF 1S), .02(XREF 1K), .04(XREF 1S), .04(XREF 1K), .04(XREF 3S), .04(XREF 3K)
    , .042(XREF 1S), .042(XREF 1K), .05(XREF 1S), .05(XREF 1K), .05(XREF 2S), .05(XREF 2K), .05(XREF 3S), .05(XREF 3K), .05(XREF 4S), .05(XREF 4K)
    , .05(XREF 5S), .05(XREF 5K), .06(XREF 1S), .06(XREF 1K), .07(XREF 1S), .07(XREF 1K), .07(XREF 2S), .07(XREF 2K), 2(XREF 1S), 2(XREF 1K)
    , 2(XREF 2S), 2(XREF 2K), 2(XREF 3S), 2(XREF 3K), 2.1(XREF 1S), 2.1(XREF 1K), 2.1(XREF 2S), 2.1(XREF 2K), 2.1(XREF 3S), 2.1(XREF 3K)
    , 2.2(XREF 1S), 2.2(XREF 1K), 2.2(XREF 2S), 2.2(XREF 2K), 2.2(XREF 3S), 2.2(XREF 3K), 2.3(XREF 1S), 2.3(XREF 1K), 2.3(XREF 2S), 2.3(XREF 2K)
    , 2.3(XREF 3S), 2.3(XREF 3K), 2.4(XREF 1S), 2.4(XREF 1K), 2.4(XREF 2S), 2.4(XREF 2K), 2.4(XREF 3S), 2.4(XREF 3K), 3(XREF 1S), 3(XREF 1K)
    , 9(XREF 1S), 9(XREF 1K), 9(XREF 2S), 9(XREF 2K), 9(XREF 3S), 9(XREF 3K), 20(XREF 1S), 20(XREF 1K), 20(XREF 2S), 20(XREF 2K)
    , 20(XREF 3S), 20(XREF 3K), 22(XREF 1S), 22(XREF 1K), 22.3(XREF 1K), 38.5(XREF 1S), 38.5(XREF 1K), 50(XREF 1S), 50(XREF 1K), 51(XREF 1S)
    , 51(XREF 1K), 52(XREF 1S), 52(XREF 1K), 53(XREF 1S), 53(XREF 1K), 54(XREF 1S), 54(XREF 1K), 55(XREF 1S), 55(XREF 1K), 57(XREF 1S)
    , 57(XREF 1K), 66(XREF 1S), 66(XREF 1K), 66(XREF 2S), 66(XREF 2K), 66(XREF 3S), 66(XREF 3K), 70(XREF 1S), 84(XREF 1S), 84(XREF 1K)
    , 90(XREF 1S), 90(XREF 1K), 91(XREF 1S), 91(XREF 1K), 95(XREF 1S), 95(XREF 1K), 124(XREF 1S), 124(XREF 1K), 127(XREF 1S), 127(XREF 2S)
    , 138.2(XREF 1S), 138.2(XREF 1K), 139.2(XREF 1S), 139.2(XREF 1K), 153.1(XREF 1S), 153.1(XREF 1K), 155(XREF 1S), 155(XREF 1K), 170(XREF 1S), 170(XREF 1K)
    , 198(XREF 1S), 198(XREF 1K), 198(XREF 2S), 198(XREF 2K), 240(XREF 1S), 240(XREF 1K), 251(XREF 1S), 251(XREF 2S), 251(XREF 3S), 251(XREF 4S)
    , 251(XREF 5S), 251(XREF 6S), 251(XREF 7S), 253(XREF 1S), 255(XREF 1S), 257(XREF 1S), 257(XREF 2S), 257(XREF 3S), 257(XREF 4S), 258(XREF 1S)
    , 258(XREF 2S), 258(XREF 3S), 264(XREF 1S), 264(XREF 2S), 267(XREF 1S), 267(XREF 2S), 1764(XREF 1S), 1764(XREF 1K)
    DIC ID20+1, IDWRITE+1, 2+1!*, 2.1+1!*, 2.2+1!*, 2.3+1!*, 2.4+1!*, 21+1!*, 22+1!*, 25.1+1!*
    , 25.2+1!*, 25.3+1!*, 39+1!*, 66+1!*, 71+1!*, 363+1!*, 363.1+1!*, 1311+1!*, 1367+1!*, 1400+1!*
    , 1400.1+1!*, 1400.2+1!*, 1400.3+1!*, 1400.4+1!*, 1400.5+1!*, 1426+1!*, 1426.1+1!*, 1426.2+1!*, 1426.3+1!*, 1426.4+1!*
    , 1571+1!*, 1571.1+1!*, 1571.2+1!*, 1571.3+1!*, 1571.4+1!*, 1571.5+1!*, 1579+1!*, 1579.1+1!*, 1579.2+1!*, 1579.3+1!*
    , 1579.4+1!*, 3838+1!*, 3839+1!*
    DIC("S" .01SCR+1*, 2+1*, 2SCR+1*, 2.1+1*, 2.1SCR+1*, 2.2+1*, 2.2SCR+1*, 2.3+1*, 2.3SCR+1*, 2.4+1*
    , 2.4SCR+1*, 21+1*, 21SCR+1*, 22+1*, 22SCR+1*, 25.1+1*, 25.1SCR+1*, 25.2+1*, 25.2SCR+1*, 25.3+1*
    , 25.3SCR+1*, 35SCR+1*, 39+1*, 39SCR+1*, 51.2SCR+1*, 51.4SCR+1*, 53.2SCR+1*, 54.2SCR+1*, 55.2SCR+1*, 66+1*
    , 66SCR+1*, 71+1*, 71SCR+1*, 134SCR+1*, 135SCR+1*, 149SCR+1*, 363+1*, 363SCR+1*, 363.1+1*, 363.1SCR+1*
    , 385SCR+1*, 386SCR+1*, 559SCR+1*, 560SCR+1*, 643SCR+1*, 644SCR+1*, 645SCR+1*, 646SCR+1*, 648SCR+1*, 791SCR+1*
    , 884SCR+1*, 943SCR+1*, 1311+1*, 1311SCR+1*, 1367+1*, 1367SCR+1*, 1400+1*, 1400SCR+1*, 1400.1+1*, 1400.1SCR+1*
    , 1400.2+1*, 1400.2SCR+1*, 1400.3+1*, 1400.3SCR+1*, 1400.4+1*, 1400.4SCR+1*, 1400.5+1*, 1400.5SCR+1*, 1426+1*, 1426SCR+1*
    , 1426.1+1*, 1426.1SCR+1*, 1426.2+1*, 1426.2SCR+1*, 1426.3+1*, 1426.3SCR+1*, 1426.4+1*, 1426.4SCR+1*, 1571+1*, 1571SCR+1*
    , 1571.1+1*, 1571.1SCR+1*, 1571.2+1*, 1571.2SCR+1*, 1571.3+1*, 1571.3SCR+1*, 1571.4+1*, 1571.4SCR+1*, 1571.5+1*, 1571.5SCR+1*
    , 1579+1*, 1579SCR+1*, 1579.1+1*, 1579.1SCR+1*, 1579.2+1*, 1579.2SCR+1*, 1579.3+1*, 1579.3SCR+1*, 1579.4+1*, 1579.4SCR+1*
    , 1764SCR+1*, 3804SCR+1*, 3811SCR+1*, 3838+1*, 3838SCR+1*, 3839+1*, 3839SCR+1*, 3857SCR+1*, 3869SCR+1*, 3885SCR+1*
    , 3907SCR+1*, 3930SCR+1*, 3931SCR+1*, 3933SCR+1*
    >> DIE 2+1, 2.1+1, 2.2+1, 2.3+1, 2.4+1, 21+1, 22+1, 25.1+1, 25.2+1, 25.3+1
    , 39+1, 66+1, 71+1, 363+1, 363.1+1, 1311+1, 1367+1, 1400+1, 1400.1+1, 1400.2+1
    , 1400.3+1, 1400.4+1, 1400.5+1, 1426+1, 1426.1+1, 1426.2+1, 1426.3+1, 1426.4+1, 1571+1, 1571.1+1
    , 1571.2+1, 1571.3+1, 1571.4+1, 1571.5+1, 1579+1, 1579.1+1, 1579.2+1, 1579.3+1, 1579.4+1, 3838+1
    , 3839+1
    >> DIG .04(XREF 1S), .04(XREF 1K), 9(XREF 1n1.4), 9(XREF 1n2.4), 9(XREF 2n1.4), 9(XREF 2n2.4), 9(XREF 3n1.4), 9(XREF 3n2.4), 70(XREF 1S), 127(XREF 1n1.4)
    , 127(XREF 2n1.4), 198(XREF 2S), 198(XREF 2K), 240(XREF 1S), 240(XREF 1K), 251(XREF 1n1.4), 251(XREF 2n1.4), 251(XREF 3n1.4), 251(XREF 4n1.4), 251(XREF 5n1.4)
    , 251(XREF 6n1.4), 251(XREF 7n1.4), 253(XREF 1n1.4), 255(XREF 1n1.4), 257(XREF 1n1.4), 257(XREF 2n1.4), 257(XREF 3n1.4), 257(XREF 4n1.4), 258(XREF 1n1.4), 258(XREF 2n1.4)
    , 258(XREF 3n1.4), 264(XREF 1n1.4), 264(XREF 2n1.4), 267(XREF 1n1.4), 267(XREF 2n1.4), 1764(XREF 1n1.4), 1764(XREF 1K)
    >> DIH .04(XREF 1S), .04(XREF 1K), 9(XREF 1n1.4), 9(XREF 1n2.4), 9(XREF 2n1.4), 9(XREF 2n2.4), 9(XREF 3n1.4), 9(XREF 3n2.4), 70(XREF 1S), 127(XREF 1n1.4)
    , 127(XREF 2n1.4), 198(XREF 2S), 198(XREF 2K), 240(XREF 1S), 240(XREF 1K), 251(XREF 1n1.4), 251(XREF 2n1.4), 251(XREF 3n1.4), 251(XREF 4n1.4), 251(XREF 5n1.4)
    , 251(XREF 6n1.4), 251(XREF 7n1.4), 253(XREF 1n1.4), 255(XREF 1n1.4), 257(XREF 1n1.4), 257(XREF 2n1.4), 257(XREF 3n1.4), 257(XREF 4n1.4), 258(XREF 1n1.4), 258(XREF 2n1.4)
    , 258(XREF 3n1.4), 264(XREF 1n1.4), 264(XREF 2n1.4), 267(XREF 1n1.4), 267(XREF 2n1.4), 1764(XREF 1n1.4), 1764(XREF 1K)
    >> DIU .04(XREF 1S), .04(XREF 1K), 9(XREF 1S), 9(XREF 1K), 9(XREF 2S), 9(XREF 2K), 9(XREF 3S), 9(XREF 3K), 70(XREF 1S), 127(XREF 1S)
    , 127(XREF 2S), 198(XREF 2S), 198(XREF 2K), 240(XREF 1S), 240(XREF 1K), 251(XREF 1S), 251(XREF 2S), 251(XREF 3S), 251(XREF 4S), 251(XREF 5S)
    , 251(XREF 6S), 251(XREF 7S), 253(XREF 1S), 255(XREF 1S), 257(XREF 1S), 257(XREF 2S), 257(XREF 3S), 257(XREF 4S), 258(XREF 1S), 258(XREF 2S)
    , 258(XREF 3S), 264(XREF 1S), 264(XREF 2S), 267(XREF 1S), 267(XREF 2S), 1764(XREF 1S), 1764(XREF 1K)
    DIV .04(XREF 1S), .04(XREF 1K), 9(XREF 1S), 9(XREF 1n1.4), 9(XREF 1K), 9(XREF 1n2.4), 9(XREF 2S), 9(XREF 2n1.4), 9(XREF 2K), 9(XREF 2n2.4)
    , 9(XREF 3S), 9(XREF 3n1.4), 9(XREF 3K), 9(XREF 3n2.4), 70(XREF 1S), 127(XREF 1S), 127(XREF 1n1.4), 127(XREF 2S), 127(XREF 2n1.4), 198(XREF 2S)
    , 198(XREF 2K), 240(XREF 1S), 240(XREF 1K), 251(XREF 1S), 251(XREF 1n1.4), 251(XREF 2S), 251(XREF 2n1.4), 251(XREF 3S), 251(XREF 3n1.4), 251(XREF 4S)
    , 251(XREF 4n1.4), 251(XREF 5S), 251(XREF 5n1.4), 251(XREF 6S), 251(XREF 6n1.4), 251(XREF 7S), 251(XREF 7n1.4), 253(XREF 1S), 253(XREF 1n1.4), 255(XREF 1S)
    , 255(XREF 1n1.4), 257(XREF 1S), 257(XREF 1n1.4), 257(XREF 2S), 257(XREF 2n1.4), 257(XREF 3S), 257(XREF 3n1.4), 257(XREF 4S), 257(XREF 4n1.4), 258(XREF 1S)
    , 258(XREF 1n1.4), 258(XREF 2S), 258(XREF 2n1.4), 258(XREF 3S), 258(XREF 3n1.4), 264(XREF 1S), 264(XREF 1n1.4), 264(XREF 2S), 264(XREF 2n1.4), 267(XREF 1S)
    , 267(XREF 1n1.4), 267(XREF 2S), 267(XREF 2n1.4), 1764(XREF 1S), 1764(XREF 1n1.4), 1764(XREF 1K)
    DIV(0 .04(XREF 1S), .04(XREF 1K), 9(XREF 1S), 9(XREF 1n1.4), 9(XREF 1K), 9(XREF 1n2.4), 9(XREF 2S), 9(XREF 2n1.4), 9(XREF 2K), 9(XREF 2n2.4)
    , 9(XREF 3S), 9(XREF 3n1.4), 9(XREF 3K), 9(XREF 3n2.4), 70(XREF 1S), 127(XREF 1S), 127(XREF 1n1.4), 127(XREF 2S), 127(XREF 2n1.4), 198(XREF 2S)
    , 198(XREF 2K), 240(XREF 1S), 240(XREF 1K), 251(XREF 1S), 251(XREF 1n1.4), 251(XREF 2S), 251(XREF 2n1.4), 251(XREF 3S), 251(XREF 3n1.4), 251(XREF 4S)
    , 251(XREF 4n1.4), 251(XREF 5S), 251(XREF 5n1.4), 251(XREF 6S), 251(XREF 6n1.4), 251(XREF 7S), 251(XREF 7n1.4), 253(XREF 1S), 253(XREF 1n1.4), 255(XREF 1S)
    , 255(XREF 1n1.4), 257(XREF 1S), 257(XREF 1n1.4), 257(XREF 2S), 257(XREF 2n1.4), 257(XREF 3S), 257(XREF 3n1.4), 257(XREF 4S), 257(XREF 4n1.4), 258(XREF 1S)
    , 258(XREF 1n1.4), 258(XREF 2S), 258(XREF 2n1.4), 258(XREF 3S), 258(XREF 3n1.4), 264(XREF 1S), 264(XREF 1n1.4), 264(XREF 2S), 264(XREF 2n1.4), 267(XREF 1S)
    , 267(XREF 1n1.4), 267(XREF 2S), 267(XREF 2n1.4), 1764(XREF 1S), 1764(XREF 1n1.4), 1764(XREF 1K)
    DT .07(XREF 3K)
    >> DTDX 64+1*
    DUZ 198(XREF 2S)
    FIELD 50.2+1*, 50.2OT+1*, 50.2(HELP ), 58.2+1*, 58.2OT+1*, 58.2(HELP ), 58.6+1*, 58.6OT+1*, 58.6(HELP ), 58.7+1*
    , 58.7OT+1*, 58.7(HELP ), 138+1*, 138OT+1*!, 138(HELP ), 138.1+1*, 138.1OT+1*!, 138.1(HELP ), 139+1*, 139OT+1*!
    , 139(HELP ), 139.1+1*, 139.1OT+1*!, 139.1(HELP )
    >> FILNUM 136OT+1*
    >> FLDNUM 136OT+1*
    >> HIERTNM 40.1+1
    >> ITFLAG 70+1*, 79+1*, 121+1*, 323+1*, 367+1*, 541+1*, 542+1*, 567+1*, 699.1+1*, 865+1*
    , 919+1*, 921+1*, 923+1*, 925+1*, 929+1*, 1306+1*, 1307+1*, 1368+1*, 1402+1*, 1548+1*
    >> NTDEL 124(XREF 2K)
    >> NTXDD 23+1*, 50.2+1*, 58.2+1*, 58.6+1*, 58.7+1*, 138+1*, 138.1+1*, 139+1*, 139.1+1*, 140+1*
    , 140.1+1*
    >> ONC138P2 138.2+1*, 138.3+1*
    ONCCITY 9(XREF 3S)
    ONCCOUNTY 9(XREF 1S)
    >> ONCF 1407+1*, 1407.1+1*, 1430+1*, 1540+1*, 1541+1*, 1542+1*, 1543+1*, 1544+1*, 1562+1*
    >> ONCFLD 30+1*, 30OT+1*, 30(HELP ), 30.1+1*, 30.1OT+1*, 30.1(HELP )
    ONCGPAT 3838(HELP ), 3839(HELP )
    ONCICD 1400OT+1~*, 1400.1OT+1~*, 1400.2OT+1~*, 1400.3OT+1~*, 1400.4OT+1~*, 1400.5OT+1~*, 1426OT+1~*, 1426.1OT+1~*, 1426.2OT+1~*, 1426.3OT+1~*
    , 1426.4OT+1~*, 1571OT+1~*, 1571.1OT+1~*, 1571.2OT+1~*, 1571.3OT+1~*, 1571.4OT+1~*, 1571.5OT+1~*, 1579OT+1~*, 1579.1OT+1~*, 1579.2OT+1~*
    , 1579.3OT+1~*, 1579.4OT+1~*
    >> ONCITM 999.1(HELP ), 999.11(HELP ), 999.12(HELP ), 999.13(HELP ), 999.14(HELP ), 999.15(HELP ), 999.16(HELP ), 999.17(HELP ), 999.18(HELP ), 999.19(HELP )
    , 999.2(HELP ), 999.21(HELP ), 999.22(HELP ), 999.23(HELP ), 999.24(HELP ), 999.25(HELP ), 999.3(HELP ), 999.4(HELP ), 999.5(HELP ), 999.6(HELP )
    , 999.7(HELP ), 999.8(HELP ), 999.9(HELP )
    >> ONCL 442+1*, 443+1*, 1401+1*, 1407+1*, 1407.1+1*, 1409.4+1*, 1409.5+1*, 1410.4+1*, 1410.5+1*, 1411.4+1*
    , 1411.5+1*, 1412.4+1*, 1412.5+1*, 1413.4+1*, 1413.5+1*, 1414.4+1*, 1414.5+1*, 1415.4+1*, 1415.5+1*, 1420+1*
    , 1422+1*, 1429+1*, 1429.1+1*, 1430+1*, 1501+1*, 1540+1*, 1541+1*, 1542+1*, 1543+1*, 1544+1*
    , 1558+1*, 1558.1+1*, 1562+1*, 1567+1*, 1572+1*, 1575+1*
    >> ONCNODE 5001+1*, 5001(HELP ), 5002+1*, 5002(HELP ), 5003+1*, 5003(HELP ), 5011+1*, 5011(HELP ), 5012+1*, 5012(HELP )
    , 5013+1*, 5013(HELP ), 5021+1*, 5021(HELP ), 5022+1*, 5022(HELP ), 5023+1*, 5023(HELP ), 5025+1*, 5025(HELP )
    , 5026+1*, 5026(HELP ), 5027+1*, 5027(HELP )
    ONCOX 20(HELP ), 22(HELP ), 30+1*, 30OT+1*, 30(HELP ), 30.1+1*, 30.1OT+1*, 30.1(HELP ), 31+1*, 31OT+1*
    , 31(HELP ), 37.1+1~*, 37.1(HELP ), 37.2+1~*, 37.2(HELP ), 37.3+1~*, 37.3(HELP ), 38+1*, 38(HELP ), 85+1~*
    , 85(HELP ), 86+1~*, 86(HELP ), 87+1~*, 87(HELP ), 88+1*, 88(HELP ), 93+1*, 93OT+1*, 93(HELP )
    , 98+1*, 98OT+1*, 98(HELP ), 99+1*, 99OT+1*, 99(HELP ), 117+1*, 117(HELP )
    >> ONCSDND 3926+1*, 3926(HELP ), 3927+1*, 3927(HELP )
    >> ONCSFFX 5031+1*, 5031(HELP ), 5032+1*, 5032(HELP ), 5033+1*, 5033(HELP ), 5033.5+1*, 5033.5(HELP ), 5034+1*, 5034(HELP )
    , 5035+1*, 5035(HELP ), 5036+1*, 5036(HELP ), 5036.5+1*, 5036.5(HELP )
    >> ONCSHLST 5004+1*, 5014+1*, 5024+1*, 5028+1*
    ONCSTATE 9(XREF 2S)
    >> ONCTNMTP 5011+1*, 5011(HELP ), 5012+1*, 5012(HELP ), 5021+1*, 5021(HELP ), 5022+1*, 5022(HELP ), 5025+1*, 5025(HELP )
    , 5026+1*, 5026(HELP )
    >> ONCYC 5025+1*, 5025(HELP ), 5026+1*, 5026(HELP )
    >> SCPFLG 138.1+1*
    >> SOSFLG 139.1+1*
    >> SPSFLG 50.2+1*, 58.7+1*
    >> SSF25 240(XREF 1S)
    STGIND 37+1*, 37.1+1~*, 37.1(HELP ), 37.2+1~*, 37.2(HELP ), 37.3+1~*, 37.3(HELP ), 38+1*, 38(HELP ), 85+1~*
    , 85(HELP ), 86+1~*, 86(HELP ), 87+1~*, 87(HELP ), 88+1*, 88(HELP ), 89.1+1*, 93+1*, 93OT+1*
    , 93(HELP ), 98+1*, 98OT+1*, 98(HELP ), 99+1*, 99OT+1*, 99(HELP ), 117+1*, 117(HELP ), 850+1*
    , 850(HELP ), 5004+1*, 5004(HELP ), 5014+1*, 5014(HELP ), 5024+1*, 5024(HELP ), 5028+1*, 5028(HELP )
    U ID20+1, IDWRITE+1, .0101+1, .023+1, .03OT+1, .04OT+1, .04(XREF 1S), .04(XREF 1K), .04(XREF 3S), .04(XREF 3K)
    , .05(XREF 1S), .05(XREF 1K), .05(XREF 2S), .05(XREF 2K), .05(XREF 5S), .05(XREF 5K), .06(XREF 1S), .06(XREF 1K), .061+1, .061OF9.2+1
    , .061OF9.3+1, .07(XREF 2S), .07(XREF 2K), .08+1, .08OF9.2+1, .09+1, .09OF9.2+1, .091+1, .091OF9.2+1, .091OF9.3+1
    , .093+1, .093OF9.2+1, .1+1, .1OF9.2+1, .1OF9.3+1, .115+1, .115OF9.2+1, .117+1, .117OF9.2+1, .12+1
    , .12OF9.2+1, .12OF9.3+1, 1.2OT+1, 2(XREF 1S), 2(XREF 1K), 2(XREF 2S), 2(XREF 2K), 2(XREF 3S), 2(XREF 3K), 2.1(XREF 1S)
    , 2.1(XREF 1K), 2.1(XREF 2S), 2.1(XREF 2K), 2.1(XREF 3S), 2.1(XREF 3K), 2.2(XREF 1S), 2.2(XREF 1K), 2.2(XREF 2S), 2.2(XREF 2K), 2.2(XREF 3S)
    , 2.2(XREF 3K), 2.3(XREF 1S), 2.3(XREF 1K), 2.3(XREF 2S), 2.3(XREF 2K), 2.3(XREF 3S), 2.3(XREF 3K), 2.4(XREF 1S), 2.4(XREF 1K), 2.4(XREF 2S)
    , 2.4(XREF 2K), 2.4(XREF 3S), 2.4(XREF 3K), 3.5+1, 5OT+1, 6OT+1, 7OT+1, 9OT+1, 9(XREF 1S), 9(XREF 1n1.4)
    , 9(XREF 1K), 9(XREF 1n2.4), 9(XREF 2S), 9(XREF 2n1.4), 9(XREF 2K), 9(XREF 2n2.4), 9(XREF 3S), 9(XREF 3n1.4), 9(XREF 3K), 9(XREF 3n2.4)
    , 18OT+1, 19OT+1, 20(XREF 2S), 20(XREF 2K), 20.1+1, 21OT+1, 22.3(XREF 1K), 22.4+1, 24OT+1, 25.1OT+1
    , 25.2OT+1, 25.3OT+1, 32+1, 33.1+1, 37OF9.2+1, 37OF9.3+1, 37OF9.4+1, 50.1OT+1, 51.1OT+1, 52.1OT+1
    , 53.1OT+1, 54.1OT+1, 55.1OT+1, 55.2OT+1, 57.1OT+1, 66(XREF 1S), 66(XREF 1K), 66(XREF 2S), 66(XREF 2K), 66(XREF 3S)
    , 66(XREF 3K), 70(XREF 1S), 71OT+1, 89OT+1, 97+1, 97OF9.2+1, 127(XREF 1S), 127(XREF 1n1.4), 127(XREF 2S), 127(XREF 2n1.4)
    , 128OT+1, 153OT+1, 153.2OT+1, 194OT+1, 198(XREF 2S), 198(XREF 2K), 202OF9.2+1, 203OF9.2+1, 204OF9.2+1, 240(XREF 1S)
    , 240(XREF 1K), 251(XREF 1S), 251(XREF 1n1.4), 251(XREF 2S), 251(XREF 2n1.4), 251(XREF 3S), 251(XREF 3n1.4), 251(XREF 4S), 251(XREF 4n1.4), 251(XREF 5S)
    , 251(XREF 5n1.4), 251(XREF 6S), 251(XREF 6n1.4), 251(XREF 7S), 251(XREF 7n1.4), 253(XREF 1S), 253(XREF 1n1.4), 255(XREF 1S), 255(XREF 1n1.4), 257(XREF 1S)
    , 257(XREF 1n1.4), 257(XREF 2S), 257(XREF 2n1.4), 257(XREF 3S), 257(XREF 3n1.4), 257(XREF 4S), 257(XREF 4n1.4), 258(XREF 1S), 258(XREF 1n1.4), 258(XREF 2S)
    , 258(XREF 2n1.4), 258(XREF 3S), 258(XREF 3n1.4), 264(XREF 1S), 264(XREF 1n1.4), 264(XREF 2S), 264(XREF 2n1.4), 267(XREF 1S), 267(XREF 1n1.4), 267(XREF 2S)
    , 267(XREF 2n1.4), 363OT+1, 363.1OT+1, 803OT+1, 804OT+1, 805OT+1, 806OT+1, 1102OT+1, 1104OT+1, 1400OT+1
    , 1400.1OT+1, 1400.2OT+1, 1400.3OT+1, 1400.4OT+1, 1400.5OT+1, 1403OT+1, 1426OT+1, 1426.1OT+1, 1426.2OT+1, 1426.3OT+1
    , 1426.4OT+1, 1571OT+1, 1571.1OT+1, 1571.2OT+1, 1571.3OT+1, 1571.4OT+1, 1571.5OT+1, 1573OT+1, 1579OT+1, 1579.1OT+1
    , 1579.2OT+1, 1579.3OT+1, 1579.4OT+1, 1764(XREF 1S), 1764(XREF 1n1.4), 1764(XREF 1K), 3838OT+1, 3839OT+1, 3884OT+1, 5502OT+1
    , 5504OT+1, 5505OT+1, 5506OT+1, 5512OT+1, 5514OT+1, 5515OT+1, 5516OT+1, 5522OT+1, 5524OT+1, 5525OT+1
    , 5526OT+1
    >> V 50+1*, 50.1+1*, 50.3+1*, 51+1*, 51.1+1*, 51.5+1*, 52+1*, 52.1+1*, 53+1*, 53.1+1*
    , 53.4+1*, 54+1*, 54.1+1*, 54.4+1*, 55+1*, 55.1+1*, 55.4+1*, 56+1*, 57+1*, 57.1+1*
    , 57.4+1*, 125+1*, 128+1*, 129+1*, 130+1*, 138.2+1*, 138.3+1*, 139.2+1*, 139.3+1*, 153.1+1*
    , 153.3+1*, 170+1*, 361+1*, 363.1+1*, 435+1*, 442+1*, 443+1*
    X .01(XREF 1S), .01(XREF 1K), .01(XREF 2S), .0101+1*, .015+1*, .017+1*, .02+1, .02(XREF 1S), .02(XREF 1K), .023+1*
    , .025+1*, .04(XREF 1S), .04(XREF 1K), .04(XREF 3S), .04(XREF 3K), .041+1*, .042(XREF 1S), .042(XREF 1K), .05+1!, .05(XREF 1S)
    , .05(XREF 1K), .05(XREF 2S), .05(XREF 2K), .05(XREF 3S), .05(XREF 3K), .05(XREF 4S), .05(XREF 4K), .05(XREF 5S), .05(XREF 5K), .06+1!
    , .06(XREF 1S), .06(XREF 1K), .061+1*, .061OF9.2+1*, .061OF9.3+1*, .07+1!, .07(XREF 1S), .07(XREF 1K), .07(XREF 2S), .07(XREF 2K)
    , .07(XREF 3S), .08+1*, .09+1*, .091+1*, .093+1*, .1+1*, .115+1*, .117+1*, .12+1*, .13+1*
    , .14+1*, 1OT+1*, 1.1OT+1*, 2+1*!, 2(XREF 1S), 2(XREF 1K), 2(XREF 2S), 2(XREF 2K), 2(XREF 3S), 2(XREF 3K)
    , 2.1+1*!, 2.1(XREF 1S), 2.1(XREF 1K), 2.1(XREF 2S), 2.1(XREF 2K), 2.1(XREF 3S), 2.1(XREF 3K), 2.2+1*!, 2.2(XREF 1S), 2.2(XREF 1K)
    , 2.2(XREF 2S), 2.2(XREF 2K), 2.2(XREF 3S), 2.2(XREF 3K), 2.3+1*!, 2.3(XREF 1S), 2.3(XREF 1K), 2.3(XREF 2S), 2.3(XREF 2K), 2.3(XREF 3S)
    , 2.3(XREF 3K), 2.4+1*!, 2.4(XREF 1S), 2.4(XREF 1K), 2.4(XREF 2S), 2.4(XREF 2K), 2.4(XREF 3S), 2.4(XREF 3K), 3+1*!, 3OT+1*
    , 3(XREF 1S), 3(XREF 1K), 3.1+1*, 3.5+1*, 8+1!, 8.1+1!, 8.2+1!, 9(XREF 1S), 9(XREF 1n1.4), 9(XREF 1K)
    , 9(XREF 1n2.4), 9(XREF 2S), 9(XREF 2n1.4), 9(XREF 2K), 9(XREF 2n2.4), 9(XREF 3S), 9(XREF 3n1.4), 9(XREF 3K), 9(XREF 3n2.4), 10+1!
    , 17OT+1*, 20(XREF 1S), 20(XREF 1K), 20(XREF 2S), 20(XREF 3S), 20(XREF 3K), 20.1+1*, 21+1*!, 22+1*!, 22(XREF 1S)
    , 22(XREF 1K), 22.1+1*, 22.4+1*, 23+1!, 24.3+1!, 24.4+1!, 24.5+1!, 24.6+1!, 25+1*!, 25OT+1*
    , 25.1+1*!, 25.2+1*!, 25.3+1*!, 29.9+1*, 30.1+1!, 30.9+1*, 32+1!*, 33+1!*, 33.1+1*, 35.1+1*
    , 37+1*, 37OF9.2+1*, 37OF9.3+1*, 37OF9.4+1*, 37.1+1!, 37.2+1!, 37.3+1!, 38+1!, 38OT+1*, 38.1+1*
    , 38.2+1*, 38.3+1*, 38.4+1*, 38.5(XREF 1S), 38.5(XREF 1K), 39+1*!, 40+1*, 40.1+1*, 40.2+1*, 42+1*
    , 43+1*, 44+1!*, 44OT+1*, 47+1!, 48+1*, 49+1*, 49.1+1*, 49.9+1*, 50+1, 50OT+1*
    , 50(XREF 1S), 50(XREF 1K), 50.2+1!, 50.3+1, 50.3OT+1*, 51+1, 51OT+1*, 51(XREF 1S), 51(XREF 1K), 51.5+1
    , 51.5OT+1*, 52+1, 52OT+1*, 52(XREF 1S), 52(XREF 1K), 53+1, 53OT+1*, 53(XREF 1S), 53(XREF 1K), 53.4+1
    , 53.4OT+1*, 54+1, 54OT+1*, 54(XREF 1S), 54(XREF 1K), 54.4+1, 54.4OT+1*, 55+1, 55OT+1*, 55(XREF 1S)
    , 55(XREF 1K), 55.4+1, 55.4OT+1*, 56+1!, 57+1, 57OT+1*, 57(XREF 1S), 57(XREF 1K), 57.4+1, 57.4OT+1*
    , 58.3OT+1*, 58.5OT+1*, 58.7+1!, 58.8+1!, 58.9+1!, 61+1*, 64+1*!, 64OT+1*, 65+1!, 66+1*!
    , 66(XREF 1S), 66(XREF 1K), 66(XREF 2S), 66(XREF 2K), 66(XREF 3S), 66(XREF 3K), 67+1*, 68+1*, 69+1!, 70OT+1*
    , 70(XREF 1S), 71+1*!, 74+1!, 79+1*!, 81+1!, 82+1!, 84(XREF 1S), 84(XREF 1K), 85+1!, 86+1!
    , 87+1!, 88+1!, 88OT+1*, 89.1+1*, 90OT+1*, 90(XREF 1S), 90(XREF 1K), 91(XREF 1S), 91(XREF 1K), 93+1!
    , 94OT+1*, 95(XREF 1S), 95(XREF 1K), 95.1+1*, 96+1*!, 96OT+1*, 97+1*, 98+1!, 99+1!, 100+1!
    , 101+1!, 117+1!, 117OT+1*, 121+1*!, 124OT+1*, 124(XREF 1S), 124(XREF 1K), 127(XREF 1S), 127(XREF 1n1.4), 127(XREF 2S)
    , 127(XREF 2n1.4), 130+1, 130OT+1*, 133+1!, 137OT+1*, 138+1!, 138.1+1!, 138.2+1, 138.2OT+1*, 138.2(XREF 1S)
    , 138.2(XREF 1K), 138.3+1, 138.3OT+1*, 139+1!, 139.1+1!, 139.2+1, 139.2OT+1*, 139.2(XREF 1S), 139.2(XREF 1K), 139.3+1
    , 139.3OT+1*, 139.7+1*!, 139.7OT+1*, 140+1!*, 140.1+1!*, 141+1!, 142+1!, 147+1!, 150+1*, 152+1*
    , 153.1+1, 153.1OT+1*, 153.1(XREF 1S), 153.1(XREF 1K), 153.3+1, 153.3OT+1*, 155OT+1*, 155(XREF 1S), 155(XREF 1K), 156+1*!
    , 156OT+1*, 160+1!, 160.7+1!, 162+1!, 162.7+1!, 164+1!, 164.7+1!, 166+1!, 166.7+1!, 169+1!
    , 169.1+1!, 170+1, 170OT+1*, 170(XREF 1S), 170(XREF 1K), 171+1*!, 171OT+1*, 172+1*!, 172OT+1*, 173+1*!
    , 173OT+1*, 174.1+1*!, 174.1OT+1*, 175.1+1*!, 175.1OT+1*, 176.1+1*!, 176.1OT+1*, 177.1+1*!, 177.1OT+1*, 178.1+1*!
    , 178.1OT+1*, 179.1+1*!, 179.1OT+1*, 180.1+1*!, 180.1OT+1*, 181.1+1*!, 181.1OT+1*, 182.1+1*!, 182.1OT+1*, 183.1+1*!
    , 183.1OT+1*, 184.1+1*!, 184.1OT+1*, 185.1+1*!, 185.1OT+1*, 186.1+1*!, 186.1OT+1*, 187.1+1*!, 187.1OT+1*, 188.1+1*!
    , 188.1OT+1*, 189.1+1*!, 189.1OT+1*, 193+1*!, 193OT+1*, 195+1*!, 195OT+1*, 196+1!, 197+1!, 197.1+1!
    , 198+1*!, 198OT+1*, 198(XREF 1S), 198(XREF 1K), 198(XREF 2S), 198(XREF 2K), 200+1*, 201+1*, 202+1*, 202OF9.2+1*
    , 203+1*, 203OF9.2+1*, 204+1*, 204OF9.2+1*, 231+1!, 232+1*!, 232OT+1*, 236+1*!, 236OT+1*, 237.1+1!
    , 240+1!, 240(XREF 1S), 240(XREF 1K), 245.3+1!, 248+1!, 249+1*!, 249OT+1*, 250+1!, 251(XREF 1S), 251(XREF 1n1.4)
    , 251(XREF 2S), 251(XREF 2n1.4), 251(XREF 3S), 251(XREF 3n1.4), 251(XREF 4S), 251(XREF 4n1.4), 251(XREF 5S), 251(XREF 5n1.4), 251(XREF 6S), 251(XREF 6n1.4)
    , 251(XREF 7S), 251(XREF 7n1.4), 253OT+1*, 253(XREF 1S), 253(XREF 1n1.4), 255OT+1*, 255(XREF 1S), 255(XREF 1n1.4), 256OT+1*, 257(XREF 1S)
    , 257(XREF 1n1.4), 257(XREF 2S), 257(XREF 2n1.4), 257(XREF 3S), 257(XREF 3n1.4), 257(XREF 4S), 257(XREF 4n1.4), 258(XREF 1S), 258(XREF 1n1.4), 258(XREF 2S)
    , 258(XREF 2n1.4), 258(XREF 3S), 258(XREF 3n1.4), 264OT+1*, 264(XREF 1S), 264(XREF 1n1.4), 264(XREF 2S), 264(XREF 2n1.4), 265OT+1*, 266OT+1*
    , 267(XREF 1S), 267(XREF 1n1.4), 267(XREF 2S), 267(XREF 2n1.4), 272OT+1*, 277OT+1*, 280.1+1!, 280.2+1*!, 283+1!, 284+1!
    , 284.1+1!, 284.2+1!, 284.3+1!, 284.4+1!, 284.5+1!, 284.6+1!, 284.7+1!, 284.8+1!, 284.9+1!, 301+1!
    , 314+1!, 315+1!, 316+1!, 323+1*!, 324+1!, 325+1!, 361+1, 361OT+1*, 362+1!, 363+1*!
    , 363.1+1*!, 435+1, 435OT+1*, 442+1!, 443+1!, 444+1!, 445+1!, 522+1!, 528+1!, 529+1!
    , 530+1!, 531+1!, 533+1!, 534+1!, 536+1!, 537+1!, 539+1!, 540+1!, 565+1!, 566+1!
    , 623+1!, 623.1+1!, 623.3+1!, 623.4+1!, 684+1!, 686+1!, 715+1!, 716+1!, 717+1!, 718+1!
    , 719+1!, 720+1!, 721+1!, 722+1!, 723+1!, 724+1!, 725+1!, 726+1!, 752+1!, 757+1!
    , 758+1!, 763+1!, 766+1!, 786+1!, 787+1!, 822+1!, 850+1!, 850OT+1*, 852+1!, 853+1!
    , 854+1!, 855+1!, 862+1!, 865OT+1*, 866+1!, 930+1!, 942+1!, 954+1!, 999.1+1!, 999.11+1!
    , 999.12+1!, 999.13+1!, 999.14+1!, 999.15+1!, 999.16+1!, 999.17+1!, 999.18+1!, 999.19+1!, 999.2+1!, 999.21+1!
    , 999.22+1!, 999.23+1!, 999.24+1!, 999.25+1!, 999.26+1!, 999.27+1!, 999.28+1!, 999.289+1!, 999.29+1!, 999.3+1!
    , 999.4+1!, 999.5+1!, 999.6+1!, 999.7+1!, 999.8+1!, 999.9+1!, 1012+1!*, 1013+1!, 1014+1!, 1015+1!
    , 1016+1!, 1017+1!, 1018+1!, 1019+1!, 1025+1!*, 1026+1!*, 1032+1!*, 1033+1!*, 1039+1!*, 1040+1!*
    , 1046+1!*, 1047+1!*, 1053+1!*, 1054+1!*, 1112+1!, 1114+1!, 1120+1!, 1306+1*!, 1307+1*!, 1311+1*!
    , 1367+1*!, 1368+1*!, 1400+1*!, 1400.1+1*!, 1400.2+1*!, 1400.3+1*!, 1400.4+1*!, 1400.5+1*!, 1401+1!, 1402+1*!
    , 1407+1!, 1407.1+1!, 1409.4+1!, 1409.5+1!, 1410.4+1!, 1410.5+1!, 1411.4+1!, 1411.5+1!, 1412.4+1!, 1412.5+1!
    , 1413.4+1!, 1413.5+1!, 1414.4+1!, 1414.5+1!, 1415.4+1!, 1415.5+1!, 1420+1!, 1422+1!, 1426+1*!, 1426.1+1*!
    , 1426.2+1*!, 1426.3+1*!, 1426.4+1*!, 1427+1!, 1428+1*!, 1429+1!, 1429.1+1!, 1430+1!, 1501+1!, 1520+1!
    , 1540+1!, 1541+1!, 1542+1!, 1543+1!, 1544+1!, 1548+1*!, 1558+1!, 1558.1+1!, 1562+1!, 1563+1!*
    , 1566+1*!, 1567+1!, 1571+1*!, 1571.1+1*!, 1571.2+1*!, 1571.3+1*!, 1571.4+1*!, 1571.5+1*!, 1572+1!, 1575+1!
    , 1579+1*!, 1579.1+1*!, 1579.2+1*!, 1579.3+1*!, 1579.4+1*!, 1764(XREF 1S), 1764(XREF 1n1.4), 1764(XREF 1K), 1772+1!, 1774+1!
    , 1776+1!, 3800+1!, 3800.1+1!, 3803+1!, 3805+1!, 3807+1!, 3810+1!, 3813+1!, 3817+1!, 3820+1!
    , 3823+1!, 3824+1!, 3826+1!, 3828+1!, 3832+1!, 3836+1!, 3837+1!, 3838+1*!, 3839+1*!, 3846+1!
    , 3848+1!, 3851+1!, 3852+1!, 3853+1!, 3860+1!, 3863+1!, 3870+1!, 3882+1!, 3883+1!, 3887+1!
    , 3888+1!, 3891+1!, 3892+1!, 3893+1!, 3895+1!, 3896+1!, 3897+1!, 3898+1!, 3899+1!, 3900+1!
    , 3901+1!, 3902+1!, 3903+1!, 3904+1!, 3908+1!, 3914+1!, 3916+1!, 3919+1!, 3920+1!, 3925+1!
    , 3926+1!, 3927+1!, 3928+1!, 3932+1!, 3934+1!, 3942+1!, 3945+1*!, 3945OT+1*, 3961+1!, 5000+1!
    , 5001+1!, 5002+1!, 5003+1!, 5004+1!, 5011+1!, 5012+1!, 5013+1!, 5014+1!, 5021+1!, 5022+1!
    , 5023+1!, 5024+1!, 5025+1!, 5026+1!, 5027+1!, 5028+1!, 5031+1!, 5032+1!, 5033+1!, 5033.5+1!
    , 5034+1!, 5035+1!, 5036+1!, 5036.5+1!, 5501+1!, 5503+1!, 5507+1!, 5511+1!, 5513+1!, 5517+1!
    , 5521+1!, 5523+1!, 5527+1!, 7002+1!, 7003+1!, 7008+1!, 7009+1!, 7010+1!, 7011+1!, 7013OT+1*
    , 7015+1!, 7016+1!, 7017OT+1*, 7019+1!, 7020+1!, 7021+1!, 7022+1!, 7026+1!, 7031+1!, 7037+1!
    , 7040+1!, 10104+1!, 10105+1!, 10106+1!, 10107+1!, 10108+1!, 10109+1!, 11132+1!, 11172+1!, 11174+1!
    >> X1 202OF9.2+1*, 203OF9.2+1*
    >> X2 202OF9.2+1*, 203OF9.2+1*
    XIPC 10+1!, 10OT+1!
    XIPC("COUNTY" 10+1, 10OT+1
    XX .04(XREF 3S), .04(XREF 3K), .05(XREF 1S), .05(XREF 1K), .06(XREF 1S), .06(XREF 1K), .07(XREF 2S), .07(XREF 2K)
    Y ID20+1*, IDWRITE+1*, .03OT+1*, .04OT+1*, .04(XREF 1S), .04(XREF 1K), .061+1*, 1OT+1, 1.1OT+1, 1.2OT+1*
    , 2+1, 2.1+1, 2.2+1, 2.3+1, 2.4+1, 3+1, 3OT+1, 5OT+1*, 6OT+1*, 7OT+1*
    , 9OT+1*, 9(XREF 1S), 9(XREF 1K), 9(XREF 2S), 9(XREF 2K), 9(XREF 3S), 9(XREF 3K), 10OT+1*, 17OT+1, 18OT+1*
    , 19OT+1*, 21+1, 21OT+1*, 22+1, 23OT+1, 24OT+1*, 24.3OT+1, 24.4OT+1, 24.5OT+1, 24.6OT+1
    , 25+1, 25OT+1, 25.1+1, 25.1OT+1*, 25.2+1, 25.2OT+1*, 25.3+1, 25.3OT+1*, 29OT+1, 29.3OT+1
    , 29.4OT+1, 29.5OT+1, 30OT+1, 30.1OT+1, 31OT+1, 32OT+1, 33OT+1, 33.1+1*, 37OF9.2+1*, 37OF9.3+1*
    , 37OF9.4+1*, 37.1OT+1*, 37.2OT+1*, 37.3OT+1*, 38OT+1, 39+1, 44+1, 44OT+1, 44.1OT+1, 44.2OT+1
    , 44.3OT+1, 44.4OT+1, 44.5OT+1, 44.6OT+1, 50OT+1, 50.1OT+1*, 50.2OT+1, 50.3OT+1, 51OT+1, 51.1OT+1*
    , 51.5OT+1, 52OT+1, 52.1OT+1*, 53OT+1, 53.1OT+1*, 53.4OT+1, 54OT+1, 54.1OT+1*, 54.4OT+1, 55OT+1
    , 55.1OT+1*, 55.2OT+1*, 55.4OT+1, 56OT+1*, 57OT+1, 57.1OT+1*, 57.4OT+1, 58.1OT+1, 58.2OT+1, 58.3OT+1
    , 58.4OT+1, 58.5OT+1, 58.6OT+1, 58.7OT+1, 64+1, 64OT+1, 66+1, 70OT+1, 70(XREF 1S), 71+1
    , 71OT+1*, 71.4OT+1*, 74OT+1, 75OT+1*, 76OT+1*, 77OT+1*, 79+1, 79OT+1, 85OT+1*, 86OT+1*
    , 87OT+1*, 88OT+1, 89OT+1*, 90OT+1, 93OT+1, 94OT+1, 96+1, 96OT+1, 98OT+1, 99OT+1
    , 117OT+1, 121+1, 121OT+1, 124OT+1, 125OT+1*, 127(XREF 1S), 127(XREF 2S), 128OT+1*, 129OT+1*, 130OT+1
    , 136OT+1, 137OT+1, 138OT+1, 138.1OT+1, 138.2OT+1, 138.3OT+1, 139OT+1, 139.1OT+1, 139.2OT+1, 139.3OT+1
    , 139.7+1, 139.7OT+1, 140OT+1, 140.1OT+1, 141OT+1, 142OT+1, 153OT+1*, 153.1OT+1, 153.2OT+1*, 153.3OT+1
    , 155OT+1, 156+1, 156OT+1, 160OT+1, 160.7OT+1, 162OT+1, 162.7OT+1, 164OT+1, 164.7OT+1, 166OT+1
    , 166.7OT+1, 170OT+1, 171+1, 171OT+1, 172+1, 172OT+1, 173+1, 173OT+1, 174.1+1, 174.1OT+1
    , 175.1+1, 175.1OT+1, 176.1+1, 176.1OT+1, 177.1+1, 177.1OT+1, 178.1+1, 178.1OT+1, 179.1+1, 179.1OT+1
    , 180.1+1, 180.1OT+1, 181.1+1, 181.1OT+1, 182.1+1, 182.1OT+1, 183.1+1, 183.1OT+1, 184.1+1, 184.1OT+1
    , 185.1+1, 185.1OT+1, 186.1+1, 186.1OT+1, 187.1+1, 187.1OT+1, 188.1+1, 188.1OT+1, 189.1+1, 189.1OT+1
    , 193+1, 193OT+1, 194OT+1*, 195+1, 195OT+1, 198+1, 198OT+1, 198(XREF 2S), 198(XREF 2K), 232+1
    , 232OT+1, 236+1, 236OT+1, 240(XREF 1S), 240(XREF 1K), 249+1, 249OT+1, 250OT+1*, 251(XREF 1S), 251(XREF 2S)
    , 251(XREF 3S), 251(XREF 4S), 251(XREF 5S), 251(XREF 6S), 251(XREF 7S), 253OT+1, 253(XREF 1S), 255OT+1, 255(XREF 1S), 256OT+1
    , 257(XREF 1S), 257(XREF 2S), 257(XREF 3S), 257(XREF 4S), 258(XREF 1S), 258(XREF 2S), 258(XREF 3S), 264OT+1, 264(XREF 1S), 264(XREF 2S)
    , 265OT+1, 266OT+1, 267(XREF 1S), 267(XREF 2S), 272OT+1, 277OT+1, 280.2+1, 301OT+1*, 314OT+1*, 315OT+1*
    , 316OT+1*, 323+1, 323OT+1, 324OT+1*, 325OT+1*, 347OT+1*, 348OT+1*, 361OT+1, 362OT+1*, 363+1
    , 363OT+1*, 363.1+1, 363.1OT+1*, 367OT+1, 435OT+1, 442OT+1*, 443OT+1*, 444OT+1*, 445OT+1*, 522OT+1*
    , 528OT+1*, 529OT+1*, 530OT+1*, 531OT+1*, 533OT+1*, 534OT+1*, 536OT+1*, 537OT+1*, 539OT+1*, 540OT+1*
    , 541OT+1, 542OT+1, 565OT+1*, 566OT+1*, 567OT+1, 623OT+1*, 623.3OT+1*, 684OT+1, 686OT+1*, 699.1OT+1
    , 715OT+1*, 716OT+1*, 717OT+1*, 718OT+1*, 719OT+1*, 720OT+1*, 721OT+1*, 722OT+1*, 723OT+1*, 724OT+1*
    , 725OT+1*, 726OT+1*, 752OT+1, 757OT+1*, 758OT+1*, 763OT+1, 786OT+1, 787OT+1*, 803OT+1*, 804OT+1*
    , 805OT+1*, 806OT+1*, 822+1*!, 822OT+1, 849OT+1*, 850OT+1, 852OT+1, 853OT+1, 854OT+1, 855OT+1
    , 856OT+1, 862OT+1, 865OT+1, 866OT+1*, 919OT+1, 921OT+1, 923OT+1, 925OT+1, 929OT+1, 930OT+1
    , 942OT+1, 954OT+1, 1012OT+1*, 1013OT+1*, 1014OT+1*, 1015OT+1*, 1016OT+1*, 1017OT+1*, 1018OT+1*, 1019OT+1*
    , 1025OT+1*, 1026OT+1*, 1032OT+1*, 1033OT+1*, 1039OT+1*, 1040OT+1*, 1046OT+1*, 1047OT+1*, 1053OT+1*, 1054OT+1*
    , 1102OT+1*, 1103OT+1, 1104OT+1*, 1105OT+1, 1112OT+1, 1114OT+1, 1120OT+1, 1132OT+1*, 1306+1, 1306OT+1
    , 1307+1, 1307OT+1, 1311+1, 1328OT+1*, 1367+1, 1368+1, 1368OT+1, 1394OT+1*, 1400+1, 1400OT+1*
    , 1400.1+1, 1400.1OT+1*, 1400.2+1, 1400.2OT+1*, 1400.3+1, 1400.3OT+1*, 1400.4+1, 1400.4OT+1*, 1400.5+1, 1400.5OT+1*
    , 1401OT+1*, 1402+1, 1402OT+1, 1403OT+1*, 1407OT+1*, 1407.1OT+1*, 1409.4OT+1, 1409.5OT+1, 1410.4OT+1, 1410.5OT+1
    , 1411.4OT+1, 1411.5OT+1, 1412.4OT+1, 1412.5OT+1, 1413.4OT+1, 1413.5OT+1, 1414.4OT+1, 1414.5OT+1, 1415.4OT+1, 1415.5OT+1
    , 1420OT+1*, 1422OT+1*, 1426+1, 1426OT+1*, 1426.1+1, 1426.1OT+1*, 1426.2+1, 1426.2OT+1*, 1426.3+1, 1426.3OT+1*
    , 1426.4+1, 1426.4OT+1*, 1428+1, 1429OT+1*, 1429.1OT+1*, 1430OT+1*, 1501OT+1*, 1520OT+1*, 1540OT+1*, 1541OT+1*
    , 1542OT+1*, 1543OT+1*, 1544OT+1*, 1548+1, 1548OT+1, 1558OT+1*, 1558.1OT+1*, 1562OT+1*, 1563OT+1*, 1566+1
    , 1567OT+1*, 1571+1, 1571OT+1*, 1571.1+1, 1571.1OT+1*, 1571.2+1, 1571.2OT+1*, 1571.3+1, 1571.3OT+1*, 1571.4+1
    , 1571.4OT+1*, 1571.5+1, 1571.5OT+1*, 1572OT+1*, 1573OT+1*, 1576OT+1*, 1576.1OT+1*, 1576.2OT+1*, 1579+1, 1579OT+1*
    , 1579.1+1, 1579.1OT+1*, 1579.2+1, 1579.2OT+1*, 1579.3+1, 1579.3OT+1*, 1579.4+1, 1579.4OT+1*, 1764(XREF 1S), 1764(XREF 1K)
    , 3836OT+1, 3838+1, 3838OT+1*, 3839+1, 3839OT+1*, 3884OT+1*, 3945+1, 3945OT+1, 5502OT+1*, 5504OT+1*
    , 5505OT+1*, 5506OT+1*, 5512OT+1*, 5514OT+1*, 5515OT+1*, 5516OT+1*, 5522OT+1*, 5524OT+1*, 5525OT+1*, 5526OT+1*
    , 7013OT+1, 7017OT+1
    Y( .061+1, .061OF9.2+1*, .061OF9.3+1*, .08+1*, .08OF9.2+1*, .09+1*, .09OF9.2+1*, .091+1, .091OF9.2+1*, .091OF9.3+1*
    , .093+1*, .093OF9.2+1*, .1+1, .1OF9.2+1*, .1OF9.3+1*, .115+1*, .115OF9.2+1*, .117+1*, .117OF9.2+1*, .12+1*
    , .12OF9.2+1*, .12OF9.3+1*, 3.5+1*, 22.4+1*, 37OF9.2+1*, 37OF9.3+1*, 37OF9.4+1*, 97+1*, 97OF9.2+1*, 202OF9.2+1*
    , 203OF9.2+1*, 204OF9.2+1*
    Y(0 .03OT+1*, .04OT+1*, 1OT+1*, 1.1OT+1*, 1.2OT+1*, 3OT+1*, 5OT+1*, 6OT+1*, 7OT+1*, 9OT+1*
    , 9(XREF 1S), 9(XREF 1K), 9(XREF 2S), 9(XREF 2K), 9(XREF 3S), 9(XREF 3K), 10OT+1*, 17OT+1*, 18OT+1*, 19OT+1*
    , 21OT+1*, 23OT+1*, 24OT+1*, 24.3OT+1*, 24.4OT+1*, 24.5OT+1*, 24.6OT+1*, 25OT+1*, 25.1OT+1*, 25.2OT+1*
    , 25.3OT+1*, 29OT+1*, 29.3OT+1*, 29.4OT+1*, 29.5OT+1*, 30OT+1*, 30.1OT+1*, 31OT+1*, 32OT+1*, 33OT+1*
    , 37.1OT+1*, 37.2OT+1*, 37.3OT+1*, 38OT+1*, 44OT+1*, 44.1OT+1*, 44.2OT+1*, 44.3OT+1*, 44.4OT+1*, 44.5OT+1*
    , 44.6OT+1*, 50OT+1*, 50.1OT+1*, 50.2OT+1*, 50.3OT+1*, 51OT+1*, 51.1OT+1*, 51.5OT+1*, 52OT+1*, 52.1OT+1*
    , 53OT+1*, 53.1OT+1*, 53.4OT+1*, 54OT+1*, 54.1OT+1*, 54.4OT+1*, 55OT+1*, 55.1OT+1*, 55.2OT+1*, 55.4OT+1*
    , 56OT+1*, 57OT+1*, 57.1OT+1*, 57.4OT+1*, 58.1OT+1*, 58.2OT+1*, 58.3OT+1*, 58.4OT+1*, 58.5OT+1*, 58.6OT+1*
    , 58.7OT+1*, 64OT+1*, 70OT+1*, 71OT+1*, 71.4OT+1*, 74OT+1*, 75OT+1*, 76OT+1*, 77OT+1*, 79OT+1*
    , 85OT+1*, 86OT+1*, 87OT+1*, 88OT+1*, 89OT+1*, 90OT+1*, 93OT+1*, 94OT+1*, 96OT+1*, 98OT+1*
    , 99OT+1*, 117OT+1*, 121OT+1*, 124OT+1*, 125OT+1*, 128OT+1*, 129OT+1*, 130OT+1*, 136OT+1*, 137OT+1*
    , 138OT+1*, 138.1OT+1*, 138.2OT+1*, 138.3OT+1*, 139OT+1*, 139.1OT+1*, 139.2OT+1*, 139.3OT+1*, 139.7OT+1*, 140OT+1*
    , 140.1OT+1*, 141OT+1*, 142OT+1*, 153OT+1*, 153.1OT+1*, 153.2OT+1*, 153.3OT+1*, 155OT+1*, 156OT+1*, 160OT+1*
    , 160.7OT+1*, 162OT+1*, 162.7OT+1*, 164OT+1*, 164.7OT+1*, 166OT+1*, 166.7OT+1*, 170OT+1*, 171OT+1*, 172OT+1*
    , 173OT+1*, 174.1OT+1*, 175.1OT+1*, 176.1OT+1*, 177.1OT+1*, 178.1OT+1*, 179.1OT+1*, 180.1OT+1*, 181.1OT+1*, 182.1OT+1*
    , 183.1OT+1*, 184.1OT+1*, 185.1OT+1*, 186.1OT+1*, 187.1OT+1*, 188.1OT+1*, 189.1OT+1*, 193OT+1*, 194OT+1*, 195OT+1*
    , 198OT+1*, 232OT+1*, 236OT+1*, 249OT+1*, 250OT+1*, 253OT+1*, 255OT+1*, 256OT+1*, 258(XREF 1S), 258(XREF 2S)
    , 258(XREF 3S), 264OT+1*, 265OT+1*, 266OT+1*, 267(XREF 1S), 267(XREF 2S), 272OT+1*, 277OT+1*, 301OT+1*, 314OT+1*
    , 315OT+1*, 316OT+1*, 323OT+1*, 324OT+1*, 325OT+1*, 347OT+1*, 348OT+1*, 361OT+1*, 362OT+1*, 363OT+1*
    , 363.1OT+1*, 367OT+1*, 435OT+1*, 442OT+1*, 443OT+1*, 444OT+1*, 445OT+1*, 522OT+1*, 528OT+1*, 529OT+1*
    , 530OT+1*, 531OT+1*, 533OT+1*, 534OT+1*, 536OT+1*, 537OT+1*, 539OT+1*, 540OT+1*, 541OT+1*, 542OT+1*
    , 565OT+1*, 566OT+1*, 567OT+1*, 623OT+1*, 623.3OT+1*, 684OT+1*, 686OT+1*, 699.1OT+1*, 715OT+1*, 716OT+1*
    , 717OT+1*, 718OT+1*, 719OT+1*, 720OT+1*, 721OT+1*, 722OT+1*, 723OT+1*, 724OT+1*, 725OT+1*, 726OT+1*
    , 752OT+1*, 757OT+1*, 758OT+1*, 763OT+1*, 786OT+1*, 787OT+1*, 803OT+1*, 804OT+1*, 805OT+1*, 806OT+1*
    , 822OT+1*, 849OT+1*, 850OT+1*, 852OT+1*, 853OT+1*, 854OT+1*, 855OT+1*, 856OT+1*, 862OT+1*, 865OT+1*
    , 866OT+1*, 919OT+1*, 921OT+1*, 923OT+1*, 925OT+1*, 929OT+1*, 930OT+1*, 942OT+1*, 954OT+1*, 1012OT+1*
    , 1013OT+1*, 1014OT+1*, 1015OT+1*, 1016OT+1*, 1017OT+1*, 1018OT+1*, 1019OT+1*, 1025OT+1*, 1026OT+1*, 1032OT+1*
    , 1033OT+1*, 1039OT+1*, 1040OT+1*, 1046OT+1*, 1047OT+1*, 1053OT+1*, 1054OT+1*, 1102OT+1*, 1103OT+1*, 1104OT+1*
    , 1105OT+1*, 1112OT+1*, 1114OT+1*, 1120OT+1*, 1132OT+1*, 1306OT+1*, 1307OT+1*, 1328OT+1*, 1368OT+1*, 1394OT+1*
    , 1400OT+1*, 1400.1OT+1*, 1400.2OT+1*, 1400.3OT+1*, 1400.4OT+1*, 1400.5OT+1*, 1401OT+1*, 1402OT+1*, 1403OT+1*, 1407OT+1*
    , 1407.1OT+1*, 1409.4OT+1*, 1409.5OT+1*, 1410.4OT+1*, 1410.5OT+1*, 1411.4OT+1*, 1411.5OT+1*, 1412.4OT+1*, 1412.5OT+1*, 1413.4OT+1*
    , 1413.5OT+1*, 1414.4OT+1*, 1414.5OT+1*, 1415.4OT+1*, 1415.5OT+1*, 1420OT+1*, 1422OT+1*, 1426OT+1*, 1426.1OT+1*, 1426.2OT+1*
    , 1426.3OT+1*, 1426.4OT+1*, 1429OT+1*, 1429.1OT+1*, 1430OT+1*, 1501OT+1*, 1520OT+1*, 1540OT+1*, 1541OT+1*, 1542OT+1*
    , 1543OT+1*, 1544OT+1*, 1548OT+1*, 1558OT+1*, 1558.1OT+1*, 1562OT+1*, 1563OT+1*, 1567OT+1*, 1571OT+1*, 1571.1OT+1*
    , 1571.2OT+1*, 1571.3OT+1*, 1571.4OT+1*, 1571.5OT+1*, 1572OT+1*, 1573OT+1*, 1576OT+1*, 1576.1OT+1*, 1576.2OT+1*, 1579OT+1*
    , 1579.1OT+1*, 1579.2OT+1*, 1579.3OT+1*, 1579.4OT+1*, 3836OT+1*, 3838OT+1*, 3839OT+1*, 3884OT+1*, 3945OT+1*, 5502OT+1*
    , 5504OT+1*, 5505OT+1*, 5506OT+1*, 5512OT+1*, 5514OT+1*, 5515OT+1*, 5516OT+1*, 5522OT+1*, 5524OT+1*, 5525OT+1*
    , 5526OT+1*, 7013OT+1*, 7017OT+1*
    Y(1 .04(XREF 1S), .04(XREF 1K), 9(XREF 1S), 9(XREF 1K), 9(XREF 2S), 9(XREF 2K), 9(XREF 3S), 9(XREF 3K), 70(XREF 1S), 127(XREF 1S)
    , 127(XREF 2S), 198(XREF 2S), 198(XREF 2K), 240(XREF 1S), 240(XREF 1K), 251(XREF 1S), 251(XREF 2S), 251(XREF 3S), 251(XREF 4S), 251(XREF 5S)
    , 251(XREF 6S), 251(XREF 7S), 253(XREF 1S), 255(XREF 1S), 257(XREF 1S), 257(XREF 2S), 257(XREF 3S), 257(XREF 4S), 258(XREF 1S), 258(XREF 2S)
    , 258(XREF 3S), 264(XREF 1S), 264(XREF 2S), 267(XREF 1S), 267(XREF 2S), 1764(XREF 1S), 1764(XREF 1K)
    >> ZS9S 3+1, 25+1, 44+1, 96+1, 156+1, 171+1, 172+1, 173+1, 174.1+1, 175.1+1
    , 176.1+1, 177.1+1, 178.1+1, 179.1+1, 180.1+1, 181.1+1, 182.1+1, 183.1+1, 184.1+1, 185.1+1
    , 186.1+1, 187.1+1, 188.1+1, 189.1+1, 193+1, 195+1
    Info |  Desc |  Directly Accessed By Routines |  Accessed By FileMan Db Calls |  Pointed To By FileMan Files |  Pointer To FileMan Files |  Fields |  ICR |  External References |  Global Variables Directly Accessed |  Naked Globals |  Local Variables  | All